Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" A2ML1 "CPAMD9, FLJ25179, p170" ENSG00000166535 "Alpha-2-macroglobulin like 1" A8K2U0 12 8822621-8887001 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 556.3;vagina: 204.8" "Cell type enriched" "Detected in some" 6 "Squamous epithelial cells: 127.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 39.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 10.9;hTCEpi: 5.5;SK-BR-3: 13.9" "Low region specificity" "Detected in many" "HPA038847, HPA038848" Enhanced "Secreted in other tissues" NA NA 10000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA038847: AB_2676236, HPA038848: AB_10672654" "unprognostic (1.13e-2)" "unprognostic (7.64e-2)" "unprognostic (1.04e-2)" "unprognostic (9.46e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (4.59e-2)" "unprognostic (7.58e-3)" "unprognostic (2.63e-1)" "unprognostic (1.57e-1)" "unprognostic (1.15e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-9)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (5.88e-2)" "unprognostic (2.42e-2)" 0.2 0.1 2.1 0.0 2.1 0.2 4.1 0.8 2.4 116.5 0.6 0.1 0.0 0.5 0.4 556.3 0.7 0.2 0.4 2.0 2.2 0.1 0.3 0.1 0.2 1.8 3.1 0.4 0.2 0.8 1.4 0.7 1.3 0.6 0.0 0.7 99.0 0.0 0.3 72.0 0.1 0.1 1.7 0.1 0.7 5.0 4.3 3.0 0.1 0.0 51.5 1.1 204.8 1.5 0.1 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.0 2.5 10.9 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 13.9 0.0 1.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 2.1 2.1 0.8 2.4 2.0 2.2 1.8 3.1 1.3 1.7 4.3 1.5 0.0 0.0 0.0 20.2 0.0 0.4 0.5 1.0 1.8 0.7 0.3 0.1 0.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.4 4.4 0.9 0.3 0.0 0.0 4.9 0.0 0.5 0.4 0.0 11.9 0.0 0.8 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 0.3 0.0 0.4 0.3 1.0 0.4 127.6 12.6 0.1 0.1 1.9 0.0 8.2 AAR2 "bA234K24.2, C20orf4" ENSG00000131043 "AAR2 splicing factor" Q9Y312 20 36236131-36270918 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034220, HPA048645" Uncertain Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB034220: AB_1564205, HPA048645: AB_2680475" "unprognostic (1.73e-1)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.54e-3)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.09e-2)" "unprognostic (6.84e-2)" "unprognostic (6.38e-2)" "unprognostic (3.79e-1)" "unprognostic (3.31e-1)" "unprognostic (4.61e-3)" "unprognostic (4.58e-2)" "unprognostic (5.85e-2)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" 22.3 26.8 14.5 14.3 15.8 22.3 21.6 15.8 15.5 19.8 19.1 27.5 15.1 25.6 25.0 17.8 23.2 16.5 18.8 14.3 14.7 20.9 23.5 19.2 17.5 15.9 15.2 22.6 18.6 25.5 10.0 17.5 15.9 19.9 17.3 7.5 18.1 21.1 23.4 25.9 18.9 27.9 15.5 18.1 23.0 16.4 15.4 26.2 17.9 20.7 19.9 25.8 16.2 17.2 26.9 30.7 28.8 33.2 48.9 32.4 22.9 25.4 33.7 58.1 45.7 69.2 35.0 18.2 35.6 36.9 44.8 36.6 46.6 48.2 35.8 17.0 28.2 57.9 19.3 43.3 36.9 39.5 27.9 39.6 68.7 41.5 31.5 29.4 36.3 36.0 36.8 34.3 32.4 32.0 56.0 48.9 25.1 39.1 49.5 30.7 48.3 42.4 33.0 19.6 33.2 36.1 37.8 100.7 32.8 26.2 57.1 42.8 26.6 54.9 34.3 33.0 32.2 31.1 42.3 34.6 39.9 26.3 29.7 60.6 46.2 41.6 43.0 49.4 43.2 32.5 40.0 41.4 49.1 35.5 50.0 43.0 8.9 58.4 58.1 39.8 50.2 57.4 14.5 15.8 15.8 15.5 14.3 14.7 15.9 15.2 15.9 15.5 15.4 17.2 11.7 6.4 12.5 4.6 10.8 5.7 10.6 11.8 6.8 4.4 10.3 9.5 6.8 11.5 8.4 9.2 8.4 21.3 10.9 7.1 11.7 19.7 2.8 6.9 8.9 11.9 11.4 14.7 6.3 21.0 14.3 12.7 6.6 6.6 15.9 10.8 11.4 11.8 15.0 15.2 7.1 10.5 12.2 15.0 2.5 3.1 11.1 8.5 10.6 3.7 12.3 6.1 14.4 5.0 9.9 17.3 7.6 15.1 7.5 11.3 8.4 8.0 11.1 3.5 6.6 9.8 13.9 17.0 14.5 9.0 7.5 18.6 7.9 15.3 8.7 8.9 ABHD11 "PP1226, WBSCR21" ENSG00000106077 "Abhydrolase domain containing 11" Q8NFV4 7 73736094-73738867 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hydrolase "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 156.9;Urothelial cells: 241.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 92.6;SK-BR-3: 113.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024042, HPA049641" Approved Supported Mitochondria NA NA 31000 "Cluster 7: Monocytes - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA024042: AB_1844445, HPA049641: AB_2680838" "unprognostic (4.74e-2)" "unprognostic (8.62e-3)" "unprognostic (1.42e-1)" "unprognostic (2.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.73e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-3)" "unprognostic (1.91e-2)" "unprognostic (9.32e-2)" "unprognostic (7.79e-2)" "unprognostic (1.74e-1)" "prognostic favorable (3.66e-7)" "unprognostic (3.61e-3)" "unprognostic (4.44e-2)" "unprognostic (1.02e-1)" "unprognostic (7.29e-2)" 7.5 13.5 9.3 5.6 9.8 4.5 12.2 10.6 11.3 9.3 16.4 31.3 15.9 7.2 5.8 13.6 13.8 8.6 21.6 9.1 9.9 29.4 9.5 9.5 4.0 11.4 11.1 3.9 25.7 12.9 16.4 7.6 11.0 23.2 17.4 3.0 21.3 8.2 11.3 13.3 19.8 3.5 10.4 8.1 9.0 7.2 12.3 3.3 28.1 10.3 5.4 8.5 6.9 10.4 46.9 10.7 7.1 16.4 3.7 5.0 39.7 21.1 8.9 12.7 14.9 13.1 51.4 22.2 6.2 9.0 17.3 20.2 3.2 12.1 8.8 8.2 15.4 10.8 6.7 8.3 6.5 11.8 11.4 4.6 5.0 16.4 7.6 4.6 9.2 7.4 15.1 11.8 12.0 92.6 9.2 14.9 8.3 29.5 39.1 5.0 11.4 41.0 29.7 21.8 18.3 7.6 17.1 113.0 7.1 5.1 36.8 7.8 9.1 10.8 10.2 46.5 22.2 7.3 4.2 14.8 17.3 11.2 20.3 10.2 19.1 19.3 8.2 32.7 6.8 10.1 9.1 8.7 19.4 12.7 8.4 5.9 15.2 14.9 33.5 9.2 6.3 11.9 9.3 9.8 10.6 11.3 9.1 9.9 11.4 11.1 11.0 10.4 12.3 10.4 7.9 44.8 15.7 3.3 10.6 5.5 60.3 39.8 10.2 16.6 43.1 21.7 16.9 54.3 60.7 57.0 4.2 86.3 8.7 156.9 72.4 52.1 1.2 98.9 17.3 9.7 62.6 9.4 5.8 40.8 120.1 9.9 35.7 98.1 15.2 6.3 4.6 8.7 28.0 5.0 4.0 106.8 95.6 11.3 10.5 2.3 9.0 13.7 14.2 4.7 10.4 26.6 14.4 3.0 3.7 38.2 151.7 3.4 10.5 53.1 128.2 55.3 127.6 15.2 0.0 10.3 14.4 6.8 7.1 23.3 6.3 127.7 9.6 22.1 128.9 241.3 AC011479.1 ENSG00000267748 "Novel protein" 19 38289151-38304910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "salivary gland: 11.6" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 28.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 2.1;CAPAN-2: 1.6;REH: 1.7;SK-BR-3: 3.5;U-266/84: 2.7" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (1.48e-2)" "unprognostic (7.63e-2)" "unprognostic (8.91e-3)" "unprognostic (1.31e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-1)" "unprognostic (4.78e-2)" "unprognostic (1.12e-1)" "unprognostic (7.66e-2)" "unprognostic (2.00e-1)" "unprognostic (3.94e-2)" "unprognostic (4.41e-2)" "unprognostic (2.40e-1)" "unprognostic (3.56e-1)" 0.1 0.5 0.4 0.0 0.4 0.3 1.0 0.4 0.7 1.0 0.5 1.2 1.7 0.4 1.2 1.7 0.3 0.2 0.1 0.4 0.4 2.1 0.2 1.1 0.4 0.5 0.4 2.2 5.1 0.2 1.8 1.1 0.5 1.9 0.6 0.0 11.6 0.8 0.2 2.2 1.1 0.0 0.4 0.5 2.0 0.8 0.4 0.3 2.3 0.0 0.1 0.5 1.2 0.5 2.1 1.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.6 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.5 0.0 0.3 0.3 0.9 0.3 1.7 0.0 0.0 0.4 0.8 0.0 0.0 0.3 3.5 0.0 0.2 0.5 1.4 0.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 0.3 19.8 4.5 22.8 0.2 2.6 0.3 4.9 2.0 0.7 17.9 7.1 4.0 3.6 2.4 0.5 2.6 22.5 0.6 8.8 0.4 0.4 0.4 0.7 0.4 0.4 0.5 0.4 0.5 0.4 0.4 0.5 0.0 28.9 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 0.0 4.3 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.5 2.5 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 AC068533.4 ENSG00000249319 "Novel protein" 7 66087761-66152277 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 10.6" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.24e-2)" "unprognostic (6.28e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" "unprognostic (2.79e-2)" "unprognostic (8.72e-2)" "unprognostic (1.74e-1)" "unprognostic (2.32e-1)" "unprognostic (2.50e-3)" "unprognostic (9.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.44e-1)" "unprognostic (3.13e-1)" "unprognostic (1.19e-1)" "unprognostic (1.34e-1)" 0.5 0.4 1.0 0.9 1.2 1.8 1.7 1.1 3.4 2.0 0.8 2.8 2.0 1.0 0.9 0.9 1.1 0.8 0.4 1.1 1.5 1.6 4.7 1.2 0.5 1.3 1.3 0.9 0.5 1.8 0.5 0.5 1.3 1.4 1.8 2.7 0.6 1.4 0.4 0.5 1.0 1.2 1.0 0.7 1.6 0.4 1.2 0.9 1.1 1.3 1.0 0.6 0.4 1.1 1.6 0.0 1.6 1.2 3.9 6.0 0.5 2.1 2.7 0.6 1.0 1.0 2.4 2.1 2.4 6.7 4.1 2.2 0.3 1.4 3.0 0.4 1.8 0.7 0.9 0.0 2.2 1.0 2.3 3.4 3.1 3.7 6.0 5.6 1.1 0.5 1.7 0.9 0.3 0.9 1.5 1.2 0.0 7.9 1.9 0.8 1.1 2.2 2.7 1.1 2.2 2.9 1.6 10.6 0.5 4.0 3.4 0.6 3.8 0.8 0.6 1.9 1.7 1.4 2.0 0.6 7.4 3.0 0.3 2.0 0.8 0.4 1.0 0.5 1.2 1.9 0.4 1.0 0.3 1.0 1.1 1.4 1.6 1.7 1.3 0.4 0.9 0.3 1.0 1.2 1.1 3.4 1.1 1.5 1.3 1.3 1.3 1.0 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 212.6;liver: 659.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 224.0;SK-BR-3: 342.9" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 42.8 54.1 47.5 24.0 54.4 44.7 41.2 54.3 49.5 28.3 42.3 56.9 101.0 20.8 44.6 56.7 19.4 29.8 84.8 44.6 48.7 212.6 659.3 34.9 26.1 54.2 50.4 20.9 59.3 47.9 24.8 17.2 53.0 55.1 51.2 4.9 38.9 25.3 48.2 30.7 89.5 18.7 50.9 41.3 42.1 15.5 53.6 28.0 32.1 53.8 30.0 43.7 33.5 54.9 35.5 39.8 13.0 40.7 55.6 32.2 44.6 32.2 47.0 36.3 34.5 52.8 38.8 21.1 22.6 52.0 17.4 24.5 34.9 54.0 20.0 31.0 37.2 27.0 35.4 155.5 35.3 63.3 59.8 59.0 39.3 31.2 22.5 23.9 49.9 49.7 26.2 24.2 41.3 49.2 60.3 45.3 13.3 224.0 47.0 13.9 25.0 34.3 103.4 110.4 10.9 16.5 31.7 342.9 23.7 18.0 35.1 48.9 36.8 21.9 21.1 43.2 44.2 31.9 21.7 16.1 34.8 54.4 34.7 79.9 114.4 130.4 48.8 159.1 41.2 33.9 45.7 47.4 178.1 36.0 45.2 42.5 76.3 71.9 187.7 104.5 77.2 82.1 47.5 54.4 54.3 49.5 44.6 48.7 54.2 50.4 53.0 50.9 53.6 54.9 30.7 41.7 38.7 50.6 45.6 33.3 56.5 57.6 40.9 36.9 48.7 37.1 3.2 98.7 44.3 66.2 14.6 91.6 61.7 356.8 166.3 98.0 4.5 40.7 38.6 25.4 55.1 40.4 25.6 78.4 64.5 34.4 76.5 39.1 19.0 32.5 37.1 686.0 81.7 8.4 24.7 73.1 48.8 93.5 86.8 9.6 35.8 83.2 58.7 14.0 89.5 43.1 53.5 12.5 30.9 100.9 270.6 33.1 44.5 60.6 441.1 721.8 26.3 16.7 32.9 28.5 27.4 19.8 11.7 48.1 35.5 99.3 44.4 186.7 84.3 87.0 ACLY "ACL, ATPCL, CLATP" ENSG00000131473 "ATP citrate lyase" P53396 17 41866917-41930542 "Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007783, HPA022434, HPA022953, HPA022959, HPA028758" Enhanced Supported Nucleoplasm,Cytosol No No 3100000 "Cluster 44: Non-specific - Transcription" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol Nucleoplasm "CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575" "unprognostic (2.21e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.41e-1)" "unprognostic (1.21e-2)" "unprognostic (2.83e-1)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.66e-4)" "unprognostic (3.38e-3)" "unprognostic (4.11e-2)" "unprognostic (5.94e-3)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.88e-3)" "unprognostic (1.66e-1)" "unprognostic (9.36e-2)" "unprognostic (3.90e-2)" "unprognostic (4.67e-3)" 64.9 30.2 24.0 43.9 27.2 34.7 46.7 33.6 55.5 33.2 22.5 35.4 49.3 34.4 34.7 30.5 36.0 31.1 27.1 24.7 66.5 47.5 27.5 35.3 42.7 80.3 48.6 21.3 46.3 37.4 22.4 42.4 76.5 62.6 35.7 23.2 39.1 28.5 15.3 28.9 43.7 42.5 34.2 39.1 38.9 32.2 43.1 48.4 30.8 14.9 40.3 36.7 29.2 43.7 127.1 423.2 194.8 168.8 296.1 274.4 178.3 174.0 188.0 213.7 266.3 217.9 141.8 204.7 108.8 245.2 200.6 197.2 253.9 298.0 177.8 184.9 243.0 117.3 228.3 227.5 136.9 191.9 147.1 219.8 88.3 376.9 75.6 140.0 228.7 155.0 147.4 158.5 180.4 130.0 317.8 107.6 127.6 84.8 75.7 205.2 236.2 262.2 221.0 222.4 364.7 200.2 124.5 382.8 133.7 167.6 229.4 181.0 248.4 165.7 135.5 169.0 291.0 91.9 127.0 193.0 280.3 145.7 137.5 32.2 29.2 36.5 30.9 30.9 29.1 21.6 24.4 27.7 33.0 18.3 18.1 20.3 14.6 24.0 39.8 19.1 34.3 33.8 24.0 27.2 33.6 55.5 24.7 66.5 80.3 48.6 76.5 34.2 43.1 43.7 28.2 28.9 26.2 12.4 20.5 25.0 10.0 25.4 12.5 12.1 38.6 21.6 12.6 31.5 21.0 23.9 4.2 22.6 25.9 26.7 11.7 33.8 73.3 31.6 35.3 33.4 65.9 34.3 10.9 33.6 46.5 28.9 23.4 29.2 15.2 28.7 41.4 53.0 31.0 18.5 14.7 54.0 20.3 39.0 25.9 17.5 61.8 27.6 32.0 16.9 42.9 7.6 25.7 11.6 13.6 42.9 16.2 51.1 17.4 35.9 40.4 87.0 31.1 9.4 13.1 17.6 25.7 17.9 36.0 21.6 33.0 22.2 25.1 49.0 22.2 15.5 ACOT8 "hACTE-III, hTE, NAP1, PTE-2, PTE1" ENSG00000101473 "Acyl-CoA thioesterase 8" O14734 20 45841721-45857405 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010261 Approved Supported Vesicles,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Mitochondria "CAB010261: AB_2221664" "unprognostic (2.36e-2)" "unprognostic (6.95e-2)" "unprognostic (2.12e-1)" "unprognostic (1.28e-2)" "unprognostic (2.13e-1)" "unprognostic (4.27e-1)" "unprognostic (1.03e-3)" "unprognostic (2.92e-2)" "unprognostic (4.70e-1)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" "unprognostic (2.03e-2)" "prognostic favorable (3.18e-4)" "unprognostic (2.79e-1)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (2.98e-1)" 8.3 31.7 27.8 8.6 29.8 18.1 7.6 28.2 35.2 9.3 24.3 18.5 21.1 8.5 11.0 17.5 10.7 9.2 28.1 29.8 28.6 21.3 26.0 11.0 12.6 27.0 28.5 8.0 15.6 15.1 15.4 7.1 28.7 12.7 12.8 9.2 12.8 5.9 28.7 17.0 20.5 6.4 26.0 12.3 21.3 20.2 28.7 13.1 11.4 17.8 9.7 11.0 10.4 28.1 16.8 20.2 6.8 13.4 18.3 11.0 11.7 11.1 9.5 15.1 13.7 29.2 22.7 20.8 48.2 16.3 35.4 32.3 13.0 27.8 6.6 15.5 22.3 21.2 25.1 28.5 16.9 19.9 19.3 12.9 21.3 15.1 10.9 22.6 9.4 23.6 18.8 24.2 11.0 47.4 28.7 27.0 11.8 32.4 52.2 14.0 12.2 37.6 16.5 19.1 23.1 10.8 24.9 61.7 39.5 10.6 34.4 48.8 11.6 37.9 8.5 19.5 18.9 20.7 33.8 14.0 46.3 21.2 20.8 34.3 34.3 43.6 24.8 34.6 21.8 27.5 23.2 21.9 36.7 27.9 20.0 21.6 25.0 16.3 34.2 23.3 31.9 26.7 27.8 29.8 28.2 35.2 29.8 28.6 27.0 28.5 28.7 26.0 28.7 28.1 8.2 35.3 14.1 5.9 17.9 6.1 12.3 21.9 8.6 19.2 9.8 10.9 9.3 11.5 17.7 12.9 16.7 34.2 11.8 104.2 64.6 21.6 38.5 14.2 10.4 10.9 19.2 17.0 12.3 21.0 20.9 11.4 19.9 14.0 14.0 27.6 11.4 25.5 27.8 8.4 12.0 37.3 10.2 18.6 7.1 90.3 9.9 17.5 10.6 3.7 27.5 17.8 34.0 5.0 9.6 21.6 68.4 8.6 21.3 11.3 105.4 81.5 27.1 22.8 13.1 5.8 12.8 27.0 10.2 16.1 8.0 19.4 13.9 37.6 30.3 16.0 ACTR6 "ARP6, FLJ13433" ENSG00000075089 "Actin related protein 6" Q9GZN1 12 100199122-100241865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038587, HPA038588" Uncertain Approved "Plasma membrane,Cytosol" No No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane, Cytosol" "HPA038587: AB_10670781, HPA038588: AB_10672719" "unprognostic (1.24e-2)" "unprognostic (8.43e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (7.70e-9)" "unprognostic (4.11e-2)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (6.98e-2)" "unprognostic (3.99e-1)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "unprognostic (3.22e-1)" "unprognostic (6.67e-3)" "unprognostic (3.40e-2)" 15.0 16.7 17.6 12.8 17.7 7.4 28.9 18.2 24.5 13.9 17.9 14.6 15.2 15.2 18.1 13.8 14.2 10.3 17.5 18.2 19.8 22.1 19.6 12.2 20.8 18.0 18.6 17.9 5.0 20.8 4.5 17.0 19.1 16.8 15.3 20.6 15.3 15.9 14.3 13.6 14.4 14.4 18.3 16.1 10.6 21.3 17.7 20.4 16.3 15.8 19.2 17.1 4.5 20.8 60.2 23.5 27.1 35.9 22.4 28.3 63.3 26.0 22.6 25.0 18.2 15.2 17.8 32.9 24.7 19.5 18.8 23.0 36.5 22.5 34.3 48.9 33.8 22.8 22.2 17.7 23.6 33.7 17.7 17.4 27.7 20.2 25.8 38.5 28.9 38.0 36.9 10.5 29.2 15.5 33.7 50.8 31.6 22.5 34.2 27.0 27.3 41.4 27.3 35.8 24.8 47.0 35.3 62.5 36.5 22.4 40.6 39.5 18.8 18.4 12.3 20.5 23.7 23.6 55.6 42.8 12.1 21.2 21.7 5.7 6.4 10.0 15.2 11.5 19.3 12.6 17.9 20.3 8.2 12.1 19.4 19.6 3.0 19.4 13.2 12.0 20.5 12.1 17.6 17.7 18.2 24.5 18.2 19.8 18.0 18.6 19.1 18.3 17.7 20.8 33.5 16.0 17.7 6.5 25.8 22.9 36.2 72.4 29.6 32.7 26.5 23.9 34.8 8.6 38.1 23.9 18.8 55.6 36.9 9.9 46.9 21.4 135.2 56.8 27.7 20.7 12.5 21.7 20.9 12.0 68.4 25.0 12.2 28.9 33.0 19.1 16.1 16.4 23.7 33.7 23.2 11.3 73.2 19.1 13.4 34.3 20.2 17.5 32.0 13.1 19.5 27.0 25.7 17.1 17.4 13.2 10.0 22.6 19.7 24.7 11.7 67.9 67.9 32.8 32.9 27.8 36.8 80.8 19.9 23.8 19.7 96.0 36.6 23.8 13.3 33.8 ADCY6 AC6 ENSG00000174233 "Adenylate cyclase 6" O43306 12 48766194-48789089 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018365 Approved Approved "Golgi apparatus" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB018365: AB_2257941" "unprognostic (1.18e-2)" "unprognostic (2.20e-2)" "unprognostic (6.89e-2)" "unprognostic (1.31e-1)" "unprognostic (3.84e-2)" "unprognostic (3.68e-2)" "prognostic unfavorable (8.23e-4)" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-3)" "unprognostic (5.10e-3)" "unprognostic (1.09e-1)" "unprognostic (3.09e-1)" "unprognostic (2.48e-2)" 43.2 15.0 8.9 6.1 7.9 1.3 23.7 5.0 9.2 19.3 10.3 26.3 18.7 20.7 19.0 10.3 17.1 13.9 57.2 8.0 11.2 21.1 9.6 13.5 3.9 5.5 5.4 22.3 22.3 20.7 14.6 14.5 6.6 16.3 20.3 5.7 33.5 16.5 12.1 15.3 21.4 13.6 1.9 4.8 25.1 4.0 14.4 2.8 17.9 12.7 3.2 12.3 12.8 6.4 14.0 25.9 30.2 18.9 32.0 15.9 32.0 16.7 17.1 19.8 13.8 45.7 45.3 0.0 37.2 15.3 8.2 10.9 9.2 11.6 7.9 0.1 13.4 12.5 37.8 8.4 17.6 0.0 10.1 20.0 13.6 17.1 6.5 37.9 18.7 0.8 1.7 4.5 15.6 23.1 0.0 0.5 10.3 21.6 12.3 4.6 11.4 7.7 23.4 41.5 4.5 18.4 17.2 68.0 15.2 13.3 53.3 3.5 21.1 18.3 13.1 9.7 7.4 7.0 3.7 0.4 16.9 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.9 7.9 5.0 9.2 8.0 11.2 5.5 5.4 6.6 1.9 14.4 6.4 11.6 0.0 6.4 18.3 0.6 2.7 3.3 7.5 4.0 10.1 22.7 15.0 8.2 7.2 9.8 18.4 20.9 7.4 0.4 38.8 0.0 5.8 0.8 6.8 8.0 8.1 8.4 0.0 17.5 4.0 2.7 7.6 14.3 11.3 1.3 14.6 5.0 7.7 2.5 10.1 18.8 24.9 8.2 0.6 2.8 1.1 11.5 0.7 7.2 7.5 0.6 3.4 0.0 15.1 7.0 9.5 30.3 9.4 0.3 6.3 26.0 2.8 5.8 9.3 19.7 9.5 26.6 1.9 1.7 3.6 2.0 5.1 0.8 13.9 23.7 9.3 ADNP "ADNP1, KIAA0784" ENSG00000101126 "Activity dependent neuroprotector homeobox" Q9H2P0 20 50888916-50931437 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006371 Supported Approved Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA006371: AB_1078105" "unprognostic (3.40e-2)" "unprognostic (6.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.06e-2)" "unprognostic (1.68e-1)" "unprognostic (6.68e-2)" "prognostic unfavorable (1.65e-5)" "unprognostic (1.73e-1)" "unprognostic (1.80e-1)" "unprognostic (4.38e-2)" "unprognostic (3.11e-1)" "unprognostic (1.39e-2)" "unprognostic (1.29e-1)" "unprognostic (4.91e-2)" "unprognostic (3.63e-1)" "unprognostic (1.90e-2)" "unprognostic (1.08e-1)" 21.1 22.3 31.9 20.2 33.1 25.3 32.6 37.5 40.0 26.6 30.6 23.3 20.1 31.4 42.1 23.9 29.4 22.3 19.4 32.1 32.7 24.9 25.4 24.0 28.9 30.8 31.7 39.3 21.8 36.1 20.5 25.3 30.7 28.6 24.1 43.6 21.9 29.9 35.7 27.9 22.8 29.7 31.2 25.0 26.7 36.6 35.1 44.8 29.6 28.4 35.6 26.7 23.9 36.9 51.2 50.9 103.2 53.7 51.3 47.3 38.8 41.2 48.1 79.0 55.8 80.4 42.3 74.0 51.7 52.9 41.9 62.1 86.6 85.1 89.5 32.6 30.8 54.2 58.1 64.0 48.9 87.7 41.2 47.1 101.3 47.8 85.7 61.2 56.7 46.2 66.7 47.2 51.6 61.6 76.4 61.4 45.5 52.7 42.8 76.2 54.4 55.5 50.9 77.2 81.2 61.9 92.7 138.0 73.6 65.8 62.7 82.5 44.7 68.6 69.4 49.0 45.8 36.3 39.2 104.0 42.2 50.5 47.3 38.5 23.8 22.3 40.5 37.4 42.7 26.0 44.6 36.9 28.3 29.8 43.8 58.4 12.3 31.4 52.8 58.2 32.8 22.5 31.9 33.1 37.5 40.0 32.1 32.7 30.8 31.7 30.7 31.2 35.1 36.9 45.5 9.6 24.4 85.5 31.1 60.0 32.9 22.9 26.7 41.3 46.9 39.2 38.0 38.6 26.4 14.7 25.0 31.4 55.4 25.6 17.6 22.2 26.3 50.0 59.9 33.4 37.1 26.9 75.6 21.9 20.3 32.8 25.0 61.3 17.2 72.5 27.1 29.5 22.5 38.7 93.5 29.3 18.3 27.4 41.0 38.8 31.4 28.9 40.9 77.8 26.7 25.0 20.6 124.1 122.7 28.5 21.1 39.9 27.0 36.1 22.1 23.2 22.0 37.1 39.5 45.9 41.2 27.9 35.2 31.2 52.0 22.2 36.6 42.8 33.7 39.8 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282573-19288770 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 248.9;liver: 154.6;pancreas: 288.4;stomach 1: 224.4" "Group enriched" "Detected in many" 5 "Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 15.9;SK-BR-3: 25.0" HPA064638 Supported "Golgi apparatus,Cytosol" NA NA 1900000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 1.6 4.0 2.3 2.6 2.4 0.3 4.2 2.8 3.2 2.3 16.7 29.2 248.9 1.4 0.4 1.8 1.8 38.0 0.6 3.3 2.6 71.1 154.6 1.0 0.4 2.7 2.9 2.6 288.4 0.3 2.2 0.2 2.6 1.9 17.4 1.5 3.5 0.3 0.4 2.6 144.8 1.4 2.5 1.3 224.4 2.1 2.9 0.1 1.8 0.1 0.2 1.0 1.6 2.6 0.5 0.0 0.5 0.3 0.5 0.2 1.8 0.1 0.1 0.2 0.1 0.5 1.9 0.2 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.5 0.2 0.7 0.8 0.2 0.2 0.2 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.7 0.5 1.7 0.3 15.9 0.6 0.7 0.1 1.6 0.0 0.1 0.9 1.4 0.3 25.0 0.6 0.1 4.1 0.5 0.4 0.3 0.2 0.9 0.3 1.2 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 2.4 2.8 3.2 3.3 2.6 2.7 2.9 2.6 2.5 2.9 2.6 0.4 0.0 0.0 7.5 3.3 0.8 0.7 0.2 0.6 1.0 13.8 9.5 0.8 140.2 0.3 29.5 0.0 0.5 0.5 133.3 119.3 3.9 3.5 0.5 0.4 0.8 20.8 11.2 4.1 31.8 0.3 0.5 348.1 0.4 4.5 0.9 4.2 119.0 0.3 0.0 3.6 87.6 4.1 3.5 0.0 4.7 0.3 4.4 0.0 1.9 0.1 3.6 0.0 2.5 1.9 18.3 125.0 0.4 0.8 1.2 1132.3 766.6 3.2 1.1 0.0 0.7 0.4 1.8 1.1 1.1 0.6 0.5 3.0 0.7 130.2 0.4 ALDH2 ENSG00000111275 "Aldehyde dehydrogenase 2 family member" P05091 12 111766887-111817532 "Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 857.7" "Cell type enhanced" "Detected in all" "Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0" "Cancer enhanced" "Detected in all" "liver cancer: 71.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 212.0;myeloid DC: 213.2" "Group enriched" "Detected in many" 4 "dendritic cells: 213.2;monocytes: 212.0" "Cell line enhanced" "Detected in many" "ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051065 Approved NA NA 2200000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA051065: AB_2681332" "unprognostic (9.22e-3)" "unprognostic (1.20e-2)" "unprognostic (4.14e-3)" "prognostic favorable (2.63e-4)" "unprognostic (1.16e-1)" "unprognostic (1.32e-3)" "prognostic favorable (3.95e-7)" "unprognostic (5.62e-3)" "unprognostic (3.00e-1)" "unprognostic (1.16e-1)" "unprognostic (8.22e-2)" "unprognostic (1.51e-1)" "prognostic favorable (5.24e-6)" "unprognostic (9.70e-2)" "unprognostic (3.40e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (7.71e-4)" 303.8 102.4 139.7 39.8 146.1 29.2 77.2 136.5 163.5 25.0 123.3 73.3 73.7 30.1 21.3 73.6 32.3 37.4 111.3 132.2 139.7 177.7 857.7 111.6 18.7 140.7 144.9 42.0 23.3 2.6 23.3 7.0 141.1 34.6 72.3 29.2 32.4 29.5 130.8 127.9 74.8 30.2 143.0 20.6 101.5 13.0 151.8 27.1 30.8 165.7 52.9 50.0 29.0 144.5 8.8 13.1 18.7 31.9 86.8 13.0 60.9 9.3 16.8 4.3 3.1 23.5 12.1 0.5 45.3 20.8 11.9 16.2 0.1 4.6 2.7 0.6 6.1 0.7 8.4 64.7 97.0 0.9 0.9 23.9 22.6 14.8 0.3 17.7 26.9 0.9 17.9 3.0 4.1 0.5 1.0 23.4 24.8 152.2 2.1 0.6 0.4 1.9 31.4 0.6 7.5 23.1 22.8 201.0 0.2 33.7 20.3 92.1 1.1 0.4 16.5 0.6 0.4 5.5 3.0 25.7 22.0 0.8 0.4 6.5 212.0 51.1 0.7 93.0 0.9 6.2 0.3 0.7 213.2 5.2 0.7 0.5 10.7 3.4 25.4 70.6 0.5 123.5 139.7 146.1 136.5 163.5 132.2 139.7 140.7 144.9 141.1 143.0 151.8 144.5 27.7 147.4 242.7 51.2 22.6 60.0 205.2 311.1 80.8 78.7 35.0 23.7 378.9 165.8 243.1 66.2 18.8 62.4 48.6 260.3 399.2 127.5 4.3 27.8 24.5 66.2 55.2 42.1 11.7 218.0 127.5 103.1 200.3 47.7 30.9 29.0 139.6 857.0 129.2 35.3 18.2 231.0 101.7 278.5 124.1 10.6 79.9 189.3 35.6 26.2 940.8 130.2 8.2 14.1 6.8 130.2 366.5 149.0 12.5 84.4 384.3 882.0 89.4 42.6 46.0 46.0 67.6 3.0 3.9 105.1 124.7 42.1 13.1 81.0 272.6 150.4 ALDH3B2 ALDH8 ENSG00000132746 "Aldehyde dehydrogenase 3 family member B2" P48448 11 67662160-67681224 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 73.0;esophagus: 152.2;skin 1: 123.0;vagina: 41.0" "Cell type enhanced" "Detected in some" "Breast glandular cells: 26.2;Endometrial ciliated cells: 12.6;Glandular and luminal cells: 28.1;Squamous epithelial cells: 53.3;Suprabasal keratinocytes: 14.8;Syncytiotrophoblasts: 14.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 71.9;SK-BR-3: 70.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA045132 Approved NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA045132: AB_10795993" "unprognostic (2.25e-1)" "unprognostic (2.41e-1)" "unprognostic (1.65e-1)" "unprognostic (8.65e-2)" "unprognostic (2.13e-1)" "unprognostic (6.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-2)" "unprognostic (2.59e-2)" "unprognostic (1.61e-1)" "unprognostic (1.15e-2)" "unprognostic (5.92e-2)" 0.3 0.0 0.1 0.1 0.0 0.2 73.0 0.0 0.0 14.4 0.0 0.1 0.1 0.8 6.8 152.2 4.6 0.3 0.1 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.3 5.2 0.1 3.2 0.0 3.3 0.1 0.5 17.3 4.8 0.3 123.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 2.4 0.0 0.0 21.1 8.3 41.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 7.9 0.0 0.0 0.1 0.0 1.3 3.5 3.3 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.3 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.9 6.8 0.0 0.1 9.0 0.0 0.0 0.0 1.9 0.0 13.0 0.0 0.1 0.0 70.7 0.1 0.4 15.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 1.7 1.2 4.9 1.2 0.0 26.2 7.2 0.4 0.0 7.3 5.5 0.0 10.6 0.2 0.0 1.9 1.1 0.0 12.6 2.6 0.2 0.0 0.0 0.1 0.2 10.6 0.2 0.0 28.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 2.0 0.0 0.8 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 53.3 14.8 14.6 0.2 0.0 0.0 7.6 ALG12 "CDG1G, ECM39" ENSG00000182858 "ALG12 alpha-1,6-mannosyltransferase" Q9BV10 22 49900229-49918438 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003076, HPA051665" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Endoplasmic reticulum" "HPA003076: AB_2666777, HPA051665: AB_2681566" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (4.39e-3)" "prognostic favorable (6.09e-4)" "unprognostic (2.29e-1)" "unprognostic (3.32e-2)" "unprognostic (4.27e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-1)" "unprognostic (3.32e-2)" "unprognostic (1.42e-1)" "unprognostic (2.21e-1)" "prognostic favorable (3.60e-5)" "unprognostic (1.62e-2)" "unprognostic (3.00e-2)" "unprognostic (9.89e-3)" "unprognostic (6.32e-2)" 6.3 8.0 3.5 7.3 4.5 5.9 6.4 6.2 4.7 7.6 4.9 8.8 11.1 8.3 6.5 8.0 7.6 6.6 8.3 3.9 2.6 10.3 14.5 7.0 5.6 4.5 4.3 7.1 11.4 11.8 6.6 5.4 4.7 9.1 4.1 3.0 12.0 5.6 6.1 7.2 8.9 4.4 3.3 7.2 10.3 4.5 4.9 6.5 11.7 4.5 4.8 7.7 6.8 8.4 8.6 8.5 8.8 14.7 16.4 7.6 9.8 8.8 7.9 10.2 8.2 14.0 12.0 4.6 7.8 7.8 11.1 15.2 10.7 10.4 5.0 7.3 15.9 4.2 14.7 14.1 18.6 10.6 8.9 11.6 10.5 9.9 14.3 11.2 9.9 10.3 5.3 11.2 5.4 19.6 10.4 8.6 8.4 11.3 7.7 17.2 11.0 12.1 10.6 9.6 5.9 9.6 14.0 26.3 11.4 11.7 10.8 9.4 7.7 11.2 8.5 7.9 6.8 9.8 4.9 6.1 12.5 8.0 10.9 21.4 8.7 7.7 11.5 8.5 11.7 4.8 8.9 11.4 7.6 6.4 7.3 8.6 7.1 16.9 10.1 7.7 12.8 8.1 3.5 4.5 6.2 4.7 3.9 2.6 4.5 4.3 4.7 3.3 4.9 8.4 6.8 9.6 3.1 21.5 10.2 4.1 10.2 12.1 9.1 5.2 11.1 10.2 1.2 8.6 10.3 18.4 2.1 20.5 8.5 16.6 3.9 15.9 6.9 6.6 8.0 8.1 6.7 7.4 23.2 13.5 22.4 10.6 11.7 9.2 8.2 7.0 5.3 15.0 18.6 3.3 30.4 12.9 12.2 9.2 5.3 4.3 8.7 8.7 10.6 9.4 9.0 2.9 18.6 17.6 40.4 10.3 9.7 8.2 15.6 11.3 18.8 6.8 5.6 5.2 0.0 8.5 7.7 12.9 9.1 10.4 6.0 26.3 11.9 8.3 16.3 9.1 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 50.3;SK-BR-3: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" NA NA "Cluster 30: Non-specific - Translation" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020" "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favorable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 6.3 6.7 45.5 6.5 86.5 2.1 21.5 144.9 82.3 12.0 0.0 26.0 39.3 23.0 125.2 16.9 19.1 21.5 81.1 60.8 86.1 95.4 16.6 24.6 6.1 82.7 61.3 11.6 11.2 131.8 14.5 15.6 97.0 20.0 20.9 123.2 42.6 40.5 80.5 39.9 27.2 13.2 21.2 10.8 15.5 8.0 87.3 9.1 41.6 94.1 7.4 10.8 14.1 114.4 8.7 4.9 30.3 0.4 0.0 1.8 23.3 0.6 0.4 0.1 0.6 22.2 16.6 0.5 9.8 0.6 0.9 12.1 16.4 14.9 0.5 0.5 11.0 0.2 9.7 0.1 6.2 0.1 0.4 14.6 9.3 7.8 0.4 26.1 3.6 0.0 4.3 20.6 6.9 29.0 0.2 1.0 13.8 23.3 26.6 0.1 21.7 4.3 5.4 50.3 15.6 2.8 0.6 49.4 0.0 33.6 28.7 0.1 10.0 0.9 2.9 13.3 1.5 0.9 0.2 0.2 5.5 0.2 18.9 1.6 0.2 0.5 2.7 0.2 2.4 4.1 4.6 1.5 0.1 1.1 5.0 1.2 0.7 1.5 0.3 2.5 0.8 1.0 45.5 86.5 144.9 82.3 60.8 86.1 82.7 61.3 97.0 21.2 87.3 114.4 0.9 44.8 174.3 20.2 14.5 19.1 21.9 17.8 38.7 490.2 26.8 20.6 189.3 12.8 42.5 53.3 225.2 38.8 3.4 62.9 19.6 10.6 28.3 139.8 26.2 3.9 30.6 0.0 859.2 8.6 9.9 13.2 15.8 153.3 12.6 66.9 7.9 0.5 4.7 43.7 881.3 12.1 14.2 4.8 1.4 11.5 28.0 3.3 8.8 23.4 4.4 41.4 0.0 592.6 1579.5 4.8 41.8 5.7 3.4 12.2 62.5 51.3 66.7 216.6 0.0 30.2 11.7 1.1 2.3 35.9 18.2 25.0 18.5 4.5 17.8 18.4 ARF1 ENSG00000143761 "ADP ribosylation factor 1" P84077 1 228082660-228099212 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007742 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Cytosol "Plasma membrane" "CAB007742: AB_562043" "unprognostic (9.54e-2)" "unprognostic (1.35e-2)" "unprognostic (2.30e-2)" "unprognostic (2.50e-3)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.73e-1)" "unprognostic (8.95e-3)" "unprognostic (6.74e-2)" "unprognostic (2.96e-2)" "unprognostic (5.85e-2)" "unprognostic (2.69e-2)" "unprognostic (1.56e-1)" "unprognostic (8.57e-2)" "unprognostic (1.94e-1)" 268.3 282.5 213.8 176.7 222.5 426.9 241.9 188.1 261.9 249.1 215.1 259.8 242.6 266.6 193.1 304.7 247.5 189.2 340.0 242.7 231.3 257.0 324.7 298.2 185.0 200.6 201.6 237.3 327.6 296.9 299.1 276.9 207.6 244.0 177.3 96.7 355.2 203.9 330.9 237.3 240.8 176.2 196.6 251.4 265.6 193.9 218.9 184.4 240.3 206.4 154.7 229.0 233.1 206.4 476.6 321.6 257.4 257.9 289.9 362.6 425.7 409.5 433.0 444.3 386.8 383.6 442.7 239.9 428.8 438.3 204.6 298.8 316.4 399.4 219.4 355.3 506.8 234.3 209.8 386.6 559.5 342.1 333.8 350.4 476.7 408.6 427.0 374.1 443.3 267.0 456.0 533.3 431.4 341.8 350.0 495.9 331.7 656.7 643.0 279.0 228.1 750.6 315.1 242.1 362.6 320.0 265.9 790.0 466.8 87.8 543.9 681.0 406.0 324.6 256.5 479.4 626.8 498.5 301.0 331.1 445.9 285.0 670.6 1003.7 556.5 625.5 387.3 527.8 472.4 276.7 328.0 359.8 423.6 261.3 253.2 280.8 863.6 345.5 528.2 571.4 417.9 1082.4 213.8 222.5 188.1 261.9 242.7 231.3 200.6 201.6 207.6 196.6 218.9 206.4 276.9 173.1 185.2 25.8 205.1 262.6 281.7 248.0 104.2 114.3 209.1 172.0 139.8 125.8 208.1 115.8 45.9 373.7 267.8 487.8 230.9 422.7 236.3 164.6 218.7 247.2 230.1 173.8 42.3 404.5 565.8 227.3 142.8 240.8 198.3 128.8 152.4 124.8 409.4 158.2 41.1 436.9 213.6 198.8 256.2 429.9 229.2 300.1 300.6 35.6 356.0 162.2 214.2 30.7 40.7 400.2 407.2 227.2 282.8 344.6 370.1 173.3 180.7 80.2 230.1 149.6 416.0 321.1 155.7 158.3 286.0 676.7 224.9 174.6 335.2 370.0 ARFGEF2 BIG2 ENSG00000124198 "ADP ribosylation factor guanine nucleotide exchange factor 2" Q9Y6D5 20 48921711-49036693 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 81.5" "Cell type enhanced" "Detected in all" "Excitatory neurons: 102.6;Inhibitory neurons: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026078, CAB026382" Supported Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Vesicles, Cytosol" "CAB026382: , HPA026078: AB_1844983" "unprognostic (1.50e-2)" "unprognostic (9.56e-3)" "unprognostic (4.14e-2)" "unprognostic (4.94e-3)" "unprognostic (5.30e-2)" "unprognostic (6.94e-2)" "unprognostic (1.57e-2)" "unprognostic (2.99e-1)" "unprognostic (8.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "prognostic favorable (6.15e-7)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (2.85e-1)" "unprognostic (3.90e-2)" 9.1 20.2 2.8 8.7 4.1 10.4 15.8 1.9 5.8 11.5 7.9 14.2 13.7 9.0 5.9 11.0 7.5 8.5 13.4 4.5 3.9 15.3 12.4 7.8 9.8 2.6 3.2 7.7 19.2 81.5 8.7 9.2 3.5 10.6 15.7 6.8 11.0 9.7 11.8 11.1 10.9 9.5 1.9 10.4 16.2 13.6 3.5 11.3 23.8 18.2 14.2 11.1 8.2 5.0 18.3 16.5 8.9 5.1 18.0 14.8 21.8 15.5 19.5 36.6 19.0 37.1 19.8 25.5 22.1 19.7 33.8 21.0 18.6 23.6 33.8 9.0 7.6 17.5 17.9 25.4 19.7 22.6 19.7 15.0 21.6 23.9 27.6 12.7 28.4 11.7 15.0 22.3 20.8 6.3 13.0 6.8 8.3 20.5 17.4 14.0 25.5 30.3 13.6 23.4 7.1 9.0 42.6 66.0 23.4 10.3 26.6 18.6 34.5 35.6 16.5 18.2 13.1 35.9 35.0 18.7 23.4 10.7 11.6 1.1 0.6 0.2 0.5 0.4 0.6 0.5 0.5 0.4 0.7 0.9 0.8 0.7 0.3 0.3 0.3 0.9 0.1 0.3 2.8 4.1 1.9 5.8 4.5 3.9 2.6 3.2 3.5 1.9 3.5 5.0 16.6 19.2 26.0 37.2 21.2 11.3 12.2 11.0 11.4 15.3 27.7 14.7 40.7 17.2 20.0 11.0 14.6 10.5 14.7 30.4 1.9 10.9 16.6 19.5 17.1 19.5 12.5 14.3 102.6 13.3 10.0 12.6 16.3 24.7 15.2 11.0 20.7 27.8 10.8 11.8 96.7 23.3 8.2 15.7 13.9 24.6 10.2 17.8 10.6 60.9 15.6 5.4 10.3 43.2 57.0 15.5 21.6 11.3 29.0 24.1 18.6 11.5 17.2 16.1 6.6 14.2 12.5 32.6 20.4 17.5 15.5 30.0 13.2 16.6 21.0 21.2 ARFGEF3 "BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33" ENSG00000112379 "ARFGEF family member 3" Q5TH69 6 138161939-138344663 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4;salivary gland: 18.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1" "Cancer enhanced" "Detected in all" "prostate cancer: 24.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036350 Uncertain NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA036350: AB_10672084" "prognostic unfavorable (8.20e-4)" "unprognostic (4.31e-2)" "unprognostic (9.91e-3)" "unprognostic (5.91e-2)" "unprognostic (2.20e-2)" "unprognostic (4.53e-2)" "unprognostic (4.30e-3)" "unprognostic (1.21e-2)" "unprognostic (7.41e-2)" "unprognostic (7.82e-2)" "unprognostic (3.46e-2)" "unprognostic (4.93e-2)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (2.38e-1)" "unprognostic (8.87e-2)" "unprognostic (1.69e-2)" 1.2 3.8 13.4 0.7 16.4 0.4 7.9 20.1 17.7 5.0 0.0 4.2 2.2 0.7 0.9 0.4 2.2 1.7 1.0 16.7 13.0 2.1 0.1 6.4 0.2 11.1 17.7 0.1 8.7 15.8 7.0 1.4 14.4 12.0 4.8 2.8 18.0 1.0 0.2 1.2 1.9 0.7 7.5 0.4 10.0 0.6 15.2 0.1 1.9 0.7 0.2 3.4 0.4 28.4 8.0 3.1 0.0 0.6 0.0 0.0 4.7 0.3 0.2 0.2 0.0 0.1 0.4 0.0 3.1 0.3 2.7 2.6 3.8 2.0 0.0 0.0 4.9 0.0 1.5 0.9 0.0 3.0 0.0 0.0 0.9 0.0 0.9 3.5 4.1 2.7 0.0 4.9 0.0 14.8 0.0 0.0 2.7 8.5 3.4 0.6 13.4 2.6 2.6 19.4 6.9 0.0 7.8 22.2 0.9 0.3 4.4 0.0 0.4 0.2 2.2 0.0 7.9 1.7 6.7 0.0 3.2 1.8 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 16.4 20.1 17.7 16.7 13.0 11.1 17.7 14.4 7.5 15.2 28.4 9.4 16.0 114.6 34.3 0.5 0.0 18.8 0.0 6.2 19.0 39.9 12.6 6.4 14.3 44.6 3.7 0.0 16.5 0.8 2.5 3.9 11.4 83.0 8.6 1.4 11.9 66.7 2.7 200.9 24.7 2.4 4.1 41.3 17.7 2.5 0.1 8.2 0.3 1.4 11.8 207.8 44.2 0.0 0.0 0.0 22.0 0.0 0.5 0.0 36.5 2.0 0.9 0.0 173.9 378.1 14.2 8.4 0.0 0.9 67.6 2.5 0.3 37.2 3.3 0.0 3.5 0.9 4.1 1.1 3.0 0.0 6.2 0.8 0.1 13.2 42.7 ARFIP2 POR1 ENSG00000132254 "ADP ribosylation factor interacting protein 2" P53365 11 6474683-6481479 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032985, HPA038156" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "CAB032985: AB_2058811, HPA038156: AB_10697243" "unprognostic (2.32e-1)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "prognostic favorable (2.00e-5)" "unprognostic (8.44e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-3)" "unprognostic (2.50e-1)" "unprognostic (2.96e-1)" "unprognostic (1.76e-1)" "unprognostic (5.70e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.53e-4)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (2.32e-2)" "unprognostic (9.48e-3)" 19.8 29.3 31.7 18.6 32.3 22.8 50.7 32.5 35.2 36.3 36.2 36.8 32.9 27.2 34.0 31.4 39.3 23.9 17.9 32.1 31.4 27.0 34.6 24.4 22.4 31.2 31.4 29.4 49.4 46.4 40.7 29.7 31.9 46.6 48.1 28.3 57.7 28.2 15.2 32.8 30.7 27.4 30.9 20.7 50.4 18.3 31.8 25.7 36.9 16.1 32.0 29.2 24.4 33.1 50.4 64.8 38.9 38.5 59.1 53.9 56.1 40.3 107.0 86.2 101.8 62.1 80.3 39.9 16.5 79.3 49.8 68.0 49.4 84.1 70.0 30.9 86.5 22.3 87.7 60.4 71.3 36.2 42.8 60.0 65.7 43.0 98.3 64.2 55.9 38.3 35.3 45.0 55.8 98.9 41.9 41.6 67.2 119.0 71.9 31.7 22.6 37.1 61.9 50.4 50.8 63.2 48.7 204.9 25.9 36.3 86.9 33.0 36.8 35.4 35.7 39.1 30.3 67.3 32.5 24.3 65.4 22.0 43.9 13.0 15.6 9.9 17.9 10.9 17.8 12.1 16.7 14.5 21.3 13.8 16.7 17.1 6.1 21.1 6.7 16.6 18.9 13.9 31.7 32.3 32.5 35.2 32.1 31.4 31.2 31.4 31.9 30.9 31.8 33.1 14.8 6.4 6.4 4.6 20.7 28.0 49.3 48.9 16.5 32.6 59.8 45.1 4.3 40.0 30.5 12.9 29.2 80.1 24.3 56.0 58.7 62.7 31.7 28.1 20.1 19.6 63.0 21.8 8.4 85.4 65.8 23.1 62.2 37.2 31.8 30.3 20.3 21.1 28.1 21.9 7.8 126.6 32.6 10.1 16.4 43.3 20.5 14.4 24.9 5.6 25.2 35.4 18.6 6.6 7.6 59.9 63.4 24.5 28.0 73.3 65.2 34.4 34.7 32.3 26.3 21.6 23.3 41.0 26.2 26.2 32.1 112.5 16.9 40.9 52.6 64.7 ARGFX ENSG00000186103 "Arginine-fifty homeobox" A6NJG6 3 121567949-121590622 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.4" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5" "Cancer enriched" "Detected in single" 119 "testis cancer: 6.4" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.7" HPA043049 Uncertain NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA043049: AB_2678288" "unprognostic (6.00e-2)" 0.1 0.2 0.7 0.3 0.7 1.2 0.3 2.4 1.1 0.0 0.7 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.4 0.7 0.2 0.2 0.4 0.1 0.0 0.2 0.7 0.2 0.2 0.6 0.4 0.1 0.5 0.8 0.3 0.1 0.0 0.3 0.4 0.3 0.6 0.1 0.3 0.1 0.3 0.1 0.0 1.9 0.1 0.2 0.3 0.3 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.3 0.4 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.2 0.3 0.3 0.6 0.3 0.1 0.5 0.9 0.1 0.5 0.1 0.1 0.2 0.0 0.4 0.3 0.8 0.0 0.3 0.2 0.5 0.4 0.1 0.1 0.3 0.2 0.2 0.2 0.5 0.3 0.3 0.2 1.7 0.1 0.3 0.2 0.2 0.4 0.4 0.3 0.4 0.1 0.5 0.2 0.4 0.3 0.3 0.2 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.8 0.6 0.3 0.4 0.2 0.1 0.7 0.7 2.4 1.1 0.8 0.4 0.7 0.2 0.7 0.0 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARHGAP32 "GC-GAP, GRIT, KIAA0712, MGC1892, RICS" ENSG00000134909 "Rho GTPase activating protein 32" A7KAX9 11 128965060-129279324 "Cancer-related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 240.6;Excitatory neurons: 403.4;Inhibitory neurons: 239.7;Oligodendrocyte precursor cells: 170.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 26.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 36.6;RT4: 39.5;SK-BR-3: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038382, HPA038389, HPA061505" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nucleoplasm, Nucleoli fibrillar center" "HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544" "unprognostic (1.17e-1)" "unprognostic (3.58e-2)" "unprognostic (2.54e-2)" "unprognostic (1.82e-1)" "unprognostic (3.89e-2)" "unprognostic (5.64e-2)" "unprognostic (1.52e-1)" "unprognostic (5.97e-2)" "unprognostic (7.32e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (1.47e-1)" "unprognostic (6.17e-3)" "unprognostic (1.17e-1)" "unprognostic (4.01e-1)" "unprognostic (5.80e-2)" "unprognostic (1.64e-2)" 4.7 7.5 2.6 3.4 8.2 2.1 10.3 0.0 26.6 11.9 0.0 14.1 21.1 8.1 9.0 26.3 13.3 7.6 4.3 15.1 0.0 7.0 5.0 5.8 1.6 0.0 0.0 10.9 15.2 10.7 6.1 8.6 0.0 6.4 15.8 33.5 15.8 4.2 7.6 20.1 20.6 5.9 0.0 3.0 12.0 10.7 0.0 10.5 3.8 4.3 6.9 9.4 17.1 5.1 12.2 6.4 19.7 0.1 6.3 6.3 14.2 4.5 6.3 2.8 3.4 14.9 24.7 0.1 6.7 8.7 14.1 27.2 9.0 11.4 5.4 0.0 3.1 0.2 3.4 5.6 3.1 0.0 0.0 6.1 14.4 2.7 16.3 6.2 3.5 10.2 0.6 0.2 4.9 9.5 10.2 0.2 5.4 36.6 6.8 24.9 5.9 2.5 3.0 39.5 19.3 7.9 6.8 42.3 8.0 7.5 21.9 3.9 6.6 9.9 5.2 5.9 8.9 0.3 0.0 0.1 4.3 27.4 6.4 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.7 0.1 0.3 0.1 0.1 2.6 8.2 0.0 26.6 15.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.3 6.4 16.8 240.6 3.4 18.2 12.7 29.1 16.5 31.6 36.5 17.1 4.3 14.3 46.6 11.0 123.0 23.1 4.8 48.7 1.9 8.3 19.0 27.7 10.0 5.6 40.7 2.5 403.4 27.2 4.2 14.1 35.2 25.4 1.3 9.8 5.0 16.2 6.5 18.5 239.7 61.9 20.3 4.1 4.2 12.3 6.8 5.7 16.0 103.0 2.9 113.6 0.0 170.9 95.0 24.5 44.2 13.2 1.5 22.7 52.7 9.9 61.6 37.9 19.7 19.4 9.5 8.6 9.6 55.4 31.1 28.5 2.0 4.0 54.0 59.5 ARHGAP40 "C20orf95, dJ1100H13.4" ENSG00000124143 "Rho GTPase activating protein 40" Q5TG30 20 38601934-38651035 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "breast: 32.4;epididymis: 35.7;esophagus: 28.7;skin 1: 45.3" "Cell type enhanced" "Detected in some" "Breast glandular cells: 14.7;Breast myoepithelial cells: 8.6;Club cells: 4.3;Collecting duct cells: 3.7;Early spermatids: 7.2;Late spermatids: 4.3;Respiratory ciliated cells: 3.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.3;HBEC3-KT: 13.6;RPTEC TERT1: 11.7;SK-BR-3: 12.7;T-47d: 15.4" "Not detected" "Not detected" "HPA042636, HPA042840" Uncertain Supported "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" No NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA042636: AB_10962149, HPA042840: AB_10963929" "unprognostic (9.89e-3)" "unprognostic (2.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.24e-3)" "unprognostic (3.11e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-3)" "unprognostic (1.69e-1)" "unprognostic (3.09e-2)" "unprognostic (4.35e-2)" "unprognostic (5.63e-3)" "unprognostic (2.52e-1)" "prognostic unfavorable (2.89e-4)" "unprognostic (2.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.26e-1)" "unprognostic (1.54e-1)" 0.1 0.0 0.3 0.0 1.3 0.0 32.4 0.1 0.6 3.2 0.2 0.0 1.7 0.7 35.7 28.7 0.1 0.1 0.0 0.2 0.3 5.6 0.1 0.8 0.0 0.3 1.8 0.0 0.3 0.0 0.0 0.0 0.8 4.6 0.0 0.0 3.6 7.9 0.4 45.3 0.0 0.0 0.2 0.0 4.6 2.7 0.6 0.0 0.9 0.0 3.7 3.2 7.4 0.2 4.5 0.0 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.0 0.1 0.2 0.9 0.0 3.6 0.0 0.0 0.0 0.0 13.6 0.2 0.0 0.0 0.2 0.0 3.4 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 12.7 0.0 1.6 15.4 0.5 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.1 0.6 0.2 0.3 0.3 1.8 0.8 0.2 0.6 0.2 0.1 0.0 1.5 0.7 0.0 0.3 0.0 1.8 0.0 0.0 14.7 8.6 0.1 0.0 4.3 3.7 0.0 0.0 0.2 0.0 0.0 0.0 7.2 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.7 0.0 0.4 3.4 0.0 0.0 0.0 0.3 0.7 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 ARL8A "ARL10B, FLJ45195, Gie2" ENSG00000143862 "ADP ribosylation factor like GTPase 8A" Q96BM9 1 202133404-202144743 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038759, HPA040515, HPA045924" Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500" "unprognostic (1.20e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (3.08e-5)" "unprognostic (5.15e-3)" "unprognostic (5.10e-2)" "unprognostic (2.50e-3)" "unprognostic (1.17e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (4.30e-1)" "unprognostic (2.26e-2)" "unprognostic (1.57e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.75e-1)" "unprognostic (5.39e-2)" "unprognostic (1.66e-2)" 41.7 40.1 61.4 25.0 83.4 70.0 37.5 82.0 78.9 37.9 36.1 36.0 21.6 35.0 16.8 32.4 34.3 21.5 43.9 67.4 70.7 34.6 45.1 46.1 21.3 89.7 81.1 35.3 28.3 26.2 31.7 31.1 82.3 29.7 10.9 18.7 30.8 19.6 46.4 37.2 26.4 21.7 72.1 38.4 32.0 19.5 78.2 18.1 32.3 26.0 13.3 31.4 33.8 103.2 24.2 25.6 26.2 31.9 23.1 19.9 11.3 28.1 36.6 31.3 24.1 9.2 18.7 23.3 18.1 29.2 29.2 34.0 17.6 19.4 10.0 45.7 24.7 14.1 13.2 9.6 45.8 28.6 63.8 21.8 50.4 27.4 23.6 32.9 32.2 23.3 13.6 34.7 22.3 26.4 20.0 39.3 37.4 8.3 8.9 19.2 22.9 20.5 29.5 20.4 24.2 62.8 22.9 73.8 46.2 32.7 34.2 31.6 38.7 25.1 22.8 43.4 24.1 54.0 54.6 19.3 20.4 15.1 21.4 3.5 2.1 7.3 1.5 2.1 1.1 1.1 1.3 1.2 1.5 1.5 0.7 0.9 5.2 0.7 2.0 2.7 1.5 0.9 61.4 83.4 82.0 78.9 67.4 70.7 89.7 81.1 82.3 72.1 78.2 103.2 45.4 19.2 10.2 17.0 16.6 41.3 24.0 12.1 7.4 36.0 39.0 33.5 2.5 22.8 13.2 11.0 14.6 33.3 37.1 11.3 5.9 38.9 0.4 20.7 28.2 26.0 20.5 7.0 17.8 29.3 14.7 25.7 14.3 26.8 19.0 26.0 20.7 39.8 57.2 53.8 18.6 14.7 14.2 57.8 51.0 2.1 33.5 45.7 32.0 6.5 35.4 47.1 18.6 13.0 82.8 50.3 21.1 27.4 14.5 31.8 16.6 27.1 10.7 23.1 26.3 22.8 28.6 1.3 5.2 13.4 51.7 76.1 21.4 16.5 10.1 37.2 ASL ASAL ENSG00000126522 "Argininosuccinate lyase" P04424 7 66075800-66094697 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 396.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1" "Cancer enhanced" "Detected in all" "liver cancer: 52.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003696, HPA016646" Enhanced Approved Cytosol NA NA 12000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB003696: AB_425316, HPA016646: AB_1845096" "unprognostic (2.95e-2)" "prognostic unfavorable (4.05e-6)" "unprognostic (4.83e-1)" "unprognostic (4.18e-3)" "unprognostic (3.52e-2)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (2.07e-1)" "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (7.25e-2)" "unprognostic (4.95e-2)" "unprognostic (2.07e-2)" "unprognostic (3.69e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (8.40e-3)" 21.7 16.1 5.9 16.7 6.0 23.9 22.0 6.6 8.5 18.2 8.7 53.8 60.7 17.0 6.7 28.7 18.1 27.7 16.9 5.9 8.0 61.2 396.4 27.4 10.3 7.4 7.1 19.7 37.1 15.1 19.8 9.1 9.8 19.5 35.7 2.4 18.3 9.8 8.7 15.1 45.6 10.1 6.2 30.5 43.9 4.5 7.6 5.3 24.9 6.9 8.8 19.3 19.8 6.7 48.4 18.9 11.2 36.7 26.3 18.1 22.1 34.0 31.8 49.5 43.6 43.7 59.0 15.9 53.7 48.5 36.6 13.4 7.1 59.1 11.1 10.5 8.9 18.8 17.9 77.2 48.8 24.0 51.3 38.3 19.5 31.8 51.8 12.5 48.1 11.3 34.4 27.8 25.4 36.6 4.8 28.9 15.8 65.5 26.1 12.1 11.0 51.6 31.9 31.6 18.4 24.3 32.3 109.7 12.3 11.4 46.0 19.7 55.1 53.7 30.8 23.5 45.2 30.2 16.9 19.0 55.0 41.5 49.5 34.2 42.6 50.8 16.9 46.6 15.1 21.8 11.5 13.4 46.2 13.8 8.2 8.5 7.3 73.7 36.1 2.5 23.4 27.3 5.9 6.0 6.6 8.5 5.9 8.0 7.4 7.1 9.8 6.2 7.6 6.7 34.5 19.2 61.4 5.2 20.4 5.5 21.4 24.2 9.1 12.7 24.5 20.4 9.2 124.4 25.8 31.3 22.9 20.7 25.4 294.6 52.8 73.7 4.0 41.2 12.1 30.7 54.0 47.1 9.4 218.6 45.7 14.4 115.7 34.1 44.5 12.0 42.8 578.0 46.0 15.2 9.7 126.5 16.2 41.2 17.6 6.3 9.3 22.3 8.8 1.9 48.3 7.2 34.0 2.5 4.8 118.3 240.4 8.2 23.4 14.9 259.9 243.1 42.8 13.2 13.1 16.9 17.5 3.2 5.7 19.5 4.3 22.3 18.0 13.5 189.4 22.0 ATAD2 "ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000" ENSG00000156802 "ATPase family AAA domain containing 2" Q6PL18 8 123319850-123416350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 28.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 79.1;Spermatocytes: 106.0;Spermatogonia: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 294.4" "Low region specificity" "Detected in all" "HPA029424, CAB056158" Enhanced Enhanced Nucleoplasm Yes Yes "Cluster 33: Neutrophils - Chromatin organization" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB056158: AB_2665580, HPA029424: AB_10611680" "unprognostic (1.56e-1)" "unprognostic (4.55e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.08e-1)" "unprognostic (4.44e-2)" "unprognostic (2.98e-2)" "unprognostic (2.74e-3)" "unprognostic (2.02e-3)" "unprognostic (5.62e-2)" "unprognostic (1.19e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.33e-15)" "unprognostic (1.15e-2)" "unprognostic (1.82e-1)" "unprognostic (4.84e-2)" "unprognostic (6.17e-2)" 2.9 3.4 3.8 7.7 3.6 26.5 6.8 2.6 3.9 12.8 2.0 5.3 5.0 4.3 3.8 6.8 3.4 3.2 5.8 3.2 4.5 1.4 9.9 4.1 14.4 2.9 3.8 7.0 3.3 1.9 3.9 4.8 2.6 10.3 6.9 1.4 4.3 4.7 9.3 6.8 5.2 4.1 2.8 4.9 4.7 18.9 5.1 28.3 3.9 3.2 12.8 4.8 3.9 2.8 103.7 39.6 55.0 19.0 9.7 12.3 24.3 79.2 27.2 66.8 73.9 30.1 43.8 67.2 23.6 25.2 26.5 48.3 74.2 25.6 106.1 94.3 39.0 121.2 41.0 61.4 3.8 44.6 57.4 4.1 3.8 63.6 21.0 14.3 20.7 38.6 57.7 66.4 50.4 107.1 129.5 32.8 10.0 77.8 38.4 66.5 65.6 36.4 23.8 46.7 70.2 30.5 114.4 294.4 20.8 22.1 60.2 41.2 13.0 50.4 69.3 40.2 96.6 21.2 40.7 60.8 32.9 72.9 40.4 5.3 0.8 3.3 1.6 0.8 2.2 2.6 2.3 2.7 1.4 1.5 1.5 1.7 0.2 2.5 1.9 0.1 4.6 1.0 3.8 3.6 2.6 3.9 3.2 4.5 2.9 3.8 2.6 2.8 5.1 2.8 4.8 6.4 11.0 9.4 18.5 15.8 27.9 9.1 14.2 2.8 17.3 21.2 27.3 2.8 10.2 3.7 4.2 14.9 15.3 9.0 1.9 3.5 54.9 7.9 17.3 9.6 1.2 79.1 25.6 2.2 26.2 17.1 13.3 17.5 14.5 37.9 7.1 16.3 11.2 1.7 16.4 13.1 4.1 8.2 6.9 24.4 7.5 11.7 1.8 14.0 6.3 6.3 17.5 11.6 2.8 3.5 4.3 13.9 34.0 20.7 3.1 1.0 5.4 1.9 0.0 9.5 17.5 106.0 82.4 23.7 12.1 13.5 22.8 3.7 14.6 24.5 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274789-193378820 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7" "Group enriched" "Detected in some" 5 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031772, HPA031774" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" Nucleoplasm "HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.0 0.1 2.3 0.0 1.9 0.2 17.3 1.5 2.7 0.0 38.5 0.0 0.0 0.1 0.8 0.7 0.1 0.0 0.2 3.1 1.8 0.2 0.0 0.5 0.1 1.6 2.3 0.2 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.8 11.7 0.0 1.3 3.9 0.0 0.0 0.8 0.0 1.6 0.4 2.4 0.0 1.3 0.1 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 2.3 1.9 1.5 2.7 3.1 1.8 1.6 2.3 1.5 0.8 2.4 1.8 0.1 0.0 0.5 37.9 0.0 0.0 0.0 0.3 0.0 0.0 5.8 5.8 0.7 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.4 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.9 0.0 0.0 0.0 26.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ATP6V0A4 "a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2" ENSG00000105929 "ATPase H+ transporting V0 subunit a4" Q9HBG4 7 138706294-138799560 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "kidney: 63.6;salivary gland: 78.4" "Cell type enhanced" "Detected in some" "Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0" "Cancer enriched" "Detected in many" 8 "renal cancer: 25.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SK-BR-3: 55.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018029, HPA064555" Enhanced Uncertain Cytosol NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA018029: AB_1845190, HPA064555: AB_2685284" "unprognostic (1.99e-2)" "unprognostic (8.60e-3)" "unprognostic (1.12e-2)" "unprognostic (3.10e-2)" "unprognostic (1.43e-1)" "unprognostic (6.53e-2)" "unprognostic (4.63e-2)" "unprognostic (4.28e-1)" "unprognostic (1.35e-1)" "unprognostic (9.79e-3)" "unprognostic (1.73e-1)" "prognostic favorable (1.32e-6)" "unprognostic (4.35e-1)" "unprognostic (1.56e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-2)" 0.2 0.0 0.3 0.0 0.4 0.0 4.7 0.1 0.5 3.7 3.1 0.0 0.1 0.1 1.2 4.9 0.0 0.0 0.0 0.6 0.2 63.6 0.0 0.4 0.0 0.3 0.2 0.0 0.1 1.6 0.1 2.5 0.2 0.9 0.0 0.0 78.4 1.5 0.0 10.2 0.0 0.0 0.2 0.0 0.1 0.2 0.3 0.4 0.0 0.0 3.7 0.1 0.2 0.3 0.2 0.5 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.6 0.6 1.8 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.7 5.0 1.9 0.0 0.1 0.0 0.1 0.1 0.6 0.0 4.5 0.2 0.0 0.0 0.1 55.7 1.9 2.9 0.1 0.0 0.2 0.6 1.3 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.5 0.6 0.2 0.3 0.2 0.2 0.2 0.3 0.3 0.0 0.0 1.1 0.3 0.0 0.0 1.1 0.9 0.0 0.0 2.5 1.4 0.5 0.0 1.7 16.5 2.1 13.4 0.3 0.0 31.3 0.0 2.2 0.9 0.1 0.1 0.0 0.0 1.4 0.0 0.7 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 1.2 0.0 57.0 0.0 0.0 2.8 0.3 0.0 7.2 1.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.3 4.4 0.1 0.0 0.0 0.1 0.6 0.7 0.0 0.1 5.1 0.2 0.0 0.0 1.3 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935900-70965431 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 127.4;salivary gland: 139.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 2.2 0.5 0.5 0.2 0.3 0.0 11.8 0.7 0.9 31.1 0.0 0.6 0.5 1.4 1.2 1.6 12.8 0.2 1.1 0.2 0.0 127.4 0.2 1.7 0.5 0.1 0.0 1.2 3.3 0.8 4.2 17.9 0.1 2.0 0.1 3.9 139.8 1.4 0.5 32.5 0.6 0.8 0.0 0.0 0.3 0.3 0.0 0.1 0.3 0.2 0.0 0.6 0.8 0.3 0.4 0.3 0.6 1.3 2.6 3.1 21.6 0.4 0.2 0.0 0.0 0.1 2.0 0.1 0.2 1.2 0.0 20.3 0.7 0.0 0.0 0.5 0.6 0.0 0.3 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.3 3.1 0.0 0.1 0.0 0.0 0.2 1.2 0.1 0.3 0.0 0.0 0.0 0.1 0.8 0.2 0.4 0.2 0.5 1.5 0.7 49.2 0.1 2.7 0.6 0.0 0.4 0.6 0.2 0.9 0.5 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.7 0.9 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.7 3.2 0.0 0.3 0.0 0.1 1.3 1.7 0.0 0.9 5.6 3.7 0.4 0.0 13.9 0.0 8.4 197.3 0.1 0.6 49.0 0.1 1.5 0.0 0.1 1.1 0.0 0.0 1.0 0.6 38.3 3.8 0.0 0.1 0.0 0.0 0.0 0.1 11.7 1.7 0.4 0.0 321.4 0.0 0.3 0.1 0.0 0.1 30.2 0.0 0.0 0.5 1.0 1.0 0.1 0.4 0.0 1.2 0.0 0.6 0.3 0.2 2.6 3.8 0.0 1.1 1.0 0.4 1.2 0.0 0.4 64.9 0.1 0.1 0.1 0.6 BAHD1 KIAA0945 ENSG00000140320 "Bromo adjacent homology domain containing 1" Q8TBE0 15 40439721-40468236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041196 Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA041196: AB_10803999" "prognostic unfavorable (1.55e-4)" "unprognostic (4.08e-1)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.35e-2)" "unprognostic (1.04e-1)" "unprognostic (7.19e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "unprognostic (2.00e-2)" "unprognostic (3.49e-3)" "unprognostic (4.81e-2)" "prognostic favorable (1.29e-10)" "unprognostic (4.95e-2)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" 9.6 21.9 10.8 8.0 11.5 8.1 9.2 8.6 10.5 11.0 9.9 12.3 9.1 12.5 10.2 12.0 13.6 6.3 14.3 11.9 9.8 14.2 11.6 12.5 9.8 10.3 9.5 21.4 13.8 13.0 13.3 8.7 9.4 10.3 5.8 5.2 12.6 10.2 12.6 11.0 12.0 7.2 9.1 12.6 12.7 18.6 10.9 11.6 16.5 7.6 9.1 12.3 9.1 10.1 16.9 8.5 14.7 24.5 11.7 9.1 32.0 13.3 9.5 14.4 14.0 23.1 7.9 12.5 17.6 12.0 17.6 32.6 24.2 10.1 8.0 24.2 15.2 32.9 13.2 11.5 11.1 14.4 24.0 12.0 10.2 8.8 8.7 12.8 12.5 15.8 32.8 10.4 8.6 16.0 16.2 21.8 14.6 19.7 15.6 27.3 16.6 10.4 15.9 19.7 23.0 13.9 8.2 42.8 9.7 9.1 34.4 23.1 14.8 15.6 17.4 22.4 14.1 15.5 18.4 14.2 16.3 22.1 10.7 0.6 0.3 1.4 1.3 0.6 0.6 0.5 0.9 0.7 0.3 0.7 1.2 1.0 0.3 1.4 1.2 0.6 0.3 0.4 10.8 11.5 8.6 10.5 11.9 9.8 10.3 9.5 9.4 9.1 10.9 10.1 9.7 19.2 7.0 7.8 4.9 8.3 3.7 4.1 6.8 3.9 11.4 9.4 11.7 5.7 7.7 11.0 2.1 5.5 5.6 20.7 1.9 5.4 1.0 6.1 4.9 8.4 7.8 2.5 10.3 7.4 7.3 4.7 2.0 8.4 8.9 5.6 9.7 12.0 5.7 16.8 8.1 7.4 2.0 12.0 4.6 2.7 10.2 5.4 0.0 7.5 6.7 5.2 10.3 9.0 8.9 6.7 8.9 5.7 1.6 5.3 11.6 5.0 5.0 4.7 6.6 6.1 5.5 6.3 10.9 6.9 7.7 4.1 5.8 7.6 8.0 4.9 BCAM "CD239, LU" ENSG00000187244 "Basal cell adhesion molecule (Lutheran blood group)" P50895 19 44809071-44821421 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Blood group antigen, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 316.8" "Cell type enhanced" "Detected in many" "Adipocytes: 374.9;Basal respiratory cells: 454.1;Collecting duct cells: 548.1;Cytotrophoblasts: 705.4;Syncytiotrophoblasts: 433.3" "Cancer enhanced" "Detected in all" "ovarian cancer: 493.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 142.7;HaCaT: 298.4;SK-BR-3: 276.8;T-47d: 157.2;U-2 OS: 130.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005654 Enhanced Approved "Nucleoli fibrillar center" NA NA 18000000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoli fibrillar center" "HPA005654: AB_2667378" "unprognostic (5.63e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (2.31e-4)" "prognostic unfavorable (1.24e-5)" "unprognostic (1.60e-2)" "unprognostic (1.23e-3)" "unprognostic (2.01e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (6.17e-2)" "unprognostic (2.61e-3)" "unprognostic (1.41e-1)" "prognostic favorable (5.94e-6)" "unprognostic (1.83e-2)" "unprognostic (5.74e-2)" "unprognostic (2.14e-2)" "unprognostic (9.97e-3)" 105.0 23.3 24.0 9.9 23.3 3.8 125.6 23.7 39.6 87.7 38.2 32.2 13.5 78.1 21.3 29.1 115.1 15.8 118.3 21.3 24.6 316.8 38.4 89.0 9.8 26.7 27.4 50.2 51.5 20.0 38.3 44.1 26.7 130.1 5.3 3.1 65.6 49.2 44.7 54.1 31.2 19.6 24.0 36.4 39.3 20.6 28.2 13.8 215.7 30.8 7.1 52.8 72.0 21.6 34.7 44.3 1.2 120.8 0.6 0.8 142.7 13.3 6.3 10.7 7.1 66.8 83.5 0.0 65.7 1.6 0.6 298.4 10.4 74.5 3.2 0.1 7.3 0.2 8.8 93.9 23.6 0.0 15.9 11.6 28.6 3.7 4.4 34.2 6.6 0.0 7.3 0.5 1.6 17.7 0.4 1.2 13.5 10.0 15.1 0.5 14.2 3.6 90.4 21.9 0.4 0.5 54.0 276.8 3.4 13.1 157.2 5.1 17.4 2.7 130.2 3.4 6.5 0.6 1.4 0.1 1.1 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 23.3 23.7 39.6 21.3 24.6 26.7 27.4 26.7 24.0 28.2 21.6 374.9 6.4 12.3 5.5 4.4 40.7 118.0 454.1 80.2 2.5 109.5 185.4 12.8 52.9 48.5 548.1 0.0 705.4 3.2 8.6 82.2 34.0 1.3 62.9 8.2 214.0 52.0 4.8 0.5 4.0 36.9 21.7 15.8 45.3 0.0 14.3 73.2 31.0 44.7 0.0 1.2 5.6 40.7 8.0 21.3 2.1 29.5 3.5 16.0 9.4 0.1 23.6 0.0 1.0 0.3 14.3 21.4 15.1 2.5 80.4 4.9 149.6 20.7 1.1 157.8 14.1 240.6 3.2 18.3 8.9 24.6 433.3 3.5 6.4 13.0 40.7 BCAS1 "AIBC1, NABC1, PMES-2" ENSG00000064787 "Brain enriched myelin associated protein 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 890.2;choroid plexus: 301.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "T-reg: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.2 0.2 506.5 6.4 627.9 0.1 3.4 551.3 890.2 7.3 301.2 69.5 19.0 1.3 2.2 7.2 1.5 8.6 0.4 421.4 525.8 3.3 0.4 2.9 0.6 749.3 660.7 0.4 0.9 0.0 1.0 0.1 649.9 33.4 74.3 0.2 22.3 0.3 0.5 1.4 31.1 2.8 584.8 0.5 159.8 3.4 562.0 0.7 0.3 0.8 6.5 35.7 7.5 724.7 0.0 8.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.0 27.8 0.2 0.0 0.3 4.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.6 0.0 44.2 0.1 0.2 0.2 90.0 0.0 2.3 0.0 1.2 0.0 179.5 0.2 0.1 0.0 368.6 0.4 0.0 12.2 0.0 0.0 0.0 0.1 3.2 0.0 0.9 0.5 1.0 0.9 0.0 0.3 0.3 0.1 0.0 0.2 0.0 1.2 0.6 0.4 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.1 0.1 2.1 0.1 506.5 627.9 551.3 890.2 421.4 525.8 749.3 660.7 649.9 584.8 562.0 724.7 0.8 9.6 1.1 1.6 2.8 0.8 6.3 8.5 0.6 0.1 6.2 1.9 2.2 7.2 35.9 3.7 0.0 0.2 0.4 182.6 1.9 2.9 15.6 9.4 11.1 0.4 8.4 0.0 1.6 22.5 0.1 0.8 202.9 11.8 4.5 0.0 0.4 0.1 0.1 0.0 2.5 371.4 18.3 0.0 2.5 16.1 0.3 1.7 16.0 0.0 0.0 0.8 0.0 538.8 718.8 22.9 102.0 0.0 1.0 21.3 12.0 0.1 100.5 0.5 0.0 1.4 2.2 15.4 6.1 0.3 0.3 0.0 1.7 0.4 35.6 56.7 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 36.2 38.2 26.8 29.4 28.2 18.0 35.5 26.5 27.6 43.2 33.2 37.0 29.1 37.0 37.3 30.1 38.8 27.5 34.3 25.6 27.1 40.4 53.5 35.4 32.9 31.0 28.5 53.6 79.9 39.9 56.0 29.8 28.0 43.4 29.8 17.1 52.9 41.6 22.5 36.1 39.4 31.3 27.5 39.4 43.1 33.0 27.5 28.2 37.5 23.4 35.7 37.4 33.2 30.1 46.2 37.6 22.0 27.3 66.5 58.3 31.8 48.1 62.8 50.6 51.5 47.3 43.4 40.5 22.9 87.7 36.4 42.1 25.6 44.0 38.3 31.6 27.7 37.5 21.5 48.2 61.4 43.2 70.2 66.2 58.1 29.8 79.6 58.7 34.7 28.2 55.7 41.3 32.7 25.0 31.7 27.3 33.6 66.8 42.3 32.6 32.6 27.7 41.8 20.3 23.9 29.0 42.9 68.5 47.7 31.5 35.2 33.6 38.6 39.0 18.0 16.0 24.0 72.2 35.9 35.6 52.7 35.6 36.4 58.5 19.0 66.0 28.4 27.5 34.1 31.9 32.5 29.1 19.0 25.0 37.4 29.6 43.5 27.9 25.8 22.1 27.4 32.5 26.8 28.2 26.5 27.6 25.6 27.1 31.0 28.5 28.0 27.5 27.5 30.1 9.8 12.8 17.0 3.9 23.0 9.3 16.8 12.8 16.5 6.8 21.3 19.0 14.5 15.7 10.7 14.7 8.4 15.8 16.9 24.4 21.5 12.8 58.8 8.6 13.2 10.6 7.8 12.0 3.6 23.4 28.2 19.4 20.9 10.1 38.0 10.2 18.2 39.3 22.7 3.3 4.4 23.1 14.2 16.4 12.7 142.9 22.1 18.4 7.2 2.8 14.8 9.1 10.3 4.0 4.7 18.6 26.1 18.8 68.3 29.2 39.2 28.7 12.6 10.4 6.6 12.8 15.9 47.2 21.8 11.9 11.6 26.3 19.4 8.9 17.1 29.3 BLOC1S3 "BLOS3, HPS8" ENSG00000189114 "Biogenesis of lysosomal organelles complex 1 subunit 3" Q6QNY0 19 45178784-45216933 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050111, HPA070609" Approved Approved "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA050111: AB_2681019, HPA070609: " "unprognostic (1.17e-1)" "unprognostic (3.97e-2)" "unprognostic (6.94e-3)" "unprognostic (6.26e-2)" "unprognostic (3.14e-1)" "unprognostic (3.04e-2)" "unprognostic (1.75e-2)" "unprognostic (2.30e-2)" "unprognostic (2.01e-1)" "unprognostic (9.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.89e-9)" "unprognostic (1.92e-2)" "unprognostic (1.93e-1)" "unprognostic (3.29e-1)" "prognostic favorable (6.86e-4)" 6.7 6.3 7.8 5.9 7.8 12.4 5.7 7.0 8.2 5.7 4.4 5.7 5.3 5.6 5.9 6.4 4.7 3.2 5.2 7.5 6.4 5.7 7.8 5.5 7.6 9.3 8.0 5.6 6.1 4.8 4.4 3.9 8.4 5.7 4.3 3.3 5.6 4.5 4.4 13.2 6.7 4.1 6.8 11.0 7.6 7.2 8.1 4.7 4.7 3.4 7.5 6.6 5.9 9.2 10.4 11.6 3.2 8.1 10.8 7.3 9.7 5.1 8.2 9.5 9.8 7.0 6.6 9.0 12.2 11.9 10.8 16.0 8.5 11.6 6.8 7.9 17.3 12.3 5.5 8.0 15.4 6.0 19.5 10.8 16.3 12.3 17.3 5.4 10.6 5.9 13.2 18.2 5.6 17.8 6.2 9.2 1.8 14.9 14.5 8.9 4.3 7.5 7.0 13.2 6.3 6.0 13.6 22.8 5.1 5.6 9.4 11.1 5.7 9.7 5.5 10.4 8.2 12.7 14.0 6.1 10.6 11.1 7.5 51.1 34.4 30.2 37.4 42.8 31.0 18.4 31.6 28.3 21.4 24.8 25.5 25.5 35.2 24.2 39.9 18.5 29.8 17.8 7.8 7.8 7.0 8.2 7.5 6.4 9.3 8.0 8.4 6.8 8.1 9.2 3.4 0.0 1.7 1.0 5.4 12.7 2.6 1.7 2.2 5.7 4.2 3.2 2.3 1.5 1.5 3.7 0.0 3.7 5.9 4.6 1.9 4.4 17.7 1.9 3.2 5.2 7.2 1.7 2.7 3.7 4.0 3.2 2.0 2.7 8.2 3.0 6.1 6.3 6.1 5.0 2.8 5.0 0.0 8.8 8.9 39.3 6.2 4.7 3.6 1.0 6.8 3.4 11.3 3.5 2.9 5.1 3.2 7.9 4.0 4.9 4.6 4.2 1.7 2.0 0.0 1.9 3.1 1.5 5.1 2.7 13.9 4.5 6.7 3.0 4.1 1.9 BPIFB1 "bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP" ENSG00000125999 "BPI fold containing family B member 1" Q8TDL5 20 33273480-33309871 "Plasma proteins, Predicted secreted proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 566.8;salivary gland: 271.3;stomach 1: 512.5" "Cell type enriched" "Detected in many" 5 "Club cells: 5748.4" "Cancer enhanced" "Detected in many" "stomach cancer: 75.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.7;OE19: 3.8;RT4: 2.2;SK-BR-3: 4.3" "Region enriched" "Detected in single" 6 "olfactory bulb: 4.8" "Low region specificity" "Detected in many" HPA024256 Enhanced "Secreted in other tissues" NA NA 2700000 "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA024256: AB_1845664" "unprognostic (2.42e-1)" "unprognostic (5.41e-2)" "unprognostic (3.67e-2)" "unprognostic (3.09e-1)" "unprognostic (6.72e-2)" "unprognostic (3.43e-2)" "unprognostic (9.37e-3)" "unprognostic (1.14e-1)" "unprognostic (2.82e-1)" "unprognostic (4.00e-2)" "unprognostic (9.01e-2)" "unprognostic (1.36e-7)" "unprognostic (3.30e-1)" "unprognostic (5.03e-2)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" 0.1 0.1 0.0 0.0 0.3 0.0 0.9 0.0 0.1 566.8 0.0 0.5 25.6 0.0 0.0 47.1 0.1 3.4 0.0 0.4 0.0 0.0 0.1 112.5 0.2 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 1.2 0.0 0.0 271.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 512.5 3.5 0.0 0.2 0.0 0.0 1.2 8.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.6 3.8 0.0 0.4 0.0 0.1 0.0 2.2 0.0 0.0 0.0 4.3 0.0 0.0 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 22.7 0.0 0.0 1.3 1.4 614.0 0.0 0.0 2.0 1.3 0.4 2.8 5748.4 0.0 0.0 0.2 0.0 0.0 0.0 0.3 63.6 0.4 0.1 1.1 0.0 0.0 0.2 0.2 0.1 3.0 31.1 0.6 3.8 0.0 0.4 0.1 0.2 0.0 0.1 0.0 1021.3 0.0 1.9 82.9 0.3 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.7 0.0 2.0 0.0 0.0 1027.4 0.0 0.0 0.4 305.5 5.8 0.8 11.6 0.4 0.1 1.0 0.0 0.0 95.9 BX276092.9 ENSG00000283599 "Chromosome X open reading frame 49-like" X 71667542-71671524 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "testis: 8.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.3 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 8.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.6 0.6 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 265.5;skeletal muscle: 367.7;tongue: 258.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 278.2;Extravillous trophoblasts: 875.6;Syncytiotrophoblasts: 762.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 26.1 18.1 8.5 26.8 10.1 45.7 49.7 6.9 14.3 19.1 9.7 51.2 28.9 18.4 9.9 42.6 20.2 17.2 265.5 10.2 6.3 37.8 18.4 20.0 30.0 5.2 6.3 16.0 30.0 6.7 10.4 80.4 6.5 19.3 56.8 88.0 23.8 34.3 367.7 55.5 30.0 39.0 5.6 16.5 50.2 11.6 6.9 33.0 36.5 258.9 38.4 59.5 26.2 8.8 91.7 81.3 138.2 201.7 67.5 118.3 125.7 126.0 156.3 117.6 124.9 201.8 129.7 208.0 143.7 96.9 87.6 181.6 164.8 141.5 152.0 27.8 99.8 129.6 84.4 117.0 70.5 180.3 79.1 90.6 74.6 104.0 187.7 92.4 171.6 149.7 251.9 43.5 96.9 105.0 90.0 210.4 143.9 259.5 174.1 111.0 91.2 216.6 113.4 152.6 179.9 106.8 50.8 419.9 67.7 156.7 187.8 149.5 97.6 93.1 119.1 141.5 136.3 89.5 92.8 288.1 45.5 220.6 340.3 2.6 46.0 5.0 27.3 55.2 44.6 44.6 39.8 36.9 98.8 42.9 56.8 47.1 2.1 56.8 41.6 38.5 31.8 44.0 8.5 10.1 6.9 14.3 10.2 6.3 5.2 6.3 6.5 5.6 6.9 8.8 32.8 22.4 60.5 3.9 30.0 57.6 69.9 60.5 82.6 55.9 52.3 57.0 278.2 17.2 53.9 47.8 64.6 214.3 26.8 42.4 58.7 47.5 9.8 31.9 43.2 42.9 30.5 63.5 48.6 65.6 875.6 43.5 110.1 40.6 21.0 33.3 8.9 13.7 65.0 6.7 32.0 49.5 61.1 33.4 46.0 6.4 12.2 30.7 24.9 12.2 47.5 19.7 19.6 19.1 17.9 47.0 42.9 9.8 31.9 52.0 19.2 20.8 32.6 106.4 6.6 30.2 54.2 11.3 4.1 99.6 51.6 762.9 29.3 52.6 90.6 79.0 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991099-67996469 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 35.6" "Cell type enhanced" "Detected in many" "Fibroblasts: 51.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 55.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 37.3" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 11.9 5.4 5.2 2.8 5.5 3.9 16.9 5.4 10.0 26.8 4.8 8.4 4.0 15.1 6.9 5.1 7.8 4.7 5.9 5.7 5.3 6.1 9.4 3.4 3.2 5.4 5.3 4.8 4.8 3.2 2.0 35.6 5.1 5.8 7.3 8.9 4.3 3.6 3.5 3.5 4.6 10.9 5.5 2.3 6.8 3.0 5.2 2.1 6.8 7.3 7.1 8.8 7.6 5.5 9.8 9.5 9.3 11.6 6.6 16.6 7.3 4.0 11.4 6.9 11.2 5.6 12.4 13.0 8.9 3.3 12.1 4.9 21.3 8.6 16.6 23.5 21.5 8.4 3.2 17.8 10.4 7.2 14.9 9.2 10.2 6.7 15.4 7.7 32.7 11.2 18.2 19.6 6.7 13.1 1.3 9.5 10.7 23.6 10.0 3.1 10.2 17.4 8.7 6.5 6.9 12.5 6.0 55.5 20.8 11.4 15.8 8.2 6.1 5.8 5.9 4.2 8.5 38.9 30.9 11.6 14.8 12.6 10.5 8.6 2.8 5.0 2.2 2.9 0.7 3.0 0.8 1.7 3.9 0.5 0.3 0.8 1.1 2.7 5.0 0.1 0.4 1.8 5.2 5.5 5.4 10.0 5.7 5.3 5.4 5.3 5.1 5.5 5.2 5.5 21.6 0.0 1.7 6.2 3.5 4.8 5.5 5.6 7.4 8.9 31.0 21.8 4.7 12.8 6.1 11.0 10.4 28.6 4.1 10.5 23.5 10.1 0.9 21.0 40.5 16.3 3.6 8.4 5.0 9.3 21.7 51.6 19.9 19.4 12.7 3.8 14.3 18.5 16.9 5.0 4.6 15.0 10.2 9.7 21.5 2.8 3.7 7.3 8.8 2.8 18.4 31.9 12.3 3.0 4.6 10.7 10.0 5.3 7.0 11.6 10.9 19.7 16.5 15.6 6.6 36.2 14.1 7.3 6.0 20.7 8.4 15.3 4.1 8.3 10.1 7.6 C8orf76 FLJ14825 ENSG00000189376 "Chromosome 8 open reading frame 76" Q96K31 8 123219967-123241377 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 136.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 164.9" HPA023708 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA023708: AB_1845785" "prognostic unfavorable (9.95e-4)" "unprognostic (1.61e-1)" "unprognostic (9.71e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.27e-1)" "unprognostic (6.78e-2)" "unprognostic (4.47e-3)" "unprognostic (1.48e-2)" "unprognostic (2.49e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-1)" "unprognostic (7.80e-2)" "prognostic unfavorable (5.95e-11)" "unprognostic (1.54e-2)" "unprognostic (1.94e-1)" "unprognostic (3.26e-1)" "unprognostic (2.71e-2)" 10.5 14.1 12.0 9.5 12.8 12.6 10.8 13.3 15.0 9.3 13.3 10.8 9.4 7.7 11.4 15.4 8.9 8.7 13.0 12.0 12.6 9.2 18.4 9.4 14.1 12.3 12.5 8.3 10.8 7.7 17.3 12.2 12.4 10.5 11.8 11.0 12.5 8.1 15.2 8.4 11.1 7.8 12.7 14.3 10.0 7.3 12.6 13.9 9.8 7.9 13.9 10.5 10.3 13.4 24.7 22.4 20.3 14.3 19.5 17.8 13.9 22.7 22.0 26.0 26.1 20.5 17.5 16.8 24.4 21.9 19.4 18.4 22.9 12.4 29.3 27.0 31.9 19.7 10.1 28.0 35.0 10.5 15.6 13.1 23.3 23.3 19.4 15.2 23.4 25.9 28.6 12.8 21.9 72.3 30.7 23.1 16.6 59.4 37.6 16.1 10.4 19.3 22.4 20.1 26.7 24.8 22.7 164.9 25.0 20.6 20.2 24.7 12.9 14.8 28.3 16.1 19.0 16.8 19.8 18.2 15.9 23.7 16.3 19.9 18.3 28.3 13.6 21.4 14.4 11.7 14.8 17.6 19.2 14.8 14.0 14.1 10.9 15.0 18.1 16.8 21.3 13.2 12.0 12.8 13.3 15.0 12.0 12.6 12.3 12.5 12.4 12.7 12.6 13.4 12.4 12.8 2.0 7.2 17.7 13.5 17.8 29.0 17.1 8.2 13.8 13.8 5.9 7.2 25.4 1.8 10.4 27.4 23.4 21.3 5.9 16.4 5.1 10.7 15.4 11.7 24.7 8.6 6.8 11.8 31.5 15.1 8.2 11.5 22.2 10.8 8.9 11.1 22.6 136.3 8.2 12.5 32.6 14.5 17.7 4.0 12.8 16.3 14.2 3.7 21.7 12.9 20.6 3.5 8.8 14.8 13.8 7.5 19.1 21.6 19.4 11.2 48.3 7.7 19.7 11.5 28.7 14.4 17.1 12.6 11.5 40.2 18.1 8.8 15.7 39.9 CACNA1I Cav3.3 ENSG00000100346 "Calcium voltage-gated channel subunit alpha1 I" Q9P0X4 22 39570753-39689735 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;thyroid gland: 5.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 16.9;Excitatory neurons: 16.8;Inhibitory neurons: 12.3" "Cancer enriched" "Detected in single" 5 "thyroid cancer: 2.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-BR-3: 1.9;T-47d: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066992 Uncertain "Plasma membrane,Cell Junctions" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "Cell Junctions" "HPA066992: " "unprognostic (3.97e-2)" "unprognostic (1.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.60e-2)" "unprognostic (3.52e-2)" "unprognostic (1.58e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-1)" "unprognostic (7.21e-2)" "unprognostic (5.20e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-2)" "unprognostic (6.14e-3)" "unprognostic (1.57e-1)" "unprognostic (3.78e-2)" "unprognostic (8.27e-4)" 0.2 3.3 5.0 0.8 5.6 0.6 0.1 1.5 9.7 0.1 0.0 0.5 0.1 0.1 0.0 0.2 0.2 0.1 0.0 8.7 1.3 0.1 0.0 0.5 1.9 7.6 1.4 0.0 0.1 0.0 0.3 0.0 7.9 0.1 0.0 2.6 0.1 0.0 0.0 0.2 3.3 0.0 0.7 1.5 0.6 0.8 2.2 0.2 5.3 0.0 0.5 0.4 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.1 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 5.0 5.6 1.5 9.7 8.7 1.3 7.6 1.4 7.9 0.7 2.2 4.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 16.9 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 0.0 0.1 0.0 0.4 16.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 3.3 12.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 1.0 2.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.1 0.1 CACNB1 CACNLB1 ENSG00000067191 "Calcium voltage-gated channel auxiliary subunit beta 1" Q02641 17 39173453-39197703 "FDA approved drug targets, Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 328.8;tongue: 216.0" "Cell type enhanced" "Detected in many" "Astrocytes: 20.9;Excitatory neurons: 14.3;Skeletal myocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023343 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "HPA023343: AB_1845866" "unprognostic (3.44e-2)" "unprognostic (1.89e-2)" "unprognostic (1.69e-3)" "prognostic unfavorable (3.80e-4)" "unprognostic (3.99e-2)" "unprognostic (1.52e-2)" "unprognostic (1.37e-2)" "unprognostic (2.80e-3)" "unprognostic (4.43e-1)" "unprognostic (1.04e-3)" "unprognostic (5.98e-2)" "unprognostic (3.38e-1)" "unprognostic (1.94e-11)" "unprognostic (7.62e-2)" "unprognostic (2.30e-1)" "unprognostic (1.34e-2)" "unprognostic (7.44e-3)" 5.7 3.6 17.8 2.6 23.7 1.4 5.6 0.0 31.7 12.2 0.0 7.6 1.5 6.3 5.4 6.8 6.9 2.1 7.5 23.4 10.9 3.2 0.9 9.3 2.5 4.4 5.9 6.7 2.6 1.6 7.7 1.7 13.0 8.1 2.5 5.5 13.5 5.4 328.8 12.1 4.1 2.9 1.0 4.7 3.7 7.6 5.0 4.4 6.8 216.0 1.8 6.5 6.5 20.4 6.1 2.7 3.3 7.6 3.6 4.4 0.1 3.6 4.4 3.3 4.1 2.0 6.0 10.4 3.6 5.4 4.7 5.6 3.2 5.9 2.4 5.0 3.7 1.5 7.4 0.8 7.4 0.2 0.9 4.9 1.9 6.9 7.8 4.3 2.4 6.4 0.9 8.9 3.5 1.7 7.6 2.8 2.4 0.9 1.9 5.1 10.9 4.6 1.3 1.9 8.3 5.0 2.1 11.2 3.5 1.2 7.9 4.1 3.4 5.9 6.8 4.4 3.7 4.1 1.5 1.7 4.8 0.0 2.4 0.0 0.4 0.0 0.6 0.1 0.9 0.0 0.6 0.8 0.1 0.0 0.2 0.3 0.0 0.6 0.1 1.0 0.1 0.2 17.8 23.7 0.0 31.7 23.4 10.9 4.4 5.9 13.0 1.0 5.0 20.4 1.4 3.2 3.2 20.9 0.8 2.9 0.7 2.3 2.8 3.1 1.5 1.1 1.7 0.0 2.2 0.0 0.0 0.1 4.0 7.1 0.0 0.6 4.2 1.1 3.3 1.5 0.0 0.4 14.3 0.9 0.1 4.9 2.6 1.7 0.0 2.1 0.4 0.1 1.0 0.0 8.3 1.4 4.1 0.8 5.1 2.4 1.8 1.6 5.4 1.0 0.6 7.2 1.0 2.5 2.1 1.5 1.0 1.2 2.3 2.4 0.0 0.0 0.8 1.4 0.0 13.4 7.0 2.9 0.8 1.1 3.0 0.1 4.6 1.6 1.0 1.1 CAMK2G CAMKG ENSG00000148660 "Calcium/calmodulin dependent protein kinase II gamma" Q13555 10 73812501-73874591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Neurogenesis" "Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 154.3" "Cell type enhanced" "Detected in many" "Astrocytes: 410.7;Cytotrophoblasts: 163.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 133.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 154.8;SK-BR-3: 177.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040656, HPA051783, HPA051785, HPA053973" Approved Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA 200000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane" "Cell Junctions, Cytosol" "HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328" "unprognostic (8.63e-3)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (3.46e-3)" "unprognostic (4.27e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-2)" "unprognostic (2.36e-1)" "unprognostic (2.48e-1)" "unprognostic (6.25e-2)" "unprognostic (2.92e-2)" "unprognostic (1.08e-1)" "unprognostic (1.73e-2)" "unprognostic (2.48e-1)" "unprognostic (8.28e-2)" "unprognostic (9.64e-2)" "unprognostic (4.62e-2)" 22.0 14.0 86.1 17.0 92.6 34.5 15.2 79.9 137.8 24.1 44.1 101.1 34.2 45.2 14.5 34.7 30.6 17.8 11.8 91.3 79.0 19.3 14.5 18.8 16.2 96.1 96.5 12.7 10.3 12.3 14.1 27.3 94.1 31.1 26.1 42.4 22.9 49.6 154.3 17.3 41.5 43.9 91.4 24.9 30.4 6.5 102.5 15.7 13.6 84.8 14.9 58.4 25.8 91.9 35.7 24.6 22.5 43.9 16.7 26.1 26.3 25.8 41.0 31.9 26.1 39.8 37.2 27.4 25.7 32.4 12.4 54.9 17.5 20.5 25.3 24.0 22.2 18.2 20.4 17.8 8.1 24.7 29.1 14.4 17.7 32.5 22.1 50.4 28.3 32.5 19.5 37.9 19.0 25.2 41.7 37.5 16.5 21.3 154.8 36.5 25.3 13.7 17.2 51.5 11.5 28.4 15.0 177.4 11.9 16.5 33.2 15.0 36.7 24.9 40.0 13.4 33.3 11.9 14.9 24.8 26.5 69.2 8.8 31.0 17.9 133.9 23.1 7.9 28.5 13.9 26.3 25.0 23.0 12.7 24.5 24.1 115.8 34.0 15.1 7.9 27.7 17.5 86.1 92.6 79.9 137.8 91.3 79.0 96.1 96.5 94.1 91.4 102.5 91.9 19.3 16.0 11.7 410.7 22.2 9.4 8.7 9.2 14.2 63.3 14.8 16.3 6.7 12.8 15.5 7.3 100.1 163.6 21.3 46.2 13.7 13.3 2.0 6.3 6.4 20.2 23.9 13.3 107.9 19.6 45.2 12.0 14.8 7.5 16.5 20.2 16.4 9.6 27.2 26.9 89.7 24.8 10.2 18.9 16.3 3.1 12.8 15.8 12.4 43.1 18.3 17.7 26.8 61.9 16.9 22.0 65.5 18.8 13.6 8.2 77.1 26.9 10.4 77.0 46.0 11.2 50.8 0.8 13.5 26.5 12.6 81.1 30.3 5.2 32.1 13.7 CAMKMT "C2orf34, CLNMT" ENSG00000143919 "Calmodulin-lysine N-methyltransferase" Q7Z624 2 44361947-44772592 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 155.1;Excitatory neurons: 88.7;Inhibitory neurons: 93.7;Microglial cells: 114.3;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 211.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067912 Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA067912: AB_2685922" "unprognostic (2.28e-1)" "unprognostic (6.15e-2)" "unprognostic (1.96e-1)" "unprognostic (2.39e-2)" "prognostic favorable (9.10e-4)" "unprognostic (1.03e-1)" "unprognostic (9.58e-3)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (7.42e-2)" "unprognostic (8.76e-2)" "unprognostic (1.37e-1)" "unprognostic (3.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.66e-2)" "unprognostic (1.70e-1)" "unprognostic (8.57e-2)" 4.2 5.3 15.9 3.9 21.1 10.2 5.3 19.4 21.1 5.9 17.8 7.0 5.3 4.1 6.5 6.1 4.9 5.7 5.0 15.5 17.1 7.5 4.8 3.9 5.4 17.7 16.4 3.9 9.8 9.8 5.6 3.3 17.3 3.5 6.8 8.5 4.8 3.9 7.8 5.8 5.7 3.9 15.5 3.7 5.8 13.2 17.9 6.2 7.3 3.3 5.4 4.5 4.7 20.4 10.2 6.2 7.4 6.8 8.0 8.1 15.0 7.4 6.0 4.3 5.5 11.9 9.0 9.6 8.6 5.6 5.3 8.3 10.6 13.2 7.6 35.2 13.3 14.2 12.1 22.4 3.1 9.4 9.5 2.6 8.0 5.9 10.9 6.1 6.4 9.9 10.4 17.1 7.1 10.9 17.6 19.1 13.9 24.6 6.1 10.3 8.3 19.4 20.8 11.6 14.0 13.4 7.6 24.1 9.2 7.0 8.8 7.7 7.6 5.5 6.4 6.1 5.9 13.3 11.5 18.2 6.1 16.5 3.9 13.1 8.2 6.2 11.1 6.9 11.5 20.9 11.2 9.7 9.7 14.7 16.9 13.4 5.2 8.7 8.4 10.1 18.3 6.9 15.9 21.1 19.4 21.1 15.5 17.1 17.7 16.4 17.3 15.5 17.9 20.4 5.4 6.4 3.1 155.1 11.0 5.2 7.9 10.9 9.1 5.3 6.6 5.2 2.2 10.0 5.5 9.2 0.0 3.3 6.9 4.5 23.5 13.3 74.3 8.2 7.2 4.0 0.0 13.3 88.7 15.6 4.5 6.2 11.7 10.0 5.7 2.0 3.3 6.3 5.8 1.7 93.7 5.5 20.3 1.9 4.9 39.0 8.1 4.3 10.6 114.3 6.4 20.3 13.4 121.2 211.7 8.6 8.3 5.7 13.3 5.8 7.2 14.5 7.4 3.0 0.0 3.6 5.0 35.5 5.8 10.7 7.4 2.6 9.2 7.9 8.1 6.0 CAPN13 FLJ23523 ENSG00000162949 "Calpain 13" Q6MZZ7 2 30722771-30820542 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 29.2;stomach 1: 28.5" "Cell type enhanced" "Detected in many" "Club cells: 76.6;Gastric mucus-secreting cells: 50.0;Proximal enterocytes: 35.2;Undifferentiated cells: 18.1;Urothelial cells: 19.4" "Cancer enhanced" "Detected in many" "endometrial cancer: 11.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "RT4: 9.3;SK-BR-3: 21.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029496, HPA029497, HPA030034" Uncertain Approved Nucleoplasm NA NA "Cluster 9: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281" "unprognostic (7.42e-2)" "unprognostic (1.19e-1)" "unprognostic (7.01e-3)" "unprognostic (1.96e-1)" "unprognostic (8.56e-2)" "unprognostic (1.51e-1)" "unprognostic (1.68e-1)" "unprognostic (1.32e-3)" "unprognostic (2.17e-1)" "unprognostic (2.66e-2)" "unprognostic (1.11e-1)" "unprognostic (2.49e-1)" "unprognostic (1.96e-2)" "unprognostic (3.64e-1)" "unprognostic (3.32e-2)" "unprognostic (5.03e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.8 0.0 1.4 0.0 7.2 0.9 1.3 9.7 1.0 11.4 20.8 0.2 0.3 0.9 1.1 2.8 0.0 0.7 0.8 2.5 0.2 7.2 0.0 1.1 1.3 0.0 3.6 0.4 0.2 0.0 1.0 3.8 24.6 0.0 1.2 0.1 0.0 0.2 29.2 0.2 1.0 0.1 28.5 0.1 1.1 0.0 0.0 0.0 0.6 4.1 0.5 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 9.3 0.1 0.4 0.0 21.9 0.0 0.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.9 1.3 0.7 0.8 1.1 1.3 1.0 1.0 1.1 2.3 0.0 6.4 3.1 0.3 0.0 0.0 10.2 3.5 4.0 0.0 4.2 1.8 1.3 0.0 76.6 1.8 0.0 0.0 0.0 16.9 0.0 1.3 0.8 2.0 0.0 0.1 15.0 0.0 0.3 5.3 0.0 0.6 50.0 0.7 1.3 0.0 0.0 0.0 0.0 0.0 1.5 12.0 6.1 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 8.4 1.9 6.2 0.0 0.0 2.7 35.2 0.2 12.4 0.0 0.0 0.0 6.1 0.0 0.1 1.4 0.0 0.0 0.1 0.0 18.1 19.4 CAPS "CAPS1, MGC126562" ENSG00000105519 Calcyphosine Q13938 19 5912339-5916211 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 334.8" "Group enriched" "Detected in many" 6 "Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4" "Cancer enriched" "Detected in all" 5 "endometrial cancer: 171.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8" "Low region specificity" "Detected in all" HPA043520 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA043520: AB_10964138" "unprognostic (2.06e-1)" "unprognostic (1.13e-2)" "unprognostic (7.94e-3)" "prognostic favorable (7.63e-5)" "unprognostic (5.18e-1)" "prognostic favorable (8.60e-4)" "unprognostic (7.07e-2)" "unprognostic (2.46e-3)" "unprognostic (1.51e-1)" "unprognostic (1.82e-1)" "unprognostic (4.70e-2)" "unprognostic (9.99e-2)" "unprognostic (4.01e-2)" "unprognostic (8.47e-2)" "unprognostic (3.25e-1)" "unprognostic (6.86e-3)" "unprognostic (5.96e-3)" 12.2 25.9 37.5 10.9 35.1 10.0 11.6 55.0 30.1 47.2 55.4 16.1 6.9 21.7 4.6 12.9 334.8 11.2 13.5 40.2 69.6 38.3 21.5 49.5 12.2 72.6 105.3 13.8 24.0 3.3 27.9 9.3 85.7 40.4 2.8 2.2 24.9 30.9 4.3 16.2 18.7 2.3 60.9 25.2 37.5 6.4 50.0 5.7 30.8 1.1 4.2 44.2 13.7 66.1 2.2 2.3 0.9 6.3 2.1 3.2 4.0 0.7 0.7 0.3 0.6 1.5 13.8 0.9 4.0 1.5 0.7 2.3 0.1 0.6 0.0 4.7 1.9 0.8 4.8 4.7 2.5 0.8 3.5 4.1 4.2 0.4 0.8 4.0 1.0 4.7 0.7 5.4 0.7 4.4 2.4 4.0 0.7 19.4 12.6 3.1 0.3 4.7 1.8 6.2 1.0 4.9 1.0 65.1 6.6 2.0 4.3 4.7 1.5 0.6 0.4 4.6 17.1 19.8 6.5 1.1 7.7 1.8 2.8 0.4 0.7 0.3 1.7 0.6 0.9 0.9 1.0 1.3 0.8 1.8 0.8 0.7 0.7 1.8 0.4 1.5 1.0 0.8 37.5 35.1 55.0 30.1 40.2 69.6 72.6 105.3 85.7 60.9 50.0 66.1 5.3 12.8 16.5 11.1 3.3 4.8 32.1 122.8 1.8 2.5 8.9 8.8 2.2 0.0 161.5 121.4 4.2 24.3 7.4 5.3 35.2 34.7 6.5 2622.9 48.3 5.5 19.2 0.4 2.6 5.9 22.8 12.9 33.6 330.8 6.3 8.1 0.0 0.0 5.2 6.7 3.2 25.1 197.4 0.0 5.9 5.7 4.7 6.6 10.6 6.5 3.0 7.7 9.2 3.5 12.9 36.9 3.3 4.9 3.8 20.4 4.2 4.5 1557.4 4.2 6.6 3.5 42.7 0.4 0.6 0.9 4.1 20.5 9.2 3.3 9.3 128.6 CAPZA2 "CAPPA2, CAPZ" ENSG00000198898 "Capping actin protein of muscle Z-line subunit alpha 2" P47755 7 116811070-116922049 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007470, HPA007643" Uncertain Approved Cytosol No No 4500000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA007470: AB_1845985, HPA007643: AB_2667886" "unprognostic (1.37e-2)" "unprognostic (2.25e-3)" "unprognostic (4.16e-2)" "unprognostic (3.16e-1)" "unprognostic (1.53e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (9.34e-5)" "unprognostic (1.90e-2)" "unprognostic (1.80e-2)" "unprognostic (2.15e-1)" "unprognostic (2.08e-3)" "unprognostic (2.52e-1)" "prognostic favorable (3.65e-6)" "unprognostic (1.40e-1)" "unprognostic (1.08e-1)" "unprognostic (2.91e-3)" "unprognostic (6.58e-2)" 26.3 20.1 17.0 20.0 17.3 43.3 21.8 22.5 25.8 18.0 16.9 24.4 20.4 19.7 19.0 20.8 14.2 20.7 45.7 21.3 17.5 37.3 33.9 23.8 20.1 17.0 17.1 12.6 13.4 19.4 7.5 24.9 20.5 20.3 23.9 13.4 14.6 20.5 64.3 12.3 23.4 28.1 14.5 22.3 20.0 8.7 19.6 16.4 22.8 53.1 17.3 28.1 11.3 18.3 30.0 19.5 19.8 25.2 35.9 37.8 9.8 28.7 41.3 28.8 32.7 14.5 38.1 20.8 46.5 41.3 36.1 18.2 20.4 24.1 45.4 22.7 14.9 31.3 18.0 24.6 22.2 21.2 40.9 30.2 26.9 22.9 21.9 34.8 63.2 12.9 20.8 35.2 57.9 13.0 28.3 35.6 29.5 31.3 16.8 19.7 26.2 42.1 69.3 24.6 20.6 23.5 27.7 104.1 29.7 25.0 14.5 25.0 23.0 47.0 14.6 37.5 28.5 27.7 21.0 39.6 28.0 29.6 34.0 57.3 34.8 45.6 11.1 45.6 13.2 14.4 13.5 11.9 33.2 12.6 12.9 13.1 69.4 15.9 54.9 18.1 18.1 45.3 17.0 17.3 22.5 25.8 21.3 17.5 17.0 17.1 20.5 14.5 19.6 18.3 177.9 73.7 67.4 44.4 109.4 243.1 219.8 224.3 94.4 106.6 85.1 67.3 219.4 71.4 146.5 171.0 27.1 151.7 96.2 147.4 516.5 193.1 9.6 139.4 113.7 189.5 121.2 263.9 59.2 160.3 204.0 124.8 103.5 340.1 126.2 48.8 262.3 110.6 314.1 107.7 48.0 102.6 286.8 238.5 274.9 16.2 74.6 262.9 181.5 64.6 222.4 164.5 72.1 49.8 47.1 193.1 147.5 110.9 83.0 140.9 182.6 519.7 99.7 95.9 92.1 122.8 188.9 43.1 47.0 94.1 218.8 144.1 108.6 78.7 109.9 207.0 CASC3 "BTZ, MLN51" ENSG00000108349 "CASC3 exon junction complex subunit" O15234 17 40140318-40172171 "Cancer-related genes, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 239.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024592, HPA050262" Approved Approved "Nuclear membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear membrane" "HPA024592: AB_1846034, HPA050262: AB_2681067" "unprognostic (3.76e-2)" "unprognostic (3.18e-1)" "unprognostic (2.00e-1)" "unprognostic (1.00e-1)" "unprognostic (1.98e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-3)" "unprognostic (3.40e-3)" "unprognostic (3.38e-1)" "unprognostic (1.16e-2)" "unprognostic (3.29e-3)" "unprognostic (2.87e-1)" "unprognostic (1.66e-2)" "unprognostic (1.15e-1)" "unprognostic (3.41e-1)" "unprognostic (1.27e-1)" "unprognostic (1.48e-2)" 45.5 27.9 88.0 29.9 96.9 37.2 38.5 79.3 95.1 41.0 62.2 48.2 22.9 49.5 38.2 30.3 46.9 25.0 24.8 77.0 90.4 29.0 20.8 35.4 34.1 94.3 88.4 55.6 33.3 35.0 26.0 30.3 89.3 36.1 31.9 39.0 31.8 47.9 55.4 38.1 32.2 47.7 84.9 34.1 35.3 54.1 94.0 40.1 40.4 43.5 37.6 47.7 33.3 96.6 44.6 44.9 58.5 64.9 46.1 48.2 34.3 45.5 40.6 61.3 52.5 48.3 38.3 81.7 67.2 57.7 50.4 77.8 71.8 48.0 83.5 54.8 58.1 58.6 55.4 50.6 42.0 74.7 39.6 50.2 43.9 59.9 93.6 46.8 77.4 45.8 64.0 61.5 50.8 25.6 110.9 44.3 44.5 39.8 26.0 67.3 74.5 85.9 32.1 39.5 85.4 49.8 63.8 239.4 59.4 91.1 78.2 58.9 50.0 51.7 53.3 48.7 71.0 56.5 56.3 81.1 50.4 40.2 57.1 7.8 9.4 13.1 12.5 11.5 11.1 8.6 9.3 11.5 10.0 8.6 10.5 10.4 35.9 10.2 18.2 5.8 9.1 8.6 88.0 96.9 79.3 95.1 77.0 90.4 94.3 88.4 89.3 84.9 94.0 96.6 32.8 19.2 36.8 31.0 29.5 19.8 22.9 11.3 31.3 40.8 38.5 32.5 26.7 14.3 31.8 23.9 22.9 19.9 38.0 21.4 21.5 17.8 14.8 30.2 38.8 34.0 31.2 23.5 29.0 24.3 21.3 26.9 26.0 31.4 16.4 32.5 23.9 21.9 17.0 30.3 32.8 20.8 18.3 26.4 29.2 24.5 36.1 25.8 35.6 22.5 23.9 23.5 26.8 15.1 34.5 21.0 17.6 29.7 26.5 27.2 17.3 18.1 27.2 38.5 13.1 42.0 40.2 59.4 67.7 28.1 19.9 27.1 30.1 22.7 20.6 24.7 CBX2 "CDCA6, MGC10561" ENSG00000173894 "Chromobox 2" Q14781 17 79778148-79787983 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Sexual differentiation, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.3;testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "REH: 96.4;SK-BR-3: 134.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023083 Approved Supported Nucleoplasm NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA023083: AB_2671063" "unprognostic (1.37e-2)" "unprognostic (1.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.72e-2)" "unprognostic (2.25e-11)" "unprognostic (1.05e-1)" "unprognostic (7.77e-2)" "unprognostic (6.34e-3)" "unprognostic (1.86e-3)" "unprognostic (1.66e-1)" "unprognostic (1.25e-8)" "unprognostic (1.34e-1)" "unprognostic (3.33e-2)" "unprognostic (2.37e-3)" "unprognostic (2.07e-1)" 1.4 0.3 1.1 0.7 0.9 2.2 1.2 0.8 0.9 1.3 0.5 0.5 0.4 1.2 1.8 4.2 1.0 0.6 2.3 0.8 0.7 1.6 0.4 1.2 1.3 1.0 0.9 2.1 1.3 0.5 0.2 2.2 1.1 0.6 0.2 0.5 0.9 0.5 0.7 2.1 0.6 0.7 0.8 1.6 0.5 12.8 1.0 7.3 0.5 1.1 1.3 1.0 1.6 1.0 7.5 20.5 37.0 67.4 0.4 0.5 13.2 2.7 1.2 1.3 2.4 21.2 1.7 29.7 5.8 0.3 4.7 3.8 43.0 1.2 0.9 4.3 23.3 1.5 24.0 14.2 1.4 9.0 6.1 0.7 2.6 0.7 1.7 1.6 7.5 31.3 20.8 2.3 1.4 31.3 47.3 22.1 36.8 10.3 23.4 96.4 27.7 18.0 1.5 10.5 45.1 69.8 11.7 134.7 8.0 17.6 24.5 13.4 5.4 13.1 38.4 4.0 5.3 8.7 4.8 18.3 0.5 24.1 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.8 0.9 0.8 0.7 1.0 0.9 1.1 0.8 1.0 1.0 5.3 0.0 0.0 0.3 0.1 1.0 0.3 0.4 0.0 1.0 0.6 1.8 2.5 0.0 0.3 1.8 2.1 0.4 2.9 0.4 1.9 3.6 32.5 0.9 1.8 8.6 0.0 5.9 0.1 0.9 1.4 0.8 1.1 1.8 0.0 10.4 3.6 1.1 1.2 0.0 0.0 0.8 0.0 0.6 0.9 39.1 0.6 0.5 3.6 0.0 0.8 4.3 0.0 0.0 0.3 1.1 0.0 0.7 0.5 0.7 0.0 0.8 0.1 0.4 0.0 0.3 1.0 1.6 14.3 4.1 1.4 0.3 1.2 0.9 0.5 0.9 CBX8 "HPC3, PC3, RC1" ENSG00000141570 "Chromobox 8" Q9HC52 17 79792132-79801683 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031462 Approved Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA031462: AB_10601252" "unprognostic (4.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" "unprognostic (8.81e-2)" "unprognostic (3.26e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.94e-6)" "unprognostic (2.92e-2)" "unprognostic (1.29e-1)" "unprognostic (6.26e-2)" "prognostic favorable (3.84e-5)" "unprognostic (4.74e-1)" "prognostic unfavorable (5.39e-7)" "unprognostic (6.99e-3)" "unprognostic (7.18e-2)" "unprognostic (4.51e-1)" "unprognostic (5.99e-2)" 4.3 3.3 1.9 2.5 1.8 2.1 3.3 1.9 1.8 3.3 1.9 2.5 2.9 2.4 10.9 2.9 8.5 1.9 3.8 1.6 1.9 7.3 5.6 3.2 3.1 2.0 1.9 2.1 3.6 6.6 7.6 2.5 2.1 2.2 0.7 4.5 2.5 2.0 2.4 2.9 2.7 1.1 1.4 3.0 2.8 10.9 2.3 3.8 3.0 0.8 2.0 2.0 1.8 2.9 12.4 24.9 6.5 23.7 3.5 2.2 8.0 6.2 4.4 5.2 3.6 13.6 6.2 9.1 17.1 3.5 4.6 11.6 8.5 1.9 2.3 7.0 11.9 3.3 13.9 14.8 4.1 13.8 27.4 1.9 3.8 3.3 0.9 5.2 1.1 10.7 8.2 4.0 1.6 15.2 15.7 20.3 2.7 9.0 13.4 14.5 5.8 16.9 4.1 8.5 9.5 19.3 8.9 28.2 14.8 2.3 14.8 17.7 2.8 10.9 15.0 4.4 9.9 11.3 4.8 6.0 6.8 13.5 6.2 0.9 5.0 15.0 3.2 6.8 1.1 4.5 1.8 1.9 5.7 1.8 1.7 1.7 6.3 3.3 7.3 4.6 1.9 2.0 1.9 1.8 1.9 1.8 1.6 1.9 2.0 1.9 2.1 1.4 2.3 2.9 2.3 0.0 0.5 0.7 2.8 1.8 1.2 4.4 4.0 5.3 2.7 2.2 4.1 8.6 2.3 3.7 8.4 7.1 4.1 3.9 0.0 4.6 2.8 15.6 4.9 2.1 9.1 0.0 0.2 5.4 2.8 2.4 5.6 5.2 5.7 2.3 0.7 2.5 5.0 8.4 0.3 7.1 2.0 2.2 1.0 0.4 0.9 2.3 1.8 0.0 1.9 7.2 2.1 0.0 1.0 4.4 5.1 2.2 2.7 0.9 4.3 2.3 5.4 11.0 0.0 0.6 3.9 6.2 11.5 3.8 1.1 2.5 3.4 4.0 4.7 0.4 CCDC6 "D10S170, H4, PTC, TPC, TST1" ENSG00000108091 "Coiled-coil domain containing 6" Q16204 10 59788747-59906556 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019049, HPA019051" Enhanced Supported Cytosol No No 12000 "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol "HPA019049: AB_1846163, HPA019051: AB_1846164" "unprognostic (1.88e-2)" "unprognostic (1.72e-2)" "unprognostic (4.41e-2)" "unprognostic (1.25e-3)" "unprognostic (5.98e-3)" "prognostic favorable (5.48e-4)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.39e-2)" "unprognostic (2.45e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.95e-4)" "unprognostic (4.08e-1)" "unprognostic (4.69e-2)" "unprognostic (2.23e-1)" "unprognostic (2.56e-1)" "unprognostic (9.95e-2)" "unprognostic (4.19e-2)" 11.9 12.2 21.1 13.9 23.4 16.8 22.4 10.2 20.0 23.4 8.5 23.5 22.8 24.9 16.7 34.1 25.3 16.7 10.0 24.9 21.4 21.2 12.1 17.3 21.4 12.4 15.8 15.7 25.2 17.9 11.5 13.2 17.4 19.4 19.8 18.3 29.0 14.3 17.3 28.6 16.2 30.8 11.9 14.7 18.6 11.4 20.8 12.1 18.3 12.2 21.6 17.3 23.1 12.6 42.9 38.0 18.7 41.9 27.8 41.6 37.9 20.6 27.2 20.2 23.7 74.4 81.8 36.5 30.2 34.6 11.7 61.7 37.7 37.5 30.0 55.1 18.7 29.8 29.1 45.5 33.5 34.5 26.9 30.3 48.7 33.7 81.8 28.3 30.2 20.4 22.6 22.7 26.6 57.6 14.5 19.8 29.9 40.1 25.6 19.2 30.5 23.0 33.9 36.2 19.0 16.6 26.1 107.8 23.1 24.1 68.7 18.4 31.1 18.8 33.9 29.3 34.9 12.0 14.9 16.3 29.6 64.6 11.9 0.0 2.0 0.0 1.0 2.3 1.1 4.3 1.5 1.3 5.0 4.9 1.3 1.0 0.1 0.8 1.3 1.3 1.4 1.0 21.1 23.4 10.2 20.0 24.9 21.4 12.4 15.8 17.4 11.9 20.8 12.6 24.0 99.3 25.9 45.1 41.6 95.0 51.7 25.3 70.0 15.1 51.2 38.7 16.5 28.6 46.3 25.8 41.7 37.8 31.4 42.6 29.4 50.2 27.6 105.2 54.6 22.4 27.0 25.7 83.2 65.3 18.8 27.8 39.8 134.5 29.1 45.2 17.2 20.1 23.1 16.8 58.4 38.9 30.5 40.7 35.3 80.6 24.5 36.4 16.0 32.8 23.0 11.5 13.4 55.3 34.2 50.2 25.0 19.5 26.4 52.2 47.1 48.4 28.1 49.8 19.7 31.4 27.0 2.3 22.4 92.3 80.1 27.0 24.3 32.5 46.3 46.1 CDC6 CDC18L ENSG00000094804 "Cell division cycle 6" Q99741 17 40287879-40304657 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA replication, Mitosis" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.2;lymphoid tissue: 17.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4" "Cell line enhanced" "Detected in all" "SK-BR-3: 500.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA050114, HPA065070" Approved Approved "Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Cytosol" "Cytokinetic bridge, Mitotic spindle" "HPA050114: AB_2681021, HPA065070: AB_2732729" "unprognostic (1.29e-1)" "unprognostic (7.22e-2)" "unprognostic (1.23e-3)" "unprognostic (7.97e-2)" "unprognostic (7.12e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (5.96e-8)" "unprognostic (2.31e-3)" "unprognostic (1.46e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (5.47e-2)" "unprognostic (3.00e-15)" "unprognostic (1.86e-2)" "unprognostic (1.35e-1)" "unprognostic (3.95e-3)" "unprognostic (3.88e-2)" 2.1 1.9 0.5 13.7 0.8 27.2 3.4 0.2 1.9 3.2 0.0 8.4 7.5 2.2 1.1 5.7 1.0 2.8 0.6 1.1 0.1 0.5 3.0 1.4 16.4 0.1 0.0 0.9 1.9 0.8 0.5 9.3 0.3 1.1 8.7 0.5 1.3 1.2 0.3 2.8 6.7 3.7 0.0 3.7 3.6 10.1 0.2 16.7 1.7 0.5 17.1 4.3 1.8 0.6 155.1 119.0 115.1 86.5 6.7 12.7 118.0 159.9 49.0 149.2 166.5 135.8 64.9 123.9 99.6 35.9 85.9 214.0 112.2 76.2 148.9 64.5 98.4 96.2 122.3 134.6 4.4 133.3 55.1 4.7 8.1 156.4 107.1 14.8 46.9 84.2 183.0 109.0 71.9 95.8 199.3 43.3 101.6 96.9 48.7 145.0 286.8 119.9 30.3 184.8 85.6 76.9 146.9 500.3 55.4 100.3 100.8 120.0 34.7 95.5 146.3 170.8 196.1 46.1 103.6 222.8 84.6 93.9 109.2 0.1 0.1 0.0 0.8 0.0 0.5 0.4 0.6 1.1 0.7 0.3 0.4 1.1 0.1 1.5 0.0 3.6 2.4 0.6 0.5 0.8 0.2 1.9 1.1 0.1 0.1 0.0 0.3 0.0 0.2 0.6 2.2 0.0 2.0 0.7 4.9 4.2 1.1 3.7 3.4 0.2 2.1 2.2 0.9 1.5 1.3 0.0 0.0 23.2 2.3 7.8 0.0 1.3 2.2 1.3 2.9 2.1 0.0 37.2 2.0 0.6 34.6 5.6 3.6 5.1 0.0 8.1 1.1 0.9 8.3 0.0 0.7 6.1 0.0 1.3 2.1 1.0 2.8 1.5 0.0 0.0 0.0 0.4 2.1 0.0 0.2 1.5 3.0 0.7 31.6 1.3 0.8 0.2 0.2 0.3 13.1 0.6 4.6 69.5 57.2 9.1 1.6 16.7 3.3 1.9 9.3 2.4 CDK12 "CRK7, CRKR, CRKRS, KIAA0904" ENSG00000167258 "Cyclin dependent kinase 12" Q9NYV4 17 39461486-39564907 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 307.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008038, HPA073305" Supported Enhanced "Nucleoplasm,Nuclear speckles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear speckles" "HPA008038: AB_1078570, HPA073305: " "unprognostic (2.02e-1)" "unprognostic (1.80e-1)" "unprognostic (2.61e-2)" "unprognostic (7.56e-2)" "unprognostic (1.05e-1)" "unprognostic (3.19e-1)" "unprognostic (2.56e-3)" "unprognostic (2.37e-2)" "unprognostic (3.86e-2)" "unprognostic (3.00e-3)" "unprognostic (6.87e-3)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "unprognostic (9.10e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-2)" "unprognostic (5.32e-1)" 9.5 7.6 2.5 14.0 1.9 34.3 9.5 8.0 4.0 11.0 4.1 9.8 9.9 10.8 6.0 10.4 9.2 9.2 6.8 1.6 2.9 8.0 12.3 9.2 15.1 3.0 1.7 11.9 8.7 13.0 6.2 11.5 1.6 9.8 10.4 11.7 9.2 9.3 6.7 10.6 10.4 10.0 0.3 12.9 10.3 17.7 3.4 17.9 12.2 7.8 15.3 13.1 9.1 3.3 31.9 40.0 24.9 22.2 17.2 19.0 21.1 28.9 24.7 39.9 29.0 48.1 19.8 45.4 24.6 31.1 38.7 51.8 49.2 36.6 38.4 29.6 38.7 49.7 26.9 36.3 16.4 66.9 33.4 20.4 25.0 48.2 37.6 16.0 24.4 27.7 85.2 30.7 22.9 14.3 57.9 17.7 23.8 16.0 16.9 36.8 50.3 25.7 14.8 38.8 24.6 15.7 37.0 307.8 25.1 34.8 38.5 29.3 26.4 34.5 27.6 24.5 37.9 23.6 18.4 63.5 24.2 28.2 23.0 11.2 2.0 3.2 2.6 1.5 1.8 1.8 1.5 1.7 1.2 3.1 1.7 1.6 7.0 4.5 1.3 2.7 1.2 0.7 2.5 1.9 8.0 4.0 1.6 2.9 3.0 1.7 1.6 0.3 3.4 3.3 41.4 25.6 29.1 50.9 59.0 64.6 58.5 31.2 50.1 46.6 38.1 26.9 14.5 32.9 40.3 38.6 64.6 33.2 59.0 44.6 13.7 30.2 25.1 49.8 63.4 40.6 31.1 39.3 53.9 27.5 29.9 39.2 45.3 63.1 29.1 43.8 32.2 46.3 27.4 35.3 52.9 39.6 42.7 45.9 49.1 17.3 37.3 41.3 26.6 32.8 41.4 27.8 48.4 47.3 53.1 47.9 33.9 33.8 53.5 81.5 33.3 16.7 38.1 65.4 32.9 48.0 48.5 140.2 104.8 53.0 69.0 58.3 59.0 46.0 39.9 84.8 CDK13 "CDC2L, CDC2L5, CHED, KIAA1791" ENSG00000065883 "Cyclin dependent kinase 13" Q14004 7 39950121-40099580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 179.0;Oligodendrocyte precursor cells: 171.9;Oligodendrocytes: 199.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059241 Uncertain Supported "Nuclear speckles,Golgi apparatus,Cytosol" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Golgi apparatus, Cytosol" "HPA059241: AB_2683956" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (2.67e-1)" "unprognostic (2.72e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (4.18e-3)" "unprognostic (3.42e-2)" "unprognostic (8.09e-2)" "unprognostic (1.13e-2)" "unprognostic (3.77e-2)" "unprognostic (8.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.21e-1)" "unprognostic (3.33e-2)" "unprognostic (3.53e-1)" "unprognostic (3.53e-2)" 11.4 10.2 8.8 14.6 10.8 28.1 11.1 19.3 9.9 12.8 6.7 11.9 10.5 13.6 14.2 14.7 15.0 12.7 10.4 8.1 10.7 12.7 15.9 12.1 21.7 10.5 8.5 20.1 12.8 17.2 8.0 13.6 8.6 11.2 13.6 19.7 12.9 11.8 11.2 12.0 12.0 12.0 7.2 16.6 12.3 19.0 10.1 19.6 20.6 14.0 20.2 13.4 10.0 14.9 28.4 16.6 28.2 27.0 24.9 24.1 19.3 22.1 23.8 19.8 24.6 17.8 19.1 51.0 12.6 23.4 34.8 33.6 23.4 19.4 29.0 25.3 17.3 22.8 20.0 16.0 23.7 34.8 23.5 14.3 25.5 22.6 30.0 22.6 23.6 23.1 39.0 34.3 20.7 14.7 28.0 24.9 40.8 20.0 19.1 30.5 18.5 20.5 18.5 28.1 20.0 28.8 27.6 59.8 19.9 36.7 24.6 43.0 28.3 27.0 26.0 17.6 30.5 28.3 26.0 41.2 19.8 30.9 35.4 7.8 2.2 4.0 4.1 1.9 2.8 6.4 3.8 3.0 1.3 10.5 3.8 3.9 5.9 4.3 3.1 3.3 3.9 1.3 8.8 10.8 19.3 9.9 8.1 10.7 10.5 8.5 8.6 7.2 10.1 14.9 47.6 44.8 72.0 131.6 49.7 21.4 18.5 15.9 29.0 47.8 36.7 27.7 30.9 25.8 37.1 31.3 70.9 13.7 91.0 23.1 7.9 20.4 13.9 54.3 51.4 30.9 18.7 5.9 179.0 15.4 9.1 31.7 30.1 72.6 17.1 95.5 19.2 23.7 13.2 37.0 166.2 17.6 14.2 23.8 17.4 9.2 26.1 31.6 14.2 145.2 27.9 22.4 53.5 171.9 199.6 28.6 12.9 17.7 50.1 21.8 15.2 12.7 32.8 69.4 6.6 38.5 32.0 36.1 33.4 34.7 26.1 12.2 49.7 56.8 20.1 25.0 CDKL1 KKIALRE ENSG00000100490 "Cyclin dependent kinase like 1" Q00532 14 50326265-50416461 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 23.4;Excitatory neurons: 46.2;Oligodendrocyte precursor cells: 46.8;Oligodendrocytes: 25.4" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059605, HPA065919" Uncertain Enhanced Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Vesicles "HPA059605: AB_2684080, HPA065919: AB_2685578" "unprognostic (4.12e-3)" "unprognostic (3.22e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.02e-1)" "unprognostic (3.23e-3)" "unprognostic (9.36e-3)" "unprognostic (2.63e-1)" "unprognostic (9.99e-2)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (5.53e-8)" "unprognostic (1.21e-1)" "unprognostic (7.96e-2)" "unprognostic (9.39e-3)" "unprognostic (3.31e-3)" 13.5 3.6 3.4 4.9 4.4 3.6 3.5 1.4 9.0 13.9 3.7 8.8 13.2 13.9 3.2 5.2 15.4 5.2 2.3 5.5 2.3 19.4 1.6 6.5 6.5 2.0 2.1 13.8 1.3 1.2 0.6 6.5 2.9 5.9 6.6 20.2 2.8 9.0 7.1 13.5 6.9 8.5 2.9 7.0 4.9 2.0 1.8 1.9 7.9 1.0 2.6 6.9 6.6 8.1 7.7 4.9 3.5 4.3 5.3 6.1 2.3 2.2 3.2 1.9 2.0 4.0 5.9 6.1 2.8 3.2 3.2 5.9 0.8 0.3 1.9 8.9 3.1 12.2 4.6 3.9 6.2 9.7 5.3 1.5 3.0 3.2 8.0 2.4 6.7 10.3 3.3 4.8 1.1 2.5 2.8 4.7 1.9 2.6 3.9 3.3 3.8 3.1 5.3 6.6 4.6 3.4 4.2 18.3 2.1 1.3 2.4 6.2 4.0 6.7 4.1 7.1 5.0 2.4 1.8 2.9 1.7 8.7 7.6 3.2 1.4 2.6 3.5 1.4 3.1 2.6 2.3 3.2 0.8 3.0 1.9 1.9 0.7 2.3 0.2 0.8 2.4 1.3 3.4 4.4 1.4 9.0 5.5 2.3 2.0 2.1 2.9 2.9 1.8 8.1 3.2 19.2 9.9 6.5 3.0 3.1 4.1 0.2 3.4 0.7 0.4 0.5 0.5 0.0 2.6 11.0 0.0 0.1 2.3 7.2 5.9 1.4 0.4 23.4 9.6 3.3 1.8 6.1 46.2 1.8 0.1 7.6 1.1 4.9 1.3 3.2 6.4 0.3 0.4 0.0 20.6 2.1 2.0 0.9 1.5 1.5 9.0 1.5 0.0 7.5 0.8 0.9 2.1 46.8 25.4 1.9 4.8 3.4 0.2 3.1 4.9 8.0 20.4 0.7 0.0 4.0 4.6 0.0 0.3 4.7 2.7 0.3 4.2 3.6 5.2 2.2 CGREF1 CGR11 ENSG00000138028 "Cell growth regulator with EF-hand domain 1" Q99674 2 27098889-27119128 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.3;salivary gland: 25.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 12.6;Excitatory neurons: 16.6;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 12.5;Spermatogonia: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 40.1;SK-BR-3: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008241, HPA071103" Uncertain Approved "Golgi apparatus" "Secreted in brain" NA NA 700000 "Cluster 65: Brain - Ion transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA008241: AB_1846605, HPA071103: " "unprognostic (1.39e-2)" "unprognostic (1.26e-2)" "unprognostic (1.62e-1)" "prognostic unfavorable (3.18e-4)" "unprognostic (8.45e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (7.57e-4)" "unprognostic (5.22e-2)" "unprognostic (7.34e-2)" "unprognostic (1.92e-1)" "unprognostic (2.57e-1)" "unprognostic (2.27e-1)" "unprognostic (2.52e-3)" "unprognostic (1.05e-1)" "unprognostic (2.30e-2)" "unprognostic (7.24e-4)" "unprognostic (1.20e-2)" 4.2 2.3 20.4 1.0 21.7 1.9 6.3 17.1 28.3 3.5 2.1 2.6 3.9 11.6 1.4 3.5 12.4 3.9 4.9 27.0 18.1 3.8 14.9 1.1 0.5 12.8 12.1 13.9 2.1 0.2 3.3 0.3 12.8 4.2 3.8 3.7 25.3 0.9 6.5 2.3 5.6 5.4 10.2 0.6 11.4 3.8 17.2 0.2 1.8 6.9 0.4 3.7 1.5 16.4 7.6 6.3 0.3 8.1 18.3 6.8 0.7 9.1 0.0 0.8 0.4 1.7 6.2 0.1 2.4 18.2 2.2 0.4 1.4 2.1 0.5 0.7 3.7 0.1 10.4 16.4 16.9 5.3 0.6 4.7 18.1 2.6 2.1 11.6 0.7 1.3 0.2 0.4 1.2 24.0 4.0 6.8 2.1 40.1 16.8 0.3 0.0 0.6 0.1 0.3 17.8 26.6 17.7 78.7 9.4 0.2 25.3 13.3 0.0 0.0 6.9 0.0 0.7 2.3 0.8 0.7 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 21.7 17.1 28.3 27.0 18.1 12.8 12.1 12.8 10.2 17.2 16.4 0.1 0.0 0.0 2.6 0.4 0.6 0.2 0.0 1.8 9.2 9.2 12.6 1.4 0.0 0.0 0.0 4.2 0.0 0.1 0.2 0.0 0.1 1.1 0.3 3.0 0.4 0.0 5.5 16.6 1.5 0.2 3.8 4.6 0.1 0.0 0.4 3.6 5.0 0.4 0.0 15.9 6.8 0.0 0.6 0.7 3.1 4.4 0.2 0.0 1.9 0.0 0.5 0.0 12.5 0.8 2.1 0.0 8.6 1.1 1.8 3.4 4.4 0.0 2.2 0.0 1.7 0.7 3.2 16.2 2.2 0.4 0.1 0.1 3.2 0.9 0.1 CHRNA7 ENSG00000175344 "Cholinergic receptor nicotinic alpha 7 subunit" P36544 15 31923438-32173018 "FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.8;intestine: 9.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8" "HPA029422, CAB033624" Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB033624: AB_784835, HPA029422: AB_10600863" "unprognostic (3.43e-2)" "unprognostic (8.44e-2)" "unprognostic (2.02e-1)" "unprognostic (4.61e-4)" "unprognostic (6.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.14e-2)" "unprognostic (5.08e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-2)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (2.40e-2)" "unprognostic (4.36e-3)" "unprognostic (5.44e-2)" "unprognostic (7.41e-3)" "unprognostic (2.43e-1)" 0.3 7.8 1.2 0.4 1.1 0.9 1.0 1.8 1.8 0.4 2.1 1.5 4.4 0.5 0.3 0.3 0.4 0.9 0.5 1.0 4.5 0.4 0.1 0.5 0.7 4.5 3.9 1.6 2.4 6.4 1.0 0.0 7.0 1.2 2.3 2.5 0.5 0.7 0.5 0.3 9.7 0.4 1.5 1.2 6.6 2.5 3.3 0.4 2.2 0.8 0.7 1.5 0.7 1.1 0.0 1.3 2.7 6.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 3.1 0.0 0.0 0.0 1.7 0.6 0.0 2.2 0.0 0.4 1.0 0.0 0.0 0.2 0.0 0.1 0.4 2.5 0.0 0.2 0.3 0.2 0.0 0.2 1.5 3.7 0.0 0.0 4.2 0.3 0.5 12.9 0.5 8.3 0.2 13.3 0.0 0.7 0.0 0.5 1.2 0.0 10.8 0.3 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.2 1.1 1.8 1.8 1.0 4.5 4.5 3.9 7.0 1.5 3.3 1.1 0.5 0.0 0.0 1.0 0.0 0.3 3.0 0.0 7.4 1.8 1.1 1.3 1.1 2.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.1 0.2 0.3 1.5 3.0 0.0 9.0 2.5 0.0 0.4 26.0 0.6 1.3 4.6 0.7 0.0 0.1 16.8 30.7 8.9 0.0 0.0 0.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.5 1.1 1.6 2.9 0.0 0.2 0.7 14.4 0.2 0.0 0.0 0.0 0.4 0.3 0.2 5.9 3.2 0.0 0.0 0.1 0.2 2.0 1.2 CKMT1B "CKMT, CKMT1, UMTCK" ENSG00000237289 "Creatine kinase, mitochondrial 1B" P12532 15 43593054-43604901 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;esophagus: 74.3;intestine: 80.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 122.4;Distal enterocytes: 146.4;Intestinal goblet cells: 78.3;Paneth cells: 69.9;Proximal enterocytes: 124.6;Syncytiotrophoblasts: 137.9;Undifferentiated cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 139.8;hTCEpi: 69.2;OE19: 156.0;SK-BR-3: 183.1;T-47d: 100.7" HPA043491 Uncertain "Intracellular and membrane" NA NA 2000000 "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA043491: AB_2678510" "unprognostic (3.47e-2)" "unprognostic (9.73e-3)" "unprognostic (3.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.29e-1)" "unprognostic (1.96e-1)" "unprognostic (5.19e-2)" "unprognostic (2.84e-1)" "unprognostic (3.64e-1)" "unprognostic (5.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (2.26e-8)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.43e-2)" "unprognostic (4.36e-2)" 1.9 1.9 24.6 6.3 25.1 0.0 6.0 38.0 58.5 8.0 14.3 80.7 63.4 0.3 0.4 74.3 1.9 8.9 0.7 26.5 31.5 5.3 0.1 0.7 0.1 32.4 25.2 0.1 3.1 11.9 9.5 12.8 34.6 3.1 66.0 23.4 28.5 0.8 0.1 26.7 49.4 4.0 13.8 0.0 29.6 0.2 28.6 0.1 6.2 0.0 13.3 8.4 22.0 22.2 0.3 0.9 0.8 0.0 0.2 0.0 35.3 0.0 0.0 0.1 0.1 7.8 23.8 0.0 1.0 0.0 7.2 139.8 28.4 55.8 0.1 0.8 16.0 0.0 3.0 3.8 0.0 0.1 8.6 0.0 69.2 0.0 6.9 0.0 0.0 5.9 9.1 0.0 0.0 38.2 0.1 0.2 12.0 156.0 14.9 0.0 0.0 0.8 3.0 3.7 55.4 19.5 0.9 183.1 10.9 2.3 100.7 0.0 0.0 0.1 1.8 0.2 2.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 25.1 38.0 58.5 26.5 31.5 32.4 25.2 34.6 13.8 28.6 22.2 0.1 0.0 0.5 2.6 0.1 25.1 10.4 40.5 3.4 7.5 3.8 4.1 0.4 5.7 12.7 5.5 18.8 122.4 0.4 146.4 21.5 4.0 0.0 0.9 0.0 0.5 21.0 0.0 37.6 28.0 26.1 0.5 33.1 0.5 0.0 1.1 0.0 0.0 9.4 6.7 36.5 78.3 10.2 0.0 0.7 0.0 0.0 0.1 3.6 2.8 0.0 2.2 0.0 5.0 2.4 18.6 69.9 0.0 0.1 2.0 124.6 0.9 6.0 12.2 0.0 0.0 0.7 0.0 0.0 17.5 24.7 137.9 0.6 0.0 123.7 19.9 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832690 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 305.0;urinary bladder: 303.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB002610 Enhanced Supported "Plasma membrane" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favorable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 2.6 0.4 0.1 23.0 0.0 0.2 69.0 0.8 0.3 61.2 4.8 256.3 126.9 26.7 24.4 305.0 75.8 48.9 0.4 0.2 0.0 116.2 4.8 64.0 1.0 0.4 1.5 1.2 116.2 51.9 13.1 36.3 0.3 82.2 123.3 0.3 204.6 39.1 0.5 180.8 190.6 7.3 0.0 0.7 13.3 0.6 0.2 10.7 111.7 0.3 37.5 303.5 105.7 0.0 358.1 4.4 0.0 1.5 0.0 0.4 395.0 3.3 0.2 0.3 0.4 184.9 761.4 0.6 28.0 0.1 2.6 193.3 0.0 0.5 0.4 0.7 0.4 0.2 20.3 127.0 0.1 0.1 0.9 0.0 1.9 0.1 0.4 0.3 0.0 0.2 0.3 0.7 0.0 400.2 0.7 1.9 0.7 402.0 495.0 0.5 6.9 7.6 92.4 340.2 79.5 1.7 0.4 636.8 0.8 21.6 250.9 0.9 0.5 0.9 13.7 3.1 3.5 0.9 0.7 0.7 0.6 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.3 0.2 0.0 0.4 1.5 0.3 0.0 0.2 0.0 5.1 275.7 230.2 0.0 12.2 16.2 3149.1 641.6 31.3 0.4 1255.2 548.4 0.8 287.4 954.3 218.8 0.0 771.7 18.7 1985.0 13.7 1026.1 0.0 1201.7 231.0 41.3 675.5 0.0 0.2 447.1 739.7 27.0 94.8 2298.8 27.3 0.2 0.4 0.5 76.3 0.0 0.1 1266.9 905.3 0.6 8.6 0.0 2.5 29.3 14.2 0.0 15.6 0.8 0.0 0.0 0.0 950.2 2081.0 0.0 2.5 2184.8 1906.1 21.6 635.6 0.0 0.0 0.1 68.2 0.0 0.2 1068.1 54.0 956.1 40.7 0.1 965.1 8033.4 CLMN "FLJ12383, KIAA0500, KIAA1188" ENSG00000165959 Calmin Q96JQ2 14 95181940-95319908 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.0" "Cell type enhanced" "Detected in many" "Early spermatids: 161.8;Late spermatids: 313.5;Oligodendrocytes: 418.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "GAMG: 13.8;SK-BR-3: 16.0;T-47d: 13.5;WM-115: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012634 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nuclear bodies" Cytosol "HPA012634: AB_1846973" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (4.20e-2)" "unprognostic (6.07e-2)" "unprognostic (8.88e-2)" "unprognostic (4.31e-1)" "unprognostic (4.18e-2)" "unprognostic (7.24e-2)" "unprognostic (8.31e-2)" "unprognostic (2.64e-1)" "unprognostic (1.29e-3)" "unprognostic (3.09e-2)" "prognostic favorable (2.68e-7)" "unprognostic (8.27e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (9.91e-3)" 11.1 1.1 16.6 4.2 38.9 1.1 10.9 11.4 28.1 7.5 6.9 11.5 3.0 4.9 7.4 2.9 9.2 5.8 5.3 15.5 12.2 13.3 14.1 4.9 1.3 21.5 25.7 2.9 17.3 1.7 2.9 2.3 23.3 6.9 12.8 9.8 9.2 5.0 3.8 3.2 6.7 2.8 7.3 3.0 7.2 32.8 42.9 1.0 5.9 5.5 1.6 4.7 6.9 67.0 6.3 8.4 1.3 0.2 4.9 2.2 0.5 0.1 0.0 0.4 0.3 0.7 10.5 0.0 0.9 0.0 13.8 5.5 0.6 3.7 0.0 4.3 1.5 0.2 0.3 5.0 0.5 0.0 0.1 2.4 3.6 1.6 5.8 1.9 4.2 2.3 0.0 1.2 3.0 5.6 0.3 0.5 0.5 7.7 2.0 4.8 4.4 2.8 3.9 10.3 1.7 1.6 2.1 16.0 8.2 1.2 13.5 0.4 1.2 0.1 3.6 0.0 0.3 1.6 0.1 5.8 2.9 2.5 15.5 7.3 6.9 0.6 0.0 2.4 0.0 3.0 0.0 0.0 1.4 1.5 0.0 0.1 5.7 0.0 1.5 2.4 0.0 2.1 16.6 38.9 11.4 28.1 15.5 12.2 21.5 25.7 23.3 7.3 42.9 67.0 12.9 16.0 3.4 21.9 18.0 6.2 39.2 11.7 37.0 61.8 39.0 22.2 58.6 42.9 17.3 58.8 14.6 2.5 3.5 93.1 27.4 53.1 161.8 76.7 16.9 11.4 23.4 0.4 9.3 47.5 1.8 12.2 33.6 37.3 4.5 0.4 2.2 81.9 7.3 38.7 11.5 72.5 8.2 11.9 7.2 313.5 22.4 15.6 3.6 1.0 17.1 3.5 0.0 5.0 418.6 40.1 44.1 10.9 21.9 62.3 15.9 21.0 115.6 28.2 105.2 4.8 100.6 4.2 15.3 7.1 2.6 2.9 2.8 0.2 50.2 51.5 CNNM4 "ACDP4, KIAA1592" ENSG00000158158 "Cyclin and CBS domain divalent metal cation transport mediator 4" Q6P4Q7 2 96760902-96811874 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Biomineralization, Ion transport, Sensory transduction, Transport, Vision" "Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 38.8" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "SK-BR-3: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017732 Enhanced Uncertain "Plasma membrane,Actin filaments" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Actin filaments" "Plasma membrane" "HPA017732: AB_1847395" "unprognostic (1.98e-3)" "unprognostic (8.95e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (3.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.54e-3)" "unprognostic (3.36e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.75e-4)" "unprognostic (4.75e-3)" "unprognostic (3.72e-1)" "unprognostic (8.14e-2)" "unprognostic (3.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" 2.8 3.6 5.0 6.1 6.8 4.9 7.0 11.2 5.4 5.8 2.8 32.4 6.2 4.0 4.7 7.1 10.4 4.4 12.5 4.9 4.4 6.8 4.4 8.0 4.6 4.1 4.5 5.1 7.4 6.3 9.1 5.8 4.2 5.7 34.3 38.8 6.8 5.1 24.8 7.2 11.3 4.7 3.5 5.3 12.8 7.9 4.5 3.5 9.5 13.1 4.9 5.5 6.4 5.7 11.1 7.2 5.7 10.5 5.8 3.9 15.6 4.8 6.8 6.9 9.3 13.2 11.8 8.1 13.5 5.0 9.5 14.1 14.9 8.1 6.3 16.3 11.7 6.4 4.8 7.2 8.1 3.1 6.2 3.8 10.0 11.0 6.6 4.6 3.8 8.0 3.3 22.3 3.6 15.7 6.6 4.5 7.5 20.5 9.8 9.7 2.6 9.3 6.9 8.6 26.7 8.0 9.1 45.7 6.8 15.9 22.3 5.3 3.4 4.0 8.9 8.8 5.4 7.7 6.6 4.0 5.9 6.1 7.2 1.2 0.4 0.1 0.8 0.4 0.2 0.9 0.4 0.4 0.6 0.5 0.2 0.5 0.2 0.2 0.7 0.4 0.2 0.3 5.0 6.8 11.2 5.4 4.9 4.4 4.1 4.5 4.2 3.5 4.5 5.7 4.5 38.5 7.7 12.4 6.4 5.7 4.9 4.0 4.6 43.1 14.7 11.2 14.1 4.3 11.6 7.3 112.6 5.4 6.1 103.4 0.0 3.2 4.9 14.3 4.4 4.0 10.1 0.8 9.8 4.2 1.7 3.2 12.2 16.1 1.3 5.9 2.2 3.3 3.3 33.7 8.3 26.4 6.1 5.4 4.8 1.6 0.9 5.9 0.0 8.4 2.3 8.3 2.1 11.1 14.6 5.2 21.3 1.2 4.5 4.1 22.3 1.2 10.6 51.5 0.0 4.6 4.3 4.6 2.5 7.3 4.1 6.7 5.4 6.7 26.5 6.1 COLEC10 CL-L1 ENSG00000184374 "Collectin subfamily member 10" Q9Y6Z7 8 118995452-119108455 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 65.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 6.9;Hepatic stellate cells: 10.4;Inhibitory neurons: 5.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.8" "Cancer enhanced" "Detected in some" "liver cancer: 1.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 3.4;SK-BR-3: 9.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 30000000 "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (3.79e-4)" "unprognostic (6.25e-3)" "unprognostic (1.80e-3)" "unprognostic (7.73e-2)" "prognostic favorable (5.79e-4)" "unprognostic (1.05e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.25e-2)" "unprognostic (9.02e-5)" "unprognostic (2.47e-1)" "unprognostic (1.82e-1)" "unprognostic (5.85e-5)" "unprognostic (7.12e-2)" 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.7 0.6 0.1 0.4 0.4 65.7 1.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 10.9 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.0 0.2 1.0 0.0 0.0 0.0 0.0 10.4 0.4 0.3 0.0 5.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 4.8 0.1 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 COX16 "C14orf112, HSPC203" ENSG00000133983 "Cytochrome c oxidase assembly factor COX16" Q9P0S2 14 70325081-70416984 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 302.9;Ionocytes: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062659 Uncertain Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "HPA062659: AB_2684823" "unprognostic (5.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.68e-1)" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (6.37e-3)" "unprognostic (1.80e-2)" "unprognostic (8.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-2)" "unprognostic (6.80e-2)" "unprognostic (7.44e-2)" "prognostic favorable (1.03e-12)" "unprognostic (4.08e-1)" "unprognostic (1.73e-1)" "unprognostic (3.97e-1)" "unprognostic (1.72e-1)" 19.4 27.1 20.2 18.2 19.9 22.8 27.8 20.4 29.2 16.5 22.9 26.6 30.2 12.8 27.1 17.1 17.3 19.4 24.4 20.1 20.7 29.3 40.5 16.7 21.7 21.0 20.1 17.2 43.5 26.9 12.7 14.3 20.5 20.7 22.1 24.3 21.9 13.7 84.0 17.5 26.7 10.5 20.2 18.9 33.4 17.7 20.2 20.8 23.3 44.5 19.0 19.3 12.6 22.5 100.2 31.2 65.9 56.0 26.7 36.0 48.3 55.0 37.1 38.9 34.7 19.2 93.5 26.2 36.6 33.8 33.5 41.8 27.6 35.5 48.9 18.9 27.5 36.9 31.3 22.1 16.1 35.9 48.7 36.1 25.1 24.0 23.0 41.5 34.2 69.2 20.8 54.6 39.0 49.6 85.4 43.8 68.3 83.3 44.5 57.6 53.2 37.0 46.2 49.0 57.8 46.0 46.2 102.4 53.9 42.2 87.4 69.1 42.5 50.2 111.6 55.4 40.6 57.6 38.9 48.2 75.4 19.1 61.1 48.6 33.8 8.0 24.2 38.0 29.2 45.7 34.5 29.1 36.3 39.8 32.3 34.8 2.5 45.6 38.3 55.7 43.6 44.0 20.2 19.9 20.4 29.2 20.1 20.7 21.0 20.1 20.5 20.2 20.2 22.5 22.0 51.3 53.9 0.0 45.0 84.4 9.4 302.9 70.6 8.2 29.7 18.8 7.1 32.9 162.2 23.9 2.1 14.8 22.9 23.8 52.8 47.1 2.7 43.6 21.3 28.5 31.2 46.0 0.0 64.8 20.2 36.0 99.4 62.1 33.5 7.4 31.8 57.7 18.2 1.7 0.0 35.8 187.2 34.6 89.3 4.6 18.3 40.0 96.0 0.0 26.3 25.2 25.7 0.0 0.0 59.1 27.0 15.8 99.3 11.2 42.5 48.6 137.1 10.0 6.6 13.6 27.5 15.4 21.0 125.7 100.7 10.9 39.8 7.3 39.4 14.4 COX6C ENSG00000164919 "Cytochrome c oxidase subunit 6C" P09669 8 99873200-99893707 "Metabolic proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014295, CAB016244" Enhanced Supported Mitochondria NA NA 210000 "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB016244: AB_2085703, HPA014295: AB_2668966" "unprognostic (4.91e-2)" "unprognostic (2.90e-2)" "unprognostic (6.90e-2)" "unprognostic (3.37e-2)" "unprognostic (1.58e-2)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (2.07e-2)" "unprognostic (1.29e-1)" "unprognostic (3.51e-1)" "unprognostic (3.70e-1)" "unprognostic (8.86e-2)" "unprognostic (3.47e-3)" "unprognostic (1.10e-1)" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (6.99e-3)" 134.0 147.5 180.8 52.9 183.9 152.6 125.7 186.1 291.0 166.4 190.2 268.1 334.8 194.0 175.6 197.3 189.5 20.4 781.6 191.8 195.6 254.9 328.5 108.4 71.1 186.0 188.4 161.9 107.3 101.7 159.5 89.9 189.2 162.6 110.4 147.0 108.1 58.1 666.1 121.4 172.3 42.7 182.4 122.9 180.0 170.8 192.7 44.8 129.1 554.1 51.5 188.7 148.6 188.9 137.6 57.8 63.8 251.3 140.0 100.5 103.1 44.5 42.7 30.1 34.3 54.7 284.5 326.8 320.1 70.1 47.7 176.4 36.4 363.3 51.0 60.5 89.1 684.6 66.9 160.4 88.9 319.3 201.9 95.1 475.3 26.0 56.4 129.2 45.1 103.8 49.8 571.1 51.6 134.2 337.9 289.6 117.9 205.5 127.7 381.0 21.2 320.6 453.4 713.3 191.8 115.2 30.9 654.2 351.5 65.0 461.7 201.1 40.1 220.4 286.0 235.8 63.8 140.7 126.3 209.6 310.2 128.2 200.8 345.8 134.7 114.1 177.8 210.5 189.0 209.7 270.6 193.5 212.9 189.8 319.7 294.9 16.6 187.7 266.5 301.9 272.7 252.9 180.8 183.9 186.1 291.0 191.8 195.6 186.0 188.4 189.2 182.4 192.7 188.9 527.8 403.8 485.1 29.7 382.1 490.8 493.5 1431.9 279.4 217.6 561.3 642.7 2146.4 491.8 731.2 605.1 102.2 978.9 416.1 1263.2 2226.5 673.6 834.3 579.3 778.7 436.9 807.5 400.2 27.6 849.4 853.9 502.0 440.4 551.9 362.5 219.3 384.1 1855.5 1066.5 156.5 33.5 1221.3 1027.4 451.1 539.5 266.5 664.8 440.8 732.8 23.4 778.0 545.0 449.0 22.6 32.1 808.6 1338.7 587.5 412.2 448.4 2173.5 1791.0 702.9 282.0 493.0 367.1 555.9 1180.5 505.2 666.4 640.6 1784.9 452.1 428.0 1246.7 715.5 CPNE3 ENSG00000085719 "Copine 3" O75131 8 86514435-86561498 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 249.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029552 Uncertain Supported Nucleoplasm,Cytosol NA NA 71000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "HPA029552: AB_10600703" "unprognostic (5.63e-3)" "unprognostic (1.47e-1)" "unprognostic (2.95e-2)" "unprognostic (4.22e-3)" "unprognostic (9.92e-2)" "unprognostic (6.58e-2)" "unprognostic (8.40e-2)" "unprognostic (4.76e-2)" "unprognostic (3.50e-1)" "unprognostic (1.19e-1)" "unprognostic (8.64e-3)" "unprognostic (2.77e-1)" "prognostic favorable (5.07e-4)" "unprognostic (1.15e-1)" "unprognostic (4.33e-1)" "unprognostic (1.65e-3)" "unprognostic (1.13e-2)" 35.4 29.3 14.6 22.4 17.4 76.6 42.3 23.0 15.0 40.7 24.3 35.0 32.1 33.2 21.4 73.6 32.0 30.1 52.4 15.5 19.2 51.5 46.2 33.8 39.5 15.3 17.6 39.2 29.7 52.1 11.8 25.5 17.3 41.2 34.2 18.2 37.1 29.9 17.5 36.3 30.8 31.7 16.4 28.4 30.1 8.3 16.2 38.5 60.9 26.4 46.5 34.9 25.5 21.8 135.1 46.8 30.9 40.9 116.9 92.1 24.6 63.3 93.3 51.9 58.2 30.4 44.5 36.7 40.6 77.6 31.6 101.2 68.7 67.5 92.5 39.5 52.1 6.0 27.2 34.7 41.0 2.3 1.5 63.0 71.2 57.6 76.0 83.1 64.6 17.6 33.2 68.4 65.0 51.6 65.9 1.8 10.5 110.6 64.4 30.7 28.9 174.4 67.4 92.2 66.2 51.5 55.4 249.3 39.6 35.7 95.0 10.3 69.3 44.5 44.1 61.3 49.4 47.0 63.3 9.9 66.0 12.6 42.9 28.6 32.6 54.3 33.2 38.1 26.2 26.4 27.5 23.8 63.1 26.9 23.8 26.1 46.5 27.6 52.5 62.2 20.9 32.0 14.6 17.4 23.0 15.0 15.5 19.2 15.3 17.6 17.3 16.4 16.2 21.8 84.1 137.8 103.9 23.2 52.0 81.8 110.6 111.8 96.2 16.2 80.2 73.9 120.2 75.8 89.3 69.9 14.6 73.0 85.4 49.4 99.7 77.9 1.6 66.9 73.5 66.3 50.2 28.4 37.0 83.7 55.1 92.6 48.9 83.5 8.2 44.7 66.4 103.9 50.4 45.4 39.9 55.3 81.4 71.0 93.8 4.5 85.7 64.0 53.4 13.1 75.0 75.6 36.0 58.3 24.5 59.3 51.7 87.6 49.4 112.5 53.3 126.1 78.8 17.4 59.2 102.1 77.4 3.2 8.8 183.2 91.1 78.0 55.2 71.4 75.1 91.8 CRACR2B "EFCAB4A, MGC45840" ENSG00000177685 "Calcium release activated channel regulator 2B" Q8N4Y2 11 826144-831991 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 208.7;salivary gland: 223.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 180.4;Breast myoepithelial cells: 116.3;Gastric mucus-secreting cells: 178.9;Hepatic stellate cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 3.4;eosinophil: 3.7;memory B-cell: 3.9;naive B-cell: 3.0;NK-cell: 1.7" "Group enriched" "Detected in many" 6 "B-cells: 3.9;granulocytes: 3.7;NK-cells: 1.7" "Cell line enhanced" "Detected in many" "NB-4: 35.2;OE19: 29.6;SK-BR-3: 111.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046217 Approved NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 25: Pancreas - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "HPA046217: AB_10960833" "unprognostic (8.87e-2)" "unprognostic (4.89e-2)" "prognostic unfavorable (1.81e-5)" "unprognostic (4.47e-3)" "unprognostic (8.20e-3)" "unprognostic (5.27e-3)" "unprognostic (7.31e-2)" "unprognostic (1.90e-2)" "unprognostic (1.63e-1)" "unprognostic (5.61e-3)" "unprognostic (3.49e-3)" "unprognostic (9.25e-3)" "unprognostic (5.28e-2)" "unprognostic (4.29e-3)" "unprognostic (3.03e-1)" "unprognostic (3.65e-1)" "unprognostic (5.15e-3)" 11.9 8.4 1.5 3.3 1.6 13.3 65.8 3.1 2.1 8.3 3.5 43.6 22.4 4.6 1.0 6.7 6.4 6.8 22.4 1.3 1.5 27.0 3.4 14.9 2.4 1.8 1.5 1.3 208.7 6.8 23.3 2.7 1.8 44.9 13.6 1.0 223.6 5.2 4.3 21.9 28.5 1.2 1.1 13.9 81.0 2.4 1.9 0.6 6.4 1.7 2.0 19.6 3.9 1.0 3.6 3.1 0.6 1.5 0.2 0.0 11.5 0.3 0.0 0.1 0.0 3.8 12.0 0.0 4.7 0.0 0.3 3.2 2.1 0.1 0.0 26.2 1.1 13.3 3.1 8.8 0.0 10.9 0.5 0.2 0.5 0.0 0.0 2.2 0.5 1.4 17.3 10.7 0.0 8.0 0.3 35.2 0.9 29.6 0.4 2.4 0.6 22.5 8.7 2.8 2.8 1.5 0.4 111.6 0.0 0.6 17.5 9.0 0.3 1.7 0.6 0.4 0.2 26.3 2.4 3.8 5.5 14.4 0.1 3.4 0.5 3.7 0.1 0.0 0.0 3.9 0.0 0.3 0.0 3.0 0.0 0.0 0.1 1.7 0.3 0.5 0.0 0.2 1.5 1.6 3.1 2.1 1.3 1.5 1.8 1.5 1.8 1.1 1.9 1.0 61.5 6.4 19.8 3.3 16.8 0.0 6.6 0.0 1.8 2.4 180.4 116.3 8.8 22.8 27.2 12.9 0.0 3.8 6.4 18.8 15.6 15.0 2.6 11.6 1.9 34.8 12.2 6.1 0.1 37.1 1.7 2.5 178.9 16.2 1.3 0.6 85.3 2.0 3.5 0.0 0.1 71.9 0.0 5.0 0.0 5.0 2.5 3.8 0.0 3.7 1.2 11.4 0.0 0.0 0.0 25.8 40.5 1.9 24.2 29.6 46.2 4.3 13.1 7.2 13.1 2.4 4.4 2.1 6.5 4.2 0.0 1.8 5.0 1.8 43.6 66.5 CRCP "C17, CGRP-RCP, POLR3I, RCP, RCP9" ENSG00000241258 "CGRP receptor component" O75575 7 66114604-66154568 "Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006883, HPA007216" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "HPA006883: , HPA007216: AB_1856160" "unprognostic (2.36e-2)" "unprognostic (4.43e-1)" "unprognostic (2.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.38e-2)" "unprognostic (6.26e-2)" "unprognostic (2.67e-3)" "unprognostic (8.17e-2)" "unprognostic (1.77e-3)" "unprognostic (2.59e-3)" "unprognostic (8.49e-2)" "unprognostic (9.35e-2)" "unprognostic (1.39e-3)" "unprognostic (3.87e-2)" "unprognostic (4.81e-1)" "unprognostic (3.50e-1)" "unprognostic (2.06e-1)" 13.5 15.3 10.8 13.8 11.4 37.5 17.6 12.7 14.1 14.7 11.2 18.3 16.8 14.7 11.3 20.0 17.3 13.1 17.5 11.3 13.7 16.5 26.5 14.5 16.4 11.6 12.2 16.9 20.6 21.2 11.1 13.7 14.1 17.3 19.6 14.2 16.1 15.8 14.8 16.1 14.7 18.2 11.3 17.4 17.9 8.3 13.9 15.2 20.0 13.6 16.6 16.6 14.4 12.4 44.0 26.9 19.5 26.4 27.0 33.7 19.0 29.9 31.9 43.7 33.7 43.5 34.6 40.6 35.7 29.0 37.0 32.4 26.7 35.9 46.1 26.0 27.3 23.1 19.1 20.9 19.4 47.6 32.6 27.0 30.9 38.3 71.6 27.8 23.7 23.1 49.3 28.8 30.0 35.0 36.7 37.7 39.8 58.7 33.6 38.4 30.1 37.8 27.8 40.5 46.1 60.3 34.3 95.2 29.2 22.8 73.6 24.0 27.6 63.4 33.6 36.5 56.3 35.4 70.0 54.3 35.9 36.8 51.6 25.9 12.0 20.4 17.6 11.1 17.1 14.4 15.4 14.9 9.1 13.4 14.5 17.3 20.9 10.9 17.0 12.0 16.0 12.0 10.8 11.4 12.7 14.1 11.3 13.7 11.6 12.2 14.1 11.3 13.9 12.4 24.8 28.9 32.5 12.1 30.4 13.4 22.2 13.9 24.5 29.9 19.7 19.2 25.7 12.8 23.0 16.5 22.9 12.6 47.8 15.5 35.2 21.3 4.4 27.7 30.3 18.1 16.1 12.2 19.5 24.8 11.8 20.5 27.5 29.4 34.1 22.8 9.7 25.2 12.1 30.3 20.5 15.4 8.2 13.6 9.2 4.3 18.6 17.7 16.0 12.2 20.6 23.0 22.6 12.5 17.2 29.8 10.2 22.2 26.5 26.2 10.5 17.6 32.8 25.8 6.6 27.2 18.5 24.5 16.7 20.9 14.8 11.5 27.3 28.6 14.7 32.1 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974361 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 106.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 49.9;Breast myoepithelial cells: 40.1;Intestinal goblet cells: 56.9;Prostatic glandular cells: 49.3" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 81.8;OE19: 82.7;SK-BR-3: 174.6;T-47d: 139.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Cluster 22: NK-cells - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 6.3 8.5 3.5 4.5 3.8 7.6 48.2 4.6 4.7 30.5 4.4 11.5 11.4 12.9 13.0 8.2 19.2 6.7 5.0 3.3 3.5 10.5 14.0 5.8 5.9 3.9 4.1 17.4 13.2 6.7 6.1 6.3 3.7 106.2 15.2 4.9 43.9 7.6 5.6 10.2 9.0 5.7 3.9 7.5 29.3 5.3 3.6 12.0 11.3 5.3 7.4 6.8 6.9 4.7 7.5 10.6 9.8 10.9 6.9 10.0 24.7 6.2 7.2 8.3 7.3 5.1 31.0 13.9 31.7 2.6 6.1 12.0 14.5 9.7 4.5 11.4 5.9 10.3 11.7 8.9 5.6 4.9 8.5 10.9 9.2 7.9 17.9 7.5 7.4 16.5 8.1 16.9 3.8 81.8 9.3 3.8 6.7 82.7 12.7 20.9 10.3 26.1 9.0 5.3 18.5 20.1 6.6 174.6 16.8 12.8 139.9 14.9 4.5 2.5 7.3 5.2 4.9 31.4 17.3 10.6 5.3 8.5 8.2 1.5 2.9 2.2 3.4 1.2 4.5 4.5 1.9 2.4 5.0 4.8 1.8 3.5 0.1 9.4 1.7 5.7 1.8 2.5 3.5 3.8 4.6 4.7 3.3 3.5 3.9 4.1 3.7 3.9 3.6 4.7 7.2 6.4 13.1 3.6 6.2 2.9 13.1 10.1 6.8 5.3 49.9 40.1 2.0 7.2 20.3 1.8 2.1 12.9 5.6 3.6 9.8 14.0 0.4 10.6 5.2 6.9 9.0 8.6 0.4 13.3 17.0 4.8 10.7 13.5 5.7 8.7 4.2 14.2 5.4 0.0 0.4 56.9 6.1 7.5 2.0 0.6 7.2 5.1 5.4 0.0 2.8 6.6 8.2 1.5 2.2 7.9 4.3 2.2 5.3 49.3 4.0 4.1 16.6 8.8 19.7 3.1 5.0 7.4 10.6 6.3 3.0 4.2 4.5 7.6 10.9 7.0 CRNKL1 "CLF, Clf1, CRN, SYF3" ENSG00000101343 "Crooked neck pre-mRNA splicing factor 1" Q9BZJ0 20 20034368-20056046 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "unprognostic (5.43e-2)" "unprognostic (1.23e-1)" "unprognostic (1.25e-1)" "unprognostic (4.56e-1)" "unprognostic (2.06e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.06e-6)" "unprognostic (1.18e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-1)" "unprognostic (2.64e-1)" "unprognostic (6.09e-2)" "unprognostic (1.43e-3)" "unprognostic (2.25e-1)" "unprognostic (1.57e-1)" "unprognostic (1.35e-1)" "unprognostic (2.78e-2)" 8.5 8.3 7.3 9.7 9.2 23.7 16.2 12.1 8.1 11.2 6.8 10.2 10.2 13.0 10.3 10.1 9.8 8.1 9.7 7.0 7.9 11.9 11.2 7.8 12.2 7.6 7.7 14.7 6.7 14.9 5.8 11.5 8.2 14.0 11.3 9.8 8.2 10.6 16.6 9.0 9.9 11.2 8.2 10.5 10.1 11.3 7.6 13.9 12.9 15.3 12.2 9.7 7.1 12.1 21.2 26.0 20.1 24.2 18.7 19.5 26.9 18.9 18.2 23.9 22.9 17.5 19.6 20.7 14.0 20.0 31.4 29.1 24.1 25.3 29.0 10.5 12.2 20.5 8.0 37.1 15.2 24.6 46.5 15.8 14.5 25.9 15.7 16.9 18.8 23.1 22.0 24.9 22.9 32.5 28.2 18.8 18.4 34.3 26.2 23.8 49.8 28.4 14.2 14.7 30.0 22.0 25.8 42.2 27.2 19.2 35.6 18.5 17.0 18.8 15.1 18.3 21.0 33.7 35.4 22.2 9.4 13.6 16.7 37.2 13.8 32.0 13.8 15.3 16.6 14.8 15.9 15.2 10.8 14.4 14.8 13.2 37.7 22.4 23.7 9.8 17.5 11.7 7.3 9.2 12.1 8.1 7.0 7.9 7.6 7.7 8.2 8.2 7.6 12.1 20.1 22.4 15.1 6.2 23.3 9.3 8.9 11.7 12.5 11.9 19.6 12.7 19.2 18.6 20.5 14.7 12.5 19.8 32.3 17.0 9.8 22.8 11.7 39.7 37.9 16.9 20.4 24.4 8.1 18.5 17.1 18.3 23.0 40.5 35.5 26.5 15.0 19.6 19.4 16.8 7.7 30.2 12.2 18.4 7.6 5.7 20.2 18.3 3.6 5.6 23.3 17.2 19.6 8.0 10.0 19.7 12.7 18.8 30.3 8.3 17.7 18.3 24.8 16.3 26.3 21.7 20.8 62.5 36.9 18.0 8.9 20.1 25.4 22.0 14.9 13.0 CRTC2 TORC2 ENSG00000160741 "CREB regulated transcription coactivator 2" Q53ET0 1 153947669-153958615 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028454, HPA028465" Supported Enhanced Nucleoplasm NA NA 13000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA028454: AB_10599617, HPA028465: AB_10601991" "unprognostic (4.91e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.75e-4)" "unprognostic (4.32e-3)" "unprognostic (2.86e-1)" "unprognostic (4.63e-3)" "unprognostic (1.54e-3)" "unprognostic (1.20e-2)" "unprognostic (1.07e-1)" "unprognostic (2.24e-2)" "unprognostic (2.17e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (1.35e-7)" "unprognostic (7.90e-2)" "unprognostic (2.59e-1)" "unprognostic (3.35e-1)" "prognostic favorable (6.12e-5)" 32.9 28.6 26.1 20.5 28.1 27.9 29.6 26.6 30.2 33.7 24.3 28.5 11.1 27.2 15.7 25.7 29.2 13.7 26.0 25.2 26.6 31.1 35.1 38.8 28.8 29.2 28.0 40.5 26.3 21.0 24.9 15.8 26.9 29.0 12.6 10.0 27.0 16.7 36.6 34.8 34.7 17.2 25.5 55.9 27.9 21.4 28.2 23.6 32.3 18.5 25.3 28.5 29.2 28.7 24.2 17.9 17.1 19.6 27.2 19.8 25.2 12.8 27.2 24.9 20.3 18.5 24.0 22.8 20.4 23.2 16.8 27.0 20.5 26.8 13.9 29.5 25.7 11.2 18.8 14.4 27.4 19.0 18.7 26.1 25.5 27.6 22.3 19.7 23.3 12.8 19.2 27.1 18.0 38.4 20.6 29.9 12.8 26.1 19.5 15.5 11.7 19.6 26.3 19.4 14.2 23.2 21.5 43.3 32.7 16.5 20.9 37.3 17.7 20.0 17.9 21.7 22.9 43.6 30.7 15.7 18.4 15.9 15.1 3.2 2.2 5.0 2.3 3.5 2.0 2.5 2.5 2.6 1.9 3.2 1.6 2.0 5.7 2.9 2.7 2.6 1.9 1.0 26.1 28.1 26.6 30.2 25.2 26.6 29.2 28.0 26.9 25.5 28.2 28.7 17.8 6.4 10.0 10.4 22.3 24.6 6.9 11.1 13.6 6.3 14.6 12.8 6.0 11.5 8.7 12.9 4.2 9.7 23.0 15.9 1.9 9.0 1.4 13.4 15.0 13.7 16.1 9.7 7.4 10.2 9.4 11.1 14.3 27.7 8.2 6.1 12.5 12.8 10.9 1.7 6.9 13.8 6.1 14.6 23.6 1.2 12.2 17.4 3.6 6.5 11.8 4.8 19.6 6.0 11.1 15.0 5.0 15.1 20.6 12.6 9.8 4.0 7.3 6.9 6.6 9.3 12.1 17.0 12.0 12.7 22.6 12.2 19.6 6.1 7.9 13.0 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 193.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 17.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 88.9 55.8 13.6 34.0 13.7 193.1 51.7 17.2 22.5 34.7 15.4 35.6 12.0 30.2 6.4 61.7 79.8 67.5 49.9 12.8 18.0 29.2 67.3 80.8 14.9 21.3 16.2 41.5 39.4 23.5 43.3 25.0 15.7 32.7 15.4 5.8 21.3 18.5 36.9 57.1 26.4 64.1 18.3 20.3 48.0 14.7 17.1 34.9 33.8 19.0 8.7 51.6 27.7 15.4 4.4 9.7 2.5 4.8 4.7 4.9 7.8 15.9 22.1 13.0 10.6 13.7 4.0 14.4 3.3 12.1 9.3 4.9 3.0 21.0 6.4 21.6 4.0 16.4 8.0 10.5 5.8 4.1 15.7 2.3 11.3 20.4 3.2 11.6 17.8 3.9 12.7 24.9 10.7 13.9 0.8 6.7 11.4 7.4 8.1 6.8 10.4 23.7 10.3 15.9 7.0 1.1 8.7 64.2 5.5 14.5 7.2 7.5 9.0 6.6 28.2 5.6 11.9 6.3 5.8 6.6 14.4 5.2 8.4 0.1 3.0 3.8 1.7 5.9 2.1 3.6 1.6 2.0 3.3 3.7 2.0 1.3 17.1 2.6 11.0 4.2 2.7 2.3 13.6 13.7 17.2 22.5 12.8 18.0 21.3 16.2 15.7 18.3 17.1 15.4 200.8 48.1 66.3 6.8 75.0 103.2 88.1 40.2 153.1 1.4 121.1 95.8 15.8 37.1 31.2 11.0 0.0 19.7 86.3 77.3 9.8 37.6 54.4 119.6 65.2 92.8 59.3 13.2 3.5 38.5 43.0 98.1 75.4 199.4 96.5 4.2 73.9 40.7 38.7 0.0 1.5 54.7 22.4 36.7 165.2 46.8 1.5 94.5 69.4 4.7 14.8 7.6 7.2 1.5 1.3 49.2 60.9 4.1 74.3 49.4 54.1 6.0 21.0 1.7 13.1 154.4 103.9 0.6 4.7 85.7 79.6 90.7 132.4 8.9 38.0 38.9 CSTF1 ENSG00000101138 "Cleavage stimulation factor subunit 1" Q05048 20 56392371-56406362 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019270, HPA047275, HPA065000" Supported Enhanced Nucleoplasm NA NA 210000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.54e-3)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (8.57e-3)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (4.05e-2)" "unprognostic (3.91e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" 6.3 6.4 4.1 8.1 4.7 5.1 11.1 6.1 5.0 7.3 5.0 7.9 5.3 8.2 8.0 8.8 9.5 7.7 8.0 4.5 4.4 9.6 10.9 8.5 12.4 4.3 4.1 11.8 10.0 11.4 4.8 9.4 4.8 8.5 8.0 14.9 10.3 7.0 9.4 8.4 5.9 8.8 3.9 7.6 7.8 17.6 5.6 14.3 10.0 14.7 14.4 8.9 5.7 6.1 18.9 17.4 22.1 15.6 22.6 20.2 23.7 25.2 27.8 49.2 36.7 37.6 26.9 39.1 26.7 19.1 31.5 31.2 35.7 43.4 57.8 12.4 12.6 38.1 29.3 23.3 13.4 32.2 23.6 19.4 24.5 27.6 23.8 19.1 30.2 24.3 32.6 18.5 30.2 44.6 36.2 17.0 20.3 37.2 23.2 26.5 47.7 34.6 23.9 19.3 24.5 17.0 34.5 93.1 25.6 25.3 37.1 22.9 17.1 39.9 25.3 16.9 24.9 13.0 21.5 42.0 32.0 21.3 19.4 11.4 16.9 13.6 20.7 14.6 26.0 21.1 25.9 23.4 21.5 24.3 28.4 24.9 13.3 31.2 13.1 23.7 33.3 20.4 4.1 4.7 6.1 5.0 4.5 4.4 4.3 4.1 4.8 3.9 5.6 6.1 8.4 9.6 13.1 4.2 11.6 9.2 10.8 29.3 12.5 9.2 9.9 8.3 8.9 14.3 16.8 18.4 14.6 30.9 11.5 7.3 19.6 17.9 25.9 7.1 9.4 13.3 4.9 21.0 4.2 14.7 21.1 12.1 9.7 6.0 17.7 12.6 11.7 22.6 15.3 5.0 4.2 9.4 14.2 16.7 7.8 7.5 13.7 8.4 5.4 9.4 18.4 14.2 12.3 5.5 6.7 11.9 11.8 12.8 10.8 12.3 8.5 21.1 12.9 14.7 19.7 11.1 9.9 84.3 30.5 11.3 8.8 21.1 14.9 16.7 9.8 8.8 CXXC5 "HSPC195, RINF, WID" ENSG00000171604 "CXXC finger protein 5" Q7LFL8 5 139647299-139683882 "Predicted intracellular proteins" Transcription "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 317.0;Early spermatids: 714.2;Horizontal cells: 541.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 7 "MAIT T-cell: 30.0;memory B-cell: 85.1;naive B-cell: 96.7;NK-cell: 71.9;plasmacytoid DC: 59.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 210.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036508, HPA058148" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA036508: AB_10673620, HPA058148: AB_2683621" "unprognostic (3.08e-2)" "unprognostic (9.03e-2)" "prognostic favorable (2.40e-4)" "prognostic unfavorable (4.10e-7)" "unprognostic (2.91e-1)" "unprognostic (2.05e-1)" "unprognostic (1.11e-3)" "unprognostic (2.28e-2)" "unprognostic (2.12e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (2.79e-2)" "unprognostic (2.63e-2)" "unprognostic (8.02e-2)" "unprognostic (1.44e-1)" "unprognostic (7.26e-2)" "unprognostic (1.57e-1)" 26.5 20.6 48.9 17.6 65.6 46.9 21.5 103.6 64.5 29.2 36.4 17.5 10.8 15.1 30.0 25.6 29.8 20.1 30.4 56.2 48.2 70.7 88.1 16.1 30.2 91.5 65.1 5.0 61.2 28.0 43.6 15.9 84.0 15.3 11.6 38.7 53.9 18.3 80.1 24.8 22.5 9.1 66.5 34.5 21.0 51.8 61.4 34.3 22.5 21.5 24.7 14.8 23.9 106.4 36.5 30.1 32.6 12.3 44.5 60.6 12.7 23.3 35.3 9.9 19.5 66.8 36.0 47.4 101.0 62.5 59.7 40.5 6.7 17.9 4.7 5.2 11.5 70.5 25.8 47.0 19.2 16.0 1.8 21.8 4.0 16.7 4.8 95.6 2.7 1.5 67.8 7.6 72.6 94.7 17.2 51.1 39.4 39.2 8.5 30.8 66.5 73.5 75.3 26.0 103.0 106.3 8.3 210.6 18.0 71.2 115.5 74.2 14.6 80.2 15.6 38.8 21.4 27.3 62.4 89.9 121.2 5.3 45.6 1.1 6.6 0.6 9.7 1.4 30.0 85.1 0.9 6.8 5.5 96.7 0.5 2.6 1.8 71.9 0.6 59.0 1.4 10.7 48.9 65.6 103.6 64.5 56.2 48.2 91.5 65.1 84.0 66.5 61.4 106.4 22.9 48.1 18.8 24.5 120.4 26.3 14.8 41.9 8.6 232.0 41.0 67.8 49.3 105.8 32.5 147.1 25.0 2.9 90.2 18.6 317.0 125.1 714.2 47.1 53.9 43.6 18.6 52.2 18.7 144.9 23.9 47.8 24.5 53.7 21.5 41.9 36.0 131.8 38.4 541.8 8.7 50.7 61.1 35.6 92.1 200.3 39.1 32.2 60.5 15.0 40.9 220.5 195.7 16.6 44.3 93.9 17.5 30.5 114.1 34.1 22.6 200.0 38.6 49.1 13.1 150.9 48.5 14.2 13.9 15.7 20.9 37.6 21.1 25.1 27.0 21.4 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350845-50358460 "Enzymes, Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071862 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 13.3 20.7 8.1 16.7 9.8 22.0 13.9 9.7 9.2 10.6 10.5 19.7 22.0 7.6 25.8 14.6 9.7 14.6 10.1 8.3 8.6 19.8 34.3 14.1 22.2 9.8 9.6 7.0 19.5 18.2 13.8 11.1 9.8 16.3 18.0 3.1 20.3 11.5 10.0 9.8 22.7 7.1 9.6 24.7 21.7 10.5 9.2 13.2 20.3 3.5 15.3 12.3 9.3 11.3 16.2 33.5 8.4 15.8 17.2 14.7 19.2 27.4 20.4 24.5 28.0 24.1 25.3 25.3 29.3 33.8 29.8 16.5 12.8 25.2 10.7 38.5 31.9 23.7 40.7 22.5 24.2 26.3 52.3 23.0 11.3 29.3 13.5 12.4 21.1 19.1 10.5 32.3 19.7 30.3 17.0 22.9 13.4 24.6 52.1 11.6 5.8 50.2 26.3 27.0 8.4 23.7 13.7 56.1 17.5 8.4 19.8 30.9 23.1 22.5 18.9 37.6 35.8 24.6 26.2 16.8 30.2 32.1 24.4 145.8 113.9 176.1 144.3 140.1 95.6 88.4 96.1 115.7 86.3 79.3 67.1 99.6 110.8 109.3 136.2 89.0 114.7 112.4 8.1 9.8 9.7 9.2 8.3 8.6 9.8 9.6 9.8 9.6 9.2 11.3 13.3 6.4 21.7 5.5 24.4 5.0 12.0 37.4 8.6 6.8 26.5 12.3 0.0 0.0 30.9 25.8 6.2 35.0 40.2 47.1 11.7 44.9 19.9 19.7 14.7 9.1 31.8 6.7 6.7 68.1 46.0 13.0 31.1 18.4 21.5 8.4 0.0 0.0 57.3 8.4 5.8 47.0 46.8 0.0 12.3 9.1 8.7 29.1 19.6 6.5 36.2 22.2 45.3 6.0 13.3 43.3 49.4 7.9 36.7 17.9 55.6 22.3 38.4 8.2 13.1 8.0 15.6 6.1 14.1 14.0 7.4 55.1 32.9 15.9 28.1 18.4 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748845-74756607 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 313 "liver: 513.4" "Cell type enriched" "Detected in some" 57 "Hepatocytes: 85.7" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-BR-3: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.2 0.3 0.5 0.2 0.5 1.0 0.1 1.6 0.8 0.0 0.2 0.0 0.2 0.2 0.4 0.1 0.2 0.2 0.1 0.5 0.5 0.2 513.4 0.4 0.3 0.6 0.5 0.1 0.0 0.0 0.0 0.7 0.6 0.1 0.1 0.4 0.2 0.3 0.3 0.6 0.2 0.0 0.1 0.3 0.2 0.3 0.6 0.1 1.4 0.0 0.1 0.1 0.0 1.3 0.4 0.3 0.8 0.5 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.4 0.8 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.4 0.9 0.6 0.1 0.0 0.7 0.3 0.1 0.1 0.0 0.0 0.3 0.1 1.3 0.7 1.3 0.0 0.2 0.9 0.3 0.4 0.3 0.2 0.9 0.8 0.3 0.1 0.7 0.7 0.3 0.6 2.3 0.1 0.6 0.5 0.2 0.2 0.3 0.4 0.3 0.3 0.3 0.2 0.5 0.3 0.9 0.3 1.5 0.3 0.5 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.2 2.1 0.4 0.2 0.4 0.1 0.1 0.5 0.5 1.6 0.8 0.5 0.5 0.6 0.5 0.6 0.1 0.6 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 85.7 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 CYP4F8 ENSG00000186526 "Cytochrome P450 family 4 subfamily F member 8" P98187 19 15615218-15630639 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "seminal vesicle: 215.6" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 1.2;Breast glandular cells: 1.7;granulocytes: 1.3;NK-cells: 1.0;Prostatic glandular cells: 1.3;Skeletal myocytes: 1.7;Urothelial cells: 2.5" "Cancer enhanced" "Detected in some" "urothelial cancer: 10.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.1" "Low region specificity" "Detected in all" HPA058960 Approved NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA058960: AB_2683862" "unprognostic (1.70e-2)" "unprognostic (5.46e-3)" "unprognostic (3.21e-2)" "unprognostic (3.97e-6)" "unprognostic (3.51e-3)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-2)" "unprognostic (1.15e-2)" "unprognostic (1.02e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.2 215.6 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.4 1.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.3 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 1.7 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 2.5 DCAF4 "DKFZp434K114, WDR21, WDR21A" ENSG00000119599 "DDB1 and CUL4 associated factor 4" Q8WV16 14 72926377-72959703 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047276 Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA047276: AB_10959615" "unprognostic (6.01e-2)" "unprognostic (1.96e-1)" "unprognostic (9.31e-2)" "unprognostic (1.78e-2)" "unprognostic (1.78e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (6.77e-4)" "unprognostic (3.93e-2)" "unprognostic (2.11e-1)" "unprognostic (1.38e-2)" "unprognostic (2.86e-1)" "unprognostic (7.56e-2)" "prognostic favorable (4.90e-4)" "unprognostic (6.80e-2)" "unprognostic (1.87e-1)" "unprognostic (9.96e-3)" "unprognostic (2.11e-2)" 6.8 7.9 5.9 4.8 6.0 4.9 7.1 5.2 6.6 7.8 4.6 7.9 4.1 7.0 5.3 7.6 5.6 3.7 5.5 6.5 6.6 9.1 7.4 4.5 6.5 7.4 6.2 9.1 12.5 5.5 3.7 9.3 7.6 6.9 6.5 2.6 6.8 5.2 12.8 12.8 6.9 6.0 5.2 6.7 8.0 7.0 6.1 3.9 11.4 5.1 7.4 8.1 7.5 6.6 20.7 9.4 2.3 10.8 9.9 12.5 19.0 11.6 11.6 14.9 17.4 11.3 8.9 26.0 8.5 21.9 13.6 15.6 16.0 18.2 25.5 13.2 8.9 10.8 4.4 15.1 13.9 7.4 17.8 21.9 17.4 15.5 29.1 10.0 5.2 25.1 16.2 16.1 12.1 35.3 12.7 18.4 6.3 20.2 20.3 8.9 12.2 15.2 22.5 12.3 12.5 4.9 7.0 37.4 14.1 10.4 12.5 9.9 7.8 8.0 18.5 22.6 5.7 22.8 23.5 17.7 11.0 6.1 4.9 0.4 1.6 0.3 4.1 2.5 6.1 11.6 5.0 4.6 3.3 8.7 5.7 6.0 0.9 9.1 5.4 2.5 7.2 3.0 5.9 6.0 5.2 6.6 6.5 6.6 7.4 6.2 7.6 5.2 6.1 6.6 2.9 6.4 5.3 3.3 10.8 6.1 7.3 5.8 8.0 3.4 5.8 5.1 4.0 2.8 8.3 3.7 4.2 20.9 4.4 4.3 3.9 6.7 3.8 4.3 6.6 4.4 4.2 4.2 5.7 5.6 15.3 4.9 12.8 7.5 0.0 10.9 1.1 4.7 5.8 0.0 4.7 4.3 6.1 2.2 4.2 2.6 3.7 1.9 1.8 3.7 4.1 2.1 4.1 3.5 5.8 4.4 7.0 5.7 4.7 4.0 2.9 6.6 2.6 3.5 0.0 4.4 4.0 7.5 18.6 6.4 6.7 5.6 5.3 11.8 7.1 3.3 DECR1 "DECR, SDR18C1" ENSG00000104325 "2,4-dienoyl-CoA reductase 1" Q16698 8 90001405-90053633 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 290.1;liver: 272.3" "Cell type enhanced" "Detected in all" "Distal tubular cells: 399.2;Proximal tubular cells: 485.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023160, HPA023162, HPA023238" Enhanced Supported Mitochondria,Cytosol No No 120000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Cytosol "HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587" "prognostic unfavorable (1.49e-4)" "unprognostic (5.76e-3)" "unprognostic (8.37e-3)" "unprognostic (6.13e-3)" "unprognostic (2.01e-1)" "unprognostic (4.45e-2)" "unprognostic (1.68e-2)" "unprognostic (8.23e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-1)" "unprognostic (9.12e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.79e-7)" "unprognostic (1.40e-1)" "unprognostic (1.73e-2)" "unprognostic (1.16e-1)" "prognostic favorable (6.06e-4)" 60.2 136.8 12.4 9.6 14.4 24.9 54.4 12.5 14.4 29.4 22.2 65.0 20.2 28.0 14.9 52.6 26.1 7.4 290.1 12.7 13.2 103.5 272.3 34.2 15.0 12.2 13.1 35.5 44.4 13.2 32.6 5.9 12.1 28.6 18.8 8.0 42.8 6.5 121.8 43.3 61.0 9.1 12.5 47.1 44.5 52.3 15.4 10.2 33.0 34.4 13.9 31.1 35.8 12.8 13.1 7.9 19.6 16.1 8.0 17.3 5.2 13.2 12.9 5.9 8.2 2.8 13.4 7.7 5.3 15.1 4.1 6.8 7.7 11.1 11.0 12.6 1.2 18.4 13.6 14.5 11.6 8.7 4.4 12.0 7.0 7.6 10.7 10.1 17.4 16.5 21.3 15.5 20.7 16.3 12.5 7.6 1.5 9.1 24.9 7.4 5.8 13.4 23.4 43.9 1.3 10.6 13.0 81.1 7.7 1.1 10.7 7.4 20.1 11.4 6.2 12.9 6.0 10.5 7.5 12.8 8.6 12.0 10.8 3.9 9.1 6.2 7.1 10.2 7.9 7.4 6.9 8.6 8.8 4.6 8.1 7.8 15.2 3.9 9.3 3.9 9.6 5.8 12.4 14.4 12.5 14.4 12.7 13.2 12.2 13.1 12.1 12.5 15.4 12.8 66.1 76.9 59.4 72.5 52.9 41.3 70.6 180.2 35.3 11.4 51.1 57.4 268.3 82.9 96.4 71.7 2.1 50.2 57.6 119.0 399.2 137.8 165.3 68.2 65.5 60.0 104.8 77.4 27.2 92.5 49.0 60.2 61.2 40.6 50.0 81.3 47.8 244.8 115.1 32.0 55.9 105.9 116.0 95.2 82.7 52.6 85.4 85.1 85.4 29.0 107.1 52.5 74.2 66.9 35.0 87.5 111.6 51.6 67.8 30.3 250.3 485.2 69.0 7.6 72.3 54.5 61.7 157.5 24.6 68.6 41.1 41.0 64.4 135.1 139.6 86.8 DEDD "CASP8IP1, DEDD1, DEFT, FLDED1, KE05" ENSG00000158796 "Death effector domain containing" O75618 1 161120974-161132688 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064486, HPA065101, HPA073628" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli" Cytosol "HPA064486: , HPA065101: , HPA073628: AB_2732230" "unprognostic (2.24e-1)" "unprognostic (2.38e-1)" "unprognostic (4.81e-2)" "unprognostic (5.09e-2)" "unprognostic (4.20e-3)" "unprognostic (5.94e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (2.52e-1)" "unprognostic (8.70e-2)" "unprognostic (7.66e-3)" "unprognostic (2.33e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.98e-7)" "unprognostic (1.53e-1)" "unprognostic (1.34e-1)" "unprognostic (4.06e-2)" "unprognostic (1.43e-2)" 34.4 21.4 20.6 19.4 22.0 29.8 29.0 21.9 20.8 26.1 18.8 30.5 20.8 24.7 14.9 25.8 26.5 21.2 24.3 20.2 20.4 21.6 24.3 28.6 21.2 21.3 20.7 28.0 21.2 18.2 17.9 22.1 20.7 23.0 13.7 23.9 20.7 15.8 56.7 29.2 23.5 21.0 20.7 27.8 22.4 28.0 21.5 22.5 24.2 34.9 18.3 26.8 25.1 22.6 24.7 24.0 27.7 24.3 21.0 22.2 19.1 20.7 29.3 23.5 26.1 16.7 41.5 26.2 20.4 31.2 17.2 22.0 21.2 32.5 15.1 26.3 23.1 24.5 30.2 22.7 37.0 17.3 35.5 26.8 34.2 25.3 40.1 31.2 38.5 35.6 21.3 38.3 27.8 38.8 42.4 18.9 46.5 49.1 24.5 34.1 19.1 35.0 23.8 29.6 29.3 44.2 21.1 55.1 37.0 29.9 33.0 34.8 27.3 25.6 27.2 30.0 30.6 52.2 35.6 46.9 30.6 18.5 18.6 64.0 36.9 52.8 27.8 34.6 23.7 24.0 27.4 27.9 33.3 22.7 30.6 25.1 41.2 27.7 38.0 29.2 38.4 31.4 20.6 22.0 21.9 20.8 20.2 20.4 21.3 20.7 20.7 20.7 21.5 22.6 27.8 25.6 9.3 8.5 16.7 25.2 13.9 11.5 14.2 6.8 10.5 8.0 10.6 18.6 10.1 9.2 6.2 19.6 16.2 12.9 23.5 13.6 42.6 9.5 8.3 22.3 11.3 13.7 4.8 19.3 19.6 13.3 15.8 11.3 16.5 7.7 21.0 10.7 14.8 13.5 5.1 8.1 2.0 19.8 27.2 43.5 11.8 16.2 14.2 4.7 20.9 6.7 8.2 5.0 10.8 15.6 13.2 9.8 24.2 10.2 12.5 13.7 7.4 13.2 6.6 12.0 16.5 23.5 18.4 22.2 24.9 27.0 15.0 5.7 9.7 17.4 DERL1 "DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577" ENSG00000136986 "Derlin 1" Q9BUN8 8 123013170-123042302 "Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Protein transport, Transport, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 225.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 825.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016562, CAB037269" Supported Supported "Endoplasmic reticulum" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB037269: AB_609868, HPA016562: AB_1847611" "prognostic unfavorable (2.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (5.66e-5)" "unprognostic (9.48e-2)" "unprognostic (4.21e-3)" "unprognostic (2.76e-1)" "unprognostic (1.28e-3)" "unprognostic (4.42e-2)" "unprognostic (5.38e-2)" "unprognostic (1.41e-3)" "unprognostic (4.35e-1)" "prognostic unfavorable (1.58e-4)" "unprognostic (1.88e-3)" "unprognostic (2.51e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" 69.1 47.6 15.2 53.7 16.4 104.1 34.1 20.2 18.2 26.6 26.6 50.0 47.9 29.4 31.4 35.4 29.4 32.9 41.3 17.9 18.3 30.8 77.5 37.1 48.7 15.7 16.4 38.1 31.6 26.9 23.0 28.0 15.7 27.0 42.8 29.6 29.6 28.7 73.3 23.6 47.0 34.4 16.7 40.0 38.5 32.1 18.0 27.2 42.4 49.1 55.5 41.8 22.5 19.5 130.8 93.9 55.7 72.6 98.3 72.8 47.1 108.9 72.1 68.7 85.1 59.7 126.9 150.7 129.8 87.4 81.2 107.0 51.8 69.3 97.4 174.9 57.6 157.2 62.9 51.6 89.2 62.2 111.0 66.9 87.8 76.0 89.8 62.5 62.8 60.6 95.9 193.7 78.7 254.8 68.5 39.4 42.1 166.4 82.5 68.3 46.2 252.1 182.2 92.1 60.5 89.8 109.9 825.1 68.6 59.6 97.3 55.4 74.2 82.2 154.1 74.1 102.1 239.5 444.6 136.5 135.4 76.4 79.4 73.1 60.7 72.6 89.3 75.7 93.0 69.8 59.5 74.0 49.5 56.1 41.0 64.0 42.1 77.8 77.9 56.6 80.0 83.3 15.2 16.4 20.2 18.2 17.9 18.3 15.7 16.4 15.7 16.7 18.0 19.5 38.6 32.1 25.9 12.4 78.3 42.3 41.8 57.3 26.7 22.6 38.3 21.3 28.1 17.2 44.8 29.5 20.9 41.0 67.6 43.3 9.8 87.7 85.5 18.9 32.3 39.2 30.5 41.0 11.5 75.4 71.4 43.8 26.5 31.2 42.6 24.0 39.3 75.9 68.0 18.5 12.8 62.2 42.7 49.4 44.2 19.9 24.5 45.6 60.5 14.0 47.6 25.5 59.8 17.6 19.1 68.4 40.6 25.6 225.0 63.7 56.6 28.0 31.3 25.6 46.0 32.7 77.6 75.4 40.3 41.0 50.7 78.0 69.8 34.8 37.5 64.4 DHRS13 "MGC23280, SDR7C5" ENSG00000167536 "Dehydrogenase/reductase 13" Q6UX07 17 28897781-28903079 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 41.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 55.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 55.3" "Cell line enhanced" "Detected in all" "SK-BR-3: 69.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022991 Uncertain Approved Vesicles "Secreted - unknown location" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "HPA022991: AB_1853865" "unprognostic (8.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (2.38e-1)" "unprognostic (4.74e-2)" "unprognostic (5.65e-2)" "unprognostic (1.20e-2)" "unprognostic (7.57e-2)" "unprognostic (1.73e-2)" "unprognostic (3.72e-2)" "unprognostic (2.63e-1)" "unprognostic (7.22e-3)" "unprognostic (2.55e-1)" 3.1 7.0 9.9 5.7 8.6 41.8 5.4 17.1 9.6 6.4 11.8 4.8 4.4 3.0 6.6 8.8 4.1 2.9 2.8 8.6 15.3 12.2 23.6 4.7 6.6 13.0 14.9 3.5 6.6 7.9 6.3 4.5 14.0 19.4 3.6 8.3 12.7 10.6 1.3 7.4 4.0 2.2 10.1 10.2 5.9 3.0 13.0 4.6 4.7 2.3 6.9 9.5 6.3 9.5 12.1 7.6 17.4 22.2 2.6 3.8 16.8 6.4 8.3 11.6 17.7 23.5 7.1 32.8 10.7 1.4 13.4 10.5 24.8 7.1 4.9 33.5 23.9 18.4 13.9 13.0 6.5 9.5 2.1 2.8 6.3 7.3 7.7 8.1 3.6 22.7 42.3 11.0 2.3 21.7 20.9 15.9 10.7 31.4 1.0 32.8 16.4 25.5 21.8 20.2 24.8 20.8 10.1 69.5 13.9 9.1 46.4 15.2 1.2 3.7 11.1 9.0 8.9 25.5 25.7 20.7 11.0 11.9 9.4 0.9 4.4 3.1 8.5 6.9 10.4 7.1 10.8 10.7 5.9 8.6 10.9 8.1 55.3 9.4 6.8 3.2 11.4 5.8 9.9 8.6 17.1 9.6 8.6 15.3 13.0 14.9 14.0 10.1 13.0 9.5 2.4 3.2 4.2 2.3 6.7 1.5 10.2 12.3 12.0 6.1 7.1 5.7 0.4 8.6 5.4 7.3 2.1 27.7 4.4 4.3 9.8 10.6 11.9 3.4 1.1 4.5 3.0 106.1 0.7 2.7 22.2 2.1 7.7 6.3 1.3 1.2 6.4 5.5 6.2 5.0 4.4 4.2 2.0 0.8 3.0 5.2 1.2 2.1 5.4 1.0 15.5 8.2 10.3 3.0 1.0 2.5 2.4 0.4 12.8 11.5 2.8 3.2 2.2 5.0 6.6 0.9 1.1 6.1 22.5 9.4 1.7 13.5 7.0 0.5 6.4 5.8 DHRS2 "HEP27, SDR25C1" ENSG00000100867 "Dehydrogenase/reductase 2" Q13268 14 23630115-23645639 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 336.3;urinary bladder: 392.6" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 15.1;Syncytiotrophoblasts: 24.8;Theca cells: 12.6;Urothelial cells: 30.6" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 141.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 719.8;RT4: 828.1;SK-BR-3: 4047.2;U-2 OS: 1286.3" "Region enriched" "Detected in single" 4 "cerebellum: 2.4" "HPA053915, HPA069551" Enhanced Supported Nucleoplasm,Mitochondria No NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Mitochondria Nucleoplasm "HPA053915: AB_2682307, HPA069551: AB_2686150" "unprognostic (3.07e-1)" "unprognostic (4.91e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (9.97e-2)" "unprognostic (5.03e-3)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-1)" "unprognostic (6.91e-2)" "unprognostic (6.66e-2)" "unprognostic (4.59e-2)" "prognostic unfavorable (3.75e-5)" "unprognostic (1.83e-1)" "unprognostic (1.46e-1)" "unprognostic (1.76e-1)" "prognostic favorable (6.45e-4)" 1.2 1.6 0.3 0.1 0.2 0.0 336.3 0.2 0.4 1.9 0.2 0.2 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.4 1.2 1.6 23.6 0.2 0.0 0.4 1.2 25.5 10.3 2.1 2.5 3.2 1.7 3.3 0.4 0.4 97.7 3.1 0.0 3.4 0.1 0.2 0.3 19.0 4.7 3.4 1.1 0.0 0.1 0.0 0.0 392.6 13.6 0.3 1.2 2.2 0.2 199.9 0.3 0.3 3.1 0.3 0.2 6.4 0.1 14.4 1.1 0.8 1.9 0.3 10.4 2.0 0.7 1.2 1.4 289.5 21.6 2.8 1.0 719.8 0.0 4.3 25.1 1.7 0.2 2.5 1.7 0.0 0.1 0.4 1.8 0.7 1.4 8.0 2.5 0.3 1.1 6.9 31.7 2.6 6.3 2.7 0.0 828.1 3.5 5.0 5.9 4047.2 4.9 0.7 3.9 1.0 0.0 2.4 1286.3 7.7 4.3 2.0 0.6 11.3 1.7 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.4 0.4 1.2 0.4 1.2 1.7 0.3 1.1 0.3 0.1 0.0 0.0 0.0 0.4 0.0 2.1 0.2 0.0 0.8 7.4 1.3 0.4 0.0 0.0 0.0 0.0 7.9 0.1 0.1 7.9 0.1 5.0 0.1 0.0 0.2 3.5 0.0 0.1 0.2 15.1 3.5 0.0 0.0 0.0 1.4 0.0 4.9 1.7 0.0 0.1 0.2 0.0 0.3 0.8 3.7 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 4.8 0.2 1.2 0.0 0.3 0.0 0.2 0.0 1.2 6.6 0.0 0.7 0.3 7.4 0.0 0.1 24.8 0.2 12.6 0.7 30.6 DIO1 TXDI1 ENSG00000211452 "Iodothyronine deiodinase 1" P49895 1 53891239-53911086 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 42 "kidney: 144.9;liver: 185.3;thyroid gland: 260.2" "Group enriched" "Detected in some" 5 "Hepatocytes: 61.5;Proximal tubular cells: 115.7" "Group enriched" "Detected in many" 8 "liver cancer: 44.7;thyroid cancer: 43.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 26 "Hep G2: 33.9;SK-BR-3: 79.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 81: Kidney & Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (4.89e-2)" "unprognostic (4.86e-2)" "unprognostic (1.81e-2)" "unprognostic (1.21e-2)" "unprognostic (1.06e-1)" "unprognostic (2.68e-2)" "unprognostic (3.91e-3)" "unprognostic (6.96e-4)" "unprognostic (6.94e-2)" "unprognostic (4.83e-2)" "unprognostic (8.81e-2)" "unprognostic (1.43e-1)" "unprognostic (3.50e-3)" "unprognostic (9.99e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (5.44e-4)" "unprognostic (3.59e-2)" 0.1 0.2 0.2 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.0 0.2 4.6 1.0 0.6 0.1 0.1 144.9 185.3 0.4 0.8 0.3 0.2 0.2 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.3 0.7 0.3 0.0 260.2 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 1.0 0.3 0.0 33.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.2 0.0 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.0 79.0 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.3 0.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.9 0.1 15.2 11.5 0.4 0.0 0.0 0.5 0.1 0.0 11.7 0.0 3.6 0.3 0.1 0.4 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 61.5 0.5 0.0 0.5 0.0 0.0 2.2 0.0 5.3 0.0 0.7 0.0 1.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.2 0.0 115.7 10.2 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 2.3 0.3 0.1 0.0 0.0 DNAJC3 "ERdj6, HP58, P58, p58(IPK), P58IPK, PRKRI" ENSG00000102580 "DnaJ heat shock protein family (Hsp40) member C3" Q13217 13 95677139-95794988 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Antiviral defense, Stress response, Translation regulation, Unfolded protein response" "Chaperone, Repressor" "Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039336, HPA041326" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 4900000 "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA039336: AB_2676451, HPA041326: AB_2677412" "unprognostic (1.44e-2)" "unprognostic (8.08e-2)" "unprognostic (2.12e-2)" "prognostic favorable (3.47e-5)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (9.69e-2)" "unprognostic (7.19e-2)" "unprognostic (3.37e-2)" "unprognostic (8.30e-3)" "unprognostic (8.18e-2)" 21.0 20.0 10.7 22.5 13.0 45.6 21.3 13.0 11.4 35.1 22.3 25.2 23.8 20.4 38.9 15.9 20.4 22.0 16.6 10.0 14.1 25.5 41.8 22.9 15.0 15.1 12.5 15.8 36.0 24.4 16.2 24.7 15.5 34.5 26.4 9.9 36.3 26.0 9.3 10.9 24.0 22.3 13.4 19.8 28.8 12.7 14.6 11.3 52.8 11.2 17.8 22.1 11.9 16.4 32.4 18.0 14.2 40.7 57.7 28.6 42.6 44.6 40.3 20.2 18.4 22.7 66.5 29.5 41.5 45.0 28.5 32.3 18.7 34.1 30.7 28.8 8.4 40.7 24.6 36.5 79.1 49.8 51.6 34.3 35.7 29.7 68.2 36.9 44.4 13.2 13.9 0.3 34.4 13.1 17.0 17.8 10.6 75.2 13.9 17.1 24.8 22.9 44.9 39.5 8.2 15.6 31.6 74.9 22.5 32.4 37.3 54.6 50.8 39.0 13.3 26.2 23.3 60.6 28.4 13.4 65.6 29.6 54.9 64.7 25.5 86.2 23.9 32.1 25.3 11.2 19.6 20.1 17.2 9.0 13.7 18.7 77.1 22.8 36.0 45.9 13.4 15.7 10.7 13.0 13.0 11.4 10.0 14.1 15.1 12.5 15.5 13.4 14.6 16.4 81.7 80.1 71.3 47.3 61.1 94.1 88.5 81.1 33.6 25.7 65.2 35.9 58.2 81.5 83.4 47.8 27.1 57.1 109.6 69.0 21.5 98.8 160.5 58.0 87.5 64.8 41.9 33.7 30.1 118.7 135.5 99.6 56.6 94.5 67.8 34.4 68.6 140.7 78.8 25.2 37.3 84.9 69.2 70.5 130.2 33.6 71.7 82.0 119.2 47.8 63.1 38.7 51.5 53.3 58.9 97.6 52.4 75.6 214.3 151.2 58.1 71.1 96.7 19.6 92.1 80.8 104.5 47.1 79.9 38.1 92.9 189.8 67.0 53.3 63.8 124.4 DNAJC30 WBSCR18 ENSG00000176410 "DnaJ heat shock protein family (Hsp40) member C30" Q96LL9 7 73680918-73683453 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" Chaperone "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 120.1;Late spermatids: 230.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017318 Supported NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA017318: AB_1858788" "unprognostic (1.86e-2)" "unprognostic (1.85e-1)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.37e-2)" "unprognostic (1.50e-1)" "unprognostic (2.66e-2)" "unprognostic (4.53e-1)" "unprognostic (3.93e-2)" "unprognostic (2.85e-3)" "unprognostic (4.60e-2)" "prognostic favorable (4.91e-8)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" 6.4 14.7 7.2 3.1 7.9 2.9 6.3 7.1 8.3 5.5 5.5 6.0 3.8 7.1 4.6 5.4 6.4 2.0 11.3 7.9 7.1 9.7 11.9 3.9 3.5 7.0 6.9 6.2 7.9 6.6 10.5 2.7 7.2 6.6 3.2 3.8 6.1 4.7 9.3 5.0 5.2 2.9 5.1 6.0 6.3 12.5 6.9 3.7 8.7 4.8 2.9 6.2 4.4 7.2 6.5 6.3 4.6 9.2 7.0 4.9 4.8 10.0 7.3 7.6 7.4 6.1 6.6 5.7 2.5 8.0 11.2 9.0 4.1 5.6 4.3 6.7 8.4 3.3 6.0 6.5 7.2 5.6 4.5 5.5 4.6 6.9 5.9 5.3 6.6 7.3 6.8 5.0 7.5 13.0 9.1 11.3 3.9 6.0 10.6 6.2 3.6 14.1 9.9 7.5 12.3 6.6 10.2 17.7 7.9 4.6 16.1 3.7 6.5 8.0 5.8 8.4 7.2 5.3 3.9 5.4 6.4 3.8 10.0 5.4 6.2 3.9 6.3 5.7 7.7 7.4 7.7 7.6 6.0 9.8 9.1 7.8 0.8 6.0 4.4 6.3 5.6 5.2 7.2 7.9 7.1 8.3 7.9 7.1 7.0 6.9 7.2 5.1 6.9 7.2 10.0 19.2 6.2 2.3 14.7 5.9 16.6 19.9 12.5 34.9 13.9 11.9 19.7 14.3 15.8 18.4 14.6 43.6 18.6 7.2 56.7 30.2 120.1 15.9 13.3 10.6 17.4 6.9 5.6 28.0 16.2 13.9 16.3 11.3 12.7 20.8 15.0 25.3 22.3 20.2 6.1 12.8 12.2 13.2 5.3 230.1 24.5 9.3 14.2 2.8 26.9 24.6 32.0 2.5 8.9 19.2 8.4 18.4 9.4 13.3 15.4 81.8 10.0 29.5 19.7 12.6 12.4 69.6 16.5 16.9 8.2 36.0 11.2 56.0 17.1 12.6 DSCC1 "DCC1, hDCC1, MGC5528" ENSG00000136982 "DNA replication and sister chromatid cohesion 1" Q9BVC3 8 119833976-119855894 "Predicted intracellular proteins" "Cell cycle, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 9.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 24.6;Extravillous trophoblasts: 17.6;Spermatogonia: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA023780, HPA024401" Uncertain Approved Nucleoplasm NA Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA023780: AB_2671311, HPA024401: AB_2671557" "unprognostic (7.36e-3)" "unprognostic (8.24e-2)" "unprognostic (1.56e-1)" "unprognostic (4.71e-3)" "unprognostic (9.91e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.92e-6)" "prognostic unfavorable (3.93e-4)" "prognostic unfavorable (5.73e-4)" "unprognostic (3.24e-3)" "unprognostic (8.12e-3)" "unprognostic (2.72e-2)" "unprognostic (2.32e-9)" "unprognostic (2.75e-2)" "unprognostic (5.01e-1)" "unprognostic (4.40e-2)" "unprognostic (8.18e-2)" 1.8 1.8 1.3 3.7 1.6 6.1 2.4 2.1 2.0 2.6 1.1 2.7 2.4 2.4 1.3 2.4 1.5 1.0 1.5 1.4 1.4 0.9 1.1 1.4 7.1 1.5 1.5 1.5 2.8 0.5 0.5 2.3 1.6 1.9 3.5 0.3 3.7 1.2 2.1 2.6 2.3 2.7 1.5 1.3 1.7 2.6 1.4 9.9 1.0 3.4 5.7 1.5 2.1 1.8 34.3 16.6 32.1 29.4 4.6 8.3 13.8 23.1 4.7 16.3 16.9 15.2 20.4 61.7 19.7 6.9 10.1 24.8 36.7 14.4 17.5 42.2 33.3 78.7 16.2 17.9 1.5 31.2 26.4 3.8 2.2 20.1 9.7 3.8 4.7 40.5 27.2 26.9 19.9 33.8 82.4 19.2 47.2 90.4 41.2 29.1 30.4 29.9 12.7 21.3 28.7 17.6 12.4 96.7 15.8 25.0 18.1 17.0 3.2 17.7 48.0 17.2 33.9 36.5 58.2 65.4 9.0 49.2 26.2 0.0 0.0 0.0 0.9 0.0 0.7 0.3 0.2 0.4 0.0 0.1 0.1 0.3 0.0 0.8 0.0 0.2 0.3 0.2 1.3 1.6 2.1 2.0 1.4 1.4 1.5 1.5 1.6 1.5 1.4 1.8 4.7 0.0 0.5 2.6 1.2 3.4 2.2 2.1 4.6 0.7 2.2 3.2 0.8 1.5 0.2 0.0 0.0 7.9 1.6 1.0 0.0 1.6 0.1 0.8 2.8 3.0 0.0 24.6 6.4 2.4 17.6 4.3 1.5 1.3 4.5 3.7 4.6 0.9 4.7 0.0 5.2 1.2 2.0 1.0 1.2 0.2 1.2 0.9 3.6 1.0 0.0 1.5 1.0 7.5 5.3 0.5 0.3 2.6 5.2 1.7 0.2 1.5 1.7 0.3 0.0 2.3 3.3 1.1 18.8 6.0 3.3 1.4 3.0 2.0 3.8 1.5 DTNB ENSG00000138101 "Dystrobrevin beta" O60941 2 25377198-25673647 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 36.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.8;Inhibitory neurons: 214.1;Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 343.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA061357 Uncertain Approved Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA061357: AB_2684489" "unprognostic (1.14e-1)" "unprognostic (1.39e-2)" "unprognostic (3.17e-2)" "unprognostic (7.40e-2)" "unprognostic (1.17e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.78e-2)" "unprognostic (3.67e-3)" "unprognostic (3.98e-2)" "unprognostic (9.45e-2)" "unprognostic (4.67e-2)" "prognostic favorable (3.47e-4)" "unprognostic (1.86e-1)" "unprognostic (1.40e-1)" "unprognostic (3.16e-2)" "unprognostic (6.49e-2)" 2.1 2.1 7.8 1.6 6.7 2.9 9.7 3.4 12.1 4.2 0.0 1.7 1.2 2.8 10.1 4.5 4.6 3.3 2.0 12.4 3.6 4.2 3.4 4.3 2.5 4.9 1.7 4.4 7.7 9.9 5.8 1.9 4.5 8.4 1.0 5.0 36.0 5.1 2.7 4.5 1.6 1.2 0.1 2.7 5.6 6.7 2.9 4.0 11.1 1.5 1.9 3.5 4.0 5.6 10.7 9.1 6.6 7.5 4.0 5.2 0.2 3.2 4.2 4.0 5.3 3.5 2.6 5.5 1.3 2.5 5.0 3.7 4.6 13.1 2.2 8.2 11.1 4.5 2.9 10.0 2.9 5.4 4.1 3.6 10.9 4.2 7.2 4.9 5.5 10.5 0.4 8.0 3.0 10.9 8.5 4.6 7.3 2.9 5.4 7.0 11.5 9.7 4.9 9.7 8.9 13.7 10.3 16.2 12.9 3.6 8.7 3.3 2.3 1.6 7.3 2.4 5.7 14.6 6.8 10.0 4.6 9.5 5.7 0.4 1.6 5.7 4.1 0.9 4.4 4.4 5.0 3.7 0.5 5.8 5.0 3.3 3.2 4.1 0.4 0.9 5.2 2.0 7.8 6.7 3.4 12.1 12.4 3.6 4.9 1.7 4.5 0.1 2.9 5.6 3.9 9.6 12.8 53.2 12.6 8.0 26.6 16.4 44.3 9.4 20.3 18.9 2.3 7.2 9.3 14.7 6.2 3.7 4.2 0.9 11.7 4.0 3.1 7.2 4.2 4.7 3.0 4.4 176.8 11.6 1.5 3.2 15.8 12.1 1.3 4.6 5.0 5.6 33.6 21.9 214.1 2.8 14.2 7.8 1.7 6.9 1.5 4.9 12.4 83.4 3.2 18.5 7.2 137.7 343.3 9.5 1.4 2.6 8.7 17.9 0.3 9.3 2.2 9.9 6.6 1.9 3.2 12.6 27.9 15.7 2.0 2.1 10.8 2.3 1.3 17.7 EEFSEC "EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153481-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 71.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 13.5 8.2 0.2 0.2 0.2 0.1 12.5 0.2 0.6 14.2 0.1 11.3 0.0 15.6 0.0 12.3 13.9 0.1 25.5 0.2 0.3 14.3 21.8 9.6 2.2 0.4 0.2 12.3 11.7 3.0 8.8 1.6 0.3 12.1 0.6 0.5 9.7 1.9 24.0 16.5 10.7 0.0 0.2 13.4 11.0 19.3 0.4 0.1 9.9 0.0 1.2 12.7 12.3 0.2 0.5 0.1 4.1 1.7 0.1 0.2 0.5 0.0 0.3 0.2 0.2 0.3 6.9 15.2 0.1 3.8 12.3 1.1 0.4 0.1 0.1 0.3 0.3 0.0 0.1 0.1 5.7 0.3 0.3 0.1 0.1 4.0 0.1 0.2 0.3 0.0 0.1 0.2 3.5 0.2 7.9 0.4 0.4 0.1 0.1 0.3 0.2 1.0 0.0 0.0 0.3 10.4 0.0 17.7 15.4 0.3 9.6 0.7 0.0 0.1 0.0 0.2 0.2 0.4 0.7 0.4 0.1 0.4 0.2 0.4 6.3 6.1 5.0 6.0 3.9 5.4 4.4 4.4 8.7 3.9 4.0 5.0 0.0 7.5 4.8 3.7 5.7 4.3 0.2 0.2 0.2 0.6 0.2 0.3 0.4 0.2 0.3 0.2 0.4 0.2 9.4 0.0 6.0 15.0 17.2 6.4 9.3 9.1 7.4 7.8 6.9 8.6 10.1 8.6 4.4 16.5 2.1 22.3 15.7 6.4 15.6 7.9 27.7 3.1 12.5 8.2 11.4 5.9 25.3 7.1 18.3 10.0 10.2 4.5 28.5 10.0 8.9 14.8 14.6 13.5 36.6 11.7 18.3 7.9 8.2 71.6 13.1 11.4 12.4 28.1 9.8 9.3 17.5 45.8 27.1 5.6 2.7 8.6 17.1 9.4 8.6 25.7 2.7 8.2 26.3 9.0 9.1 27.9 16.9 10.8 9.9 29.7 13.7 11.9 10.6 6.0 EFHD1 FLJ13612 ENSG00000115468 "EF-hand domain family member D1" Q9BUP0 2 232606057-232682780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 414.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 241.8;Breast myoepithelial cells: 129.0;Distal tubular cells: 393.2;Oligodendrocytes: 173.4;Sertoli cells: 197.2;Smooth muscle cells: 130.9;Syncytiotrophoblasts: 263.9" "Cancer enriched" "Detected in all" 5 "breast cancer: 100.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 125.8;RPTEC TERT1: 68.6;SK-BR-3: 301.8;T-47d: 236.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049331, HPA056959" Enhanced Supported "Nucleoli fibrillar center,Golgi apparatus" No NA 14000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "Golgi apparatus" "Nucleoli fibrillar center" "HPA049331: AB_2680716, HPA056959: AB_2683288" "unprognostic (9.51e-3)" "unprognostic (2.21e-2)" "unprognostic (4.78e-3)" "unprognostic (3.25e-1)" "unprognostic (3.40e-1)" "unprognostic (9.70e-2)" "unprognostic (9.02e-2)" "unprognostic (1.13e-1)" "unprognostic (3.29e-3)" "unprognostic (1.21e-1)" "unprognostic (5.57e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.93e-7)" "unprognostic (2.00e-2)" "unprognostic (1.84e-1)" "unprognostic (2.51e-2)" "unprognostic (2.29e-3)" 86.3 7.0 199.7 3.7 303.2 0.8 180.7 244.9 261.3 86.9 129.9 16.9 4.4 72.4 33.7 9.6 73.7 12.0 46.0 196.6 217.4 186.2 54.6 15.3 3.9 253.6 258.7 76.5 86.5 10.5 16.5 77.9 261.8 25.6 5.7 9.5 22.2 27.7 35.5 30.9 16.2 20.6 201.4 52.5 17.6 20.1 237.8 3.0 32.7 42.7 2.4 22.0 44.5 414.6 0.0 3.4 5.7 1.4 2.2 0.1 125.8 26.8 2.1 2.3 1.9 0.9 0.6 0.1 2.0 11.6 2.9 0.2 19.0 0.0 0.3 0.5 9.2 0.0 2.4 1.9 0.0 0.1 0.3 1.0 0.4 0.2 0.0 0.4 0.0 5.5 3.9 0.5 0.5 2.3 0.6 0.2 8.4 0.0 0.2 0.6 7.2 0.4 68.6 0.7 0.3 3.2 9.1 301.8 18.3 42.3 236.9 2.6 0.0 0.0 1.8 0.4 0.8 0.2 0.1 0.1 0.3 0.1 13.4 1.0 0.2 0.1 0.2 0.1 0.4 0.3 0.3 0.4 0.1 0.1 0.6 0.6 2.2 0.1 0.1 0.2 0.1 0.1 199.7 303.2 244.9 261.3 196.6 217.4 253.6 258.7 261.8 201.4 237.8 414.6 15.6 0.0 0.0 37.5 1.5 3.6 2.8 1.3 1.2 0.5 241.8 129.0 7.4 1.5 4.6 35.0 0.0 112.0 3.0 0.3 393.2 0.0 9.0 1.1 37.8 16.8 0.0 2.7 2.6 0.0 19.7 41.1 0.0 1.7 0.0 3.2 6.4 89.4 8.7 0.0 5.3 0.1 59.0 1.3 3.0 7.0 44.4 2.1 8.8 18.7 0.0 48.0 0.0 1.5 173.4 0.0 0.0 57.2 0.1 4.6 0.0 116.5 1.9 1.4 197.2 8.7 130.9 17.3 13.6 0.4 3.1 263.9 2.5 1.5 0.3 2.0 EFR3B "FLJ37871, KIAA0953" ENSG00000084710 "EFR3 homolog B" Q9Y2G0 2 25042076-25159135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.1;skeletal muscle: 20.0" "Cell type enhanced" "Detected in many" "Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038089, HPA071831" Uncertain Supported "Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Actin filaments, Cytosol" "HPA038089: AB_10672618, HPA071831: " "unprognostic (9.31e-2)" "unprognostic (3.92e-1)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.90e-1)" "unprognostic (2.44e-2)" "unprognostic (1.24e-3)" "unprognostic (3.82e-1)" "unprognostic (3.42e-1)" "unprognostic (1.32e-2)" "unprognostic (4.49e-6)" "unprognostic (4.83e-2)" "unprognostic (4.43e-2)" "unprognostic (1.89e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" 0.8 1.6 23.0 0.6 53.1 0.3 0.5 22.4 29.5 0.5 0.0 1.1 0.4 0.7 5.1 0.3 0.6 0.5 4.5 51.7 19.0 1.3 0.2 2.5 0.3 45.3 24.0 0.8 0.4 3.9 9.3 1.7 47.5 0.5 0.6 11.0 0.3 0.8 20.0 0.6 0.5 1.2 9.8 3.4 0.9 2.5 27.7 0.3 3.4 3.8 0.2 0.5 0.4 12.1 0.2 8.3 9.5 10.3 0.5 0.1 12.0 1.0 0.2 0.5 0.1 6.7 0.4 0.1 0.6 1.4 3.3 0.6 7.5 0.0 0.1 1.6 1.8 1.6 0.3 0.6 0.0 0.1 0.8 0.1 0.0 2.3 0.1 0.7 0.3 0.2 0.1 0.4 0.2 0.9 0.2 0.5 1.9 0.1 6.6 0.8 9.1 0.3 0.1 0.3 4.0 10.7 1.2 18.0 5.9 5.3 0.9 0.1 0.5 0.5 2.7 4.1 2.0 0.7 0.9 0.1 7.3 0.1 1.9 1.3 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.0 23.0 53.1 22.4 29.5 51.7 19.0 45.3 24.0 47.5 9.8 27.7 12.1 3.1 28.9 1.1 127.0 0.0 0.0 0.8 0.0 0.0 9.9 0.3 1.0 9.7 0.0 0.0 9.2 22.9 0.1 0.1 0.7 0.0 0.3 20.6 1.3 0.3 6.7 3.6 0.0 58.5 0.8 0.2 1.0 0.0 0.3 0.0 1.1 2.9 0.0 0.9 5.0 110.7 0.1 0.0 0.0 0.3 46.0 1.2 0.1 0.0 54.4 0.0 22.0 0.0 19.6 51.2 0.7 0.0 2.6 0.1 0.6 0.5 0.1 0.0 10.7 0.0 1.6 1.4 2.4 2.2 0.0 0.1 0.1 0.1 0.2 0.3 0.4 EGF ENSG00000138798 "Epidermal growth factor" P01133 4 109912883-110013766 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 110.2;pancreas: 89.5;skeletal muscle: 29.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 12.9;Breast myoepithelial cells: 8.1;Cardiomyocytes: 8.2;Distal tubular cells: 7.9;Excitatory neurons: 8.5;Inhibitory neurons: 11.2;Muller glia cells: 26.2;Skeletal myocytes: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 6.4;SK-BR-3: 11.6;U-251 MG: 3.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" NA NA 209000 680000 "Cluster 1: Neutrophils - Mixed function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 37: Myocytes - Muscle contraction" "unprognostic (2.83e-2)" "unprognostic (1.02e-2)" "unprognostic (8.50e-3)" "unprognostic (1.88e-3)" "unprognostic (4.24e-2)" "unprognostic (1.64e-3)" "unprognostic (5.06e-4)" "unprognostic (8.30e-2)" "unprognostic (2.21e-3)" "unprognostic (4.25e-2)" "unprognostic (1.80e-2)" "unprognostic (2.95e-1)" "unprognostic (7.72e-3)" "unprognostic (4.64e-5)" "unprognostic (2.63e-1)" "unprognostic (9.80e-5)" "unprognostic (3.92e-3)" 0.0 0.0 1.0 0.1 1.0 0.2 14.7 0.2 0.8 0.0 0.2 0.8 0.0 0.4 2.4 0.7 0.3 1.0 2.8 0.9 2.0 110.2 0.0 0.5 0.0 1.4 0.9 0.0 89.5 0.2 0.4 0.0 1.5 1.4 1.1 13.6 15.7 0.4 29.6 0.7 0.2 0.5 1.2 0.1 0.0 0.1 0.7 0.0 3.0 17.4 0.0 0.4 0.1 1.8 0.2 0.2 1.9 0.0 0.0 0.1 0.0 0.4 1.1 0.5 0.4 0.1 0.0 0.0 6.4 0.6 1.6 0.0 0.3 0.0 0.4 0.0 0.3 0.1 0.6 1.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.3 0.1 0.6 0.1 0.0 0.0 2.3 0.0 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.0 11.6 0.4 1.2 2.8 0.0 0.0 0.9 1.3 0.0 3.6 0.0 0.0 0.0 1.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 1.0 1.0 0.2 0.8 0.9 2.0 1.4 0.9 1.5 1.2 0.7 1.8 0.1 0.0 0.0 3.3 0.0 1.0 0.2 0.1 0.0 1.0 12.9 8.1 8.2 0.0 0.5 0.0 0.0 0.0 0.2 2.0 7.9 0.2 5.6 0.2 0.1 0.6 0.0 0.0 8.5 5.7 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.7 11.2 0.1 0.0 0.0 0.0 1.5 0.0 1.0 0.0 0.0 0.3 26.2 0.0 1.5 0.3 1.0 0.4 0.0 0.0 1.1 0.1 1.2 1.0 1.2 0.0 8.2 0.2 0.5 0.4 0.0 1.4 0.0 0.1 0.1 1.6 0.3 EIF2B5 "EIF-2B, EIF2Bepsilon" ENSG00000145191 "Eukaryotic translation initiation factor 2B subunit epsilon" Q13144 3 184135038-184146127 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015412, HPA064370, HPA069303" Approved Enhanced Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (9.05e-3)" "unprognostic (3.33e-2)" "unprognostic (1.15e-2)" "unprognostic (9.33e-2)" "prognostic unfavorable (3.38e-8)" "unprognostic (8.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.21e-2)" "unprognostic (3.80e-1)" "unprognostic (1.32e-2)" "unprognostic (9.97e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" 16.1 18.9 10.1 8.2 10.1 5.3 17.6 11.2 12.5 17.2 13.0 19.6 9.4 15.3 5.6 24.7 14.9 6.5 22.3 9.8 11.7 15.5 20.1 15.8 9.7 11.2 10.1 14.9 19.0 22.1 18.0 11.8 10.6 18.1 13.8 2.3 23.9 11.2 53.9 24.7 19.4 11.6 10.9 20.3 21.0 10.1 10.8 18.2 16.7 33.6 19.0 18.8 19.6 9.3 60.7 25.4 24.3 25.4 32.4 23.4 28.0 29.1 36.2 51.7 42.4 41.5 24.5 48.6 37.8 32.5 65.0 34.7 56.6 39.1 47.7 39.7 55.4 75.6 28.4 42.4 24.8 61.8 32.9 19.6 32.1 28.7 24.1 19.5 37.3 49.7 46.7 29.2 35.2 49.5 49.5 34.3 39.9 76.1 49.3 45.1 37.6 61.3 43.1 38.6 35.2 34.2 27.9 91.9 41.5 20.3 83.6 60.8 33.6 22.9 35.4 28.5 62.7 24.3 61.2 69.6 33.0 58.8 35.2 9.5 10.0 14.7 8.7 9.1 11.5 15.4 12.2 13.3 11.8 16.9 18.1 11.5 1.3 14.3 9.8 5.1 11.6 7.6 10.1 10.1 11.2 12.5 9.8 11.7 11.2 10.1 10.6 10.9 10.8 9.3 19.8 25.6 22.7 8.8 31.6 30.8 36.6 18.2 29.6 18.5 33.1 30.1 25.8 17.2 28.4 36.8 8.4 39.3 25.4 32.0 52.8 27.5 3.7 20.5 17.7 24.0 45.9 27.6 14.6 36.0 28.8 17.8 35.2 23.3 16.5 21.3 13.6 27.1 24.9 35.3 18.6 28.0 24.4 18.5 22.6 2.7 18.3 18.2 19.6 12.2 30.8 14.5 22.6 18.1 15.3 26.3 17.9 14.7 19.0 34.6 27.2 30.0 21.9 16.7 13.1 17.5 22.8 17.7 17.0 31.2 29.0 38.6 26.5 34.2 34.7 44.9 EIF3H "eIF3-gamma, eIF3-p40, EIF3S3" ENSG00000147677 "Eukaryotic translation initiation factor 3 subunit H" O15372 8 116642130-116766925 "Cancer-related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 1808.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023117, HPA023553" Approved Approved Cytosol NA NA 38000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA023117: AB_1848076, HPA023553: AB_1848077" "prognostic unfavorable (5.26e-4)" "prognostic unfavorable (8.07e-4)" "unprognostic (1.81e-1)" "unprognostic (1.15e-1)" "unprognostic (6.69e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (8.34e-4)" "unprognostic (3.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.96e-1)" "unprognostic (1.12e-3)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.36e-2)" "unprognostic (1.48e-1)" "unprognostic (9.19e-2)" "unprognostic (1.11e-1)" 212.3 164.1 111.0 168.6 119.8 341.1 246.8 114.8 138.5 270.2 104.2 233.1 172.7 212.7 180.0 232.0 211.3 159.2 223.6 106.9 121.0 184.2 181.0 149.2 283.2 118.4 113.7 392.6 249.9 184.0 147.6 161.7 120.6 179.5 201.9 131.0 219.9 158.1 372.6 201.8 167.9 182.5 124.2 171.4 195.2 144.4 111.9 291.0 215.5 278.3 307.1 221.7 237.0 130.2 455.0 256.2 302.2 264.9 390.3 678.0 300.4 292.5 374.4 316.7 306.5 266.1 521.6 719.4 288.6 307.2 230.4 284.4 335.5 445.2 395.5 468.5 271.9 636.0 212.0 400.6 487.8 278.1 325.7 630.0 606.4 287.0 659.5 536.4 348.8 555.5 548.2 370.1 360.4 335.7 778.2 388.1 308.6 995.6 404.5 443.6 201.8 517.6 479.8 327.8 341.6 412.4 153.5 1808.1 504.9 294.8 538.3 550.5 322.5 201.8 374.5 301.5 388.8 591.3 574.4 591.3 280.2 483.4 281.8 165.2 361.6 132.2 217.9 356.8 358.9 438.1 393.5 317.9 468.6 381.4 511.0 432.1 74.4 314.6 366.1 260.9 477.7 585.7 111.0 119.8 114.8 138.5 106.9 121.0 118.4 113.7 120.6 124.2 111.9 130.2 138.9 182.7 210.7 42.4 314.6 337.5 423.7 444.2 266.9 62.7 317.2 273.4 160.8 191.6 253.0 93.8 12.5 488.0 211.4 117.0 448.0 290.5 387.2 81.2 196.0 185.8 201.0 215.8 47.8 380.5 551.0 183.7 125.9 159.2 194.4 166.2 168.8 104.6 332.4 26.9 49.9 301.6 170.9 386.6 402.8 265.0 331.5 261.5 209.9 51.5 509.9 136.0 224.6 58.3 70.3 292.9 240.5 220.1 166.7 338.5 260.2 443.9 92.9 76.8 197.2 251.5 504.1 233.0 176.0 317.4 356.5 577.2 287.5 241.4 345.5 481.2 ELF3 "EPR-1, ERT, ESE-1, ESX" ENSG00000163435 "E74 like ETS transcription factor 3" P78545 1 202007945-202017183 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Inflammatory response, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003316, HPA003479" Enhanced Enhanced Nucleoplasm NA NA "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA003316: AB_1078757, HPA003479: AB_1078756" "unprognostic (9.90e-3)" "unprognostic (1.72e-1)" "unprognostic (7.50e-2)" "unprognostic (1.12e-1)" "unprognostic (2.96e-3)" "unprognostic (3.88e-2)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (1.69e-1)" "unprognostic (5.05e-3)" "unprognostic (7.67e-3)" "unprognostic (7.07e-2)" "unprognostic (9.92e-3)" "unprognostic (4.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-1)" "unprognostic (3.37e-3)" 1.6 0.2 0.2 12.7 0.1 0.8 79.2 0.8 0.4 55.3 0.1 161.3 142.9 12.9 4.5 237.0 35.5 77.6 5.0 0.1 0.2 66.7 79.2 59.8 0.3 0.0 0.0 1.2 120.7 8.4 3.9 6.1 0.1 58.7 127.5 1.0 147.1 14.8 0.2 14.5 145.6 7.3 0.0 0.5 122.7 0.2 0.1 1.6 6.6 0.0 16.0 165.2 93.6 0.2 56.1 209.6 0.0 0.4 0.0 0.0 63.5 0.0 7.9 0.0 0.1 47.3 296.0 0.3 24.0 0.0 1.7 53.8 0.0 0.2 0.0 6.7 0.2 0.0 38.3 9.2 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 40.7 0.3 0.7 3.3 196.3 17.6 0.1 0.1 3.0 78.3 215.3 0.3 0.4 2.4 405.7 0.2 9.2 28.8 0.0 0.1 0.0 0.7 0.4 0.5 1.2 3.9 0.3 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.4 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 2.7 294.9 422.9 0.0 12.2 5.1 691.3 879.7 113.8 1.5 470.3 180.3 1.5 586.2 1130.0 329.2 18.8 76.6 9.5 1599.6 41.1 792.7 0.0 812.3 90.8 16.4 452.2 2.7 0.4 641.0 122.2 15.9 1390.9 1127.5 40.6 0.2 0.4 38.6 9.3 0.0 0.2 1225.3 1102.7 2.5 2.7 0.0 0.0 18.6 8.8 0.0 15.4 2.6 1.0 0.5 0.1 512.5 1506.1 0.0 6.0 1014.2 1476.3 147.1 888.2 67.3 0.0 0.8 46.3 0.0 0.3 418.5 8.4 257.2 18.7 0.3 983.0 1628.9 ELOC "SIII, TCEB1" ENSG00000154582 "Elongin C" Q15369 8 73939169-73972287 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 266.1;Extravillous trophoblasts: 326.2;Hofbauer cells: 313.7;Pancreatic endocrine cells: 317.3;Proximal tubular cells: 341.3;Syncytiotrophoblasts: 332.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078113 Approved "Nucleoli,Vesicles,Cell Junctions" NA NA 140000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Vesicles "Nucleoli, Cell Junctions" "HPA078113: AB_2686877" "prognostic unfavorable (6.48e-4)" "unprognostic (1.60e-1)" "unprognostic (3.14e-1)" "unprognostic (2.83e-2)" "unprognostic (2.46e-2)" "unprognostic (8.02e-3)" "unprognostic (5.84e-3)" "unprognostic (2.19e-2)" "unprognostic (1.77e-1)" "unprognostic (6.99e-3)" "unprognostic (4.02e-3)" "unprognostic (3.33e-2)" "unprognostic (2.77e-3)" "unprognostic (3.84e-2)" "unprognostic (5.33e-2)" "unprognostic (1.67e-1)" "unprognostic (8.95e-2)" 78.3 83.9 86.5 45.0 89.6 93.1 59.9 88.6 116.1 47.9 79.8 61.3 30.2 48.1 67.0 75.3 46.2 39.3 141.0 92.5 85.3 97.2 76.0 62.0 52.5 83.6 83.9 46.1 41.1 58.5 57.2 56.0 83.9 45.2 44.8 69.4 46.7 43.7 190.3 48.4 40.7 54.8 84.2 48.2 57.3 111.2 85.1 64.4 43.3 125.6 65.7 69.3 52.0 89.5 211.2 169.2 151.1 110.2 113.0 146.7 108.1 203.6 165.3 194.8 199.0 151.1 178.2 106.3 160.7 181.9 263.4 147.2 168.7 203.6 256.8 123.2 141.5 185.7 174.2 243.0 147.3 120.4 133.6 149.4 159.9 177.0 226.8 144.2 184.8 180.2 166.2 137.8 260.2 155.9 311.7 214.9 137.5 341.9 271.8 111.9 95.1 100.8 216.2 181.9 142.1 134.3 85.2 458.9 202.4 155.1 169.2 127.9 142.2 140.1 160.6 156.1 208.1 155.6 204.5 198.9 169.6 130.2 175.0 138.6 66.4 85.6 62.0 78.6 68.3 83.1 74.2 70.8 73.6 73.9 66.5 67.5 79.8 73.4 77.3 118.4 99.1 60.0 86.5 89.6 88.6 116.1 92.5 85.3 83.6 83.9 83.9 84.2 85.1 89.5 236.0 67.3 98.9 0.0 24.8 0.0 0.0 0.0 0.0 0.0 147.6 185.4 0.0 0.0 49.5 119.5 0.0 220.1 74.5 0.0 266.1 216.7 0.0 147.9 98.9 77.1 0.0 0.0 0.0 227.2 326.2 66.0 0.0 168.8 69.4 65.9 0.0 0.0 313.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.9 0.0 0.0 112.7 0.0 0.0 0.0 0.0 317.3 0.0 0.0 12.1 0.0 0.0 341.3 63.4 0.0 0.0 0.0 78.2 0.0 0.0 0.0 0.0 332.5 40.7 98.8 0.0 0.0 ELOVL1 Ssc1 ENSG00000066322 "ELOVL fatty acid elongase 1" Q9BW60 1 43363398-43368074 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033426, HPA056557" Enhanced Supported "Endoplasmic reticulum" NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Endoplasmic reticulum" "CAB033426: AB_2099896, HPA056557: AB_2683173" "unprognostic (5.23e-2)" "prognostic unfavorable (3.63e-5)" "unprognostic (8.00e-2)" "unprognostic (8.45e-2)" "unprognostic (7.60e-2)" "unprognostic (7.40e-2)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.74e-2)" "unprognostic (1.33e-1)" "unprognostic (4.37e-1)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (1.73e-1)" "unprognostic (9.00e-2)" 78.5 54.7 77.2 39.8 115.6 52.9 66.6 121.1 116.9 57.1 61.4 63.9 51.6 46.5 30.6 176.6 38.9 42.4 47.2 76.8 93.2 59.7 45.8 59.6 40.1 152.0 110.1 28.9 55.4 46.2 27.2 51.0 140.7 58.7 48.6 8.4 72.7 48.8 24.1 201.9 55.4 50.8 114.8 57.1 70.6 18.6 107.7 22.2 66.8 28.0 55.7 68.5 86.8 165.7 108.0 119.5 22.6 44.8 148.4 138.2 70.2 125.2 154.5 153.5 122.4 105.9 182.5 73.9 94.3 193.6 130.3 119.4 79.7 152.2 93.2 94.6 53.9 96.6 77.3 77.1 128.2 84.2 98.0 106.2 168.2 180.9 198.4 114.8 155.0 27.7 68.1 54.8 178.5 79.5 19.9 69.5 33.5 136.9 120.2 43.6 59.9 89.7 195.5 128.7 27.4 28.8 73.7 258.4 105.8 66.8 121.2 82.4 132.2 129.7 82.5 161.2 161.3 26.6 31.2 35.4 127.8 85.2 120.1 134.9 189.6 172.7 105.1 180.0 93.4 109.0 98.4 103.2 212.8 94.2 63.5 88.0 133.0 114.7 179.6 148.8 113.8 203.1 77.2 115.6 121.1 116.9 76.8 93.2 152.0 110.1 140.7 114.8 107.7 165.7 44.0 19.2 12.5 7.5 28.1 15.6 25.9 61.1 29.6 5.7 60.3 37.5 4.7 34.3 40.2 40.5 10.4 93.4 36.0 114.0 7.9 91.5 3.4 22.9 26.3 43.6 19.2 67.8 3.8 100.1 127.4 26.1 48.4 45.2 21.0 52.6 24.7 16.7 74.9 3.3 3.4 33.8 46.8 46.3 37.5 4.6 20.2 41.5 12.4 7.5 92.5 13.7 32.0 3.0 66.1 133.3 63.9 25.6 19.0 44.7 66.0 23.3 14.5 9.5 19.7 10.0 39.7 8.4 11.2 70.1 31.0 95.9 31.5 50.8 47.2 49.2 EMP2 XMP ENSG00000213853 "Epithelial membrane protein 2" P54851 16 10528422-10580632 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 230.6" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 4163.5;Suprabasal keratinocytes: 1174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 268.1;RT4: 182.0;SK-BR-3: 256.2;T-47d: 156.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014711, HPA070816" Approved Approved Nucleoplasm,Cytosol No Yes "Cluster 42: Non-specific - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Cytosol "HPA014711: AB_1848147, HPA070816: " "unprognostic (1.75e-1)" "unprognostic (4.05e-2)" "unprognostic (3.45e-3)" "unprognostic (4.82e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (9.27e-2)" "unprognostic (8.90e-2)" "unprognostic (2.41e-2)" "unprognostic (4.40e-1)" "unprognostic (1.86e-1)" "unprognostic (6.24e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (2.85e-8)" "unprognostic (9.54e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (9.52e-2)" 56.8 9.7 15.5 12.4 15.5 0.7 49.5 14.8 17.1 51.0 18.6 48.0 15.5 25.9 45.5 152.1 35.5 17.7 64.1 13.6 15.6 20.3 83.2 230.6 5.7 16.1 16.8 54.9 13.7 32.8 13.3 23.0 16.0 38.8 34.1 2.0 39.2 17.3 22.5 140.6 28.3 22.3 15.2 16.0 39.1 7.2 18.8 5.3 27.7 25.4 32.8 39.6 72.9 15.7 28.7 39.1 15.9 18.9 35.0 30.0 31.3 40.0 36.8 23.9 35.7 128.5 98.2 0.2 12.6 48.4 17.2 123.9 41.1 49.8 31.3 0.1 26.1 0.1 76.6 72.1 6.1 0.2 0.4 18.4 13.1 31.9 3.2 5.4 10.1 0.1 9.6 2.6 66.9 268.1 0.4 0.6 18.3 46.4 9.5 7.5 18.2 61.7 5.5 182.0 22.0 25.0 49.6 256.2 15.2 45.2 156.6 6.2 5.7 75.5 32.2 25.6 22.7 0.8 1.0 0.2 33.2 0.5 75.7 1.3 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 1.1 0.3 0.3 0.3 0.2 0.1 15.5 15.5 14.8 17.1 13.6 15.6 16.1 16.8 16.0 15.2 18.8 15.7 239.7 4163.5 368.4 13.1 3.1 356.9 137.9 172.2 111.0 2.3 105.0 94.0 53.1 100.1 255.8 42.3 0.0 74.2 3.1 119.5 0.0 3.8 8.0 78.8 30.9 183.9 104.9 0.0 0.7 67.0 17.8 152.7 46.4 51.9 36.7 68.7 161.0 235.1 10.1 0.0 0.6 207.8 81.4 19.6 136.5 9.3 190.7 17.0 87.2 41.2 33.6 5.7 0.0 22.6 0.6 32.9 158.4 276.1 1.6 86.0 21.0 0.2 142.8 2.2 52.6 256.3 129.3 5.7 12.9 319.5 1174.3 48.0 9.3 73.3 178.5 221.4 ENDOU "P11, PP11, PRSS26" ENSG00000111405 "Endonuclease, poly(U) specific" P21128 12 47709734-47725567 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 82.9;vagina: 31.0" "Cell type enhanced" "Detected in some" "Adipocytes: 6.9;Glandular and luminal cells: 9.6;Squamous epithelial cells: 5.2;Suprabasal keratinocytes: 9.1;Syncytiotrophoblasts: 34.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.2;SK-BR-3: 4.9;SuSa: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012388, HPA067448" Enhanced "Secreted in other tissues" NA NA 14000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "HPA012388: AB_1854860, HPA067448: AB_2685843" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.29e-4)" "unprognostic (6.50e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" 1.8 0.1 2.5 0.1 2.8 0.2 1.7 2.6 3.1 19.5 1.8 0.7 0.1 0.5 1.0 82.9 0.9 0.5 0.6 2.8 2.1 1.1 0.1 0.7 0.3 2.5 2.6 1.8 0.2 0.0 0.5 2.5 2.7 0.4 0.1 0.1 23.2 0.2 0.5 21.1 0.4 0.5 2.2 0.3 0.6 0.3 2.7 0.1 0.9 0.1 8.8 0.7 31.0 2.3 0.0 0.0 0.0 0.0 0.3 1.1 0.7 0.2 0.9 0.8 0.7 0.1 0.0 2.2 0.5 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 4.6 0.1 0.0 0.1 0.2 0.0 0.6 0.1 1.2 1.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.8 2.6 3.1 2.8 2.1 2.5 2.6 2.7 2.2 2.7 2.3 6.9 0.0 0.0 2.0 0.1 1.7 0.2 0.0 0.0 0.2 0.4 0.4 1.2 0.0 0.7 0.0 0.0 1.0 0.0 0.1 0.0 0.1 0.1 2.4 0.8 3.5 0.0 0.0 0.1 0.0 1.0 0.8 0.0 9.6 0.0 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.1 1.5 0.1 3.6 1.0 0.1 0.1 0.0 0.5 0.5 0.1 0.0 1.2 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.2 0.0 0.0 5.2 9.1 34.3 0.0 0.2 0.0 0.1 ENGASE FLJ21865 ENSG00000167280 Endo-beta-N-acetylglucosaminidase Q8NFI3 17 79074824-79088599 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 33.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021551 Enhanced Approved Centrosome,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Centrosome "HPA021551: AB_1848156" "unprognostic (7.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.65e-2)" "unprognostic (6.16e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-3)" "unprognostic (9.62e-2)" "unprognostic (4.09e-2)" "unprognostic (9.07e-2)" "unprognostic (7.00e-3)" "prognostic favorable (2.60e-4)" "unprognostic (4.79e-2)" "prognostic unfavorable (8.97e-6)" "unprognostic (8.38e-3)" "unprognostic (6.03e-1)" "unprognostic (2.06e-2)" "prognostic favorable (8.73e-5)" 9.3 8.4 8.4 8.2 9.4 7.2 9.1 8.6 11.5 11.9 10.2 14.5 14.3 9.6 2.0 5.4 10.7 5.9 9.1 8.3 9.9 7.6 8.8 9.4 9.2 10.0 10.7 13.7 7.9 6.7 7.1 5.6 10.1 10.8 9.2 6.1 9.1 4.3 24.0 9.6 14.9 5.2 8.4 20.0 11.0 3.4 11.0 7.2 11.8 10.4 5.8 11.6 9.5 12.3 6.3 12.8 5.7 10.0 4.4 2.5 9.6 5.6 3.5 4.6 3.9 7.2 6.4 0.0 5.9 5.1 6.2 9.7 7.2 5.4 2.3 4.3 12.5 5.9 14.8 4.2 4.2 6.7 11.2 5.8 7.9 3.4 3.3 7.8 4.9 14.7 9.1 3.6 2.5 5.1 0.6 7.3 2.7 15.4 12.1 12.7 16.8 5.3 2.4 16.4 4.2 9.2 7.3 33.5 4.2 6.8 10.8 7.8 6.4 6.8 6.1 6.4 4.4 10.9 1.9 2.9 4.0 13.6 5.1 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.1 0.0 0.4 0.1 0.0 0.7 0.1 8.4 9.4 8.6 11.5 8.3 9.9 10.0 10.7 10.1 8.4 11.0 12.3 6.9 0.0 16.0 18.3 6.1 4.5 5.6 3.4 3.4 11.1 7.5 7.4 6.3 5.7 5.7 11.0 35.5 5.3 7.1 23.3 0.0 4.2 1.8 3.9 6.3 7.6 26.2 3.8 5.4 4.3 5.4 6.7 18.8 4.8 5.1 11.5 8.2 11.5 8.6 8.4 10.1 18.6 0.0 13.2 9.8 1.3 3.4 15.5 0.0 14.0 8.8 5.3 6.2 3.5 11.0 2.5 10.7 1.9 5.7 5.3 16.5 2.9 2.9 24.5 13.1 7.9 8.3 1.9 1.6 4.1 5.8 6.7 7.4 7.5 27.5 4.4 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 129.1;retina: 117.8;testis: 145.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.4;thalamus: 6.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 2.6" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 5.7 0.4 2.6 1.0 28.0 9.2 13.4 1.0 30.3 0.2 28.2 90.4 2.4 39.9 34.3 18.6 0.3 0.9 0.4 1.7 63.4 129.1 3.2 0.3 0.6 1.3 0.4 0.9 26.8 42.1 0.9 1.1 10.0 6.8 117.8 9.4 6.2 0.8 91.7 89.5 0.8 0.3 0.9 2.7 145.3 6.1 1.6 0.4 0.0 1.7 1.3 22.3 0.5 14.1 0.7 0.6 0.1 0.0 0.0 48.9 0.0 0.0 0.2 0.0 29.9 1.5 0.5 6.5 0.0 0.1 32.6 2.3 0.1 0.0 2.0 0.7 0.4 0.7 81.5 0.0 0.6 2.7 0.1 0.6 0.0 0.0 0.0 0.0 1.0 17.6 0.0 0.0 28.2 0.2 1.0 0.6 3.8 12.2 0.0 0.4 10.9 0.2 0.1 21.0 0.7 3.7 160.1 5.0 0.3 53.6 7.4 15.6 0.1 0.8 0.6 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 13.4 1.0 0.4 1.7 0.6 1.3 1.1 0.3 6.1 0.5 0.2 0.0 0.6 0.0 0.8 7.8 2.4 4.5 12.5 5.6 10.7 3.9 1.4 11.5 3.8 9.2 68.8 3.0 0.2 175.5 13.7 0.2 137.5 19.1 0.9 0.8 6.0 8.2 0.2 3.1 0.5 0.3 5.6 12.4 0.0 0.0 3.9 109.4 0.2 0.0 0.2 36.3 8.2 3.2 0.9 461.6 3.7 1.5 0.0 0.0 0.0 272.5 0.0 0.0 0.1 0.1 186.3 2.2 0.0 1.6 512.1 102.2 9.0 72.5 0.0 0.0 0.2 12.3 3.9 17.6 22.7 6.6 1.5 0.0 35.3 2.9 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein subunit alpha" P13804 15 76215353-76311472 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 389.7;tongue: 493.5" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 402.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria NA NA 680000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favorable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 93.0 112.3 33.8 55.0 36.0 63.0 70.4 36.0 54.6 38.7 40.3 131.4 135.6 27.0 30.6 85.1 30.1 44.7 243.0 34.2 37.6 180.0 389.7 39.0 60.9 35.6 35.7 25.6 81.6 71.0 13.9 70.9 36.0 42.2 123.5 34.3 49.3 38.2 300.8 40.1 116.3 65.7 35.5 38.8 67.7 28.4 38.2 54.5 38.7 493.5 65.9 74.0 33.1 36.9 122.4 196.7 128.2 134.8 141.7 149.1 201.0 144.4 166.2 183.0 162.8 175.3 221.3 203.5 141.3 144.3 138.5 304.6 502.7 200.2 211.9 245.8 98.0 222.2 131.4 205.2 114.7 214.5 158.7 112.7 185.9 93.1 153.5 100.0 187.8 64.7 214.1 205.2 190.3 191.2 44.9 178.2 99.9 225.3 58.4 192.8 158.6 272.8 202.1 386.9 133.3 67.2 218.2 492.2 205.0 294.4 254.1 223.4 111.4 178.2 119.5 157.0 177.4 99.0 221.0 255.9 127.8 281.1 128.5 50.0 120.3 82.7 65.4 110.3 61.7 77.3 60.6 67.6 159.4 67.3 48.8 60.1 30.2 122.9 96.1 63.4 95.8 141.9 33.8 36.0 36.0 54.6 34.2 37.6 35.6 35.7 36.0 35.5 38.2 36.9 65.7 57.7 41.6 45.1 54.3 53.4 110.8 151.5 44.9 13.1 47.2 46.4 352.9 65.8 84.5 36.8 22.9 277.4 61.1 250.9 209.4 106.5 11.7 29.5 45.1 51.8 65.4 117.8 26.0 84.1 180.8 66.8 90.2 37.0 38.6 53.1 48.9 348.8 132.3 53.8 31.5 141.6 89.5 79.0 84.5 7.9 59.4 103.0 56.9 28.1 129.0 26.7 85.5 37.2 46.9 92.1 176.2 58.3 87.8 92.4 231.1 402.9 50.2 20.4 46.0 44.0 113.7 66.4 40.5 79.5 57.1 300.2 55.5 123.4 187.3 162.0 FAM110A "bA371L19.3, C20orf55" ENSG00000125898 "Family with sequence similarity 110 member A" Q9BQ89 20 833715-857463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 71.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 71.7;Extravillous trophoblasts: 138.2;Langerhans cells: 74.2;Macrophages: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "basophil: 543.5;eosinophil: 163.4;intermediate monocyte: 160.6;non-classical monocyte: 248.6" "Group enriched" "Detected in all" 9 "granulocytes: 543.5;monocytes: 248.6" "Cell line enhanced" "Detected in all" "SK-BR-3: 84.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034110, HPA069240" Uncertain Uncertain Nucleoplasm,Vesicles,Cytosol Yes Yes "Cluster 10: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" Cytosol "CAB034110: AB_1562838, HPA069240: AB_2686103" "unprognostic (6.33e-2)" "unprognostic (2.53e-2)" "unprognostic (1.57e-2)" "unprognostic (3.43e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "unprognostic (4.90e-3)" "unprognostic (5.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.78e-2)" "unprognostic (2.35e-2)" "unprognostic (2.47e-1)" "prognostic unfavorable (4.42e-4)" "unprognostic (9.64e-3)" "unprognostic (1.17e-2)" "unprognostic (6.42e-3)" "unprognostic (4.21e-3)" 4.2 5.5 4.2 5.9 5.2 8.8 9.0 3.1 3.6 10.1 3.9 5.5 10.0 2.5 4.7 39.3 2.5 2.3 4.0 2.8 3.4 8.8 3.6 12.3 6.7 5.5 5.3 2.8 5.5 11.0 7.9 6.6 5.6 19.3 3.2 1.2 18.4 3.6 4.0 71.2 9.7 1.1 3.3 23.4 6.1 3.7 6.6 6.9 7.6 0.6 7.8 9.2 18.4 3.6 27.7 7.3 4.1 7.6 4.4 1.9 27.8 8.5 4.7 5.3 4.7 16.0 16.9 8.9 3.7 5.3 7.6 43.7 3.3 22.2 4.4 7.3 2.3 18.6 4.9 4.2 2.0 5.1 6.3 1.2 27.1 7.3 7.1 1.6 3.6 8.1 10.2 21.5 4.9 16.4 14.3 13.8 5.3 17.7 12.3 14.1 7.0 11.7 4.1 19.6 7.7 9.1 7.4 84.0 3.8 1.7 34.9 7.5 4.8 12.6 9.1 11.5 9.6 7.8 7.3 3.8 2.0 13.2 9.2 543.5 28.3 163.4 13.2 160.6 11.7 7.0 23.7 27.2 36.2 11.7 28.1 27.9 15.3 6.9 248.6 3.9 43.0 24.2 4.2 5.2 3.1 3.6 2.8 3.4 5.5 5.3 5.6 3.3 6.6 3.6 3.5 0.0 7.0 0.0 18.5 32.6 17.0 31.6 71.7 0.3 26.7 20.1 2.9 7.2 15.7 11.0 0.0 41.5 24.3 5.1 1.9 10.1 9.9 3.0 1.7 8.0 10.8 16.2 0.5 6.0 138.2 3.6 5.1 5.2 51.5 1.4 17.2 0.7 20.0 5.0 0.4 8.8 16.2 36.7 74.2 24.3 3.4 70.0 7.2 1.9 29.9 0.3 25.7 0.5 0.1 13.4 7.8 1.9 3.5 20.9 16.1 2.4 7.4 2.6 6.6 1.1 4.3 3.4 4.9 57.7 36.8 31.3 26.1 14.2 10.4 24.6 FAM149B1 KIAA0974 ENSG00000138286 "Family with sequence similarity 149 member B1" Q96BN6 10 73168119-73244504 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039189, HPA039859" Uncertain Approved Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA039189: AB_10805355, HPA039859: AB_2676712" "unprognostic (2.23e-1)" "unprognostic (7.04e-2)" "unprognostic (1.52e-1)" "unprognostic (4.88e-2)" "unprognostic (6.21e-2)" "unprognostic (1.45e-1)" "unprognostic (2.34e-1)" "unprognostic (4.66e-2)" "unprognostic (3.01e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (5.13e-2)" "unprognostic (1.96e-3)" "unprognostic (1.22e-1)" "unprognostic (9.21e-3)" "unprognostic (2.68e-1)" "unprognostic (5.24e-2)" 12.3 10.6 20.7 6.4 23.1 5.2 12.4 22.8 22.9 14.1 18.9 9.2 7.7 11.5 12.6 11.7 13.6 12.6 12.6 19.2 21.3 21.8 19.1 10.4 9.4 21.6 22.1 15.0 12.2 13.9 6.2 13.3 22.8 10.9 9.9 11.8 11.3 10.6 13.6 7.8 8.9 11.5 21.1 8.0 9.9 21.9 21.3 12.4 12.3 17.2 9.7 10.6 7.6 25.3 8.7 8.4 19.8 19.0 45.9 28.5 13.9 12.5 28.6 9.8 17.1 2.5 23.6 8.1 5.8 25.8 10.8 10.1 12.6 18.4 11.7 11.1 4.7 6.3 5.6 7.4 23.8 10.2 6.1 24.6 13.4 12.6 48.6 44.5 24.9 11.7 5.8 15.2 18.0 10.4 7.7 12.9 8.7 29.8 19.7 4.3 11.2 9.9 26.4 12.1 3.3 20.1 11.1 30.1 19.6 17.8 18.6 9.9 12.7 8.2 6.6 8.2 12.6 20.0 8.8 4.4 15.9 11.3 7.0 0.7 0.2 0.6 0.3 0.6 0.2 0.3 0.1 0.2 0.4 0.4 0.5 0.4 0.5 1.0 0.2 0.6 0.1 0.1 20.7 23.1 22.8 22.9 19.2 21.3 21.6 22.1 22.8 21.1 21.3 25.3 5.4 3.2 3.1 24.8 3.9 2.0 3.5 4.6 6.8 6.7 5.3 5.2 12.2 5.7 5.4 1.8 6.2 7.4 2.4 4.6 1.9 3.9 21.8 6.1 7.0 6.2 7.7 3.0 19.7 3.6 5.8 7.2 5.1 6.1 2.5 8.2 7.1 4.0 5.4 3.3 24.9 5.0 6.1 6.3 3.1 27.6 8.4 4.0 1.8 12.2 4.1 4.6 1.0 23.6 41.3 4.2 2.2 4.5 1.8 4.6 6.6 6.9 9.8 11.4 13.1 5.9 5.0 13.4 5.1 5.3 3.7 8.2 3.4 7.2 5.4 4.3 FAM25A bA96C23.5 ENSG00000188100 "Family with sequence similarity 25 member A" B3EWG3 10 87020294-87024730 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 143.3;esophagus: 519.5;salivary gland: 140.0;skin 1: 175.0;vagina: 193.1" "Group enriched" "Detected in some" 4 "Suprabasal keratinocytes: 49.6;Syncytiotrophoblasts: 16.1" "Cancer enriched" "Detected in many" 4 "head and neck cancer: 53.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A-431: 30.3;SK-BR-3: 70.0" "Low region specificity" "Detected in single" HPA044808 Uncertain NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA044808: AB_2679096" "unprognostic (9.94e-2)" "unprognostic (2.57e-1)" "unprognostic (7.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (1.05e-5)" "unprognostic (1.21e-1)" 0.3 2.0 0.0 0.0 0.0 0.0 5.7 0.0 0.1 143.3 0.0 0.1 0.0 0.1 0.0 519.5 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 1.5 0.0 0.1 0.0 0.0 140.0 0.0 1.2 175.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 1.4 0.0 0.0 63.6 0.1 193.1 0.1 30.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.3 0.0 0.0 0.2 0.0 0.0 9.0 0.1 0.0 0.0 0.2 2.0 0.0 0.3 0.0 1.6 1.2 0.0 0.0 0.0 70.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.6 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.9 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 1.8 2.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.1 49.6 16.1 0.0 0.0 0.0 1.9 FAM25C bA164N7.4 ENSG00000276430 "Family with sequence similarity 25 member C" B3EWG5 10 47995322-47999791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "cervix: 14.8;esophagus: 30.1;salivary gland: 15.4;skin 1: 43.6;vagina: 13.4" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 1.3;Basal respiratory cells: 3.0;Suprabasal keratinocytes: 3.1" "Cancer enriched" "Detected in single" 5 "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 10.7" HPA044808 Uncertain NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA044808: AB_2679096" "unprognostic (2.93e-1)" "unprognostic (2.21e-1)" 0.1 0.1 0.0 0.0 0.0 0.0 3.5 0.0 0.1 14.8 0.0 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 43.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 2.4 0.0 13.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 3.1 0.0 0.0 0.0 0.0 0.0 FAM25G bA301J7.4 ENSG00000189090 "Family with sequence similarity 25 member G" B3EWG6 10 47487219-47491693 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 18.6;skin 1: 43.3" "Group enriched" "Detected in some" 4 "Pancreatic endocrine cells: 57.1;Spermatogonia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 13.8" HPA044808 Uncertain NA NA "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA044808: AB_2679096" "unprognostic (1.97e-2)" 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.4 10.4 0.0 0.2 0.2 0.0 0.0 18.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.9 0.0 0.7 43.3 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 10.0 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.1 0.0 0.0 0.0 7.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 19.8 3.9 0.0 0.4 0.0 0.0 0.1 0.1 FAM91A1 FLJ23790 ENSG00000176853 "Family with sequence similarity 91 member A1" Q658Y4 8 123768439-123815452 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027978 Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Microtubules" "HPA027978: AB_10600004" "unprognostic (2.21e-2)" "unprognostic (6.13e-2)" "unprognostic (2.95e-2)" "unprognostic (4.56e-3)" "unprognostic (2.39e-1)" "unprognostic (3.80e-2)" "unprognostic (4.42e-3)" "unprognostic (2.59e-2)" "unprognostic (2.53e-1)" "unprognostic (8.55e-2)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (1.31e-1)" "unprognostic (1.50e-1)" "unprognostic (2.58e-1)" "unprognostic (5.40e-2)" "unprognostic (6.19e-2)" 12.9 11.7 6.8 15.9 7.9 42.9 14.0 8.4 8.2 12.8 12.2 13.0 14.5 13.8 11.9 13.1 10.3 16.0 7.1 7.0 9.0 18.4 26.6 13.1 18.7 9.1 8.2 12.8 14.0 21.0 9.3 20.2 8.6 11.6 14.8 11.7 11.4 11.0 6.1 11.6 14.2 11.7 8.7 19.6 13.9 10.9 8.5 14.3 18.3 6.2 17.0 17.1 10.6 11.6 63.9 42.4 12.9 22.4 24.4 26.3 20.8 36.2 39.4 33.7 42.5 21.3 25.8 29.9 39.2 29.9 26.7 30.4 30.8 39.2 60.0 57.5 29.8 47.2 21.9 25.6 38.0 21.7 58.9 25.0 31.1 44.1 54.3 23.0 31.0 18.4 17.1 41.3 30.7 75.8 37.7 14.4 12.7 51.8 37.3 20.4 21.5 22.4 28.4 64.7 15.5 21.6 48.1 102.4 49.8 18.8 31.5 22.9 31.5 32.0 57.4 35.7 53.1 31.9 65.8 28.4 50.2 38.7 39.9 7.0 8.0 11.3 3.2 9.5 2.9 5.1 3.2 2.7 8.2 4.2 2.7 3.7 10.1 5.9 8.5 3.1 3.1 4.3 6.8 7.9 8.4 8.2 7.0 9.0 9.1 8.2 8.6 8.7 8.5 11.6 31.9 25.6 13.2 17.6 30.6 39.6 21.9 19.0 20.5 15.0 24.0 17.7 8.4 22.8 19.3 25.8 22.9 10.4 25.3 21.3 5.9 12.1 22.4 20.8 22.9 27.5 27.5 10.3 21.0 15.5 12.7 19.3 26.5 33.0 8.8 18.2 18.5 59.3 27.1 23.5 22.0 22.0 16.2 73.6 43.5 26.0 14.0 45.9 21.4 24.4 40.1 17.6 19.6 23.6 45.8 35.1 21.7 14.7 25.8 34.8 18.7 20.8 16.5 21.7 13.1 26.5 22.4 14.2 10.7 27.0 46.7 19.2 19.6 16.0 14.5 45.3 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078338-82098294 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 372.8;breast: 271.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 1109.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" No No 3400000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 372.8 30.9 25.0 14.9 44.2 18.7 271.6 67.3 49.9 31.7 0.0 25.5 11.5 18.0 6.2 63.6 15.2 6.6 21.9 39.9 15.0 11.8 191.4 54.1 7.2 84.4 75.7 16.3 18.6 8.5 72.4 12.1 101.7 69.0 3.0 4.3 38.3 14.3 27.9 89.4 28.8 5.3 12.5 8.8 63.6 11.9 33.7 9.6 21.2 2.3 3.0 27.0 31.8 60.8 179.1 182.0 81.7 56.7 130.1 87.2 176.9 34.3 43.3 35.5 64.6 190.6 116.7 58.8 29.2 26.3 99.5 144.0 79.2 157.8 6.5 30.0 358.0 123.9 140.0 257.2 36.8 67.5 19.2 84.2 40.4 90.8 21.0 12.1 40.1 54.8 193.2 50.7 12.6 304.1 78.9 105.5 161.1 28.1 107.1 64.1 47.8 116.5 40.3 220.7 205.0 117.0 50.6 1109.2 93.6 29.5 199.4 123.4 71.1 52.3 107.0 45.2 88.4 68.5 17.1 60.6 31.2 71.1 79.5 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 25.0 44.2 67.3 49.9 39.9 15.0 84.4 75.7 101.7 12.5 33.7 60.8 9.6 25.6 126.0 28.4 7.4 7.8 12.7 33.2 8.0 28.7 442.9 165.4 5.9 21.5 28.4 11.0 6.2 32.0 12.8 35.7 3.9 19.2 1.5 19.6 19.8 10.8 18.1 20.6 11.9 29.2 77.7 13.4 33.6 17.1 12.7 29.9 10.8 244.1 13.9 30.3 12.5 22.3 22.4 9.8 6.2 3.4 16.4 7.0 17.8 4.7 6.2 14.1 8.2 11.6 17.6 19.1 23.6 11.3 9.7 60.4 6.5 5.9 23.7 13.1 0.0 9.0 14.9 1.8 11.7 34.1 13.8 29.6 10.6 27.9 27.4 19.6 FBXL20 "Fbl2, Fbl20, MGC15482" ENSG00000108306 "F-box and leucine rich repeat protein 20" Q96IG2 17 39252663-39402523 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.6;Inhibitory neurons: 126.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 65.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044748, HPA050397" Uncertain Supported Microtubules NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules "HPA044748: AB_2679072, HPA050397: AB_2681112" "unprognostic (7.21e-2)" "unprognostic (1.00e-1)" "unprognostic (2.23e-1)" "unprognostic (1.01e-1)" "unprognostic (1.33e-1)" "unprognostic (7.55e-2)" "unprognostic (5.10e-2)" "unprognostic (1.32e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.54e-4)" "unprognostic (1.65e-1)" "unprognostic (3.29e-1)" "unprognostic (9.95e-2)" "unprognostic (2.19e-1)" "unprognostic (2.60e-1)" "unprognostic (2.04e-2)" "unprognostic (1.90e-2)" 4.1 5.4 7.8 3.4 8.2 8.2 4.5 6.8 11.4 4.6 1.0 4.1 3.5 4.4 3.4 4.1 4.0 3.7 3.5 8.8 9.7 4.1 4.7 4.0 3.6 3.3 4.8 4.7 4.3 4.6 3.5 5.5 5.0 3.7 4.1 8.3 3.7 3.5 3.6 6.5 4.2 5.0 2.3 4.4 3.8 12.7 8.8 7.5 3.9 5.2 4.0 3.9 4.3 5.2 4.0 8.2 8.0 8.5 10.1 7.2 4.6 5.6 7.5 6.3 7.7 2.6 9.3 6.3 12.3 7.3 12.6 9.3 9.4 6.5 9.1 12.1 12.5 6.7 7.2 7.9 7.3 9.5 8.1 6.0 7.5 6.2 7.2 8.9 7.7 8.0 13.4 4.5 6.1 5.9 9.4 6.7 2.1 8.1 3.5 4.6 15.9 4.2 3.2 6.2 5.1 4.0 10.6 65.7 7.1 10.4 10.3 9.0 6.3 7.0 6.9 5.3 5.3 7.9 8.9 5.2 8.7 4.3 5.5 30.2 5.5 18.3 4.2 4.5 3.9 4.0 3.9 3.9 4.1 6.2 3.6 3.5 26.9 8.2 6.7 5.3 8.3 2.4 7.8 8.2 6.8 11.4 8.8 9.7 3.3 4.8 5.0 2.3 8.8 5.2 13.5 19.2 20.4 61.4 15.4 4.0 7.1 2.6 10.2 31.4 13.0 10.9 6.5 11.5 6.7 12.9 58.4 14.4 23.9 18.4 1.9 11.2 14.1 28.3 16.3 12.5 9.6 34.9 122.6 6.1 8.2 14.4 5.1 25.6 8.8 23.7 22.5 12.0 10.5 20.2 126.8 10.0 12.2 25.2 3.8 15.6 18.0 16.1 1.8 71.2 24.0 12.0 32.0 74.9 79.6 13.8 10.0 11.3 14.2 15.9 26.5 6.3 8.8 39.2 6.6 15.3 14.3 51.2 39.9 10.5 5.5 24.2 18.1 11.7 10.6 15.3 FO681492.1 ENSG00000277758 Synaptotagmin-15 10 47749758-47763592 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.3;lung: 12.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.5" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 11.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 68.9" "HPA036971, HPA036972, HPA064559" Approved Approved "Golgi apparatus" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (2.61e-2)" "unprognostic (1.25e-2)" "unprognostic (1.13e-1)" "unprognostic (1.15e-2)" "unprognostic (5.70e-2)" "unprognostic (4.59e-1)" "unprognostic (2.51e-1)" "unprognostic (2.06e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (2.69e-2)" "unprognostic (1.97e-1)" "unprognostic (3.49e-5)" "unprognostic (4.52e-2)" "unprognostic (5.13e-2)" "unprognostic (6.35e-2)" "unprognostic (1.11e-2)" 2.7 0.7 2.1 1.2 2.4 0.1 2.2 0.0 11.3 2.3 0.0 0.8 0.3 1.3 0.5 2.5 2.1 1.1 1.3 5.0 0.0 0.5 0.4 12.2 3.7 0.0 0.0 0.7 4.1 0.8 0.3 2.5 0.0 1.1 0.6 0.5 1.8 1.3 0.6 3.2 0.8 0.9 0.2 0.9 0.6 0.3 0.2 0.8 1.1 0.6 1.9 1.1 2.0 1.0 0.4 4.1 0.4 0.5 0.2 0.3 0.2 2.8 0.4 0.3 0.3 4.5 4.0 0.1 0.3 2.2 1.3 0.5 0.0 0.1 0.4 0.1 1.6 0.0 0.8 0.4 3.9 0.3 0.8 0.4 0.2 0.3 0.7 0.4 0.3 1.9 0.1 0.4 0.2 7.6 0.2 0.6 0.1 0.0 0.0 0.2 0.1 0.2 0.3 0.2 0.6 0.2 5.2 68.9 0.2 0.2 5.4 0.3 0.5 0.3 0.7 0.3 0.2 0.3 0.3 0.2 0.4 0.1 0.9 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 2.4 0.0 11.3 5.0 0.0 0.0 0.0 0.0 0.2 0.2 1.0 0.1 3.2 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GALNT17 "GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17" ENSG00000185274 "Polypeptide N-acetylgalactosaminyltransferase 17" Q6IS24 7 71132144-71713600 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3" "Cancer enhanced" "Detected in many" "prostate cancer: 8.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013624, HPA047986" Approved Uncertain "Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus" NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Golgi apparatus" "Nucleoli, Nuclear bodies" "HPA013624: AB_1858787, HPA047986: " "unprognostic (2.79e-2)" "unprognostic (6.83e-2)" "unprognostic (5.54e-2)" "unprognostic (3.66e-3)" "unprognostic (1.50e-1)" "unprognostic (2.62e-1)" "unprognostic (6.41e-2)" "unprognostic (5.18e-2)" "unprognostic (1.00e-1)" "prognostic favorable (4.60e-4)" "unprognostic (2.00e-1)" "unprognostic (4.73e-1)" "unprognostic (1.96e-2)" "unprognostic (9.63e-3)" "prognostic favorable (3.91e-4)" "unprognostic (1.92e-1)" "unprognostic (7.94e-3)" 3.2 8.7 30.5 1.9 37.9 0.0 2.0 35.9 51.2 4.0 46.0 16.6 0.3 16.6 3.1 9.3 8.7 2.5 43.5 55.0 3.2 5.7 0.4 9.3 0.0 2.1 3.8 31.6 10.1 1.2 13.3 0.2 3.0 14.7 1.0 3.3 3.3 8.2 4.7 2.2 3.9 8.3 0.0 3.4 2.4 5.0 11.2 2.6 10.1 2.9 1.5 21.2 3.3 24.8 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.7 0.0 0.0 45.7 0.0 14.1 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.5 37.9 35.9 51.2 55.0 3.2 2.1 3.8 3.0 0.0 11.2 24.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 GALNT6 GalNAc-T6 ENSG00000139629 "Polypeptide N-acetylgalactosaminyltransferase 6" Q8NCL4 12 51351247-51392867 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 62.6" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 49.2;Gastric mucus-secreting cells: 130.5;granulocytes: 164.5;Oligodendrocytes: 57.6" "Cancer enhanced" "Detected in many" "breast cancer: 31.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 29.1" "Group enriched" "Detected in all" 4 "granulocytes: 29.1;monocytes: 9.7;NK-cells: 15.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 107.0;CACO-2: 104.1;OE19: 97.6;SK-BR-3: 110.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA011762, HPA017086" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 4800000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Golgi apparatus" "HPA011762: AB_1849450, HPA017086: AB_1849452" "unprognostic (2.03e-1)" "unprognostic (6.65e-2)" "unprognostic (2.26e-2)" "prognostic favorable (9.85e-4)" "unprognostic (1.35e-2)" "unprognostic (1.18e-1)" "unprognostic (7.15e-3)" "unprognostic (2.05e-1)" "unprognostic (2.27e-2)" "prognostic favorable (5.40e-4)" "unprognostic (1.88e-2)" "unprognostic (5.25e-2)" "unprognostic (7.13e-4)" "unprognostic (5.65e-3)" "unprognostic (3.18e-1)" "unprognostic (2.16e-2)" "unprognostic (1.18e-2)" 1.7 3.1 3.3 8.0 11.8 9.6 18.1 7.2 9.1 32.2 0.2 6.7 21.2 1.3 24.7 2.4 6.5 2.4 0.4 4.2 7.3 2.9 1.2 5.7 7.2 8.8 11.1 0.9 8.3 1.4 1.1 9.6 10.8 0.9 6.9 0.1 31.0 3.2 0.4 5.6 21.6 1.6 5.2 8.2 62.6 0.6 9.7 6.8 2.5 0.1 5.9 3.7 1.8 18.1 39.0 4.1 0.7 0.1 0.0 0.6 59.8 63.0 107.0 25.4 17.0 104.1 19.0 0.5 5.8 34.4 0.0 35.9 1.5 27.3 17.1 8.3 4.1 24.6 0.7 0.8 1.0 13.6 82.2 2.3 25.2 23.1 23.0 0.2 65.7 14.2 5.4 1.0 0.1 73.7 43.2 10.1 5.3 97.6 66.6 0.2 0.1 10.3 21.3 2.2 0.5 23.5 0.4 110.5 0.1 12.2 59.3 5.9 75.7 0.2 12.9 0.2 0.3 2.1 0.5 3.6 7.2 29.5 0.2 7.1 5.8 29.1 3.8 5.2 1.6 1.2 2.2 3.1 4.5 3.3 3.4 2.9 1.1 15.5 9.7 4.1 1.7 3.2 3.3 11.8 7.2 9.1 4.2 7.3 8.8 11.1 10.8 5.2 9.7 18.1 0.8 3.2 2.4 0.3 11.8 2.9 3.8 5.8 5.7 0.4 38.9 18.4 1.3 1.5 15.6 1.8 0.0 14.1 11.3 12.4 3.9 2.6 2.0 3.5 0.3 4.1 0.0 15.3 1.0 10.9 49.2 1.6 130.5 5.8 164.5 3.8 1.4 0.3 14.4 0.0 0.5 17.4 2.0 16.3 10.3 1.5 0.0 15.1 1.8 1.0 7.2 0.2 9.2 0.0 57.6 24.3 33.9 0.4 5.5 7.6 39.6 2.0 12.4 0.0 0.0 1.5 1.5 0.4 1.6 2.6 9.2 4.8 14.9 1.8 11.8 5.8 GCC1 "FLJ22035, GCC1P, GCC88, MGC20706" ENSG00000179562 "GRIP and coiled-coil domain containing 1" Q96CN9 7 127580628-127593611 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 9 "Early spermatids: 102.7;Late spermatids: 131.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019369, HPA021323" Enhanced Supported "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA019369: AB_1849552, HPA021323: AB_1849554" "unprognostic (1.09e-1)" "unprognostic (4.96e-2)" "unprognostic (1.83e-1)" "unprognostic (9.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.20e-2)" "unprognostic (1.26e-1)" "unprognostic (2.54e-2)" "unprognostic (1.83e-1)" "unprognostic (5.08e-2)" "unprognostic (4.81e-2)" "unprognostic (4.50e-3)" "unprognostic (1.17e-3)" "unprognostic (4.17e-3)" "unprognostic (1.22e-1)" "unprognostic (8.65e-2)" "unprognostic (9.96e-2)" 6.6 6.6 5.4 7.8 6.3 13.5 9.2 6.4 5.7 7.0 6.2 6.9 6.5 6.1 6.5 7.0 5.9 6.3 4.8 5.2 5.9 6.2 10.6 6.9 8.6 6.3 6.3 8.0 6.9 9.4 4.5 7.5 6.1 7.3 6.2 3.6 8.2 6.7 6.6 7.8 6.5 5.1 6.2 8.3 7.7 11.0 6.1 8.3 7.7 6.7 9.9 7.1 4.7 7.2 15.7 20.8 9.0 19.5 19.7 13.5 12.4 13.4 15.5 13.2 16.5 17.5 10.5 14.4 8.0 12.6 29.7 17.0 13.1 14.7 14.1 20.3 11.9 10.6 11.4 9.2 29.2 18.5 16.9 12.7 39.7 14.1 27.8 12.4 12.6 14.2 17.6 16.1 15.0 15.6 18.0 16.0 18.8 17.2 16.1 12.7 9.8 16.5 11.4 12.0 14.2 20.6 14.4 67.9 27.5 16.1 11.6 13.2 16.4 19.5 6.3 17.0 15.6 43.6 20.6 9.1 19.3 18.6 20.2 5.3 7.1 13.2 7.1 6.9 9.1 6.6 6.4 7.0 6.6 6.3 5.1 5.2 13.1 8.7 8.2 3.8 6.5 8.1 5.4 6.3 6.4 5.7 5.2 5.9 6.3 6.3 6.1 6.2 6.1 7.2 4.8 12.8 7.7 0.0 9.6 10.6 5.0 2.7 12.0 4.1 11.5 6.1 3.6 4.3 3.7 3.7 4.2 7.2 7.3 10.0 5.9 5.1 102.7 4.3 5.5 6.7 7.2 8.2 0.0 6.4 4.6 5.0 8.6 6.8 1.3 5.9 5.0 7.4 5.2 11.8 0.0 8.2 2.0 10.1 8.3 131.7 5.3 7.6 12.4 0.0 6.9 4.9 5.2 0.0 0.0 5.9 6.6 3.8 6.3 5.4 6.0 4.5 2.4 5.9 6.6 5.9 6.5 7.8 4.6 6.3 10.4 10.4 8.8 5.8 5.8 5.4 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113537 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.6" "Cell type enriched" "Detected in many" 4 "Late spermatids: 447.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 2.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.4" "Cell line enhanced" "Detected in many" "Hep G2: 32.1;MCF7: 50.6;OE19: 53.3;SK-BR-3: 165.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 7.1 2.4 6.1 6.0 6.1 1.8 5.4 6.8 11.4 18.7 5.9 25.9 8.4 5.3 9.3 45.6 5.7 2.5 5.2 6.0 6.1 17.9 2.1 6.4 4.2 7.5 6.1 6.8 2.2 0.4 4.8 11.4 8.0 5.7 17.2 6.5 9.0 2.2 2.1 11.0 10.2 5.2 6.3 9.0 18.8 1.8 6.1 4.1 4.7 0.9 20.9 5.4 19.1 6.8 21.8 0.3 5.2 1.5 1.6 5.5 5.5 0.6 1.3 1.8 1.7 1.0 15.2 0.6 2.9 1.5 0.6 1.8 1.6 0.5 1.8 2.5 4.0 0.2 1.0 32.1 1.0 0.7 1.3 0.2 1.6 4.5 0.3 4.1 5.1 4.2 1.0 2.3 2.2 50.6 1.5 2.0 2.6 53.3 0.6 6.3 1.4 7.1 2.6 7.4 1.1 2.2 0.2 165.0 0.5 1.6 3.0 2.7 2.7 0.9 1.1 1.9 1.8 2.7 0.9 1.5 4.2 2.7 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.1 0.0 6.1 6.1 6.8 11.4 6.0 6.1 7.5 6.1 8.0 6.3 6.1 6.8 5.9 6.4 1.1 1.6 1.0 1.3 0.9 4.4 1.2 1.6 4.1 3.0 1.5 0.0 22.2 5.5 0.0 24.2 1.2 98.2 5.9 0.9 67.8 2.6 3.8 4.3 3.5 0.0 0.6 1.3 71.9 2.1 30.1 4.1 0.0 2.0 3.9 0.3 3.1 1.7 0.8 34.2 6.1 1.9 1.0 447.4 3.4 1.4 1.8 1.9 1.2 0.6 0.0 1.5 1.2 19.2 36.7 3.0 0.1 1.1 46.0 100.6 9.0 1.7 6.6 0.6 2.7 1.4 1.3 5.1 2.0 9.3 1.9 1.3 13.9 4.8 GGCT "C7orf24, CRF21, GCTG, Ggc, MGC3077" ENSG00000006625 Gamma-glutamylcyclotransferase O75223 7 30496621-30504841 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 414.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020735, HPA029914" Approved NA Yes 2100000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA020735: AB_1845754, HPA029914: AB_10602321" "prognostic unfavorable (7.68e-4)" "unprognostic (2.66e-1)" "unprognostic (2.51e-2)" "unprognostic (2.62e-1)" "unprognostic (2.54e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (7.23e-4)" "unprognostic (1.33e-3)" "unprognostic (2.19e-2)" "unprognostic (6.42e-3)" "unprognostic (2.66e-3)" "unprognostic (1.68e-1)" "unprognostic (2.27e-2)" "unprognostic (1.19e-1)" "unprognostic (8.12e-3)" "unprognostic (2.00e-3)" "unprognostic (9.92e-2)" 58.6 25.6 18.1 28.4 20.5 22.4 44.8 16.9 24.4 19.2 19.5 38.6 31.3 17.3 105.2 51.7 24.4 25.9 13.0 20.0 18.3 31.9 35.6 16.6 27.8 18.0 18.1 15.5 23.3 43.5 15.9 34.8 17.3 24.9 39.4 10.7 33.4 15.9 16.9 56.5 26.6 21.2 17.3 16.0 22.7 12.1 19.7 21.9 19.3 20.8 32.2 33.1 31.2 17.8 194.0 50.0 79.4 107.7 32.6 58.8 92.5 64.6 25.1 60.5 72.4 66.6 66.1 123.7 42.0 24.3 68.9 238.8 84.1 67.8 78.6 24.0 93.1 87.7 104.6 88.6 42.6 150.1 65.4 57.6 53.4 63.4 81.0 20.9 62.1 58.7 126.8 69.4 48.6 108.6 91.4 202.1 115.6 198.3 79.5 90.1 91.9 123.8 59.5 174.0 100.3 101.2 58.0 355.9 73.5 102.8 228.7 140.7 37.7 39.6 75.6 75.6 128.6 50.8 129.2 96.7 30.9 201.4 75.9 10.4 19.9 7.0 14.1 20.4 19.9 22.7 18.8 18.4 34.2 17.2 17.8 17.4 1.1 25.0 12.2 30.0 26.1 17.2 18.1 20.5 16.9 24.4 20.0 18.3 18.0 18.1 17.3 17.3 19.7 17.8 37.9 16.0 39.4 10.1 25.1 77.0 50.1 96.0 60.3 23.4 107.0 109.5 51.6 24.3 67.0 44.1 4.2 414.7 21.8 56.9 123.3 99.8 29.2 129.6 40.4 46.3 28.3 53.0 26.0 80.1 167.7 41.4 44.9 103.8 27.3 53.5 33.5 51.4 129.8 33.7 10.1 90.1 67.1 44.5 57.4 10.0 24.8 42.8 62.2 12.2 36.2 32.2 24.7 8.5 8.9 60.1 50.6 39.1 33.4 68.8 60.6 188.4 69.4 15.1 26.3 25.2 45.1 63.3 46.7 147.0 74.7 135.6 26.7 67.7 138.0 69.6 GJA5 CX40 ENSG00000265107 "Gap junction protein alpha 5" P36382 1 147756199-147773362 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Atrial fibrillation, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 36.7;placenta: 85.4" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 135.3;Extravillous trophoblasts: 345.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 133.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB013080, HPA071370" Enhanced NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "CAB013080: AB_2533263, HPA071370: " "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-2)" "unprognostic (2.94e-2)" "unprognostic (3.88e-2)" "unprognostic (8.95e-2)" "unprognostic (1.23e-3)" "unprognostic (5.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (7.57e-2)" "unprognostic (1.97e-2)" "unprognostic (2.44e-1)" "unprognostic (4.41e-2)" "unprognostic (3.43e-2)" "unprognostic (8.93e-2)" 18.6 2.2 2.5 6.0 3.4 0.0 10.5 2.4 4.1 5.5 2.6 4.7 3.4 10.8 2.3 4.8 8.2 6.3 36.7 2.4 2.2 17.1 1.2 26.4 1.7 2.8 2.6 4.0 2.6 3.4 0.5 85.4 2.5 4.0 4.1 0.2 1.6 9.4 2.1 1.4 5.9 8.2 2.6 3.9 3.0 2.9 2.7 0.6 5.3 8.9 2.3 7.4 3.8 2.7 1.8 0.0 0.3 0.0 0.0 0.0 5.7 4.4 2.2 2.2 0.5 0.1 0.2 0.0 1.4 0.7 0.0 0.3 0.0 9.3 3.5 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.1 13.1 0.0 0.1 0.1 0.2 133.8 0.0 12.2 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.4 2.4 4.1 2.4 2.2 2.8 2.6 2.5 2.6 2.7 2.7 14.3 3.2 4.2 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.2 1.5 17.7 0.0 0.0 3.7 0.0 135.3 0.1 0.0 0.0 0.0 7.6 0.1 0.3 14.7 0.0 0.0 0.0 0.0 345.3 3.7 0.0 0.1 0.0 19.9 37.9 0.0 15.8 0.0 0.0 0.0 0.0 0.6 0.0 9.8 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 39.5 0.5 11.1 4.3 0.4 0.2 0.3 31.1 0.5 0.1 0.0 0.1 GLIPR1L2 MGC39497 ENSG00000180481 "GLIPR1 like 2" Q4G1C9 12 75391089-75432688 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 46.8" "Group enriched" "Detected in many" 7 "Early spermatids: 254.0;Spermatocytes: 306.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 4.2;SK-BR-3: 5.6;U-2 OS: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039795, HPA039866" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Vesicles "HPA039795: AB_10805595, HPA039866: AB_10795235" "unprognostic (1.23e-1)" "unprognostic (1.87e-1)" "unprognostic (3.32e-1)" "unprognostic (2.27e-1)" "unprognostic (7.74e-2)" "unprognostic (1.33e-1)" "unprognostic (8.78e-3)" "unprognostic (2.29e-2)" "unprognostic (1.48e-1)" "unprognostic (2.82e-1)" "unprognostic (7.68e-3)" "unprognostic (1.20e-1)" "unprognostic (1.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (5.91e-2)" "unprognostic (2.57e-2)" 1.0 2.7 5.1 0.8 5.2 0.3 2.4 6.5 5.9 2.1 2.5 0.9 0.6 2.3 3.7 1.0 3.1 1.0 2.3 5.5 5.0 2.0 1.5 1.2 0.7 4.0 4.3 7.1 2.6 4.1 2.6 0.9 4.4 1.5 0.4 3.0 1.0 3.0 2.3 1.9 0.8 1.1 4.0 1.6 0.7 46.8 4.7 1.3 2.4 1.6 0.4 0.9 0.9 6.3 0.2 0.4 0.2 0.4 2.9 1.6 0.5 0.4 0.3 0.1 0.2 0.1 0.3 0.2 1.0 0.3 0.7 0.1 0.0 0.1 0.3 0.6 0.2 0.1 0.6 4.2 2.1 0.4 0.0 0.5 0.9 0.4 1.5 2.5 0.1 0.1 0.2 0.5 0.8 0.1 0.4 0.3 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.3 0.7 0.3 0.5 5.6 1.7 0.2 1.7 0.1 0.8 0.6 7.6 0.9 0.3 0.7 0.7 0.2 0.2 0.2 0.5 0.7 0.0 0.1 0.3 0.0 0.1 0.3 0.3 0.5 0.1 0.3 0.5 0.9 0.6 0.3 0.1 0.7 1.0 0.2 5.1 5.2 6.5 5.9 5.5 5.0 4.0 4.3 4.4 4.0 4.7 6.3 1.5 0.0 3.1 15.0 0.3 0.9 4.6 1.7 3.4 5.6 2.9 3.0 4.0 1.5 1.8 0.0 0.0 1.7 1.5 0.1 9.8 0.6 254.0 4.9 1.4 1.5 0.0 0.4 7.4 0.0 0.2 3.0 1.1 0.5 1.3 1.4 0.0 0.2 0.6 1.7 13.3 0.1 0.0 0.3 0.3 39.0 7.5 0.7 0.0 10.3 0.0 6.7 0.0 27.2 28.1 0.1 0.0 5.7 0.1 1.2 0.1 1.4 14.1 2.0 6.6 5.6 1.9 306.8 19.4 0.3 0.4 0.4 0.6 2.1 0.3 2.1 GLYATL2 "BXMAS2-10, MGC24009" ENSG00000156689 "Glycine-N-acyltransferase like 2" Q8WU03 11 58834065-58904215 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "breast: 12.0;cervix: 19.9;salivary gland: 33.4" "Cell type enhanced" "Detected in some" "Breast glandular cells: 14.8;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 3.6;Sertoli cells: 6.6" "Group enriched" "Detected in many" 4 "breast cancer: 16.7;endometrial cancer: 15.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+ RasG12V: 3.7;HAP1: 6.0;SK-BR-3: 14.1;U-2197: 6.6" "Low region specificity" "Detected in many" "HPA060292, HPA065454" Uncertain Approved Mitochondria NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" Mitochondria "HPA060292: AB_2684245, HPA065454: " "unprognostic (1.02e-2)" "unprognostic (3.79e-3)" "unprognostic (8.11e-4)" "prognostic favorable (9.05e-7)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "unprognostic (2.66e-2)" "unprognostic (9.98e-3)" "unprognostic (1.27e-1)" "unprognostic (9.18e-3)" "unprognostic (1.64e-1)" "unprognostic (1.59e-1)" "unprognostic (7.42e-5)" "unprognostic (7.79e-3)" "unprognostic (8.28e-2)" "unprognostic (9.11e-3)" "unprognostic (2.31e-2)" 0.2 0.1 0.2 0.1 0.3 0.1 12.0 0.2 0.5 19.9 0.0 0.1 0.3 0.4 0.3 0.9 0.1 7.5 0.3 0.2 0.4 0.9 0.1 0.0 0.3 0.7 0.2 0.0 0.1 0.0 0.1 0.0 0.6 0.9 0.2 0.3 33.4 0.1 0.0 1.4 0.1 0.3 0.7 0.3 0.1 0.0 0.2 0.1 0.1 0.5 0.4 0.1 0.3 1.1 0.0 0.0 0.4 0.0 0.7 2.6 0.0 1.7 5.3 2.3 3.7 0.0 0.0 0.1 0.0 1.4 1.0 0.4 6.0 0.0 1.9 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.0 0.5 0.2 2.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.1 14.1 0.0 0.0 0.0 0.0 0.0 1.8 0.1 6.6 2.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.5 0.2 0.4 0.7 0.2 0.6 0.7 0.2 1.1 0.2 0.0 0.0 0.0 0.0 1.0 2.3 1.4 0.0 0.5 14.8 2.2 0.1 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 1.1 0.0 0.0 1.5 1.4 0.0 0.5 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 3.0 0.4 0.1 0.0 0.0 0.0 3.6 0.0 0.2 0.1 0.1 6.6 0.2 0.6 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 1.9 GMPPB KIAA1851 ENSG00000173540 "GDP-mannose pyrophosphorylase B" Q9Y5P6 3 49716844-49723973 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 130.2;Syncytiotrophoblasts: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014657 Uncertain NA NA 38000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "HPA014657: AB_1849852" "unprognostic (3.48e-2)" "unprognostic (9.84e-2)" "unprognostic (2.77e-2)" "prognostic favorable (6.19e-6)" "unprognostic (1.01e-2)" "unprognostic (5.11e-3)" "unprognostic (1.54e-2)" "unprognostic (4.01e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-2)" "unprognostic (5.01e-3)" "unprognostic (5.73e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" 14.5 30.1 6.1 16.1 6.0 11.8 15.3 5.7 6.6 20.8 9.2 23.1 14.5 18.6 14.5 26.3 19.5 9.5 18.2 6.0 6.3 17.5 44.2 21.4 13.0 6.7 6.5 14.0 57.4 10.1 39.4 7.5 6.1 27.9 12.2 4.1 35.4 14.7 13.4 14.9 21.8 9.4 6.1 27.9 26.2 9.6 6.8 9.3 26.3 5.7 13.0 15.9 16.8 5.9 31.8 27.0 21.0 12.3 15.6 10.8 21.7 36.1 17.1 29.0 26.1 18.7 21.5 17.6 15.8 18.1 22.2 16.7 18.6 29.0 10.6 17.2 14.5 13.5 27.2 21.5 31.1 19.0 19.6 8.2 15.1 40.0 34.8 11.3 24.8 20.2 10.4 32.0 16.3 20.3 27.3 11.7 12.2 22.5 34.3 9.2 12.5 30.4 16.3 24.0 13.8 16.0 15.7 36.5 12.5 10.6 20.6 13.9 21.9 25.7 25.0 33.4 38.8 33.7 11.1 13.6 25.4 14.7 28.6 22.1 15.6 6.7 18.3 21.3 18.6 22.7 15.9 19.3 14.7 22.5 11.8 14.6 4.0 11.3 21.8 61.8 12.0 14.8 6.1 6.0 5.7 6.6 6.0 6.3 6.7 6.5 6.1 6.1 6.8 5.9 7.3 9.6 17.2 1.6 35.4 0.8 22.8 0.7 2.8 3.7 34.1 14.1 4.5 15.7 3.8 18.4 2.1 28.5 28.5 43.6 29.4 39.8 10.0 18.3 14.3 10.7 16.7 9.9 0.8 50.6 67.2 15.5 34.7 17.8 0.0 11.2 9.3 28.4 39.0 6.7 0.8 55.9 0.0 10.7 1.7 10.0 15.5 13.7 1.8 1.0 40.9 5.8 19.6 1.0 0.4 31.9 27.1 7.5 130.2 40.9 29.2 25.7 14.4 6.2 0.0 5.3 12.2 22.9 12.6 14.7 1.7 79.5 14.7 13.1 32.8 37.1 GORASP1 "FLJ23443, GOLPH5, GRASP65, P65" ENSG00000114745 "Golgi reassembly stacking protein 1" Q9BQQ3 3 39096599-39107863 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 98.9;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056283 Supported Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA056283: AB_2683085" "unprognostic (1.06e-1)" "unprognostic (8.31e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.92e-6)" "unprognostic (2.77e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.13e-2)" "unprognostic (8.79e-3)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.73e-3)" "prognostic favorable (1.91e-6)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.44e-1)" "unprognostic (3.24e-3)" 16.9 13.5 35.4 12.8 36.4 11.5 18.6 38.7 35.7 25.2 30.3 23.6 13.6 18.8 16.6 20.0 22.2 15.6 21.3 34.1 35.9 26.9 26.3 19.6 13.4 41.7 36.9 13.3 24.5 22.5 15.4 21.0 38.0 22.1 26.0 20.6 26.2 30.7 16.3 16.4 18.5 24.0 42.0 21.5 19.1 10.5 38.8 11.8 18.4 19.0 17.4 17.9 14.8 46.6 15.6 19.0 18.0 17.8 42.8 28.1 16.6 27.1 31.1 27.5 24.6 11.3 18.4 16.8 15.7 41.4 17.2 24.7 20.7 32.2 19.3 22.4 14.3 23.8 18.7 16.0 19.3 20.0 25.8 22.0 43.8 28.5 28.0 30.6 38.2 6.0 19.8 20.3 26.3 22.6 5.6 18.9 13.1 35.7 23.1 6.0 10.7 23.8 27.4 28.1 7.1 14.0 25.7 51.4 16.1 24.4 33.2 20.7 29.0 15.4 14.3 37.0 15.0 14.1 14.8 4.1 18.3 16.7 23.0 6.5 12.0 7.0 3.3 12.7 4.5 11.7 4.1 3.1 12.8 9.3 4.7 3.4 6.9 2.8 17.2 7.2 6.7 8.0 35.4 36.4 38.7 35.7 34.1 35.9 41.7 36.9 38.0 42.0 38.8 46.6 21.1 3.2 9.8 23.2 8.7 4.1 10.6 6.5 8.0 8.5 12.9 9.7 8.7 12.8 7.2 12.9 0.0 14.0 3.4 21.4 11.7 10.7 98.9 15.5 11.4 13.4 11.4 5.5 7.7 8.7 11.1 8.9 24.5 16.3 1.3 8.8 8.9 11.4 9.5 8.4 9.2 15.3 8.2 7.2 9.8 56.1 7.2 9.5 12.4 9.4 7.0 7.3 0.0 9.0 9.6 11.0 8.0 6.4 5.7 11.4 14.2 6.0 10.7 11.1 0.0 8.8 10.0 10.1 6.8 8.0 5.8 19.8 4.4 6.5 15.1 12.6 GOSR1 "GOLIM2, GOS-28, GOS28, GS28, P28" ENSG00000108587 "Golgi SNAP receptor complex member 1" O95249 17 30477362-30527592 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020590 Uncertain NA NA "Cluster 6: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA020590: AB_1850374" "unprognostic (1.54e-1)" "unprognostic (4.02e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.41e-1)" "unprognostic (2.83e-2)" "unprognostic (4.98e-2)" "unprognostic (1.16e-2)" "unprognostic (1.71e-1)" "unprognostic (4.34e-2)" "unprognostic (9.93e-2)" "unprognostic (1.13e-1)" "prognostic favorable (2.26e-4)" "unprognostic (8.64e-2)" "unprognostic (3.68e-1)" "unprognostic (7.56e-2)" "unprognostic (1.14e-2)" 18.3 15.2 9.5 16.0 9.6 12.6 22.3 11.5 11.1 19.0 10.0 19.8 15.9 21.0 15.4 18.0 23.5 16.0 17.9 9.9 10.0 25.0 30.8 16.6 17.6 9.7 10.2 20.8 22.0 28.2 13.1 19.5 9.5 21.0 23.4 19.5 18.5 17.8 17.2 14.8 18.0 20.8 8.5 14.6 19.4 22.8 9.9 24.1 24.2 19.4 24.6 19.8 12.4 10.4 33.7 54.9 35.5 26.1 27.6 27.1 25.2 35.2 35.2 50.1 45.0 48.8 22.8 34.0 33.6 38.9 44.8 29.8 43.1 36.2 57.0 20.3 34.6 35.0 41.4 32.3 37.5 55.5 39.6 27.6 28.8 48.8 54.3 27.2 32.8 36.0 55.4 30.9 33.9 23.1 43.8 28.9 36.3 55.5 21.9 41.0 47.6 27.2 25.7 47.0 31.7 30.3 36.6 76.2 44.8 38.5 58.9 40.6 37.0 33.6 29.9 31.4 46.2 41.0 56.3 60.6 32.4 26.7 45.1 26.0 21.6 29.5 29.8 27.8 34.8 33.8 28.5 28.2 30.0 35.8 33.7 32.8 26.2 36.1 27.4 30.6 33.6 19.3 9.5 9.6 11.5 11.1 9.9 10.0 9.7 10.2 9.5 8.5 9.9 10.4 45.9 28.9 52.9 35.3 40.6 27.0 34.9 51.3 30.1 62.4 36.0 38.7 45.9 38.6 61.2 42.3 62.6 48.0 28.2 26.7 50.9 39.8 124.3 41.5 44.2 38.4 41.9 21.7 42.8 40.1 39.6 42.5 26.0 33.5 61.4 38.0 35.3 47.7 27.8 104.3 40.8 31.4 40.7 29.4 21.6 46.7 29.5 27.6 16.0 35.6 31.6 70.2 26.8 37.7 49.5 36.9 23.8 28.2 26.2 37.8 26.2 41.9 75.3 67.5 19.7 52.9 45.3 80.2 44.3 27.4 27.1 73.1 33.0 33.4 29.9 31.0 GPHN KIAA1385 ENSG00000171723 Gephyrin Q9NQX3 14 66507407-67181803 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis" "Multifunctional enzyme, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 62.4" "Group enriched" "Detected in many" 4 "Astrocytes: 493.0;Excitatory neurons: 686.5;Inhibitory neurons: 866.7;Oligodendrocyte precursor cells: 576.1;Oligodendrocytes: 597.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003116, CAB004419, HPA024694" Enhanced Approved Vesicles,Cytosol NA NA 6900 "Cluster 16: MAIT-cells - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Cytosol "CAB004419: AB_627670, HPA003116: AB_1078963, HPA024694: AB_1849616" "unprognostic (8.37e-2)" "unprognostic (2.53e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-1)" "unprognostic (5.14e-2)" "unprognostic (4.89e-3)" "unprognostic (8.29e-2)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (2.23e-1)" "unprognostic (2.49e-2)" "unprognostic (8.54e-2)" "prognostic favorable (5.25e-12)" "unprognostic (9.81e-2)" "unprognostic (2.27e-1)" "unprognostic (7.50e-2)" "prognostic unfavorable (4.61e-5)" 13.8 11.1 35.5 3.5 36.0 2.6 13.4 48.4 54.1 9.7 20.9 11.8 7.4 9.9 11.6 12.2 11.1 6.2 17.1 36.1 37.6 25.3 62.4 9.3 3.8 32.7 35.3 8.9 23.9 11.7 13.6 3.6 32.3 11.3 10.1 23.1 9.4 6.6 24.5 15.2 9.0 6.2 32.4 6.7 14.7 6.2 34.6 5.8 11.9 13.8 4.3 11.4 10.7 39.5 39.9 8.8 13.7 15.9 14.2 17.5 9.5 11.1 5.7 12.7 12.2 2.8 17.9 0.0 1.8 7.7 5.5 13.1 17.0 19.9 18.9 15.0 14.9 15.8 9.4 22.3 7.8 9.1 15.8 13.3 13.8 2.9 16.0 4.8 11.8 13.8 9.3 14.2 7.1 19.2 11.9 22.2 5.0 28.3 17.0 0.0 32.5 13.2 16.7 7.5 25.8 10.3 10.2 31.6 12.4 3.3 18.5 11.5 6.7 14.1 24.8 11.3 13.0 22.8 9.1 0.3 10.5 0.8 11.2 0.0 0.7 0.3 2.0 1.2 3.2 1.2 2.5 1.7 1.1 1.9 1.7 1.6 0.0 1.3 1.0 1.5 3.0 0.7 35.5 36.0 48.4 54.1 36.1 37.6 32.7 35.3 32.3 32.4 34.6 39.5 11.5 6.4 13.1 493.0 11.8 4.7 9.2 5.8 27.9 34.3 12.4 6.7 12.7 8.6 10.8 1.8 52.1 3.9 3.5 8.6 13.7 4.0 3.8 7.2 13.5 10.7 6.0 7.6 686.5 5.3 2.3 8.7 19.9 13.6 0.0 3.9 15.7 47.6 3.7 43.7 866.7 15.0 8.2 5.8 1.7 5.0 11.1 4.5 1.8 148.0 1.3 8.9 1.0 576.1 597.5 3.1 7.8 5.7 15.1 11.5 7.1 20.1 2.4 34.9 0.0 12.5 11.8 11.8 8.9 26.7 5.8 2.1 7.9 9.0 10.4 6.5 GPR157 FLJ12132 ENSG00000180758 "G protein-coupled receptor 157" Q5UAW9 1 9100305-9129102 "G-protein coupled receptors, Predicted membrane proteins" Differentiation "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 59.6" "Cell type enhanced" "Detected in many" "Langerhans cells: 268.1;monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 31.8;SK-BR-3: 62.7;U-266/70: 30.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA028697 Uncertain Uncertain "Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" "Nucleoli, Nucleoli rim" "Plasma membrane, Cell Junctions" "HPA028697: AB_10601810" "unprognostic (2.83e-3)" "unprognostic (1.13e-2)" "unprognostic (5.91e-2)" "unprognostic (5.42e-2)" "unprognostic (2.13e-4)" "unprognostic (7.11e-2)" "unprognostic (7.52e-3)" "unprognostic (3.60e-2)" "unprognostic (9.20e-2)" "unprognostic (1.26e-1)" "unprognostic (9.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.02e-2)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-3)" 3.3 4.8 0.7 4.4 0.8 1.3 3.3 1.1 1.2 7.9 10.7 3.1 4.0 2.9 1.3 30.2 2.9 2.0 12.9 1.4 0.6 2.3 9.0 6.7 3.1 1.7 0.9 4.3 4.1 15.1 1.4 8.7 1.2 3.5 2.2 0.9 8.9 2.3 59.6 22.6 2.8 1.7 0.7 3.9 3.7 2.0 1.1 2.5 3.3 23.9 7.5 6.7 13.7 1.0 9.0 5.0 1.5 4.1 1.4 1.3 8.0 2.8 1.8 2.3 3.1 4.1 3.4 1.1 3.4 3.0 2.9 18.9 4.6 1.8 3.4 25.2 7.6 0.1 16.0 6.2 4.9 0.1 2.0 1.2 3.9 3.9 2.4 2.3 1.8 3.7 1.4 31.8 0.9 6.5 3.8 1.9 1.7 4.4 6.3 0.6 1.3 4.3 1.4 6.0 2.3 6.1 10.8 62.7 5.2 3.0 8.9 1.1 13.3 7.8 2.0 20.5 1.3 30.6 5.2 0.1 5.8 12.6 3.3 0.7 0.4 0.1 0.6 0.3 0.5 0.4 0.4 0.6 0.2 0.6 0.4 0.5 1.2 0.2 0.1 0.2 0.2 0.2 0.7 0.8 1.1 1.2 1.4 0.6 1.7 0.9 1.2 0.7 1.1 1.0 3.1 6.4 8.9 0.0 5.3 13.6 10.2 17.8 12.5 0.7 14.7 8.4 13.4 2.8 12.3 5.5 2.1 34.8 2.9 6.8 0.0 3.5 0.1 13.7 6.9 4.0 0.0 0.0 1.4 3.9 10.0 4.8 5.1 26.5 0.0 3.2 2.5 14.8 4.0 1.7 1.2 4.8 10.2 0.8 268.1 0.2 1.8 13.1 7.2 0.0 107.4 1.0 0.0 0.0 0.2 13.9 4.3 5.3 4.7 6.8 7.5 1.6 7.4 1.4 0.0 5.5 4.2 0.6 2.3 43.6 24.3 48.2 3.5 5.0 5.5 16.1 GPRIN2 "KIAA0514, MGC15171" ENSG00000204175 "G protein regulated inducer of neurite outgrowth 2" O60269 10 46549044-46555530 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 10.5;skin 1: 17.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0" "Low region specificity" "Detected in many" "HPA038129, HPA070760" Approved Approved "Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA038129: AB_2675846, HPA070760: " "unprognostic (1.00e-2)" "unprognostic (1.91e-1)" "unprognostic (1.77e-2)" "prognostic unfavorable (8.60e-8)" "unprognostic (5.77e-2)" "prognostic favorable (3.47e-4)" "unprognostic (2.23e-1)" "unprognostic (2.67e-2)" "unprognostic (2.54e-1)" "unprognostic (1.27e-1)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.97e-2)" "unprognostic (1.98e-2)" "unprognostic (2.37e-1)" "unprognostic (1.23e-1)" "unprognostic (5.67e-3)" 0.1 0.0 1.7 0.6 1.6 0.0 0.9 5.9 2.1 0.9 0.4 6.2 3.6 0.0 0.0 4.4 0.3 0.2 0.0 0.6 6.7 5.7 0.3 10.5 0.0 5.5 4.9 0.1 5.7 2.1 4.2 0.0 5.7 1.9 3.4 0.1 2.8 1.1 0.1 17.4 8.0 0.1 1.8 0.0 5.1 3.0 9.7 0.0 3.4 0.0 0.5 0.6 2.0 1.0 10.2 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.2 0.0 0.7 0.8 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.9 0.0 0.0 0.0 0.0 1.7 0.3 0.3 0.1 3.7 12.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 5.9 2.1 0.6 6.7 5.5 4.9 5.7 1.8 9.7 1.0 0.0 19.2 3.7 0.0 0.0 1.7 2.8 1.9 2.8 0.3 1.4 1.0 0.2 7.2 2.1 3.7 0.0 0.0 0.0 30.4 0.0 11.3 9.3 0.0 0.0 0.1 6.6 0.0 0.7 20.2 0.0 0.1 3.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.9 30.8 0.0 0.0 0.3 20.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 13.1 0.4 0.0 2.1 21.7 4.0 1.8 0.1 0.0 0.0 0.2 2.9 0.8 2.4 6.1 0.0 0.1 0.0 7.3 1.3 GSDMB "GSDML, PRO2521" ENSG00000073605 "Gasdermin B" Q8TAX9 17 39904595-39919854 "Predicted intracellular proteins, Transporters" "Cytolysis, Necrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.2;liver: 52.8;stomach 1: 47.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 45.7;Gastric mucus-secreting cells: 62.2;Intestinal goblet cells: 30.7;Paneth cells: 54.2;Proximal enterocytes: 108.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 8 "SK-BR-3: 458.1" "Not detected" "Not detected" "CAB013681, HPA023925, HPA052407" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Cytosol "CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819" "unprognostic (5.78e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "unprognostic (6.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.10e-1)" "unprognostic (6.44e-2)" "unprognostic (3.81e-1)" "unprognostic (8.72e-2)" "unprognostic (2.34e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (5.13e-11)" "unprognostic (1.88e-1)" "unprognostic (1.99e-1)" "unprognostic (8.91e-2)" "prognostic favorable (5.91e-9)" 13.5 1.4 12.2 13.1 12.4 5.1 9.3 12.9 22.6 6.0 11.6 45.0 66.9 3.4 5.1 4.8 6.2 12.5 4.8 12.5 11.3 6.0 52.8 7.9 11.0 11.5 11.4 6.3 8.2 0.3 4.0 2.9 11.6 10.9 57.0 5.3 4.6 4.4 1.5 8.3 76.2 5.0 11.2 15.0 47.4 4.3 11.9 10.8 8.9 0.4 8.4 20.1 5.6 13.2 2.0 1.5 2.9 0.8 6.7 4.3 2.6 1.8 1.1 0.6 1.8 1.7 55.2 2.8 2.5 1.7 0.9 7.6 1.6 1.6 4.0 11.7 1.8 1.1 0.8 0.8 2.0 0.3 0.7 2.9 9.2 2.4 3.3 4.6 1.2 9.0 1.3 3.5 0.7 0.6 3.3 6.2 0.8 18.2 2.0 3.1 1.1 4.5 0.2 1.8 1.1 1.4 0.6 458.1 1.9 13.2 2.4 1.9 1.7 2.0 3.0 5.1 1.0 9.9 9.2 2.8 0.7 1.9 0.3 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 12.2 12.4 12.9 22.6 12.5 11.3 11.5 11.4 11.6 11.2 11.9 13.2 1.5 3.2 12.0 9.1 3.9 1.9 1.4 4.9 4.0 2.8 3.3 2.9 2.5 8.6 8.1 5.5 4.2 1.6 3.5 45.7 0.0 1.7 5.5 1.5 1.8 1.8 6.1 0.0 20.1 7.8 0.6 1.2 62.2 1.8 1.3 3.0 0.4 8.1 0.3 1.7 9.2 30.7 0.0 1.3 2.0 5.4 1.2 1.1 3.6 3.7 1.5 1.3 2.1 7.1 5.1 8.9 54.2 1.9 5.6 1.4 108.2 0.3 14.1 2.3 0.0 1.4 2.2 0.4 1.4 1.8 3.4 0.3 4.8 3.0 23.7 6.7 GTF2IRD2 "FLJ37938, GTF2IRD2A" ENSG00000196275 "GTF2I repeat domain containing 2" Q86UP8 7 74796144-74851551 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 59.0" "HPA056679, HPA056680" Supported Nucleoplasm NA NA "Cluster 37: B-cells - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA056679: AB_2683205, HPA056680: AB_2683206" "unprognostic (7.91e-5)" "unprognostic (3.90e-3)" "unprognostic (1.43e-2)" "unprognostic (5.35e-2)" "unprognostic (2.02e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" "unprognostic (6.80e-3)" "unprognostic (1.22e-1)" "unprognostic (6.11e-2)" "unprognostic (4.43e-5)" "unprognostic (3.18e-2)" "unprognostic (8.97e-3)" "unprognostic (2.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.19e-1)" "unprognostic (1.59e-4)" 11.6 12.7 6.5 4.6 7.5 8.5 12.6 7.3 7.1 16.8 7.6 16.3 5.9 13.0 5.0 9.6 15.5 4.6 18.7 6.5 7.7 13.2 17.4 9.1 5.7 7.3 7.5 19.6 15.3 6.7 13.0 3.8 7.6 15.4 6.5 7.7 11.9 6.8 38.7 9.3 9.7 7.4 6.9 8.9 15.1 7.4 7.4 8.2 13.5 17.8 5.5 14.0 11.3 10.0 16.6 5.4 7.3 10.6 10.2 6.6 5.6 5.6 5.7 6.4 7.3 1.5 13.9 4.3 1.3 9.1 11.0 3.3 0.1 3.4 5.5 2.1 1.3 3.5 8.3 7.9 9.6 5.8 0.7 6.3 5.3 1.8 4.9 8.0 6.6 3.3 10.3 8.8 5.8 14.6 2.3 16.5 11.5 18.2 3.8 4.3 2.6 15.8 15.7 14.6 5.1 16.7 22.8 59.0 13.3 6.3 12.5 11.3 6.0 9.8 2.5 1.7 8.9 6.6 3.0 4.7 8.0 3.9 20.9 12.3 7.1 7.8 3.2 4.1 4.7 18.9 7.2 9.5 7.3 11.6 8.7 5.5 1.0 5.5 3.6 13.0 7.1 7.6 6.5 7.5 7.3 7.1 6.5 7.7 7.3 7.5 7.6 6.9 7.4 10.0 6.7 19.2 27.4 23.5 20.7 3.2 11.7 6.9 15.4 27.4 15.8 13.1 11.7 21.5 15.5 12.9 56.3 7.2 11.2 18.1 3.9 21.4 20.3 15.5 10.6 7.2 27.0 3.8 4.5 28.1 7.4 14.3 17.9 11.1 14.0 32.0 18.5 9.6 4.7 37.0 8.5 19.9 6.1 7.9 4.6 5.2 43.8 6.8 10.6 3.7 11.7 12.4 26.8 14.6 20.5 28.8 18.0 25.9 8.5 12.3 15.0 6.7 22.5 40.7 13.1 29.2 13.2 2.8 2.6 11.2 4.3 6.4 12.0 18.2 21.1 8.0 HDAC11 ENSG00000163517 "Histone deacetylase 11" Q96DB2 3 13479724-13506424 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 122.7" "Group enriched" "Detected in many" 6 "Early spermatids: 357.7;Late spermatids: 692.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 47.7;T-47d: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (5.22e-2)" "unprognostic (3.58e-2)" "unprognostic (1.83e-1)" "unprognostic (5.69e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (4.50e-2)" "unprognostic (5.67e-3)" "unprognostic (1.78e-2)" "unprognostic (9.87e-2)" "unprognostic (3.94e-1)" "prognostic favorable (7.88e-10)" "unprognostic (3.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-1)" "unprognostic (1.39e-3)" 7.7 10.1 92.5 3.9 115.5 0.8 9.4 89.2 98.4 16.9 62.8 18.0 12.2 11.8 6.5 17.6 13.3 9.1 31.4 82.5 90.5 25.1 6.6 9.1 2.8 95.2 100.1 16.7 38.1 23.2 22.8 4.6 87.4 15.9 6.9 6.2 17.4 12.2 51.5 18.7 13.4 7.3 83.9 5.3 12.8 84.2 100.5 4.9 16.5 15.5 4.1 14.7 14.4 122.7 12.0 8.0 8.0 6.6 11.9 10.4 6.5 7.5 5.4 7.8 5.1 4.0 10.4 1.0 9.3 11.6 12.3 8.9 4.7 14.6 5.0 5.1 4.4 2.4 3.7 11.3 12.6 0.2 4.1 9.0 26.6 8.7 6.8 14.2 5.8 7.6 5.0 2.1 7.7 12.2 1.5 1.7 2.1 8.1 20.9 1.7 11.8 3.4 16.6 9.0 1.3 6.2 12.1 47.7 21.8 6.6 42.6 2.8 5.3 6.7 13.0 13.0 4.7 1.5 4.5 0.2 2.1 1.8 4.1 0.1 2.6 5.8 3.3 1.6 2.3 1.1 3.1 2.6 1.8 0.4 3.0 2.1 1.0 9.6 0.6 1.7 2.6 1.9 92.5 115.5 89.2 98.4 82.5 90.5 95.2 100.1 87.4 83.9 100.5 122.7 5.2 9.6 5.0 11.4 0.9 11.5 7.7 11.0 8.6 8.5 10.6 8.0 84.6 8.6 8.9 11.0 0.0 18.9 2.8 23.1 19.6 14.6 357.7 8.6 5.2 6.3 8.9 0.8 6.9 11.4 3.1 9.7 9.7 7.8 1.3 5.0 7.1 2.8 6.0 10.1 7.1 14.4 18.3 3.5 3.8 692.3 16.1 3.6 8.8 1.0 4.6 21.8 2.1 12.5 46.9 11.1 13.6 15.4 0.7 5.1 36.1 24.9 12.0 5.6 0.0 5.6 9.5 15.3 7.3 10.1 10.5 5.7 3.3 3.1 20.0 6.8 HIBADH NS5ATP1 ENSG00000106049 "3-hydroxyisobutyrate dehydrogenase" P31937 7 27525442-27662883 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 543.9;Proximal tubular cells: 355.1;Syncytiotrophoblasts: 272.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019522, HPA021002" Enhanced NA NA 820000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA019522: AB_1850690, HPA021002: AB_1850692" "unprognostic (6.76e-2)" "unprognostic (1.09e-1)" "unprognostic (7.50e-2)" "unprognostic (9.79e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-3)" "unprognostic (7.22e-3)" "unprognostic (3.14e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" "unprognostic (2.05e-2)" "prognostic favorable (5.56e-11)" "unprognostic (2.49e-2)" "unprognostic (5.47e-2)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" 62.1 79.0 15.0 11.9 18.0 7.6 56.5 18.8 18.4 37.2 27.6 33.8 35.0 35.3 11.6 20.4 41.6 28.4 66.7 13.2 18.2 160.5 197.9 20.4 15.1 16.1 17.0 33.4 34.2 97.4 14.1 47.4 16.9 44.7 34.5 31.5 45.4 42.4 117.4 13.1 32.0 37.2 15.6 18.0 34.0 26.4 17.4 21.2 54.5 203.2 14.8 33.5 18.0 17.5 74.0 46.8 31.0 50.1 89.1 109.8 29.3 44.8 83.8 46.3 52.8 27.6 85.2 29.9 38.4 81.4 79.4 67.1 34.5 66.5 67.3 20.9 34.6 14.6 73.0 114.3 73.8 22.4 16.1 101.2 54.1 34.8 120.6 112.1 61.7 35.3 59.7 29.2 117.2 31.2 21.4 34.7 30.0 110.4 56.0 21.2 31.2 33.1 106.5 43.6 28.6 31.7 93.8 173.5 77.9 76.4 75.0 48.6 40.3 28.6 49.5 47.1 31.2 51.8 39.7 17.8 41.2 67.8 85.1 5.3 17.3 8.2 16.7 22.8 22.5 18.2 18.4 19.3 19.3 16.4 24.0 19.8 3.0 22.9 22.0 9.1 13.2 17.4 15.0 18.0 18.8 18.4 13.2 18.2 16.1 17.0 16.9 15.6 17.4 17.5 17.3 9.6 6.4 56.2 14.1 21.3 43.6 51.9 17.1 15.8 58.8 28.2 105.8 58.6 37.7 47.8 4.2 181.1 8.1 23.3 543.9 35.8 58.5 22.8 28.5 21.5 15.6 33.2 64.4 29.1 138.9 44.6 43.3 27.3 2.5 12.0 25.4 149.8 53.7 23.5 85.9 28.9 40.7 28.3 10.0 62.3 44.7 18.5 65.8 51.5 11.0 34.1 8.2 147.2 131.6 28.0 24.1 36.9 20.1 46.1 58.4 355.1 50.8 11.9 46.0 31.6 35.4 35.0 44.3 22.4 15.5 272.4 15.2 77.3 38.8 47.3 HID1 "C17orf28, DMC1, HID-1" ENSG00000167861 "HID1 domain containing" Q8IV36 17 74950742-74973166 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 111.2" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031406 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Cytosol" "HPA031406: AB_2673866" "unprognostic (7.41e-2)" "unprognostic (1.96e-1)" "unprognostic (2.69e-1)" "unprognostic (2.22e-3)" "unprognostic (4.47e-3)" "unprognostic (6.79e-3)" "unprognostic (4.00e-2)" "unprognostic (1.11e-1)" "unprognostic (2.78e-1)" "unprognostic (3.90e-1)" "unprognostic (1.54e-3)" "unprognostic (1.37e-1)" "prognostic favorable (3.13e-5)" "unprognostic (1.17e-1)" "unprognostic (2.83e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.34e-4)" 13.2 5.8 21.7 6.6 26.9 2.0 23.2 41.5 33.3 19.9 2.8 17.9 39.1 11.9 29.1 5.5 19.0 21.6 12.4 22.0 24.3 12.3 4.4 20.4 5.3 27.4 22.7 3.0 111.2 14.4 44.0 20.1 30.3 36.2 17.9 8.7 86.2 20.2 4.6 7.6 27.3 6.3 10.4 16.7 68.7 6.8 25.4 2.8 16.8 5.7 6.3 12.3 7.6 39.1 5.2 11.4 1.3 15.8 0.0 0.0 2.7 0.0 0.6 1.1 1.0 10.6 5.8 0.0 1.0 0.0 1.4 4.9 14.5 1.0 0.8 0.0 11.4 0.1 0.3 10.1 2.7 0.0 1.1 0.2 6.0 0.1 2.4 0.3 26.0 3.8 0.7 4.0 0.0 115.9 0.7 0.2 0.4 99.2 7.1 0.2 0.0 21.8 14.5 44.8 21.1 56.7 0.0 172.6 0.0 3.6 101.2 0.0 0.5 0.1 1.4 0.4 0.0 2.0 0.3 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.6 0.9 0.7 0.0 0.1 1.0 1.1 0.0 0.0 0.0 2.6 0.0 0.4 21.7 26.9 41.5 33.3 22.0 24.3 27.4 22.7 30.3 10.4 25.4 39.1 21.4 0.0 5.5 4.9 4.6 1.5 2.6 3.1 0.6 14.3 20.4 12.3 3.8 4.3 8.6 0.0 0.0 26.3 1.1 16.0 3.9 19.0 0.4 10.2 3.0 19.1 35.3 0.0 16.1 26.9 1.7 1.0 71.4 20.3 0.0 1.1 20.7 0.4 2.5 20.2 15.5 89.5 16.2 0.8 0.4 1.0 0.9 0.7 7.2 6.5 0.6 2.8 0.0 8.0 50.9 22.9 87.8 0.0 22.7 17.8 107.4 0.5 6.5 4.4 0.0 1.5 1.8 0.4 2.1 0.5 0.4 35.0 1.8 0.1 15.6 13.9 HILPDA "C7orf68, FLJ21076, HIG-2, HIG2" ENSG00000135245 "Hypoxia inducible lipid droplet associated" Q9Y5L2 7 128455849-128458418 "Predicted membrane proteins" "Stress response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 164.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 170.8;Club cells: 140.2;Extravillous trophoblasts: 246.8;Ionocytes: 311.3;Syncytiotrophoblasts: 241.1" "Cancer enhanced" "Detected in all" "renal cancer: 72.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 67.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 116.1" "Low region specificity" "Detected in all" HPA010515 Approved Supported "Nucleoplasm,Lipid droplets" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Lipid droplets" Nucleoplasm "HPA010515: AB_1850710" "unprognostic (1.10e-2)" "unprognostic (1.68e-2)" "unprognostic (1.88e-2)" "unprognostic (2.27e-1)" "unprognostic (2.10e-2)" "unprognostic (2.70e-2)" "prognostic unfavorable (4.30e-11)" "unprognostic (9.20e-3)" "unprognostic (4.07e-3)" "unprognostic (2.49e-1)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "prognostic unfavorable (2.05e-7)" "unprognostic (2.23e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" 101.1 8.1 14.9 6.9 19.8 20.2 59.9 22.6 18.7 59.1 12.8 23.5 5.7 11.1 7.5 164.3 10.9 8.8 56.9 15.9 18.9 40.2 38.8 50.3 5.9 26.5 26.8 45.5 12.4 4.4 13.8 36.2 22.3 14.8 7.3 43.3 23.6 7.0 6.0 50.6 8.0 8.2 21.1 8.8 19.0 17.1 25.4 7.6 14.5 5.5 7.4 38.3 86.1 21.0 30.0 61.3 34.1 37.6 45.5 16.9 62.5 11.0 13.4 22.6 24.6 15.0 26.5 21.2 8.3 16.5 22.9 19.6 19.4 23.3 28.6 11.3 17.3 12.2 13.9 14.1 10.2 19.8 16.7 28.0 19.7 17.8 11.8 23.0 18.8 32.5 18.2 8.1 22.6 37.2 60.9 36.8 41.2 22.3 26.7 45.5 15.5 31.0 12.5 44.8 32.3 29.1 17.0 116.1 21.8 30.5 95.6 18.4 13.3 28.6 13.9 21.4 13.5 8.2 6.3 25.7 51.7 30.1 25.0 23.4 6.6 67.8 4.5 7.5 6.3 17.6 5.5 5.3 6.8 17.6 5.4 5.3 2.6 13.9 5.9 11.9 4.0 4.1 14.9 19.8 22.6 18.7 15.9 18.9 26.5 26.8 22.3 21.1 25.4 21.0 22.6 9.6 5.5 0.0 9.3 64.2 14.8 170.8 9.1 6.5 11.1 13.8 4.1 2.8 140.2 1.8 18.8 114.3 5.0 10.0 0.0 27.5 0.5 23.6 49.1 30.9 13.1 12.6 0.0 8.9 246.8 44.0 6.6 38.6 18.9 85.6 11.0 3.3 27.6 26.9 0.0 11.2 311.3 4.4 89.2 2.4 30.4 14.8 37.4 0.0 13.7 15.8 3.1 0.0 0.0 35.5 4.5 24.5 6.4 27.1 2.4 9.6 98.9 23.2 6.6 7.0 43.4 7.8 17.3 10.0 52.0 241.1 9.7 16.2 14.9 122.4 IBA57 "C1orf69, FLJ12734" ENSG00000181873 "Iron-sulfur cluster assembly factor IBA57" Q5T440 1 228165804-228182257 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Heme biosynthesis" Transferase "Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 49.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030555, HPA030556, HPA030557" Approved Supported Mitochondria NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "HPA030555: AB_2673522, HPA030556: AB_2673523, HPA030557: AB_10670433" "unprognostic (3.00e-2)" "unprognostic (1.71e-1)" "unprognostic (1.36e-1)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "unprognostic (8.16e-3)" "unprognostic (1.03e-1)" "unprognostic (6.11e-2)" "unprognostic (7.01e-2)" "unprognostic (8.00e-3)" "unprognostic (2.87e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.71e-9)" "unprognostic (4.94e-2)" "unprognostic (5.02e-1)" "unprognostic (5.04e-3)" "unprognostic (7.14e-2)" 2.0 2.7 2.6 1.4 2.3 4.1 1.4 2.9 2.5 1.3 2.2 1.8 1.6 1.8 0.5 1.6 1.3 1.0 3.3 2.1 2.0 2.0 2.8 1.9 1.6 2.7 2.2 1.9 2.9 2.1 0.9 1.4 2.3 1.2 1.4 0.5 1.7 1.0 6.1 3.0 1.7 1.7 2.1 1.7 2.0 1.1 2.8 1.3 1.3 4.0 1.7 1.3 1.2 3.5 2.5 2.5 2.7 1.2 1.3 1.4 3.3 1.5 0.7 1.1 0.6 5.3 2.1 5.3 3.1 1.6 0.6 4.4 2.0 3.2 1.0 1.1 4.5 3.1 3.5 2.6 1.1 3.7 3.5 2.2 1.8 1.3 1.5 1.0 1.6 3.2 5.4 2.4 1.1 2.0 3.6 2.2 2.0 3.4 2.8 4.4 3.1 2.4 1.6 5.1 4.1 2.8 2.4 7.5 1.9 0.5 6.0 4.9 3.8 3.0 2.8 2.1 3.7 1.8 0.9 2.6 1.4 1.6 2.3 1.6 0.4 0.2 0.6 0.4 1.0 0.4 0.5 0.5 0.3 0.7 0.7 0.7 0.5 0.8 0.4 1.0 0.5 0.2 2.6 2.3 2.9 2.5 2.1 2.0 2.7 2.2 2.3 2.1 2.8 3.5 5.7 9.6 11.0 4.2 10.2 8.2 8.8 3.9 2.8 5.8 5.6 5.6 15.3 8.6 9.2 0.0 12.5 10.7 5.0 14.5 7.9 5.4 22.2 5.2 6.0 8.8 7.2 49.3 3.8 6.9 8.6 5.2 5.1 10.3 15.2 6.7 5.3 7.9 5.5 3.3 4.1 8.0 4.1 4.4 6.4 30.7 3.7 6.0 7.2 6.5 4.2 4.4 4.1 3.0 5.8 8.8 6.3 7.2 5.8 6.3 9.4 6.7 3.2 19.5 6.6 9.7 4.7 14.9 11.2 4.4 6.0 16.3 7.2 8.3 11.9 8.3 IFRD2 "IFNRP, SKMc15, SM15" ENSG00000214706 "Interferon related developmental regulator 2" Q12894 3 50287732-50292918 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 139.9;Prostatic glandular cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068560 Approved Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA068560: AB_2686005" "prognostic favorable (7.22e-4)" "unprognostic (5.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.61e-3)" "unprognostic (3.88e-1)" "unprognostic (2.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.91e-2)" "unprognostic (7.78e-3)" "prognostic favorable (2.50e-4)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" 39.4 44.9 16.7 13.9 17.8 15.6 33.9 17.4 20.9 24.4 19.2 33.2 20.1 26.8 11.8 44.3 28.2 10.9 69.4 16.2 16.6 39.3 97.0 30.7 14.1 18.0 17.7 23.1 87.3 17.8 22.1 9.3 17.2 45.1 15.0 3.6 33.7 16.7 109.6 25.4 28.1 14.9 17.9 28.3 67.9 17.4 18.0 8.4 31.9 44.6 12.5 36.1 23.6 18.0 70.1 70.5 19.1 60.3 19.2 22.0 44.0 52.4 28.2 62.8 44.3 58.3 69.5 47.3 37.7 36.3 53.9 40.0 40.2 83.8 32.3 45.4 80.7 68.4 93.5 69.5 37.9 70.1 41.4 20.4 70.6 65.7 81.9 20.7 54.0 41.8 44.2 37.9 37.6 65.1 46.5 82.0 48.1 86.1 135.4 29.8 27.7 108.1 38.0 41.3 33.7 32.5 33.2 90.4 34.4 18.3 43.1 66.4 39.5 52.2 65.6 91.3 107.9 26.5 48.9 41.8 41.4 91.1 77.9 11.7 24.1 3.6 33.1 34.4 47.5 32.4 35.0 32.3 35.2 34.0 36.7 33.3 2.3 39.0 19.7 35.0 30.9 30.5 16.7 17.8 17.4 20.9 16.2 16.6 18.0 17.7 17.2 17.9 18.0 18.0 36.9 19.2 24.6 5.9 26.8 67.3 71.7 51.7 31.9 17.3 48.5 37.1 1.7 32.9 36.4 20.2 20.9 35.3 23.8 22.1 29.4 68.8 67.2 11.3 27.8 30.3 15.6 93.6 7.1 89.6 49.5 24.8 62.7 13.1 7.6 28.6 13.9 50.7 31.2 18.5 6.7 29.6 34.6 13.7 28.4 139.9 13.7 15.2 35.6 2.8 16.5 13.3 25.7 4.5 7.3 68.2 26.8 14.3 31.9 153.3 31.3 58.6 10.4 12.0 0.0 30.8 34.9 21.9 19.1 43.1 68.6 30.4 19.2 40.3 56.3 76.8 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988835-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6" "Region enhanced" "Detected in single" "cerebral cortex: 2.8" "Not detected" "Not detected" HPA001886 Uncertain "Secreted to blood" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.3 0.4 0.9 0.6 0.9 1.5 0.7 0.9 2.0 0.2 0.3 0.8 0.5 0.3 0.1 4.1 2.1 0.2 0.8 0.8 0.8 0.4 0.1 2.1 0.8 0.9 1.1 0.5 0.5 0.0 0.5 0.1 1.0 0.3 0.4 0.1 0.3 0.1 0.2 0.1 0.8 0.2 0.7 1.2 0.5 0.3 0.9 0.4 0.2 0.7 0.5 0.7 0.6 1.1 3.1 0.3 0.4 2.6 0.0 0.2 0.2 3.3 2.1 3.9 8.1 1.2 0.1 0.0 0.2 0.5 4.5 0.3 0.8 0.5 3.6 13.2 4.1 0.1 0.2 0.9 2.5 0.7 6.1 0.6 1.0 6.9 2.7 2.7 1.2 0.3 0.0 2.1 2.4 0.1 0.1 0.0 0.4 0.1 1.8 2.4 0.0 0.4 0.4 0.2 0.1 1.2 0.0 17.6 0.5 0.6 0.9 1.4 0.9 0.8 0.8 2.3 6.3 1.4 0.0 0.0 1.5 5.9 0.8 0.0 0.0 0.5 0.3 0.1 0.5 0.5 0.1 0.6 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.9 0.9 2.0 0.8 0.8 0.9 1.1 1.0 0.7 0.9 1.1 1.0 0.0 0.6 1.0 3.4 0.1 2.1 1.0 1.2 0.0 1.6 2.2 0.4 0.0 1.1 0.0 0.0 0.1 0.7 0.3 0.0 1.5 0.0 3.9 0.2 1.4 2.4 0.8 0.1 0.0 0.0 0.4 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.9 4.1 0.3 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 4.0 1.3 0.4 0.2 0.0 2.1 2.9 0.1 0.0 6.1 0.0 6.6 1.5 0.3 0.4 2.9 2.6 0.1 0.0 0.7 0.1 0.5 1.3 IMPDH1 "LCA11, RP10, sWSS2608" ENSG00000106348 "Inosine monophosphate dehydrogenase 1" P20839 7 128392277-128410252 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 106.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 165.8;Cone photoreceptor cells: 141.8;Horizontal cells: 121.1;Rod photoreceptor cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 89.1;eosinophil: 89.1;intermediate monocyte: 104.5;myeloid DC: 59.9;neutrophil: 197.5;non-classical monocyte: 135.9" "Group enriched" "Detected in all" 5 "dendritic cells: 59.9;granulocytes: 197.5;monocytes: 135.9" "Cell line enhanced" "Detected in all" "SK-BR-3: 374.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001400 Approved Supported "Cytosol,Rods & Rings" NA NA 17000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 79: Retina - Phototransduction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Cytosol "Rods & Rings" "HPA001400: AB_1079139" "unprognostic (2.84e-1)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.23e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (7.31e-5)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.12e-7)" "unprognostic (1.24e-1)" "unprognostic (7.45e-3)" "unprognostic (1.03e-2)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "prognostic unfavorable (1.78e-12)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (3.72e-5)" 54.8 15.9 19.2 33.8 18.5 44.1 38.7 15.7 23.7 18.5 12.7 24.8 8.3 15.1 2.5 30.0 17.7 11.9 23.7 18.1 17.8 15.8 5.7 31.7 25.5 26.3 18.7 20.5 30.1 5.3 26.7 11.4 25.6 27.8 9.8 106.2 29.5 13.1 4.7 23.2 19.1 19.6 17.1 55.9 48.9 16.5 20.0 8.4 11.5 6.2 15.9 29.4 20.4 17.1 111.5 93.2 13.8 102.8 56.5 40.7 38.8 74.1 46.4 61.9 40.1 68.3 35.0 70.8 24.7 111.1 64.4 83.3 78.6 104.1 30.9 25.8 87.1 46.4 66.8 49.1 51.4 62.1 21.1 49.4 49.5 63.2 62.5 29.2 74.5 42.0 46.9 51.8 21.0 76.1 44.1 164.9 77.4 87.7 108.0 51.9 25.2 150.8 27.5 35.1 58.3 55.6 48.0 374.6 68.3 8.6 42.7 119.7 68.5 103.6 37.7 55.0 53.6 38.5 38.3 90.6 53.0 134.0 64.6 11.2 89.1 89.1 22.7 104.5 24.4 15.5 17.9 20.2 59.9 8.9 10.3 12.7 197.5 11.7 135.9 6.0 21.5 58.3 19.2 18.5 15.7 23.7 18.1 17.8 26.3 18.7 25.6 17.1 20.0 17.1 66.8 0.0 11.2 4.6 13.5 8.8 9.3 13.6 9.6 165.8 12.8 9.9 5.1 2.8 8.6 5.5 141.8 3.3 11.1 6.3 5.9 8.1 0.5 4.0 10.9 20.3 9.6 9.7 8.2 17.8 21.3 15.1 44.9 6.5 21.0 46.0 13.6 1.0 46.1 121.1 11.2 10.1 28.5 58.5 21.7 2.0 4.7 38.2 16.0 3.7 65.3 27.3 24.7 2.0 1.5 10.9 3.1 6.8 29.6 21.5 0.8 1.1 7.4 205.5 0.0 9.0 17.3 2.9 16.9 15.8 7.4 2.3 20.4 18.6 11.9 10.3 INHA ENSG00000123999 "Inhibin subunit alpha" P05111 2 219569162-219575711 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 75.6;ovary: 104.4;testis: 95.3" "Cell type enhanced" "Detected in some" "Granulosa cells: 254.3;Syncytiotrophoblasts: 331.0;Theca cells: 75.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.5;HEL: 4.5;SK-BR-3: 9.9;SuSa: 4.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 1.2 75.6 3.4 0.2 3.7 0.1 1.4 2.7 4.8 2.0 2.2 0.9 0.2 2.0 2.2 0.8 3.0 0.4 16.3 3.5 3.2 3.1 0.7 0.8 0.1 3.4 2.9 104.4 12.3 0.7 6.6 11.3 3.5 3.1 0.0 1.9 1.5 1.1 0.8 2.1 0.4 0.4 2.5 0.4 0.7 95.3 3.4 0.0 3.3 0.0 0.0 1.0 1.8 3.0 0.4 0.2 0.0 1.9 0.6 0.1 3.5 0.3 0.2 0.5 0.2 0.3 3.2 0.0 0.2 0.7 0.5 2.0 0.2 0.5 0.0 0.0 0.6 4.5 1.8 2.4 0.3 0.0 0.0 0.6 0.8 0.0 0.5 1.4 0.0 0.0 2.8 0.0 0.0 2.3 0.0 0.1 1.2 0.1 0.9 0.1 0.2 0.0 0.5 0.2 0.3 0.8 1.1 9.9 0.3 4.9 0.5 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.7 2.7 4.8 3.5 3.2 3.4 2.9 3.5 2.5 3.4 3.0 0.1 0.0 0.0 5.9 0.0 0.0 0.1 0.8 0.0 2.7 0.3 0.3 2.2 0.0 0.1 7.3 2.1 11.8 0.0 0.0 0.0 2.8 0.8 0.5 0.5 0.2 0.0 0.0 5.9 8.9 35.5 1.2 0.0 0.5 0.0 254.3 0.7 0.1 2.6 6.7 6.9 0.0 0.0 0.3 0.0 5.0 4.1 0.2 0.0 0.0 0.0 3.7 0.0 1.0 0.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 3.4 0.6 0.0 0.0 331.0 0.0 75.6 0.0 0.0 INHBB ENSG00000163083 "Inhibin subunit beta B" P09529 2 120346136-120351803 "Cancer-related genes, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 52.5;breast: 43.3" "Group enriched" "Detected in many" 7 "Adipocytes: 200.5;Granulosa cells: 653.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 44.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 47.6;ASC diff: 63.1;BJ hTERT+ SV40 Large T+ RasG12V: 38.5;MCF7: 58.4;PC-3: 91.7;SK-BR-3: 163.4;T-47d: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 130000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.80e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (1.26e-2)" "unprognostic (4.26e-2)" "unprognostic (3.61e-3)" "unprognostic (2.13e-2)" "unprognostic (5.52e-2)" "unprognostic (6.99e-2)" "unprognostic (3.59e-1)" "unprognostic (1.59e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.57e-3)" "unprognostic (4.14e-1)" "prognostic favorable (1.02e-4)" "unprognostic (1.76e-2)" 52.5 3.7 5.6 0.9 5.5 0.2 43.3 8.0 4.0 6.9 3.4 3.4 1.3 7.4 2.6 2.5 6.2 2.5 6.4 3.9 4.8 4.3 20.2 4.4 1.1 9.7 7.4 2.5 4.2 6.3 8.0 1.2 6.0 8.2 0.3 1.0 16.4 0.8 10.4 17.1 2.4 2.2 6.2 0.5 3.6 17.1 7.9 0.4 20.9 2.4 0.7 8.2 6.4 4.2 24.5 47.6 0.2 0.0 63.1 4.9 0.0 3.3 3.8 20.7 38.5 1.0 0.0 0.0 8.3 1.2 0.1 0.1 3.7 0.0 28.9 0.1 0.8 0.0 0.0 1.2 1.0 0.0 0.1 2.6 3.5 0.7 0.0 0.3 0.4 0.0 0.0 0.0 0.1 58.4 0.0 0.1 0.0 4.7 91.7 0.0 0.0 1.2 5.6 0.0 5.4 0.0 0.2 163.4 0.0 0.0 39.2 0.5 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 5.5 8.0 4.0 3.9 4.8 9.7 7.4 6.0 6.2 7.9 4.2 200.5 3.2 2.2 8.1 0.2 4.0 2.2 5.5 0.0 0.1 53.7 24.4 0.7 8.6 9.2 1.8 25.0 0.1 0.7 0.1 0.0 0.4 0.6 9.2 1.6 24.3 0.0 2.7 0.1 0.0 0.2 9.8 0.0 12.5 0.0 653.3 24.7 19.4 0.1 0.0 1.3 0.0 8.2 1.3 6.6 3.6 11.8 1.3 1.8 1.0 0.0 0.2 0.0 2.5 0.0 0.2 0.0 6.8 0.3 8.9 0.0 0.0 30.0 0.6 0.0 37.3 3.1 0.8 6.0 0.6 3.0 0.1 0.6 0.2 0.0 3.2 INPP5J "INPP5, PIB5PA, PIPP" ENSG00000185133 "Inositol polyphosphate-5-phosphatase J" Q15735 22 31122731-31134697 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 123.2;thyroid gland: 204.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 35.0;Distal enterocytes: 24.0;Inhibitory neurons: 19.5;Muller glia cells: 25.2;Proximal enterocytes: 62.3" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 63.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HL-60: 19.6;SK-BR-3: 41.1;T-47d: 25.7;U-698: 18.1" "Region enhanced" "Detected in all" "olfactory bulb: 131.0" "Low region specificity" "Detected in all" HPA034539 Approved "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Cytosol "Nucleoli fibrillar center" "HPA034539: AB_10670974" "unprognostic (1.76e-1)" "unprognostic (2.09e-1)" "unprognostic (1.73e-1)" "unprognostic (7.05e-2)" "unprognostic (1.68e-1)" "unprognostic (1.19e-2)" "unprognostic (2.21e-3)" "prognostic favorable (1.47e-5)" "unprognostic (6.81e-2)" "unprognostic (1.86e-2)" "unprognostic (4.29e-4)" "unprognostic (1.47e-1)" "prognostic favorable (1.12e-7)" "unprognostic (2.79e-3)" "unprognostic (3.65e-2)" "unprognostic (2.14e-1)" "unprognostic (1.39e-2)" 0.8 2.1 3.2 0.8 4.8 0.1 8.9 17.3 13.2 4.0 2.4 10.4 16.3 3.0 0.6 2.4 2.3 1.2 27.8 11.5 15.2 32.1 0.4 2.3 0.5 6.0 4.0 1.2 15.7 123.2 10.1 0.1 5.2 9.2 3.7 5.3 33.1 12.1 2.8 4.4 26.2 1.5 1.4 0.3 13.6 4.4 8.3 0.2 204.2 2.6 0.4 2.7 2.4 5.7 2.1 2.0 1.2 2.3 0.3 0.2 1.1 0.8 0.8 4.1 4.0 1.2 1.3 0.1 1.0 0.4 0.4 2.4 2.5 1.2 1.7 0.0 6.5 0.0 9.7 0.4 0.8 19.6 0.2 0.2 1.3 3.4 0.4 2.7 0.3 0.1 1.8 2.8 0.1 6.4 0.1 0.1 2.3 2.8 0.4 0.0 0.4 4.5 1.7 2.5 9.9 7.5 1.6 41.1 0.5 1.1 25.7 1.6 0.0 0.2 7.3 0.8 0.5 0.1 3.5 18.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 4.8 17.3 13.2 11.5 15.2 6.0 4.0 5.2 1.4 8.3 5.7 0.7 0.0 4.1 3.3 0.0 0.9 2.3 0.3 1.2 9.5 15.8 7.5 6.1 0.0 1.1 35.0 0.0 0.0 0.2 24.0 11.7 1.4 0.4 1.9 0.4 0.5 0.0 0.0 5.5 2.2 0.2 0.6 4.6 2.7 0.0 0.8 0.0 0.0 0.1 5.0 19.5 6.4 0.0 0.0 1.9 0.6 0.0 0.3 0.0 1.0 0.6 25.2 0.0 2.0 1.0 0.8 12.3 0.0 0.1 2.5 62.3 0.5 0.5 3.1 0.0 0.5 1.3 2.4 1.2 1.1 1.3 0.1 0.4 0.4 8.8 1.6 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728050-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 14.3 18.7 1.7 10.8 2.0 2.9 14.7 0.5 3.2 16.8 0.9 16.1 4.2 18.3 13.4 12.1 20.7 9.7 13.0 2.2 2.1 15.9 11.8 14.9 8.6 2.7 0.9 23.3 13.0 8.2 17.8 9.6 1.3 11.9 6.5 3.6 12.1 11.3 14.9 12.2 12.9 9.4 0.0 13.2 16.7 12.8 4.4 6.7 15.3 8.3 7.7 13.6 14.4 1.5 26.2 15.8 14.0 19.2 21.3 17.4 19.1 18.2 8.7 21.7 17.4 8.5 24.5 21.3 37.8 24.2 11.8 27.0 28.0 18.7 10.2 24.6 23.0 15.4 37.7 3.8 13.8 18.8 20.5 12.3 7.5 9.5 11.7 17.5 14.4 13.8 19.2 14.6 9.0 8.5 18.6 10.0 23.6 25.5 26.8 24.5 6.4 13.1 8.1 24.7 11.8 15.5 18.9 39.7 11.4 18.4 13.3 25.3 6.1 22.7 6.7 18.1 18.1 17.1 13.7 19.5 24.9 8.9 11.3 0.0 0.8 0.9 0.9 0.5 0.8 0.3 0.3 0.5 1.2 0.3 0.2 0.5 0.8 0.7 2.9 0.3 0.5 0.2 1.7 2.0 0.5 3.2 2.2 2.1 2.7 0.9 1.3 0.0 4.4 1.5 29.1 22.4 22.8 59.7 11.9 10.5 9.5 10.4 15.9 23.7 20.2 22.4 4.6 10.0 11.7 31.3 20.9 13.9 11.6 9.2 0.0 11.9 13.1 39.3 29.4 21.5 12.1 10.9 30.8 8.4 13.4 16.3 23.9 38.8 5.7 32.9 26.7 13.9 12.2 21.9 26.1 16.5 8.2 9.1 22.0 7.6 9.6 14.6 7.2 30.0 17.6 15.4 14.4 27.2 29.7 9.9 14.9 12.0 11.6 10.6 9.8 13.3 25.9 22.4 26.3 11.2 16.5 10.2 12.2 13.9 10.2 10.3 10.0 20.2 14.0 12.2 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "thyroid gland: 472.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2" "Group enriched" "Detected in some" 13 "hippocampal formation: 7.4;thalamus: 2.4" "Low region specificity" "Detected in all" HPA059627 Enhanced Supported "Plasma membrane" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 1: Thyroid gland - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" "HPA059627: AB_2684086" "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favorable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.0 0.4 0.6 0.3 0.3 0.5 0.6 0.6 0.1 0.2 6.4 18.1 0.2 0.6 0.0 0.0 8.9 0.5 0.3 0.1 26.6 33.6 0.7 0.5 0.5 0.4 0.0 0.4 0.0 0.0 0.0 0.6 0.2 6.5 0.2 0.1 0.0 0.0 0.2 19.6 0.2 0.0 0.1 2.0 0.2 0.5 0.0 472.7 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 3.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 1.6 0.5 0.3 0.2 0.4 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.2 1.9 0.7 0.2 0.3 0.2 1.3 0.4 0.3 0.6 0.6 0.3 0.1 0.5 0.4 0.6 0.0 0.5 0.5 0.7 3.2 7.8 0.0 0.0 0.1 0.6 0.2 0.0 0.1 0.3 0.4 0.8 14.3 8.9 0.0 0.0 0.1 0.0 23.7 1.9 0.3 0.0 0.9 0.3 0.4 3.6 2.7 0.1 0.2 0.0 0.7 0.0 2.2 1.3 0.1 1.1 25.1 0.1 0.0 0.1 21.8 0.0 0.0 1.2 0.1 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 22.5 0.0 0.0 1.0 89.1 35.4 3.6 1.3 0.0 1.7 0.3 0.1 0.1 0.0 0.4 0.3 0.9 0.4 11.5 0.7 JPH1 JP-1 ENSG00000104369 "Junctophilin 1" Q9HDC5 8 74234700-74321540 "Human disease related genes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 13 "skeletal muscle: 237.4;tongue: 106.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA008996, HPA009413, CAB013461" Enhanced Enhanced Nucleoplasm NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163" "unprognostic (2.91e-3)" "unprognostic (3.01e-1)" "unprognostic (8.85e-2)" "unprognostic (8.73e-6)" "unprognostic (2.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.63e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.97e-2)" "unprognostic (1.30e-1)" "unprognostic (2.38e-1)" "unprognostic (5.99e-2)" "unprognostic (9.80e-2)" "unprognostic (6.87e-2)" "unprognostic (3.03e-1)" "unprognostic (4.88e-2)" "unprognostic (1.08e-2)" 0.3 0.2 2.9 0.5 7.5 0.0 0.7 7.6 5.3 0.7 13.2 3.3 0.7 3.2 0.8 2.8 0.3 0.3 8.4 5.9 1.5 0.8 0.4 3.7 0.1 3.0 1.5 0.1 6.5 0.8 0.5 1.4 2.4 2.8 5.0 0.4 2.8 0.5 237.4 0.6 1.0 1.9 1.9 0.1 0.9 1.0 1.9 3.2 1.4 106.0 1.1 2.3 1.4 3.6 1.1 0.0 0.4 0.0 0.0 0.0 0.1 0.1 1.1 1.1 0.5 0.2 4.4 0.0 1.5 0.0 1.0 6.4 5.6 4.3 1.4 0.0 8.3 0.0 5.2 0.0 0.7 2.9 0.3 0.8 3.7 0.0 4.0 0.0 0.0 10.9 0.8 0.0 0.4 4.1 15.1 0.0 9.7 17.7 2.9 7.6 5.4 0.0 0.2 12.7 7.3 1.0 0.1 34.4 1.8 1.6 24.2 0.2 0.0 1.6 2.3 0.6 1.4 0.0 0.0 0.0 2.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.5 7.6 5.3 5.9 1.5 3.0 1.5 2.4 1.9 1.9 3.6 1.1 38.5 12.9 3.9 0.2 2.8 32.8 3.0 6.2 0.4 2.4 1.5 35.7 0.0 10.8 1.8 6.2 0.0 0.1 7.1 0.0 0.3 2.4 2.9 8.9 1.7 12.6 0.0 82.2 1.4 0.0 2.6 7.7 3.7 0.0 0.0 0.0 0.0 0.1 0.0 50.3 9.9 2.0 0.0 0.4 0.5 0.9 0.4 1.8 3.7 0.0 0.4 0.0 14.1 4.6 3.4 6.2 0.0 0.0 32.8 0.0 1.0 6.2 0.1 0.0 25.0 1.4 0.1 4.3 7.4 2.0 0.0 0.2 0.1 6.7 25.6 KIAA0100 "BCOX, BCOX1, CT101, DKFZp686M0843, FMP27, MGC111488" ENSG00000007202 KIAA0100 Q14667 17 28614446-28645454 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042781 Uncertain Approved "Nuclear speckles,Cytosol" "Secreted to blood" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles, Cytosol" "HPA042781: AB_10797020" "unprognostic (1.91e-1)" "unprognostic (1.03e-2)" "unprognostic (3.47e-2)" "unprognostic (5.26e-3)" "unprognostic (2.43e-1)" "unprognostic (6.89e-2)" "prognostic unfavorable (3.47e-5)" "unprognostic (4.99e-2)" "unprognostic (3.04e-1)" "unprognostic (3.03e-3)" "unprognostic (2.40e-2)" "unprognostic (2.53e-1)" "unprognostic (4.24e-3)" "unprognostic (7.58e-2)" "unprognostic (5.84e-2)" "unprognostic (1.22e-1)" "unprognostic (6.67e-2)" 36.1 30.7 22.4 28.5 20.7 31.5 30.6 18.2 23.5 22.7 31.7 30.8 19.7 23.1 25.7 31.3 29.2 20.5 24.2 24.4 21.3 43.0 18.6 30.7 28.4 29.9 24.4 23.9 24.4 51.8 25.2 29.6 29.3 27.1 34.8 27.5 28.9 27.1 51.9 31.8 26.7 35.3 20.2 28.8 23.3 24.9 26.5 32.3 35.4 42.5 34.9 30.3 16.0 20.6 66.5 123.8 61.4 58.8 109.3 64.8 44.8 60.9 80.1 72.3 67.6 85.9 29.4 92.0 71.2 111.2 75.3 86.2 91.4 89.6 87.1 102.8 88.7 73.2 95.9 47.2 47.0 129.1 121.3 66.5 68.2 98.0 74.1 56.1 104.9 64.1 70.6 29.0 66.8 94.4 94.5 61.1 26.9 119.0 46.6 71.7 69.0 60.0 43.4 116.9 60.2 46.5 76.8 205.5 50.7 76.0 123.2 88.6 98.1 55.0 60.4 74.5 116.2 27.2 33.8 58.0 62.8 81.7 65.4 0.3 1.1 1.5 1.2 1.0 1.2 1.1 0.5 1.0 1.3 0.6 0.6 0.7 0.7 0.8 1.2 2.9 0.7 0.7 22.4 20.7 18.2 23.5 24.4 21.3 29.9 24.4 29.3 20.2 26.5 20.6 21.5 16.0 17.8 15.0 16.5 10.3 8.9 8.7 15.4 31.7 19.3 14.7 30.2 14.3 13.0 12.9 29.2 15.3 34.4 30.5 5.9 9.9 19.4 20.4 16.1 16.4 12.1 14.1 19.1 11.0 9.4 14.1 21.4 16.4 8.2 20.4 18.5 30.5 10.6 28.6 18.3 16.4 8.2 31.5 18.6 23.2 9.3 19.9 10.6 14.0 25.3 14.3 21.6 11.6 12.7 9.8 12.1 6.4 17.1 15.8 17.9 15.1 15.1 22.5 0.0 20.3 20.1 30.5 28.1 22.9 11.1 45.6 17.0 24.2 22.6 11.7 KIF16B "C20orf23, dJ971B4.1, FLJ20135, SNX23" ENSG00000089177 "Kinesin family member 16B" Q96L93 20 16272104-16573448 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 94.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 38.1" "Low region specificity" "Detected in all" HPA051198 Approved Uncertain Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA051198: AB_2681385" "unprognostic (3.33e-1)" "unprognostic (1.74e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-1)" "unprognostic (3.92e-2)" "unprognostic (2.44e-1)" "unprognostic (6.32e-3)" "unprognostic (7.85e-2)" "unprognostic (2.38e-1)" "unprognostic (5.34e-2)" "unprognostic (3.95e-2)" "unprognostic (5.52e-1)" "prognostic favorable (7.61e-6)" "unprognostic (4.04e-2)" "unprognostic (2.78e-1)" "unprognostic (4.74e-2)" "unprognostic (1.61e-2)" 10.1 27.4 5.4 6.4 6.1 5.9 15.8 4.9 8.6 6.3 3.6 24.5 16.7 6.1 12.5 9.4 5.1 8.3 11.5 4.3 6.4 18.1 11.7 8.8 5.3 6.4 5.4 12.8 6.5 31.5 5.2 4.8 6.0 7.3 19.1 9.7 7.3 10.8 17.1 11.9 20.8 7.4 3.9 8.2 12.8 5.1 6.3 5.9 11.1 13.1 4.7 7.9 6.2 7.9 7.7 19.3 9.1 8.3 6.8 5.0 8.8 7.4 4.5 4.6 5.0 9.5 18.5 10.7 4.7 8.0 12.7 6.9 10.8 11.0 6.8 5.7 6.2 4.8 4.7 17.6 4.2 0.0 10.5 8.0 21.4 5.5 10.6 7.0 1.8 8.1 8.7 0.0 7.5 12.2 0.1 2.0 2.6 24.9 8.7 8.1 7.2 18.9 7.2 12.2 4.0 7.9 8.0 38.1 23.9 10.7 11.3 6.3 3.7 7.0 5.9 11.4 3.4 0.0 4.9 3.2 6.6 3.2 14.3 0.0 2.1 0.5 2.0 1.7 2.7 2.7 2.2 1.5 3.4 2.6 2.3 1.7 0.2 4.5 1.8 1.6 1.6 1.7 5.4 6.1 4.9 8.6 4.3 6.4 6.4 5.4 6.0 3.9 6.3 7.9 13.1 19.2 31.7 54.9 9.8 19.1 16.1 11.0 37.5 8.7 30.5 16.0 29.2 4.3 14.8 5.5 18.8 15.7 7.7 60.6 3.9 6.5 12.6 13.2 14.2 13.6 23.4 5.0 67.6 12.3 5.5 15.1 18.3 20.8 9.5 13.6 12.5 15.9 19.1 37.0 84.2 38.9 4.1 12.2 35.7 9.8 11.5 19.8 10.6 59.0 4.9 8.6 10.3 60.3 94.1 13.3 40.9 14.7 6.9 11.1 36.8 21.1 11.6 11.5 6.6 22.7 13.4 12.9 15.0 26.3 22.4 37.5 9.4 12.9 24.8 19.3 KL ENSG00000133116 Klotho Q9UEF7 13 33016423-33066143 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2" "Cell type enriched" "Detected in some" 7 "Proximal tubular cells: 123.3" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HMC-1: 2.4;SK-BR-3: 4.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2" "Secreted to blood" NA NA 510000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favorable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favorable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 3.3 1.4 0.9 0.8 3.1 0.1 2.5 0.8 1.5 1.8 47.1 2.1 2.7 1.2 8.8 1.1 0.8 1.3 1.1 4.2 1.1 128.7 0.4 3.5 1.0 0.5 0.5 0.1 1.2 135.2 0.3 30.4 0.5 8.0 0.9 0.0 0.8 2.5 0.7 0.6 2.6 1.2 0.6 2.4 2.0 0.5 0.8 0.5 1.3 1.5 0.5 1.6 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.1 0.8 1.5 4.2 1.1 0.5 0.5 0.5 0.6 0.8 0.5 15.8 0.0 0.5 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.6 0.3 1.0 0.0 0.7 12.9 0.0 0.2 0.0 0.4 5.9 0.0 1.8 0.1 2.5 10.2 16.3 0.4 1.2 0.0 0.1 1.6 0.0 0.1 0.0 0.1 1.1 0.2 2.8 0.0 0.5 1.1 0.0 0.9 1.0 0.8 0.3 1.9 0.0 6.5 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 3.6 1.8 123.3 0.7 0.0 0.0 1.1 2.3 1.4 0.5 0.0 0.1 0.1 1.1 0.1 1.9 0.1 KLHDC2 "HCLP-1, LCP" ENSG00000165516 "Kelch domain containing 2" Q9Y2U9 14 49768130-49786385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000628 Approved Supported "Nucleoplasm,Nuclear membrane,Nuclear bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nuclear membrane" "Nuclear bodies" "HPA000628: AB_2666051" "unprognostic (2.65e-1)" "unprognostic (8.29e-2)" "unprognostic (1.30e-2)" "unprognostic (9.01e-2)" "unprognostic (2.57e-2)" "unprognostic (5.52e-3)" "unprognostic (4.54e-2)" "unprognostic (9.72e-3)" "unprognostic (7.43e-2)" "unprognostic (1.24e-1)" "unprognostic (4.81e-3)" "unprognostic (6.77e-3)" "prognostic favorable (2.75e-10)" "unprognostic (2.20e-2)" "unprognostic (2.08e-1)" "unprognostic (1.32e-2)" "unprognostic (9.34e-2)" 21.5 22.3 12.8 8.6 13.3 10.1 19.6 13.7 16.1 18.8 15.0 23.8 18.4 20.7 14.8 15.0 17.0 13.8 38.0 14.4 14.0 34.1 49.1 14.5 10.9 12.4 12.3 25.1 30.3 16.8 17.7 12.7 13.9 18.5 18.0 23.9 20.1 20.1 53.0 18.8 21.6 14.1 13.3 12.3 24.4 23.3 12.6 15.2 28.2 38.2 10.5 22.3 16.2 14.9 14.7 12.2 22.5 11.0 31.7 27.5 23.7 15.0 28.8 18.8 19.0 7.1 19.6 29.1 20.4 27.4 10.8 12.8 13.9 13.9 15.9 20.1 14.7 9.1 8.6 17.0 23.1 19.6 7.8 28.6 23.5 8.6 16.9 23.1 17.4 24.6 11.8 21.5 15.1 17.3 20.1 8.6 16.6 17.0 34.8 15.3 24.0 18.1 8.6 31.2 27.4 22.0 25.1 46.4 17.1 17.2 17.8 7.4 14.9 17.2 13.3 13.7 7.8 29.0 19.7 17.1 9.7 10.0 9.2 12.3 9.1 19.9 11.1 6.1 13.8 18.2 16.8 17.4 9.0 19.0 23.5 15.8 8.4 16.8 5.8 6.8 18.0 12.3 12.8 13.3 13.7 16.1 14.4 14.0 12.4 12.3 13.9 13.3 12.6 14.9 40.6 41.7 52.4 30.3 42.1 48.9 53.5 64.8 53.5 65.1 48.6 40.9 9.3 77.2 53.9 47.8 50.1 102.5 40.7 68.9 107.6 59.8 96.8 44.8 41.9 36.4 57.2 47.8 30.6 85.8 68.6 51.2 67.2 38.7 30.4 62.8 45.3 91.8 33.2 65.6 35.4 75.3 63.1 28.7 33.6 27.1 81.4 26.5 39.2 18.7 36.3 73.9 54.6 28.1 33.1 54.8 78.9 77.5 74.5 53.9 143.9 170.1 27.8 98.1 65.7 46.3 90.5 238.7 93.2 42.7 66.3 82.4 44.9 54.7 78.9 55.5 KLHL11 FLJ10572 ENSG00000178502 "Kelch like family member 11" Q9NVR0 17 41848518-41865423 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 108.3;Late spermatids: 41.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023021, HPA052403, HPA054269" Uncertain Approved "Nucleoplasm,Nuclear membrane" "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear membrane" "HPA023021: AB_1852568, HPA052403: , HPA054269: AB_2682432" "unprognostic (9.90e-2)" "unprognostic (2.00e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-1)" "unprognostic (2.07e-1)" "unprognostic (1.84e-2)" "unprognostic (1.32e-1)" "unprognostic (3.11e-2)" "unprognostic (1.50e-1)" "unprognostic (1.83e-2)" "unprognostic (3.25e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-3)" "unprognostic (4.05e-1)" "unprognostic (2.79e-1)" "unprognostic (3.09e-2)" "unprognostic (5.07e-2)" 2.0 2.5 7.5 2.0 6.9 9.1 3.6 8.7 8.2 2.2 1.6 2.0 1.7 2.8 4.0 1.8 2.5 1.6 2.0 9.7 7.6 2.6 2.5 2.3 2.8 6.8 6.3 3.9 3.0 4.6 0.8 2.0 7.4 2.9 1.8 7.1 2.2 2.7 4.3 3.2 1.7 1.8 5.1 2.8 2.2 9.7 7.5 2.7 4.5 1.9 2.8 1.6 0.8 7.0 3.3 5.6 3.9 10.3 5.3 2.8 6.8 3.1 2.9 3.3 3.1 5.2 2.5 10.7 3.4 3.8 3.0 9.3 10.1 4.4 6.0 4.1 4.5 3.8 8.2 7.1 4.9 4.7 4.1 3.4 4.0 4.4 8.3 3.4 3.4 5.3 3.4 9.1 4.3 4.2 7.1 4.9 3.4 2.9 1.8 6.1 9.5 7.7 3.7 5.7 9.8 4.8 5.4 24.9 4.2 3.8 10.9 3.8 5.3 5.1 6.9 4.9 6.2 5.6 5.1 7.9 5.4 4.9 4.8 0.2 0.5 0.3 0.5 0.7 0.8 0.6 0.6 0.6 0.5 0.8 0.7 0.6 0.2 0.4 0.4 0.3 0.4 0.4 7.5 6.9 8.7 8.2 9.7 7.6 6.8 6.3 7.4 5.1 7.5 7.0 1.2 0.0 0.5 6.8 4.5 0.5 1.4 0.2 14.8 3.8 0.9 1.8 0.2 0.0 1.5 0.0 4.2 0.4 3.6 0.3 0.0 0.4 108.3 1.6 3.4 1.5 0.0 3.0 16.6 0.2 0.4 3.0 10.7 1.9 0.0 1.1 0.0 0.0 0.3 8.4 18.0 0.7 0.0 0.0 1.0 41.8 0.3 1.5 1.8 4.7 0.9 1.8 1.0 11.1 13.9 0.5 0.1 0.0 5.8 0.9 0.9 0.2 0.0 3.6 6.6 2.2 3.2 5.5 2.1 5.5 0.3 0.4 4.6 0.9 0.6 0.9 KLRG2 "CLEC15B, FLJ44186" ENSG00000188883 "Killer cell lectin like receptor G2" A4D1S0 7 139452690-139483673 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.0;salivary gland: 4.3;thyroid gland: 4.1" "Group enriched" "Detected in some" 4 "Basal squamous epithelial cells: 5.2;Collecting duct cells: 7.3;Squamous epithelial cells: 14.2;Syncytiotrophoblasts: 7.7" "Cancer enriched" "Detected in many" 11 "testis cancer: 42.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.7;HAP1: 15.7;NTERA-2: 8.2;SCLC-21H: 7.4;SK-BR-3: 31.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA018199 Uncertain Uncertain Nucleoplasm NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA018199: AB_2133260" "unprognostic (2.50e-2)" "unprognostic (3.05e-2)" "unprognostic (9.82e-2)" "unprognostic (5.38e-8)" "unprognostic (2.41e-1)" "unprognostic (1.97e-2)" "unprognostic (3.13e-2)" "prognostic favorable (8.61e-4)" "unprognostic (2.14e-2)" "unprognostic (2.92e-1)" "unprognostic (5.19e-2)" "unprognostic (8.83e-2)" "unprognostic (1.10e-3)" "unprognostic (5.66e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-2)" "unprognostic (2.34e-2)" 0.1 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.0 0.0 0.0 0.4 2.5 0.0 2.9 0.0 0.1 0.0 0.0 0.1 2.8 0.3 0.4 0.1 0.1 0.1 0.0 4.3 0.2 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.9 4.1 0.1 0.7 0.1 1.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.1 0.0 2.0 0.0 0.0 4.3 0.0 0.0 2.2 15.7 0.0 0.0 0.0 3.9 0.0 0.6 0.0 0.1 0.0 0.3 0.0 6.6 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 2.8 2.5 0.0 8.2 0.0 0.1 0.0 0.0 0.0 0.5 0.1 7.4 0.4 2.3 31.9 0.0 6.1 7.1 1.5 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.5 0.8 0.3 5.2 0.0 1.3 1.4 0.5 0.0 0.1 7.3 0.0 1.5 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 1.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.5 1.6 0.0 0.1 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 14.2 1.0 7.7 0.0 0.0 0.3 0.5 KPNA7 IPOA8 ENSG00000185467 "Karyopherin subunit alpha 7" A9QM74 7 99173572-99250075 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "stomach 1: 3.6" "Cell type enhanced" "Detected in some" "Ductal cells: 5.7;Gastric mucus-secreting cells: 5.1;Pancreatic endocrine cells: 11.7;Respiratory ciliated cells: 4.4;Urothelial cells: 11.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 3.8;CAPAN-2: 2.8;OE19: 2.8;SK-BR-3: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA031395 Uncertain NA NA "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA031395: AB_10601584" "unprognostic (7.38e-2)" "unprognostic (7.99e-2)" "unprognostic (2.23e-1)" "unprognostic (8.44e-2)" "unprognostic (8.37e-2)" "unprognostic (9.35e-2)" "unprognostic (9.77e-2)" "unprognostic (2.25e-2)" "unprognostic (2.30e-1)" "unprognostic (3.23e-1)" "unprognostic (7.94e-3)" "unprognostic (5.89e-2)" "unprognostic (2.28e-13)" "unprognostic (2.21e-2)" "unprognostic (1.23e-1)" "unprognostic (3.54e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.5 0.7 0.0 0.5 1.8 0.4 0.0 0.0 0.2 0.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 5.7 0.0 1.3 0.1 0.0 0.0 0.0 0.8 3.1 0.1 0.4 5.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 11.7 2.2 0.0 0.1 1.9 0.1 0.0 4.4 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.1 11.4 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" NA NA 300000000 "Cluster 40: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 89.3 18.7 2.0 61.7 2.4 0.3 403.3 7.9 2.5 250.0 1.6 525.7 348.3 57.9 72.0 889.0 176.1 298.6 13.5 1.5 1.7 141.8 7.7 204.1 0.4 1.6 2.9 74.4 48.8 14.3 15.6 175.1 2.2 208.3 359.2 0.1 810.7 194.2 1.3 141.9 776.1 46.5 1.4 1.2 631.5 3.4 1.8 127.8 28.3 1.6 98.3 781.4 317.0 1.8 2.6 343.4 0.0 6.3 0.7 1.8 1169.3 412.1 0.5 12.8 2.9 992.6 1945.3 0.4 393.3 199.0 1.5 1044.6 0.1 2945.0 2.5 0.8 10.4 0.2 213.4 692.3 30.3 0.0 82.0 0.7 524.9 9.0 0.4 0.2 26.2 0.0 148.4 2.5 0.1 2220.9 5.9 3.0 18.5 1323.5 492.7 2.9 0.1 5.8 1335.4 3146.7 40.0 1.7 3.3 5446.1 0.1 266.5 3674.2 0.3 1.7 3.6 6.1 7.7 0.7 1.1 0.8 2.0 1.5 0.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 2.4 7.9 2.5 1.5 1.7 1.6 2.9 2.2 1.4 1.8 1.8 10.5 673.1 185.5 0.0 17.8 5.2 4317.3 7444.0 1715.8 0.0 1393.0 867.5 2.9 662.0 5055.9 892.0 0.0 1160.8 20.5 3599.6 1.9 4717.9 0.1 737.2 102.8 41.9 362.5 0.0 0.1 2589.9 6919.3 171.8 1571.4 1010.7 94.6 1.0 1.1 0.7 179.0 0.0 0.1 1382.4 2720.0 2.6 2.5 2.6 37.9 25.5 190.3 1.0 30.0 0.8 0.0 0.0 0.0 7374.9 3399.6 88.8 19.9 2228.8 8623.3 26.7 1954.3 0.0 0.0 0.0 240.0 1.1 1.6 1302.6 1.1 2127.5 36.1 4.8 1619.0 5959.8 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703752 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "esophagus: 178.0;lymphoid tissue: 76.3" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 6.0;Fibroblasts: 4.6;Leydig cells: 3.1;Syncytiotrophoblasts: 4.0" "Group enriched" "Detected in some" 4 "cervical cancer: 9.6;head and neck cancer: 15.0;urothelial cancer: 6.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 7.0" "Region enriched" "Detected in single" 10 "cerebellum: 1.0" "Low region specificity" "Detected in some" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" No NA 300000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 5.3 0.0 8.0 0.0 0.1 16.7 178.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 0.0 0.0 5.8 0.2 2.2 1.6 0.0 0.0 0.3 0.5 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 76.3 2.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.2 4.6 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 4.0 0.0 0.0 0.0 0.0 LACTB2 CGI-83 ENSG00000147592 "Lactamase beta 2" Q53H82 8 70635318-70669185 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.0" "Cell type enhanced" "Detected in all" "Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 437.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044391, HPA053040" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 37000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Nucleoplasm, Golgi apparatus" "HPA044391: AB_10965168, HPA053040: AB_2682022" "unprognostic (6.33e-3)" "unprognostic (3.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.23e-2)" "unprognostic (1.82e-1)" "unprognostic (4.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.34e-1)" "unprognostic (8.10e-2)" "unprognostic (3.95e-1)" "unprognostic (7.73e-3)" "unprognostic (1.96e-1)" "prognostic favorable (5.60e-4)" "unprognostic (3.70e-1)" "unprognostic (7.49e-2)" "unprognostic (2.93e-1)" "unprognostic (5.93e-2)" 20.4 39.3 6.4 12.9 8.0 3.2 18.4 8.4 9.0 10.8 8.7 21.9 38.8 9.6 11.5 10.2 9.3 28.7 29.8 5.8 8.3 77.0 96.0 20.1 15.6 8.1 7.9 10.0 14.8 21.0 8.3 10.6 8.9 15.4 21.3 12.7 15.0 9.2 28.2 12.4 33.8 15.7 8.1 11.5 16.0 63.2 7.6 14.5 20.2 32.1 13.5 13.2 7.9 10.6 65.7 66.4 20.8 8.6 35.6 53.7 12.5 36.0 20.7 37.7 28.2 32.3 72.3 0.1 14.4 17.4 75.7 45.9 25.0 38.0 30.2 38.8 26.6 30.5 8.1 18.0 74.0 30.1 25.5 64.6 44.8 18.6 28.2 18.0 10.0 23.2 53.4 60.1 50.6 19.6 17.1 5.5 22.3 88.2 60.3 15.2 12.1 14.0 146.3 33.8 29.6 10.3 79.7 437.8 41.0 27.0 72.7 40.1 16.0 3.0 20.8 67.4 29.4 47.7 38.1 0.2 21.1 50.6 28.7 15.8 13.8 13.0 8.5 16.8 10.6 12.6 8.8 8.4 17.3 11.7 8.3 9.2 5.8 11.0 16.7 11.9 13.4 5.9 6.4 8.0 8.4 9.0 5.8 8.3 8.1 7.9 8.9 8.1 7.6 10.6 15.1 57.7 45.1 3.6 16.0 16.4 22.1 58.9 12.5 15.4 12.1 15.1 38.4 18.6 43.9 18.4 8.4 25.1 12.0 27.2 76.3 51.2 286.3 29.4 11.7 15.3 12.1 19.6 3.9 117.2 15.3 15.1 20.4 31.5 9.5 8.7 19.2 76.1 48.0 8.4 4.6 25.8 34.6 34.5 11.2 40.9 20.5 24.2 16.0 3.7 19.4 35.3 8.2 2.5 10.3 70.2 25.1 15.1 18.3 16.0 59.8 325.7 44.9 14.7 6.6 9.6 14.4 263.1 25.0 12.4 16.8 19.4 13.9 34.2 34.7 11.0 LGALS3BP "90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B" ENSG00000108679 "Galectin 3 binding protein" Q08380 17 78971238-78979947 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 629.8;Paneth cells: 584.1;Proximal enterocytes: 931.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "monocytes: 27.2;T-cells: 68.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 862.9;SK-BR-3: 2270.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000410, HPA000554" Uncertain "Secreted to blood" NA NA 7100000000 "Cluster 32: T-cells - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA000410: , HPA000554: AB_1079246" "unprognostic (1.23e-2)" "unprognostic (1.40e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-2)" "unprognostic (9.63e-3)" "unprognostic (1.62e-2)" "unprognostic (1.68e-2)" "unprognostic (1.48e-1)" "unprognostic (3.12e-2)" "unprognostic (1.57e-2)" "unprognostic (4.55e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (1.58e-1)" "unprognostic (1.65e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" 192.8 218.6 51.2 75.0 91.4 48.6 109.5 95.6 62.3 188.8 159.8 210.8 312.9 121.4 45.2 114.2 155.6 240.8 311.4 46.6 81.4 103.1 68.5 182.8 52.7 145.6 88.3 155.6 79.1 107.8 134.9 147.0 116.8 114.3 92.6 10.0 498.7 154.2 20.0 54.0 260.9 80.2 104.3 76.8 315.6 70.1 89.8 48.8 102.0 20.4 25.3 125.0 119.0 152.5 499.0 255.3 7.2 11.2 157.3 181.4 147.9 55.7 49.0 371.3 725.7 107.5 862.9 2.8 372.7 33.5 361.7 200.1 53.6 203.7 11.5 1.2 319.0 33.8 206.0 481.0 387.7 0.4 31.6 305.8 111.5 197.5 12.6 83.8 9.9 68.7 3.4 1.5 87.7 62.8 151.2 6.0 13.0 163.7 170.7 100.1 209.9 4.8 155.5 352.6 235.1 267.4 52.7 2270.3 754.5 14.0 57.5 16.1 16.3 245.5 169.8 7.1 225.8 0.8 2.2 3.7 332.1 96.8 263.7 0.8 17.7 4.9 12.0 27.2 25.0 4.7 43.3 17.9 7.6 2.4 68.4 33.0 1.2 9.4 14.7 0.6 26.0 25.1 51.2 91.4 95.6 62.3 46.6 81.4 145.6 88.3 116.8 104.3 89.8 152.5 88.0 189.1 144.3 9.8 5.6 31.1 146.8 462.5 60.3 37.2 60.5 43.1 180.7 127.2 306.2 139.8 6.2 179.1 3.4 629.8 17.6 275.0 7.2 77.4 118.7 26.8 168.2 4.4 0.3 136.5 336.0 284.6 257.9 126.9 13.3 316.5 46.8 45.8 88.3 74.0 5.3 328.7 309.3 36.8 23.7 37.1 282.7 36.0 81.8 8.4 27.9 80.8 2.1 11.6 33.9 132.4 584.1 266.3 3.5 72.4 931.4 49.2 123.9 24.3 177.5 80.5 119.6 4.5 2.1 83.8 27.3 108.9 15.4 228.3 400.5 128.2 LIPK "bA186O14.2, LIPL2" ENSG00000204021 "Lipase family member K" Q5VXJ0 10 88724544-88752756 "Predicted secreted proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "skin 1: 32.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-BR-3: 2.6" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 61: Skin - Cornification" "Cluster 8: SK-BR-3 - Unknown function" "unprognostic (7.65e-2)" "unprognostic (8.64e-2)" "unprognostic (3.57e-2)" "unprognostic (3.19e-7)" "unprognostic (1.25e-1)" "unprognostic (1.60e-2)" "unprognostic (2.13e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL scribble cell polarity complex component 2" Q6P1M3 17 75525080-75575209 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favorable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 3.9 7.8 2.7 14.2 6.0 4.6 9.0 6.2 3.6 16.3 9.5 64.5 54.5 4.1 24.0 55.5 14.9 21.3 3.4 2.1 4.1 56.7 26.9 27.6 5.1 6.0 5.9 4.9 74.5 17.3 11.2 6.3 6.2 14.7 28.4 10.4 43.4 12.5 1.3 34.1 55.4 1.9 4.0 24.5 64.2 6.9 4.5 2.3 17.8 0.9 5.7 9.6 25.9 9.8 60.1 54.7 0.3 10.4 0.0 0.0 22.7 0.4 0.6 1.1 0.6 92.6 134.2 4.0 13.6 0.2 5.0 73.7 10.1 10.1 0.2 5.1 18.1 4.0 16.1 35.1 0.6 0.6 8.5 0.0 13.6 0.2 2.1 1.3 2.0 5.8 7.9 5.4 0.0 132.1 3.5 7.1 7.4 101.6 21.2 6.9 0.2 14.9 28.4 92.9 22.1 4.5 11.8 127.5 4.0 12.2 96.6 9.4 0.5 0.2 0.6 0.2 1.0 6.4 9.3 1.8 0.4 0.3 2.7 0.0 0.1 0.1 3.1 0.3 0.7 0.3 0.7 2.1 0.1 0.3 0.1 1.2 0.1 2.1 0.1 1.1 0.5 0.4 2.7 6.0 6.2 3.6 2.1 4.1 6.0 5.9 6.2 4.0 4.5 9.8 7.7 89.8 51.6 3.6 9.0 10.6 34.7 17.3 12.0 15.5 28.8 20.1 3.8 74.4 40.5 90.1 166.8 3.7 44.7 297.5 31.3 84.1 0.6 88.7 7.2 9.0 95.1 0.8 1.1 138.9 8.5 3.5 158.5 87.7 22.2 7.2 4.6 25.0 6.0 8.4 0.8 113.0 32.6 3.8 6.0 1.0 4.7 4.7 3.6 5.6 5.5 28.1 50.4 0.5 49.9 249.4 159.8 4.1 16.1 37.6 84.5 47.0 53.9 117.5 6.6 1.3 6.4 1.5 18.9 27.5 21.7 4.4 21.8 7.5 136.1 89.7 LMTK3 "KIAA1883, LMR3, PPP1R101, TYKLM3" ENSG00000142235 "Lemur tyrosine kinase 3" Q96Q04 19 48485271-48513935 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 44.0" "Cell type enhanced" "Detected in many" "Club cells: 41.4;Excitatory neurons: 37.0;Inhibitory neurons: 38.8;Urothelial cells: 49.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HMC-1: 9.4;SK-BR-3: 16.4;U-266/70: 9.8;U-266/84: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040203, HPA077070" Enhanced Supported Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 10: Brain - Neuronal signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Cell Junctions" "HPA040203: AB_10671690, HPA077070: AB_2732330" "unprognostic (2.41e-1)" "unprognostic (1.48e-1)" "unprognostic (5.37e-2)" "unprognostic (5.45e-2)" "unprognostic (2.95e-1)" "unprognostic (1.71e-2)" "unprognostic (5.67e-2)" "unprognostic (2.46e-1)" "unprognostic (2.09e-1)" "unprognostic (2.51e-3)" "unprognostic (5.71e-2)" "unprognostic (1.47e-1)" "prognostic favorable (3.18e-8)" "unprognostic (1.38e-1)" "unprognostic (3.22e-2)" "unprognostic (3.24e-1)" "unprognostic (6.11e-2)" 0.0 1.7 23.1 0.7 27.5 0.4 0.7 6.1 44.0 0.6 0.0 0.2 3.7 0.1 1.1 0.6 0.3 0.4 0.3 31.7 6.7 1.1 0.0 1.3 1.1 9.9 1.2 0.1 0.8 3.6 5.7 0.6 1.5 1.5 0.0 2.7 2.6 1.1 0.0 0.8 1.9 0.0 0.7 0.6 1.2 0.2 8.4 0.4 0.8 0.0 0.8 0.2 0.0 21.8 6.0 4.4 0.5 0.5 0.0 0.0 5.1 0.1 0.4 0.0 0.2 3.7 5.2 1.6 1.5 0.0 1.4 3.0 0.8 1.9 0.0 0.7 2.8 0.2 2.5 0.9 0.0 0.0 9.4 0.1 1.1 0.3 0.0 2.0 0.0 5.0 1.6 3.6 0.0 7.9 1.1 4.1 1.2 3.4 1.5 4.8 0.0 2.1 1.7 1.2 1.5 2.9 0.2 16.4 0.9 1.2 5.6 0.2 0.1 0.0 1.5 0.1 0.0 9.8 9.3 1.9 0.3 4.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.4 0.0 23.1 27.5 6.1 44.0 31.7 6.7 9.9 1.2 1.5 0.7 8.4 21.8 0.3 3.2 1.7 11.8 2.1 0.5 13.1 17.0 2.8 15.9 20.5 6.2 2.7 2.8 41.4 7.3 0.0 4.9 0.6 0.4 25.4 21.5 0.1 8.4 0.6 0.5 0.0 0.0 37.0 0.4 2.8 0.9 6.6 8.1 0.0 0.6 1.4 0.4 1.3 18.5 38.8 1.2 8.2 0.6 0.9 0.2 0.6 0.4 3.6 1.9 0.2 6.9 0.0 26.2 9.6 17.2 0.1 0.0 14.5 18.8 3.0 0.6 25.9 2.2 0.0 0.4 3.3 4.0 3.3 7.1 1.8 6.8 1.3 2.9 1.5 49.5 LRP8 "APOER2, HSZ75190, LRP-8, MCI1" ENSG00000157193 "LDL receptor related protein 8" Q14114 1 53242364-53328469 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.0;thyroid gland: 41.5" "Cell type enhanced" "Detected in many" "Astrocytes: 30.7;Bipolar cells: 45.3;Excitatory neurons: 35.9;Granulosa cells: 67.0;Inhibitory neurons: 116.4;Microglial cells: 43.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073031 Enhanced "Secreted in other tissues" NA NA 2000000 "Cluster 11: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" "HPA073031: AB_2732217" "unprognostic (3.83e-2)" "unprognostic (6.06e-2)" "unprognostic (6.36e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (3.46e-1)" "unprognostic (6.13e-2)" "unprognostic (1.03e-3)" "prognostic unfavorable (7.02e-4)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (1.66e-1)" "unprognostic (9.11e-2)" "unprognostic (8.88e-16)" "unprognostic (7.73e-3)" "unprognostic (5.47e-2)" "unprognostic (6.98e-2)" "unprognostic (3.00e-2)" 1.9 1.4 13.6 4.9 14.2 5.3 1.4 13.6 15.4 1.9 15.5 1.4 1.4 1.6 1.8 7.5 2.7 1.3 1.2 13.7 13.3 1.4 0.3 2.9 5.2 11.2 10.6 1.1 0.7 0.4 5.2 2.0 12.9 1.1 1.8 11.9 1.5 1.2 0.7 1.6 2.1 2.0 7.9 2.6 1.0 24.0 13.4 2.8 41.5 0.4 4.8 1.6 2.7 13.3 22.2 37.4 18.0 22.5 10.1 10.3 22.9 30.5 19.1 32.4 24.2 10.4 23.2 29.3 29.5 13.3 48.0 35.7 13.3 25.2 15.9 22.2 11.4 20.8 43.3 20.2 9.5 38.2 31.9 3.4 2.7 33.1 17.0 5.8 26.6 24.8 7.5 14.6 6.5 23.6 21.1 19.8 34.8 21.0 27.4 32.1 25.8 31.6 15.6 15.3 38.7 15.3 13.1 67.0 14.6 11.3 8.4 25.1 25.5 9.5 14.6 23.1 51.4 25.6 37.5 12.8 47.9 54.4 53.3 1.4 0.4 0.2 0.5 0.1 0.4 0.3 0.3 0.3 0.2 0.4 0.2 0.3 1.3 0.4 0.1 1.3 0.5 0.2 13.6 14.2 13.6 15.4 13.7 13.3 11.2 10.6 12.9 7.9 13.4 13.3 0.8 0.0 6.1 30.7 2.2 1.5 2.5 1.6 0.0 45.3 1.2 0.8 2.6 0.0 4.3 0.0 0.0 2.1 8.9 0.3 0.0 2.1 7.4 4.4 2.5 4.1 2.4 3.4 35.9 2.4 1.8 1.7 0.0 10.1 1.3 67.0 0.7 0.1 1.9 26.9 116.4 2.2 2.0 3.2 2.1 5.1 0.6 2.4 0.0 43.1 7.0 1.5 5.2 17.6 2.4 4.4 0.2 2.6 4.4 13.7 0.0 0.1 10.2 2.8 0.0 2.8 2.2 3.6 1.1 4.4 1.4 9.7 3.0 1.8 0.8 8.1 LRRC56 "DKFZp761L1518, FLJ00101" ENSG00000161328 "Leucine rich repeat containing 56" Q8IYG6 11 537527-554912 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.3;testis: 22.3" "Group enriched" "Detected in many" 6 "Early spermatids: 68.0;Late spermatids: 141.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.8;Daudi: 1.3;Karpas-707: 2.4;SK-BR-3: 1.6;T-47d: 2.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038728 Approved NA NA "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA038728: AB_10671864" "unprognostic (2.77e-2)" "unprognostic (9.54e-3)" "unprognostic (1.28e-2)" "prognostic favorable (7.39e-4)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (2.29e-2)" "prognostic favorable (6.19e-4)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "prognostic favorable (6.32e-4)" "unprognostic (1.17e-1)" "unprognostic (7.89e-2)" "unprognostic (1.33e-1)" "unprognostic (1.22e-1)" "unprognostic (4.56e-1)" "unprognostic (1.52e-3)" 0.8 0.8 0.5 0.1 1.9 0.2 1.6 0.3 0.5 2.4 0.6 1.7 0.1 0.9 1.3 2.7 6.4 0.0 0.5 0.8 0.3 3.2 1.6 2.9 0.0 0.5 0.3 1.8 2.4 0.0 12.3 0.0 0.1 3.7 0.0 0.1 2.0 0.3 1.2 2.5 2.2 0.0 0.4 2.2 2.1 22.3 0.6 0.1 2.7 0.0 0.2 1.2 2.0 0.3 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.4 1.1 0.4 0.8 0.0 0.2 0.0 0.0 0.5 0.0 2.4 0.0 0.0 0.1 0.7 0.0 0.7 0.7 0.0 0.0 0.5 0.2 0.0 0.3 0.2 0.0 1.6 0.0 0.0 2.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 1.9 0.3 0.5 0.8 0.3 0.5 0.3 0.1 0.4 0.6 0.3 0.5 0.0 3.4 3.3 3.0 1.7 1.5 1.5 0.0 1.1 2.1 0.9 0.6 1.5 2.4 3.7 16.7 0.3 0.6 4.9 0.0 1.1 68.0 11.6 0.6 0.5 12.5 0.4 5.2 0.4 0.2 1.1 1.5 1.3 0.0 0.5 1.1 0.3 0.3 6.7 3.8 2.1 6.1 0.6 0.3 141.2 1.2 0.3 1.8 1.0 0.0 2.7 1.0 1.5 2.8 0.5 1.4 1.2 0.1 1.2 0.2 0.8 14.4 7.0 0.0 0.2 0.6 6.6 2.2 0.6 0.9 0.5 1.4 0.7 0.6 0.8 LYNX1 SLURP2 ENSG00000180155 "Ly6/neurotoxin 1" P0DP58 8 142771197-142777810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 136.8;heart muscle: 79.0" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 34.8;Cardiomyocytes: 76.0;Club cells: 110.5;Excitatory neurons: 35.3;Hepatocytes: 34.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "intermediate monocyte: 6.6;non-classical monocyte: 17.5" "Lineage enriched" "Detected in many" 17 "monocytes: 17.5" "Cell line enhanced" "Detected in many" "BJ: 7.9;fHDF/TERT166: 8.9;GAMG: 11.4;HHSteC: 8.3;HSkMC: 7.5;OE19: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 310000 "Cluster 51: Monocytes - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (8.67e-2)" "unprognostic (6.96e-2)" "unprognostic (1.31e-2)" "unprognostic (2.79e-3)" "unprognostic (1.04e-3)" "unprognostic (5.13e-3)" "unprognostic (1.33e-1)" "unprognostic (5.55e-3)" "unprognostic (1.12e-1)" "unprognostic (3.61e-3)" "unprognostic (7.21e-2)" "unprognostic (1.03e-2)" "prognostic favorable (2.82e-4)" "unprognostic (2.02e-2)" "unprognostic (2.28e-1)" "unprognostic (1.64e-2)" "unprognostic (1.85e-1)" 11.2 28.5 11.4 3.5 22.1 0.3 10.4 3.0 136.8 13.2 0.0 18.6 4.0 19.7 4.9 20.8 18.8 9.1 79.0 79.6 7.1 14.4 35.0 9.2 1.8 47.0 14.8 12.8 10.1 28.4 15.0 2.9 41.2 17.5 2.5 7.0 17.3 13.4 6.2 23.9 6.4 11.2 0.0 13.1 11.4 3.1 33.3 0.8 9.4 11.5 2.1 15.0 13.5 56.7 0.1 5.6 0.3 0.0 2.2 0.3 0.1 7.9 0.6 1.1 1.3 0.3 1.3 0.0 3.9 8.9 11.4 1.5 0.2 0.0 0.3 0.0 0.2 0.0 0.2 1.4 8.3 0.0 3.8 7.5 1.3 2.3 0.0 0.2 0.9 0.0 0.0 0.3 0.8 0.0 0.0 0.1 1.9 7.8 0.1 0.0 0.0 0.0 3.0 0.0 0.6 4.5 0.6 6.1 0.0 3.5 6.5 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 0.2 6.6 0.1 0.0 0.0 0.0 1.0 0.0 0.3 0.1 0.0 0.0 17.5 0.0 0.0 0.3 11.4 22.1 3.0 136.8 79.6 7.1 47.0 14.8 41.2 0.0 33.3 56.7 2.5 0.0 0.0 8.8 0.3 5.7 1.1 34.8 0.6 8.7 7.8 3.8 76.0 4.3 110.5 0.0 0.0 0.2 0.1 0.0 3.9 1.0 0.3 0.1 1.5 5.8 0.0 2.7 35.3 0.4 0.3 6.1 1.1 0.1 1.3 1.1 15.4 34.5 3.5 21.9 22.0 0.2 16.2 3.2 3.6 1.2 5.0 1.7 5.4 8.4 0.4 12.3 0.0 7.1 12.9 0.3 0.0 8.2 0.1 1.0 0.0 2.7 26.6 6.3 6.6 6.9 18.9 0.7 1.9 30.7 33.2 0.5 0.3 2.4 0.0 3.1 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465608 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 1066.8;skin 1: 669.3;vagina: 487.0" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 504.7;Squamous epithelial cells: 811.7;Suprabasal keratinocytes: 2306.1;Syncytiotrophoblasts: 715.8;Urothelial cells: 642.9" "Cancer enhanced" "Detected in many" "cervical cancer: 158.5;head and neck cancer: 235.7" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 5.5" "Group enriched" "Detected in many" 9 "dendritic cells: 2.6;granulocytes: 2.1;T-cells: 5.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5;HaCaT: 99.5;MCF7: 114.2;RT4: 108.2;SK-BR-3: 158.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA 7600000 "Cluster 32: T-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 1.7 3.5 0.7 1.7 0.8 6.6 32.1 0.6 1.0 259.1 1.4 1.1 0.5 7.6 1.8 1066.8 3.5 1.3 1.3 0.7 0.9 2.9 1.2 1.6 2.6 0.7 0.8 8.9 1.3 1.8 2.3 12.3 0.7 11.9 0.7 1.0 183.3 1.3 2.8 669.3 1.6 0.8 0.7 2.1 3.3 1.1 0.8 12.2 1.2 0.2 131.9 55.0 487.0 0.7 38.6 0.6 0.2 0.6 0.3 0.0 15.3 1.5 3.9 1.4 1.9 0.5 42.5 0.4 1.7 1.1 5.6 99.5 0.2 4.4 0.7 0.0 0.3 0.7 4.5 0.8 0.4 0.0 0.9 1.7 37.2 0.2 0.3 1.7 0.0 3.1 0.2 0.1 0.1 114.2 0.9 0.0 0.2 24.3 8.3 0.5 0.0 0.2 1.0 108.2 0.1 0.3 0.5 158.9 1.8 4.7 17.7 0.1 0.0 0.0 0.7 0.5 0.7 0.6 3.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 0.8 0.0 1.1 0.1 2.9 1.1 2.6 0.0 5.5 4.7 2.1 0.0 0.0 0.3 0.9 1.2 0.7 0.8 0.6 1.0 0.7 0.9 0.7 0.8 0.7 0.7 0.8 0.7 0.9 0.0 1.1 0.0 1.3 504.7 102.5 161.2 111.0 0.7 66.6 38.0 0.6 2.8 72.6 14.7 0.0 96.5 2.1 0.9 1.9 1.6 0.1 4.5 4.4 7.5 0.0 0.4 0.0 0.2 87.2 18.1 3.6 24.5 5.7 0.5 0.0 0.3 14.0 3.3 0.1 2.2 24.4 0.3 139.8 0.0 0.6 23.2 147.7 0.0 0.7 4.5 0.0 0.0 0.2 4.7 0.2 0.4 0.0 40.4 0.3 0.7 5.7 0.5 0.0 1.5 10.5 0.1 0.9 811.7 2306.1 715.8 9.6 0.5 1.1 642.9 LYSMD1 "MGC35223, RP11-68I18.5, SB145" ENSG00000163155 "LysM domain containing 1" Q96S90 1 151159748-151165948 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028055, HPA064537" Uncertain Enhanced Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA028055: AB_10601912, HPA064537: AB_2685281" "unprognostic (1.71e-1)" "unprognostic (1.45e-2)" "unprognostic (1.19e-2)" "unprognostic (3.60e-3)" "unprognostic (2.59e-3)" "unprognostic (8.26e-2)" "unprognostic (7.24e-3)" "unprognostic (7.31e-3)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.88e-1)" "unprognostic (2.24e-2)" "unprognostic (8.72e-3)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (8.47e-3)" "unprognostic (6.33e-2)" 4.9 7.0 7.4 2.7 7.6 1.1 5.6 9.5 10.1 7.2 6.9 6.8 6.1 6.2 4.2 5.0 7.1 3.4 8.6 7.4 7.4 5.4 6.5 3.3 3.2 7.5 7.0 10.9 4.9 9.8 5.5 7.4 7.7 5.6 5.4 9.6 4.9 6.3 13.8 6.5 4.2 5.9 6.6 4.2 5.8 4.2 7.3 6.2 6.2 13.5 3.3 7.2 6.1 7.8 5.0 5.3 11.4 8.9 6.5 7.2 8.9 7.2 6.2 8.4 7.5 3.4 5.9 6.6 8.6 4.6 4.3 8.6 8.9 5.1 6.2 12.8 9.8 3.8 8.7 3.6 10.2 4.0 6.0 10.1 10.9 7.9 11.2 11.3 3.5 14.9 7.7 6.2 5.8 7.9 10.3 5.0 7.2 5.0 6.8 7.2 8.3 3.9 6.1 2.3 13.6 16.6 5.4 16.4 9.5 14.3 10.0 13.4 3.6 6.4 3.5 4.1 9.6 19.6 16.0 3.1 5.5 1.6 6.2 1.6 0.8 1.4 0.8 0.5 0.9 0.7 1.0 0.5 0.7 1.7 1.3 1.4 3.1 1.3 0.8 1.4 1.5 0.3 7.4 7.6 9.5 10.1 7.4 7.4 7.5 7.0 7.7 6.6 7.3 7.8 2.2 0.0 0.5 3.3 0.3 0.9 0.9 0.8 1.8 4.0 4.1 2.0 8.8 0.0 2.8 5.5 6.2 4.6 0.1 3.4 3.9 1.8 0.3 2.9 5.1 2.0 4.2 3.2 3.1 0.6 3.1 3.0 0.0 2.1 0.0 5.0 3.9 4.2 0.6 1.7 3.4 1.7 2.0 0.0 0.8 0.4 4.4 0.2 1.8 1.0 0.1 3.7 0.0 2.5 4.3 2.2 1.1 6.0 0.3 1.1 3.8 8.2 2.4 8.0 0.0 2.5 3.9 2.0 2.7 1.3 1.1 2.9 0.5 3.0 2.7 1.0 LYZL2 ENSG00000151033 "Lysozyme like 2" Q7Z4W2 10 30611779-30629762 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 712 "testis: 71.1" "Group enriched" "Detected in some" 43 "Early spermatids: 786.1;Late spermatids: 204.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SK-BR-3: 3.0" "Secreted in male reproductive system" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.83e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 786.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 204.1 7.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAB21L4 "C2orf54, FLJ22671" ENSG00000172478 "Mab-21 like 4" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 262.6;vagina: 80.4" "Cell type enriched" "Detected in single" 7 "Cytotrophoblasts: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 45.9;HaCaT: 34.3;SK-BR-3: 117.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.2 0.1 0.3 1.0 0.5 0.0 1.8 0.5 1.3 36.0 0.0 2.9 11.5 0.2 0.1 262.6 0.9 0.5 0.1 0.8 0.0 13.3 13.0 10.0 0.3 0.3 0.0 0.1 1.2 0.0 0.2 0.8 0.5 1.5 2.5 0.3 29.2 0.2 0.3 60.8 4.9 0.1 0.0 0.2 5.8 0.2 0.2 1.1 0.1 0.0 23.5 2.0 80.4 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 45.9 2.7 0.3 0.3 0.0 0.0 34.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 5.7 0.1 0.1 0.2 7.3 0.0 0.1 0.0 11.4 0.3 5.9 2.3 0.0 0.0 117.0 0.0 0.2 0.9 0.7 0.0 0.0 1.2 0.1 0.0 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.3 0.8 0.0 0.3 0.0 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MAL2 ENSG00000147676 "Mal, T cell differentiation protein 2" Q969L2 8 119165034-119245673 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 259.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 389.9;Distal enterocytes: 433.3;Pancreatic endocrine cells: 329.8;Suprabasal keratinocytes: 455.8;Urothelial cells: 594.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 1042.5;HaCaT: 451.8;OE19: 1132.4;RPTEC TERT1: 385.4;SK-BR-3: 1439.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043831 Uncertain NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "HPA043831: " "prognostic unfavorable (4.57e-6)" "unprognostic (3.12e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (2.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.03e-2)" "unprognostic (7.20e-2)" "unprognostic (5.86e-2)" "unprognostic (2.00e-3)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.09e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.48e-2)" "unprognostic (1.34e-1)" "unprognostic (3.33e-1)" "unprognostic (9.27e-3)" 14.1 1.8 8.5 10.6 13.4 0.0 65.6 15.3 28.0 41.9 0.0 102.9 64.3 6.7 14.2 259.2 54.4 33.1 2.1 22.2 17.0 85.7 47.0 81.6 1.3 0.0 4.2 0.5 37.4 43.5 35.8 12.0 0.0 26.9 94.2 2.6 62.6 41.2 0.4 121.0 53.0 2.6 0.0 0.4 137.6 12.5 8.3 4.3 147.5 0.1 56.0 69.0 102.6 3.4 1042.5 0.0 1.0 0.3 0.2 0.0 92.9 0.1 2.3 1.2 1.6 87.7 329.0 0.3 56.2 0.0 0.4 451.8 0.8 32.9 0.5 0.9 2.6 0.0 13.8 86.1 0.3 0.6 0.3 0.0 225.5 0.0 34.3 1.7 0.3 0.0 0.2 0.5 0.0 244.9 0.8 0.3 8.2 1132.4 309.2 0.6 0.0 0.7 385.4 257.4 56.7 0.3 17.8 1439.4 2.7 6.8 191.4 3.0 0.0 0.6 3.1 1.3 1.9 5.5 0.8 1.0 0.4 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 13.4 15.3 28.0 22.2 17.0 0.0 4.2 0.0 0.0 8.3 3.4 0.5 112.2 130.8 4.2 2.7 114.7 79.9 59.3 19.9 1.5 118.9 50.7 1.6 90.1 119.7 389.9 0.0 25.0 0.4 433.3 109.5 206.0 0.5 71.8 10.3 3.7 41.9 0.0 62.4 178.6 23.5 4.7 149.9 139.4 14.7 0.0 3.6 44.9 2.9 5.0 9.8 145.9 71.2 0.3 14.3 2.2 0.6 2.3 16.0 3.7 3.6 1.0 0.0 3.5 3.6 329.8 252.9 0.0 1.2 285.4 70.2 19.9 107.5 1.0 0.0 0.0 7.0 1.9 9.7 268.8 455.8 9.3 2.8 0.0 122.5 594.5 MAP11 "C7orf43, FLJ10925, TRAPPC14" ENSG00000146826 "Microtubule associated protein 11" Q8WVR3 7 100154420-100158723 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 7.0;Extravillous trophoblasts: 7.2;Hofbauer cells: 7.7;Syncytiotrophoblasts: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019359, HPA029463, HPA029464" Approved Enhanced "Vesicles,Plasma membrane,Centriolar satellite" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Vesicles "Plasma membrane, Centriolar satellite" "HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205" "unprognostic (1.57e-2)" "unprognostic (1.24e-1)" "unprognostic (6.19e-3)" "unprognostic (2.59e-1)" "unprognostic (5.23e-2)" "unprognostic (1.06e-1)" "unprognostic (9.36e-3)" "unprognostic (5.68e-3)" "unprognostic (6.97e-3)" "unprognostic (1.25e-1)" "prognostic favorable (6.19e-5)" "unprognostic (2.42e-2)" "unprognostic (1.85e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-1)" "unprognostic (3.26e-1)" "unprognostic (6.54e-3)" 7.5 13.3 9.4 16.7 9.6 11.9 8.4 9.6 10.7 9.7 7.4 20.0 14.2 11.8 6.4 15.9 9.5 7.1 7.3 10.4 12.1 16.6 17.2 10.7 20.7 11.5 11.4 6.7 13.8 17.6 17.9 7.3 12.3 12.8 11.5 4.9 15.3 8.4 5.6 25.0 22.5 5.7 7.0 32.2 17.8 30.3 12.0 13.9 15.5 3.8 12.4 9.4 10.9 9.4 7.6 9.7 11.1 18.8 6.8 3.7 12.5 13.9 10.8 9.4 6.8 7.6 8.8 9.6 12.4 10.5 14.6 14.4 5.3 11.0 3.6 18.1 10.6 7.3 13.5 6.7 8.1 9.0 32.1 7.5 7.4 9.1 7.0 6.8 8.3 9.7 15.9 16.9 12.4 23.6 20.7 19.3 12.4 14.0 13.9 12.3 5.1 10.7 8.2 8.6 14.0 14.8 12.5 35.7 7.6 7.3 7.2 10.7 11.5 18.6 15.7 24.7 10.9 24.8 25.4 9.7 10.5 12.3 20.2 0.6 0.3 1.4 0.6 0.6 0.5 0.2 0.8 0.6 0.2 0.6 0.4 0.7 1.9 0.2 0.6 0.2 0.0 0.2 9.4 9.6 9.6 10.7 10.4 12.1 11.5 11.4 12.3 7.0 12.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 7.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 MAP1LC3A "ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3" ENSG00000101460 "Microtubule associated protein 1 light chain 3 alpha" Q9H492 20 34546854-34560345 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 674.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 85.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 85.4" "Cell line enhanced" "Detected in many" "HHSteC: 57.5;HSkMC: 71.2;SK-BR-3: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007649, CAB037174, HPA042824, HPA052474, HPA052484" Enhanced Approved Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" Vesicles "CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.02e-1)" "unprognostic (1.99e-2)" "unprognostic (4.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.55e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-2)" "unprognostic (1.98e-1)" "prognostic favorable (5.31e-5)" "unprognostic (2.82e-2)" "unprognostic (1.59e-3)" "unprognostic (3.84e-1)" "unprognostic (1.35e-1)" "unprognostic (7.90e-2)" "unprognostic (2.76e-1)" 53.0 26.6 120.8 13.7 122.1 16.4 40.6 114.4 177.2 49.6 69.7 56.3 30.6 44.9 17.8 22.6 41.7 23.9 81.7 123.7 148.4 54.2 53.2 39.4 28.1 137.1 135.6 38.3 24.8 23.7 84.8 12.4 155.9 46.6 19.7 31.6 31.0 20.3 54.7 64.8 44.9 19.1 101.2 22.0 36.6 52.8 116.2 6.9 52.9 34.1 30.4 39.1 43.5 123.3 0.0 7.0 4.2 0.0 28.4 37.3 0.2 26.1 21.9 16.3 14.9 0.1 0.5 0.0 0.3 21.3 39.5 4.8 0.1 8.1 3.2 6.2 2.0 0.1 17.2 0.0 57.5 0.0 14.0 71.2 1.4 11.4 4.9 0.1 13.5 0.0 0.0 0.1 17.4 0.0 0.2 0.5 1.6 5.3 5.2 0.0 0.0 0.0 0.0 0.0 41.4 31.9 29.6 62.2 0.0 16.3 0.3 22.7 20.5 45.2 0.4 9.8 11.2 0.0 6.5 0.0 29.4 0.0 16.1 4.0 3.2 11.0 5.1 4.8 3.7 9.4 5.5 5.4 1.0 6.0 1.7 3.4 85.4 3.3 1.7 4.5 12.1 2.9 120.8 122.1 114.4 177.2 123.7 148.4 137.1 135.6 155.9 101.2 116.2 123.3 107.4 0.0 6.6 19.2 18.3 57.7 123.0 50.5 12.5 127.2 41.9 57.8 25.4 41.5 27.1 46.0 85.5 25.7 26.1 67.3 113.5 42.0 137.3 98.4 78.4 64.4 165.1 3.6 48.4 23.5 15.8 75.4 34.1 90.6 18.4 90.8 75.7 44.6 37.9 70.7 58.8 70.5 136.3 16.1 47.1 674.0 95.1 17.5 62.2 14.0 21.0 98.7 7.2 12.5 54.6 44.7 82.5 108.7 10.1 146.3 149.4 120.0 40.7 127.7 138.1 77.7 119.3 53.0 21.6 5.8 51.4 211.8 26.4 79.8 76.7 98.1 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911020 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: AB_2686722" "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 11.3 13.8 12.6 21.1 16.1 24.0 16.8 8.1 16.3 18.5 10.8 25.9 26.1 14.6 7.7 51.8 16.6 14.1 20.9 14.9 9.3 13.9 13.1 17.0 21.5 11.8 9.3 12.0 22.4 19.4 19.8 14.9 11.5 20.5 22.4 8.8 27.0 13.1 20.8 40.9 25.1 16.3 7.3 24.1 20.9 10.6 9.5 23.2 19.5 13.7 24.0 19.3 25.0 17.9 52.0 34.1 26.6 28.6 14.6 18.6 35.2 20.8 20.0 29.5 22.3 34.1 49.5 37.8 35.6 20.8 32.0 57.5 26.9 28.7 24.6 26.7 20.9 40.7 23.9 20.3 17.0 45.9 51.4 10.9 36.8 27.0 21.4 13.5 24.7 33.6 35.7 36.5 19.5 64.4 49.3 29.9 31.7 36.0 24.2 39.9 20.4 39.7 19.1 39.8 37.9 25.4 34.7 90.2 24.3 28.9 65.1 26.4 22.7 30.3 19.1 39.6 23.4 24.5 28.8 36.7 20.1 23.2 25.3 1.4 0.7 2.1 1.3 0.7 2.1 0.9 1.0 1.3 1.0 1.6 0.8 0.9 3.6 1.6 1.1 0.9 0.6 0.7 12.6 16.1 8.1 16.3 14.9 9.3 11.8 9.3 11.5 7.3 9.5 17.9 17.3 6.4 6.8 29.7 18.5 25.2 21.1 9.1 19.4 26.8 30.0 18.2 12.8 27.1 11.9 20.2 8.4 26.0 33.4 90.3 1.9 20.2 0.6 29.5 15.8 14.7 29.9 14.7 43.6 21.4 20.6 11.7 27.0 41.0 17.2 21.1 13.6 13.0 17.9 20.2 30.3 39.9 10.2 26.7 18.5 0.9 12.8 25.0 3.6 29.0 17.0 18.8 36.0 31.7 51.8 27.3 39.4 10.9 15.6 30.4 33.4 8.1 14.5 18.1 19.7 19.6 13.1 9.1 18.4 39.9 34.4 65.0 23.6 16.0 33.6 44.3 MAVS "Cardif, IPS-1, KIAA1271, VISA" ENSG00000088888 "Mitochondrial antiviral signaling protein" Q7Z434 20 3846799-3876123 "Predicted membrane proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009187, HPA049850, HPA053524" Enhanced Enhanced Mitochondria NA NA 600000 "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177" "unprognostic (1.30e-2)" "unprognostic (4.51e-2)" "unprognostic (2.17e-1)" "unprognostic (6.67e-2)" "unprognostic (1.42e-1)" "unprognostic (1.75e-1)" "unprognostic (1.18e-3)" "unprognostic (2.23e-2)" "unprognostic (2.30e-2)" "unprognostic (5.95e-2)" "prognostic favorable (3.81e-4)" "unprognostic (1.92e-1)" "prognostic favorable (4.13e-5)" "unprognostic (4.97e-2)" "unprognostic (3.03e-1)" "unprognostic (3.12e-2)" "unprognostic (7.39e-2)" 14.2 12.5 13.0 11.5 16.0 10.3 13.0 13.9 13.6 11.6 14.1 19.4 14.8 12.0 8.4 14.9 13.2 6.7 21.3 12.1 11.5 15.8 15.5 13.3 9.9 18.6 15.7 16.8 17.6 15.4 12.1 9.4 15.9 14.2 15.4 8.1 13.0 10.3 37.5 18.9 16.9 9.6 14.0 14.3 15.4 4.9 16.1 10.4 14.0 29.2 10.8 14.3 11.0 16.6 31.6 36.0 14.3 17.9 38.8 26.2 11.2 18.7 23.8 19.5 14.2 28.4 19.9 13.6 11.1 26.4 55.6 38.7 17.3 28.0 19.9 8.4 8.4 26.3 14.6 45.5 21.4 16.6 10.6 26.7 23.4 33.2 19.6 19.4 20.1 17.6 30.2 10.1 19.3 28.5 25.3 14.1 9.2 15.7 19.6 18.8 19.9 13.7 20.8 31.2 10.7 11.2 21.3 41.0 18.1 20.3 21.9 15.3 30.5 26.5 9.7 31.7 22.1 20.7 26.6 9.4 10.5 20.1 13.7 1.7 2.1 2.0 1.4 1.6 1.0 1.1 1.1 1.1 1.4 1.3 1.2 1.2 1.9 1.8 1.9 1.7 0.9 1.6 13.0 16.0 13.9 13.6 12.1 11.5 18.6 15.7 15.9 14.0 16.1 16.6 16.6 57.7 48.5 24.8 17.3 2.2 13.9 3.7 19.4 34.0 19.9 13.2 61.0 58.6 21.7 29.5 16.7 33.6 22.5 100.0 13.7 25.9 1.1 16.1 27.5 26.8 34.7 17.1 13.6 30.5 27.5 22.8 25.0 16.6 8.8 36.5 44.3 45.7 25.5 45.4 15.9 32.6 2.0 37.7 2.9 3.2 30.7 20.7 1.8 15.9 32.4 20.7 20.6 12.5 19.9 32.7 29.5 28.2 14.2 18.1 42.8 19.6 16.2 33.7 32.9 26.2 17.5 6.2 4.1 15.6 2.0 18.1 16.7 27.5 57.9 16.6 MB PVALB ENSG00000198125 Myoglobin P02144 22 35606764-35637951 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Oxygen transport, Transport" "Muscle protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 38 "heart muscle: 13154.5;skeletal muscle: 40709.4;tongue: 29085.2" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 5182.1" "Group enriched" "Detected in many" 7 "breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "NK-cell: 1.3" "Lineage enriched" "Detected in single" 6 "NK-cells: 1.3" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 175.6" "Low region specificity" "Detected in many" "CAB000060, HPA003123" Enhanced NA NA 13500000 140000000 "Cluster 48: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB000060: , HPA003123: AB_1079442" "unprognostic (7.51e-2)" "unprognostic (3.92e-3)" "unprognostic (1.07e-1)" "unprognostic (7.71e-2)" "unprognostic (2.35e-1)" "unprognostic (4.66e-3)" "unprognostic (5.78e-3)" "unprognostic (1.18e-1)" "unprognostic (2.74e-1)" "unprognostic (1.72e-1)" "unprognostic (2.74e-3)" "unprognostic (1.17e-2)" "unprognostic (8.34e-2)" "unprognostic (1.51e-2)" "unprognostic (2.35e-1)" "unprognostic (3.44e-3)" "unprognostic (1.19e-2)" 8.1 4.6 1.2 1.5 1.2 0.3 43.4 1.2 2.2 2.9 0.9 14.6 1.8 2.3 0.3 736.1 18.7 4.1 13154.5 1.0 1.9 2.8 5.8 14.9 5.3 1.4 1.4 5.3 26.9 16.1 10.6 3.1 1.2 214.2 12.9 0.2 367.1 0.5 40709.4 23.0 11.1 1.4 1.2 2.1 3.8 4.5 1.5 0.8 8.5 29085.2 1.8 1.3 4.5 1.0 1.9 7.6 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.0 0.0 4.6 0.7 0.1 0.3 1.0 0.8 0.2 0.0 0.0 5.4 0.3 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.2 0.4 0.0 0.2 0.0 0.0 0.5 0.5 0.0 19.2 0.1 0.6 0.0 1.9 2.3 0.9 0.5 8.0 0.0 6.4 1.5 0.2 19.0 175.6 0.0 0.3 39.4 0.1 0.4 0.5 1.2 2.2 0.2 0.0 0.0 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.2 1.2 1.2 2.2 1.0 1.9 1.4 1.4 1.2 1.2 1.5 1.0 0.3 0.0 0.0 0.3 0.1 0.3 4.3 12.5 0.0 0.0 30.7 23.9 5182.1 0.0 30.8 0.0 0.0 0.1 0.5 3.8 0.0 4.7 20.1 20.2 0.1 40.7 11.5 0.0 0.0 0.2 0.0 145.2 0.0 0.2 0.0 0.8 0.0 0.4 0.0 0.0 0.1 114.6 14.2 0.0 0.4 70.0 0.0 2.1 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.8 0.7 0.0 21.8 2.6 0.1 19.9 0.0 0.0 420.9 42.0 0.3 0.7 0.6 0.1 0.3 2.8 0.1 2.9 15.1 MBLAC1 MGC49416 ENSG00000214309 "Metallo-beta-lactamase domain containing 1" A4D2B0 7 100126785-100128495 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 11.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071574 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA071574: AB_2686419" "unprognostic (8.28e-3)" "unprognostic (4.83e-2)" "unprognostic (8.85e-2)" "unprognostic (1.41e-1)" "unprognostic (6.84e-3)" "unprognostic (2.38e-4)" "unprognostic (1.18e-1)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-1)" "prognostic favorable (1.18e-4)" "unprognostic (1.21e-1)" "prognostic favorable (7.90e-5)" "unprognostic (7.83e-2)" "unprognostic (5.30e-2)" "unprognostic (4.07e-1)" "unprognostic (5.88e-2)" 1.7 2.3 2.9 0.9 3.1 1.0 1.9 5.1 5.5 3.3 0.0 2.7 2.7 3.2 0.5 2.8 3.0 0.6 3.1 2.8 0.8 2.8 2.3 1.3 1.0 1.8 0.9 3.5 2.2 1.2 3.9 0.4 1.8 4.0 0.6 1.1 2.8 1.7 2.6 2.3 2.1 0.7 0.4 2.0 2.3 2.8 1.1 1.2 2.5 0.6 0.5 2.8 2.7 2.8 2.5 2.7 1.3 1.5 1.5 0.3 1.9 2.8 1.0 1.2 1.0 3.3 1.8 1.5 2.5 1.2 3.8 1.2 0.5 0.0 0.2 5.3 3.0 0.8 1.8 2.6 1.3 2.7 2.3 0.9 0.2 0.8 0.6 1.2 1.0 2.0 2.0 7.0 0.9 2.8 5.1 1.8 1.6 0.3 5.2 3.4 2.0 2.7 0.4 3.0 1.9 4.1 4.3 6.2 2.4 0.4 0.7 1.0 1.3 3.3 5.8 2.2 4.1 4.2 2.9 6.0 1.2 2.1 3.8 0.0 0.2 0.7 0.3 0.2 0.3 0.1 0.5 0.6 0.2 0.9 0.7 0.7 0.9 0.4 0.6 0.2 0.0 0.1 2.9 3.1 5.1 5.5 2.8 0.8 1.8 0.9 1.8 0.4 1.1 2.8 1.7 0.0 1.1 2.9 1.6 0.5 4.3 0.6 1.8 5.7 3.3 3.0 3.9 2.8 1.3 3.7 4.2 1.7 3.4 4.0 11.7 3.8 0.4 2.2 2.3 2.1 3.0 2.7 2.1 5.0 1.2 2.9 0.0 2.1 0.0 2.7 3.3 2.5 2.8 5.0 1.8 2.5 2.0 0.6 1.0 1.2 7.5 1.6 0.0 1.9 2.8 6.2 3.1 1.5 1.1 3.0 1.6 4.1 1.0 3.1 3.2 8.2 0.7 4.7 6.6 3.5 2.9 2.3 2.1 2.3 1.1 2.1 2.2 3.7 2.0 2.4 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003709 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 171.1;Erythroid cells: 162.6;Excitatory neurons: 134.6;Horizontal cells: 141.3;Oligodendrocyte precursor cells: 177.4;Oligodendrocytes: 230.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.7;eosinophil: 1.7;neutrophil: 4.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 41.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.32e-4)" 2.2 2.1 16.4 2.4 23.6 26.9 9.0 20.5 18.4 7.7 26.2 7.6 2.4 4.6 2.7 15.8 2.9 3.6 4.6 18.9 21.9 7.0 0.8 6.7 1.9 21.8 22.2 5.8 1.4 29.3 5.4 3.2 22.4 14.4 8.5 15.6 5.7 2.3 1.1 11.6 3.7 3.9 20.6 2.4 6.1 2.1 21.9 2.4 4.5 1.1 4.8 3.8 8.4 29.3 14.0 4.2 12.7 5.4 5.6 12.5 7.3 6.5 2.4 8.5 5.6 1.1 21.9 3.9 7.5 15.9 6.8 10.5 11.4 13.5 12.6 12.3 19.0 16.7 5.9 0.0 6.9 0.0 5.0 9.1 7.8 8.1 5.6 18.5 4.5 5.5 14.4 3.0 7.5 3.6 4.9 0.3 5.0 6.4 15.8 7.4 20.0 0.1 12.6 2.0 7.6 23.0 6.9 41.1 6.6 6.2 7.7 4.8 2.5 14.7 7.7 11.6 19.0 1.1 0.4 4.3 23.3 2.4 5.1 4.7 0.4 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 4.0 0.0 0.1 0.1 0.0 0.2 16.4 23.6 20.5 18.4 18.9 21.9 21.8 22.2 22.4 20.6 21.9 29.3 7.7 19.2 12.7 171.1 1.7 3.3 4.6 33.1 0.6 20.6 18.1 12.1 12.2 7.2 54.7 40.5 8.4 3.9 1.1 28.2 5.9 5.6 9.7 3.2 19.4 13.4 37.6 162.6 134.6 1.5 1.4 12.7 21.4 2.9 8.2 14.7 4.6 0.2 1.8 141.3 107.8 59.3 32.6 1.9 17.7 12.7 5.3 5.0 14.2 33.7 29.0 98.7 0.0 177.4 230.5 88.1 42.9 7.5 0.3 19.5 1.6 10.4 45.7 8.8 6.6 10.5 15.2 12.1 24.8 24.4 5.1 1.9 2.0 1.9 12.7 66.4 MED1 "CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2" ENSG00000125686 "Mediator complex subunit 1" Q15648 17 39404285-39451272 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 206.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017696, HPA052818" Approved Supported Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB017696: AB_1128703, HPA052818: AB_2681962" "unprognostic (1.77e-1)" "unprognostic (1.63e-1)" "unprognostic (9.26e-2)" "unprognostic (1.21e-1)" "unprognostic (2.18e-2)" "unprognostic (1.67e-1)" "unprognostic (1.21e-2)" "unprognostic (4.50e-1)" "unprognostic (7.86e-2)" "unprognostic (1.95e-3)" "unprognostic (4.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.78e-2)" "unprognostic (2.00e-1)" "unprognostic (5.94e-2)" "unprognostic (9.40e-2)" "unprognostic (5.79e-2)" 10.3 8.7 7.2 11.3 7.7 12.9 10.6 8.5 8.2 9.7 7.4 10.6 7.7 11.0 5.9 9.8 9.3 7.6 9.6 6.9 7.4 8.8 9.0 8.7 13.3 7.2 7.3 11.3 7.9 16.8 6.0 10.4 7.5 8.3 9.5 8.0 8.6 7.7 13.7 11.1 9.7 11.2 7.4 11.2 8.6 10.7 7.7 16.9 9.1 12.2 14.7 10.9 9.1 8.8 20.1 24.5 32.5 22.7 23.1 23.7 25.8 24.0 25.6 30.6 30.1 24.9 20.1 51.4 26.2 28.9 37.2 38.3 38.0 22.9 50.0 49.2 31.8 32.3 24.1 24.0 24.4 59.8 33.9 22.1 23.6 39.3 55.0 20.1 28.1 30.6 42.1 28.4 25.7 10.7 56.5 23.2 20.9 19.4 15.1 41.3 43.1 22.9 18.5 22.4 20.3 23.2 30.9 206.2 27.6 28.0 38.5 33.4 23.7 24.8 31.1 28.1 42.3 25.3 36.4 53.6 24.3 28.4 32.0 1.3 1.4 1.8 1.6 1.4 1.9 2.2 1.8 1.8 1.5 2.0 1.8 2.1 1.2 1.9 0.8 1.5 1.5 1.0 7.2 7.7 8.5 8.2 6.9 7.4 7.2 7.3 7.5 7.4 7.7 8.8 18.8 25.6 13.9 10.1 24.7 27.1 14.2 13.1 19.4 13.7 18.0 13.8 18.9 12.8 21.0 9.2 14.6 17.2 20.6 12.7 3.9 12.3 7.9 19.0 27.1 21.2 13.8 26.9 13.4 12.0 12.8 19.7 10.7 27.0 9.5 19.9 17.2 20.2 14.9 11.8 13.9 14.8 16.2 20.0 16.5 7.7 14.6 16.4 21.4 11.2 21.0 13.5 17.5 11.1 16.0 13.7 12.1 18.0 20.2 19.9 9.4 8.5 17.4 12.0 19.7 26.1 21.2 22.3 17.0 21.7 32.7 22.2 22.8 18.7 15.0 18.7 MED24 "CRSP100, CRSP4, DRIP100, KIAA0130, MED5, THRAP4, TRAP100" ENSG00000008838 "Mediator complex subunit 24" O75448 17 40019097-40061215 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 178.1;Club cells: 100.6;Ionocytes: 99.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 244.1;SK-BR-3: 283.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (3.93e-2)" "unprognostic (1.65e-1)" "unprognostic (4.10e-2)" "unprognostic (8.27e-2)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.56e-1)" "unprognostic (1.33e-1)" "unprognostic (1.19e-2)" "unprognostic (4.04e-2)" "unprognostic (3.18e-3)" "unprognostic (4.36e-2)" "unprognostic (1.03e-1)" "unprognostic (2.16e-1)" "unprognostic (3.97e-1)" 28.4 30.6 21.6 24.8 23.0 37.3 29.1 20.7 29.2 37.8 18.3 29.5 28.6 33.9 19.0 32.6 31.8 16.8 35.3 24.2 19.0 29.1 25.7 46.5 26.7 18.3 21.2 38.8 25.6 31.2 39.1 23.8 19.5 28.1 24.5 26.4 31.4 17.9 84.0 35.2 30.1 24.3 16.9 30.1 30.5 35.8 19.3 32.7 28.9 48.9 27.9 25.8 30.1 19.6 31.8 63.3 57.3 59.1 38.7 36.1 44.6 41.7 32.5 56.7 50.4 63.1 42.2 65.0 71.6 46.5 28.2 72.8 89.7 244.1 45.3 59.8 147.2 34.0 59.2 84.0 32.2 84.4 63.0 45.0 45.5 56.3 34.1 36.8 75.0 42.8 98.1 41.9 38.6 42.1 93.7 55.2 37.7 36.7 72.4 71.2 45.2 54.5 29.7 36.5 79.9 57.8 43.9 283.0 33.4 49.3 62.4 75.4 45.2 31.1 26.0 34.5 53.6 39.0 41.4 49.5 56.5 42.2 42.7 0.5 4.8 6.0 5.3 6.0 4.2 4.6 3.7 6.1 6.8 4.0 3.5 4.2 0.3 3.5 3.9 2.8 3.9 5.1 21.6 23.0 20.7 29.2 24.2 19.0 18.3 21.2 19.5 16.9 19.3 19.6 14.9 22.4 51.3 13.1 12.7 11.3 25.1 178.1 13.1 11.9 31.4 24.9 16.3 20.0 100.6 23.9 16.7 28.9 8.3 24.8 15.6 15.1 14.8 20.6 10.2 43.3 28.1 27.0 17.6 18.0 23.3 12.2 42.3 27.0 10.8 28.5 9.3 14.8 20.0 10.1 20.3 34.1 99.7 12.0 19.2 8.6 9.9 8.6 14.2 9.4 15.4 10.8 6.2 13.6 13.9 18.5 43.7 9.4 14.2 10.4 23.7 17.6 66.3 11.5 6.6 10.9 13.5 13.4 15.5 12.0 18.6 22.6 10.7 18.0 33.3 28.6 MFAP3L "KIAA0626, NYD-sp9" ENSG00000198948 "Microfibril associated protein 3 like" O75121 4 169986597-170033031 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 65.5;choroid plexus: 88.8" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1840.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5" "Lineage enriched" "Detected in single" 8 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017986, HPA062306, HPA077490" Enhanced Supported "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Cell Junctions" "HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842" "unprognostic (8.04e-3)" "unprognostic (8.67e-3)" "unprognostic (3.74e-1)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (7.92e-2)" "unprognostic (3.50e-2)" "unprognostic (3.14e-2)" "unprognostic (2.67e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-1)" "unprognostic (7.58e-2)" "prognostic favorable (1.42e-8)" "unprognostic (6.59e-3)" "unprognostic (2.12e-1)" "unprognostic (1.62e-4)" "unprognostic (2.40e-3)" 2.0 3.4 32.9 0.9 61.0 3.2 12.0 49.1 34.4 13.0 88.8 2.7 0.6 5.1 38.9 0.8 4.2 2.6 1.7 35.2 40.1 30.0 37.4 2.7 0.9 46.3 58.3 0.6 1.5 6.5 4.1 3.0 48.5 2.8 2.0 25.0 2.1 12.8 5.1 24.5 1.0 4.1 38.8 1.5 1.3 46.3 54.9 0.6 2.8 2.3 0.5 10.1 1.8 65.5 0.4 5.7 3.0 3.1 2.6 1.3 1.1 6.2 0.9 2.8 2.5 1.9 0.4 0.0 0.2 9.6 5.4 2.9 10.9 1.4 1.2 0.0 4.7 0.0 6.7 2.4 1.4 0.0 22.5 1.8 3.4 0.3 1.0 1.5 0.3 3.5 0.9 1.1 5.8 3.4 1.0 0.8 3.1 0.7 4.7 0.0 1.8 0.0 8.1 38.0 2.5 5.5 5.1 34.3 11.6 19.1 1.9 0.0 0.2 2.9 11.2 5.5 11.9 0.6 0.0 0.0 7.5 1.2 11.4 5.7 0.1 1.8 0.6 0.7 0.3 0.0 0.5 0.1 0.2 0.0 0.2 0.1 3.5 0.0 0.0 0.5 0.1 4.6 32.9 61.0 49.1 34.4 35.2 40.1 46.3 58.3 48.5 38.8 54.9 65.5 1.0 0.0 5.6 112.6 0.6 2.5 0.4 0.1 2.8 12.2 8.5 9.7 3.4 0.0 0.2 36.8 20.9 3.1 0.2 0.6 5.9 0.5 417.5 8.5 1.1 2.0 2.4 11.2 36.3 1.1 1.0 0.6 0.0 12.4 4.5 11.0 3.3 49.1 1.2 3.3 25.0 0.3 0.0 1.0 0.7 1840.0 5.3 13.5 7.2 3.7 1.5 2.9 2.1 53.8 127.6 1.4 0.3 9.1 0.5 0.9 0.3 24.0 0.3 15.8 19.7 1.7 4.2 17.6 13.2 0.3 8.4 9.4 0.6 1.4 0.8 2.2 MINAR2 KIAA1024L ENSG00000186367 "Membrane integral NOTCH2 associated receptor 2" P59773 5 129748094-129766732 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 35.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA013760 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "HPA013760: AB_1852363" "unprognostic (1.77e-1)" "unprognostic (5.13e-1)" 0.2 0.1 1.1 0.0 1.0 0.1 0.2 1.1 1.4 0.1 0.6 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.0 1.2 0.0 0.1 0.2 0.1 1.1 1.0 0.0 0.1 0.0 0.0 0.4 1.0 0.1 0.0 0.2 0.0 0.1 35.9 0.1 0.0 0.1 0.7 0.4 0.1 0.5 1.6 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.3 0.3 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.4 0.1 0.2 0.1 0.0 0.0 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.6 0.1 0.0 0.4 0.5 0.3 0.0 0.4 0.1 0.1 0.1 0.0 0.2 0.2 1.4 0.0 0.9 0.2 0.0 0.3 0.1 0.0 0.5 0.3 0.2 0.1 0.0 0.2 0.1 0.3 0.0 0.7 1.3 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.6 0.1 0.2 0.8 0.1 0.0 1.1 1.0 1.1 1.4 1.0 1.2 1.1 1.0 1.0 0.7 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MISP "C19orf21, Caprice, DKFZp686H18209, MISP1" ENSG00000099812 "Mitotic spindle positioning" Q8IVT2 19 751112-764318 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "intestine: 196.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 133.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA049511, HPA062232" Enhanced Enhanced "Plasma membrane,Focal adhesion sites" No No "Cluster 9: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Focal adhesion sites" "HPA049511: AB_2680798, HPA062232: AB_2684719" "unprognostic (7.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" "unprognostic (6.50e-2)" "unprognostic (1.78e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.49e-1)" "unprognostic (2.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.78e-3)" "unprognostic (2.29e-1)" "unprognostic (4.80e-1)" "unprognostic (5.27e-2)" 1.3 0.0 0.3 12.1 0.3 0.0 0.9 0.5 0.4 4.4 0.1 95.5 171.0 0.7 0.0 0.3 9.8 11.3 0.0 0.4 0.3 8.8 0.1 9.3 0.1 0.5 0.5 0.3 1.7 0.0 8.1 1.2 0.5 5.6 48.4 0.0 1.0 0.5 0.0 0.6 196.6 3.3 0.2 0.0 22.9 0.5 0.3 0.3 0.1 0.0 0.0 9.0 0.6 0.2 30.4 121.4 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.1 0.0 42.1 44.2 10.8 11.5 0.0 0.1 90.2 0.0 37.7 0.0 0.0 0.1 0.0 47.0 13.3 0.0 0.0 1.9 0.0 82.6 0.3 4.5 0.0 0.0 0.0 0.0 0.4 0.2 63.2 0.1 0.7 0.1 76.9 24.6 0.2 0.4 1.0 30.1 33.7 1.4 0.4 42.9 134.3 0.1 0.1 29.3 0.0 0.0 0.0 14.8 1.8 0.2 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.4 0.4 0.3 0.5 0.5 0.5 0.2 0.3 0.2 0.1 38.5 8.0 0.3 2.9 0.1 4.5 22.5 0.0 0.0 4.7 2.3 0.5 10.0 39.7 11.0 0.0 0.6 0.0 793.4 1.9 39.9 0.6 40.5 1.5 0.8 58.0 0.0 0.2 46.0 6.0 2.4 56.6 14.3 8.9 0.0 0.0 0.0 0.1 0.0 0.3 230.9 28.5 0.0 0.0 0.9 0.0 0.6 0.0 1.0 0.6 0.0 0.0 0.0 0.2 157.7 646.7 0.0 0.1 41.6 1115.2 27.5 41.3 0.0 0.0 0.0 2.6 0.0 1.2 0.0 0.3 2.1 1.6 0.0 220.7 62.1 MKKS BBS6 ENSG00000125863 "McKusick-Kaufman syndrome" Q9NPJ1 20 10401009-10434222 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Chaperone "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041071, HPA044233" Enhanced Supported Centrosome NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Centrosome "HPA041071: AB_10960408, HPA044233: AB_10962986" "unprognostic (9.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.00e-1)" "unprognostic (3.17e-2)" "unprognostic (1.84e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.84e-5)" "unprognostic (5.54e-2)" "unprognostic (1.19e-1)" "unprognostic (2.58e-1)" "unprognostic (1.01e-2)" "unprognostic (1.85e-1)" "prognostic favorable (3.79e-9)" "unprognostic (3.69e-1)" "unprognostic (6.18e-2)" "unprognostic (1.63e-2)" "unprognostic (3.01e-1)" 12.0 13.3 15.3 6.7 16.6 1.9 12.3 17.9 19.2 14.3 19.6 18.9 17.3 12.6 13.7 12.7 13.1 12.7 20.6 17.0 17.2 28.8 26.0 9.9 8.4 16.4 15.2 13.8 12.4 25.5 14.8 9.6 17.0 15.0 19.4 22.8 13.0 15.4 25.4 9.3 14.5 14.3 15.4 11.8 13.9 16.2 16.3 12.2 17.6 40.6 10.7 14.4 13.3 16.0 18.9 23.3 21.7 32.9 23.3 20.9 6.7 12.7 14.4 16.6 13.3 7.7 9.6 16.2 5.3 12.4 30.0 25.0 27.6 25.1 20.6 2.9 10.4 37.1 5.8 20.9 15.8 23.4 7.5 18.5 47.5 16.0 31.7 28.0 13.5 14.8 18.8 11.7 19.7 7.1 22.3 14.2 15.6 60.8 16.4 13.2 21.5 14.5 25.7 8.6 33.0 20.9 11.9 61.3 29.7 14.5 16.8 15.5 6.3 14.6 12.4 17.8 23.3 8.6 36.3 6.9 12.1 24.3 15.3 19.5 16.0 13.4 11.7 14.2 13.8 11.3 13.0 9.9 16.8 7.8 15.1 14.1 7.9 11.9 16.9 10.8 11.0 16.4 15.3 16.6 17.9 19.2 17.0 17.2 16.4 15.2 17.0 15.4 16.3 16.0 15.0 3.2 17.9 20.5 29.8 33.9 56.5 143.1 39.9 39.1 11.5 13.7 225.7 118.7 67.0 9.2 12.5 101.6 50.3 116.4 68.4 27.0 95.4 14.7 11.5 41.2 71.2 43.5 30.2 19.8 83.4 40.1 37.8 11.5 22.8 9.1 57.5 182.4 127.1 69.0 36.1 90.0 89.5 62.5 67.5 41.7 62.4 34.5 49.8 11.2 51.1 70.7 55.6 25.6 24.7 17.6 92.9 63.9 31.5 87.4 99.6 47.4 54.7 40.1 52.6 43.9 51.5 229.1 73.6 86.4 42.8 96.9 23.5 13.0 100.7 75.5 MMEL1 "MMEL2, NEPII, NL1, NL2, SEP" ENSG00000142606 "Membrane metalloendopeptidase like 1" Q495T6 1 2590639-2633016 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.6" "Cell type enhanced" "Detected in many" "Early spermatids: 131.2;Late spermatids: 36.1;Paneth cells: 54.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA007876, HPA008205, CAB020786" Uncertain "Intracellular and membrane" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011" "unprognostic (5.80e-2)" "unprognostic (4.61e-2)" "unprognostic (1.87e-1)" "unprognostic (4.27e-2)" "unprognostic (1.33e-1)" "unprognostic (2.71e-2)" "unprognostic (1.45e-1)" "unprognostic (7.96e-2)" "unprognostic (1.36e-2)" "unprognostic (2.37e-1)" "unprognostic (4.54e-3)" "unprognostic (2.44e-2)" "unprognostic (4.79e-2)" "unprognostic (3.18e-1)" "unprognostic (2.82e-1)" "unprognostic (2.18e-3)" "unprognostic (7.01e-4)" 2.9 1.4 0.6 0.0 0.6 0.0 3.0 0.5 0.9 3.2 0.4 3.7 2.6 0.7 0.9 4.8 2.9 0.0 0.5 0.5 0.8 3.7 0.5 2.8 0.0 1.0 1.0 0.4 2.0 0.6 0.7 0.0 0.8 6.5 0.3 0.1 1.6 0.3 0.2 0.7 4.2 0.0 0.7 2.5 8.2 24.6 0.7 0.0 1.1 0.0 0.0 3.1 3.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.1 0.0 14.2 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.0 4.7 0.3 2.6 0.2 0.4 1.0 0.4 0.7 0.0 2.7 1.3 0.6 1.8 3.6 0.1 4.2 1.7 0.6 0.6 0.5 0.9 0.5 0.8 1.0 1.0 0.8 0.7 0.7 0.6 5.9 0.0 0.0 0.3 0.4 0.0 5.2 5.2 1.2 0.0 10.3 8.9 1.1 20.0 10.2 18.4 0.0 0.0 0.3 12.1 0.0 9.4 131.2 7.1 0.5 2.3 1.2 2.5 0.1 3.4 0.0 1.3 8.6 7.3 0.0 0.0 1.4 0.2 1.2 0.0 0.2 16.5 2.0 1.0 0.2 36.1 1.8 2.4 0.0 0.0 0.9 0.5 0.0 0.5 0.0 4.0 54.9 1.2 0.2 6.7 20.8 0.1 8.8 0.2 0.0 0.0 0.6 0.6 1.1 0.6 0.0 0.0 0.8 0.4 9.7 12.6 MMP24OS MMP24-AS1 ENSG00000126005 "MMP24 opposite strand" A0A0U1RRL7 20 35201745-35278131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 167.3;Distal tubular cells: 403.0;Ductal cells: 225.8;Exocrine glandular cells: 205.2;Pancreatic endocrine cells: 278.9;Proximal tubular cells: 388.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "unprognostic (6.31e-2)" "unprognostic (4.34e-2)" "unprognostic (1.14e-1)" "unprognostic (4.42e-2)" "unprognostic (5.73e-3)" "unprognostic (2.10e-1)" "unprognostic (1.72e-1)" "unprognostic (4.34e-3)" "unprognostic (5.75e-2)" "unprognostic (4.33e-1)" "unprognostic (1.90e-2)" "unprognostic (1.38e-1)" "unprognostic (1.47e-3)" "unprognostic (4.57e-2)" "unprognostic (2.73e-1)" "unprognostic (6.64e-2)" "unprognostic (7.58e-2)" 49.6 51.2 31.0 15.2 24.7 26.0 38.1 23.4 40.7 35.4 41.6 32.3 27.1 31.3 10.0 48.7 27.4 15.5 31.4 24.7 27.7 69.1 44.8 31.5 12.2 30.8 23.8 32.9 36.4 14.9 50.1 9.2 30.2 37.2 19.1 4.2 34.9 18.4 24.9 39.0 29.0 11.5 17.9 24.3 31.8 20.0 33.8 10.9 27.6 8.9 9.9 31.1 36.4 25.3 3.3 22.6 1.6 10.2 21.8 39.2 12.3 44.3 31.1 37.4 58.4 15.5 27.1 11.4 22.5 30.6 25.8 14.6 5.9 46.7 31.1 19.2 27.1 36.0 8.4 6.5 13.4 13.9 30.1 36.6 41.3 21.0 29.7 13.1 16.2 12.1 11.0 24.2 53.2 17.1 47.8 20.5 7.1 9.2 29.0 20.8 11.1 23.2 35.2 12.5 10.7 13.3 31.5 72.3 35.5 22.2 31.8 8.4 37.4 65.5 5.4 25.1 23.0 10.1 3.2 4.6 35.5 6.2 21.8 2.9 2.1 7.5 2.3 3.2 2.2 1.8 1.5 1.6 1.6 2.4 1.5 2.2 6.7 0.9 5.5 2.3 0.6 0.8 31.0 24.7 23.4 40.7 24.7 27.7 30.8 23.8 30.2 17.9 33.8 25.3 49.1 22.4 28.6 0.0 14.9 0.0 0.0 0.0 0.0 0.0 98.3 99.8 0.0 0.0 14.2 167.3 0.0 46.8 58.1 0.0 403.0 225.8 0.0 85.3 45.2 16.4 0.0 0.0 0.0 205.2 80.2 26.0 0.0 65.5 7.6 44.5 0.0 0.0 110.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.8 0.0 0.0 98.8 0.0 0.0 0.0 0.0 278.9 0.0 0.0 11.7 0.0 0.0 388.2 9.5 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 75.4 22.5 68.2 0.0 0.0 MOCS3 "dJ914P20.3, UBA4" ENSG00000124217 "Molybdenum cofactor synthesis 3" O95396 20 50958818-50963929 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis, tRNA processing" "Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9;Late spermatids: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027556 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "HPA027556: AB_2672333" "unprognostic (1.29e-1)" "unprognostic (2.57e-1)" "unprognostic (3.16e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.76e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-2)" "unprognostic (8.67e-3)" "unprognostic (4.90e-2)" "prognostic favorable (7.55e-4)" "unprognostic (8.39e-2)" "unprognostic (8.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" 1.5 1.9 1.8 1.9 1.6 1.0 1.8 1.8 1.9 1.6 1.7 1.8 2.1 1.8 2.7 2.3 2.6 1.4 1.6 1.6 1.8 1.8 2.5 1.5 2.4 1.5 1.5 2.7 2.2 2.1 1.2 1.8 1.5 1.7 1.6 1.4 2.3 1.8 2.4 2.1 2.2 1.4 1.2 2.3 2.0 5.0 1.8 2.0 2.2 1.4 2.2 1.9 1.3 1.6 3.5 5.9 3.6 5.0 5.0 4.1 6.6 4.1 4.4 10.1 4.3 12.8 5.1 5.3 5.3 3.7 6.6 10.0 3.8 10.1 6.4 1.9 4.0 4.2 4.7 7.4 5.1 4.2 4.3 4.6 8.4 4.2 4.1 3.3 3.5 4.6 6.2 3.1 3.8 5.8 7.0 5.1 5.3 5.4 10.2 2.7 5.6 4.7 4.0 5.4 5.2 6.0 6.4 20.3 6.8 4.0 8.5 8.0 4.2 7.6 4.3 4.2 4.5 7.7 7.4 2.2 6.8 2.5 3.3 2.8 4.1 3.8 3.2 3.8 4.2 4.7 3.4 3.6 4.8 3.3 5.6 4.4 2.1 4.5 5.9 2.6 5.9 3.9 1.8 1.6 1.8 1.9 1.6 1.8 1.5 1.5 1.5 1.2 1.8 1.6 2.2 0.0 1.5 0.3 3.7 1.8 5.0 5.2 5.7 5.6 3.8 3.8 2.0 4.3 4.6 0.0 4.2 10.3 1.3 4.0 1.9 7.8 90.9 7.4 5.3 2.7 2.4 5.2 1.7 8.0 6.3 3.4 2.0 5.5 0.0 6.6 6.1 7.5 4.9 0.0 1.8 3.8 4.1 3.8 1.1 26.2 5.0 3.2 3.6 0.0 5.2 6.9 5.2 0.5 1.0 5.9 2.5 3.0 2.0 3.2 3.7 7.3 7.7 5.9 13.1 2.2 3.3 20.0 7.6 5.4 3.8 11.6 3.1 5.8 4.6 4.8 MOGS "CWH41, DER7, GCS1" ENSG00000115275 "Mannosyl-oligosaccharide glucosidase" Q13724 2 74461057-74465410 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 222.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011322, HPA011969" Approved Supported "Endoplasmic reticulum" NA NA 1500000 "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA011322: AB_2668483, HPA011969: AB_1849579" "unprognostic (5.66e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.34e-6)" "unprognostic (1.48e-2)" "unprognostic (2.66e-2)" "unprognostic (3.32e-2)" "unprognostic (6.21e-2)" "unprognostic (4.36e-1)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.40e-2)" "unprognostic (3.06e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" 18.4 18.3 8.1 20.2 9.1 8.5 18.6 9.0 13.3 19.2 9.2 22.8 41.7 18.3 5.5 22.5 20.0 14.4 16.9 8.3 9.0 20.9 34.3 24.9 21.6 9.4 8.7 18.6 42.3 21.5 21.7 34.5 9.9 23.3 13.4 9.6 31.1 14.6 21.3 24.9 29.7 11.4 9.3 31.7 35.5 19.0 8.9 19.8 21.9 16.2 18.1 20.1 19.1 9.8 53.1 46.2 23.5 29.6 55.3 38.9 90.1 38.7 58.3 59.8 58.2 81.9 58.7 45.2 34.9 36.3 46.7 50.6 40.2 43.3 32.5 46.7 39.9 20.3 14.4 68.6 54.9 49.8 46.6 25.6 77.1 41.9 39.0 62.2 68.4 27.8 39.6 51.6 28.5 58.8 32.3 62.0 42.6 64.1 22.5 35.5 57.4 74.1 38.0 19.5 19.7 29.2 15.5 84.8 62.7 21.8 38.7 34.3 40.1 26.5 49.7 36.3 56.5 66.5 36.5 22.7 46.9 49.3 39.0 6.7 2.4 1.9 2.6 1.5 3.3 1.2 2.3 2.5 2.1 1.9 1.4 1.6 0.4 8.4 3.3 2.1 3.3 1.7 8.1 9.1 9.0 13.3 8.3 9.0 9.4 8.7 9.9 9.3 8.9 9.8 13.9 6.4 15.9 16.3 22.0 15.8 21.8 20.8 18.2 14.9 18.9 12.8 8.6 24.3 21.3 23.9 18.8 39.5 34.6 18.7 5.9 21.9 65.6 12.4 12.2 13.3 13.9 16.4 13.9 26.1 50.5 12.3 40.8 17.4 4.5 20.9 17.9 25.6 19.9 6.7 12.1 25.7 20.3 12.9 14.8 222.0 15.2 17.9 10.6 12.2 25.5 7.0 30.9 11.1 10.7 22.3 19.7 7.2 43.6 22.7 37.7 7.4 17.7 14.1 13.1 9.4 12.7 13.0 5.1 15.2 17.3 52.0 21.2 16.5 23.3 19.6 MROH6 C8orf73 ENSG00000204839 "Maestro heat like repeat family member 6" A6NGR9 8 143566192-143572772 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 13.8;Hepatocytes: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 11.6;HaCaT: 13.6;OE19: 14.8;SK-BR-3: 30.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA068049 Uncertain Approved Nucleoplasm NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA068049: AB_2685945" "unprognostic (2.10e-2)" "unprognostic (1.96e-2)" "unprognostic (1.07e-3)" "unprognostic (2.26e-3)" "unprognostic (8.04e-2)" "unprognostic (8.96e-2)" "unprognostic (2.28e-1)" "unprognostic (1.73e-1)" "unprognostic (5.97e-2)" "unprognostic (2.81e-2)" "unprognostic (1.09e-2)" "unprognostic (9.04e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (1.44e-1)" "unprognostic (9.16e-3)" "unprognostic (1.18e-1)" 2.5 3.1 1.1 0.5 1.2 1.7 2.1 1.2 1.4 6.5 1.0 4.5 2.0 2.4 0.1 23.4 2.4 0.7 1.4 1.2 0.9 3.7 7.4 4.0 0.3 1.2 1.2 3.2 1.1 0.2 1.9 0.2 1.1 2.8 0.0 0.1 4.2 0.4 0.9 13.9 5.0 0.1 1.0 4.6 2.9 5.8 1.2 0.3 1.7 0.1 0.7 3.3 8.5 1.0 11.6 2.0 0.2 0.4 0.7 0.7 0.5 0.5 0.4 0.5 0.2 0.4 6.0 1.1 0.6 0.2 0.0 13.6 0.0 2.7 0.0 1.2 1.2 1.3 4.3 0.3 0.6 0.5 1.1 0.7 0.7 0.0 0.0 0.0 0.2 0.4 0.6 0.7 0.0 2.8 0.6 0.3 0.0 14.8 1.1 0.7 0.4 1.1 0.7 1.1 0.2 0.3 0.6 30.0 0.7 0.0 1.3 0.9 0.0 0.4 3.9 0.7 1.2 0.5 0.4 0.3 0.5 6.8 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 1.2 1.2 1.4 1.2 0.9 1.2 1.2 1.1 1.0 1.2 1.0 4.0 0.0 4.7 3.9 1.6 2.8 2.2 1.4 4.0 1.4 7.2 4.3 1.5 7.2 2.7 9.2 0.0 1.0 3.7 13.8 1.9 1.3 0.0 1.5 2.9 2.4 1.8 6.1 1.4 0.7 3.4 3.0 6.6 3.0 1.3 3.6 1.1 13.4 5.2 1.7 1.3 4.5 0.0 8.1 3.7 1.3 4.7 6.0 3.6 0.0 3.3 3.5 4.1 0.5 0.3 7.2 6.0 2.6 3.1 2.1 7.3 2.3 0.9 0.3 0.0 2.8 2.3 0.7 7.6 3.2 2.6 1.0 2.6 2.3 8.2 2.8 MRPL13 "L13, L13A, L13mt, RPL13, RPML13" ENSG00000172172 "Mitochondrial ribosomal protein L13" Q9BYD1 8 120380761-120445402 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 264.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 497.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060899 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA060899: AB_2684382" "prognostic unfavorable (1.37e-4)" "unprognostic (4.91e-2)" "unprognostic (8.50e-2)" "unprognostic (3.61e-2)" "unprognostic (1.81e-1)" "unprognostic (1.66e-1)" "unprognostic (7.28e-3)" "unprognostic (1.34e-3)" "unprognostic (1.18e-1)" "unprognostic (1.56e-2)" "unprognostic (1.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (7.48e-2)" "unprognostic (2.32e-1)" "unprognostic (1.45e-1)" "unprognostic (1.84e-1)" 21.3 37.8 18.2 19.1 18.5 22.1 26.6 19.5 27.3 17.0 20.0 37.6 24.4 16.3 24.2 35.6 16.2 15.8 38.2 17.7 20.3 45.6 51.1 16.4 24.8 18.9 19.0 13.1 18.1 33.5 15.2 20.9 19.1 18.2 36.5 21.4 22.0 14.6 33.8 17.7 22.5 19.3 20.1 18.3 24.2 15.1 19.2 28.2 18.2 47.2 25.0 24.7 21.8 20.4 106.5 53.8 62.8 52.7 43.0 62.7 51.2 58.3 57.1 81.3 88.5 56.6 80.2 78.8 85.4 49.4 54.6 56.5 82.1 74.9 114.2 107.4 84.2 99.6 39.0 81.8 51.8 62.7 47.1 48.7 123.2 68.6 71.8 46.4 67.2 78.7 103.8 56.5 73.4 59.7 101.8 60.9 60.5 194.0 122.7 52.9 61.1 107.7 90.7 57.1 74.0 38.1 41.0 497.7 78.4 55.1 96.0 65.9 39.3 42.0 87.1 53.3 107.7 45.2 98.9 110.7 77.8 112.6 76.3 48.4 59.7 66.0 47.6 92.2 56.1 58.9 57.4 62.4 89.8 46.8 55.1 56.4 10.4 68.3 103.1 72.4 77.2 92.2 18.2 18.5 19.5 27.3 17.7 20.3 18.9 19.0 19.1 20.1 19.2 20.4 48.4 70.5 41.9 5.5 37.2 33.6 55.9 235.1 46.7 18.3 37.8 52.1 119.6 44.3 117.8 55.2 20.9 134.2 33.2 56.4 262.2 121.0 10.4 68.4 53.1 45.6 45.0 54.5 14.7 100.7 171.0 49.1 30.5 51.4 36.8 39.3 35.0 78.1 103.3 16.8 14.1 93.3 177.0 33.6 31.4 9.4 38.2 47.5 32.0 9.4 80.1 49.9 32.0 10.1 14.3 95.1 84.9 35.3 42.3 46.5 81.9 264.8 140.7 25.6 39.5 29.0 66.4 103.2 64.8 65.3 45.3 115.9 39.9 114.0 100.8 70.2 MRPS28 "HSPC007, MRP-S28, MRPS35" ENSG00000147586 "Mitochondrial ribosomal protein S28" Q9Y2Q9 8 79918717-80030289 "Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 359.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027202 Approved Supported Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "HPA027202: AB_1854126" "unprognostic (3.63e-3)" "unprognostic (6.41e-2)" "unprognostic (9.61e-3)" "unprognostic (1.31e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-3)" "unprognostic (2.17e-1)" "unprognostic (1.27e-1)" "unprognostic (3.23e-1)" "unprognostic (4.55e-1)" "unprognostic (4.18e-1)" "unprognostic (2.11e-1)" "prognostic favorable (1.20e-6)" "unprognostic (4.48e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-1)" "unprognostic (7.18e-2)" 47.5 88.8 65.1 32.9 67.7 29.1 47.5 70.0 85.3 33.3 73.0 52.9 30.9 27.3 38.3 41.0 35.2 28.8 104.0 64.0 70.2 79.2 110.9 30.4 37.7 70.1 69.8 28.6 32.3 69.6 40.4 40.9 70.1 31.3 41.0 51.7 35.4 33.4 160.3 29.0 29.4 32.8 69.7 26.7 35.3 24.3 66.9 44.9 53.7 137.7 37.9 39.0 30.7 75.3 85.2 84.1 73.0 17.3 60.9 77.2 79.8 94.3 85.7 122.1 104.2 74.0 66.4 107.2 105.3 75.6 124.2 68.5 102.1 105.5 99.0 85.3 89.8 128.8 74.8 114.4 67.7 57.6 55.3 66.4 88.9 71.8 97.4 67.1 81.0 85.2 93.4 42.3 123.7 81.3 133.8 93.5 29.8 219.5 139.5 89.9 58.1 62.0 158.0 81.8 34.8 58.6 41.1 359.5 91.1 83.8 86.6 68.1 59.0 45.8 116.4 81.6 82.7 46.5 81.4 97.2 77.4 66.7 36.8 95.4 53.8 29.1 48.2 77.3 52.3 51.2 52.8 59.4 98.8 54.4 64.1 62.1 11.1 71.5 70.1 111.1 73.0 49.8 65.1 67.7 70.0 85.3 64.0 70.2 70.1 69.8 70.1 69.7 66.9 75.3 32.5 22.4 22.2 57.8 20.8 35.2 19.5 124.5 36.5 10.9 23.4 28.1 51.6 42.9 67.0 33.1 4.2 78.7 20.9 18.1 101.8 67.3 15.1 28.5 16.1 26.2 37.3 21.7 39.0 47.4 74.3 21.2 17.9 24.1 50.0 10.5 23.9 65.5 49.5 5.0 42.5 23.5 69.2 25.5 28.5 10.4 17.7 26.9 44.4 70.3 40.0 23.7 26.8 93.5 81.8 36.0 20.6 22.2 19.9 13.4 24.5 126.9 79.7 17.2 32.9 31.1 26.1 18.6 33.4 41.6 37.8 59.4 20.0 23.2 36.4 16.0 MSL1 "DKFZp686P24239, hMSL1, MSL-1" ENSG00000188895 "MSL complex subunit 1" Q68DK7 17 40121971-40136917 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 8.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 358.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022800, HPA023567" Uncertain Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA022800: AB_1853057, HPA023567: AB_1853059" "unprognostic (1.94e-1)" "unprognostic (6.28e-2)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (4.71e-2)" "unprognostic (5.39e-2)" "unprognostic (2.33e-2)" "unprognostic (1.60e-1)" "unprognostic (1.06e-2)" "unprognostic (2.24e-1)" "unprognostic (3.46e-1)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.06e-6)" "unprognostic (2.92e-2)" "unprognostic (7.91e-2)" "unprognostic (5.80e-2)" "unprognostic (2.61e-2)" 60.2 52.0 34.3 48.0 33.6 56.7 56.7 26.1 39.6 76.6 16.1 62.7 51.7 75.1 55.9 48.1 77.5 38.6 46.8 32.1 26.5 57.1 43.9 61.5 50.8 24.1 25.7 58.3 59.3 47.8 78.8 48.5 22.2 59.8 46.8 41.1 56.5 51.9 63.6 60.8 61.6 53.7 21.8 88.2 57.1 66.2 27.9 62.3 79.8 51.6 51.6 53.3 62.0 27.7 35.9 42.2 88.3 57.9 78.5 67.6 45.0 61.6 65.3 76.1 68.4 42.4 37.8 78.8 45.6 65.0 48.4 65.2 74.7 40.5 78.2 68.0 59.6 43.6 60.5 50.6 40.9 59.7 81.6 56.9 63.6 56.1 46.5 77.4 71.0 47.2 69.3 62.8 61.4 22.8 95.0 64.8 37.6 39.4 27.2 77.1 48.7 72.1 55.4 38.9 80.9 48.0 57.5 358.8 46.5 80.1 83.5 81.0 58.7 51.0 56.4 37.8 52.3 98.5 58.5 77.7 52.0 43.7 60.7 0.0 1.0 0.8 1.7 0.6 0.8 1.1 0.9 1.3 0.7 0.9 0.9 0.8 8.7 0.7 0.8 1.4 0.6 0.5 34.3 33.6 26.1 39.6 32.1 26.5 24.1 25.7 22.2 21.8 27.9 27.7 44.1 28.9 40.7 42.7 22.7 50.0 37.8 21.7 69.4 55.2 41.6 32.3 29.5 25.8 25.8 11.0 12.5 15.4 43.8 36.4 3.9 17.2 16.1 35.8 53.9 43.3 31.2 22.3 39.8 20.7 15.4 37.4 20.4 48.1 3.8 24.8 36.4 35.9 25.2 52.2 33.4 29.1 8.2 36.4 42.8 28.5 58.4 34.2 32.0 33.7 30.6 31.3 30.9 25.1 32.4 24.7 32.1 39.9 26.8 72.7 35.4 9.0 32.7 28.4 39.5 29.2 40.7 71.8 49.2 57.5 65.8 17.0 29.9 27.5 31.4 58.7 MSTO1 "FLJ10504, LST005, misato, MST" ENSG00000125459 "Misato mitochondrial distribution and morphology regulator 1" Q9BUK6 1 155610205-155614951 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1482.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005899, HPA005914, HPA006075" Approved Enhanced Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA005899: AB_2667460, HPA005914: AB_2667466, HPA006075: " "unprognostic (1.80e-2)" "unprognostic (3.43e-1)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (1.15e-1)" "unprognostic (4.46e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (9.63e-2)" "unprognostic (1.26e-1)" "unprognostic (5.28e-2)" "unprognostic (3.73e-2)" "unprognostic (3.67e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.56e-1)" "unprognostic (1.12e-1)" "unprognostic (5.35e-2)" "unprognostic (1.28e-1)" 18.5 18.2 7.9 10.2 8.2 7.3 18.9 9.0 9.4 18.0 7.6 11.7 8.7 16.1 18.0 14.7 16.7 7.2 14.1 9.0 8.8 17.8 31.7 12.7 11.5 10.0 9.4 17.0 25.1 14.9 24.3 8.6 10.3 20.7 9.0 7.8 14.4 14.8 6.8 11.9 15.7 11.8 7.9 21.2 14.6 23.1 10.0 8.6 18.5 4.7 10.7 15.9 12.8 8.4 23.0 31.1 26.7 41.1 21.9 18.5 33.3 28.8 24.5 35.1 27.9 30.8 14.3 39.5 26.1 25.9 22.6 24.7 40.2 38.8 24.2 15.3 33.6 34.1 29.5 17.8 34.8 36.7 26.4 19.2 19.4 38.8 55.7 15.6 29.2 28.5 28.4 17.3 29.3 37.7 24.7 24.9 35.4 38.6 40.8 21.2 25.0 35.4 29.6 23.1 22.0 26.7 20.2 60.6 26.3 31.2 33.5 49.2 19.5 22.2 24.3 24.0 44.9 36.4 33.8 29.3 25.0 35.6 30.9 3.5 5.9 0.4 10.0 8.3 11.2 7.4 9.4 9.1 8.4 5.5 9.8 6.2 0.7 9.6 5.5 8.4 7.5 6.8 7.9 8.2 9.0 9.4 9.0 8.8 10.0 9.4 10.3 7.9 10.0 8.4 4.6 6.4 6.0 3.9 8.8 2.7 6.1 8.6 5.2 9.1 6.6 4.4 9.7 2.8 7.2 7.3 22.9 7.9 5.8 2.9 3.9 9.6 324.5 4.2 8.2 6.1 5.4 3.8 2.0 13.4 23.7 6.3 12.8 4.7 14.5 9.5 2.2 7.1 8.7 11.8 2.1 4.9 2.0 2.6 3.5 1482.8 9.0 5.5 3.6 1.0 6.3 4.6 3.1 2.5 2.2 8.0 0.9 11.3 17.0 5.5 2.8 9.9 10.9 9.7 0.0 6.7 6.4 23.0 12.6 6.3 1.4 6.6 7.2 7.1 4.6 2.8 MTBP ENSG00000172167 "MDM2 binding protein" Q96DY7 8 120445400-120542133 "Predicted intracellular proteins" "Cell cycle, Growth arrest, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 12.8;Excitatory neurons: 14.7;Oligodendrocytes: 16.1;Spermatocytes: 16.2;Spermatogonia: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA025694, HPA050594" Uncertain Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 22: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA025694: AB_1854169, HPA050594: AB_2681185" "unprognostic (1.92e-2)" "unprognostic (1.07e-1)" "unprognostic (4.47e-1)" "unprognostic (3.53e-4)" "unprognostic (1.20e-1)" "unprognostic (5.40e-3)" "unprognostic (2.77e-6)" "unprognostic (3.99e-3)" "unprognostic (1.50e-2)" "unprognostic (7.86e-3)" "unprognostic (3.38e-3)" "unprognostic (3.29e-1)" "unprognostic (5.20e-10)" "unprognostic (3.41e-3)" "unprognostic (2.51e-1)" "unprognostic (3.02e-2)" "unprognostic (5.86e-2)" 1.3 1.1 1.0 2.5 1.2 4.0 2.6 3.6 1.7 1.6 0.7 1.7 1.5 2.1 2.4 1.4 1.7 1.2 0.6 1.0 0.9 1.0 0.8 1.3 4.3 1.0 1.0 2.4 0.9 1.0 0.8 2.1 1.2 1.5 2.6 4.3 1.1 1.0 0.7 3.0 1.3 2.0 0.9 1.8 1.1 5.0 1.1 4.6 0.8 0.8 4.0 1.0 1.3 1.4 15.3 4.5 14.6 6.0 2.1 3.5 7.1 11.4 6.5 16.4 21.0 4.9 8.3 13.8 11.2 3.8 4.9 13.0 13.9 6.8 20.3 11.5 10.6 11.6 6.7 5.6 1.1 12.4 8.6 1.3 2.9 12.7 8.1 2.5 7.3 12.6 7.6 10.2 9.7 6.9 19.8 7.6 6.5 12.0 9.0 11.3 15.0 9.8 3.9 5.3 7.4 8.6 7.7 44.8 7.0 7.9 8.5 8.9 4.5 7.0 12.7 9.0 18.6 3.9 8.9 8.0 6.6 15.1 8.3 0.0 0.1 0.1 0.3 0.6 0.5 0.7 0.5 0.7 0.2 0.5 0.8 0.7 0.0 0.5 0.3 0.0 0.7 0.3 1.0 1.2 3.6 1.7 1.0 0.9 1.0 1.0 1.2 0.9 1.1 1.4 1.6 0.0 1.5 7.5 2.9 0.8 1.7 1.5 1.8 0.0 1.4 1.3 1.1 0.0 1.1 1.8 0.0 2.3 2.5 0.5 0.0 0.9 0.8 1.3 2.6 1.1 0.0 12.8 14.7 1.8 3.0 2.5 2.6 1.5 2.5 5.0 1.8 0.9 1.6 0.0 9.1 0.9 0.0 0.3 1.8 0.4 1.5 1.7 1.8 3.7 1.0 0.0 2.1 9.0 16.1 0.6 0.1 1.2 2.3 1.2 0.3 0.3 2.4 0.0 0.0 5.6 2.6 16.2 10.2 1.4 0.6 0.7 3.3 1.5 0.8 0.8 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720884-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 58.5;kidney: 69.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 170000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 6.7 5.1 4.3 1.3 5.0 0.9 7.9 7.0 6.7 23.0 3.0 30.0 3.0 5.0 4.5 58.5 20.0 6.4 6.3 3.6 3.4 69.7 21.1 7.9 0.8 4.1 2.7 11.8 16.1 2.0 16.5 0.5 4.0 20.9 7.2 8.1 40.3 1.1 7.0 8.0 14.7 0.8 1.4 6.1 9.8 8.5 4.2 0.8 16.2 1.0 1.4 21.0 26.0 5.0 0.9 0.0 0.2 0.7 0.4 0.0 0.7 0.0 0.2 0.0 0.1 0.0 3.7 0.1 0.7 0.0 0.2 1.5 0.1 0.0 0.1 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.4 0.1 0.7 3.9 0.1 1.0 0.1 1.1 0.1 3.6 1.3 0.4 0.0 28.1 0.2 0.5 0.2 0.0 0.0 0.2 0.8 1.0 0.1 1.3 1.7 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.0 7.0 6.7 3.6 3.4 4.1 2.7 4.0 1.4 4.2 5.0 0.9 35.3 16.7 16.6 0.5 1.8 10.0 6.4 0.6 19.9 3.2 1.5 0.7 14.3 43.7 22.0 35.5 0.1 0.2 53.2 1.9 55.5 0.1 3.5 1.3 1.7 13.8 5.3 7.5 9.9 0.1 1.8 13.3 6.2 1.3 5.3 3.3 7.3 0.5 11.8 7.7 7.3 152.5 1.0 0.8 0.4 5.3 1.1 3.6 1.0 0.0 4.7 0.0 5.0 3.0 12.2 16.9 6.4 1.7 14.2 16.9 3.3 66.5 20.5 0.0 8.8 3.3 1.3 1.3 4.3 1.8 0.0 1.7 1.0 15.2 84.4 MUCL1 SBEM ENSG00000172551 "Mucin like 1" Q96DR8 12 54830518-54896008 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "breast: 3241.2" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4494.5;Breast myoepithelial cells: 1273.2;Melanocytes: 1060.1" "Cancer enriched" "Detected in many" 30 "breast cancer: 298.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;hTCEpi: 1.3;MCF7: 2.1;SK-BR-3: 4.8;SuSa: 3.3" HPA039093 Enhanced "Secreted in other tissues" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "HPA039093: AB_10795577" "unprognostic (2.26e-1)" "unprognostic (3.38e-1)" "unprognostic (1.90e-1)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (8.34e-3)" "unprognostic (5.55e-2)" "unprognostic (2.00e-1)" "unprognostic (3.11e-2)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (9.90e-2)" 35.4 0.4 0.2 1.1 0.4 0.0 3241.2 0.2 0.6 1.3 0.1 1.8 0.0 0.2 1.5 0.4 2.1 0.2 2.6 0.3 0.2 2.3 1.0 1.1 0.1 0.2 0.2 0.3 0.3 0.0 0.3 0.4 0.2 1.1 0.0 0.0 207.3 0.0 1.9 762.2 0.3 0.1 0.2 0.2 0.7 1.2 0.2 2.4 0.2 0.0 0.0 1.2 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 4.8 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.5 10.4 0.0 1.1 0.0 3.8 188.4 0.4 2.1 0.0 0.0 4494.5 1273.2 0.1 0.0 3.4 0.0 0.0 0.0 12.9 0.0 3.9 0.0 0.0 1.8 0.0 3.4 0.0 0.0 1.4 0.2 0.0 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 2.0 0.0 14.1 0.2 0.0 45.5 1060.1 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 5.9 0.0 0.1 2.6 0.0 0.0 0.0 6.1 0.2 0.6 0.0 10.1 0.0 2.5 0.1 0.0 3.8 MYD88 ENSG00000172936 "MYD88 innate immune signal transduction adaptor" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 172.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favorable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 20.1 14.2 6.9 43.5 7.4 51.8 15.0 7.2 7.5 15.2 8.0 30.3 32.2 12.1 18.6 36.6 14.4 23.5 9.4 6.7 7.7 13.7 61.1 42.6 35.2 9.5 7.5 11.4 11.6 11.6 9.2 22.6 8.0 14.3 31.7 2.1 18.0 12.0 3.2 17.7 32.2 24.5 8.6 40.7 27.6 7.7 9.2 38.3 9.4 8.8 41.6 47.4 20.3 8.5 25.1 34.2 5.9 33.2 25.0 32.0 10.8 23.6 39.0 68.1 72.9 22.7 30.9 52.8 13.8 44.7 15.8 30.9 43.2 24.2 22.1 39.5 8.7 28.5 16.6 36.6 21.4 36.2 72.0 38.4 26.6 39.2 15.3 13.2 39.9 40.3 13.3 22.3 36.8 25.7 61.3 12.2 22.1 52.8 35.7 24.8 7.0 23.1 37.6 58.9 3.0 12.0 33.4 172.1 22.3 4.8 25.8 40.8 35.5 13.8 7.9 60.6 24.0 28.9 32.9 38.5 25.0 63.0 28.9 288.5 236.9 296.9 67.2 333.6 58.1 43.7 60.6 69.3 203.6 35.2 42.1 59.5 284.7 54.6 436.1 99.9 87.4 257.3 6.9 7.4 7.2 7.5 6.7 7.7 9.5 7.5 8.0 8.6 9.2 8.5 13.4 6.4 15.2 2.0 19.5 14.4 13.5 12.7 14.2 1.0 11.3 10.8 1.6 5.7 16.4 5.5 0.0 14.6 35.3 40.8 7.9 24.5 1.4 10.9 30.2 15.9 9.6 9.7 0.2 27.3 24.4 10.8 23.9 18.6 24.1 10.0 10.4 33.2 32.2 0.0 0.4 14.9 10.2 75.4 40.5 0.9 13.7 61.5 3.6 1.9 58.1 4.1 28.8 2.5 0.3 64.0 34.8 10.5 12.9 16.0 28.0 12.2 12.1 0.1 13.1 4.3 7.2 8.6 0.6 15.1 17.2 12.0 19.6 10.2 15.9 49.4 MYORG "KIAA1161, NET37" ENSG00000164976 "Myogenesis regulating glycosidase (putative)" Q6NSJ0 9 34366666-34376898 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 55.5;Exocrine glandular cells: 11.8;Pancreatic endocrine cells: 10.3;Proximal tubular cells: 9.2;Syncytiotrophoblasts: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 35.4;SK-BR-3: 56.8;T-47d: 52.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060533, HPA067487" Enhanced Approved Mitochondria NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Mitochondria "HPA060533: AB_2684311, HPA067487: AB_2685848" "unprognostic (6.56e-2)" "unprognostic (1.51e-1)" "unprognostic (3.03e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (2.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.44e-1)" "unprognostic (2.03e-2)" "unprognostic (1.55e-1)" "unprognostic (4.68e-3)" "unprognostic (1.91e-3)" "unprognostic (3.20e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.08e-3)" "unprognostic (3.68e-1)" "unprognostic (3.09e-1)" "unprognostic (1.00e-3)" 8.1 6.2 30.6 3.4 30.3 2.0 3.4 27.1 31.5 1.7 16.8 19.0 27.3 2.7 1.9 5.3 4.5 6.1 3.9 28.4 28.2 14.5 41.5 3.2 1.5 34.0 33.5 1.0 11.1 1.5 5.5 19.8 28.7 3.2 16.2 3.4 5.6 5.2 84.2 3.7 25.8 4.4 24.5 1.4 15.0 1.3 31.8 1.1 1.9 39.2 1.8 3.1 2.4 24.2 8.1 5.5 9.2 5.6 3.8 1.2 19.7 1.4 1.1 0.8 1.3 13.9 8.3 4.4 15.9 1.4 4.0 16.4 6.7 15.5 1.1 1.4 3.6 0.8 24.6 35.4 0.5 0.8 2.7 1.8 7.2 2.6 3.0 4.3 3.8 3.3 1.1 4.2 2.0 13.4 2.5 1.2 5.5 27.4 4.4 4.0 4.6 1.3 4.9 2.9 1.3 13.0 10.8 56.8 0.9 7.8 52.8 1.3 3.2 1.8 11.0 1.6 3.5 2.8 6.5 1.6 1.6 3.1 1.6 0.4 0.1 0.2 0.7 0.1 0.5 0.2 0.4 0.4 0.0 0.2 0.2 0.3 0.3 0.4 0.1 0.1 0.6 0.1 30.6 30.3 27.1 31.5 28.4 28.2 34.0 33.5 28.7 24.5 31.8 24.2 3.9 9.6 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.0 0.0 2.5 3.7 0.0 55.5 0.3 0.0 1.9 5.7 0.0 3.4 0.7 2.1 0.0 0.0 0.0 11.8 3.6 1.1 0.0 2.0 1.3 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 9.2 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 17.4 0.3 0.1 0.0 0.0 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113532-178126081 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 35.7;Extravillous trophoblasts: 130.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "memory B-cell: 1.7;naive B-cell: 1.6;naive CD8 T-cell: 1.2;plasmacytoid DC: 2.1" "Group enriched" "Detected in many" 16 "B-cells: 1.7;dendritic cells: 2.1;T-cells: 1.2" "Cell line enhanced" "Detected in many" "BEWO: 14.9;MCF7: 21.2;RH-30: 20.3;SK-BR-3: 72.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favorable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 1.9 0.8 1.6 1.0 1.0 2.9 2.5 3.0 3.7 2.6 0.6 1.4 0.5 0.8 0.3 15.7 1.0 0.7 2.3 1.0 2.1 3.1 0.1 3.9 1.8 2.6 1.8 0.5 0.7 4.1 2.2 8.3 2.7 1.0 0.4 4.7 6.8 0.8 4.4 7.8 1.8 0.5 0.2 1.8 2.2 0.9 4.1 0.9 1.4 3.0 2.9 1.4 4.0 2.1 0.1 0.1 2.3 1.7 0.2 0.0 14.9 0.0 0.0 0.0 0.0 3.3 1.1 1.4 2.0 0.0 0.1 4.7 0.4 0.1 0.0 2.5 0.8 4.1 1.8 0.1 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.0 12.0 1.3 2.6 0.9 0.0 21.2 0.2 0.3 11.2 3.6 0.1 11.6 20.3 5.4 1.2 2.4 1.7 0.8 0.6 72.2 4.9 2.8 2.8 0.1 2.4 0.0 1.7 0.0 0.0 3.2 2.3 13.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 1.7 0.1 0.1 0.0 1.6 0.4 1.2 0.0 0.1 0.0 2.1 0.0 0.2 1.6 1.0 3.0 3.7 1.0 2.1 2.6 1.8 2.7 0.2 4.1 2.1 7.8 3.2 0.6 0.0 12.7 9.4 13.1 6.7 4.0 35.7 7.3 3.6 1.7 2.8 3.4 1.8 12.5 3.0 10.4 9.4 13.7 3.4 0.4 1.9 1.1 15.7 4.2 0.0 2.9 0.8 130.4 1.6 6.6 5.8 4.5 0.5 0.4 0.2 2.3 1.7 4.9 3.7 6.1 0.0 1.7 0.8 0.6 1.0 12.4 3.7 1.1 2.0 0.0 0.5 0.2 7.3 8.7 1.9 6.1 10.3 0.1 0.8 0.3 9.2 0.0 2.5 0.7 0.2 8.1 14.1 6.8 23.1 3.0 0.7 3.5 12.1 NANS SAS ENSG00000095380 "N-acetylneuraminate synthase" Q9NR45 9 98056732-98083077 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Intestinal goblet cells: 362.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019223 Approved Enhanced Nucleoplasm No No 410000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 4: Stomach - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA019223: AB_1854298" "unprognostic (2.95e-1)" "unprognostic (5.10e-3)" "unprognostic (2.24e-2)" "prognostic favorable (1.71e-4)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.42e-4)" "unprognostic (2.08e-1)" "unprognostic (7.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-2)" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (1.64e-1)" "unprognostic (7.36e-2)" "unprognostic (3.62e-3)" "unprognostic (1.79e-1)" 39.4 28.9 16.2 49.3 15.0 67.8 36.5 13.8 18.2 49.9 29.8 133.5 52.2 28.5 33.5 51.4 29.4 34.2 46.3 15.1 17.0 32.8 67.0 45.9 59.5 16.2 17.2 26.2 67.6 20.4 42.5 31.7 18.4 106.4 129.2 8.3 120.0 19.7 34.2 29.2 47.8 29.0 15.1 53.3 76.1 27.2 17.2 18.8 27.3 17.4 60.5 47.5 41.5 17.2 387.9 111.8 32.5 94.5 64.0 68.8 70.5 120.9 93.7 96.3 78.3 134.8 53.6 118.1 57.2 133.3 101.9 134.1 61.0 103.6 80.0 95.7 91.0 70.3 128.4 271.9 176.3 80.3 55.3 58.4 69.1 102.9 116.4 111.8 104.3 57.9 129.9 119.8 71.2 265.0 54.1 114.9 56.2 277.5 143.3 103.4 89.0 121.5 78.2 116.6 65.7 34.4 77.8 414.4 107.2 35.8 137.6 85.3 274.2 74.8 72.5 193.4 125.8 110.7 99.3 45.7 88.4 95.9 59.6 30.9 190.9 29.5 34.9 237.6 53.4 55.6 45.5 36.8 194.7 54.9 48.8 33.7 77.4 38.9 217.0 178.8 58.3 91.4 16.2 15.0 13.8 18.2 15.1 17.0 16.2 17.2 18.4 15.1 17.2 17.2 46.7 28.9 54.9 3.6 57.0 70.1 134.0 183.0 30.7 11.4 61.6 45.5 25.3 42.9 206.3 22.0 18.8 86.7 50.2 234.3 70.5 49.4 42.8 63.4 37.9 63.4 64.9 18.7 6.7 100.7 159.2 50.6 99.4 55.8 43.8 29.5 34.2 33.6 160.0 10.1 7.2 362.7 95.6 67.7 107.6 71.5 32.3 89.8 129.9 6.5 53.1 14.1 14.4 2.0 3.1 70.9 181.0 26.4 141.1 213.6 66.5 68.3 204.5 8.0 13.1 32.9 91.3 10.5 21.9 42.0 61.7 150.8 50.6 44.6 260.1 223.3 NAXD "CARKD, FLJ10769, LP3298" ENSG00000213995 "NAD(P)HX dehydratase" Q8IW45 13 110615545-110639996 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 34.8;Distal tubular cells: 39.2;Extravillous trophoblasts: 26.7;Granulosa cells: 27.6;Syncytiotrophoblasts: 30.9;Theca cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010551 Approved NA NA 390000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "HPA010551: AB_1848669" "unprognostic (1.24e-1)" "unprognostic (5.14e-2)" "unprognostic (1.79e-2)" "prognostic favorable (3.15e-4)" "unprognostic (1.78e-1)" "unprognostic (1.81e-1)" "unprognostic (3.48e-2)" "unprognostic (2.89e-1)" "unprognostic (3.20e-1)" "unprognostic (9.01e-2)" "unprognostic (1.94e-2)" "unprognostic (4.36e-3)" "prognostic favorable (4.63e-5)" "unprognostic (2.19e-2)" "unprognostic (1.27e-1)" "unprognostic (2.30e-1)" "unprognostic (1.62e-2)" 17.3 37.1 44.0 16.0 43.7 8.2 19.4 43.6 46.3 16.7 40.8 23.1 22.9 18.7 26.6 23.4 22.6 21.3 26.4 45.7 42.8 24.9 65.4 18.8 20.8 45.9 45.0 39.0 36.2 28.4 22.4 23.3 44.5 25.8 19.7 14.3 22.8 28.9 31.9 30.5 23.0 21.7 43.9 21.8 30.3 24.2 46.2 18.3 25.4 33.6 17.1 17.3 15.0 45.2 36.0 15.7 28.1 24.3 29.8 23.6 35.4 27.9 22.7 24.6 26.2 43.9 35.1 7.3 28.4 21.7 25.3 28.1 16.3 24.4 16.0 31.6 27.4 22.5 47.9 23.5 34.2 29.3 20.2 29.1 42.4 19.8 17.7 32.5 21.9 31.8 19.6 0.2 22.3 30.0 23.1 48.4 21.2 64.4 17.2 8.2 14.4 5.9 30.3 30.1 42.5 28.6 16.8 75.4 21.6 18.5 39.7 54.4 25.3 17.1 14.3 0.1 22.4 25.6 18.7 0.3 27.7 8.7 28.9 0.0 8.3 0.8 9.6 9.0 6.3 8.4 9.6 8.9 10.4 8.2 9.9 9.1 1.0 9.2 6.5 10.1 10.5 8.3 44.0 43.7 43.6 46.3 45.7 42.8 45.9 45.0 44.5 43.9 46.2 45.2 9.3 19.2 12.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 14.2 11.3 0.0 0.0 9.9 22.0 0.0 34.8 5.4 0.0 39.2 15.0 0.0 7.3 10.5 4.0 0.0 0.0 0.0 11.8 26.7 6.2 0.0 8.8 1.3 27.6 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 10.3 0.0 0.0 0.0 0.0 11.6 0.0 0.0 2.1 0.0 0.0 22.4 8.7 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 30.9 2.1 24.4 0.0 0.0 NBEAL2 KIAA0540 ENSG00000160796 "Neurobeachin like 2" Q6ZNJ1 3 46979666-47009704 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.2" "Cell type enriched" "Detected in many" 4 "Gastric mucus-secreting cells: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HEL: 69.1;SK-BR-3: 64.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051969 Approved NA NA 31000 "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA051969: " "unprognostic (3.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-1)" "unprognostic (3.37e-2)" "unprognostic (5.99e-3)" "prognostic favorable (4.60e-4)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (6.27e-2)" "unprognostic (5.29e-2)" "unprognostic (1.06e-3)" "unprognostic (3.75e-1)" "unprognostic (6.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.34e-2)" 16.7 16.0 4.0 23.3 3.6 92.1 19.3 3.3 5.7 34.3 4.4 21.5 12.8 10.5 4.6 103.2 14.7 11.0 15.2 3.3 3.4 36.9 11.2 54.0 20.9 4.2 3.8 7.9 40.7 6.7 11.3 4.8 4.5 21.5 8.4 0.8 35.6 8.4 6.5 86.0 31.0 5.6 3.8 70.0 42.5 6.3 4.6 11.2 14.7 2.9 15.8 16.6 56.8 3.7 20.2 22.1 4.0 11.3 2.3 0.8 12.9 2.8 1.7 3.8 2.5 19.4 14.2 17.4 7.7 2.4 3.7 13.0 8.3 9.0 1.9 15.4 12.4 69.1 27.8 12.2 2.2 11.9 48.5 1.9 14.8 3.9 6.0 4.6 34.2 36.2 14.6 26.3 1.9 31.2 20.5 32.7 10.6 31.9 10.0 21.6 0.5 23.0 9.1 41.1 6.1 9.9 2.4 64.4 5.7 4.9 31.5 19.9 25.3 0.3 11.7 5.1 8.9 20.1 20.7 16.3 5.1 55.0 2.9 0.2 0.6 0.4 0.5 0.6 0.1 0.0 0.2 0.5 0.1 0.0 0.1 0.1 4.4 0.4 0.4 0.1 0.2 0.3 4.0 3.6 3.3 5.7 3.3 3.4 4.2 3.8 4.5 3.8 4.6 3.7 15.0 12.8 9.4 7.8 10.0 3.3 5.5 2.4 5.7 1.3 16.3 18.2 4.3 8.6 9.3 33.1 18.8 2.2 30.8 15.1 1.9 22.9 1.4 20.0 4.1 9.8 7.2 10.3 4.0 23.1 1.1 3.0 144.3 23.9 6.3 5.1 11.7 1.2 11.1 0.0 1.5 11.5 4.1 12.9 8.3 1.0 1.2 27.9 0.0 6.5 14.6 1.5 26.8 1.0 1.4 31.4 5.6 0.0 14.2 6.2 3.4 1.3 6.6 1.9 13.1 3.4 3.5 0.5 2.4 33.6 8.0 1.9 26.3 4.5 15.1 21.0 NBN "AT-V1, AT-V2, ATV, NBS, NBS1" ENSG00000104320 Nibrin O60934 8 89933331-90003228 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 265.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001429, CAB003836" Supported Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Nucleoplasm "CAB003836: AB_562172, HPA001429: AB_1854460" "unprognostic (1.52e-1)" "unprognostic (1.72e-1)" "unprognostic (2.32e-3)" "unprognostic (7.46e-2)" "unprognostic (2.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (5.05e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.15e-1)" "unprognostic (6.68e-2)" "unprognostic (3.14e-2)" "unprognostic (3.28e-1)" "unprognostic (2.84e-2)" "unprognostic (1.03e-1)" 22.5 12.4 9.2 27.8 12.8 54.0 25.4 9.3 10.0 16.9 7.4 18.3 15.1 22.3 11.4 20.0 14.5 22.5 12.1 10.2 12.5 20.7 22.3 18.1 24.3 10.7 8.6 16.9 15.5 15.4 9.0 14.1 9.9 17.5 22.5 9.8 16.6 14.9 10.0 10.3 16.0 24.2 11.0 23.4 12.7 16.4 11.0 19.0 22.7 16.2 26.4 21.8 9.6 15.0 54.8 30.1 29.3 15.6 16.5 38.7 18.9 37.9 49.5 46.6 50.8 17.2 41.8 83.8 42.2 35.5 19.1 17.7 35.7 35.7 59.8 38.0 19.7 67.7 16.8 23.6 30.8 40.0 35.2 30.5 18.3 27.2 57.9 22.8 39.5 33.9 50.6 46.6 55.3 46.9 65.6 26.0 8.5 39.5 31.4 42.3 25.3 47.0 62.8 73.8 8.1 26.6 23.5 265.1 23.1 16.3 49.8 31.4 29.2 40.9 28.0 25.5 38.0 21.2 25.0 45.5 41.3 39.4 39.1 32.4 17.7 32.9 11.9 19.7 12.7 15.2 8.5 8.8 18.9 8.9 8.1 9.0 34.4 16.1 31.5 10.4 5.9 13.1 9.2 12.8 9.3 10.0 10.2 12.5 10.7 8.6 9.9 11.0 11.0 15.0 36.9 48.1 14.2 24.5 39.8 11.9 13.5 20.4 23.9 25.4 29.7 22.9 30.3 14.3 33.7 27.6 2.1 23.0 29.3 11.2 43.0 35.1 17.6 45.4 46.9 22.9 12.1 31.7 45.0 32.0 19.7 36.3 19.9 31.2 79.7 38.3 18.9 30.6 25.9 13.5 39.9 16.9 16.2 29.2 27.1 7.2 19.0 51.1 12.4 32.8 54.7 29.4 36.0 40.7 40.3 24.7 9.9 26.4 38.8 11.6 9.9 40.5 36.4 11.2 6.6 50.3 31.7 20.2 46.0 31.5 13.5 10.8 35.3 68.7 19.4 11.0 NBPF9 AE01 ENSG00000269713 "NBPF member 9" P0DPF3 1 149054027-149103561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Hepatocytes: 28.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 49.5" "Group enriched" "Detected in all" 4 "granulocytes: 49.5;monocytes: 14.2" "Low cell line specificity" "Detected in all" "HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Approved Approved Microtubules,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol Microtubules "HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (1.25e-2)" "unprognostic (1.02e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-1)" "unprognostic (3.33e-3)" "unprognostic (1.94e-1)" "unprognostic (2.15e-2)" "unprognostic (2.93e-1)" "unprognostic (2.10e-1)" "unprognostic (6.90e-2)" "unprognostic (9.42e-6)" "unprognostic (6.23e-2)" "unprognostic (2.76e-1)" "unprognostic (6.63e-3)" "unprognostic (8.80e-2)" 15.8 10.5 8.8 11.5 8.6 8.9 13.7 17.3 9.1 16.6 11.4 14.4 6.4 14.2 17.0 9.6 14.6 9.5 10.0 9.0 8.9 11.5 33.8 17.2 13.6 9.6 10.2 14.9 18.6 9.6 13.8 7.5 8.7 12.8 9.0 21.4 10.2 7.2 6.8 12.8 15.2 11.5 7.5 15.5 13.2 10.7 10.6 4.0 25.9 2.6 10.7 12.4 12.5 8.1 50.1 21.4 26.2 35.5 23.0 28.1 20.7 44.7 32.5 23.1 25.0 16.2 21.0 11.9 12.1 23.1 27.8 14.7 18.2 20.9 39.4 30.2 19.1 3.8 41.2 9.7 26.7 5.0 13.8 27.8 15.4 25.4 44.1 42.7 20.5 9.0 14.1 30.1 28.4 38.8 1.4 7.4 9.8 8.8 28.8 13.5 16.3 18.0 18.8 22.9 16.9 34.9 14.8 35.7 19.5 16.0 26.5 9.3 48.6 52.0 15.2 38.2 69.8 36.7 20.8 23.0 18.9 3.2 18.6 49.5 14.2 0.6 0.6 5.1 1.0 2.7 1.8 0.6 1.9 5.5 2.5 1.4 8.2 7.8 2.0 7.7 2.5 1.4 8.8 8.6 17.3 9.1 9.0 8.9 9.6 10.2 8.7 7.5 10.6 8.1 2.5 38.5 16.0 8.5 9.0 5.5 8.7 2.6 2.8 4.8 4.7 2.8 4.2 4.3 12.5 5.5 6.2 2.9 7.2 0.8 0.0 3.4 11.1 8.6 8.7 5.3 1.8 2.1 8.5 2.0 4.0 12.4 4.1 8.8 18.9 7.3 2.2 28.2 3.6 0.0 6.2 1.0 4.1 12.1 17.0 3.8 7.2 12.7 3.6 6.5 14.3 3.7 3.1 7.5 3.2 2.9 7.7 4.1 9.8 3.6 1.6 1.0 6.8 12.0 6.6 7.0 5.2 9.9 4.2 5.9 14.2 1.4 6.3 3.8 1.1 5.9 NCCRP1 "FBXO50, LOC342897, NCCRP-1" ENSG00000188505 "NCCRP1, F-box associated domain containing" Q6ZVX7 19 39196964-39201884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 453.4;skin 1: 273.2;vagina: 181.7" "Cell type enriched" "Detected in some" 12 "monocytes: 563.9" "Group enriched" "Detected in many" 4 "cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 30.8" "Region enhanced" "Detected in single" "olfactory bulb: 1.6" "Low region specificity" "Detected in some" HPA052812 Approved NA NA 400000 "Cluster 17: Basophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" "HPA052812: AB_2681960" "unprognostic (3.56e-3)" "unprognostic (3.69e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.59e-3)" "unprognostic (3.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.37e-3)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (2.04e-2)" "unprognostic (1.90e-1)" "unprognostic (6.37e-6)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" 0.3 0.2 1.3 2.1 0.9 1.0 6.3 1.9 1.8 97.0 0.0 0.4 2.0 0.6 0.8 453.4 1.1 0.8 0.4 1.0 0.8 2.8 0.2 0.4 2.7 1.0 0.9 0.4 8.8 1.4 0.4 1.1 1.3 1.4 1.9 1.7 54.0 1.2 0.9 273.2 0.7 0.5 0.9 1.4 0.5 0.5 1.0 4.1 0.6 0.0 124.9 5.2 181.7 1.4 0.2 0.2 1.1 0.2 0.1 0.7 2.4 0.1 0.0 0.1 0.2 0.5 0.5 0.7 2.3 0.4 0.2 1.0 1.7 0.7 0.5 0.0 0.4 0.2 0.9 0.1 0.2 0.5 0.3 0.5 0.5 0.1 0.3 0.3 0.3 0.5 0.4 0.2 0.3 0.1 0.2 0.2 0.7 0.2 0.2 0.2 0.4 0.4 0.1 0.6 0.6 1.0 2.9 30.8 0.2 0.9 0.4 0.9 0.2 0.2 0.2 0.2 0.5 0.2 0.2 0.6 0.6 0.2 0.5 1.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 1.3 0.9 1.9 1.8 1.0 0.8 1.0 0.9 1.3 0.9 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 1.6 8.5 0.0 0.3 4.7 2.4 0.3 0.0 30.8 3.7 0.0 0.4 0.2 0.1 0.0 2.7 0.0 0.7 0.4 0.2 0.0 0.0 0.0 2.3 3.1 1.0 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 6.1 0.0 4.7 0.2 0.0 0.7 1.8 0.0 563.9 0.3 0.0 0.0 0.0 4.2 0.7 0.0 1.2 1.1 0.0 0.1 1.6 0.0 0.0 0.1 2.0 0.1 0.5 7.3 7.1 11.1 0.2 0.1 0.0 46.4 NCOA6 "AIB3, ASC2, KIAA0181, NRC, PRIP, RAP250, TRBP" ENSG00000198646 "Nuclear receptor coactivator 6" Q14686 20 34689097-34825651 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 130.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004198, HPA050211" Supported Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA004198: AB_1078228, HPA050211: AB_2681052" "unprognostic (2.48e-1)" "unprognostic (4.81e-2)" "unprognostic (1.72e-1)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.65e-4)" "unprognostic (2.05e-1)" "unprognostic (2.16e-1)" "unprognostic (1.40e-1)" "unprognostic (3.87e-2)" "unprognostic (1.51e-1)" "prognostic favorable (8.78e-5)" "unprognostic (9.04e-2)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.42e-2)" 10.2 9.0 5.2 9.1 6.7 14.0 9.2 12.7 12.4 10.8 4.8 12.9 13.2 10.7 12.2 11.7 11.3 8.8 9.2 6.1 8.2 9.9 8.4 10.4 8.9 6.3 4.6 11.6 12.6 22.0 10.0 13.5 4.6 9.8 14.5 26.7 12.9 11.3 12.7 13.5 12.0 13.2 2.3 9.4 11.4 18.8 7.4 18.1 13.8 13.1 10.3 10.4 10.5 9.6 25.2 14.7 32.6 19.7 17.5 19.4 21.3 12.0 15.3 21.1 16.9 37.9 17.2 17.7 12.9 21.5 25.8 30.0 29.3 20.2 23.9 9.0 13.2 41.6 16.7 22.4 19.3 23.5 29.4 14.8 36.5 19.8 24.5 14.6 20.2 20.1 21.5 23.7 17.7 16.3 37.5 14.8 6.7 21.0 21.1 24.9 39.3 15.9 15.6 16.6 27.2 18.5 22.0 52.5 20.5 15.0 22.2 18.5 20.0 34.1 20.7 25.6 20.2 26.9 24.3 20.0 22.5 13.5 15.5 1.1 0.6 2.5 0.9 0.5 0.8 1.0 0.8 0.8 1.1 0.8 0.7 0.5 1.5 0.7 0.7 1.0 0.5 0.5 5.2 6.7 12.7 12.4 6.1 8.2 6.3 4.6 4.6 2.3 7.4 9.6 17.3 25.6 16.0 54.9 11.0 17.0 9.1 10.6 13.6 28.8 14.3 10.9 20.1 18.6 11.6 16.5 29.2 13.0 12.2 31.9 5.9 12.5 23.5 16.4 21.3 14.0 10.8 13.3 50.9 12.4 12.1 14.5 15.8 23.3 6.3 18.5 13.9 12.1 10.8 33.7 58.8 17.4 20.3 12.2 10.3 17.3 18.0 13.0 10.6 45.9 17.6 11.5 13.4 54.3 130.4 15.4 12.4 13.5 14.2 16.9 20.3 9.3 17.5 29.8 26.3 16.6 16.9 25.6 27.1 19.2 20.9 15.9 13.1 13.6 17.6 14.6 NDRG3 ENSG00000101079 "NDRG family member 3" Q9UGV2 20 36651766-36746090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 114.7" "Group enriched" "Detected in all" 10 "Early spermatids: 962.7;Late spermatids: 356.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017851, HPA018256" Enhanced NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "HPA017851: AB_1854340, HPA018256: AB_1854341" "unprognostic (4.59e-2)" "unprognostic (9.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.34e-2)" "unprognostic (2.80e-1)" "unprognostic (9.27e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.56e-1)" "unprognostic (1.30e-2)" "unprognostic (5.42e-3)" "unprognostic (2.48e-3)" "unprognostic (3.52e-1)" "unprognostic (9.57e-2)" "unprognostic (2.66e-2)" "unprognostic (3.39e-1)" "unprognostic (3.98e-2)" "unprognostic (1.61e-1)" 16.2 38.2 45.6 14.3 47.5 8.2 18.4 63.2 67.9 22.8 21.4 25.9 19.2 22.6 15.9 18.6 18.9 15.6 30.6 58.5 50.3 18.3 8.1 16.9 18.3 63.6 42.6 27.3 14.4 39.6 22.3 11.6 66.3 54.6 21.5 114.7 18.5 17.1 20.8 17.3 17.4 24.5 40.4 18.6 15.0 75.5 54.9 20.9 15.5 16.5 21.7 16.4 19.1 51.2 49.3 27.3 34.9 20.8 36.2 39.5 11.5 20.2 24.3 33.8 33.0 52.9 25.0 24.9 23.0 41.4 53.2 44.9 45.5 71.1 38.1 18.8 33.7 69.4 37.0 59.6 19.0 18.2 21.0 37.2 40.3 28.8 8.3 38.5 43.2 43.7 27.6 52.1 30.3 18.4 25.2 25.4 10.5 62.0 47.2 21.9 54.9 18.2 40.0 22.4 31.0 26.6 31.4 136.5 30.7 28.1 63.6 16.0 18.9 32.7 21.2 13.2 25.6 24.3 21.6 15.8 61.2 31.3 17.7 6.7 7.2 14.9 16.9 9.6 17.5 12.9 17.4 16.0 11.1 8.8 14.6 15.5 10.6 27.3 12.0 5.7 18.3 10.2 45.6 47.5 63.2 67.9 58.5 50.3 63.6 42.6 66.3 40.4 54.9 51.2 12.9 22.4 6.9 22.2 13.4 11.1 15.3 11.4 15.9 49.8 10.3 8.9 24.6 11.5 9.6 7.3 50.1 9.8 10.4 15.0 27.4 14.0 962.7 6.7 11.3 11.5 7.3 5.0 64.6 14.2 12.5 14.0 12.2 7.5 5.7 14.2 11.4 5.2 27.1 21.9 65.3 9.4 18.3 23.4 12.7 356.6 27.7 14.6 12.4 22.5 9.6 25.9 17.5 39.7 29.1 13.2 6.0 27.8 10.8 13.2 13.1 12.0 9.9 65.2 26.3 12.8 16.8 22.4 20.2 25.2 7.7 6.8 17.5 13.8 13.3 8.8 NDST1 "HSST, NST1" ENSG00000070614 "N-deacetylase and N-sulfotransferase 1" P52848 5 150485818-150558211 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" "Hydrolase, Multifunctional enzyme, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 1.4;classical monocyte: 5.5;eosinophil: 3.6;intermediate monocyte: 1.7;myeloid DC: 4.2;neutrophil: 5.4;non-classical monocyte: 4.7" "Group enriched" "Detected in many" 10 "dendritic cells: 4.2;granulocytes: 5.4;monocytes: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060532 Approved NA NA 1400000 "Cluster 14: Monocytes - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA060532: AB_2684310" "unprognostic (1.36e-1)" "unprognostic (5.54e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.77e-1)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (5.13e-4)" "unprognostic (4.97e-3)" "unprognostic (6.92e-2)" "unprognostic (7.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.08e-2)" 37.2 22.7 39.4 14.0 45.1 7.6 28.6 43.8 38.9 16.0 3.9 17.6 12.5 17.3 7.9 38.8 14.7 15.2 26.8 30.8 30.7 15.4 42.6 34.3 7.3 62.6 48.8 23.0 39.7 20.5 6.7 12.2 50.3 14.5 9.5 13.9 37.4 16.8 23.6 34.2 17.4 19.2 47.8 43.4 16.0 14.5 51.5 4.2 22.9 13.0 9.9 14.1 18.7 60.0 32.4 28.3 46.1 56.4 45.3 44.9 46.3 58.1 75.9 56.8 84.8 84.1 33.3 22.0 57.6 116.8 91.0 54.4 25.1 118.0 37.6 2.6 38.9 26.0 18.5 13.2 33.5 19.5 45.5 61.6 48.1 68.7 31.0 56.9 78.3 12.9 25.3 7.8 56.3 27.5 2.3 6.2 21.6 9.1 33.0 37.6 38.4 9.8 33.4 32.5 13.8 48.3 35.2 108.5 46.3 32.7 58.3 4.8 38.8 96.4 86.2 42.3 48.3 17.1 4.7 8.1 79.2 30.1 38.0 1.4 5.5 3.6 0.1 1.7 0.0 0.4 0.0 0.4 4.2 0.1 0.0 0.2 5.4 0.0 4.7 0.3 0.0 2.8 39.4 45.1 43.8 38.9 30.8 30.7 62.6 48.8 50.3 47.8 51.5 60.0 29.8 38.5 8.7 23.8 1.9 5.7 3.5 14.4 6.2 11.6 29.9 15.4 11.5 17.2 9.6 16.5 8.4 8.6 0.5 20.9 1.9 10.4 0.7 5.5 7.7 35.5 1.2 3.2 12.0 10.5 11.3 11.0 2.0 6.8 1.3 20.4 31.8 47.5 7.7 13.5 11.7 5.3 8.2 14.4 7.6 1.9 12.5 8.7 10.6 16.9 7.4 12.1 0.0 12.1 39.7 18.8 6.6 32.0 3.7 7.9 17.8 8.8 3.8 11.3 0.0 8.7 11.5 0.7 1.6 17.4 12.4 4.5 1.2 11.8 5.8 5.3 NDUFA4 "CI-9k, COXFA4, MLRQ" ENSG00000189043 "NDUFA4 mitochondrial complex associated" O00483 7 10931943-10940153 "Disease related genes, Metabolic proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 513.5;skeletal muscle: 525.0;tongue: 652.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 4615.5;Distal tubular cells: 3960.0;Proximal tubular cells: 3331.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055323, HPA078265" Approved Supported Mitochondria NA NA 50000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA055323: , HPA078265: " "unprognostic (1.83e-1)" "unprognostic (6.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.51e-1)" "unprognostic (2.16e-1)" "unprognostic (4.97e-3)" "unprognostic (3.85e-1)" "unprognostic (2.25e-1)" "unprognostic (1.69e-1)" "unprognostic (3.90e-2)" "unprognostic (8.65e-3)" "unprognostic (1.74e-1)" "prognostic favorable (4.61e-8)" "unprognostic (1.24e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-3)" "unprognostic (2.08e-1)" 78.6 90.1 188.7 40.8 196.2 67.5 76.0 192.9 263.4 54.7 192.8 84.1 74.2 74.2 81.1 66.9 69.5 36.2 513.5 201.9 205.0 156.6 140.3 62.8 42.5 194.4 189.6 60.1 61.3 251.9 23.3 31.6 197.6 66.0 56.6 128.4 108.6 84.4 525.0 58.3 58.8 60.9 194.1 59.6 107.0 24.3 194.3 64.0 66.3 652.5 46.1 73.7 54.1 200.1 55.3 90.9 155.0 176.8 84.0 78.4 70.3 68.2 63.2 61.3 53.6 115.2 144.7 104.6 63.0 96.7 168.0 94.1 102.1 79.4 66.5 52.2 74.0 88.2 93.4 108.6 73.2 123.3 84.3 84.8 78.4 75.4 66.0 116.7 86.6 92.7 133.2 139.0 129.8 103.8 56.2 109.3 169.2 364.2 181.6 74.7 108.6 118.6 158.0 115.4 95.2 99.7 106.9 303.7 64.7 210.3 191.6 149.6 76.8 73.3 102.0 107.0 115.0 84.6 115.8 120.5 101.3 130.8 232.5 236.7 110.2 160.6 74.3 135.8 88.3 95.7 103.3 93.9 138.9 74.6 106.1 93.3 25.3 79.4 146.4 131.2 131.6 192.8 188.7 196.2 192.9 263.4 201.9 205.0 194.4 189.6 197.6 194.1 194.3 200.1 422.2 490.4 470.7 52.9 366.9 407.1 605.8 1642.7 307.9 521.0 742.3 936.0 4615.5 843.6 879.3 952.7 266.9 875.9 357.5 543.8 3960.0 865.1 160.6 626.2 471.6 447.0 209.7 358.3 54.1 955.5 763.9 557.9 404.7 477.7 576.4 507.5 656.1 1887.5 964.5 158.2 72.7 780.8 1373.2 589.0 589.8 106.8 493.6 517.6 916.0 49.6 596.6 721.5 374.9 36.7 57.9 776.6 626.7 784.3 467.9 696.6 596.2 3331.1 803.0 666.0 335.2 546.5 846.5 172.7 295.5 581.7 482.9 658.8 389.1 443.5 712.4 803.2 NDUFAF3 "2P1, C3orf60, DKFZP564J0123, E3-3, MGC10527" ENSG00000178057 "NADH:ubiquinone oxidoreductase complex assembly factor 3" Q9BU61 3 49020459-49023495 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 329.8" "Group enriched" "Detected in all" 4 "Distal tubular cells: 475.4;Early spermatids: 1124.6;Late spermatids: 1303.4;Proximal tubular cells: 658.1;Spermatocytes: 913.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035376, HPA035377" Enhanced NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA035376: AB_2674597, HPA035377: AB_10673219" "unprognostic (2.90e-2)" "unprognostic (2.72e-2)" "unprognostic (6.88e-2)" "unprognostic (3.03e-2)" "unprognostic (3.57e-2)" "unprognostic (2.61e-1)" "unprognostic (6.28e-3)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.64e-2)" "unprognostic (8.62e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.86e-5)" "unprognostic (7.97e-2)" "unprognostic (1.73e-1)" "unprognostic (8.02e-2)" "unprognostic (1.60e-1)" 69.0 121.9 112.1 36.4 119.9 51.7 60.7 124.3 123.6 58.4 117.3 43.5 34.9 58.6 47.7 48.5 61.7 32.3 166.0 109.4 117.8 88.6 85.2 52.2 45.3 121.2 116.5 59.4 48.8 84.1 99.0 29.9 120.2 57.2 27.0 26.2 70.7 51.5 127.0 33.1 41.4 30.7 120.5 53.9 49.8 329.8 118.0 52.0 71.2 99.6 37.7 51.1 45.7 126.8 47.7 68.4 60.6 59.9 78.5 66.6 35.0 59.6 57.5 82.8 64.5 98.9 75.1 55.1 68.5 92.1 113.4 34.9 43.3 95.4 29.6 72.9 76.8 109.5 129.9 124.8 110.4 92.2 50.8 68.5 72.5 116.6 85.8 98.9 73.0 169.4 31.4 136.0 90.8 73.9 134.1 46.5 20.1 78.1 183.0 41.1 24.3 169.3 136.7 97.4 52.9 61.6 55.0 115.1 59.1 27.3 66.5 177.6 64.4 76.4 52.0 108.0 100.1 110.8 79.3 86.6 93.2 48.4 121.8 144.3 164.6 143.9 157.6 175.3 168.4 244.1 172.6 160.6 144.9 234.0 223.3 170.2 51.8 154.9 201.2 297.8 180.5 250.4 112.1 119.9 124.3 123.6 109.4 117.8 121.2 116.5 120.2 120.5 118.0 126.8 117.4 93.0 95.2 7.2 95.3 53.3 143.7 113.6 66.0 60.4 119.4 125.5 198.0 104.4 109.6 150.8 2.1 135.2 81.9 124.6 475.4 171.7 1124.6 123.4 81.8 104.3 132.0 118.2 7.2 155.7 128.0 121.2 50.0 58.2 117.3 73.1 114.9 150.6 217.8 69.0 8.3 118.1 103.7 114.1 73.8 1303.4 170.2 129.5 136.9 11.2 149.6 171.5 103.0 6.6 19.6 139.5 148.0 120.7 151.1 175.5 176.9 658.1 199.2 52.8 72.3 87.5 106.4 913.0 88.6 108.4 54.8 106.9 91.2 105.6 109.4 154.9 NDUFB9 "B22, LYRM3, UQOR22" ENSG00000147684 "NADH:ubiquinone oxidoreductase subunit B9" Q9Y6M9 8 124539101-124580648 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1314.9;tongue: 1486.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 2950.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042768 Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA042768: AB_10797508" "unprognostic (1.18e-2)" "unprognostic (2.00e-2)" "unprognostic (1.30e-1)" "unprognostic (2.03e-3)" "unprognostic (8.32e-2)" "unprognostic (9.71e-2)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.16e-2)" "unprognostic (3.80e-2)" "unprognostic (1.51e-1)" "unprognostic (3.64e-1)" "prognostic favorable (3.42e-5)" "unprognostic (9.54e-2)" "unprognostic (9.64e-2)" "unprognostic (4.94e-2)" "unprognostic (2.74e-1)" 155.6 158.2 259.0 78.5 263.8 265.2 157.8 281.1 381.2 109.7 245.0 226.4 184.6 129.5 147.4 209.2 126.0 70.4 789.5 257.6 288.7 324.9 325.0 122.9 96.5 279.3 277.8 107.1 209.4 282.9 124.0 81.2 281.5 117.8 191.0 135.8 210.9 115.1 1314.9 149.3 162.9 111.1 253.4 116.8 241.2 204.7 286.2 102.8 154.2 1486.4 104.1 139.9 124.7 274.1 348.2 316.8 236.1 321.2 240.6 204.2 196.0 165.2 189.3 297.4 222.4 417.7 327.6 341.0 421.0 193.6 153.9 385.5 347.3 266.7 279.9 395.8 464.8 831.3 199.6 505.9 320.8 261.8 218.2 239.6 382.1 271.9 587.9 160.1 275.9 241.1 523.7 277.6 243.4 1089.0 415.8 522.7 237.5 1247.0 692.7 276.3 179.9 468.0 400.0 288.8 326.6 255.0 362.4 2950.7 382.8 141.1 407.3 348.2 219.7 172.5 444.1 162.9 399.5 354.8 517.7 392.5 298.6 515.4 233.1 302.2 253.1 136.2 210.5 179.2 209.6 260.9 275.8 237.1 247.5 201.4 269.1 223.9 49.2 188.9 136.1 183.1 346.0 345.8 259.0 263.8 281.1 381.2 257.6 288.7 279.3 277.8 281.5 253.4 286.2 274.1 169.0 125.0 124.8 7.8 147.7 217.8 277.5 448.3 178.7 77.4 247.3 313.0 1005.6 260.2 267.3 286.9 98.0 494.6 119.9 525.0 800.3 338.0 389.8 120.7 100.6 164.1 233.7 227.6 10.5 405.7 296.0 187.9 169.7 109.2 139.4 149.9 167.4 517.7 380.6 37.0 14.9 421.0 488.3 206.0 137.6 865.4 158.8 183.0 247.3 15.9 226.3 144.1 171.0 7.1 18.2 378.1 450.0 152.7 169.1 290.3 584.6 789.7 208.6 91.1 170.9 221.2 511.8 317.6 264.8 377.0 188.4 523.0 155.6 216.0 521.7 315.8 NFYB "CBF-A, HAP3, NF-YB" ENSG00000120837 "Nuclear transcription factor Y subunit beta" P25208 12 104117086-104138241 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Syncytiotrophoblasts: 433.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004211, HPA065646" Supported Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "CAB004211: AB_628018, HPA065646: " "unprognostic (5.82e-2)" "unprognostic (2.44e-3)" "unprognostic (4.90e-2)" "unprognostic (7.10e-3)" "unprognostic (2.67e-1)" "unprognostic (4.65e-2)" "unprognostic (2.10e-2)" "unprognostic (2.44e-1)" "unprognostic (7.36e-2)" "unprognostic (2.63e-1)" "unprognostic (9.39e-2)" "unprognostic (8.51e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.62e-3)" "unprognostic (4.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.81e-3)" 32.9 40.8 34.0 15.2 34.3 14.7 27.2 30.5 50.8 28.6 26.8 60.4 15.0 30.5 33.1 16.1 30.1 18.5 37.4 31.0 31.2 24.0 30.6 29.0 24.7 32.9 34.0 23.2 21.3 21.7 17.4 23.6 32.0 39.0 18.4 21.2 20.6 67.9 36.2 18.4 21.7 21.1 34.7 19.4 26.3 22.6 32.1 26.3 22.7 36.3 22.8 38.1 23.9 36.2 30.1 25.3 55.3 35.7 34.2 35.6 48.6 31.5 27.2 37.2 25.6 21.2 14.0 44.4 15.1 30.3 22.9 22.0 46.5 20.9 37.4 28.9 14.7 27.4 31.0 19.7 31.0 35.0 17.6 49.3 25.6 14.5 25.5 62.0 24.0 40.1 27.1 16.2 31.6 29.6 53.2 40.5 52.8 22.1 26.0 43.5 30.9 18.8 27.3 25.3 31.3 26.2 58.0 132.5 19.3 36.8 53.1 42.9 15.2 21.3 13.1 17.5 24.0 28.5 29.5 42.0 12.5 23.7 22.8 18.0 5.7 18.5 12.1 7.8 16.6 12.3 12.1 12.5 5.7 8.5 13.0 13.7 7.2 13.5 9.0 5.0 16.9 9.1 34.0 34.3 30.5 50.8 31.0 31.2 32.9 34.0 32.0 34.7 32.1 36.2 42.5 54.5 26.7 8.8 21.1 37.3 106.8 42.9 15.9 22.7 24.3 31.8 39.5 12.8 30.3 18.4 4.2 58.8 24.5 13.3 37.2 24.2 6.2 20.4 36.4 36.5 12.0 39.4 13.1 18.3 86.3 43.0 11.2 17.5 21.5 30.8 77.1 31.2 23.1 15.2 13.7 15.4 30.5 14.4 29.8 5.4 34.2 19.2 28.4 8.4 20.2 43.3 22.6 11.1 25.3 27.3 16.9 30.5 17.1 54.5 12.6 42.5 26.7 27.2 19.7 35.4 40.0 90.0 32.4 18.0 37.1 433.2 25.6 18.8 18.3 55.7 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.9 21.5 13.1 18.1 13.8 64.7 32.3 19.3 14.1 27.0 12.8 18.6 17.6 26.3 15.3 24.4 20.2 22.6 40.0 11.2 14.2 29.2 77.7 19.7 22.3 10.8 13.4 26.4 34.9 21.9 12.7 25.6 11.8 27.7 21.2 17.0 32.8 20.0 60.3 17.2 15.4 28.3 12.1 21.1 42.5 16.0 13.0 18.7 25.2 34.5 24.7 39.3 16.5 13.9 68.7 39.2 37.8 38.6 46.3 63.1 51.9 76.3 57.9 55.9 64.8 66.5 54.9 86.4 94.8 53.8 39.3 43.8 60.9 56.1 86.4 90.2 37.4 89.0 31.4 41.7 50.7 108.0 51.7 53.2 40.9 39.7 129.1 59.4 61.4 29.9 66.3 46.3 66.8 155.7 49.6 41.3 47.4 82.1 61.7 59.8 54.5 87.9 53.1 153.2 59.8 37.3 43.5 105.2 63.9 40.9 78.3 49.0 54.2 44.1 31.5 51.3 93.4 75.6 54.5 87.1 55.5 69.5 61.5 30.5 16.6 8.9 16.5 17.6 25.9 17.3 19.2 20.4 19.8 15.6 25.3 20.1 3.6 35.4 11.4 11.0 26.8 20.7 13.1 13.8 19.3 14.1 11.2 14.2 10.8 13.4 11.8 12.1 13.0 13.9 30.6 19.2 14.6 22.9 25.3 64.9 52.9 23.8 34.7 24.7 26.8 16.5 43.9 21.5 25.1 11.0 14.6 33.3 25.2 14.0 35.2 25.6 19.3 13.8 29.6 30.1 13.8 32.2 16.6 38.9 48.8 34.0 31.1 19.3 25.4 20.3 22.1 41.6 23.4 30.3 15.3 19.4 26.4 33.1 47.0 7.0 25.4 21.6 24.9 12.2 26.1 12.8 21.6 19.6 18.2 33.0 13.9 27.4 20.9 46.7 19.7 39.9 18.5 20.8 26.3 29.1 87.5 39.2 27.4 33.4 74.3 56.6 25.8 24.4 21.2 72.7 NME1-NME2 "NM23-LV, NMELV" ENSG00000011052 "NME1-NME2 readthrough" 17 51153590-51171744 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 51.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 43.5;Basal keratinocytes: 38.4;Basal respiratory cells: 23.3;Club cells: 31.1;granulocytes: 22.7;Langerhans cells: 35.0;Melanocytes: 23.2;Suprabasal keratinocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002169, HPA008467, HPA041113, CAB076057" Approved Approved Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 77: Retina - Visual perception" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Cytosol "CAB002169: AB_563917, CAB076057: , HPA008467: AB_1079492, HPA041113: AB_2677305" "unprognostic (2.39e-1)" "unprognostic (5.29e-2)" "unprognostic (9.70e-2)" "unprognostic (5.13e-2)" "prognostic favorable (6.66e-4)" "unprognostic (2.46e-2)" "unprognostic (4.82e-3)" "unprognostic (8.39e-2)" "unprognostic (2.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.58e-6)" "unprognostic (1.03e-1)" "unprognostic (2.74e-6)" "unprognostic (1.84e-1)" "unprognostic (9.72e-2)" "unprognostic (1.50e-1)" "unprognostic (1.43e-3)" 12.3 21.0 7.2 15.1 7.4 10.9 8.7 6.5 10.3 8.7 6.3 6.7 3.6 9.3 0.8 14.7 9.4 2.2 9.9 8.7 6.8 12.4 16.4 9.2 8.7 7.8 6.7 5.6 16.6 6.4 11.9 7.1 7.8 6.8 2.9 51.2 13.8 2.2 12.9 12.2 4.9 6.8 6.5 7.9 9.0 3.0 7.7 6.2 7.4 3.6 3.7 13.1 9.9 7.3 22.4 5.5 21.2 48.3 27.9 13.1 7.7 32.3 20.8 15.9 9.5 11.1 8.6 30.1 34.3 41.3 33.2 21.9 25.1 44.7 8.8 51.0 46.6 15.2 9.1 22.7 30.5 25.5 42.2 25.4 36.2 21.2 31.4 49.6 28.0 38.8 21.2 36.7 12.3 14.6 141.2 37.4 19.6 66.5 9.5 49.5 21.0 85.0 23.0 9.4 70.1 56.4 13.9 112.7 38.3 37.8 87.8 86.3 34.1 57.0 14.6 76.8 26.2 60.8 52.2 41.4 26.7 24.6 46.4 0.4 16.0 0.7 18.2 24.1 26.9 14.1 15.7 17.1 45.9 23.4 13.9 16.9 1.7 14.4 11.9 28.4 16.9 20.8 7.2 7.4 6.5 10.3 8.7 6.8 7.8 6.7 7.8 6.5 7.7 7.3 0.0 16.0 43.5 0.0 1.5 38.4 0.0 23.3 2.2 0.0 0.0 0.0 2.2 0.0 31.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.2 0.2 5.1 1.8 0.4 3.9 0.0 0.1 12.1 1.5 0.2 22.7 0.1 0.4 0.6 0.0 0.0 3.5 7.2 10.2 0.0 35.0 0.0 0.3 6.8 23.2 0.0 0.0 0.0 0.0 2.0 0.9 0.0 1.1 0.0 2.0 0.0 0.0 0.1 16.3 0.0 0.0 0.0 16.4 0.1 0.0 3.8 51.9 0.0 3.0 0.0 7.8 0.1 NSMCE2 "C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7" ENSG00000156831 "NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase" Q96MF7 8 125091679-125367120 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway" Transferase "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 136.1;Excitatory neurons: 150.1;Inhibitory neurons: 156.8;Microglial cells: 157.4;Oligodendrocyte precursor cells: 139.2;Oligodendrocytes: 386.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051614, HPA065734" Supported Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 52: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA051614: AB_2681551, HPA065734: AB_2685549" "unprognostic (1.14e-3)" "unprognostic (1.29e-1)" "unprognostic (6.56e-2)" "unprognostic (1.22e-3)" "unprognostic (8.65e-2)" "unprognostic (8.89e-3)" "prognostic unfavorable (7.54e-4)" "unprognostic (3.99e-2)" "unprognostic (2.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.09e-2)" "unprognostic (1.17e-1)" "unprognostic (7.53e-2)" "unprognostic (2.61e-2)" "unprognostic (6.85e-2)" 19.9 18.1 11.0 14.1 12.8 30.3 23.7 12.4 12.9 17.0 13.4 18.6 12.5 15.8 18.6 17.0 13.4 15.9 23.8 11.2 12.4 18.9 17.8 14.2 21.7 12.2 11.9 19.0 12.8 17.8 11.2 19.6 12.6 13.2 17.5 16.7 16.0 13.9 33.6 15.8 12.3 16.1 11.8 14.5 16.6 15.5 12.7 26.0 18.1 27.2 26.1 20.7 14.7 16.1 43.0 36.3 42.3 26.9 32.7 48.9 20.5 33.5 62.5 58.2 67.0 23.4 39.9 53.2 38.5 32.0 42.9 31.1 33.4 28.2 58.8 60.0 32.4 75.4 20.0 34.1 47.7 22.8 22.1 36.5 38.4 33.6 43.6 38.8 53.2 27.5 44.1 34.2 51.4 74.3 58.9 20.9 9.3 48.4 48.0 33.3 29.4 48.6 35.5 32.1 28.0 29.7 40.1 119.2 56.3 24.9 50.9 25.9 33.3 22.3 62.9 27.8 48.3 45.1 86.6 67.6 35.4 43.4 35.3 12.9 23.9 69.4 22.0 21.7 24.3 25.0 23.1 24.8 24.4 25.5 23.7 25.9 11.3 22.0 23.3 14.2 37.6 24.5 11.0 12.8 12.4 12.9 11.2 12.4 12.2 11.9 12.6 11.8 12.7 16.1 21.8 9.6 13.1 136.1 22.0 23.8 36.3 39.1 21.1 23.8 23.3 24.8 20.1 21.5 26.0 11.0 16.7 34.2 20.3 16.2 27.4 33.1 28.0 26.4 19.7 23.0 13.8 36.2 150.1 42.5 27.8 21.4 13.7 20.7 25.4 24.1 23.2 13.7 44.3 15.2 156.8 17.7 18.3 26.5 24.3 9.9 23.3 24.4 17.8 157.4 29.4 18.4 20.6 139.2 386.0 34.2 19.5 24.5 20.2 28.1 20.6 35.2 23.4 26.4 6.6 20.7 23.4 44.4 31.7 16.0 18.9 46.7 24.6 20.9 19.8 37.6 NSRP1 "CCDC55, DKFZP434K1421, NSrp70" ENSG00000126653 "Nuclear speckle splicing regulatory protein 1" Q9H0G5 17 30115521-30186475 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015593, HPA015603" Enhanced Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA015593: AB_2072217, HPA015603: AB_1846157" "unprognostic (3.96e-1)" "unprognostic (2.16e-2)" "unprognostic (5.45e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" "unprognostic (7.76e-2)" "unprognostic (1.83e-1)" "unprognostic (5.93e-3)" "unprognostic (6.12e-2)" "unprognostic (2.21e-1)" "unprognostic (3.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.43e-1)" 23.1 18.8 25.0 18.8 28.4 25.0 21.9 34.0 34.4 18.6 32.5 25.0 16.8 22.9 22.5 19.5 19.6 19.6 25.8 21.7 28.5 21.4 20.2 18.8 22.3 29.8 25.5 22.8 20.3 24.2 17.9 22.0 27.9 20.5 18.3 19.5 18.0 17.9 25.2 25.0 17.9 21.1 25.0 19.4 19.1 19.3 26.9 17.6 25.5 20.8 19.9 21.1 18.0 34.7 30.9 27.3 26.3 21.0 35.0 33.0 18.6 41.8 42.6 31.4 33.5 28.3 19.6 56.1 32.6 39.8 38.5 44.4 41.1 32.2 50.8 13.5 55.7 25.6 43.8 21.1 56.5 40.0 29.8 38.3 41.5 50.1 64.6 36.5 29.7 20.3 41.0 35.6 43.8 22.1 26.9 39.0 17.4 33.8 22.0 30.8 43.3 37.8 32.5 32.9 24.8 21.6 32.1 84.2 38.6 26.4 44.1 44.3 32.4 37.7 26.7 40.0 67.1 25.8 36.9 44.1 46.5 35.5 44.1 66.1 39.7 33.1 32.2 38.2 36.0 62.1 35.8 32.1 21.5 57.9 34.6 31.5 59.5 32.8 44.4 62.4 35.6 14.5 25.0 28.4 34.0 34.4 21.7 28.5 29.8 25.5 27.9 25.0 26.9 34.7 97.5 76.9 91.0 49.0 59.2 67.6 95.9 124.0 88.8 62.6 51.4 64.1 147.3 72.9 80.6 84.6 35.5 58.3 54.0 57.5 97.8 71.7 259.2 79.2 89.6 91.9 31.3 68.0 30.6 75.2 69.5 76.3 37.8 76.6 83.4 43.6 94.9 143.7 53.6 74.0 41.9 65.1 59.0 63.1 46.5 137.0 77.0 52.3 49.8 69.3 70.6 78.7 63.8 52.8 88.5 71.1 54.1 71.5 48.2 75.8 57.9 90.6 84.9 56.8 72.3 113.1 97.1 186.9 105.8 40.7 52.0 110.8 52.5 56.1 54.3 63.2 NTAQ1 "C8orf32, FLJ10204, WDYHV1" ENSG00000156795 "N-terminal glutamine amidase 1" Q96HA8 8 123416726-123470028 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 109.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024823, HPA053680" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA024823: AB_1845773, HPA053680: AB_2682228" "unprognostic (9.97e-2)" "unprognostic (4.82e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (4.93e-5)" "unprognostic (1.69e-1)" "unprognostic (5.00e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (1.90e-1)" "unprognostic (1.19e-1)" "unprognostic (5.79e-2)" "unprognostic (2.81e-2)" "unprognostic (1.26e-1)" "unprognostic (5.39e-2)" "unprognostic (7.46e-2)" "unprognostic (2.37e-1)" 7.1 10.9 16.2 5.1 16.7 5.9 13.5 16.3 24.0 12.8 15.5 7.5 4.3 8.1 8.9 6.9 7.5 6.7 20.1 14.8 17.8 13.0 6.8 6.8 7.4 17.0 17.9 18.2 9.6 11.0 10.5 6.8 17.4 10.2 7.9 14.9 6.9 8.8 16.0 7.7 4.4 9.5 15.8 5.2 8.5 12.7 20.0 7.1 12.8 17.6 10.1 8.8 7.2 17.7 26.6 26.9 39.2 18.1 15.3 40.9 14.5 19.1 21.3 23.4 26.1 15.8 17.8 19.7 19.8 23.8 32.7 12.8 25.8 29.7 31.4 53.1 15.8 25.6 13.2 22.4 21.2 12.7 10.9 24.1 16.0 29.3 32.8 27.1 22.6 41.2 18.8 29.0 33.5 84.3 30.2 14.4 12.3 65.6 20.5 13.5 20.0 20.4 31.1 22.6 18.6 34.1 20.7 109.0 35.8 44.5 17.6 12.2 9.8 26.5 46.2 19.7 26.4 17.4 38.1 24.1 18.8 14.1 19.1 16.3 5.7 2.1 6.2 8.7 7.4 5.0 7.3 7.7 9.0 4.1 6.2 6.9 1.5 16.0 3.8 5.2 10.6 4.6 16.2 16.7 16.3 24.0 14.8 17.8 17.0 17.9 17.4 15.8 20.0 17.7 5.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 13.9 2.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 23.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 10.0 0.3 0.0 0.0 0.0 NUFIP2 "182-FIP, 82-FIP, FIP-82, KIAA1321, MGC117262, PIG1" ENSG00000108256 "Nuclear FMR1 interacting protein 2" Q7Z417 17 29255839-29294148 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 79.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067443 Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear bodies, Cytosol" "HPA067443: AB_2685841" "unprognostic (6.51e-2)" "unprognostic (6.96e-3)" "unprognostic (1.17e-1)" "unprognostic (2.95e-2)" "unprognostic (3.38e-1)" "unprognostic (2.12e-1)" "unprognostic (4.94e-3)" "unprognostic (1.40e-1)" "unprognostic (3.79e-2)" "unprognostic (9.42e-3)" "unprognostic (1.60e-3)" "unprognostic (5.24e-2)" "unprognostic (1.28e-3)" "unprognostic (3.45e-1)" "unprognostic (1.79e-1)" "unprognostic (7.18e-2)" "unprognostic (6.04e-3)" 15.3 14.9 4.4 22.7 3.6 79.9 12.5 10.3 20.4 12.7 11.7 14.9 16.2 11.5 11.9 17.2 10.9 14.0 13.6 5.1 19.9 13.0 24.0 21.0 19.8 12.1 14.7 12.0 14.7 18.4 11.0 29.6 11.0 12.1 13.0 23.1 15.5 9.8 15.9 12.1 13.2 10.3 2.1 20.7 18.7 14.2 10.8 18.0 13.5 17.6 17.5 16.4 14.2 14.1 42.5 67.1 38.9 27.2 32.8 38.0 65.1 41.3 24.8 31.1 28.4 75.0 22.5 68.5 60.1 28.5 27.7 58.6 31.4 28.9 39.3 74.0 55.9 51.8 64.7 19.8 30.3 66.6 53.8 33.1 34.5 34.4 36.7 35.9 23.2 24.8 86.2 49.5 32.1 34.8 70.6 30.1 40.2 32.2 24.9 57.2 66.8 29.4 26.1 68.4 37.1 23.5 73.6 136.6 44.6 51.5 47.3 44.2 38.5 59.1 59.1 35.0 71.3 68.4 68.9 79.3 39.0 34.9 51.6 13.6 6.1 8.5 5.6 5.9 4.3 8.5 5.5 6.2 5.2 7.6 7.0 5.9 25.4 5.1 9.6 12.1 3.2 2.3 4.4 3.6 10.3 20.4 5.1 19.9 12.1 14.7 11.0 2.1 10.8 14.1 139.7 80.1 67.0 58.1 76.8 99.5 78.2 40.0 118.4 55.3 105.0 124.8 81.7 38.6 69.3 31.3 95.9 69.2 124.3 72.6 15.6 33.9 35.2 108.2 139.0 85.9 48.3 55.6 47.4 27.9 31.3 86.4 82.6 154.2 46.2 41.2 55.0 54.6 44.6 57.2 47.1 62.5 20.3 74.7 108.8 24.9 35.4 122.9 40.9 41.2 50.0 35.2 37.0 44.7 85.9 37.4 43.1 35.0 65.2 91.8 26.5 27.6 88.8 60.6 19.7 171.7 78.5 36.6 29.8 120.8 97.7 182.0 93.8 51.8 57.1 111.9 OLAH "FLJ11106, SAST, THEDC1" ENSG00000152463 "Oleoyl-ACP hydrolase" Q9NV23 10 15032227-15073853 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 9.0;testis: 27.0" "Cell type enriched" "Detected in some" 4 "Early spermatids: 537.8" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.6" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 2.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.6" "Cell line enhanced" "Detected in some" "HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037947, HPA037948" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "HPA037947: AB_10795028, HPA037948: AB_10805352" "unprognostic (2.01e-1)" "unprognostic (6.12e-2)" "unprognostic (8.20e-3)" "unprognostic (4.04e-3)" "unprognostic (1.92e-1)" "unprognostic (8.09e-2)" "unprognostic (7.12e-2)" "unprognostic (5.12e-2)" "unprognostic (4.55e-1)" "unprognostic (3.74e-2)" "unprognostic (4.70e-1)" "unprognostic (1.69e-1)" "unprognostic (5.22e-10)" "unprognostic (4.55e-2)" "unprognostic (2.09e-1)" "unprognostic (5.11e-2)" "unprognostic (9.78e-2)" 1.5 0.9 1.1 0.2 0.8 1.1 5.5 0.6 1.5 0.8 0.8 0.2 0.1 0.4 0.4 3.0 1.7 1.0 0.2 1.1 0.3 1.1 0.3 1.7 0.3 0.5 0.3 0.2 0.1 0.3 1.0 3.2 0.3 0.3 0.0 0.7 2.7 0.1 0.2 0.7 0.5 0.2 0.2 9.0 0.3 27.0 0.7 0.1 0.4 0.3 0.0 0.2 0.8 1.2 0.0 0.0 0.1 0.2 0.2 0.7 1.2 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.5 0.0 0.4 3.6 4.8 0.5 0.0 0.0 0.4 0.1 0.2 0.1 3.6 0.0 0.3 0.2 0.2 0.0 0.3 0.4 0.7 0.2 0.0 0.0 0.0 0.1 0.1 5.3 0.0 2.6 0.1 0.1 0.2 0.0 1.8 0.1 0.1 3.1 0.7 0.2 1.1 0.2 0.0 0.8 0.1 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 2.6 0.4 0.0 0.5 0.2 0.0 1.1 0.8 0.6 1.5 1.1 0.3 0.5 0.3 0.3 0.2 0.7 1.2 0.7 3.2 0.6 0.3 0.1 0.3 0.5 0.0 0.0 0.1 131.3 0.9 0.4 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 2.7 537.8 0.1 0.2 0.3 0.0 0.0 0.1 0.0 1.7 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 2.2 0.3 66.1 4.4 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 8.2 0.0 0.4 0.0 0.0 0.8 0.7 6.6 0.5 1.0 2.8 1.9 0.0 0.3 11.4 0.9 0.1 0.0 0.1 OSBPL2 "DFNA67, KIAA0772, ORP-2" ENSG00000130703 "Oxysterol binding protein like 2" Q9H1P3 20 62231922-62296213 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Lipid transport, Transport" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 94.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 94.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041127, HPA042659" Uncertain Approved Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA041127: AB_10962008, HPA042659: AB_10960683" "unprognostic (1.00e-3)" "unprognostic (7.20e-3)" "unprognostic (1.31e-1)" "unprognostic (6.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.73e-3)" "unprognostic (3.79e-2)" "unprognostic (9.60e-2)" "unprognostic (6.22e-2)" "unprognostic (1.50e-1)" "unprognostic (1.73e-1)" "unprognostic (6.82e-3)" "prognostic favorable (4.20e-5)" "unprognostic (3.86e-2)" "unprognostic (8.13e-2)" "unprognostic (4.00e-1)" "unprognostic (3.32e-2)" 14.6 15.2 21.1 13.4 21.2 32.9 18.9 38.9 21.4 21.9 20.0 24.3 22.8 14.0 15.8 40.7 15.6 20.0 25.4 16.6 20.3 20.8 18.0 16.2 14.3 23.7 24.0 15.8 39.7 26.4 26.4 13.7 22.3 19.8 22.7 14.5 24.9 18.8 18.0 43.5 21.6 17.4 19.4 24.9 27.9 14.9 29.8 17.2 21.9 11.9 20.4 23.1 29.8 19.4 23.9 17.0 19.6 18.3 19.4 19.1 18.5 14.2 27.9 46.6 32.1 61.0 24.1 11.5 37.1 28.4 41.8 40.7 18.9 42.4 25.7 13.7 17.7 30.6 21.5 31.2 19.0 11.8 26.6 17.7 61.0 20.8 23.3 22.1 19.1 29.4 20.3 21.2 13.5 19.4 17.2 19.8 6.4 43.5 15.0 15.9 23.5 15.3 23.6 48.2 25.6 16.7 25.7 48.2 24.3 25.9 32.1 21.0 13.2 23.2 17.0 24.7 17.3 24.5 37.4 17.5 25.7 8.4 14.9 16.1 9.2 34.5 13.0 11.7 11.4 13.7 10.5 13.7 9.9 10.9 9.5 11.4 94.6 16.8 9.9 7.1 17.5 10.9 21.1 21.2 38.9 21.4 16.6 20.3 23.7 24.0 22.3 19.4 29.8 19.4 27.1 16.0 18.3 17.3 16.5 20.1 24.8 24.4 14.2 18.9 24.7 16.6 61.2 15.7 28.2 11.0 6.2 13.4 21.6 44.5 31.3 22.7 33.0 22.6 12.0 18.1 16.3 24.2 13.9 20.1 14.8 17.8 42.8 34.2 10.8 19.2 12.8 14.1 12.3 18.5 21.7 29.6 22.4 11.1 8.0 17.4 17.4 14.3 8.8 10.3 16.8 18.2 27.8 9.0 15.5 39.8 37.0 13.2 21.9 38.8 30.2 14.1 34.3 15.9 13.1 14.8 13.1 22.8 11.1 25.2 27.8 37.1 18.5 12.0 25.7 58.7 OSGIN2 "C8orf1, hT41" ENSG00000164823 "Oxidative stress induced growth inhibitor family member 2" Q9Y236 8 89901849-89927888 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 246.6;Granulosa cells: 144.4;Late spermatids: 216.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 22.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 22.2" "Cell line enhanced" "Detected in all" "SK-BR-3: 149.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028515, HPA050595" Approved Approved Nucleoli NA NA "Cluster 10: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Nucleoli "HPA028515: AB_10602014, HPA050595: AB_2681186" "unprognostic (3.29e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (4.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.26e-2)" "prognostic unfavorable (3.91e-6)" "prognostic unfavorable (2.93e-4)" "unprognostic (2.32e-1)" "unprognostic (2.22e-3)" "unprognostic (4.38e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-1)" "unprognostic (1.09e-1)" "unprognostic (7.25e-2)" 19.2 7.6 9.6 8.6 9.3 51.9 12.1 10.9 12.1 8.6 7.0 10.5 7.9 18.4 5.7 8.3 5.9 16.3 14.8 10.6 17.9 17.1 18.5 16.4 10.8 12.4 11.4 17.8 7.9 33.2 9.8 7.0 12.5 10.0 8.9 12.9 7.4 7.8 15.2 5.2 7.1 21.1 14.9 9.3 6.0 23.1 10.2 8.9 14.1 18.8 10.0 11.0 4.7 18.3 32.1 30.6 7.9 16.2 17.5 14.0 9.9 23.5 49.9 21.7 22.2 14.3 29.6 21.9 45.7 13.0 26.1 11.6 16.0 18.8 34.6 33.3 11.7 34.2 11.7 8.0 31.9 17.0 20.4 16.1 23.2 24.5 22.6 20.9 28.6 28.7 19.7 38.3 16.2 24.8 29.7 11.7 4.4 33.6 16.7 13.1 11.5 18.6 33.2 24.2 7.1 18.1 17.3 149.6 29.5 12.9 30.1 27.9 20.2 23.2 20.2 20.1 22.2 35.0 32.2 24.2 38.6 21.9 17.5 22.2 1.6 7.5 1.9 1.2 2.7 3.5 2.8 1.7 1.8 2.0 2.3 2.6 12.4 2.5 1.5 1.3 3.1 1.6 9.6 9.3 10.9 12.1 10.6 17.9 12.4 11.4 12.5 14.9 10.2 18.3 9.8 64.1 14.8 49.3 10.4 6.0 6.9 9.2 2.8 9.0 13.3 6.7 13.9 17.2 12.5 7.3 2.1 6.8 10.6 4.2 9.8 13.6 246.6 11.6 10.8 7.4 9.6 8.6 14.9 16.0 8.4 13.7 2.0 14.1 17.1 144.4 13.6 17.6 16.5 3.3 14.9 3.8 20.3 19.1 9.4 216.8 12.5 15.7 7.2 9.4 13.3 25.3 5.2 7.5 7.8 14.0 3.4 12.4 6.1 7.2 3.0 14.8 15.2 6.0 13.1 18.9 9.0 28.9 8.8 4.5 4.3 1.6 8.3 3.0 5.1 7.6 OTOR "FDP, MIAL, MIAL1" ENSG00000125879 Otoraplin Q9NRC9 20 16748358-16770062 "Predicted secreted proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024335 Uncertain "Secreted in other tissues" NA NA "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "HPA024335: AB_1854838" "unprognostic (8.50e-3)" "unprognostic (9.56e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-1)" "unprognostic (1.72e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 12.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OTUD6B "CGI-77, DUBA5" ENSG00000155100 "OTU deubiquitinase 6B" Q8N6M0 8 91070196-91087095 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024046, HPA024503, HPA024772" Approved Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus, Cytosol" "HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846" "prognostic unfavorable (7.50e-4)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (4.78e-3)" "unprognostic (4.91e-2)" "unprognostic (1.49e-1)" "unprognostic (1.52e-2)" "unprognostic (1.16e-3)" "unprognostic (2.17e-1)" "unprognostic (5.51e-2)" "unprognostic (1.27e-2)" "unprognostic (8.61e-3)" "unprognostic (1.87e-2)" "unprognostic (1.96e-1)" "unprognostic (4.53e-1)" "unprognostic (8.78e-2)" "unprognostic (5.71e-2)" 6.6 6.2 5.7 6.3 6.1 5.9 7.2 5.9 8.6 5.2 5.0 5.3 4.2 6.0 4.6 6.4 4.2 3.9 6.5 5.4 6.1 5.4 5.4 4.7 7.4 6.2 6.2 5.3 4.6 4.0 3.5 8.0 6.3 5.8 5.4 3.1 4.3 4.7 10.2 6.4 4.4 5.5 6.3 5.0 4.3 6.4 5.9 5.7 6.0 9.2 6.1 6.3 5.4 7.5 27.6 11.1 12.8 10.4 6.4 5.6 14.5 19.1 7.4 19.1 12.6 8.6 16.6 25.6 9.0 10.2 7.6 9.1 26.4 16.1 31.6 21.6 16.9 34.5 11.7 8.3 13.3 18.7 21.0 7.2 9.8 14.0 35.5 11.6 17.5 19.4 36.5 19.1 18.9 9.6 31.7 17.5 8.1 20.3 27.3 19.4 11.2 28.9 18.9 15.1 3.5 14.6 2.6 55.9 22.7 16.3 25.5 11.8 15.8 12.3 17.2 20.6 20.5 17.1 29.5 37.2 16.8 26.2 23.1 1.7 1.9 1.1 1.5 2.7 2.0 2.0 1.4 1.7 2.6 1.8 2.1 1.9 0.2 3.4 2.1 4.0 0.8 1.0 5.7 6.1 5.9 8.6 5.4 6.1 6.2 6.2 6.3 6.3 5.9 7.5 11.9 9.6 11.3 9.8 13.7 23.2 6.5 4.0 10.8 13.0 6.5 5.2 14.3 8.6 9.2 1.8 33.3 10.8 16.5 5.1 9.8 4.8 0.9 10.6 9.9 10.9 10.8 8.2 18.0 4.9 10.0 9.0 7.7 8.6 18.4 10.7 8.9 11.7 8.1 11.8 15.5 4.9 4.1 8.7 12.5 2.2 9.6 8.3 3.6 12.2 10.2 12.2 11.3 18.6 21.6 6.6 3.7 4.1 12.0 8.9 2.8 8.2 8.8 15.3 0.0 8.2 9.6 3.2 7.0 12.5 18.2 6.7 10.7 9.9 6.4 5.9 OXSR1 "KIAA1101, OSR1" ENSG00000172939 "Oxidative stress responsive kinase 1" O95747 3 38165089-38255484 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008237, CAB017181" Supported Enhanced Cytosol NA NA 300000 "Cluster 38: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol "CAB017181: , HPA008237: AB_1079540" "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (1.79e-2)" "unprognostic (4.55e-3)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (3.53e-3)" "unprognostic (4.05e-2)" "unprognostic (4.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.95e-3)" "unprognostic (1.88e-2)" "unprognostic (1.87e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.71e-1)" "unprognostic (6.99e-3)" 18.4 17.2 9.7 15.7 10.0 33.8 15.6 13.6 12.5 17.8 13.0 18.3 15.2 14.8 15.6 34.1 12.8 15.1 16.9 9.9 10.8 21.5 18.6 15.5 18.5 11.0 11.0 16.1 12.1 26.3 11.5 16.5 11.1 16.5 19.7 13.0 15.2 16.3 36.7 19.5 15.7 17.6 10.2 15.0 16.8 14.1 11.0 25.1 14.8 35.4 23.4 26.7 21.1 11.2 48.5 21.9 42.5 29.8 29.0 33.3 48.2 41.9 57.1 59.2 63.8 28.3 30.8 53.4 20.8 50.5 25.4 29.4 57.8 43.1 77.5 57.6 24.5 58.6 46.1 31.1 34.6 36.6 34.2 26.6 49.6 54.8 87.8 55.7 37.5 67.7 45.2 29.9 102.7 13.7 71.1 26.4 44.8 31.2 26.1 24.2 35.7 41.4 36.4 36.4 22.0 34.0 45.9 114.2 29.0 46.3 37.7 23.7 34.4 37.0 36.6 56.8 63.0 22.7 29.0 38.7 50.7 44.6 75.3 6.8 1.6 3.9 1.8 2.8 1.9 1.0 2.2 1.7 2.6 1.2 1.7 2.1 3.2 3.1 2.5 1.4 2.8 0.9 9.7 10.0 13.6 12.5 9.9 10.8 11.0 11.0 11.1 10.2 11.0 11.2 19.0 12.8 25.8 46.7 27.3 44.1 35.5 25.3 26.7 13.3 19.4 16.5 32.6 4.3 27.6 27.6 20.9 12.1 27.4 44.0 19.6 28.4 3.9 39.9 32.1 19.0 24.1 29.7 59.6 14.5 21.0 18.4 90.7 91.2 15.8 24.9 14.6 20.5 14.9 21.9 51.9 24.5 10.2 29.8 79.0 2.3 9.6 58.0 7.2 29.0 35.2 8.0 18.6 44.7 42.8 46.5 29.4 12.8 19.5 56.5 27.0 22.5 16.1 7.0 13.1 23.7 22.6 15.1 18.5 41.9 51.9 33.0 29.6 19.6 21.6 115.3 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264498-73305103 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 32.5" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 124.3;Syncytiotrophoblasts: 272.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 12 "myeloid DC: 27.2;plasmacytoid DC: 87.5" "Lineage enriched" "Detected in many" 19 "dendritic cells: 87.5" "Cell line enhanced" "Detected in many" "AN3-CA: 59.2;EFO-21: 18.1;MCF7: 30.4;SK-BR-3: 53.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074751 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.9 1.5 0.9 7.0 1.1 0.8 1.2 0.6 1.8 1.7 0.8 2.2 2.4 0.8 0.5 2.5 1.1 1.5 2.8 1.4 0.7 7.5 0.9 2.9 3.1 1.2 0.8 0.3 1.4 0.2 2.3 10.7 1.0 2.0 1.7 0.8 1.4 0.6 2.7 0.7 4.0 2.7 0.5 32.5 1.8 0.5 1.3 1.4 4.9 0.3 1.3 3.1 1.4 1.4 1.3 12.9 0.1 59.2 0.0 0.1 13.7 0.2 0.0 0.2 0.1 11.6 0.2 0.1 18.1 0.4 0.1 3.0 0.1 0.1 0.1 0.3 0.1 0.1 1.2 8.1 0.0 0.2 0.3 0.2 0.0 0.7 0.0 1.0 0.1 0.1 0.1 0.4 0.2 30.4 0.1 2.8 0.2 0.4 0.2 0.1 0.1 1.4 11.0 0.2 0.2 0.7 1.7 53.4 0.1 1.2 13.4 2.7 0.3 2.0 0.1 1.8 0.1 0.5 0.2 0.1 2.7 4.0 0.1 2.3 2.7 0.2 0.1 4.6 0.3 0.1 0.1 0.1 27.2 0.2 0.1 0.1 0.6 3.4 1.5 87.5 0.1 2.2 0.9 1.1 0.6 1.8 1.4 0.7 1.2 0.8 1.0 0.5 1.3 1.4 0.3 0.0 0.6 0.3 1.5 0.1 0.4 0.4 0.6 0.0 0.6 1.0 0.8 0.0 0.7 9.2 0.0 124.3 16.9 0.1 3.9 2.7 0.4 0.3 0.1 8.9 0.0 2.7 0.7 14.4 11.6 1.8 0.0 0.4 0.0 0.2 1.1 0.1 19.8 0.0 0.1 0.3 0.0 9.2 9.8 2.3 0.0 12.9 0.0 13.1 13.4 1.1 0.0 0.5 0.0 14.9 0.0 0.0 12.6 0.3 2.9 12.0 0.9 0.1 0.0 2.4 0.8 0.0 0.1 0.2 0.4 272.5 0.6 0.5 0.2 0.5 PADI2 "KIAA0994, PDI2" ENSG00000117115 "Peptidyl arginine deiminase 2" Q9Y2J8 1 17066761-17119451 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 240.6;skeletal muscle: 311.8;tongue: 492.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3" "Cancer enhanced" "Detected in many" "glioma: 24.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 43.3;neutrophil: 100.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 100.6" "Cell line enhanced" "Detected in some" "A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047735 Enhanced NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA047735: AB_2680139" "unprognostic (2.61e-2)" "unprognostic (3.60e-2)" "unprognostic (8.94e-3)" "unprognostic (1.57e-1)" "unprognostic (2.33e-2)" "unprognostic (2.44e-1)" "unprognostic (1.49e-1)" "unprognostic (3.74e-3)" "unprognostic (2.78e-3)" "unprognostic (3.28e-3)" "unprognostic (1.29e-1)" "unprognostic (3.07e-1)" "unprognostic (2.87e-1)" "unprognostic (3.64e-2)" "unprognostic (3.15e-1)" "unprognostic (2.27e-1)" "unprognostic (5.91e-3)" 2.1 0.9 85.9 9.3 161.5 23.7 41.1 164.3 103.9 3.3 33.5 89.8 1.4 0.8 0.6 6.1 2.7 1.6 0.6 82.2 165.1 12.7 0.7 4.4 1.0 205.8 167.0 0.2 1.5 2.1 3.7 1.4 212.0 2.6 92.3 50.5 44.4 1.6 311.8 9.6 8.4 5.8 189.3 13.4 2.2 0.8 144.3 2.1 0.6 492.3 1.3 2.5 1.0 240.6 0.0 11.6 0.1 0.0 0.0 0.0 0.7 0.3 0.0 0.1 0.1 0.1 4.9 0.2 1.5 0.5 0.1 1.6 0.4 0.1 0.3 0.0 0.8 0.5 0.0 0.0 0.0 0.7 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.9 3.8 0.6 1.4 1.6 3.9 0.0 0.0 0.0 0.4 33.1 0.0 2.1 0.2 0.0 50.7 0.0 2.7 13.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.9 0.0 1.3 16.2 43.3 0.0 0.9 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 100.6 0.0 0.2 0.4 0.0 6.4 85.9 161.5 164.3 103.9 82.2 165.1 205.8 167.0 212.0 189.3 144.3 240.6 0.2 0.0 1.3 28.4 1.0 0.3 0.4 0.6 0.0 2.2 31.2 32.5 0.4 0.0 3.3 1.8 95.9 0.2 0.7 178.7 11.7 0.6 6.1 0.0 0.0 8.2 3.6 0.0 1.5 0.0 0.5 0.6 0.0 0.1 17.1 0.5 0.7 0.0 7.2 0.0 1.4 77.3 2.0 4.8 25.8 10.3 0.3 9.2 28.4 15.9 33.8 33.6 0.0 13.6 117.1 0.0 72.3 0.7 0.4 0.5 15.0 0.3 0.2 29.6 0.0 5.6 1.3 0.2 0.4 0.0 0.4 0.1 0.4 0.0 51.8 0.2 PBX1 ENSG00000185630 "PBX homeobox 1" P40424 1 164555584-164899296 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 382.3;Excitatory neurons: 475.9;Inhibitory neurons: 405.0;Oligodendrocyte precursor cells: 327.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 93.0;NTERA-2: 111.5;SK-BR-3: 186.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003505, HPA003881, CAB018768" Supported Enhanced "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies, Cytosol" "CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020" "unprognostic (2.26e-2)" "unprognostic (1.95e-1)" "unprognostic (9.09e-2)" "unprognostic (2.14e-2)" "unprognostic (5.21e-3)" "unprognostic (6.94e-3)" "unprognostic (5.95e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "unprognostic (2.24e-3)" "unprognostic (2.30e-1)" "unprognostic (8.81e-2)" "unprognostic (1.34e-2)" "unprognostic (2.13e-1)" "unprognostic (5.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 24.3 32.1 16.5 11.8 22.3 3.1 36.1 10.7 18.0 88.3 1.9 52.3 22.4 136.8 21.6 30.1 74.6 37.6 24.0 15.3 14.1 29.4 7.7 20.7 4.5 8.8 32.7 52.1 48.1 29.5 14.3 19.5 6.7 38.0 19.8 17.1 43.8 53.8 36.3 10.2 19.9 125.2 13.7 10.2 21.9 6.8 12.6 10.9 35.1 26.5 8.1 40.2 41.5 12.1 2.9 74.4 82.4 19.1 50.8 23.3 3.4 25.2 20.9 8.4 6.1 14.2 11.8 0.0 5.5 47.8 4.3 22.8 31.7 8.1 3.6 3.1 31.3 93.0 56.5 0.3 34.7 0.0 22.2 24.4 0.0 5.4 2.1 19.2 0.3 0.0 0.2 0.0 2.2 47.1 0.2 0.6 111.5 3.8 4.5 0.0 21.6 27.0 6.3 44.1 2.5 39.6 27.8 186.1 0.1 71.4 73.2 0.0 0.5 3.7 8.6 24.2 8.1 8.5 61.2 0.1 0.4 0.2 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 16.5 22.3 10.7 18.0 15.3 14.1 8.8 32.7 6.7 13.7 12.6 12.1 28.6 22.4 18.6 382.3 2.8 22.8 115.0 39.8 70.6 39.9 129.9 87.8 50.0 98.7 25.3 33.1 110.5 101.3 1.5 29.2 33.2 47.9 91.3 47.7 144.3 47.0 90.9 30.3 475.9 68.7 7.3 126.7 32.1 38.5 71.7 57.6 68.9 18.7 9.7 5.0 405.0 38.2 50.8 1.9 17.5 124.4 63.6 12.1 16.0 125.5 1.6 33.5 1.0 327.2 227.4 31.7 72.5 103.8 2.8 41.5 40.4 57.9 37.3 30.6 39.5 142.0 70.9 2.3 17.5 83.6 28.1 104.7 7.6 168.0 43.7 75.9 PEX1 "ZWS, ZWS1" ENSG00000127980 "Peroxisomal biogenesis factor 1" O43933 7 92487020-92528520 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis, Protein transport, Transport" "Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020235 Approved Supported Peroxisomes NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Peroxisomes "HPA020235: AB_1855224" "unprognostic (4.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-2)" "unprognostic (1.53e-2)" "unprognostic (4.85e-1)" "unprognostic (2.41e-2)" "unprognostic (7.81e-2)" "unprognostic (9.79e-3)" "unprognostic (2.17e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-2)" "unprognostic (3.61e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.49e-1)" "unprognostic (5.35e-3)" "unprognostic (4.90e-2)" 5.8 6.9 2.6 6.0 4.7 4.1 8.7 4.6 4.3 6.4 2.5 8.6 6.6 6.7 11.2 6.1 5.6 4.7 8.9 2.4 3.1 14.2 13.0 5.3 6.9 3.5 3.5 6.8 8.8 11.7 6.3 4.2 4.1 7.8 9.5 13.2 9.1 7.0 9.1 7.9 8.1 5.4 2.8 6.0 8.2 6.7 3.0 7.9 8.6 9.9 6.7 5.6 5.8 6.3 8.3 8.9 14.4 24.6 8.9 7.6 13.0 5.4 7.1 6.3 9.1 5.5 8.7 12.2 12.0 6.3 9.6 8.4 11.0 9.9 10.0 12.7 9.7 5.8 9.5 7.0 6.2 10.6 6.4 8.2 8.6 9.4 12.7 8.0 9.9 12.6 21.9 17.2 10.1 15.5 21.3 10.4 10.0 12.3 8.3 15.0 16.0 15.3 8.8 12.0 10.6 17.1 12.4 34.3 10.8 20.2 7.1 4.4 8.1 6.0 8.1 23.0 5.7 18.9 15.9 16.7 5.7 6.2 9.8 0.8 1.1 1.8 2.5 1.8 2.5 3.0 2.6 2.8 1.2 2.8 2.9 3.3 0.9 4.7 2.2 0.7 2.8 1.1 2.6 4.7 4.6 4.3 2.4 3.1 3.5 3.5 4.1 2.8 3.0 6.3 14.2 28.9 18.4 26.1 14.1 5.9 8.4 8.1 10.8 43.5 11.7 12.6 29.7 5.7 13.1 5.5 35.5 9.0 13.6 17.2 9.8 6.6 7.3 22.6 14.7 11.6 13.9 12.4 30.0 7.5 3.9 11.6 21.9 14.2 8.8 20.5 8.2 14.2 5.4 40.4 45.7 12.0 8.2 7.6 3.1 4.8 14.3 8.4 7.2 13.1 12.7 14.2 14.4 23.6 55.2 6.0 11.3 15.1 11.6 9.6 16.5 19.2 32.4 42.9 6.6 15.5 12.6 36.6 14.4 11.2 7.7 8.3 12.0 11.8 15.2 7.7 PEX11A "MGC119947, MGC138534, PEX11-ALPHA" ENSG00000166821 "Peroxisomal biogenesis factor 11 alpha" O75192 15 89677764-89690783 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 38.7;Late spermatids: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (1.40e-1)" "unprognostic (6.17e-2)" "unprognostic (6.80e-3)" "unprognostic (2.82e-2)" "unprognostic (2.38e-1)" "unprognostic (3.24e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-2)" "unprognostic (5.44e-2)" "unprognostic (4.82e-2)" "unprognostic (1.32e-2)" 25.6 10.4 7.9 3.4 8.3 0.8 20.0 6.9 8.5 7.2 12.8 14.5 16.3 6.0 10.5 6.5 9.6 5.4 8.1 7.9 8.7 11.7 39.1 6.1 2.5 7.1 7.8 13.1 11.8 10.0 5.5 3.6 7.2 18.3 12.0 12.7 11.3 10.1 17.9 5.4 12.2 5.5 7.2 4.1 11.3 11.4 9.0 2.3 10.9 12.0 3.7 9.2 6.1 7.9 10.2 6.1 4.6 0.3 23.4 8.4 3.7 5.0 8.5 7.4 12.0 4.3 11.9 4.7 5.5 5.8 10.6 13.3 0.0 7.6 8.5 7.5 16.8 7.1 7.2 6.0 16.8 4.7 2.4 10.4 9.2 4.3 7.1 5.8 5.2 4.6 0.1 1.8 5.6 10.2 0.0 0.6 2.6 20.6 11.1 0.0 0.0 4.2 6.1 6.8 3.4 8.7 16.0 54.4 15.5 8.3 14.4 4.4 4.7 4.9 4.8 13.2 4.0 5.3 9.5 0.2 11.9 0.7 4.3 1.2 0.7 2.3 3.6 1.0 2.0 1.6 1.8 2.0 1.8 0.9 2.2 2.5 0.8 3.1 0.7 0.4 1.7 1.5 7.9 8.3 6.9 8.5 7.9 8.7 7.1 7.8 7.2 7.2 9.0 7.9 1.5 6.4 8.4 12.4 2.0 1.8 9.3 5.2 7.4 8.6 15.3 10.9 8.7 10.0 11.4 5.5 2.1 10.8 1.3 22.1 5.9 7.6 24.8 7.1 5.5 3.1 3.6 0.8 3.0 4.6 7.1 4.6 3.1 5.2 1.3 6.2 4.6 38.7 4.0 18.5 3.5 8.9 6.1 3.5 0.8 39.0 5.3 1.6 3.6 2.8 1.9 14.5 1.0 3.5 3.5 5.5 11.6 2.6 0.6 11.5 20.7 12.6 16.2 9.7 0.0 6.4 4.6 22.6 8.7 5.0 2.0 2.7 1.5 11.0 11.8 11.9 PEX2 "PAF-1, PMP35, PXMP3, RNF72, ZWS3" ENSG00000164751 "Peroxisomal biogenesis factor 2" P28328 8 76980258-77001044 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010983, HPA011410, HPA027729" Approved Supported Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Vesicles "HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416" "unprognostic (6.42e-2)" "unprognostic (2.90e-2)" "unprognostic (4.64e-2)" "unprognostic (2.35e-1)" "unprognostic (9.91e-2)" "unprognostic (2.33e-1)" "unprognostic (6.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-2)" "unprognostic (9.57e-3)" "unprognostic (2.48e-1)" "unprognostic (9.49e-2)" "unprognostic (3.06e-2)" "unprognostic (1.09e-3)" 39.8 45.9 33.1 33.5 36.6 35.8 53.9 34.2 45.6 40.7 38.6 43.1 39.8 33.3 42.4 32.9 41.8 31.9 39.7 32.1 35.1 53.6 43.7 36.5 39.4 37.3 34.5 33.3 39.0 57.7 27.2 24.7 37.6 44.2 39.6 66.5 50.9 83.4 61.8 24.5 41.0 35.3 37.3 36.5 48.3 22.1 34.5 48.8 53.2 44.6 35.7 35.7 31.3 43.3 88.2 29.3 46.9 47.9 50.7 63.2 24.5 64.4 75.3 49.9 55.2 18.4 76.9 50.2 93.6 59.9 39.7 33.3 33.1 50.1 61.2 93.3 28.5 61.1 26.0 28.3 33.9 51.5 46.5 70.9 43.5 37.8 45.6 77.0 55.3 79.3 34.4 46.7 53.9 26.4 90.4 30.1 27.2 126.4 26.3 16.5 37.4 42.1 59.9 61.6 16.7 43.0 41.9 192.0 36.9 39.8 58.7 36.1 54.7 44.4 58.1 57.7 32.4 86.0 53.8 87.9 56.5 26.7 50.2 179.9 55.6 102.6 57.2 58.0 51.2 46.1 39.6 46.5 46.3 50.5 51.6 49.3 38.6 83.1 67.8 46.8 48.6 71.7 33.1 36.6 34.2 45.6 32.1 35.1 37.3 34.5 37.6 37.3 34.5 43.3 28.0 48.1 25.2 32.3 29.7 18.1 31.0 57.8 28.5 28.9 38.9 33.1 27.2 28.6 38.4 27.6 12.5 42.8 38.3 30.2 133.1 52.3 5.6 36.5 19.9 20.7 28.9 25.6 11.9 49.1 24.8 29.8 20.4 22.2 18.3 20.2 25.7 36.7 26.6 13.5 15.2 37.5 48.8 39.1 22.4 7.3 29.5 26.8 28.4 16.9 36.3 68.4 53.5 31.7 45.9 42.0 28.2 35.7 41.7 36.3 43.3 61.4 36.6 34.4 6.6 34.9 24.6 13.7 20.8 28.6 21.0 34.8 37.6 27.7 30.0 43.0 PGM5 PGMRP ENSG00000154330 "Phosphoglucomutase 5" Q15124 9 68328308-68531061 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Cell adhesion, Glucose metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 269.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9" "Cancer enhanced" "Detected in many" "prostate cancer: 16.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "neutrophil: 4.8" "Lineage enriched" "Detected in single" 48 "granulocytes: 4.8" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034397, HPA046329, HPA067102" Enhanced Uncertain Cytosol NA NA 450000 "Cluster 1: Neutrophils - Mixed function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758" "unprognostic (3.43e-1)" "unprognostic (2.17e-2)" "unprognostic (3.98e-3)" "unprognostic (5.75e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-4)" "unprognostic (1.22e-3)" "unprognostic (2.79e-1)" "unprognostic (5.28e-3)" "unprognostic (4.78e-2)" "unprognostic (2.28e-2)" "prognostic favorable (1.83e-5)" "unprognostic (3.04e-2)" "unprognostic (2.91e-1)" "unprognostic (2.48e-1)" "unprognostic (4.73e-2)" 28.9 61.0 3.7 12.6 4.1 0.0 21.0 5.8 3.8 51.7 3.3 269.4 15.4 154.0 40.8 98.6 96.5 19.6 126.1 3.1 4.1 11.5 5.1 14.6 5.8 4.6 4.0 19.8 2.7 5.0 4.3 5.8 4.3 159.0 34.2 8.0 6.7 214.0 37.5 11.1 72.0 132.5 4.7 10.8 65.2 3.0 4.6 2.9 13.1 30.5 2.9 216.7 40.6 4.6 0.2 0.2 0.0 0.0 0.7 0.0 0.3 8.2 6.3 3.8 1.7 0.0 0.0 0.2 0.0 0.0 0.1 0.1 9.2 0.0 9.4 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 28.7 0.0 0.0 0.0 0.1 0.0 4.1 0.1 0.7 0.0 0.0 56.5 0.0 38.8 1.8 1.5 0.0 0.0 0.2 0.1 47.8 2.8 1.2 0.0 0.0 0.1 0.0 5.7 0.3 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 3.7 4.1 5.8 3.8 3.1 4.1 4.6 4.0 4.3 4.7 4.6 4.6 21.6 0.0 1.7 0.7 0.2 2.3 5.6 0.0 0.6 25.3 0.2 1.5 107.2 2.8 1.8 12.9 4.2 0.0 0.1 0.1 1.9 0.1 1.8 3.7 2.8 36.6 0.0 4.0 1.4 0.0 0.2 12.4 0.0 1.1 0.0 18.7 39.3 0.1 0.1 0.0 1.7 2.7 0.0 4.0 2.8 0.5 8.1 2.1 3.6 124.6 1.0 8.3 0.0 1.0 2.3 0.1 0.1 4.9 0.0 2.1 0.8 1.2 0.8 1.9 52.6 1.7 35.9 0.1 0.2 0.4 2.4 0.0 0.6 30.0 1.6 1.5 PHF12 "KIAA1523, PF1" ENSG00000109118 "PHD finger protein 12" Q96QT6 17 28905250-28951771 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 40.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 40.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021410, HPA021452" Approved Enhanced Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA021410: AB_1855287, HPA021452: AB_2670708" "unprognostic (9.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-2)" "unprognostic (1.21e-2)" "unprognostic (2.81e-1)" "unprognostic (1.46e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-2)" "unprognostic (8.73e-2)" "unprognostic (5.38e-2)" "unprognostic (1.02e-3)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.24e-5)" "unprognostic (2.16e-2)" "unprognostic (3.11e-1)" "unprognostic (3.24e-1)" "unprognostic (1.08e-3)" 13.7 11.0 11.6 15.6 12.6 39.9 14.4 14.1 12.1 17.9 7.2 18.2 11.5 18.7 14.0 10.6 17.2 11.0 11.0 10.7 11.9 12.3 14.7 16.7 18.2 11.5 11.1 17.9 19.1 13.8 16.9 10.9 9.1 21.8 11.4 14.9 15.7 17.0 15.7 15.2 17.7 14.6 7.2 22.9 14.8 9.9 11.3 25.3 17.0 14.2 17.2 16.8 13.8 14.0 15.0 24.4 33.1 19.8 18.6 13.8 15.0 14.6 22.0 23.0 21.2 16.9 14.3 17.3 17.9 17.4 19.0 15.9 21.5 13.0 21.8 27.9 22.5 18.8 27.2 13.2 16.8 20.5 22.7 15.8 13.8 20.9 19.0 21.3 16.7 23.0 16.0 18.6 14.2 16.6 38.3 26.7 19.0 33.6 10.4 38.2 26.8 17.6 15.2 19.3 22.8 18.7 22.6 35.7 17.6 17.5 19.6 26.6 9.9 18.9 16.8 18.2 18.4 21.9 19.9 20.2 14.7 15.2 19.5 25.2 4.4 7.2 6.3 3.6 6.1 4.4 4.9 6.6 2.5 6.5 4.4 5.2 40.1 6.3 4.3 8.2 3.1 2.9 11.6 12.6 14.1 12.1 10.7 11.9 11.5 11.1 9.1 7.2 11.3 14.0 13.1 16.0 8.6 27.1 24.7 15.3 8.5 7.5 26.7 22.7 17.6 15.1 6.9 8.6 12.2 3.7 14.6 7.9 24.5 12.0 1.9 9.1 9.5 17.5 16.4 14.4 10.7 27.0 16.3 10.4 7.6 11.9 12.8 23.8 14.5 14.4 14.3 11.7 9.2 25.2 18.6 16.5 12.2 15.7 18.9 7.4 17.1 16.5 12.4 27.2 20.0 12.9 17.5 30.2 31.3 9.7 6.5 16.6 31.4 27.1 8.9 5.9 8.1 21.3 26.3 11.2 17.2 13.5 12.6 22.2 16.3 6.0 35.3 11.4 10.8 14.0 PHF14 KIAA0783 ENSG00000106443 "PHD finger protein 14" O94880 7 10973336-11169623 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000538, HPA017376" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "Nucleoplasm, Cytosol" "HPA000538: AB_1079604, HPA017376: AB_2732420" "unprognostic (1.16e-1)" "unprognostic (3.17e-1)" "unprognostic (3.73e-3)" "unprognostic (7.38e-3)" "unprognostic (8.05e-2)" "unprognostic (3.38e-1)" "unprognostic (4.66e-3)" "unprognostic (1.80e-1)" "unprognostic (5.32e-3)" "unprognostic (6.76e-2)" "unprognostic (2.94e-2)" "unprognostic (3.10e-1)" "unprognostic (4.84e-3)" "unprognostic (1.24e-1)" "unprognostic (2.30e-2)" "unprognostic (1.87e-2)" "unprognostic (2.33e-1)" 9.9 8.0 17.2 8.6 15.6 5.5 13.7 17.5 26.9 9.1 12.7 9.8 8.2 13.1 7.8 8.4 8.8 9.3 5.3 17.0 16.1 10.0 11.4 8.6 9.9 16.5 16.7 14.5 7.1 9.5 7.9 8.4 17.3 10.0 10.4 6.7 7.9 8.1 6.0 8.5 8.2 11.0 14.2 10.3 10.3 9.3 16.0 17.8 9.2 7.8 10.2 9.2 7.6 16.9 16.4 32.8 46.4 49.2 16.2 15.6 23.1 12.6 10.0 14.5 15.9 29.5 28.9 62.4 22.7 11.7 32.7 22.8 42.4 14.6 16.0 23.1 17.3 31.1 28.1 38.0 14.8 70.2 28.8 14.2 15.0 17.3 30.9 20.4 21.2 24.2 42.4 21.6 17.6 21.6 28.0 30.4 39.3 68.1 24.4 45.9 30.3 19.8 15.0 30.6 42.2 58.3 19.5 64.6 21.1 33.6 34.6 50.1 20.6 20.3 27.1 13.6 25.0 27.7 51.1 43.2 14.4 57.8 48.6 1.0 0.9 0.6 1.3 0.8 1.0 1.8 1.4 1.6 0.5 1.4 1.9 1.7 0.0 1.4 0.8 2.7 1.9 0.4 17.2 15.6 17.5 26.9 17.0 16.1 16.5 16.7 17.3 14.2 16.0 16.9 80.6 41.7 41.6 141.0 66.9 57.5 68.6 27.5 68.9 92.7 80.3 91.3 22.7 37.1 44.2 33.1 58.4 68.8 58.4 54.6 27.4 92.0 23.9 40.9 82.7 77.4 92.2 46.9 223.8 84.3 80.9 65.9 55.5 48.1 56.5 103.7 64.2 43.6 42.1 79.1 260.6 72.3 42.7 39.6 24.7 16.2 102.9 39.1 37.4 116.2 58.0 36.5 87.6 263.4 200.8 90.4 45.9 116.9 34.3 82.0 46.0 35.9 28.0 63.3 52.6 71.0 67.6 142.3 133.7 56.5 52.4 39.8 58.6 73.7 72.0 54.2 PIGS ENSG00000087111 "Phosphatidylinositol glycan anchor biosynthesis class S" Q96S52 17 28553383-28571794 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018149 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA018149: AB_1855373" "unprognostic (2.29e-2)" "unprognostic (1.37e-2)" "unprognostic (3.89e-1)" "unprognostic (2.52e-1)" "unprognostic (6.61e-2)" "unprognostic (3.82e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.65e-1)" "unprognostic (9.09e-2)" "unprognostic (2.25e-3)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (2.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.06e-3)" "unprognostic (1.65e-1)" "prognostic unfavorable (5.31e-4)" 25.0 15.5 8.3 15.5 8.5 25.3 11.4 8.2 8.6 12.9 18.6 25.5 30.9 12.0 3.3 23.5 20.1 15.6 25.4 10.5 9.1 16.6 4.9 20.2 18.9 8.8 9.4 13.3 16.8 28.5 3.3 17.4 8.8 17.7 15.7 3.4 14.8 16.2 31.4 18.5 32.2 16.1 7.8 18.2 26.9 13.4 8.7 17.5 24.3 19.7 13.7 17.7 5.3 8.0 34.7 57.4 26.5 67.9 51.1 38.2 40.1 42.3 34.5 44.4 58.1 60.4 33.8 22.3 62.9 57.8 43.1 64.5 32.4 48.2 16.6 65.8 92.5 30.1 45.3 26.2 47.8 58.5 73.8 46.7 33.6 27.8 37.8 44.5 60.3 37.8 89.3 34.1 38.5 42.6 36.9 40.2 13.2 77.9 17.6 31.2 87.8 73.6 30.6 36.9 54.3 37.7 60.3 115.4 32.8 26.4 105.4 69.5 52.2 31.5 32.5 27.1 35.0 56.5 84.0 17.0 56.6 56.8 45.1 86.2 60.4 78.9 34.3 55.0 31.0 23.5 27.5 32.5 64.9 22.3 28.8 24.0 29.4 43.0 39.6 49.8 45.2 46.3 8.3 8.5 8.2 8.6 10.5 9.1 8.8 9.4 8.8 7.8 8.7 8.0 15.7 44.8 21.4 10.7 15.9 8.3 11.3 21.1 13.6 20.5 20.5 17.1 40.7 20.0 18.8 46.0 64.6 35.0 31.6 48.5 11.7 43.5 9.5 15.3 15.7 18.7 40.7 17.9 10.9 26.3 53.4 14.9 18.3 21.5 3.8 17.1 26.4 7.9 31.1 52.2 12.6 28.3 24.4 28.1 8.0 13.1 23.9 22.9 7.2 1.9 66.1 17.5 93.7 9.0 11.7 22.5 21.6 22.6 16.8 15.0 49.0 19.1 14.4 56.1 6.6 12.3 15.9 74.2 62.0 19.3 12.5 36.4 21.8 25.0 27.6 12.4 PIGU "bA346K17.2, CDC91L1, GAB1" ENSG00000101464 "Phosphatidylinositol glycan anchor biosynthesis class U" Q9H490 20 34560542-34698790 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041706, HPA046766" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA041706: AB_2677627, HPA046766: AB_2679794" "unprognostic (1.87e-2)" "unprognostic (1.26e-2)" "unprognostic (1.88e-2)" "unprognostic (1.48e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.64e-1)" "unprognostic (8.42e-3)" "unprognostic (7.94e-3)" "unprognostic (2.69e-1)" "unprognostic (9.86e-2)" "unprognostic (8.82e-3)" "unprognostic (3.75e-1)" "unprognostic (1.55e-1)" "unprognostic (5.27e-2)" "unprognostic (4.21e-3)" 11.0 14.8 20.8 9.7 25.3 10.6 13.5 23.4 25.3 13.6 18.0 20.0 12.2 16.3 19.8 18.6 25.1 11.4 16.2 21.2 22.0 16.0 13.8 10.3 11.8 24.5 22.5 20.9 11.5 28.9 14.3 15.9 24.7 12.3 22.3 16.5 12.3 13.5 16.2 12.9 13.3 17.6 23.3 9.6 10.9 19.1 22.7 14.7 13.2 20.5 15.8 14.2 13.8 31.7 30.2 37.2 47.0 34.4 30.0 36.1 46.8 30.0 35.8 50.3 43.9 69.3 61.9 38.4 48.0 30.0 65.1 54.5 43.1 57.0 50.6 16.5 23.2 87.3 22.6 78.9 27.9 53.4 20.0 32.1 36.2 28.9 32.8 23.2 36.7 37.9 44.4 33.4 43.0 33.5 45.6 54.0 23.7 68.8 55.9 32.7 58.5 61.8 44.5 27.4 30.0 28.2 56.6 101.0 38.0 26.0 55.8 37.1 21.7 82.0 29.1 44.8 30.8 22.2 33.3 25.4 49.9 54.8 36.0 14.0 5.6 2.4 16.2 8.4 14.4 10.7 14.5 17.8 13.6 12.6 14.4 14.5 1.0 16.7 6.8 13.2 14.1 8.8 20.8 25.3 23.4 25.3 21.2 22.0 24.5 22.5 24.7 23.3 22.7 31.7 5.2 9.6 4.8 26.8 6.4 4.5 11.8 32.7 7.4 8.9 4.9 4.7 6.6 8.6 21.6 11.0 16.7 40.1 5.7 15.4 1.9 19.2 17.8 14.4 7.2 9.1 10.2 9.1 30.4 17.6 29.3 10.1 4.6 11.5 8.2 19.5 7.1 8.5 15.8 1.7 39.0 15.3 22.4 6.5 2.2 16.7 5.6 4.7 1.8 16.9 5.7 8.5 5.2 46.3 78.5 10.4 19.0 7.9 7.6 10.6 9.0 9.2 28.5 9.5 19.7 8.3 13.7 34.6 12.8 9.5 5.8 21.2 6.8 9.8 24.3 8.7 PIK3IP1 "HGFL, MGC17330, TrIP" ENSG00000100100 "Phosphoinositide-3-kinase interacting protein 1" Q96FE7 22 31281594-31292534 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "T-cells: 143.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive CD4 T-cell: 499.2" "Lineage enriched" "Detected in all" 6 "T-cells: 499.2" "Cell line enhanced" "Detected in many" "RT4: 24.1;SK-BR-3: 26.1;U-698: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes 6800000 "Cluster 32: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.02e-1)" "unprognostic (1.97e-3)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (8.19e-2)" "unprognostic (1.61e-3)" "unprognostic (5.78e-2)" "unprognostic (1.63e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.99e-1)" "unprognostic (9.95e-3)" "unprognostic (1.28e-2)" "unprognostic (2.65e-3)" "unprognostic (4.42e-2)" "unprognostic (8.68e-2)" "prognostic favorable (3.80e-4)" 51.2 41.7 35.4 59.3 42.5 41.7 39.5 38.3 40.2 21.4 23.7 35.5 17.5 34.9 13.2 21.7 24.1 27.0 34.8 33.4 39.3 27.6 9.3 45.7 109.8 53.5 40.4 22.8 11.3 16.9 15.1 25.3 48.5 27.1 15.5 11.4 52.4 31.7 20.9 58.2 61.6 22.9 43.8 71.3 24.7 20.3 42.4 68.2 37.6 16.1 79.7 34.8 27.1 52.7 0.5 0.2 0.8 0.1 11.8 20.4 0.9 3.1 9.7 0.2 1.1 0.3 20.4 15.9 11.4 4.9 1.3 13.4 0.1 5.8 0.2 2.6 1.9 0.5 2.3 2.2 4.0 1.1 0.7 20.0 8.3 0.2 0.1 18.9 6.4 2.3 0.9 19.6 1.5 1.3 0.1 2.5 0.9 1.8 0.4 1.2 0.8 11.9 5.1 24.1 1.2 2.6 1.0 26.1 1.2 10.7 2.1 2.3 20.0 0.0 4.5 0.2 0.0 8.9 4.1 34.7 0.5 2.8 0.4 46.0 18.4 16.5 79.7 22.8 95.5 38.2 207.1 113.7 5.9 79.3 499.2 318.3 7.6 59.2 34.2 2.6 257.0 214.7 35.4 42.5 38.3 40.2 33.4 39.3 53.5 40.4 48.5 43.8 42.4 52.7 26.1 44.8 12.3 17.6 63.7 10.3 19.0 44.6 5.7 29.9 15.5 11.3 11.3 10.0 36.9 31.3 10.4 30.7 89.8 8.3 1.9 50.2 1.6 10.6 10.3 20.9 8.4 12.0 6.5 10.5 3.7 23.8 10.7 24.4 30.4 10.1 32.9 2.0 45.1 6.7 8.6 13.1 32.6 42.5 11.4 3.8 24.5 40.3 12.4 9.4 19.2 82.0 74.2 9.5 25.1 51.7 8.6 30.9 33.1 23.4 19.8 7.9 25.1 9.2 6.6 10.2 14.6 16.5 32.3 4.9 11.5 12.3 143.6 27.4 10.1 60.0 PILRB "FDFACT1, FDFACT2" ENSG00000121716 "Paired immunoglobin like type 2 receptor beta" Q9UKJ0 7 100352176-100367733 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 221.1;neutrophil: 141.8" "Group enriched" "Detected in all" 8 "granulocytes: 221.1;monocytes: 75.5" "Cell line enhanced" "Detected in all" "SK-BR-3: 344.6" HPA026750 Approved Approved Mitochondria "Intracellular and membrane" NA Yes "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Mitochondria "HPA026750: AB_10670828" "unprognostic (8.33e-3)" "unprognostic (9.31e-2)" "unprognostic (1.32e-2)" "unprognostic (9.15e-2)" "unprognostic (1.02e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (3.17e-1)" "unprognostic (1.20e-1)" "unprognostic (8.76e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (4.85e-3)" "unprognostic (1.66e-1)" "unprognostic (4.40e-2)" "unprognostic (3.35e-3)" 63.2 89.0 72.9 71.0 75.0 71.7 77.6 104.3 86.3 87.0 90.9 65.8 66.1 62.9 67.6 47.2 83.8 52.2 47.7 75.5 70.8 118.8 125.0 43.9 83.7 71.8 70.8 82.1 91.7 58.3 182.0 32.9 71.5 102.7 57.4 66.8 66.4 58.0 78.7 90.1 75.9 42.3 64.2 113.5 68.7 157.5 74.3 59.0 122.9 34.3 65.7 61.9 56.2 78.1 62.5 51.4 57.9 100.7 63.0 14.4 56.2 37.0 16.5 25.7 24.9 36.5 70.3 50.3 68.0 19.0 45.7 65.1 32.3 38.9 17.5 41.6 47.3 46.5 204.8 32.2 14.0 47.4 116.0 18.1 44.8 34.8 70.2 31.9 21.8 73.6 50.7 118.9 18.3 83.9 74.8 243.3 25.2 51.7 26.9 43.3 16.9 51.6 116.4 100.3 53.8 38.5 31.2 344.6 45.7 61.7 60.5 72.3 52.4 90.8 57.9 58.8 48.7 71.2 98.6 61.8 25.5 69.4 54.6 21.2 35.6 221.1 10.7 59.2 6.7 0.6 1.3 7.1 17.8 1.6 1.2 2.6 141.8 17.9 75.5 0.5 0.6 25.7 72.9 75.0 104.3 86.3 75.5 70.8 71.8 70.8 71.5 64.2 74.3 78.1 22.8 38.5 45.9 0.0 25.3 15.7 18.1 17.1 11.4 44.7 32.9 33.7 1.1 44.3 32.2 14.7 68.8 12.9 49.5 12.3 1.9 7.6 18.4 43.1 17.5 19.8 29.4 7.4 0.0 5.6 12.1 13.4 36.2 57.2 25.2 26.0 24.3 77.7 10.0 75.7 0.0 21.2 22.4 16.0 16.6 13.6 74.0 11.7 19.6 0.0 10.0 19.0 134.9 0.0 0.0 7.4 16.2 51.1 14.5 17.9 20.3 4.9 40.3 64.9 26.3 18.2 14.3 49.4 10.2 10.5 13.5 15.7 37.0 23.5 22.4 16.7 PLEKHD1 UPF0639 ENSG00000175985 "Pleckstrin homology and coiled-coil domain containing D1" A6NEE1 14 69484692-69531551 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.1;parathyroid gland: 6.0;retina: 8.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 60.9;Horizontal cells: 230.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 13 "plasmacytoid DC: 3.7" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.7" "Cell line enhanced" "Detected in some" "OE19: 1.1;SK-BR-3: 2.4;T-47d: 2.3;U-266/70: 1.0" "Region enhanced" "Detected in many" "cerebellum: 30.0" "Low region specificity" "Detected in many" HPA051875 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "HPA051875: AB_2681648" "unprognostic (8.73e-2)" "unprognostic (4.64e-3)" "unprognostic (3.73e-2)" "unprognostic (4.03e-2)" "unprognostic (7.58e-2)" "unprognostic (3.15e-3)" "unprognostic (1.44e-1)" "unprognostic (1.64e-3)" "unprognostic (3.28e-1)" "unprognostic (1.83e-1)" "unprognostic (4.56e-3)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (8.08e-2)" "unprognostic (2.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.42e-2)" 0.1 0.2 1.2 0.1 0.5 0.5 0.6 8.1 2.4 0.3 0.0 0.0 0.2 0.1 1.6 0.1 0.1 0.1 0.1 0.3 1.4 1.4 0.0 0.2 0.9 1.4 3.2 0.1 0.2 6.0 0.3 0.1 1.6 0.1 0.0 8.8 1.6 0.3 0.1 1.5 0.1 0.0 0.4 0.2 0.2 1.2 4.5 0.1 2.2 0.0 0.2 0.0 0.0 1.1 0.1 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.4 0.1 0.1 0.2 1.1 0.0 0.1 0.0 0.1 0.2 0.2 0.3 0.7 0.0 2.4 0.0 0.0 2.3 0.0 0.0 0.1 0.3 0.1 0.1 1.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.7 0.0 0.0 1.2 0.5 8.1 2.4 0.3 1.4 1.4 3.2 1.6 0.4 4.5 1.1 0.5 0.0 7.3 0.3 0.0 0.4 1.8 0.1 0.0 60.9 0.6 0.4 1.3 0.0 2.0 0.0 4.2 0.1 11.2 0.1 3.9 0.1 0.5 0.4 0.2 1.0 0.0 0.0 6.3 0.2 0.1 0.6 0.0 0.6 1.3 0.1 0.4 0.0 0.1 230.5 3.3 0.0 0.0 0.0 0.6 0.1 0.0 1.0 0.0 0.0 0.6 1.7 1.0 0.0 0.1 0.3 0.0 0.0 0.0 1.4 0.2 0.5 0.9 5.9 0.0 1.4 0.6 0.8 0.3 0.0 0.3 0.1 2.3 0.2 0.1 0.7 PLXNB2 "KIAA0315, MM1, PLEXB2" ENSG00000196576 "Plexin B2" O15031 22 50274979-50307646 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Gastric mucus-secreting cells: 296.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 11.1;intermediate monocyte: 16.4;myeloid DC: 8.3;non-classical monocyte: 21.2;plasmacytoid DC: 6.6" "Group enriched" "Detected in many" 25 "dendritic cells: 8.3;monocytes: 21.2" "Cell line enhanced" "Detected in many" "SK-BR-3: 306.0" "Low region specificity" "Detected in all" HPA003100 Uncertain NA NA 78000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "HPA003100: AB_1079638" "unprognostic (4.43e-3)" "unprognostic (1.34e-1)" "unprognostic (2.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.28e-2)" "unprognostic (4.96e-2)" "unprognostic (2.69e-2)" "unprognostic (1.10e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (7.37e-4)" "unprognostic (8.47e-3)" "unprognostic (9.84e-2)" "unprognostic (3.05e-2)" "prognostic favorable (4.75e-4)" "unprognostic (1.61e-2)" "unprognostic (9.41e-3)" "unprognostic (6.05e-2)" 28.1 42.9 12.5 31.2 11.5 14.6 25.0 43.2 14.7 38.8 61.2 45.8 45.0 44.0 7.7 48.6 50.6 51.5 20.1 9.8 12.3 42.5 33.2 40.2 22.8 21.1 22.9 49.6 47.5 22.5 33.8 35.7 16.9 40.0 16.4 9.3 53.0 45.6 7.0 50.2 50.3 20.2 13.2 74.2 87.4 18.6 16.7 7.8 53.8 3.1 15.3 33.3 41.3 15.5 77.0 125.0 58.2 78.7 35.2 43.2 98.9 104.8 55.8 36.8 36.1 87.0 102.0 59.9 114.1 86.8 22.6 145.9 10.2 77.5 9.1 10.8 50.3 11.2 233.2 64.3 79.2 2.0 54.6 67.8 117.5 39.1 29.9 64.8 30.0 0.1 15.9 14.3 38.7 132.4 1.1 21.0 15.5 45.9 31.3 64.2 97.8 18.8 39.4 237.5 29.6 53.6 103.0 306.0 22.6 16.9 119.9 72.0 64.9 76.1 112.6 39.7 37.9 8.1 1.5 11.0 60.4 3.5 101.5 0.0 11.1 0.0 0.0 16.4 0.2 0.0 0.0 0.0 8.3 0.0 0.0 0.1 0.4 0.1 21.2 6.6 0.5 7.7 12.5 11.5 43.2 14.7 9.8 12.3 21.1 22.9 16.9 13.2 16.7 15.5 15.2 64.1 54.5 33.0 6.2 22.9 22.7 70.6 23.9 15.5 48.2 40.8 15.5 62.9 94.4 136.1 16.7 3.1 11.8 172.0 3.9 93.1 9.0 87.8 33.4 24.8 49.7 2.1 13.5 57.5 29.3 28.7 296.2 72.6 5.1 43.2 21.4 58.8 36.3 13.5 9.3 77.9 40.7 46.8 38.2 4.3 24.2 49.9 14.2 24.4 45.1 54.1 2.1 4.5 1.6 117.5 111.4 19.2 4.9 54.3 110.5 36.4 154.6 10.4 26.3 18.9 35.8 2.2 2.4 34.5 25.1 6.4 4.1 48.5 56.5 45.1 PPFIA3 "KIAA0654, LPNA3, MGC126567, MGC126569" ENSG00000177380 "PTPRF interacting protein alpha 3" O75145 19 49119544-49151026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 45.0;skin 1: 42.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 40.8;Horizontal cells: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 23.1;PC-3: 36.1;SK-BR-3: 29.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043567, HPA050340" Enhanced Uncertain "Nucleoli fibrillar center,Vesicles" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "Nucleoli fibrillar center, Vesicles" "HPA043567: AB_2678558, HPA050340: AB_2681096" "prognostic unfavorable (3.09e-4)" "unprognostic (4.70e-2)" "unprognostic (5.14e-3)" "prognostic favorable (8.65e-4)" "unprognostic (3.46e-1)" "prognostic favorable (6.46e-7)" "prognostic unfavorable (2.24e-5)" "unprognostic (1.27e-1)" "unprognostic (8.36e-2)" "unprognostic (9.41e-3)" "unprognostic (5.21e-3)" "unprognostic (8.52e-2)" "unprognostic (1.00e-2)" "unprognostic (1.22e-2)" "unprognostic (1.52e-1)" "unprognostic (3.92e-2)" "unprognostic (1.32e-1)" 2.0 4.5 16.4 0.8 18.8 0.2 2.7 11.7 28.6 4.6 0.0 6.6 3.0 2.2 0.3 14.1 1.9 0.6 3.1 18.2 11.4 3.1 2.7 2.9 0.8 10.1 8.7 1.3 4.7 2.1 45.0 0.4 9.9 5.6 1.0 3.7 5.3 0.6 1.4 42.3 3.7 0.4 3.5 2.2 2.4 4.2 11.7 2.4 2.8 0.2 1.1 1.4 8.1 16.6 3.3 3.3 3.3 8.0 0.1 0.0 6.0 0.4 0.4 1.5 2.2 2.2 1.3 7.3 4.3 0.4 2.4 1.7 5.0 0.7 0.4 7.9 10.8 4.6 3.5 1.7 0.4 1.9 11.4 0.4 1.8 1.0 0.5 0.7 0.0 12.1 9.0 11.2 0.1 14.2 2.3 3.2 1.4 23.1 36.1 7.6 6.5 3.6 0.5 1.6 7.2 9.5 1.3 29.7 3.3 0.0 16.5 4.4 0.7 1.7 6.1 1.1 0.2 21.0 18.2 5.4 1.7 7.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 18.8 11.7 28.6 18.2 11.4 10.1 8.7 9.9 3.5 11.7 16.6 15.7 0.0 0.6 8.5 0.8 7.1 8.0 3.5 11.4 40.8 10.4 6.1 4.2 8.6 3.0 5.5 14.6 0.5 3.6 19.3 19.6 2.7 1.2 1.3 3.6 15.2 26.5 2.7 19.9 4.4 2.1 3.4 3.6 2.4 0.0 2.7 23.2 8.6 2.5 43.7 21.5 26.3 8.2 2.2 2.4 1.7 5.6 2.7 16.0 2.8 0.0 16.2 0.0 10.6 2.7 1.9 13.7 3.8 1.2 18.2 15.0 4.6 0.9 17.9 0.0 0.6 5.5 2.5 5.9 8.7 11.8 0.5 0.7 13.2 20.4 6.3 PPIAL4A "COAS2, PPIAL4, PPIAL4B" ENSG00000263353 "Peptidylprolyl isomerase A like 4A" Q9Y536 1 120889746-120890405 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "Distal tubular cells: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;NB-4: 1.8;SK-BR-3: 1.9" HPA058345 Uncertain NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA058345: AB_2683685" "unprognostic (3.49e-3)" "unprognostic (2.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.42e-1)" "unprognostic (4.17e-1)" "unprognostic (1.77e-1)" "unprognostic (2.09e-1)" "unprognostic (1.42e-2)" "unprognostic (7.94e-3)" "unprognostic (1.72e-2)" "unprognostic (1.91e-1)" "unprognostic (7.11e-2)" "unprognostic (5.32e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-1)" "unprognostic (1.83e-2)" "unprognostic (1.74e-1)" 0.0 0.2 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.1 0.4 0.8 1.8 1.0 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.4 0.1 0.1 1.9 0.2 0.0 1.3 1.1 0.3 1.2 0.4 1.2 0.7 0.5 0.4 1.0 1.1 0.7 1.3 0.0 0.4 0.2 0.4 0.4 0.4 0.8 0.6 0.7 0.9 0.6 0.4 0.7 0.0 0.7 0.3 0.9 0.7 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PPP1R35 "C7orf47, MGC22793" ENSG00000160813 "Protein phosphatase 1 regulatory subunit 35" Q8TAP8 7 100435282-100436497 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.7" "Cell type enhanced" "Detected in all" "Spermatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021604, HPA051607" Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021604: AB_2670774, HPA051607: AB_2681548" "unprognostic (2.17e-3)" "unprognostic (2.17e-1)" "unprognostic (7.40e-3)" "unprognostic (1.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.15e-1)" "unprognostic (3.53e-2)" "unprognostic (1.33e-1)" "unprognostic (6.99e-2)" "unprognostic (1.20e-1)" "unprognostic (6.77e-2)" "unprognostic (5.17e-2)" "unprognostic (1.85e-3)" "unprognostic (1.40e-1)" "unprognostic (9.51e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.97e-4)" 8.8 16.7 7.8 11.9 7.7 8.7 9.7 9.6 13.8 12.3 8.7 10.6 11.5 10.9 2.2 11.1 11.0 3.1 9.4 7.7 8.0 12.4 12.9 9.4 14.5 8.2 7.7 13.5 10.5 7.8 11.9 6.8 7.8 11.2 2.4 2.4 9.9 5.4 6.3 7.8 12.0 2.8 8.0 22.1 10.9 48.7 8.2 15.3 12.0 3.5 5.5 10.3 10.3 7.7 41.0 14.7 11.1 19.4 3.3 4.9 14.5 11.6 10.5 8.2 9.4 6.8 36.2 14.0 22.2 6.4 39.3 17.4 5.9 9.4 1.8 30.9 18.3 11.6 11.8 14.1 14.5 12.2 16.4 6.8 17.0 7.3 12.0 14.1 17.2 38.8 21.1 24.1 9.9 34.1 36.2 64.6 23.0 17.1 20.1 14.6 4.7 37.9 11.4 9.5 11.8 35.0 8.9 62.5 35.0 6.9 18.0 28.8 13.9 12.2 18.4 16.4 28.9 37.9 23.1 20.2 13.3 19.6 25.0 17.1 2.3 5.7 5.8 1.0 6.2 4.3 5.9 6.6 1.7 5.4 3.3 3.2 10.5 3.8 0.7 7.6 7.6 2.7 7.8 7.7 9.6 13.8 7.7 8.0 8.2 7.7 7.8 8.0 8.2 7.7 47.7 16.0 9.6 13.1 30.8 21.0 39.9 13.9 28.5 35.7 51.3 60.6 2.0 27.1 7.8 47.8 8.4 66.5 47.8 23.6 52.8 9.1 17.3 34.6 22.7 22.1 18.6 17.2 10.2 10.0 40.2 16.5 20.4 24.9 8.2 28.3 15.4 16.1 16.8 48.8 11.8 32.0 18.3 12.0 15.4 8.7 18.0 17.4 17.8 12.2 11.6 26.8 27.8 12.1 12.5 10.7 30.2 9.4 24.2 55.2 26.2 39.5 16.5 37.7 13.1 12.4 17.8 106.1 29.8 36.7 33.4 33.9 37.6 35.2 28.1 43.9 PPP4R3A "FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1" ENSG00000100796 "Protein phosphatase 4 regulatory subunit 3A" Q6IN85 14 91457508-91510554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002568, HPA063917" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nuclear speckles, Cytosol" "HPA002568: AB_1079207, HPA063917: AB_2685153" "unprognostic (5.51e-2)" "unprognostic (2.93e-2)" "unprognostic (3.26e-1)" "unprognostic (1.40e-1)" "unprognostic (4.40e-2)" "unprognostic (9.95e-3)" "unprognostic (4.10e-2)" "unprognostic (5.71e-3)" "unprognostic (1.05e-1)" "unprognostic (8.34e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.57e-1)" "unprognostic (4.53e-2)" 19.3 13.5 14.4 18.2 14.5 50.0 19.6 16.6 15.2 19.1 16.2 21.2 17.2 20.0 15.9 21.4 20.4 12.3 16.2 12.6 13.3 18.3 23.7 20.2 28.3 13.6 14.2 22.0 19.8 16.8 14.8 17.5 13.7 18.4 18.5 10.9 20.8 13.1 24.5 25.4 24.4 15.0 12.7 24.1 20.6 22.3 14.5 27.4 17.7 16.7 25.4 19.5 19.4 16.9 24.5 41.4 34.1 27.1 22.5 20.9 60.9 23.2 21.4 24.5 24.6 35.2 32.1 63.1 30.2 19.2 15.0 27.8 36.6 28.9 39.8 52.0 19.7 32.5 25.7 24.5 26.3 59.1 33.1 15.1 50.4 19.7 31.1 20.1 26.7 29.4 33.5 36.2 33.1 52.1 42.8 38.0 31.2 46.5 29.8 54.0 40.6 26.5 30.3 41.5 41.6 25.4 35.3 77.0 32.5 33.6 39.4 37.8 28.0 19.2 20.6 21.1 26.8 36.0 67.0 69.3 25.2 31.8 34.7 6.2 1.9 2.9 4.9 2.6 6.6 4.6 4.5 4.4 2.1 7.4 5.6 4.8 2.5 9.0 3.7 5.0 6.9 2.6 14.4 14.5 16.6 15.2 12.6 13.3 13.6 14.2 13.7 12.7 14.5 16.9 44.1 32.1 48.3 0.0 83.0 0.0 46.7 0.0 58.1 27.9 35.9 23.5 0.0 32.9 30.3 46.0 20.9 33.9 91.8 21.1 29.4 21.2 13.0 86.9 46.5 33.3 13.3 47.5 0.0 25.1 29.0 27.3 45.3 70.7 20.2 39.8 28.9 51.8 25.8 32.0 0.0 28.2 0.0 48.7 0.0 8.5 37.6 70.7 0.0 0.0 41.8 21.0 44.3 0.0 0.0 27.8 25.7 42.5 75.8 56.6 37.3 23.5 16.8 27.3 26.3 45.9 27.1 91.0 59.9 58.0 0.0 44.3 80.1 33.0 25.8 75.2 PRKCD ENSG00000163932 "Protein kinase C delta" Q05655 3 53156009-53192717 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 7 "dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 267.7;THP-1: 194.0" "Group enriched" "Detected in all" 5 "basal ganglia: 121.4;thalamus: 334.6" "Low region specificity" "Detected in all" "HPA001863, HPA001890, CAB010469, CAB013225" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 30000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Endoplasmic reticulum, Golgi apparatus" "CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628" "unprognostic (3.59e-1)" "unprognostic (4.85e-2)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.24e-4)" "prognostic favorable (9.01e-4)" "unprognostic (1.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.89e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (2.48e-2)" "unprognostic (2.06e-3)" "unprognostic (2.95e-3)" 46.1 59.7 10.4 45.4 11.1 90.3 28.9 4.4 11.7 25.9 7.3 43.5 54.8 9.1 39.1 32.7 42.3 32.8 19.6 12.8 11.0 25.6 8.8 44.3 46.8 9.9 8.5 13.6 33.2 20.7 8.2 20.5 7.5 39.3 41.5 2.2 25.9 31.9 6.8 34.0 55.7 16.2 9.5 54.2 65.1 20.8 9.0 16.3 41.8 9.2 62.1 44.2 23.2 12.3 33.5 14.4 5.2 8.7 35.9 21.6 46.2 20.4 25.7 24.5 23.7 34.4 31.9 86.5 8.3 45.6 42.9 14.5 34.1 49.8 20.6 75.2 23.6 50.1 18.3 32.0 23.6 64.8 103.4 17.1 35.8 25.6 23.2 21.8 22.4 9.3 9.7 11.8 36.1 85.0 7.0 81.0 13.0 51.5 23.0 7.6 13.6 20.6 25.5 72.8 8.3 6.5 15.4 267.7 39.6 24.0 22.6 194.0 31.5 11.7 14.4 15.4 19.2 18.1 33.6 45.9 27.6 116.4 22.6 51.8 73.7 50.1 3.6 71.3 2.2 6.2 2.1 2.5 57.0 8.2 2.2 2.0 52.9 6.9 47.7 16.3 2.6 24.1 10.4 11.1 4.4 11.7 12.8 11.0 9.9 8.5 7.5 9.5 9.0 12.3 4.3 3.2 23.5 2.0 25.7 29.2 26.3 8.0 23.9 0.3 11.8 4.3 6.4 14.3 16.1 14.7 0.0 3.1 24.7 61.8 3.9 8.9 34.5 18.5 4.4 2.7 26.5 5.2 3.4 10.7 16.0 6.7 54.0 17.8 5.7 8.9 3.3 2.3 44.8 1.7 4.2 37.1 4.1 47.4 43.0 75.6 9.0 41.5 10.6 20.6 44.9 2.0 8.2 1.0 0.5 13.2 55.4 6.8 25.8 19.7 64.5 13.1 16.5 0.2 6.6 6.5 12.1 23.1 3.7 23.9 27.8 8.8 10.0 10.4 23.0 34.6 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 83000 "Cluster 32: T-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 0.9 1.8 3.9 1.1 5.0 1.5 1.2 10.1 11.6 1.3 0.3 1.3 0.4 1.2 1.2 1.2 7.6 1.1 1.1 4.4 1.1 1.3 0.4 0.9 1.2 5.1 1.9 1.3 1.8 15.3 11.0 0.3 5.3 2.5 0.3 2.2 2.3 1.7 1.4 2.3 0.9 0.9 0.0 0.9 1.1 2.1 3.6 1.3 2.2 0.2 1.3 1.8 1.1 4.8 0.4 1.0 3.6 4.7 17.2 2.3 1.2 1.8 3.4 2.0 4.5 0.3 3.4 2.0 0.4 4.2 2.1 0.3 1.3 4.5 0.9 9.8 2.0 0.7 1.9 0.2 1.7 0.4 1.7 4.4 0.3 1.7 0.7 9.7 0.8 6.0 1.0 4.7 2.5 23.1 4.4 0.4 8.5 0.1 2.1 2.8 0.4 1.9 1.0 0.4 6.6 4.4 1.8 33.6 0.7 1.4 9.1 0.4 0.7 0.4 4.6 0.9 1.3 6.1 6.6 0.6 10.9 0.3 1.3 0.5 0.2 0.2 1.2 0.1 1.4 0.5 1.3 1.2 0.0 0.6 1.4 1.3 0.3 0.7 0.1 0.6 0.2 0.4 3.9 5.0 10.1 11.6 4.4 1.1 5.1 1.9 5.3 0.0 3.6 4.8 3.3 0.0 2.0 3.9 2.9 2.7 3.8 3.7 3.4 22.8 7.4 6.2 3.0 7.2 3.4 11.0 14.6 0.7 4.4 4.5 3.9 2.9 4.3 5.0 5.4 3.3 11.3 2.1 14.7 5.0 0.5 5.2 5.6 4.9 1.3 7.9 2.2 2.9 3.8 15.2 10.8 5.4 2.0 2.5 2.6 3.5 5.6 2.2 1.8 2.8 11.3 8.6 11.3 5.5 3.7 3.1 1.0 2.6 2.2 4.2 6.4 8.0 12.4 21.6 0.0 7.2 5.3 10.4 6.4 3.4 2.3 0.4 5.6 7.8 4.7 3.0 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852730-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 79.6;salivary gland: 26.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 221.0;Club cells: 343.9;Ionocytes: 207.5;Pancreatic endocrine cells: 380.6;Urothelial cells: 479.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CAPAN-2: 17.3;MCF7: 14.6;RT4: 10.4;SK-BR-3: 22.9" "Region enhanced" "Detected in some" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA049161: AB_2680660" "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 23.4 0.0 0.5 0.3 0.7 0.4 79.6 1.3 0.8 0.0 0.0 0.0 16.7 0.5 2.9 0.0 0.0 0.0 0.0 5.8 1.5 2.4 1.1 0.0 6.0 0.5 0.0 26.9 0.3 0.0 3.2 0.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.3 0.0 2.2 2.5 23.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 17.3 0.0 0.0 0.0 0.0 1.8 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 22.9 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 4.2 0.0 0.2 23.2 221.0 128.8 28.5 0.0 42.8 23.7 0.3 38.6 343.9 16.5 0.0 36.7 1.9 18.5 1.9 113.1 0.0 28.4 4.6 1.8 3.6 0.0 0.0 98.3 37.1 1.3 52.5 56.6 0.0 0.0 0.0 0.1 2.3 0.0 0.0 7.5 207.5 0.0 1.4 0.0 0.0 0.9 7.2 0.0 1.0 0.0 0.0 0.0 0.0 380.6 32.3 0.0 0.3 75.4 0.6 0.2 108.0 0.0 0.0 0.0 13.7 0.1 0.2 22.7 27.6 10.5 2.7 0.0 6.9 479.5 PRSS27 "CAPH2, MPN" ENSG00000172382 "Serine protease 27" Q9BQR3 16 2712419-2720551 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 83.5;esophagus: 388.6;vagina: 134.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Horizontal cells: 11.8;Squamous epithelial cells: 9.6;Urothelial cells: 11.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;SK-BR-3: 24.4;T-47d: 14.6;U-266/70: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB024920, HPA028848" Approved Approved Vesicles "Secreted to digestive system" NA NA 8700000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" Vesicles "CAB024920: , HPA028848: " "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (3.46e-3)" "unprognostic (5.35e-2)" "unprognostic (5.25e-2)" "unprognostic (2.48e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (4.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.79e-2)" "unprognostic (4.40e-3)" "unprognostic (4.03e-3)" "unprognostic (2.40e-1)" "unprognostic (2.26e-1)" "unprognostic (2.04e-2)" "unprognostic (1.28e-2)" 1.0 0.4 0.9 0.2 0.9 0.3 1.3 1.0 2.0 83.5 0.6 1.0 0.0 1.0 0.0 388.6 0.7 0.2 0.4 0.8 1.4 1.1 0.6 0.6 0.3 1.2 1.5 0.5 0.8 0.7 1.5 0.1 1.0 1.0 0.0 0.2 52.5 0.4 0.3 3.3 0.6 0.0 1.0 0.6 0.8 2.6 1.2 0.6 0.8 0.0 29.9 0.8 134.2 0.9 0.1 0.3 0.4 2.1 0.3 0.7 6.1 0.0 0.2 0.2 0.2 0.1 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.1 0.1 0.0 1.0 0.0 0.3 1.2 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.6 0.0 2.0 0.0 1.1 1.4 0.2 0.0 1.0 0.2 0.1 0.2 0.3 0.7 2.8 0.0 24.4 0.6 0.1 14.6 1.8 0.0 0.4 0.0 0.1 0.0 5.2 3.7 0.5 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.9 1.0 2.0 0.8 1.4 1.2 1.5 1.0 1.0 1.2 0.9 1.5 9.6 5.8 0.0 0.5 1.8 2.5 1.3 0.6 5.2 5.1 6.2 1.2 1.5 5.6 1.8 4.2 0.7 0.5 1.2 0.0 1.5 3.3 0.6 1.4 1.8 0.0 0.0 0.4 1.4 0.6 1.4 1.1 1.6 3.8 1.1 0.4 0.7 0.3 11.8 0.8 0.5 0.0 0.3 3.1 1.0 0.3 0.8 1.8 1.9 0.9 2.6 0.0 0.0 0.3 1.1 1.2 0.0 0.2 1.7 0.1 0.7 3.4 6.6 0.0 2.7 1.5 3.0 3.9 9.6 2.4 3.3 1.3 0.6 1.4 11.1 PSMD3 "P58, Rpn3, S3, TSTA2" ENSG00000108344 "Proteasome 26S subunit, non-ATPase 3" O43242 17 39980807-39997959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 252.5" "Cell type enhanced" "Detected in all" "Early spermatids: 247.0;Syncytiotrophoblasts: 271.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 842.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017038, HPA048972" Approved Enhanced Nucleoplasm,Cytosol No No 3100000 "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "CAB017038: , HPA048972: AB_2680579" "unprognostic (3.44e-2)" "unprognostic (3.10e-1)" "unprognostic (2.22e-2)" "unprognostic (5.21e-2)" "unprognostic (7.87e-2)" "unprognostic (8.36e-3)" "unprognostic (5.75e-3)" "unprognostic (7.46e-2)" "unprognostic (6.19e-2)" "unprognostic (1.61e-1)" "unprognostic (6.89e-2)" "unprognostic (4.42e-2)" "prognostic unfavorable (4.47e-7)" "unprognostic (1.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.85e-2)" "unprognostic (7.45e-2)" 56.5 64.2 44.5 47.6 45.4 48.1 53.6 44.1 50.0 54.6 40.7 60.3 43.3 61.8 35.0 69.6 51.6 25.3 76.5 47.4 47.0 47.8 93.6 51.0 45.7 45.9 43.0 52.7 57.1 55.4 48.3 47.4 48.0 47.7 46.1 31.3 54.2 37.2 252.5 86.1 48.9 45.2 42.9 49.3 52.7 52.9 44.2 56.9 45.9 103.3 51.1 53.6 53.2 46.6 203.7 247.8 133.2 192.9 106.3 68.2 158.3 146.2 150.7 257.3 198.3 206.4 170.0 242.3 357.7 157.6 172.5 310.2 238.6 190.7 172.9 245.5 266.2 140.4 120.5 207.2 96.5 191.3 151.0 91.5 160.0 272.7 118.8 86.4 147.6 166.0 291.5 146.9 121.2 148.0 298.2 131.2 185.5 130.9 145.2 216.2 184.7 227.7 130.5 135.3 174.9 132.5 139.7 842.6 124.3 160.9 190.2 162.7 132.9 110.7 195.8 165.6 266.2 158.2 217.2 269.3 169.4 142.2 182.6 8.1 22.4 19.0 17.6 21.3 17.2 16.6 17.0 20.4 29.8 17.7 15.3 19.1 6.3 16.6 18.3 20.4 16.3 17.9 44.5 45.4 44.1 50.0 47.4 47.0 45.9 43.0 48.0 42.9 44.2 46.6 32.4 44.8 40.1 16.6 43.3 46.7 57.2 71.5 33.0 70.8 31.7 25.7 21.3 15.7 48.6 16.5 20.9 165.3 38.0 98.3 46.9 101.4 247.0 30.7 35.9 46.5 26.4 44.6 18.0 106.3 131.6 50.6 34.7 28.5 25.3 70.2 32.2 50.9 96.3 60.6 17.6 59.2 69.2 27.4 37.0 51.8 62.7 39.1 65.8 4.7 57.4 89.9 35.0 11.1 16.5 101.4 68.3 54.2 57.2 76.3 75.3 54.8 32.0 56.9 26.3 51.1 50.7 87.3 54.0 38.7 44.6 271.7 32.4 78.8 77.2 53.7 PTCD1 KIAA0632 ENSG00000106246 "Pentatricopeptide repeat domain 1" O75127 7 99416739-99466163 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 29.2" "HPA020106, HPA047679" Uncertain Approved Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA020106: AB_2176551, HPA047679: AB_2680119" "unprognostic (4.70e-2)" "unprognostic (3.38e-2)" "unprognostic (4.19e-2)" "unprognostic (6.05e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-2)" "prognostic unfavorable (2.34e-4)" "unprognostic (4.39e-2)" "unprognostic (2.00e-1)" "unprognostic (4.09e-2)" "unprognostic (1.14e-2)" "unprognostic (8.87e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.49e-1)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (7.10e-3)" 3.4 3.6 3.5 2.6 3.5 5.6 3.4 4.2 4.0 3.3 2.8 3.8 2.7 3.7 0.8 4.4 3.8 2.7 4.1 3.2 3.1 3.2 4.7 2.8 3.4 4.1 3.6 3.4 3.6 1.6 2.9 1.8 3.6 4.2 1.3 1.7 3.4 2.1 6.7 4.3 4.0 1.0 3.1 4.9 3.9 4.3 3.6 1.3 3.2 2.6 1.5 3.6 3.4 4.2 4.8 9.8 3.3 9.3 3.1 2.5 9.2 6.6 2.4 4.6 3.3 29.2 5.7 9.6 7.4 1.8 7.7 5.1 4.0 5.9 1.6 7.7 11.2 4.9 8.1 7.2 4.8 5.1 9.0 2.0 3.7 3.8 3.8 3.1 1.4 6.0 10.0 6.4 2.3 13.8 9.0 12.9 6.1 4.8 8.0 5.4 4.3 11.9 2.5 5.1 6.1 6.5 7.4 24.2 6.3 4.7 5.2 5.3 2.7 6.9 8.1 13.7 7.1 9.5 9.1 10.2 7.1 6.7 9.7 1.8 2.0 0.9 3.3 2.3 2.2 1.8 2.1 2.2 1.4 2.5 2.4 3.0 1.9 2.0 1.7 2.1 1.5 1.5 3.5 3.5 4.2 4.0 3.2 3.1 4.1 3.6 3.6 3.1 3.6 4.2 3.5 0.0 5.8 0.0 6.6 6.2 4.0 5.2 4.6 7.9 4.9 4.7 5.8 4.3 4.0 5.5 10.4 9.9 4.1 4.2 1.9 5.3 2.1 4.7 8.6 5.3 7.3 2.5 0.0 6.7 5.6 4.2 3.6 5.2 12.7 12.9 4.6 6.1 6.6 8.4 0.0 6.2 6.1 3.2 6.1 1.8 3.7 3.7 3.6 0.0 3.8 5.6 1.0 0.0 0.0 5.0 2.5 3.0 4.1 3.6 4.5 3.2 5.8 9.3 0.0 8.6 6.7 8.7 7.6 5.1 4.1 5.6 5.7 6.2 6.3 2.6 PXMP4 PMP24 ENSG00000101417 "Peroxisomal membrane protein 4" Q9Y6I8 20 33702758-33720319 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 73.6;Late spermatids: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 42.3;SK-BR-3: 75.8;T-47d: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050077 Approved Approved "Nucleoli fibrillar center,Peroxisomes" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Peroxisomes "Nucleoli fibrillar center" "HPA050077: AB_2681006" "unprognostic (3.41e-2)" "unprognostic (1.11e-1)" "unprognostic (2.59e-1)" "unprognostic (1.75e-1)" "unprognostic (5.08e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-1)" "prognostic favorable (3.88e-4)" "unprognostic (3.53e-1)" "unprognostic (4.47e-2)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.03e-10)" "unprognostic (3.84e-2)" "unprognostic (2.20e-1)" "unprognostic (6.08e-2)" "unprognostic (2.20e-1)" 4.1 11.2 5.1 3.0 5.2 3.2 11.9 3.8 5.6 5.6 4.3 6.2 8.2 4.1 5.1 6.3 6.0 3.3 6.4 5.0 4.0 4.9 8.9 13.9 3.6 4.6 4.5 6.8 6.8 14.7 3.5 3.2 4.1 8.7 5.7 4.4 15.2 6.4 8.0 11.1 7.4 5.1 4.2 4.6 6.8 2.5 5.3 3.5 11.5 6.9 3.9 5.4 5.8 6.5 2.8 12.1 3.3 11.9 5.7 8.3 8.5 8.7 4.7 6.6 2.9 42.3 13.2 0.1 16.2 7.3 16.1 12.5 9.0 10.1 4.7 3.7 3.4 14.0 9.7 0.1 5.3 0.7 10.3 6.4 10.8 9.0 3.0 3.3 4.3 4.4 7.9 8.6 4.7 26.4 12.9 9.8 0.3 21.7 0.0 6.8 16.3 1.7 4.2 9.0 10.7 5.4 24.2 75.8 7.9 1.9 64.0 4.7 8.2 4.7 5.4 11.9 8.2 5.5 13.2 0.2 9.0 4.6 8.1 2.2 11.1 17.5 10.8 22.2 11.3 7.6 10.9 10.9 8.8 9.9 8.3 11.2 2.9 9.1 34.2 5.3 8.5 8.6 5.1 5.2 3.8 5.6 5.0 4.0 4.6 4.5 4.1 4.2 5.3 6.5 5.2 19.2 73.6 7.2 5.5 1.7 4.3 9.4 4.0 11.1 16.8 12.3 12.6 7.2 17.8 18.4 14.6 12.9 3.5 14.2 9.8 8.2 28.7 6.3 6.1 7.6 4.2 9.9 6.4 9.9 24.3 8.5 6.6 5.7 3.8 6.7 8.9 36.0 15.1 5.0 5.7 10.8 6.1 7.5 1.6 44.0 10.5 6.2 3.6 6.5 7.5 13.6 9.2 9.0 10.8 8.5 10.3 11.3 7.0 4.5 23.0 11.2 7.8 11.4 6.6 8.8 7.8 4.6 9.8 9.5 2.4 4.4 5.8 16.9 13.0 4.0 RAB20 FLJ20429 ENSG00000139832 "RAB20, member RAS oncogene family" Q9NX57 13 110523066-110561722 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA002882, HPA052111, HPA068647" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "Golgi apparatus, Vesicles" "HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013" "unprognostic (5.59e-3)" "unprognostic (1.30e-1)" "unprognostic (3.48e-1)" "unprognostic (1.42e-3)" "unprognostic (1.30e-1)" "unprognostic (3.82e-2)" "unprognostic (1.14e-2)" "unprognostic (5.99e-2)" "unprognostic (9.43e-2)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (2.65e-1)" "prognostic favorable (8.57e-4)" "unprognostic (6.96e-2)" "unprognostic (4.32e-2)" "unprognostic (2.28e-2)" "prognostic favorable (4.48e-4)" 31.1 55.4 5.7 21.7 5.5 25.3 23.4 5.6 7.9 11.7 9.6 20.7 27.6 6.9 4.8 4.6 11.5 18.0 21.4 5.2 7.0 26.1 51.4 30.7 16.4 7.0 6.0 20.5 24.2 6.2 9.7 22.8 6.8 12.1 14.3 2.6 10.7 5.0 5.8 4.6 25.3 7.6 6.6 44.5 28.6 10.6 7.4 3.9 22.0 2.3 5.1 20.6 6.7 8.4 20.1 2.9 1.9 3.8 12.4 3.3 31.3 1.7 6.2 8.1 12.5 47.9 39.9 0.0 13.9 1.7 10.8 7.5 3.8 12.3 4.2 22.5 3.0 19.8 3.6 22.6 7.8 2.8 5.7 6.9 2.0 4.2 1.2 6.3 3.1 3.3 3.8 0.0 1.8 24.0 0.1 29.0 4.0 60.9 8.5 1.9 0.1 9.0 14.2 26.3 0.5 2.1 3.8 85.7 27.4 6.2 54.4 30.5 2.3 2.0 4.2 0.2 2.7 0.1 0.0 0.2 27.7 38.9 4.2 7.8 35.5 7.1 1.0 33.3 1.3 3.5 2.8 0.9 15.8 2.8 6.5 2.3 26.3 0.0 26.6 0.8 0.9 11.2 5.7 5.5 5.6 7.9 5.2 7.0 7.0 6.0 6.8 6.6 7.4 8.4 18.6 19.2 20.4 4.2 10.6 4.5 10.9 14.1 10.8 0.2 12.8 13.0 5.0 48.6 16.2 25.8 0.0 34.6 1.8 31.1 31.3 60.3 1.6 20.7 2.6 10.3 18.0 0.0 0.4 67.9 91.3 11.5 15.3 23.2 21.0 41.1 53.6 34.5 105.0 0.0 0.4 23.9 28.5 92.1 19.9 1.6 3.7 100.5 7.2 8.4 16.2 7.4 0.0 4.5 0.1 36.4 17.2 6.4 0.4 8.0 48.1 68.9 20.4 2.0 13.1 6.2 26.2 1.0 13.2 1.9 3.0 20.0 3.6 7.2 24.0 11.1 RAB22A ENSG00000124209 "RAB22A, member RAS oncogene family" Q9UL26 20 58309715-58367507 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066920 Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "HPA066920: AB_2685749" "unprognostic (4.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.68e-1)" "unprognostic (8.34e-3)" "unprognostic (6.20e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (3.12e-1)" "unprognostic (2.00e-2)" "unprognostic (3.59e-2)" "unprognostic (1.12e-2)" "unprognostic (2.16e-1)" "unprognostic (2.55e-1)" "unprognostic (7.52e-2)" "unprognostic (7.01e-3)" 6.4 10.2 8.7 5.3 10.4 4.7 6.4 5.9 11.0 6.9 0.7 6.9 7.1 6.2 7.8 11.6 4.7 5.6 4.2 11.3 9.9 7.5 7.4 6.0 5.8 8.4 8.3 5.6 5.5 11.6 6.1 4.8 9.7 5.2 6.8 5.4 6.4 5.6 4.5 7.5 6.9 5.8 8.0 6.1 7.0 5.4 10.1 6.3 8.5 5.0 7.2 7.0 7.7 8.7 17.5 7.1 8.8 5.7 17.9 16.7 5.2 12.9 14.9 17.4 10.4 11.9 11.8 9.6 15.7 18.2 19.5 13.7 4.5 20.4 19.7 6.5 4.4 6.8 10.0 9.5 13.8 8.5 11.5 11.4 24.4 12.4 12.7 12.3 11.0 7.5 6.0 13.4 18.4 25.1 10.0 8.0 2.2 15.3 17.4 5.2 8.6 8.3 10.9 11.1 6.7 9.1 18.2 34.0 15.6 4.6 12.6 11.5 17.6 28.7 11.9 18.0 15.6 11.5 17.0 6.3 29.5 8.0 10.0 1.5 1.0 0.8 2.2 1.3 2.1 1.5 1.7 1.9 1.4 1.4 1.5 1.8 2.0 2.2 2.1 1.1 1.5 0.8 8.7 10.4 5.9 11.0 11.3 9.9 8.4 8.3 9.7 8.0 10.1 8.7 34.2 22.4 16.2 25.1 34.2 56.0 68.9 21.3 32.5 14.6 32.7 22.5 18.6 32.9 20.9 20.2 8.4 16.6 39.7 39.9 50.9 37.0 6.4 30.1 32.8 29.9 19.2 22.3 27.8 36.0 24.7 39.3 31.1 33.7 11.4 19.9 26.0 25.3 28.0 11.8 26.5 23.5 22.4 23.0 69.7 9.2 31.4 33.6 24.9 35.6 23.0 27.9 34.0 24.6 32.1 75.2 26.2 20.7 29.3 75.4 24.5 44.1 22.4 12.6 13.1 42.4 39.7 22.2 39.7 47.6 68.9 35.4 40.6 30.1 22.5 124.3 RAB3D "D2-2, GOV, RAB16, RAD3D" ENSG00000105514 "RAB3D, member RAS oncogene family" O95716 19 11322068-11346270 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 68.5;skin 1: 53.1" "Cell type enhanced" "Detected in many" "monocytes: 53.1;Squamous epithelial cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 169.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 47.3;Karpas-707: 45.6;MCF7: 54.6;SK-BR-3: 68.8" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "spinal cord: 73.1" "CAB018067, HPA063283" Approved Approved Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Vesicles "CAB018067: AB_606903, HPA063283: AB_2684976" "unprognostic (4.71e-3)" "unprognostic (3.00e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (4.17e-3)" "unprognostic (7.27e-3)" "unprognostic (1.55e-1)" "unprognostic (2.80e-1)" "unprognostic (8.76e-2)" "unprognostic (9.92e-2)" "unprognostic (4.45e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-1)" "unprognostic (9.15e-2)" "unprognostic (1.34e-1)" 5.5 3.4 11.5 5.1 9.9 17.6 12.2 8.5 13.0 15.0 6.3 8.1 8.1 7.3 6.1 34.1 8.7 3.9 3.6 16.1 13.0 5.8 1.8 8.7 2.4 20.7 10.8 4.2 68.5 4.4 4.7 7.2 23.4 17.1 8.6 1.7 30.1 8.1 2.5 53.1 6.1 8.8 12.2 8.8 19.5 1.4 15.2 4.7 6.2 4.2 9.1 7.0 15.2 14.1 1.5 14.2 4.4 17.7 7.1 12.3 0.9 1.3 3.8 2.5 2.5 5.1 0.5 0.6 16.0 8.6 4.7 19.1 7.5 11.9 2.2 7.8 1.1 5.8 6.7 5.8 4.4 3.1 13.2 5.3 47.3 2.1 5.1 6.5 20.5 4.3 2.1 45.6 0.8 54.6 2.2 6.9 3.7 28.7 14.4 2.1 0.0 16.1 22.0 14.2 4.9 9.5 4.3 68.8 9.3 6.0 41.1 35.1 7.9 2.4 0.8 11.4 0.2 15.5 21.3 3.2 8.4 19.0 2.6 123.5 84.1 95.6 3.2 51.4 5.6 2.2 3.2 2.6 35.5 2.2 2.2 2.7 169.1 1.6 41.3 0.9 5.7 26.3 11.5 9.9 8.5 13.0 16.1 13.0 20.7 10.8 23.4 12.2 15.2 14.1 10.0 6.4 17.2 4.6 4.0 15.7 4.5 13.7 12.5 0.7 23.6 14.1 4.3 10.0 19.1 14.7 0.0 8.0 4.4 5.7 11.7 4.8 0.5 5.4 6.6 9.7 18.6 5.9 9.2 25.6 6.6 5.4 23.0 14.0 12.7 4.1 17.9 1.5 9.4 0.0 5.4 29.3 4.1 40.0 2.4 0.2 4.4 16.0 8.8 5.6 53.1 5.3 2.1 1.0 1.3 12.7 5.8 4.9 8.5 11.7 1.4 3.6 1.8 0.4 6.6 3.3 8.5 0.1 2.5 47.8 37.8 10.4 3.9 3.8 15.4 5.9 RAB5C "RAB5CL, RABL" ENSG00000108774 "RAB5C, member RAS oncogene family" P51148 17 42124978-42155044 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003426, HPA004167" Approved Enhanced Endosomes NA NA 480000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Endosomes "HPA003426: AB_1079735, HPA004167: AB_2667156" "unprognostic (1.41e-1)" "unprognostic (6.02e-2)" "unprognostic (6.75e-3)" "unprognostic (3.69e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (7.08e-4)" "unprognostic (1.56e-3)" "unprognostic (4.85e-2)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (2.79e-1)" "unprognostic (2.98e-2)" "unprognostic (6.06e-3)" "unprognostic (4.37e-1)" "unprognostic (2.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.12e-2)" 133.5 118.1 91.7 113.7 99.2 203.5 119.4 97.4 107.9 90.9 77.1 106.9 135.7 103.1 67.3 92.3 87.3 88.6 69.7 89.0 101.9 145.9 99.7 120.1 94.6 98.5 98.1 82.4 76.4 102.6 48.7 106.8 98.5 70.6 86.3 40.5 84.5 84.3 46.7 91.5 124.1 97.6 96.7 116.4 118.0 41.7 104.3 87.1 109.7 54.6 79.2 115.1 83.0 100.6 169.5 311.3 96.2 140.1 210.7 144.8 184.7 201.6 212.5 273.9 238.1 223.5 163.5 81.5 172.9 254.4 194.8 231.8 179.1 197.9 175.7 104.9 232.6 124.8 120.6 326.1 206.4 165.8 195.6 187.3 204.7 208.1 144.6 143.1 292.6 110.2 145.8 123.6 189.7 154.7 170.3 148.6 95.2 294.7 0.9 110.0 165.2 139.4 209.0 246.1 53.6 136.2 103.7 651.5 220.6 149.5 288.7 159.9 276.6 279.8 155.0 237.9 218.5 113.0 157.1 104.1 185.1 127.6 290.4 56.9 119.7 129.5 45.7 103.4 40.6 42.8 44.5 46.2 83.4 43.6 36.5 37.2 194.5 56.8 110.0 55.1 56.0 99.2 91.7 99.2 97.4 107.9 89.0 101.9 98.5 98.1 98.5 96.7 104.3 100.6 185.1 6.4 9.7 23.5 83.7 111.3 89.6 139.6 62.0 51.0 86.8 80.0 5.4 77.2 66.3 106.7 12.5 189.6 95.3 198.8 252.4 207.0 63.7 43.5 51.3 146.6 78.6 64.6 12.0 173.8 210.6 81.8 78.0 51.1 44.4 59.1 165.2 63.9 443.6 38.7 12.6 115.2 142.4 204.1 213.8 100.4 108.7 171.2 158.3 24.4 207.5 105.7 133.9 18.6 21.2 247.2 189.9 155.7 64.3 105.0 243.3 408.8 33.7 43.1 131.5 57.5 137.3 28.9 60.8 74.8 130.8 274.9 83.0 65.0 99.9 145.1 RAC1 "p21-Rac1, Rac-1, TC-25" ENSG00000136238 "Rac family small GTPase 1" P63000 7 6374527-6403967 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 1980.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035994, HPA047820" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA 3900000 "Cluster 26: Non-specific - Mitochondria" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" Nucleoli "CAB035994: , HPA047820: AB_2680167" "unprognostic (8.66e-3)" "unprognostic (2.47e-1)" "unprognostic (4.00e-1)" "unprognostic (2.40e-2)" "unprognostic (1.88e-3)" "unprognostic (4.06e-2)" "prognostic unfavorable (1.74e-5)" "prognostic unfavorable (4.59e-4)" "unprognostic (1.59e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (4.57e-5)" "unprognostic (3.63e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.95e-1)" "unprognostic (2.11e-2)" "unprognostic (4.13e-2)" "unprognostic (8.72e-3)" 157.4 108.0 237.0 96.8 250.4 94.5 146.4 242.4 290.7 154.8 206.5 190.5 167.4 150.7 149.9 316.9 145.1 125.9 129.4 240.2 240.6 150.5 136.2 147.5 96.4 249.4 244.8 135.8 92.2 151.1 77.5 180.2 249.2 122.8 199.6 52.2 137.9 145.0 179.5 189.2 161.9 179.3 260.2 96.6 160.6 51.6 241.1 115.3 127.2 141.1 169.6 205.3 188.6 262.9 519.9 230.9 233.0 255.1 270.1 341.8 138.6 284.9 348.0 371.6 375.8 227.3 474.8 145.5 179.7 400.9 384.2 359.4 251.5 345.9 471.9 68.3 207.8 146.6 171.7 166.5 323.7 134.0 114.6 229.7 302.8 268.4 297.6 281.7 333.4 141.3 266.2 111.7 406.4 377.3 74.0 312.4 419.1 261.9 272.3 129.2 236.9 214.6 481.7 322.7 175.8 295.9 201.7 726.1 241.4 264.7 409.6 396.3 341.8 242.4 364.3 300.7 334.5 84.1 99.5 135.4 223.9 250.9 470.6 31.0 117.3 63.0 23.8 83.0 15.1 46.8 26.8 30.9 112.8 49.9 33.0 21.8 168.6 26.1 83.5 64.5 46.1 47.0 237.0 250.4 242.4 290.7 240.2 240.6 249.4 244.8 249.2 260.2 241.1 262.9 755.4 147.4 123.6 28.7 155.9 934.1 981.6 232.1 429.2 90.4 485.3 593.8 200.6 484.7 164.8 356.8 25.0 802.8 224.1 920.9 536.1 183.5 77.6 388.7 362.9 641.2 336.7 313.3 43.3 174.2 1064.1 415.9 305.3 422.8 130.9 325.4 580.8 367.1 832.0 146.4 35.3 632.9 179.0 811.3 1066.7 58.8 476.3 705.7 458.9 66.5 607.2 341.1 191.6 23.1 56.7 299.1 754.4 472.8 212.2 1495.5 816.4 832.0 214.1 64.2 479.9 346.6 466.6 216.6 373.1 774.5 1148.6 845.4 180.0 353.6 573.7 1980.7 RAE1 "Gle2, Mnrp41" ENSG00000101146 "Ribonucleic acid export 1" P78406 20 57351223-57379211 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 103.0" "Cell type enhanced" "Detected in all" "Early spermatids: 113.6;Spermatocytes: 256.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048795 Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli fibrillar center" "HPA048795: AB_2680523" "unprognostic (1.20e-1)" "unprognostic (5.98e-2)" "unprognostic (4.55e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (3.23e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (1.88e-1)" "unprognostic (8.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.50e-3)" "unprognostic (3.88e-2)" "unprognostic (7.48e-2)" "unprognostic (3.55e-1)" "unprognostic (9.49e-2)" "unprognostic (2.89e-1)" "unprognostic (2.01e-1)" 14.0 13.9 18.6 13.5 19.1 50.5 17.0 18.5 19.1 15.5 17.6 14.2 11.9 16.6 18.2 20.5 17.4 9.0 13.3 18.3 19.9 14.1 16.5 10.0 20.8 16.3 15.9 16.3 10.8 19.1 13.3 14.6 17.0 12.4 16.2 20.1 12.8 15.0 15.0 22.9 13.6 16.3 17.2 17.0 12.8 103.0 21.4 29.2 12.1 15.8 26.5 14.5 16.0 19.6 43.5 52.6 52.8 29.3 30.1 29.0 46.1 33.9 47.2 172.2 70.3 166.1 33.8 69.2 46.8 52.8 63.8 56.6 101.6 88.3 142.1 20.8 45.2 47.0 46.0 74.9 59.0 57.1 41.3 41.3 74.0 75.8 83.1 29.1 49.9 47.2 84.8 32.5 53.0 114.8 88.3 53.2 32.9 86.3 93.3 47.6 49.4 46.0 37.3 45.5 55.2 47.6 58.4 129.4 61.0 41.2 71.5 54.0 29.7 70.6 63.0 41.7 57.7 34.9 83.9 81.8 48.3 36.1 35.6 21.2 42.0 77.0 27.0 36.8 32.9 31.2 26.0 26.8 32.3 28.1 33.9 30.7 36.2 24.7 37.9 23.8 24.6 40.4 18.6 19.1 18.5 19.1 18.3 19.9 16.3 15.9 17.0 17.2 21.4 19.6 17.5 19.2 16.7 8.5 21.0 17.2 16.3 42.0 15.9 15.9 12.6 19.3 10.4 11.5 24.1 18.4 14.6 52.8 20.8 11.6 27.4 30.3 113.6 16.5 16.7 17.9 6.6 18.7 10.2 14.3 39.3 18.6 12.2 15.3 38.0 25.6 11.0 13.5 38.3 3.3 9.5 15.2 18.3 59.5 14.5 63.9 21.8 33.5 10.6 14.0 40.0 19.9 27.8 5.5 13.1 22.2 24.3 22.6 15.9 14.0 10.1 20.6 24.1 17.9 19.7 11.6 19.9 256.9 83.1 19.2 21.0 70.5 24.2 34.9 20.1 16.2 RALGAPB "DKFZp781M2411, KIAA1219, RalGAPbeta" ENSG00000170471 "Ral GTPase activating protein non-catalytic subunit beta" Q86X10 20 38472816-38578859 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051454 Approved Approved "Nuclear speckles" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nuclear speckles" "HPA051454: AB_2681490" "unprognostic (1.06e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-2)" "unprognostic (3.42e-3)" "unprognostic (1.34e-1)" "unprognostic (1.06e-1)" "unprognostic (2.72e-3)" "unprognostic (7.28e-2)" "unprognostic (2.33e-1)" "unprognostic (8.93e-3)" "unprognostic (2.71e-1)" "unprognostic (9.51e-2)" "prognostic favorable (7.25e-4)" "unprognostic (3.03e-1)" "unprognostic (3.95e-1)" "unprognostic (1.63e-1)" "unprognostic (7.99e-2)" 9.6 10.6 7.6 12.1 9.5 12.3 16.1 13.4 10.8 12.1 14.3 11.9 12.1 12.0 12.7 13.9 10.9 10.7 10.5 9.6 9.4 14.4 8.5 11.1 12.2 8.7 8.0 11.6 11.7 24.2 10.5 14.3 8.5 14.4 13.3 18.7 10.8 12.7 12.1 13.7 11.9 12.9 7.6 11.1 12.4 20.8 9.7 17.6 18.1 14.4 14.9 15.3 9.3 9.8 25.3 23.4 23.8 17.5 22.5 25.9 25.3 20.3 23.6 24.8 24.3 42.3 18.6 23.7 18.9 23.7 36.5 29.2 22.6 30.8 34.8 13.6 9.6 36.2 21.0 24.3 21.3 29.6 18.4 18.5 39.1 29.3 32.0 19.7 32.9 20.0 26.8 22.9 24.2 16.5 34.1 12.5 17.5 24.9 30.1 19.4 34.0 15.9 16.5 46.7 25.1 27.6 44.9 59.8 37.4 27.2 34.8 15.0 39.2 49.9 19.9 28.6 20.8 26.6 34.9 21.1 36.1 14.2 22.5 1.2 0.9 2.4 1.2 0.7 1.6 1.3 1.7 1.5 1.4 1.0 1.5 1.2 1.7 2.0 1.3 0.9 0.8 0.6 7.6 9.5 13.4 10.8 9.6 9.4 8.7 8.0 8.5 7.6 9.7 9.8 23.1 22.4 17.1 47.7 18.6 13.9 7.4 12.4 17.1 24.4 19.5 12.3 20.0 10.0 17.7 31.3 27.1 10.4 23.4 26.9 3.9 9.4 11.8 24.3 20.2 17.4 12.6 14.9 63.3 9.3 7.8 15.7 30.5 28.8 16.5 19.4 23.2 12.1 9.7 20.2 66.0 16.1 16.2 17.7 11.6 8.7 16.8 14.7 10.6 49.6 15.1 10.0 16.5 58.3 81.0 15.2 20.4 18.8 16.7 16.1 26.9 9.0 20.9 18.3 13.1 16.8 13.5 31.8 24.0 19.7 18.0 15.2 19.4 15.9 15.8 14.2 RER1 ENSG00000157916 "Retention in endoplasmic reticulum sorting receptor 1" O15258 1 2391775-2405442 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037240, HPA051400" Supported Supported "Golgi apparatus" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus" "CAB037240: AB_2179604, HPA051400: AB_2681469" "unprognostic (2.90e-2)" "unprognostic (3.35e-2)" "unprognostic (3.17e-2)" "unprognostic (2.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.07e-1)" "unprognostic (1.53e-2)" "unprognostic (1.24e-1)" "unprognostic (2.28e-1)" "unprognostic (2.72e-1)" "unprognostic (1.14e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.23e-8)" "unprognostic (1.01e-1)" "unprognostic (5.41e-2)" "unprognostic (1.06e-1)" "unprognostic (3.27e-2)" 100.4 154.2 60.0 89.3 67.6 81.6 97.1 67.0 62.8 93.6 78.3 137.4 114.8 74.4 122.7 176.4 86.1 86.9 75.7 61.1 64.1 106.3 224.8 79.6 94.6 67.0 65.1 92.9 122.3 100.9 82.9 99.0 66.9 94.3 151.4 73.8 101.1 104.2 105.2 101.7 120.0 104.6 65.6 102.2 118.6 107.1 68.5 94.5 85.9 85.1 143.5 101.0 106.5 76.1 203.1 111.0 131.1 146.8 233.7 275.7 100.9 297.1 261.1 254.3 253.2 157.6 299.3 143.9 242.7 297.7 205.1 213.3 152.2 176.7 322.2 180.8 156.1 163.9 247.2 153.0 252.5 181.3 188.6 225.0 176.1 264.3 233.1 175.4 235.8 160.3 197.8 232.6 299.8 141.5 127.2 127.3 87.5 314.1 279.0 146.0 131.9 183.7 227.5 94.3 109.9 126.2 167.9 376.9 242.9 143.7 149.6 127.4 171.8 197.3 114.1 355.9 219.5 223.0 270.2 255.3 209.6 254.8 102.8 239.1 235.5 284.5 195.9 268.2 180.0 169.0 169.8 210.0 221.2 151.7 127.0 155.9 351.3 164.8 275.9 256.1 244.5 309.0 60.0 67.6 67.0 62.8 61.1 64.1 67.0 65.1 66.9 65.6 68.5 76.1 88.7 64.1 50.0 23.5 73.1 53.2 84.4 214.2 50.1 33.6 111.9 123.6 41.6 118.7 131.4 104.8 33.3 233.8 97.5 218.9 66.5 213.4 475.6 89.5 93.5 68.2 36.5 57.2 16.7 258.4 321.8 94.3 71.9 118.8 44.3 76.5 82.1 233.5 217.9 37.0 16.8 158.6 122.1 104.3 73.2 464.0 82.6 99.9 62.2 15.9 126.1 97.0 114.4 19.1 25.8 256.4 195.4 76.0 145.1 142.5 238.7 119.6 136.3 62.6 111.7 60.9 141.6 291.4 145.2 103.4 67.1 467.9 74.3 159.0 162.0 141.0 RHOB "ARH6, ARHB, MST081, RHOH6" ENSG00000143878 "Ras homolog family member B" P62745 2 20447074-20449440 "Cancer-related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Protein transport, Transport" "Developmental protein" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 1272.8;Basal squamous epithelial cells: 1327.7;Hepatocytes: 1360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 5.6;eosinophil: 18.0;intermediate monocyte: 11.4;neutrophil: 21.5;non-classical monocyte: 13.3" "Group enriched" "Detected in many" 13 "granulocytes: 21.5;monocytes: 13.3" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 297.9;RPTEC TERT1: 462.9;SK-BR-3: 561.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (9.66e-3)" "unprognostic (5.57e-3)" "unprognostic (8.29e-2)" "unprognostic (6.48e-2)" "unprognostic (2.85e-1)" "unprognostic (9.16e-3)" "unprognostic (5.41e-3)" "unprognostic (4.91e-2)" "unprognostic (1.04e-2)" "unprognostic (3.22e-2)" "unprognostic (3.29e-1)" "unprognostic (2.13e-2)" "prognostic favorable (4.23e-4)" "unprognostic (5.71e-2)" "unprognostic (2.56e-1)" "unprognostic (3.01e-2)" "unprognostic (2.49e-2)" 592.1 538.8 216.9 94.7 331.1 71.9 459.9 309.1 207.4 495.7 106.2 657.1 40.4 370.7 67.0 166.4 599.0 166.4 354.7 181.8 260.8 173.7 642.3 386.6 43.7 356.0 315.0 437.3 111.5 34.4 135.2 170.3 317.1 342.9 81.0 27.5 136.0 219.7 366.7 391.8 203.4 260.8 328.1 115.7 438.5 52.9 286.8 52.4 171.1 153.4 13.1 490.0 353.6 356.2 29.0 42.5 79.9 19.4 202.3 48.1 112.7 133.5 48.2 58.0 19.6 27.2 32.9 0.1 13.8 68.2 113.8 16.4 1.3 27.4 20.5 33.5 86.8 1.5 118.4 224.4 52.7 0.4 86.0 88.7 93.3 34.6 45.5 55.8 297.9 0.2 8.6 51.1 35.6 78.0 1.4 10.9 35.4 45.3 17.7 7.5 35.8 52.4 462.9 66.6 64.7 39.7 27.9 561.2 81.7 224.2 98.6 7.3 178.8 25.8 61.2 10.8 51.7 96.4 15.3 0.5 6.6 0.4 24.3 5.6 2.5 18.0 0.6 11.4 0.1 0.2 0.0 0.4 1.3 0.2 0.0 0.1 21.5 0.9 13.3 0.1 0.1 1.1 216.9 331.1 309.1 207.4 181.8 260.8 356.0 315.0 317.1 328.1 286.8 356.2 1272.8 48.1 101.9 238.3 118.7 73.9 281.4 53.0 1327.7 20.4 465.1 460.4 118.6 700.6 70.6 77.3 2.1 114.2 66.8 655.2 64.6 296.4 6.0 346.3 283.8 409.6 561.2 33.7 17.3 119.9 134.5 621.3 670.7 364.6 24.7 390.9 376.6 1360.8 190.1 33.7 18.2 496.4 73.2 418.1 136.4 20.9 270.6 473.4 96.0 43.1 31.6 344.8 5.2 32.6 91.9 200.8 318.8 197.5 191.6 212.1 203.1 289.0 89.1 19.3 927.0 542.5 800.5 6.5 22.5 701.2 90.5 270.1 62.5 244.6 340.7 85.2 RHOV "ARHV, Chp, WRCH2" ENSG00000104140 "Ras homolog family member V" Q96L33 15 40872214-40874234 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 211.8;skin 1: 129.8;vagina: 92.2" "Cell type enhanced" "Detected in many" "Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1" "Cancer enhanced" "Detected in many" "cervical cancer: 91.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 328.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053343 Enhanced NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA053343: AB_2682122" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (8.29e-3)" "unprognostic (4.34e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (3.29e-3)" "unprognostic (1.05e-1)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (8.43e-3)" "unprognostic (5.63e-3)" 0.5 0.1 0.9 0.2 0.9 0.2 16.0 1.1 1.8 26.3 0.5 2.8 0.6 0.7 9.5 211.8 2.7 0.5 0.1 1.0 1.1 5.5 0.2 2.3 0.2 2.1 0.8 0.3 16.3 2.2 3.0 3.2 2.4 16.6 2.6 0.0 44.3 2.4 0.2 129.8 0.6 0.1 0.8 0.1 1.2 0.3 1.9 2.6 0.5 0.0 23.3 20.7 92.2 0.9 1.6 9.7 0.1 2.7 0.2 0.0 5.2 0.1 0.8 0.4 0.2 4.0 4.4 0.0 2.4 0.0 0.3 77.9 4.5 0.6 0.2 10.5 12.5 0.5 11.3 0.6 0.0 0.5 0.0 0.3 6.0 0.3 0.1 0.4 0.1 2.3 2.1 0.5 0.0 27.2 0.6 2.3 1.7 19.3 3.7 4.0 0.4 1.8 5.1 34.3 4.0 0.8 8.0 328.9 0.2 0.5 40.9 0.3 0.1 0.0 1.1 0.2 0.3 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.1 1.8 1.0 1.1 2.1 0.8 2.4 0.8 1.9 0.9 0.6 0.0 3.2 0.3 0.5 84.1 42.5 80.9 19.9 0.0 75.2 48.5 0.9 2.8 103.0 29.5 0.0 60.7 1.9 43.1 13.7 107.5 0.0 18.5 1.9 2.5 22.7 0.0 1.5 56.2 6.0 2.0 7.1 25.5 1.3 0.4 0.0 0.0 4.6 0.0 0.5 54.7 67.1 0.0 13.3 0.0 0.0 0.8 32.0 0.0 3.6 0.0 0.0 0.0 0.3 13.8 142.3 0.7 0.1 89.8 1.0 0.9 26.2 0.0 0.0 0.2 7.3 0.0 0.9 375.0 283.0 42.4 1.9 0.0 66.3 275.1 RIOX1 "C14orf169, FLJ21802, JMJD9, MAPJD, NO66" ENSG00000170468 "Ribosomal oxygenase 1" Q9H6W3 14 73490933-73493394 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 9.1;dendritic cells: 8.0;Extravillous trophoblasts: 6.9;Hofbauer cells: 8.2;monocytes: 7.2;Proximal tubular cells: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003730 Supported "Nucleoli rim" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoli rim" "HPA003730: AB_2667040" "unprognostic (4.70e-3)" "unprognostic (1.94e-2)" "unprognostic (2.45e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-3)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-2)" "unprognostic (5.36e-2)" "unprognostic (1.35e-3)" "unprognostic (4.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (7.97e-3)" "unprognostic (8.62e-2)" 3.8 4.2 5.1 5.1 4.5 7.8 3.7 6.5 5.0 3.7 4.6 4.5 3.9 5.3 4.8 5.5 4.4 2.4 4.9 4.5 4.9 4.2 6.8 3.9 6.7 4.3 4.1 3.8 6.4 5.4 3.5 2.8 4.1 3.3 3.7 1.9 4.6 3.8 3.6 4.0 5.1 4.0 3.7 5.6 4.9 13.6 4.9 9.4 3.4 3.0 6.9 4.5 3.3 5.7 17.5 15.5 9.9 15.3 12.5 7.0 19.0 11.7 8.5 11.8 10.6 13.5 8.8 29.7 8.4 10.1 9.9 20.4 19.1 11.6 9.8 19.0 21.0 18.7 9.0 9.0 6.9 0.0 24.1 7.6 10.6 11.4 5.2 7.5 10.8 17.0 13.8 10.7 10.7 27.6 33.1 21.4 10.8 15.1 26.0 26.1 15.4 9.0 11.8 12.9 20.5 14.8 19.4 34.4 12.7 9.8 34.4 18.6 15.6 0.0 19.5 10.2 0.1 14.6 16.9 10.2 5.2 15.3 11.8 0.1 1.3 3.4 3.7 2.3 4.3 2.3 3.6 2.9 1.8 1.6 3.3 2.5 0.5 3.2 1.4 3.1 1.7 0.8 5.1 4.5 6.5 5.0 4.5 4.9 4.3 4.1 4.1 3.7 4.9 5.7 2.9 3.2 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 5.4 3.2 0.0 0.0 3.1 5.5 0.0 9.1 8.0 0.0 5.9 3.8 0.0 4.2 4.0 2.1 0.0 0.0 0.0 5.7 6.9 1.5 0.0 4.7 2.5 5.2 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 7.2 0.0 0.0 0.0 0.0 3.4 0.0 0.0 1.2 0.0 0.0 7.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.4 3.4 3.5 0.0 0.0 RIPK3 RIP3 ENSG00000129465 "Receptor interacting serine/threonine kinase 3" Q9Y572 14 24336025-24340022 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.5;Exocrine glandular cells: 35.2;Gastric mucus-secreting cells: 22.4;Paneth cells: 21.4;Proximal enterocytes: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.0;HDLM-2: 4.1;OE19: 10.1;SK-BR-3: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.19e-1)" "unprognostic (2.32e-1)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-2)" "unprognostic (1.11e-1)" "unprognostic (5.26e-3)" "unprognostic (9.58e-2)" "unprognostic (5.58e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-2)" 8.6 1.7 0.7 5.6 0.7 4.9 8.0 0.7 1.4 6.4 0.8 15.2 10.2 3.2 1.4 11.9 3.8 5.4 4.1 0.7 0.7 6.2 1.7 8.1 7.7 1.2 0.8 0.7 7.9 0.8 1.2 3.2 1.1 3.4 11.0 0.0 8.9 1.5 1.5 6.5 18.3 2.1 0.8 18.6 10.6 1.1 1.1 3.5 10.7 1.3 7.6 5.4 7.5 1.1 0.0 0.0 0.0 0.0 2.4 2.7 0.0 0.6 3.4 0.0 0.0 0.1 7.0 0.1 1.7 0.3 0.0 1.6 0.0 0.1 0.0 4.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.2 1.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 10.1 0.0 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.0 11.1 0.0 0.0 1.9 2.9 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 1.7 3.3 4.2 3.7 5.1 3.9 2.1 3.1 3.7 3.3 2.4 1.6 2.3 1.9 2.7 6.0 1.6 6.1 2.9 0.7 0.7 0.7 1.4 0.7 0.7 1.2 0.8 1.1 0.8 1.1 1.1 5.5 3.2 9.1 0.0 5.7 1.5 1.4 5.8 1.8 0.0 2.0 0.9 0.7 2.8 4.7 3.7 0.0 0.3 9.6 38.5 3.9 8.1 0.1 3.2 0.8 4.2 6.1 1.3 0.0 35.2 0.4 1.9 22.4 5.4 12.6 0.0 0.7 0.0 12.7 0.0 0.0 14.4 4.1 9.5 1.6 0.3 0.0 7.7 3.6 1.9 11.6 0.0 10.3 0.0 0.0 17.8 21.4 0.0 5.5 0.5 22.5 0.1 3.7 0.0 0.0 0.2 1.0 0.0 0.3 3.9 1.4 0.3 8.3 0.1 8.0 3.3 RMDN1 "CGI-90, FAM82B, FLJ20665, RMD1" ENSG00000176623 "Regulator of microtubule dynamics 1" Q96DB5 8 86468257-86514357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026495 Approved Supported "Actin filaments,Centrosome" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Centrosome "Actin filaments" "HPA026495: AB_1848414" "unprognostic (1.68e-2)" "unprognostic (1.52e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.32e-1)" "unprognostic (1.81e-2)" "unprognostic (1.68e-1)" "unprognostic (3.02e-1)" "unprognostic (2.09e-1)" "unprognostic (1.60e-1)" "prognostic favorable (8.51e-4)" "unprognostic (2.08e-1)" "unprognostic (7.15e-2)" "unprognostic (4.71e-3)" "unprognostic (3.47e-1)" 35.6 26.1 25.8 20.9 30.1 24.7 24.3 30.4 27.8 15.5 25.3 26.7 28.7 17.6 19.8 29.4 21.1 22.5 63.0 23.0 29.5 51.7 56.8 23.4 30.3 29.8 29.7 17.0 17.5 26.3 12.9 18.9 30.0 21.2 29.0 30.9 16.4 20.7 71.7 32.8 29.2 20.2 28.3 25.2 30.6 26.4 29.6 23.0 50.4 70.5 31.5 20.1 16.3 30.5 64.0 27.1 31.3 17.8 60.3 97.8 38.5 45.9 41.1 35.8 34.6 32.2 39.9 76.2 38.1 38.2 33.2 61.0 39.8 46.0 42.1 64.6 31.9 40.2 32.8 82.1 32.1 18.4 1.0 53.3 42.6 47.6 72.9 63.9 81.6 44.3 42.4 40.7 57.5 57.3 65.1 8.6 15.9 111.3 67.5 36.6 43.6 78.9 42.5 39.3 14.8 32.8 38.2 149.2 67.6 32.5 83.9 33.6 44.6 39.5 64.0 50.8 28.2 52.4 46.5 59.7 51.2 28.7 54.4 16.4 38.5 94.2 26.6 50.7 31.1 42.2 27.1 31.3 45.2 30.8 22.3 29.0 15.5 39.0 70.3 51.3 43.2 30.7 25.8 30.1 30.4 27.8 23.0 29.5 29.8 29.7 30.0 28.3 29.6 30.5 24.0 41.7 39.0 38.8 23.8 13.5 13.2 40.1 22.2 14.5 16.8 15.0 117.3 20.0 42.4 20.2 16.7 42.5 29.9 22.2 49.0 42.9 97.8 28.3 26.6 24.3 10.2 27.3 22.5 53.0 57.1 24.0 32.1 24.8 1.3 18.9 21.8 57.7 53.7 20.2 29.9 20.6 18.3 40.1 14.8 77.1 13.1 28.3 16.0 33.7 48.5 27.4 21.6 42.3 51.9 45.8 17.2 9.1 21.8 9.2 45.7 73.0 34.4 21.5 0.0 19.9 32.9 65.7 33.5 31.0 15.5 28.5 21.6 53.1 26.9 15.2 RND1 "ARHS, Rho6, RHOS" ENSG00000172602 "Rho family GTPase 1" Q92730 12 48857145-48865870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 131.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 205.5;Ductal cells: 220.6;Exocrine glandular cells: 147.1;Pancreatic endocrine cells: 350.9" "Cancer enhanced" "Detected in many" "liver cancer: 16.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SK-BR-3: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077800 Supported "Vesicles,Plasma membrane,Actin filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Vesicles, Plasma membrane, Actin filaments" "HPA077800: AB_2686854" "unprognostic (5.60e-2)" "unprognostic (3.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.16e-1)" "unprognostic (6.90e-2)" "unprognostic (1.32e-3)" "unprognostic (3.59e-2)" "unprognostic (7.43e-2)" "unprognostic (2.21e-3)" "unprognostic (2.97e-1)" "unprognostic (1.93e-1)" "unprognostic (1.66e-1)" "unprognostic (3.89e-1)" "unprognostic (8.38e-3)" "unprognostic (6.18e-2)" "unprognostic (6.60e-2)" "unprognostic (3.35e-3)" 9.6 0.8 24.4 2.6 26.9 1.8 5.6 18.9 40.6 1.6 15.4 4.8 2.4 3.9 1.0 3.1 2.7 14.5 7.3 26.8 20.4 4.4 131.8 37.9 1.0 21.4 23.6 1.2 2.8 2.4 8.0 1.2 21.9 6.5 1.9 1.7 3.9 0.8 1.0 1.6 2.6 2.4 19.9 0.8 23.4 0.9 22.1 2.4 15.4 0.6 2.3 14.0 2.7 23.2 1.1 7.9 3.8 2.0 0.8 0.0 0.6 0.0 0.4 1.2 1.3 4.9 1.7 6.0 1.4 0.0 0.4 0.1 3.1 0.3 0.7 1.8 1.9 0.8 0.0 3.0 0.4 1.8 1.1 0.0 0.2 0.6 0.8 0.0 2.0 3.9 0.2 6.0 0.0 10.2 0.9 0.5 8.9 13.6 0.5 1.9 0.4 2.6 1.1 1.5 0.0 1.0 0.2 67.7 0.3 9.1 6.9 0.4 0.2 0.0 0.7 0.0 0.9 2.9 5.4 10.9 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 24.4 26.9 18.9 40.6 26.8 20.4 21.4 23.6 21.9 19.9 22.1 23.2 28.9 28.9 205.5 5.9 8.5 11.5 8.4 14.1 9.1 2.5 37.5 25.4 3.8 18.6 27.5 1.8 8.4 1.1 9.0 21.7 0.0 220.6 0.4 4.5 2.0 87.3 31.5 2.7 10.6 147.1 0.7 10.5 55.5 12.6 15.2 0.8 6.1 10.9 1.2 0.0 2.7 11.4 18.3 0.8 24.1 0.0 0.0 6.6 14.2 1.0 6.4 3.0 0.0 7.1 1.0 350.9 42.2 0.4 6.5 19.5 11.1 1.7 7.7 3.6 0.0 5.8 16.7 0.8 1.6 4.3 10.5 1.5 9.9 0.6 5.4 8.6 RNF103 "hkf-1, KF1, ZFP103" ENSG00000239305 "Ring finger protein 103" O00237 2 86603398-86623866 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 7.2" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057922 Approved NA NA "Cluster 46: Basophils - DNA binding" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "HPA057922: AB_2683555" "unprognostic (4.41e-1)" "unprognostic (1.56e-1)" "unprognostic (6.04e-2)" "unprognostic (3.26e-1)" "unprognostic (3.20e-2)" "unprognostic (1.79e-1)" "unprognostic (7.42e-2)" "unprognostic (8.37e-2)" "unprognostic (4.06e-1)" "unprognostic (1.13e-2)" "unprognostic (6.21e-2)" "unprognostic (1.44e-1)" "unprognostic (3.54e-3)" "unprognostic (1.50e-1)" "unprognostic (1.77e-1)" "unprognostic (3.67e-2)" "prognostic favorable (6.77e-5)" 14.6 15.3 25.7 9.0 28.8 13.6 20.9 35.8 31.6 15.9 22.6 21.9 18.7 23.7 45.4 14.0 16.9 19.4 37.7 24.8 25.1 15.3 54.5 11.3 8.1 26.8 27.2 16.0 24.7 25.2 15.6 15.6 25.7 23.3 16.5 10.3 18.7 17.7 21.4 14.3 23.0 21.0 27.2 10.5 22.6 15.4 26.7 8.1 10.2 19.1 10.0 14.4 13.9 30.6 9.6 12.9 6.4 9.9 28.6 18.3 10.3 13.6 20.6 6.8 9.2 7.5 16.1 15.9 15.9 20.4 24.8 11.5 8.7 10.7 10.2 13.4 11.7 9.1 5.4 16.7 27.1 3.0 13.0 26.9 21.8 10.1 12.6 24.3 20.7 7.4 3.3 9.3 19.0 11.9 7.0 8.0 2.9 19.0 9.0 4.3 27.5 9.4 25.1 14.9 10.2 10.4 16.0 35.2 14.0 8.0 13.5 7.4 23.6 13.2 6.3 13.4 8.2 32.3 11.5 10.7 10.5 5.1 6.5 4.5 0.5 7.2 0.7 0.7 1.0 0.9 1.1 1.6 1.1 1.0 1.2 0.9 1.0 2.3 0.4 0.8 2.5 0.6 25.7 28.8 35.8 31.6 24.8 25.1 26.8 27.2 25.7 27.2 26.7 30.6 22.6 9.6 14.5 0.0 16.6 48.3 35.5 13.9 33.6 15.8 45.9 31.1 40.0 31.5 22.1 20.2 4.2 13.6 15.7 72.4 1.9 17.6 16.8 20.4 17.9 22.4 31.8 16.4 0.0 28.4 7.8 27.6 44.4 30.0 18.4 19.9 22.9 68.9 9.6 18.5 0.0 45.9 12.2 14.1 29.5 9.3 25.4 19.8 10.6 0.0 8.0 17.2 2.1 0.0 0.0 33.9 41.5 23.0 41.1 45.0 56.1 12.9 33.6 9.5 6.6 40.3 25.7 27.5 12.6 32.6 44.2 40.9 19.5 9.0 24.3 48.6 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953885 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 6 "Early spermatids: 1500.7;Late spermatids: 923.4;Spermatocytes: 558.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 561.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.36e-2)" 32.8 32.0 43.3 29.7 48.2 51.6 31.2 46.6 45.1 37.2 41.0 45.0 42.8 28.7 32.8 30.8 34.7 28.8 37.6 40.4 44.9 48.6 49.0 37.9 39.3 47.3 46.5 39.0 52.2 30.2 28.1 35.1 46.6 33.9 40.0 16.7 41.0 34.1 83.3 24.2 40.8 25.4 47.1 52.4 35.9 166.1 47.2 39.1 37.9 52.8 37.3 28.9 28.7 49.9 83.9 80.5 42.9 43.7 84.3 57.8 118.0 73.0 86.2 153.2 64.4 241.7 67.6 39.9 142.9 40.1 91.6 66.3 62.5 74.7 90.6 73.5 44.3 51.5 50.1 173.2 73.3 95.3 59.5 51.5 68.8 58.4 39.9 52.6 36.8 69.7 98.0 46.7 45.5 281.0 82.6 98.0 42.3 67.4 114.3 85.7 45.5 73.6 83.4 67.9 63.2 45.4 88.8 561.6 118.5 45.4 149.7 86.6 47.8 134.6 62.3 71.6 87.0 93.6 107.1 79.2 76.4 63.2 76.1 112.2 97.8 86.1 48.1 92.5 53.1 63.9 52.6 48.6 75.3 71.2 61.6 50.2 100.5 57.8 112.5 61.9 68.9 92.7 43.3 48.2 46.6 45.1 40.4 44.9 47.3 46.5 46.6 47.1 47.2 49.9 47.1 48.1 53.7 13.4 69.9 107.2 127.8 103.4 63.2 24.4 50.7 55.8 46.1 41.5 101.4 69.9 12.5 91.3 61.0 61.7 72.4 107.5 1500.7 72.2 36.3 55.3 60.4 45.4 22.8 101.1 77.4 61.9 41.3 71.4 45.0 31.9 46.1 63.7 110.6 40.4 24.4 79.5 42.7 76.6 146.5 923.4 70.5 66.0 71.2 27.2 96.3 38.0 56.7 10.6 26.2 92.1 77.9 59.8 81.9 122.5 96.4 120.9 75.8 22.6 39.5 45.5 59.2 558.0 138.4 45.8 87.1 124.8 69.2 46.5 80.4 113.3 RNF139 "HRCA1, RCA1, TRC8" ENSG00000170881 "Ring finger protein 139" Q8WU17 8 124474880-124488618 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 93.2" "Group enriched" "Detected in all" 10 "Early spermatids: 810.1;Late spermatids: 992.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001202 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "HPA001202: AB_1079824" "unprognostic (3.28e-3)" "unprognostic (2.92e-2)" "unprognostic (5.16e-2)" "unprognostic (5.43e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (2.71e-2)" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (9.85e-2)" "unprognostic (1.53e-2)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" "unprognostic (7.75e-2)" "unprognostic (1.45e-1)" 23.5 20.8 10.0 15.9 11.1 93.2 18.9 14.8 12.7 16.6 11.2 15.6 9.2 20.2 13.6 16.5 16.7 16.8 15.3 11.0 11.0 15.3 26.1 16.6 17.3 11.0 10.8 23.6 14.4 11.8 10.2 19.4 11.0 14.9 14.8 12.4 16.5 13.3 20.3 17.2 14.2 20.3 11.8 13.9 13.9 68.7 11.7 19.3 16.3 22.6 14.8 16.7 12.4 15.0 26.6 17.1 21.6 20.3 43.2 34.1 16.6 23.5 44.4 18.6 24.7 10.9 21.6 27.5 27.8 31.7 14.3 19.7 18.3 28.4 28.9 37.6 24.5 41.1 11.9 22.9 33.3 19.6 23.2 30.5 41.0 20.5 55.9 27.1 26.2 26.8 29.1 41.3 22.2 70.2 32.9 13.6 14.3 52.6 25.6 13.2 14.9 27.0 35.3 34.4 9.4 22.3 31.0 76.5 33.4 16.5 35.7 20.7 20.6 13.9 29.7 22.2 26.3 32.9 40.9 28.6 19.9 31.7 13.9 2.7 6.2 10.1 8.7 4.1 11.0 7.9 7.8 10.5 8.4 7.1 8.1 8.4 8.5 7.2 11.4 4.0 11.4 6.7 10.0 11.1 14.8 12.7 11.0 11.0 11.0 10.8 11.0 11.8 11.7 15.0 21.1 3.2 8.4 11.8 66.2 66.2 62.1 27.2 58.6 14.5 31.6 19.7 16.2 34.3 18.5 22.0 6.2 42.3 58.5 22.5 11.7 19.9 810.1 31.3 22.6 24.9 21.7 27.1 12.9 18.0 55.9 40.1 23.4 37.1 20.3 23.2 22.9 31.8 25.0 16.8 12.8 18.5 10.2 33.7 74.4 992.2 29.5 43.4 35.6 12.2 26.5 21.3 26.8 8.5 18.5 22.5 11.4 27.1 35.4 41.1 17.0 16.9 20.1 22.7 19.7 39.7 49.2 62.3 24.3 46.7 70.5 75.5 83.5 22.6 18.2 55.5 RNF213 "ALO17, C17orf27, KIAA1554, KIAA1618, MYMY2, NET57" ENSG00000173821 "Ring finger protein 213" Q63HN8 17 80260866-80398786 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Ubl conjugation pathway" "Hydrolase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 396.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 90.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003347, HPA026790" Approved Supported Cytosol NA NA 3500 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA003347: AB_1079204, HPA026790: AB_10602296" "unprognostic (8.98e-2)" "unprognostic (1.60e-1)" "unprognostic (8.97e-3)" "prognostic unfavorable (4.65e-5)" "unprognostic (7.39e-2)" "unprognostic (3.99e-2)" "unprognostic (2.23e-2)" "unprognostic (1.52e-1)" "unprognostic (4.57e-2)" "unprognostic (3.85e-1)" "unprognostic (1.96e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-3)" "unprognostic (8.92e-2)" "unprognostic (1.13e-2)" "unprognostic (1.40e-1)" "unprognostic (4.56e-2)" 7.4 9.9 6.8 18.6 12.9 25.6 7.0 9.0 11.3 8.0 13.0 9.0 8.7 7.8 8.7 7.1 8.6 10.7 6.5 5.1 6.9 10.5 6.2 13.2 17.9 23.5 11.4 9.0 7.8 34.2 6.6 10.0 18.3 7.1 7.8 12.0 10.8 6.8 6.6 8.8 10.6 9.1 13.8 18.7 11.1 3.4 16.5 20.2 11.0 7.6 14.5 11.0 7.1 17.3 40.1 69.7 6.9 4.9 24.4 37.0 5.1 9.9 21.4 43.7 37.1 7.5 18.1 2.6 8.3 20.8 46.6 22.7 9.3 12.9 14.7 90.8 4.3 6.3 29.9 13.3 10.5 6.7 6.2 20.5 8.6 24.6 10.6 13.7 34.3 28.3 11.8 14.5 16.5 9.7 26.7 2.8 5.1 7.5 16.0 18.0 15.9 3.1 12.1 34.1 6.6 9.2 24.1 50.3 17.3 15.3 11.6 8.2 44.5 24.2 19.0 14.4 10.3 6.3 6.3 7.0 18.2 7.6 8.9 19.5 20.8 10.4 26.2 18.5 17.5 15.3 18.6 21.6 5.4 15.5 14.6 18.2 84.5 26.1 17.1 32.0 15.4 4.8 6.8 12.9 9.0 11.3 5.1 6.9 23.5 11.4 18.3 13.8 16.5 17.3 76.1 89.8 56.9 56.8 89.9 35.8 37.2 39.2 43.3 21.2 59.9 41.7 32.6 75.8 50.3 101.2 50.1 21.0 240.8 117.4 13.7 120.3 1.4 58.7 58.9 90.7 46.0 30.3 23.6 162.4 31.5 50.8 158.0 93.4 46.7 140.7 74.3 56.4 98.0 23.5 15.5 68.2 32.6 136.5 94.9 3.7 60.9 128.9 30.2 87.1 194.6 26.1 396.5 32.2 70.4 166.1 76.2 51.6 167.6 100.8 116.3 92.2 66.2 68.5 65.7 52.3 53.7 1.4 8.2 43.0 34.4 21.8 211.6 84.7 54.9 66.5 RNF222 ENSG00000189051 "Ring finger protein 222" A6NCQ9 17 8390704-8397826 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 16.9;skin 1: 6.9;vagina: 5.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.3;NK-cells: 2.1;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 1.4;Syncytiotrophoblasts: 1.2;Urothelial cells: 1.7" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "SK-BR-3: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA048916 Uncertain NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "HPA048916: AB_2680555" "unprognostic (2.49e-1)" "unprognostic (4.19e-2)" "unprognostic (2.32e-2)" "unprognostic (8.19e-4)" "unprognostic (2.81e-1)" "unprognostic (5.30e-2)" "unprognostic (2.02e-1)" "unprognostic (3.93e-2)" "unprognostic (9.55e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-1)" "unprognostic (1.20e-3)" "unprognostic (5.82e-2)" "unprognostic (6.70e-2)" "unprognostic (5.98e-3)" "unprognostic (3.97e-2)" 0.0 0.0 0.2 0.1 0.1 1.2 0.3 0.6 0.2 3.3 0.2 0.0 0.0 0.0 0.1 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 1.9 0.0 0.1 6.9 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 2.2 0.0 5.9 0.4 0.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 0.2 0.2 0.0 0.3 0.1 0.2 0.1 0.2 0.4 0.2 0.0 1.3 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.4 0.6 0.1 0.0 0.0 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.7 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.0 0.0 0.4 0.2 0.2 0.1 0.0 1.4 1.2 0.7 0.1 0.0 1.7 RNPEP APB ENSG00000176393 "Arginyl aminopeptidase" Q9H4A4 1 201982372-202006147 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036074, HPA036075, HPA061487" Approved Approved "Golgi apparatus" "Secreted - unknown location" NA NA 7800000 "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537" "unprognostic (8.57e-2)" "unprognostic (3.43e-2)" "unprognostic (2.81e-1)" "unprognostic (5.45e-2)" "unprognostic (2.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.87e-2)" "unprognostic (1.93e-3)" "unprognostic (1.80e-1)" "unprognostic (1.07e-1)" "unprognostic (1.28e-1)" "unprognostic (3.50e-3)" "unprognostic (1.91e-1)" "unprognostic (6.00e-2)" "unprognostic (1.97e-2)" "unprognostic (1.68e-1)" 25.2 31.1 8.0 22.8 8.3 25.2 25.8 8.1 8.5 26.7 16.1 53.6 68.5 25.6 39.0 53.8 40.6 22.3 14.7 8.5 8.7 25.9 32.4 30.5 22.1 9.9 9.1 23.4 34.1 25.4 13.3 27.5 9.1 25.9 57.0 4.2 38.3 27.6 18.8 37.0 58.1 28.1 9.1 33.4 28.5 17.9 10.6 21.7 33.2 12.7 26.5 23.3 28.8 11.8 66.2 71.0 40.8 62.7 65.1 61.3 102.1 49.5 95.6 60.9 67.6 51.8 83.1 14.3 61.8 87.8 38.0 117.4 52.5 97.2 42.4 39.1 67.6 35.5 32.5 48.7 55.1 92.3 121.3 55.9 97.9 54.1 62.0 74.7 110.6 34.8 82.5 21.6 62.1 61.0 12.8 40.2 58.4 105.4 34.4 48.3 57.5 101.6 128.7 61.2 46.9 39.9 122.2 155.9 52.1 78.9 116.6 52.4 79.9 28.9 38.0 28.7 61.3 45.3 39.6 12.9 27.8 77.3 58.1 22.9 14.9 22.1 3.0 25.9 4.1 2.5 3.2 3.4 19.8 4.6 2.8 3.2 11.0 2.9 29.9 7.2 5.4 4.0 8.0 8.3 8.1 8.5 8.5 8.7 9.9 9.1 9.1 9.1 10.6 11.8 26.7 9.6 21.5 8.5 19.7 28.8 40.5 31.2 40.5 15.5 32.8 33.1 12.2 38.6 26.7 25.8 10.4 116.6 21.4 136.6 19.6 71.1 5.4 35.9 17.7 26.1 44.9 19.0 12.7 51.2 91.1 26.1 45.3 21.5 15.2 23.2 27.1 51.4 103.7 11.8 11.1 71.9 14.2 81.0 39.4 4.9 25.4 72.9 24.9 15.0 86.7 12.6 17.5 5.5 8.1 47.8 83.4 23.0 23.6 25.0 201.7 65.8 39.1 8.0 26.3 11.4 28.2 22.7 9.5 53.6 21.6 87.6 17.7 33.2 86.6 34.8 RPL19 "DKFZp779D216, FLJ27452, L19, MGC71997" ENSG00000108298 "Ribosomal protein L19" P84098 17 39200283-39204840 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 37509.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043014, HPA051987" Approved Enhanced Nucleoli,Cytosol NA NA 160000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 32: Non-specific - Translation" "Nucleoli, Cytosol" "HPA043014: AB_10965840, HPA051987: AB_2681682" "unprognostic (4.07e-3)" "unprognostic (1.33e-1)" "unprognostic (3.18e-1)" "unprognostic (4.46e-2)" "unprognostic (4.25e-2)" "unprognostic (6.40e-2)" "unprognostic (9.70e-3)" "unprognostic (1.50e-1)" "unprognostic (5.46e-1)" "unprognostic (1.16e-2)" "unprognostic (3.32e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.48e-2)" "unprognostic (8.60e-2)" 2108.0 1641.8 1232.8 1325.7 1302.0 3445.4 2213.5 1236.2 1473.8 2449.2 1230.5 1983.7 1161.3 1717.3 1256.1 2160.0 1997.7 1159.4 1539.0 1175.0 1252.5 1725.6 1485.2 1453.6 2835.1 1303.7 1237.8 3638.0 3006.2 1537.0 1362.5 1050.7 1304.9 1733.7 1231.5 383.6 2136.0 1214.5 2763.0 2809.4 1733.8 1104.6 1324.2 2003.5 1872.5 615.5 1268.5 2335.8 1462.6 1879.2 2543.6 1915.1 2121.1 1325.7 1943.7 2617.7 1849.0 2258.4 3300.1 4133.6 1894.3 1788.5 3631.1 3629.7 2895.6 2872.0 1801.2 4740.4 3047.1 2580.8 2122.7 3228.2 2807.4 3714.8 1852.4 1922.4 4931.8 1693.5 1876.5 3797.5 5133.2 4201.0 2240.4 4647.6 3995.5 2805.3 5031.4 3396.2 3177.6 3991.6 3007.3 2696.5 2544.2 1939.5 5610.7 5814.7 1891.0 2269.3 1912.1 3270.3 2620.6 4777.9 3324.4 2419.1 2225.5 2457.9 1084.0 37509.3 5867.6 1982.1 3626.8 5201.1 1883.8 1410.9 1894.7 2165.8 3336.2 3504.5 3756.7 3505.5 1906.0 3147.3 1854.1 1051.1 2648.2 975.0 2486.9 2147.2 3862.3 4698.0 3984.2 3158.7 3263.9 4349.1 4920.5 4086.9 380.6 2830.2 1793.7 3012.9 3456.9 9398.3 1232.8 1302.0 1236.2 1473.8 1175.0 1252.5 1303.7 1237.8 1304.9 1324.2 1268.5 1325.7 2477.2 884.6 1438.4 49.0 5591.4 5551.7 6227.1 4092.6 3998.1 241.7 5532.9 7926.2 556.3 2332.0 2100.3 1138.5 93.8 3720.2 4011.1 1443.7 3623.4 3025.0 1451.9 1129.0 2357.2 2714.5 1957.2 2708.2 30.8 6238.2 5441.3 2425.2 1705.4 1503.7 1586.0 3024.3 2836.8 2406.3 4189.9 132.9 33.6 3550.3 1464.8 4218.0 5326.1 4539.9 3920.2 3259.8 3272.8 46.9 4282.6 1495.1 3932.1 20.1 51.1 3972.8 3267.4 2040.2 3289.0 6219.8 3226.4 5182.0 1049.1 390.5 1531.7 3215.1 3875.5 962.9 981.4 5376.4 6619.2 3899.7 4615.5 3399.1 3895.2 7406.6 RPL7 "humL7-1, L7" ENSG00000147604 "Ribosomal protein L7" P18124 8 73290242-73295789 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 17748.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058373 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 380000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA058373: AB_2683694" "unprognostic (3.75e-1)" "unprognostic (3.60e-2)" "unprognostic (6.99e-2)" "unprognostic (1.80e-1)" "unprognostic (2.37e-2)" "unprognostic (7.32e-2)" "unprognostic (1.45e-2)" "unprognostic (3.41e-2)" "unprognostic (8.31e-2)" "unprognostic (4.78e-2)" "unprognostic (1.76e-1)" "unprognostic (3.09e-1)" "unprognostic (1.63e-2)" "unprognostic (9.89e-2)" "unprognostic (5.52e-2)" "unprognostic (3.14e-1)" "unprognostic (2.31e-1)" 2254.0 1352.4 835.1 1322.3 886.2 3071.3 3298.9 846.6 1224.8 2495.7 843.0 1841.6 1316.8 1844.3 1839.2 2058.4 2057.2 1033.9 1342.4 799.0 860.0 1634.0 1593.8 1327.3 2285.6 859.3 828.4 4528.2 3067.3 1217.6 1195.0 1202.5 870.8 1650.4 1681.7 889.4 1843.5 1261.6 2391.6 2826.4 1420.5 1381.5 914.8 1388.9 1853.0 527.0 848.2 2225.3 1616.5 1832.1 2665.8 1978.5 2103.5 900.4 2902.0 2050.6 2163.3 2615.7 4308.7 5473.7 2120.8 3100.6 2474.6 2069.9 1621.0 2487.3 2940.4 8517.8 2467.6 2517.8 1409.2 2703.0 2888.8 3960.2 3204.7 2313.1 2394.1 4682.9 2687.5 2594.4 2583.2 3343.2 2298.0 5174.5 4574.0 1921.5 5950.9 3797.5 3412.0 2840.5 4261.7 3140.1 2980.2 2448.1 5345.2 5080.8 2528.5 5238.5 2182.9 3552.8 2474.4 3353.9 3241.5 2848.0 2977.1 2160.3 1454.9 17748.7 4599.1 1766.2 4497.4 4312.2 3227.1 1575.4 2407.3 2031.7 2913.1 1799.2 2782.6 5514.9 1649.7 4062.8 2654.8 3331.3 7192.1 1787.5 6932.4 5967.0 12630.9 14333.5 12042.7 9069.1 9565.2 12188.2 17585.4 12433.8 894.5 9240.8 5307.0 7970.3 10207.4 26909.6 835.1 886.2 846.6 1224.8 799.0 860.0 859.3 828.4 870.8 914.8 848.2 900.4 622.3 817.3 1610.8 26.1 2654.7 8054.8 9929.5 10766.1 1684.6 268.0 5251.9 4462.2 623.2 2396.3 3812.0 1311.3 125.1 4882.8 1798.3 926.5 5576.1 2795.4 1720.0 1068.3 2371.5 2338.1 1617.8 1779.1 27.0 5044.8 7032.5 2096.9 721.7 1300.7 1491.1 1110.8 2680.0 1876.1 3252.9 94.2 27.6 3112.1 3057.8 3661.5 5169.4 806.4 4246.4 1893.5 3705.1 25.3 4752.6 1792.8 3105.1 19.6 33.6 3149.3 2514.2 2310.6 952.9 5766.4 2274.7 5797.7 1454.2 380.6 1459.4 4118.3 2651.4 953.5 374.0 2143.1 9487.1 4878.7 2546.9 2145.3 4018.0 7816.6 RPN2 "RIBIIR, RPN-II, RPNII, SWP1" ENSG00000118705 "Ribophorin II" P04844 20 37178410-37241619 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008297, CAB019277, HPA025922" Enhanced Supported "Endoplasmic reticulum" NA NA 1300000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458" "unprognostic (9.59e-3)" "unprognostic (5.22e-2)" "unprognostic (1.66e-2)" "unprognostic (1.06e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.44e-10)" "unprognostic (2.83e-1)" "unprognostic (6.99e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.44e-4)" 112.6 132.5 48.2 131.9 50.4 180.8 146.1 49.9 55.9 161.8 98.0 156.9 125.5 108.7 344.1 106.8 122.9 119.8 107.3 49.5 56.5 145.1 212.1 129.7 109.2 54.0 50.6 94.8 159.6 180.9 79.1 257.9 53.9 164.4 175.2 117.0 158.2 157.5 110.4 91.5 110.9 156.6 53.8 118.1 145.1 144.2 55.4 108.5 232.5 75.1 143.3 165.4 87.9 61.9 328.2 290.6 302.7 401.2 413.1 308.2 586.7 426.7 516.8 544.8 459.2 939.2 564.8 255.3 501.6 572.3 506.4 468.4 318.8 516.4 492.0 121.2 196.5 295.3 308.4 634.1 398.9 468.4 467.0 294.6 505.1 432.3 447.5 519.8 530.4 239.2 458.7 805.1 389.1 300.9 270.6 451.0 240.4 839.3 415.7 242.3 549.1 852.7 371.6 304.3 246.4 261.0 517.9 1231.1 489.4 353.6 606.1 765.6 338.0 600.8 358.2 317.1 371.9 474.7 608.4 259.9 583.4 314.9 493.2 424.2 427.5 285.5 365.5 410.5 417.0 291.0 336.1 363.8 481.2 232.4 298.8 308.7 78.3 398.8 357.6 591.0 338.2 676.5 48.2 50.4 49.9 55.9 49.5 56.5 54.0 50.6 53.9 53.8 55.4 61.9 85.7 118.6 158.0 22.2 107.8 61.8 134.1 264.6 62.0 72.6 90.0 74.2 81.4 133.0 197.7 80.9 45.9 461.6 109.6 113.9 23.5 278.0 37.3 73.2 103.5 98.6 63.0 91.7 18.8 241.1 599.6 127.4 84.1 151.2 105.2 109.3 100.6 206.3 233.2 63.9 18.6 168.5 162.8 150.4 75.3 24.4 105.0 117.0 90.7 20.6 122.2 136.8 65.9 24.1 20.5 160.1 109.5 110.9 392.3 121.3 64.6 82.3 98.5 100.8 85.5 65.3 122.0 335.2 288.9 67.7 57.8 621.0 81.5 213.7 138.7 117.6 RRBP1 "ES/130, hES" ENSG00000125844 "Ribosome binding protein 1" Q9P2E9 20 17613678-17682295 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 497.7" "Cell type enhanced" "Detected in all" "Distal enterocytes: 588.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 37.8;plasmacytoid DC: 44.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009026, HPA011924" Enhanced Enhanced "Endoplasmic reticulum" NA NA 320000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 25: Pancreas - Digestion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "HPA009026: AB_1079852, HPA011924: AB_1856476" "unprognostic (1.56e-3)" "unprognostic (2.26e-3)" "unprognostic (8.46e-2)" "prognostic favorable (1.41e-4)" "unprognostic (1.04e-1)" "unprognostic (1.05e-1)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (6.89e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (6.63e-2)" "unprognostic (9.21e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.38e-4)" 64.2 72.3 27.0 62.8 41.9 28.1 54.6 41.1 32.2 69.1 52.3 98.3 76.1 59.5 55.0 67.8 45.1 71.5 59.1 27.5 35.3 77.4 219.0 80.2 28.2 49.3 42.2 48.3 497.7 72.4 63.4 107.9 45.5 66.5 65.9 17.7 228.2 63.4 21.9 43.6 82.7 46.0 37.7 57.7 123.1 48.4 40.9 14.4 130.4 14.7 27.0 57.6 55.2 49.2 173.5 121.0 35.7 80.4 160.3 172.2 186.2 264.3 221.3 110.0 148.2 271.2 159.3 66.5 87.3 252.2 113.4 170.4 38.7 215.4 89.1 30.9 29.7 76.2 34.9 283.6 229.4 29.0 93.0 228.9 63.8 178.7 104.3 161.7 109.7 23.4 32.6 62.9 167.6 78.8 11.4 65.5 41.6 383.3 115.8 20.1 94.2 231.3 93.0 58.4 18.2 13.7 151.1 353.2 108.4 75.0 62.0 43.5 198.7 232.7 85.9 122.1 88.5 114.6 93.6 21.6 88.1 30.7 121.1 11.7 8.4 37.8 4.3 5.5 3.2 1.0 1.4 2.6 4.6 1.4 1.4 1.6 7.8 10.7 8.4 44.4 1.5 3.1 27.0 41.9 41.1 32.2 27.5 35.3 49.3 42.2 45.5 37.7 40.9 49.2 146.8 96.1 197.1 15.0 72.5 59.1 92.3 90.3 55.2 21.9 127.0 76.3 46.4 144.4 158.2 95.6 31.3 262.0 180.6 588.9 45.0 199.7 47.2 117.5 228.4 155.8 97.0 31.6 3.0 414.6 235.8 219.7 294.6 322.8 118.9 78.1 118.9 279.9 117.4 25.2 4.9 507.9 50.8 62.0 85.7 44.3 127.1 91.6 71.2 17.8 75.1 144.3 79.3 23.1 27.6 357.7 452.3 83.1 570.6 145.6 221.6 57.2 121.8 35.5 32.9 165.1 169.8 77.5 139.9 73.2 55.8 532.9 56.9 114.6 329.3 218.5 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA053986: AB_2682333" "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 73.8 72.7 101.4 65.9 113.3 128.5 65.7 117.4 106.7 66.2 88.3 79.2 60.5 70.6 48.9 64.2 64.8 49.2 85.9 97.2 106.7 68.7 63.8 58.1 70.7 113.7 109.6 71.1 59.3 63.0 67.8 55.4 115.0 58.2 54.2 61.3 51.2 62.2 181.4 69.6 60.8 65.4 111.1 67.8 59.3 57.0 108.4 79.2 60.6 111.1 76.2 73.8 57.5 123.5 132.8 93.3 91.1 91.3 111.1 97.9 85.9 198.5 148.1 280.0 158.5 192.6 125.2 110.4 232.0 161.5 139.7 144.9 92.4 153.8 190.7 52.6 72.9 138.9 97.4 150.8 127.9 201.3 186.6 88.1 156.5 126.0 106.9 119.7 121.3 118.1 109.6 114.3 139.1 253.9 171.6 173.0 68.8 185.2 175.9 116.3 247.2 149.5 119.1 86.1 95.1 103.1 208.2 355.0 199.0 66.7 165.0 191.7 131.5 242.2 156.0 133.0 165.1 94.6 116.1 156.9 190.7 134.7 135.1 309.4 205.4 562.3 125.6 192.8 106.2 115.7 106.4 122.5 223.6 134.0 119.7 110.6 580.4 197.4 200.5 189.6 152.2 254.1 101.4 113.3 117.4 106.7 97.2 106.7 113.7 109.6 115.0 111.1 108.4 123.5 87.2 51.3 61.2 0.0 20.9 0.0 0.0 0.0 0.0 0.0 54.1 56.9 0.0 0.0 34.0 66.2 0.0 162.8 50.9 0.0 156.5 104.5 0.0 47.8 51.2 38.8 0.0 0.0 0.0 96.3 109.5 37.3 0.0 47.7 90.8 57.9 0.0 0.0 110.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 92.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 5.3 0.0 0.0 149.9 34.2 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 182.9 26.4 89.8 0.0 0.0 RTN2 "NSP2, NSPL1, SPG12" ENSG00000125744 "Reticulon 2" O75298 19 45485294-45497055 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "skeletal muscle: 509.8;tongue: 207.7" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 134.3;Extravillous trophoblasts: 145.7;Skeletal myocytes: 73.2;Syncytiotrophoblasts: 120.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.2;eosinophil: 2.6;plasmacytoid DC: 1.6" "Group enriched" "Detected in many" 10 "dendritic cells: 1.6;granulocytes: 6.2" "Cell line enhanced" "Detected in many" "RH-30: 44.3;RT4: 45.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034941, HPA034948" Approved Approved "Nuclear speckles" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nuclear speckles" "HPA034941: AB_10671358, HPA034948: AB_2674375" "unprognostic (3.08e-1)" "unprognostic (1.42e-1)" "unprognostic (6.68e-3)" "unprognostic (5.07e-3)" "unprognostic (1.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.89e-2)" "unprognostic (3.09e-1)" "unprognostic (6.44e-2)" "unprognostic (5.10e-3)" "unprognostic (2.96e-2)" "prognostic unfavorable (5.58e-6)" "unprognostic (4.34e-1)" "unprognostic (3.23e-1)" "unprognostic (2.21e-1)" "unprognostic (2.03e-1)" 9.9 13.6 21.4 3.4 25.7 1.7 12.0 15.9 43.6 5.9 7.8 21.8 2.8 15.2 2.5 12.1 4.6 7.9 21.9 24.7 22.0 7.1 3.9 8.2 4.7 27.3 19.3 1.9 4.8 10.1 7.6 19.2 27.0 17.0 2.2 5.7 22.3 10.6 509.8 9.1 8.7 7.3 14.1 11.2 7.9 1.6 25.1 1.1 4.9 207.7 2.0 12.4 7.8 29.0 3.8 5.2 8.6 6.7 14.4 17.6 16.9 8.5 20.0 5.2 9.9 10.4 3.2 3.3 11.4 9.3 4.2 7.2 5.6 4.1 1.7 7.9 8.2 23.0 3.9 7.8 6.2 1.4 25.0 19.5 2.2 2.3 4.2 9.2 9.6 0.9 12.9 6.2 15.6 2.9 0.0 4.3 6.3 17.0 6.8 3.6 44.3 18.8 3.0 45.0 24.1 23.1 1.7 40.7 13.2 8.0 32.3 9.1 8.6 14.7 4.4 0.4 1.9 3.5 8.7 7.7 3.9 5.2 7.7 6.2 0.1 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.2 0.3 1.6 0.0 0.2 21.4 25.7 15.9 43.6 24.7 22.0 27.3 19.3 27.0 14.1 25.1 29.0 9.8 3.2 8.1 2.6 0.8 6.4 27.7 8.9 6.8 10.4 18.4 21.1 4.6 4.3 4.6 3.7 6.2 134.3 2.9 0.9 0.0 21.3 0.3 2.1 7.0 15.3 11.4 1.7 21.0 6.8 145.7 14.0 3.1 3.4 16.5 4.2 18.9 3.1 27.3 23.5 13.3 2.2 12.2 12.9 12.0 0.4 5.6 10.7 23.2 1.9 6.5 9.1 1.0 4.5 2.1 13.1 0.3 6.8 2.5 13.0 0.3 0.3 1.3 13.6 13.1 73.2 12.3 0.5 3.9 2.3 3.4 120.1 1.0 16.4 0.7 23.2 RTP2 "MGC78665, Z3CXXC2" ENSG00000198471 "Receptor transporter protein 2" Q5QGT7 3 187698259-187702557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 2.0;testis: 1.2" "Group enriched" "Detected in some" 5 "Early spermatids: 15.8;Late spermatids: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SK-BR-3: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (5.86e-2)" "unprognostic (1.12e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 2477.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 1369.9;SK-BR-3: 1618.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 190000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 166.8 79.1 81.3 61.9 79.8 0.8 159.7 78.6 98.0 333.0 70.8 139.7 121.5 78.4 19.8 2477.7 68.2 81.6 122.3 79.8 80.1 219.0 209.9 161.3 28.4 104.2 80.9 83.4 41.0 76.6 42.0 71.8 84.9 77.8 105.0 7.0 438.1 38.1 51.7 474.9 109.8 79.0 84.8 118.5 100.4 60.3 103.4 25.0 72.4 52.1 205.0 163.2 713.3 84.6 670.4 318.1 16.0 36.7 102.5 386.8 42.8 367.9 341.4 302.7 265.2 315.4 366.1 0.3 577.5 553.0 69.0 479.6 1.1 839.2 175.3 1.9 0.6 0.4 260.5 90.8 117.5 0.2 0.9 182.7 787.6 731.6 567.9 390.9 1369.9 0.0 8.5 0.8 677.3 918.7 0.9 1.4 69.0 1171.0 887.9 0.9 187.4 1.8 1150.3 236.1 0.8 1.9 267.6 1618.0 55.7 140.5 504.7 3.5 743.9 178.2 289.5 171.5 848.6 0.5 3.5 2.4 525.0 0.9 122.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 81.3 79.8 78.6 98.0 79.8 80.1 104.2 80.9 84.9 84.8 103.4 84.6 275.6 38.5 25.5 10.4 6.8 633.9 995.4 531.6 157.6 0.5 225.4 191.3 33.0 124.4 290.6 108.5 2.1 20.3 4.4 500.7 72.4 610.9 4.9 50.9 172.5 293.5 139.0 16.0 0.0 193.9 8.7 112.2 96.8 128.5 19.1 154.1 365.9 132.7 5.0 0.0 0.1 286.4 164.8 15.7 95.4 17.4 67.1 7.4 112.1 5.6 7.2 72.5 0.0 7.5 0.7 1307.3 610.0 61.3 5.6 1141.1 353.3 169.7 48.6 2.1 6.6 70.9 91.2 8.0 1.3 1028.7 908.8 8.2 12.9 1528.4 320.2 1522.5 S100A7 "PSOR1, S100A7c" ENSG00000143556 "S100 calcium binding protein A7" P31151 1 153457744-153460651 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 1065.7;lymphoid tissue: 1239.6;skin 1: 346.5;vagina: 1020.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 59.3;Club cells: 70.4;Ionocytes: 18.3;Suprabasal keratinocytes: 89.6;Syncytiotrophoblasts: 26.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 1201.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HaCaT: 7.2;SK-BR-3: 16.9" "CAB001453, HPA006997, CAB033766" Enhanced Uncertain Cytosol "Secreted in other tissues" NA NA 14000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860" "unprognostic (3.28e-1)" "unprognostic (9.85e-2)" "unprognostic (1.32e-2)" "unprognostic (2.16e-2)" "unprognostic (3.17e-1)" "unprognostic (2.94e-2)" "unprognostic (1.03e-2)" "unprognostic (4.00e-1)" "unprognostic (1.25e-1)" "unprognostic (1.27e-1)" "unprognostic (2.99e-1)" "unprognostic (5.41e-2)" "unprognostic (1.21e-2)" 1.0 0.2 0.9 0.0 0.8 0.8 15.6 1.4 2.1 174.8 0.7 0.3 0.0 1.2 27.6 1065.7 0.3 0.2 0.5 0.8 0.8 0.1 0.5 0.4 0.2 0.9 0.8 0.5 0.4 0.0 0.2 0.2 0.8 0.5 0.0 0.0 55.5 0.2 0.4 346.5 0.2 1.4 0.8 0.3 0.4 0.3 0.7 12.4 0.2 0.0 1239.6 1.2 1020.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 7.2 0.0 2.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.2 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.7 16.9 0.0 0.9 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.4 2.1 0.8 0.8 0.9 0.8 0.8 0.8 0.7 1.1 0.0 0.0 0.0 0.0 0.0 11.7 0.2 59.3 0.0 0.0 1.1 0.0 0.0 0.0 70.4 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.3 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.3 0.0 1.9 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.3 0.0 0.0 0.0 4.7 0.2 0.2 3.8 89.6 26.4 0.1 8.4 0.6 0.4 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391073 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4" "Group enriched" "Detected in many" 7 "Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 9 "classical monocyte: 26833.7;neutrophil: 52973.6" "Group enriched" "Detected in all" 9 "granulocytes: 52973.6;monocytes: 26833.7" "Group enriched" "Detected in some" 24 "hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" NA NA 10900000 370000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 582.3 54.3 41.7 1245.8 45.6 35382.0 70.0 43.4 88.0 5650.6 45.5 55.2 15.4 23.1 5.5 24565.6 236.1 99.0 121.1 40.9 42.7 103.0 176.7 1061.7 29.5 47.7 44.8 25.8 52.0 9.6 41.7 205.8 50.7 43.1 14.7 5.6 3988.2 5.0 48.5 267.3 47.7 430.2 44.2 3239.5 93.8 16.2 45.5 281.3 48.8 174.8 8952.6 561.9 11166.4 46.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.0 1.3 0.0 0.3 12.4 0.0 18.7 0.0 0.1 0.0 3.5 0.0 0.0 0.0 5.6 0.1 0.0 241.8 0.0 7.5 0.0 0.0 0.0 9.6 1.2 0.0 0.9 0.4 1.5 0.3 0.0 0.0 0.4 5.8 1.0 0.0 0.0 0.4 0.5 3.6 719.0 0.0 0.0 4.7 400.6 10.6 0.0 0.2 0.9 0.1 0.2 1.3 2.7 0.3 13.9 0.0 848.0 26833.7 3023.7 33.4 1999.2 49.2 57.2 21.8 18.2 4686.1 23.5 21.6 23.3 52973.6 27.1 493.1 188.1 37.1 24979.9 41.7 45.6 43.4 88.0 40.9 42.7 47.7 44.8 50.7 44.2 45.5 46.2 1.1 224.4 489.8 0.0 77.2 19.6 3.5 4126.5 50.7 0.0 13.2 3.9 10.0 70.1 817.0 14.7 0.0 5.8 67.1 0.3 0.0 1.0 210.7 0.5 0.6 33.1 0.0 143.5 0.0 0.9 8.5 61.3 1.1 0.5 227.1 0.1 76.1 54.6 417.5 0.0 0.0 0.2 207.5 6348.0 5.1 172.4 4.1 3758.3 0.0 0.0 6932.6 0.0 289.4 0.0 0.0 1.4 0.0 1.5 26.1 0.9 0.0 25.0 162.8 0.0 0.0 7.7 32.3 2.1 1.0 8480.1 113.2 6.7 91.4 0.0 0.0 31.3 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361023 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 24579.6;neutrophil: 33654.0" "Group enriched" "Detected in all" 6 "granulocytes: 33654.0;monocytes: 24579.6" "Cell line enriched" "Detected in many" 6 "SK-BR-3: 2398.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1200000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 706.4 126.1 19.7 1505.7 24.3 32194.3 189.8 21.4 67.8 7849.1 28.5 123.9 24.1 50.0 2.0 30581.7 486.1 147.4 208.5 19.4 21.9 171.7 284.0 1629.4 69.3 28.7 24.2 51.5 73.9 11.5 65.4 370.1 30.0 91.3 20.2 3.6 5790.0 9.6 92.2 416.7 120.6 480.7 22.0 5381.4 187.6 16.7 26.5 197.7 90.4 150.4 4378.8 955.1 14027.7 25.4 24.6 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.5 0.0 9.2 372.2 0.0 0.4 23.0 0.0 157.3 0.0 0.4 0.0 6.2 0.0 0.1 0.0 7.8 0.0 0.0 130.2 0.0 8.4 0.0 0.0 0.1 7.6 3.5 0.0 31.4 0.8 3.3 0.1 3.1 0.2 0.8 5.1 82.2 0.3 100.4 1.3 0.6 4.0 2398.2 1.7 1.2 38.1 312.3 6.8 0.0 3.3 0.4 0.4 0.7 1.6 3.3 0.5 71.7 0.0 373.8 24579.6 2626.3 30.5 1754.8 52.6 29.7 25.3 17.2 4664.8 24.8 17.7 15.4 33654.0 18.8 860.2 153.3 29.2 24461.7 19.7 24.3 21.4 67.8 19.4 21.9 28.7 24.2 30.0 22.0 26.5 25.4 1.8 230.8 392.4 0.0 92.1 20.0 123.1 5771.3 28.5 0.0 55.6 6.7 8.0 57.2 1685.0 36.8 0.0 126.1 115.1 7.7 5.9 102.6 1.7 1.2 1.9 26.9 0.0 92.8 0.0 39.4 52.9 50.9 3.6 9.4 164.0 0.2 70.6 54.5 1926.0 0.0 0.0 3.7 309.3 7537.0 13.4 4.0 5.9 3678.1 0.0 0.0 11103.1 0.0 483.0 0.0 0.0 15.3 1.4 0.0 13.1 55.6 0.8 25.2 262.8 0.3 0.0 13.3 60.4 0.3 1.2 3263.1 33.2 1236.0 79.9 0.0 12.5 551.3 SAMD12 FLJ39458 ENSG00000177570 "Sterile alpha motif domain containing 12" Q8N8I0 8 118189455-118622112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Excitatory neurons: 537.6;Inhibitory neurons: 531.7;Oligodendrocytes: 1158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.6;U-266/70: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024634 Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus, Cytosol" "HPA024634: AB_1856549" "unprognostic (6.96e-2)" "unprognostic (9.35e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (4.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.92e-2)" "unprognostic (2.99e-2)" "unprognostic (1.68e-1)" "unprognostic (3.94e-3)" "unprognostic (2.01e-1)" "prognostic favorable (1.52e-6)" "unprognostic (3.31e-2)" "unprognostic (1.76e-1)" "unprognostic (1.94e-1)" "unprognostic (6.35e-3)" 0.7 1.4 2.4 1.1 4.9 0.4 3.0 0.7 8.8 2.3 0.0 4.0 3.7 1.1 4.0 4.1 5.3 3.6 6.9 7.5 0.8 5.2 1.6 4.2 0.7 1.4 0.5 0.9 1.9 9.6 3.3 0.1 2.6 3.7 4.7 5.9 2.4 5.0 0.8 0.8 2.0 0.7 0.9 2.6 5.7 1.3 2.1 1.0 10.2 0.1 2.0 4.4 1.1 8.4 10.2 0.7 0.9 0.0 0.0 0.0 2.1 3.4 10.4 7.8 4.3 1.1 12.1 3.4 0.8 8.2 1.6 1.9 2.0 4.7 11.9 0.1 1.1 0.0 5.7 0.0 0.0 0.0 0.2 0.0 2.3 4.6 0.4 2.8 0.2 5.9 0.0 6.0 6.0 2.0 1.6 0.0 0.8 13.2 1.3 0.0 0.0 9.7 5.4 13.5 4.0 0.0 2.8 34.6 0.0 2.1 0.5 0.0 0.0 0.1 3.8 1.4 1.2 14.9 10.2 0.4 1.8 0.0 1.1 0.1 0.0 0.0 0.1 0.0 1.0 1.5 0.8 0.5 0.0 1.0 1.0 0.6 0.1 0.6 0.0 0.3 0.8 0.2 2.4 4.9 0.7 8.8 7.5 0.8 1.4 0.5 2.6 0.9 2.1 8.4 4.7 112.2 95.0 53.5 8.0 1.7 10.1 10.3 13.1 16.8 10.9 5.1 12.1 12.8 57.5 29.5 43.8 0.0 3.3 10.5 19.6 12.9 5.2 12.1 1.5 13.0 14.3 2.1 537.6 12.4 0.1 9.1 26.5 16.4 56.8 4.4 7.5 5.2 0.1 30.3 531.7 11.2 14.2 0.3 0.0 6.1 0.3 6.5 7.2 163.0 0.7 4.5 4.1 122.6 1158.0 13.0 3.5 0.4 16.9 5.0 8.6 17.4 68.0 26.9 0.0 0.5 0.9 0.5 2.4 15.9 1.7 0.0 8.9 4.5 11.9 13.6 SCGB2A2 "MGB1, MGC71974, PSBP1, UGB2" ENSG00000110484 "Secretoglobin family 2A member 2" Q13296 11 62270158-62273160 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "breast: 2805.9;skin 1: 708.1" "Group enriched" "Detected in some" 11 "Breast glandular cells: 2119.6;Breast myoepithelial cells: 1028.8;Melanocytes: 1762.7" "Cancer enriched" "Detected in many" 23 "breast cancer: 823.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 124 "SK-BR-3: 18.0" CAB026270 Enhanced "Secreted in female reproductive system" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "CAB026270: AB_912980" "unprognostic (2.38e-1)" "unprognostic (7.28e-2)" "prognostic favorable (9.57e-8)" "unprognostic (4.17e-1)" "unprognostic (3.75e-1)" 34.4 0.2 0.0 0.0 0.0 0.0 2805.9 0.0 0.0 309.2 0.0 0.4 0.0 4.1 0.0 76.6 0.1 0.0 4.0 0.0 0.0 0.5 0.3 0.2 0.0 0.0 0.0 0.2 0.4 0.0 1.6 1.3 0.0 0.2 0.0 0.0 159.3 0.1 1.8 708.1 0.2 0.0 0.0 0.2 0.3 1.1 0.0 2.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 6.6 49.6 0.3 0.0 0.0 0.0 2119.6 1028.8 0.1 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 1.4 41.9 21.6 11.3 0.0 0.0 0.0 0.0 0.0 6.7 0.0 141.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 3.2 1762.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 10.9 0.0 9.2 0.0 0.0 0.0 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660182 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 46.4;kidney: 47.1;placenta: 77.6" "Cell type enhanced" "Detected in many" "Collecting duct cells: 334.8;Distal enterocytes: 100.7;Early spermatids: 124.6;Hofbauer cells: 99.9;Paneth cells: 138.6;Proximal enterocytes: 318.4" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 94.3;SK-BR-3: 102.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA020518, HPA024264" Enhanced Approved "Plasma membrane,Cytosol" No No 2300000 "Cluster 17: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" Cytosol "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favorable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 2.9 1.0 3.6 1.3 4.5 1.3 0.9 4.6 5.3 1.3 2.9 18.3 26.7 1.3 0.5 17.9 4.1 2.8 0.3 3.8 4.8 47.1 0.3 4.1 0.6 9.4 6.8 0.7 0.9 1.1 2.6 77.6 9.7 3.2 16.0 2.4 10.7 1.1 0.5 3.6 46.4 1.1 7.1 0.5 19.6 7.1 5.7 0.6 1.1 1.7 4.3 3.5 1.3 12.3 0.2 0.2 0.2 0.8 0.0 0.0 0.3 0.3 0.1 0.1 0.5 0.1 0.5 0.3 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.1 10.4 0.1 1.3 0.2 0.1 0.4 0.3 0.2 1.4 0.4 0.0 0.2 0.1 0.2 0.4 20.8 0.5 0.5 0.2 1.4 0.2 5.7 3.2 0.3 0.5 0.1 94.3 3.6 4.1 0.2 1.0 102.8 0.1 0.7 10.8 0.6 0.1 0.3 0.8 2.0 0.2 3.4 0.2 0.2 0.1 0.4 0.1 1.2 0.2 0.2 0.3 0.2 0.3 1.1 0.3 0.3 0.2 0.5 0.3 0.3 0.6 0.4 0.3 0.3 0.2 0.1 3.6 4.5 4.6 5.3 3.8 4.8 9.4 6.8 9.7 7.1 5.7 12.3 3.5 0.0 23.6 0.0 0.7 2.8 1.5 1.6 0.6 3.2 3.3 1.7 1.2 4.3 8.5 334.8 0.0 23.8 0.2 100.7 82.2 0.6 124.6 25.5 1.0 6.7 9.1 0.0 0.1 0.2 4.7 2.7 55.5 11.3 39.9 0.0 0.4 0.1 99.9 0.0 0.2 62.9 46.8 3.0 0.5 87.8 0.3 2.8 10.6 15.0 1.7 0.4 0.0 0.0 0.3 8.6 138.6 1.2 1.4 4.7 318.4 3.2 17.2 3.0 0.0 0.9 1.0 3.8 5.5 26.6 6.5 65.8 2.2 0.1 21.4 23.1 SCN7A "NaG, Nav2.1, Nav2.2, SCN6A" ENSG00000136546 "Sodium voltage-gated channel alpha subunit 7" Q01118 2 166403573-166611482 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 45.4" "Group enriched" "Detected in many" 4 "Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.1" "Group enriched" "Detected in some" 5 "HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 7.6" HPA072715 Approved Approved "Plasma membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA072715: " "unprognostic (1.22e-1)" "unprognostic (6.42e-3)" "unprognostic (9.72e-2)" "unprognostic (7.43e-2)" "unprognostic (2.18e-1)" "unprognostic (1.78e-1)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (5.21e-2)" "unprognostic (6.84e-3)" "unprognostic (6.88e-2)" "unprognostic (1.27e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-2)" "unprognostic (1.47e-2)" "unprognostic (1.35e-1)" "unprognostic (1.22e-4)" 4.6 8.6 3.4 3.4 3.0 0.3 10.2 0.1 1.8 7.8 0.0 35.8 3.4 9.0 6.3 10.1 10.9 3.8 20.6 1.1 7.1 1.8 1.2 27.6 0.5 4.0 7.1 45.4 4.9 0.7 1.0 12.3 5.4 11.0 8.5 10.6 6.1 10.1 7.2 2.4 6.8 7.6 2.9 3.2 7.8 5.6 9.8 3.2 1.2 15.0 0.4 4.7 7.1 1.2 0.1 0.1 0.7 0.9 0.2 0.0 0.8 0.7 0.0 1.3 0.0 0.6 0.2 0.4 0.1 0.0 0.3 0.3 0.1 0.1 0.0 7.9 0.5 0.2 1.5 0.6 0.0 0.2 4.5 0.0 0.0 0.4 0.1 0.4 0.0 0.4 1.2 5.8 0.0 1.0 0.8 0.5 1.1 0.3 0.3 0.0 0.5 0.0 0.1 0.8 0.2 0.4 0.3 15.4 0.0 0.3 0.4 0.1 0.4 0.2 1.0 0.7 0.4 1.0 0.3 1.1 0.2 0.2 0.4 1.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.8 3.4 3.0 0.1 1.8 1.1 7.1 4.0 7.1 5.4 2.9 9.8 1.2 1.4 0.0 1.1 1.0 0.0 0.3 0.2 0.0 5.7 21.5 0.2 0.3 16.2 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.9 0.0 2.4 0.0 0.3 4.1 0.0 0.0 7.7 0.0 0.0 102.0 0.0 0.0 15.9 0.1 9.3 0.0 0.2 0.0 20.9 0.0 0.0 0.0 1.2 4.1 100.9 1.8 5.4 14.0 0.0 4.9 0.0 14.1 0.3 0.1 0.0 159.9 1.2 0.5 0.0 0.5 0.0 1.8 151.2 16.7 26.1 0.5 1.2 1.7 1.1 0.0 0.2 0.3 0.0 0.3 SELENBP1 "hSBP, hSP56, LPSB" ENSG00000143416 "Selenium binding protein 1" Q13228 1 151364304-151372707 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein transport, Transport" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 509.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 2.4" "Lineage enhanced" "Detected in single" "dendritic cells: 2.4" "Cell line enhanced" "Detected in many" "ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005741, CAB008366, HPA011731" Enhanced Supported Nucleoli NA NA 59000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli "CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663" "unprognostic (1.51e-1)" "unprognostic (7.01e-2)" "unprognostic (8.52e-3)" "unprognostic (6.25e-3)" "unprognostic (6.28e-2)" "prognostic favorable (6.63e-4)" "unprognostic (1.08e-2)" "unprognostic (1.21e-2)" "unprognostic (3.78e-3)" "unprognostic (2.86e-1)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-2)" "unprognostic (6.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.86e-2)" "unprognostic (6.86e-3)" 128.3 18.7 49.8 24.9 53.0 95.9 76.3 45.5 54.8 57.0 47.4 509.3 74.7 31.3 43.4 31.8 132.7 52.2 69.1 47.1 48.2 77.2 261.7 181.0 10.9 47.8 51.0 49.4 29.0 11.9 15.0 20.4 46.5 44.2 471.7 3.9 61.6 48.8 72.9 25.2 94.2 49.5 46.9 51.1 126.4 6.1 51.0 7.1 115.1 138.1 6.8 58.3 29.3 45.7 0.0 17.2 31.9 1.8 144.9 59.1 8.4 5.9 2.6 3.1 6.5 18.1 5.4 0.0 30.7 10.7 0.0 0.4 0.0 0.4 2.8 0.1 14.8 120.5 53.1 28.9 30.5 0.2 0.0 75.9 1.0 5.3 0.1 0.4 19.0 0.0 12.4 0.0 8.0 13.2 0.0 0.0 26.6 92.8 32.2 0.1 1.7 0.7 7.1 0.0 0.4 0.7 0.5 274.4 0.0 25.1 49.4 1.8 1.8 0.0 1.1 16.8 0.1 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 49.8 53.0 45.5 54.8 47.1 48.2 47.8 51.0 46.5 46.9 51.0 45.7 36.6 294.9 525.6 38.2 4.0 10.8 27.7 56.4 30.7 0.3 73.0 59.9 135.7 75.8 123.9 5.5 0.0 2.4 1.9 1056.9 115.4 17.1 0.7 30.9 14.9 27.5 155.0 590.9 0.1 9.1 2.1 85.2 163.6 14.1 27.3 10.9 26.0 501.5 15.3 0.0 0.1 137.2 79.3 39.6 12.4 4.2 66.5 3.9 33.8 13.1 0.2 37.4 0.0 0.0 2.0 6.5 451.4 80.9 0.8 25.6 251.0 148.3 101.5 1.4 52.6 15.6 102.3 0.1 0.3 22.7 9.9 4.0 5.7 30.5 452.4 71.0 SEMA3E "coll-5, KIAA0331, M-SemaK, SEMAH" ENSG00000170381 "Semaphorin 3E" O15041 7 83363238-83649139 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 176.3;Alveolar cells type 2: 110.2;Bipolar cells: 75.7;Excitatory neurons: 84.9;Oligodendrocyte precursor cells: 250.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.9;SK-BR-3: 19.9;U-2 OS: 6.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029419, HPA063804" Uncertain Approved Nucleoplasm,Vesicles "Secreted in other tissues" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA029419: AB_10602090, HPA063804: AB_2685127" "unprognostic (4.42e-2)" "unprognostic (1.48e-2)" "unprognostic (7.82e-2)" "unprognostic (4.42e-2)" "unprognostic (2.60e-1)" "unprognostic (4.27e-2)" "unprognostic (9.36e-2)" "unprognostic (4.09e-2)" "unprognostic (3.25e-1)" "unprognostic (1.42e-1)" "unprognostic (9.09e-2)" "unprognostic (2.60e-1)" "unprognostic (1.46e-6)" "unprognostic (1.32e-2)" "unprognostic (1.14e-1)" "unprognostic (7.17e-3)" "unprognostic (2.62e-1)" 1.2 0.1 3.1 0.2 2.8 0.0 2.8 0.6 2.3 1.8 0.1 2.1 0.6 1.9 0.3 1.2 0.6 2.3 0.1 5.0 5.3 0.1 0.1 2.2 0.0 1.6 4.3 0.1 0.4 0.0 0.2 0.2 1.3 4.3 1.7 3.9 2.2 3.3 0.2 0.5 1.2 1.1 3.2 0.0 1.3 0.0 4.3 1.7 0.6 1.0 0.1 3.2 0.7 3.7 0.2 1.1 0.2 0.0 0.5 3.1 0.0 0.0 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.5 0.0 3.4 0.0 1.3 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.9 0.0 0.0 0.5 0.4 1.1 0.0 2.0 0.0 0.0 0.8 0.1 0.0 0.0 19.9 0.0 3.2 1.6 0.0 0.0 0.7 6.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.8 0.6 2.3 5.0 5.3 1.6 4.3 1.3 3.2 4.3 3.7 10.5 176.3 110.2 2.9 0.2 1.1 1.3 1.6 0.0 75.7 19.0 7.5 1.7 18.6 43.2 1.8 0.0 0.8 0.2 0.1 0.0 3.9 1.1 3.8 1.2 10.7 0.0 0.0 84.9 1.1 0.4 21.3 3.1 9.3 24.0 0.2 0.0 0.3 0.1 0.0 12.3 0.0 4.1 1.0 2.1 0.0 0.9 3.6 1.8 1.0 1.0 29.6 0.0 250.3 6.0 6.2 0.0 0.0 0.3 2.6 0.1 0.5 35.7 3.6 0.0 0.8 1.0 0.3 0.6 0.3 0.4 0.3 2.8 0.0 0.0 2.5 SERHL2 ENSG00000183569 "Serine hydrolase like 2" Q9H4I8 22 42553617-42574382 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "breast: 420.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 18.1;Hepatic stellate cells: 21.8;Sertoli cells: 19.7" "Group enriched" "Detected in all" 5 "breast cancer: 8.0;prostate cancer: 5.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "memory B-cell: 3.5;naive B-cell: 8.4;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 12 "B-cells: 8.4;dendritic cells: 3.9" "Cell line enriched" "Detected in many" 10 "SK-BR-3: 276.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 5: Breast - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "unprognostic (3.14e-1)" "unprognostic (1.56e-2)" "unprognostic (8.61e-2)" "unprognostic (2.52e-2)" "unprognostic (3.27e-1)" "unprognostic (7.24e-2)" "unprognostic (1.25e-3)" "unprognostic (1.47e-2)" "unprognostic (1.55e-3)" "unprognostic (1.23e-1)" "unprognostic (1.55e-2)" "unprognostic (2.92e-1)" "unprognostic (7.04e-2)" "unprognostic (4.08e-2)" "unprognostic (2.06e-1)" "unprognostic (1.52e-1)" "unprognostic (1.42e-1)" 2.0 2.6 4.8 1.0 5.9 2.1 420.6 5.8 7.4 3.4 3.8 2.3 0.7 3.1 36.4 2.3 3.4 1.6 3.9 4.8 5.2 3.0 1.7 1.6 4.0 4.3 4.3 13.7 0.6 5.3 1.1 0.8 4.7 10.2 1.2 1.1 6.3 5.4 1.4 13.9 2.1 2.0 4.2 1.9 3.0 2.9 5.1 0.7 2.8 1.3 1.4 2.5 2.8 5.1 0.7 0.0 1.6 3.0 3.7 8.7 0.5 2.2 2.0 2.0 2.6 0.1 0.5 1.3 1.2 5.4 1.2 1.4 1.5 0.9 1.1 0.5 0.9 1.2 0.1 2.9 1.9 1.8 2.5 8.7 1.5 1.3 0.2 1.7 0.6 0.2 11.7 0.2 2.1 5.8 29.0 1.8 0.3 0.7 0.7 15.6 0.0 0.5 0.9 0.7 0.5 0.8 0.5 276.7 0.3 2.9 1.2 1.9 2.0 1.0 0.3 1.5 0.0 1.2 0.1 13.5 1.8 0.2 1.2 0.0 0.0 0.4 0.1 0.0 0.2 3.5 0.1 0.3 0.1 8.4 0.0 0.1 0.0 0.2 0.1 3.9 0.0 0.3 4.8 5.9 5.8 7.4 4.8 5.2 4.3 4.3 4.7 4.2 5.1 5.1 2.6 3.2 0.0 3.6 3.2 1.3 6.1 1.5 1.8 1.4 18.1 6.3 0.5 1.5 2.4 12.9 0.0 5.4 3.2 0.5 3.9 1.3 3.5 2.4 2.2 8.5 0.0 2.7 5.0 0.2 3.7 4.0 0.5 5.0 0.0 0.7 21.8 1.2 1.2 1.7 4.4 1.7 0.0 1.6 1.9 3.1 5.3 2.4 5.4 4.7 0.0 4.1 1.0 3.0 9.9 0.5 0.6 6.8 0.1 13.2 0.4 1.0 2.5 1.5 19.7 3.1 3.3 5.3 8.3 2.6 1.6 8.1 1.3 3.3 1.2 4.5 SERTAD4 DJ667H12.2 ENSG00000082497 "SERTA domain containing 4" Q9NUC0 1 210232796-210246631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 28.5;Breast glandular cells: 23.1;Extravillous trophoblasts: 54.9;Ionocytes: 24.4;Squamous epithelial cells: 27.4" "Cancer enhanced" "Detected in many" "breast cancer: 10.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 7.5;BEWO: 7.4;SCLC-21H: 7.4;SK-BR-3: 8.5;T-47d: 10.5;U-2 OS: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027344, HPA028514" Uncertain Supported Nucleoplasm NA NA "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA027344: AB_10601770, HPA028514: AB_10611391" "unprognostic (1.75e-2)" "unprognostic (3.92e-2)" "unprognostic (3.83e-2)" "unprognostic (9.74e-2)" "unprognostic (1.98e-2)" "unprognostic (1.27e-1)" "unprognostic (6.46e-2)" "unprognostic (1.03e-1)" "unprognostic (7.74e-2)" "unprognostic (8.49e-2)" "unprognostic (1.69e-2)" "unprognostic (5.98e-2)" "unprognostic (6.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.85e-2)" "unprognostic (6.55e-2)" "unprognostic (4.24e-1)" 1.1 0.3 0.6 0.3 1.6 0.0 3.6 1.0 1.1 2.0 0.2 4.8 0.4 3.8 0.6 4.2 1.7 0.7 3.0 0.6 1.0 1.9 0.0 1.5 0.1 0.9 1.4 1.0 0.1 0.6 0.9 1.0 1.0 1.8 1.4 0.1 5.9 1.4 0.2 3.3 0.8 2.7 1.2 0.1 1.4 0.2 0.8 0.6 1.4 0.7 0.7 0.6 1.8 1.1 7.5 0.1 1.6 0.0 0.8 0.7 7.4 1.8 1.8 1.4 2.4 0.3 0.8 0.0 0.2 0.4 1.1 3.6 0.2 0.6 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 1.7 0.2 0.0 0.0 0.0 0.3 1.8 0.0 0.0 5.2 6.0 0.3 0.0 2.4 0.0 1.2 1.3 7.4 6.3 1.2 8.5 0.1 2.9 10.5 0.0 2.3 2.0 8.7 0.1 5.6 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 1.0 1.1 0.6 1.0 0.9 1.4 1.0 1.2 0.8 1.1 5.0 6.4 3.9 1.6 0.0 16.7 9.6 16.0 28.5 2.5 23.1 9.3 0.7 1.5 10.9 9.2 0.0 14.2 0.0 1.5 7.9 2.1 0.5 4.8 1.2 5.2 1.2 0.0 10.1 3.9 54.9 7.5 2.6 5.8 0.0 9.3 2.5 0.0 1.4 0.0 3.7 5.6 24.4 0.0 5.0 0.6 0.6 0.3 10.6 3.7 0.0 0.5 0.0 1.0 9.4 8.1 1.3 1.5 0.0 2.5 0.0 0.4 13.9 0.3 0.0 1.8 3.7 0.1 1.7 27.4 4.7 4.4 0.3 0.1 6.5 3.4 SGSH "HSS, MPS3A, SFMD" ENSG00000181523 "N-sulfoglucosamine sulfohydrolase" P51688 17 80206716-80220923 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 32.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 62.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023436, HPA023451" Enhanced "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "HPA023436: AB_1856806, HPA023451: AB_1856807" "unprognostic (4.33e-2)" "unprognostic (4.03e-2)" "unprognostic (1.06e-2)" "unprognostic (4.01e-2)" "unprognostic (4.26e-3)" "unprognostic (1.39e-3)" "prognostic unfavorable (7.71e-4)" "prognostic favorable (2.72e-4)" "unprognostic (6.08e-2)" "unprognostic (3.65e-1)" "prognostic favorable (3.10e-4)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.42e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (7.50e-2)" "unprognostic (3.68e-2)" 16.6 45.9 1.7 12.2 2.3 3.6 17.2 0.7 5.2 13.5 8.8 14.8 12.7 17.2 4.6 11.0 16.0 10.6 9.9 2.0 5.4 15.7 9.5 18.1 13.4 4.4 7.6 12.3 20.4 16.0 17.0 12.4 4.2 19.7 6.5 2.8 21.8 11.1 7.0 18.9 16.7 10.6 2.5 28.4 17.8 3.9 5.3 4.2 21.2 4.6 6.9 15.5 11.5 1.8 2.6 7.9 9.8 15.6 22.5 20.2 10.4 16.0 40.4 27.7 24.2 9.0 9.5 0.1 25.7 24.9 13.2 9.9 6.2 11.7 4.7 5.3 9.6 0.0 22.3 25.0 62.2 0.0 5.9 33.9 12.0 9.9 10.5 5.8 50.7 4.7 7.1 26.2 17.9 16.2 0.3 0.2 3.3 10.0 13.2 1.4 3.7 21.1 20.2 18.5 2.0 11.7 18.4 44.1 10.6 4.9 32.8 0.5 32.5 31.9 7.0 11.4 7.4 26.1 3.6 3.9 13.6 0.0 16.3 0.0 20.6 0.0 12.1 8.0 16.0 3.5 10.5 11.3 20.4 3.8 8.2 6.7 2.1 9.3 8.0 1.5 13.5 12.7 1.7 2.3 0.7 5.2 2.0 5.4 4.4 7.6 4.2 2.5 5.3 1.8 7.5 3.2 10.8 4.2 5.5 5.1 3.7 5.9 5.7 3.7 9.3 9.3 1.7 5.7 7.3 7.3 8.4 18.2 5.2 12.0 0.0 8.9 0.2 5.3 9.2 10.1 3.0 2.7 2.6 15.9 8.7 10.1 17.9 10.0 0.0 13.6 9.7 4.5 17.7 0.0 3.4 9.3 4.1 18.2 7.6 0.5 11.5 13.0 1.8 2.8 8.4 4.1 6.2 4.5 1.7 6.8 6.0 14.3 5.5 5.5 8.1 4.9 3.8 3.9 13.1 4.0 5.3 0.3 0.5 6.4 5.5 27.0 7.2 32.0 8.0 2.9 SLC12A9 CIP1 ENSG00000146828 "Solute carrier family 12 member 9" Q9BXP2 7 100826820-100867010 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 61.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067536 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA067536: AB_2732768" "unprognostic (6.53e-2)" "unprognostic (3.65e-1)" "unprognostic (8.75e-3)" "unprognostic (3.11e-3)" "unprognostic (3.47e-2)" "unprognostic (2.37e-2)" "unprognostic (8.38e-3)" "prognostic favorable (5.97e-4)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.00e-4)" "unprognostic (2.47e-2)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.52e-2)" "unprognostic (6.00e-2)" "unprognostic (6.74e-3)" "unprognostic (6.38e-2)" 6.9 8.1 7.4 8.7 11.2 7.6 6.3 10.7 10.8 8.3 6.5 8.3 7.8 8.2 1.2 7.3 6.7 9.5 4.2 7.3 8.7 7.4 6.8 8.2 7.3 12.5 10.6 6.7 10.5 6.3 3.6 14.0 11.4 8.0 5.6 0.7 7.4 6.4 2.6 7.9 8.3 6.7 10.1 14.1 7.0 2.7 9.3 5.9 5.8 3.1 3.8 9.2 6.1 13.1 16.1 12.4 4.2 33.9 12.4 7.3 42.2 7.9 15.1 11.7 16.6 17.7 26.7 11.5 25.1 15.0 18.8 17.3 7.3 17.6 3.1 12.3 12.1 4.4 13.8 12.6 15.1 5.4 18.0 18.0 9.9 9.3 9.4 9.5 23.2 9.1 10.5 6.1 16.8 49.8 5.7 25.5 8.3 33.3 24.6 13.3 4.2 17.9 11.6 14.3 7.0 15.8 8.7 61.7 16.7 7.0 7.7 19.1 14.5 14.4 14.3 23.8 14.4 3.2 13.7 4.0 10.2 18.0 17.4 0.0 1.5 0.0 0.2 1.8 0.3 0.6 0.1 0.1 2.4 0.6 0.2 0.1 1.4 0.2 1.9 1.2 0.3 0.9 7.4 11.2 10.7 10.8 7.3 8.7 12.5 10.6 11.4 10.1 9.3 13.1 10.6 3.2 16.1 3.9 12.3 11.0 12.0 6.9 10.8 6.6 12.6 11.0 2.1 11.5 10.1 18.4 2.1 90.0 21.7 14.1 0.0 12.7 0.9 5.6 9.1 13.6 11.4 1.7 2.0 13.4 28.2 10.2 18.3 9.5 1.3 14.7 15.7 6.9 31.2 6.7 2.6 13.6 10.2 23.9 18.3 0.7 9.0 27.2 8.8 3.7 24.6 18.7 8.2 6.0 5.8 14.9 23.7 6.4 9.7 8.3 14.7 10.9 4.8 6.7 13.1 9.4 7.3 1.7 7.8 12.9 11.4 50.2 13.4 17.2 19.6 9.6 SLC15A1 "HPECT1, HPEPT1, PEPT1" ENSG00000088386 "Solute carrier family 15 member 1" P46059 13 98683801-98752672 "Metabolic proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 203.0" "Cell type enriched" "Detected in some" 5 "Proximal enterocytes: 414.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 55.5;SK-BR-3: 54.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA002827 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 56: Intestine - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Cytosol" "HPA002827: AB_1856974" "unprognostic (8.76e-2)" "unprognostic (1.87e-1)" "unprognostic (4.72e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (6.26e-2)" "unprognostic (7.83e-2)" "unprognostic (5.47e-2)" "unprognostic (1.92e-1)" "unprognostic (2.37e-1)" "unprognostic (6.79e-2)" "unprognostic (6.88e-4)" "unprognostic (2.11e-2)" "unprognostic (2.84e-1)" "unprognostic (2.64e-1)" "unprognostic (9.01e-2)" "unprognostic (3.87e-2)" 0.1 0.0 0.3 0.4 0.3 0.5 1.1 0.6 0.4 2.4 1.4 4.5 151.6 5.5 5.9 2.1 0.1 43.1 0.0 0.2 0.6 6.1 18.2 0.1 0.3 0.3 0.6 0.1 8.3 20.6 0.3 0.1 0.4 1.4 2.7 0.0 0.5 0.5 0.7 23.2 203.0 0.4 0.1 0.1 1.2 0.2 1.4 0.2 0.3 0.0 0.6 2.5 3.9 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.2 55.5 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.5 12.8 0.0 0.1 0.1 3.3 3.2 1.2 0.1 0.6 0.1 54.7 0.0 2.6 0.2 0.0 0.0 0.4 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.6 0.4 0.2 0.6 0.3 0.6 0.4 0.1 1.4 0.7 0.6 3.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.5 50.1 2.4 1.8 0.0 0.0 0.0 33.0 1.9 10.7 0.0 8.2 9.9 0.4 3.6 0.0 0.3 0.9 0.0 0.2 0.0 77.6 0.0 7.2 0.4 32.4 0.1 0.0 0.2 12.0 0.0 0.8 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.5 0.3 2.2 13.8 0.0 0.0 0.6 414.1 10.4 1.7 0.0 0.0 1.3 0.8 0.0 0.3 0.0 0.9 0.1 0.4 0.0 5.8 0.5 SLC25A44 "FLJ90431, KIAA0446" ENSG00000160785 "Solute carrier family 25 member 44" Q96H78 1 156193932-156212796 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 114.1;Late spermatids: 95.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 70.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065411 Approved Nucleoplasm,Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" Mitochondria Nucleoplasm "HPA065411: AB_2685486" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-1)" "unprognostic (2.44e-3)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.72e-2)" "unprognostic (8.92e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "prognostic favorable (2.49e-4)" "unprognostic (3.37e-2)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (2.67e-1)" "unprognostic (8.13e-2)" "unprognostic (2.37e-1)" 18.3 11.6 17.5 10.4 18.7 12.8 9.5 14.4 23.1 8.8 8.5 11.2 18.2 9.5 11.2 11.9 9.2 11.2 14.1 19.5 17.2 27.7 35.3 11.4 10.4 15.8 16.9 6.8 8.8 17.2 13.4 8.3 17.4 9.4 11.5 18.2 8.7 9.3 17.6 11.1 13.0 11.5 13.6 16.6 11.4 12.4 18.0 14.6 10.4 21.2 12.4 14.8 8.4 18.3 18.3 30.5 14.6 19.5 31.0 16.7 11.6 19.2 27.9 33.8 27.5 30.1 16.4 14.4 16.3 28.6 18.3 26.6 53.9 22.5 29.8 16.6 18.0 13.1 18.8 18.4 23.8 17.2 23.2 23.6 19.3 34.3 20.6 16.3 27.8 17.5 14.0 23.0 23.6 32.7 18.1 12.2 34.6 34.6 31.2 11.5 14.8 24.6 44.2 21.2 22.8 30.7 22.3 40.0 26.1 25.6 30.1 27.8 22.7 19.6 16.4 22.0 23.1 23.4 19.2 21.5 21.6 17.8 19.8 14.2 18.2 19.3 9.3 19.1 9.6 8.2 7.4 8.9 13.4 5.4 6.0 7.3 70.5 9.4 16.1 5.8 7.3 13.5 17.5 18.7 14.4 23.1 19.5 17.2 15.8 16.9 17.4 13.6 18.0 18.3 16.4 12.8 22.4 7.5 11.1 27.8 6.2 5.5 10.8 14.4 33.0 25.4 41.1 11.5 11.5 9.2 20.9 5.2 12.0 10.4 5.9 6.0 114.1 17.9 12.3 16.6 6.0 9.5 12.0 5.6 4.0 15.6 12.2 35.4 5.1 5.3 11.7 34.0 7.5 20.2 12.4 11.7 8.2 11.3 34.4 95.6 7.2 19.1 12.4 6.5 10.1 8.2 22.6 5.5 11.6 6.2 6.1 5.7 10.2 6.6 13.8 17.1 5.2 9.0 19.7 40.7 10.8 9.6 10.3 17.6 34.1 8.2 12.8 7.3 8.5 6.9 SLC2A11 "GLUT10, GLUT11" ENSG00000133460 "Solute carrier family 2 member 11" Q9BYW1 22 23856703-23886309 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 298.2;Rod photoreceptor cells: 188.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 9.2" "Low region specificity" "Detected in all" "HPA042960, HPA071184" Uncertain Uncertain "Nucleoplasm,Cell Junctions" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "Cell Junctions" Nucleoplasm "HPA042960: AB_2678241, HPA071184: AB_2686355" "unprognostic (1.31e-1)" "unprognostic (1.14e-1)" "unprognostic (3.69e-2)" "unprognostic (6.97e-2)" "unprognostic (7.93e-2)" "unprognostic (1.32e-1)" "unprognostic (4.24e-2)" "unprognostic (1.60e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "prognostic favorable (3.83e-4)" "unprognostic (2.32e-1)" "prognostic favorable (5.77e-7)" "unprognostic (1.25e-1)" "unprognostic (1.70e-1)" "unprognostic (3.85e-1)" "unprognostic (6.29e-2)" 2.3 6.3 3.9 1.7 3.7 1.1 3.3 5.3 4.5 4.8 3.4 5.2 1.2 3.4 3.0 1.6 3.6 1.3 10.2 3.3 4.1 16.5 5.1 2.3 2.7 3.7 3.7 4.9 12.9 6.1 13.2 2.7 4.1 5.1 2.0 19.5 3.9 2.9 6.3 2.3 4.6 1.8 3.0 4.2 4.4 3.2 4.1 0.7 7.2 1.9 2.2 4.3 2.2 3.5 2.2 1.0 1.2 5.7 1.2 2.5 0.6 1.3 1.6 1.4 0.9 1.3 1.5 2.7 0.7 1.7 1.2 1.7 2.4 0.8 0.7 2.0 2.2 1.3 2.5 2.0 1.8 1.3 1.4 1.0 2.4 2.0 1.7 6.3 0.5 2.1 0.5 6.4 0.7 2.2 0.3 0.5 2.1 1.3 1.6 3.7 0.2 3.1 4.3 0.6 3.2 1.8 0.6 9.2 2.2 1.5 4.8 0.7 0.4 0.5 0.9 0.5 0.6 5.5 1.6 2.6 1.1 0.9 1.4 0.4 0.1 0.4 0.2 0.3 0.1 0.6 0.2 0.2 0.0 0.5 0.4 0.2 0.2 0.3 0.2 1.4 0.0 0.1 3.9 3.7 5.3 4.5 3.3 4.1 3.7 3.7 4.1 3.0 4.1 3.5 2.9 19.2 15.0 14.4 23.4 3.2 9.3 4.4 8.6 56.0 15.0 13.5 31.2 7.2 5.6 25.8 298.2 9.8 15.5 5.7 13.7 4.9 8.4 4.8 8.2 4.4 10.8 5.0 21.6 5.6 9.8 8.3 5.1 5.3 2.5 19.5 6.1 7.3 5.8 37.0 30.0 5.8 10.2 4.8 4.6 10.4 9.3 4.3 3.6 4.7 4.2 16.4 10.3 8.0 14.2 2.7 2.7 9.8 15.2 7.3 3.7 24.7 6.3 188.8 0.0 11.8 7.5 4.2 5.7 5.3 3.1 20.0 8.3 28.3 7.5 6.0 SLC35C2 "bA394O2.1, C20orf5, CGI-15, OVCOV1" ENSG00000080189 "Solute carrier family 35 member C2" Q9NQQ7 20 46345980-46364458 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027011 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA027011: AB_2672082" "unprognostic (7.25e-2)" "unprognostic (1.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.27e-2)" "unprognostic (1.06e-2)" "unprognostic (2.90e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.34e-1)" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (4.05e-2)" "unprognostic (1.29e-2)" "prognostic unfavorable (8.68e-4)" "unprognostic (9.31e-2)" "unprognostic (7.15e-2)" "unprognostic (1.18e-2)" "unprognostic (3.88e-1)" 23.2 36.3 23.1 17.2 22.3 27.1 23.2 21.3 25.2 26.4 22.6 23.9 21.3 23.1 17.4 31.8 23.2 18.2 17.2 21.8 20.6 27.7 38.3 22.8 24.0 22.6 23.1 25.5 34.9 14.9 20.3 18.2 22.3 31.2 10.1 11.3 30.3 14.0 18.3 32.7 26.4 10.4 21.2 33.6 27.7 25.0 23.4 14.4 29.2 8.2 13.4 22.4 25.6 22.8 35.9 45.1 17.5 15.0 23.9 23.2 36.3 17.6 33.7 19.7 22.6 60.9 54.6 22.5 63.2 19.9 24.7 49.0 9.3 40.5 6.7 19.6 32.5 20.2 29.5 49.0 46.6 27.6 23.6 33.6 51.0 27.4 29.8 20.8 15.2 23.7 33.3 41.5 14.2 85.0 19.8 40.7 24.3 34.1 36.7 18.9 19.7 45.3 25.8 35.1 28.1 39.6 16.4 87.1 60.9 10.4 56.0 47.8 15.7 53.2 33.7 27.5 32.0 55.6 51.5 25.2 58.0 29.7 23.9 42.7 37.9 48.0 37.5 39.9 35.4 29.7 39.0 38.8 42.4 27.9 44.5 40.3 33.5 33.4 30.8 72.9 41.1 44.1 23.1 22.3 21.3 25.2 21.8 20.6 22.6 23.1 22.3 21.2 23.4 22.8 17.0 16.0 19.1 24.5 27.6 14.4 29.0 35.5 29.0 41.3 32.4 25.4 6.7 21.5 29.2 27.6 41.7 89.5 32.6 26.9 13.7 41.3 5.9 12.8 13.0 18.4 21.0 12.4 13.6 61.8 49.2 24.0 26.0 13.9 14.7 20.3 31.8 27.5 38.7 18.5 13.6 35.1 26.4 22.8 8.2 6.7 19.3 23.6 21.4 14.0 36.4 23.4 34.0 11.1 14.2 35.0 26.9 19.2 28.8 50.0 34.8 18.3 18.7 33.6 19.7 20.1 19.0 16.1 23.6 24.8 16.6 79.2 25.9 24.8 30.2 33.1 SLC39A1 "ZIP1, ZIRTL" ENSG00000143570 "Solute carrier family 39 member 1" Q9NY26 1 153959099-153968184 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 342.4;Ductal cells: 219.3;Extravillous trophoblasts: 297.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "unprognostic (6.27e-2)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.13e-1)" "unprognostic (2.63e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (5.26e-5)" "prognostic unfavorable (4.12e-7)" "unprognostic (2.36e-2)" "unprognostic (2.62e-2)" "unprognostic (4.41e-1)" "unprognostic (4.83e-3)" "unprognostic (1.93e-1)" "unprognostic (5.10e-3)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (5.51e-2)" "unprognostic (6.68e-2)" 67.1 73.2 39.0 48.6 42.7 10.6 62.5 41.9 41.6 56.7 45.1 53.8 36.2 59.9 33.8 50.1 53.8 55.2 62.1 37.4 42.1 77.0 76.7 87.4 35.3 51.7 43.8 54.7 48.9 65.5 30.5 94.9 44.5 56.8 38.2 10.2 51.9 46.4 45.4 65.3 48.4 49.9 44.8 56.0 59.0 20.6 45.3 26.1 56.6 38.7 36.2 60.5 48.3 43.7 122.5 138.3 111.5 93.7 103.4 105.2 244.2 76.8 188.7 128.1 140.2 203.6 303.0 47.2 240.0 108.5 106.8 266.8 114.8 118.9 72.6 146.5 92.5 64.3 138.9 92.9 118.3 49.4 71.1 128.6 108.9 101.1 99.8 119.2 92.7 54.2 62.6 53.5 104.5 251.5 51.0 64.1 158.6 253.4 107.2 56.3 96.3 57.2 202.7 88.1 49.3 116.0 143.6 363.4 136.4 142.9 195.7 104.8 81.6 114.7 105.6 84.3 113.6 64.8 87.1 61.8 82.0 38.8 157.0 16.6 68.1 20.3 33.9 78.9 21.1 34.8 25.1 25.6 56.0 39.8 27.2 24.7 67.3 30.6 95.5 51.3 26.9 58.1 39.0 42.7 41.9 41.6 37.4 42.1 51.7 43.8 44.5 44.8 45.3 43.7 71.0 9.6 3.3 7.5 21.9 56.5 97.7 105.8 59.2 7.7 56.7 50.2 13.5 61.5 39.0 53.3 2.1 342.4 35.6 33.9 13.7 219.3 1.0 21.4 38.9 70.1 19.2 17.4 1.8 113.8 297.2 60.6 17.3 35.7 36.8 22.2 49.6 25.6 116.5 18.5 3.1 28.4 40.7 63.6 43.4 3.4 48.4 57.8 48.0 8.4 78.6 36.5 28.8 6.0 6.6 127.8 33.9 62.1 19.8 127.4 49.8 39.6 19.2 6.9 46.0 41.3 55.2 31.3 35.7 26.1 53.4 153.1 21.3 42.5 32.3 74.0 SLC39A7 "D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7" ENSG00000112473 "Solute carrier family 39 member 7" Q92504 6 33200445-33204439 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 168.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053999 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Endoplasmic reticulum" "HPA053999: AB_2682338" "unprognostic (3.63e-2)" "unprognostic (1.23e-1)" "unprognostic (1.21e-1)" "unprognostic (3.24e-2)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (4.87e-2)" "unprognostic (9.92e-2)" "unprognostic (7.20e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-1)" "unprognostic (1.99e-2)" "unprognostic (4.80e-1)" "unprognostic (1.50e-1)" "unprognostic (8.22e-3)" "unprognostic (1.12e-2)" 52.5 73.7 2.2 3.6 2.4 2.4 51.1 2.5 2.7 51.0 5.4 66.7 7.2 60.8 8.6 47.1 44.4 5.8 63.2 2.0 2.8 45.1 75.0 64.9 3.0 3.1 2.6 40.9 98.7 12.8 74.1 8.2 3.2 55.8 8.7 1.9 90.9 7.5 31.5 38.4 58.5 8.3 2.5 47.7 71.4 29.0 3.2 2.8 67.2 2.8 4.4 42.4 41.2 2.9 10.7 9.6 8.6 8.2 25.8 15.9 13.2 17.8 25.3 23.1 23.1 16.7 6.6 5.1 11.9 22.9 12.4 7.5 8.3 14.5 9.7 16.6 10.1 9.4 10.0 25.1 18.2 10.0 30.7 16.0 13.6 15.1 20.6 13.5 11.7 8.3 15.5 7.7 10.2 9.8 4.3 7.4 8.1 23.2 9.9 5.7 6.8 12.2 14.0 5.8 6.8 5.1 8.6 37.2 13.2 5.4 25.0 10.3 10.9 13.1 17.4 8.2 9.8 18.3 15.1 3.9 7.5 8.7 15.0 2.2 1.8 2.0 3.3 1.1 4.4 1.2 2.0 1.2 0.7 1.2 1.8 1.7 0.8 2.1 1.0 1.3 1.0 1.5 2.2 2.4 2.5 2.7 2.0 2.8 3.1 2.6 3.2 2.5 3.2 2.9 40.0 25.6 34.8 7.2 23.4 36.1 29.4 53.6 19.4 27.4 36.7 18.5 33.1 34.3 54.7 25.8 29.2 103.0 22.9 75.5 5.9 73.8 0.8 26.9 47.3 40.9 25.3 28.4 4.3 86.1 129.1 64.4 66.8 53.7 20.8 29.5 28.2 34.4 42.9 11.8 5.9 135.1 48.8 14.8 35.3 2.7 46.0 22.1 40.9 5.6 23.7 42.9 24.7 8.5 8.3 67.8 54.9 42.9 91.6 60.2 56.0 25.9 28.3 26.8 19.7 35.4 43.0 9.4 11.5 26.0 40.9 168.7 23.1 69.2 61.7 51.3 SLC44A2 CTL2 ENSG00000129353 "Solute carrier family 44 member 2" Q8IWA5 19 10602457-10644557 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 171.1;Extravillous trophoblasts: 257.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 333.2;SK-BR-3: 306.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003228, HPA070799" Approved Approved "Vesicles,Cell Junctions" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cell Junctions" "HPA003228: AB_1080009, HPA070799: AB_2686314" "unprognostic (6.35e-3)" "unprognostic (5.75e-2)" "unprognostic (4.34e-1)" "unprognostic (3.06e-3)" "unprognostic (4.38e-2)" "unprognostic (8.41e-3)" "unprognostic (1.64e-1)" "unprognostic (2.52e-1)" "unprognostic (2.66e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (8.63e-2)" "prognostic favorable (1.71e-5)" "unprognostic (1.28e-1)" "unprognostic (1.67e-1)" "unprognostic (8.21e-3)" "unprognostic (3.61e-2)" 74.7 33.2 69.6 43.9 85.0 65.0 72.7 78.4 67.4 64.6 33.4 58.3 26.7 43.0 36.2 81.6 59.0 55.8 71.4 62.7 69.7 68.7 17.8 98.5 75.3 99.6 76.5 32.3 41.2 48.7 20.5 157.5 87.0 43.8 49.5 29.1 55.5 65.8 141.2 78.3 50.8 43.6 84.3 115.5 112.9 82.5 79.1 48.8 64.9 92.4 77.7 56.3 69.2 97.6 333.2 8.3 70.0 42.1 103.9 63.5 201.1 69.6 169.5 112.3 131.6 75.6 154.9 65.6 91.1 193.9 13.6 254.1 10.7 53.2 71.6 1.7 9.3 42.0 39.3 3.1 115.0 0.6 33.9 69.2 69.8 42.3 37.2 91.0 86.8 30.2 20.2 10.8 172.6 243.6 35.1 32.1 24.9 96.9 29.3 74.1 102.7 2.9 37.1 171.8 6.9 42.0 56.7 306.1 7.7 73.8 123.0 3.2 79.8 50.1 18.4 60.5 18.0 4.0 7.9 64.8 12.5 29.1 57.3 146.3 39.4 227.9 114.1 113.0 90.4 92.1 78.5 87.4 20.7 94.8 83.3 87.1 482.8 79.2 278.3 100.4 95.7 147.4 69.6 85.0 78.4 67.4 62.7 69.7 99.6 76.5 87.0 84.3 79.1 97.6 84.0 54.5 29.1 32.3 53.4 9.7 17.3 17.2 13.1 12.3 45.8 29.1 38.6 28.6 47.7 92.0 14.6 137.8 51.9 49.9 1.9 44.1 171.1 15.8 31.4 52.7 9.6 45.0 14.3 44.3 257.0 22.6 84.6 38.6 20.3 7.1 75.7 1.9 37.0 3.3 15.5 17.7 14.2 38.7 3.9 35.1 38.8 22.8 5.4 15.9 10.2 36.4 88.6 18.6 18.4 41.1 31.9 56.4 18.9 9.8 20.1 3.7 19.0 3.0 59.2 26.3 29.4 3.2 2.9 33.5 8.5 93.4 41.2 6.8 23.4 20.6 SLC5A8 AIT ENSG00000256870 "Solute carrier family 5 member 8" Q8N695 12 101155493-101210238 "Metabolic proteins, Predicted membrane proteins, Transporters" "Apoptosis, Ion transport, Sodium transport, Symport, Transport" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "cervix: 20.3;kidney: 5.6;thyroid gland: 15.5" "Cell type enhanced" "Detected in some" "Club cells: 9.1;Early spermatids: 7.9;Enteroendocrine cells: 31.5;Excitatory neurons: 14.6;Horizontal cells: 10.1;Inhibitory neurons: 17.3;Proximal tubular cells: 21.4" "Group enriched" "Detected in many" 4 "breast cancer: 2.7;renal cancer: 7.6;thyroid cancer: 5.3" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "SK-BR-3: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "prognostic favorable (9.04e-6)" "unprognostic (1.84e-1)" "unprognostic (1.17e-2)" "unprognostic (1.27e-3)" "unprognostic (1.24e-1)" "unprognostic (5.20e-1)" "unprognostic (1.16e-2)" "prognostic favorable (1.97e-4)" "unprognostic (6.16e-2)" "unprognostic (2.30e-2)" "unprognostic (2.87e-2)" 0.0 2.4 0.5 0.0 0.5 0.0 0.0 0.3 1.2 20.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 5.6 0.0 0.9 0.0 0.9 0.3 1.0 0.0 0.0 0.1 0.0 0.5 0.8 0.0 0.1 0.9 0.0 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.2 1.5 0.2 15.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.3 1.2 0.4 0.8 0.9 0.3 0.5 0.5 1.5 0.8 0.0 0.0 5.3 1.3 0.0 0.0 0.0 4.6 0.0 3.9 0.1 0.1 0.6 0.0 9.1 1.8 0.0 0.0 0.0 0.3 1.9 0.0 7.9 0.0 0.1 0.0 31.5 0.0 14.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 17.3 0.2 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.2 21.4 2.1 0.1 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.9 SLC9A8 "KIAA0939, NHE8" ENSG00000197818 "Solute carrier family 9 member A8" Q9Y2E8 20 49812713-49892242 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "SK-BR-3: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033682 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB033682: AB_2270441" "unprognostic (1.90e-1)" "unprognostic (1.90e-1)" "unprognostic (6.11e-2)" "unprognostic (2.73e-2)" "unprognostic (2.58e-1)" "unprognostic (1.29e-2)" "unprognostic (4.49e-2)" "unprognostic (3.22e-1)" "unprognostic (3.96e-2)" "unprognostic (5.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.32e-1)" "unprognostic (2.19e-2)" "unprognostic (1.96e-2)" "unprognostic (1.10e-1)" "unprognostic (1.48e-2)" "unprognostic (5.28e-2)" 5.3 6.8 3.9 7.0 3.7 20.3 4.5 3.0 3.4 4.4 2.0 5.4 5.7 4.2 3.9 8.6 4.8 4.8 3.8 3.5 4.5 3.9 6.4 5.5 6.7 5.4 4.4 3.9 5.6 5.5 5.0 3.7 4.0 5.0 5.0 4.0 6.5 4.2 11.4 4.2 5.7 3.3 4.1 8.1 7.6 6.7 5.0 6.8 6.5 4.8 5.8 5.4 4.4 3.9 5.7 10.3 4.5 4.5 5.6 3.5 11.4 5.8 7.8 10.8 5.1 7.3 12.7 6.8 7.3 8.3 8.9 12.5 4.8 5.9 5.5 6.0 2.7 3.4 7.1 3.8 7.8 6.1 8.0 6.7 6.6 5.7 11.5 5.6 4.7 8.9 6.7 6.9 6.7 6.3 5.6 4.1 3.7 8.6 4.8 4.1 5.3 4.9 6.4 6.1 4.5 3.9 9.6 35.3 7.0 3.0 11.5 9.8 7.1 14.7 8.1 7.2 5.7 10.5 4.9 4.9 20.1 8.0 6.2 1.9 0.6 1.6 0.9 0.4 0.9 0.7 0.7 0.8 0.6 0.8 0.7 0.4 2.9 0.4 0.7 0.3 0.5 0.7 3.9 3.7 3.0 3.4 3.5 4.5 5.4 4.4 4.0 4.1 5.0 3.9 6.3 12.8 8.8 24.5 9.9 2.5 4.4 9.2 4.0 5.7 5.7 5.0 4.9 7.2 14.8 3.7 14.6 6.1 10.6 17.9 1.9 7.1 2.7 12.3 6.5 5.4 6.7 9.3 13.8 6.4 4.1 5.1 19.4 18.7 22.2 7.0 8.6 15.5 5.1 6.7 20.0 7.0 6.1 9.2 4.1 8.4 3.7 11.8 1.8 19.7 5.8 5.7 5.2 15.1 25.3 9.4 9.0 4.9 8.0 5.2 7.6 3.4 21.5 9.6 0.0 5.9 5.2 8.9 6.7 10.2 1.8 3.4 9.8 4.7 7.3 9.4 SLX1B "GIYD2, MGC5178" ENSG00000181625 "SLX1 homolog B, structure-specific endonuclease subunit" Q9BQ83 16 29454501-29458219 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.8;Erythroid cells: 12.4;Plasma cells: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 59.3" HPA047038 Uncertain Approved Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA047038: AB_2679913" "unprognostic (2.93e-1)" "unprognostic (1.11e-1)" "unprognostic (2.16e-2)" "unprognostic (5.12e-2)" "unprognostic (7.05e-2)" "unprognostic (1.78e-1)" "unprognostic (7.20e-2)" "unprognostic (2.72e-2)" "unprognostic (2.35e-3)" "unprognostic (3.63e-1)" "unprognostic (1.22e-1)" "unprognostic (3.64e-2)" "unprognostic (2.51e-7)" "unprognostic (4.84e-2)" "unprognostic (1.96e-1)" "unprognostic (4.44e-1)" "unprognostic (5.25e-3)" 15.7 8.3 11.1 12.8 12.0 11.8 14.9 12.2 19.9 14.7 10.5 11.6 22.4 15.3 0.5 9.0 14.5 1.4 7.5 11.5 12.4 8.8 30.4 16.4 7.2 11.2 10.7 12.1 7.6 4.4 6.5 5.4 12.7 11.0 3.8 4.4 19.0 2.6 32.5 17.3 21.3 3.6 9.9 15.8 16.2 1.3 11.1 15.8 16.2 3.5 5.9 15.3 11.8 12.2 6.7 10.7 17.2 6.4 2.9 2.3 6.7 4.1 8.5 10.4 6.0 3.9 20.4 4.0 5.9 5.1 7.3 7.1 3.0 7.7 3.4 2.8 2.7 5.4 9.1 22.8 6.4 4.5 10.3 5.2 2.1 12.1 6.9 12.2 1.7 29.3 2.3 25.6 4.0 16.1 13.4 7.0 7.5 19.8 2.6 26.7 0.2 19.2 8.2 9.5 5.8 8.4 1.4 59.3 4.5 4.1 8.3 13.5 11.2 15.9 2.0 7.2 2.9 8.5 17.9 11.1 16.9 6.8 9.1 3.6 18.1 9.2 6.7 22.2 2.6 10.0 6.8 7.5 16.5 7.7 3.4 4.0 13.3 8.4 15.5 3.9 18.2 9.7 11.1 12.0 12.2 19.9 11.5 12.4 11.2 10.7 12.7 9.9 11.1 12.2 0.3 0.0 0.5 0.0 1.7 0.0 0.1 0.0 2.8 0.0 0.3 0.1 14.8 0.0 0.0 0.0 0.0 1.7 0.1 0.5 0.0 0.8 0.1 0.1 0.2 1.7 0.0 12.4 0.0 1.5 0.6 1.6 2.6 0.1 0.0 0.1 0.4 0.5 1.1 0.0 0.0 0.2 0.0 0.9 0.4 0.0 0.0 2.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.4 3.7 0.3 3.6 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 0.1 1.4 1.7 0.0 0.6 0.2 SND1 "p100, TDRD11" ENSG00000197157 "Staphylococcal nuclease and tudor domain containing 1" Q7KZF4 7 127652194-128092609 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002529, HPA002632, CAB019323" Enhanced Enhanced Cytosol NA NA 1800000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316" "unprognostic (2.06e-1)" "unprognostic (8.27e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.95e-4)" "unprognostic (5.10e-3)" "unprognostic (6.83e-2)" "unprognostic (1.17e-2)" "unprognostic (2.91e-2)" "unprognostic (4.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.30e-1)" "unprognostic (1.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.42e-2)" "unprognostic (2.26e-3)" 48.5 52.5 19.1 57.8 22.6 65.8 56.7 25.3 21.4 76.9 41.0 51.3 54.2 67.2 90.6 47.7 65.1 37.3 45.3 19.9 33.3 33.9 67.5 46.7 53.0 29.7 29.4 87.3 179.0 50.8 52.7 86.7 29.9 59.0 49.4 32.1 102.2 57.7 41.9 43.7 45.3 66.5 26.2 45.8 65.7 38.5 25.4 67.5 66.0 40.0 65.3 50.0 41.8 33.5 160.0 141.8 106.3 193.5 156.6 162.7 145.3 183.5 214.8 163.8 182.5 184.6 134.6 210.6 90.4 225.7 137.8 130.4 150.7 198.1 158.6 116.1 127.2 116.1 153.0 177.9 284.2 181.9 109.6 241.3 216.3 140.0 232.3 185.7 206.2 85.1 131.3 204.9 165.0 118.6 199.5 135.6 119.5 159.7 173.6 136.8 94.6 476.1 128.1 110.5 133.0 143.7 132.8 606.6 217.5 157.8 76.2 127.2 207.3 132.3 86.4 243.3 144.7 250.1 101.1 217.0 265.6 153.6 245.2 49.7 86.4 17.1 67.0 76.6 78.0 70.1 50.0 54.0 87.4 44.6 34.9 39.8 6.2 59.7 66.1 92.9 43.4 92.9 19.1 22.6 25.3 21.4 19.9 33.3 29.7 29.4 29.9 26.2 25.4 33.5 20.3 16.0 44.7 60.4 56.7 19.6 24.7 32.9 22.2 17.1 41.0 28.6 29.2 35.8 28.9 29.5 20.9 255.0 44.3 28.8 17.6 62.8 20.1 21.9 51.9 30.3 73.1 47.5 128.0 96.7 106.1 40.7 54.6 39.5 34.9 54.4 25.0 49.8 81.9 30.3 116.0 59.4 18.3 52.8 36.7 68.1 45.7 50.8 33.8 78.7 72.5 16.7 32.0 84.9 89.9 58.6 29.8 41.3 124.6 42.8 38.2 33.1 19.0 32.7 32.9 27.0 34.4 23.4 28.0 37.6 27.4 267.6 37.2 74.0 58.3 27.0 SORD ENSG00000140263 "Sorbitol dehydrogenase" Q00796 15 45023147-45077185 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 163.8;liver: 247.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2" "Group enriched" "Detected in all" 4 "liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "basophil: 86.3;eosinophil: 55.9" "Lineage enriched" "Detected in all" 12 "granulocytes: 86.3" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040260, HPA040621" Enhanced Approved Cytosol NA NA 2800000 "Cluster 52: Eosinophils - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA040260: AB_10794872, HPA040621: AB_10795384" "unprognostic (8.18e-2)" "unprognostic (7.58e-2)" "unprognostic (8.19e-2)" "unprognostic (1.51e-1)" "unprognostic (5.69e-3)" "unprognostic (3.90e-2)" "prognostic favorable (6.14e-5)" "unprognostic (3.33e-3)" "unprognostic (1.67e-1)" "unprognostic (4.95e-2)" "unprognostic (7.04e-3)" "unprognostic (1.40e-1)" "unprognostic (4.26e-2)" "unprognostic (1.23e-2)" "unprognostic (8.53e-2)" "unprognostic (2.31e-2)" "unprognostic (1.56e-1)" 2.0 15.7 4.9 3.1 3.8 2.8 53.8 7.4 8.4 163.8 1.9 5.3 7.5 4.3 6.9 10.2 6.7 8.2 5.6 5.0 4.5 50.3 247.0 3.2 2.6 4.3 3.7 2.4 5.7 4.4 3.1 2.5 4.0 87.9 7.8 4.8 5.3 27.0 2.2 16.6 7.2 3.5 4.2 2.3 9.2 12.2 3.9 3.7 89.4 2.8 3.4 9.1 6.9 6.3 12.3 12.2 4.7 20.8 4.4 5.3 5.9 1.8 3.5 12.2 7.0 12.2 5.8 2.7 8.0 5.4 4.1 17.6 19.9 19.1 9.2 29.9 12.3 13.5 12.1 50.3 0.2 18.0 25.5 6.7 18.0 6.6 9.5 5.4 12.5 15.1 11.7 10.6 14.9 8.1 18.4 38.3 39.0 29.4 13.8 0.9 16.6 6.4 16.8 12.1 25.1 12.2 2.1 57.3 5.9 5.2 16.4 22.5 4.7 3.5 38.0 1.6 5.8 8.7 4.5 4.4 14.2 18.6 10.6 86.3 1.7 55.9 1.6 1.5 1.7 5.4 1.3 1.6 1.7 6.9 1.6 1.4 3.8 1.1 2.1 2.4 2.5 2.0 4.9 3.8 7.4 8.4 5.0 4.5 4.3 3.7 4.0 4.2 3.9 6.3 3.9 0.0 3.1 5.5 11.9 7.8 26.5 14.8 17.6 10.8 24.7 17.5 3.2 25.8 28.1 33.1 0.0 1.3 2.3 15.0 29.4 68.2 31.7 40.2 17.4 4.9 84.8 37.5 4.8 138.7 5.1 7.5 31.1 43.7 8.8 11.5 15.7 649.4 16.0 3.3 5.4 32.5 22.4 24.2 6.4 24.1 3.7 12.2 16.0 1.0 13.3 9.0 2.1 7.1 8.9 89.0 18.1 6.0 7.9 218.8 8.0 270.2 42.5 4.7 0.0 8.9 8.9 7.4 2.8 35.1 20.3 1.0 6.5 15.3 39.4 131.2 SOX13 "ICA12, MGC117216, Sox-13" ENSG00000143842 "SRY-box transcription factor 13" Q9UN79 1 204073115-204127743 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Sertoli cells: 39.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.9;SK-BR-3: 138.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051790, HPA054843" Enhanced Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA051790: AB_2681610, HPA054843: AB_2682622" "unprognostic (4.88e-3)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (4.74e-2)" "unprognostic (2.65e-1)" "unprognostic (3.08e-2)" "unprognostic (1.02e-1)" "unprognostic (1.27e-2)" "unprognostic (2.75e-1)" "unprognostic (2.95e-1)" "unprognostic (1.28e-2)" "unprognostic (1.25e-1)" "unprognostic (1.48e-3)" "unprognostic (1.04e-1)" "unprognostic (8.20e-2)" "unprognostic (7.98e-2)" "unprognostic (1.92e-1)" 39.9 15.4 16.8 4.9 18.5 0.5 29.2 16.3 14.7 36.6 13.0 28.5 14.0 41.0 8.8 15.9 39.8 9.5 17.4 12.1 14.8 31.4 22.6 36.8 4.7 21.6 23.5 19.2 17.2 24.3 8.6 25.9 18.6 35.4 8.1 2.0 21.8 17.8 21.1 17.5 21.4 17.9 18.2 14.2 14.6 7.1 18.3 1.9 17.2 13.9 3.9 29.7 33.2 19.8 24.8 15.6 32.7 2.2 30.6 9.2 65.9 9.4 5.5 14.7 9.0 13.1 18.0 0.2 30.4 6.0 3.8 39.0 12.6 12.2 6.9 11.5 6.4 0.0 11.2 14.6 6.9 0.2 14.0 9.5 6.1 9.2 8.0 7.0 21.7 0.5 0.2 0.1 3.0 30.1 0.3 0.2 43.6 39.5 18.6 0.2 11.1 15.3 11.0 55.9 5.1 2.7 9.5 138.2 42.4 29.0 61.7 3.0 12.4 3.2 8.6 14.2 6.6 0.1 0.1 0.0 5.2 0.5 8.8 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.4 0.5 0.0 0.0 0.0 0.3 0.1 1.6 0.0 0.0 0.0 0.1 16.8 18.5 16.3 14.7 12.1 14.8 21.6 23.5 18.6 18.2 18.3 19.8 20.5 6.4 7.7 26.8 0.2 2.2 8.7 3.5 2.8 0.9 8.7 7.6 28.3 5.7 4.9 9.2 0.0 5.2 3.9 16.3 1.9 3.6 9.2 13.3 13.0 17.4 7.7 0.0 0.5 1.5 5.6 8.4 5.1 22.3 17.1 0.2 8.9 6.0 1.4 0.0 7.6 5.3 8.2 0.9 2.1 27.7 20.8 1.2 1.8 21.5 0.0 4.9 4.1 50.8 16.8 3.7 7.6 19.5 0.5 7.8 16.0 4.5 4.1 1.0 39.5 9.7 22.3 0.3 0.5 6.6 1.6 1.9 2.3 2.9 5.5 7.7 SPATA2 "KIAA0757, PD1, PPP1R145, tamo" ENSG00000158480 "Spermatogenesis associated 2" Q9UM82 20 49903391-49915529 "Predicted intracellular proteins" Necrosis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 45.2;Late spermatids: 62.5;Spermatocytes: 41.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048581, HPA052224" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli fibrillar center" Nucleoplasm "HPA048581: AB_2680449, HPA052224: AB_2681769" "unprognostic (4.02e-2)" "unprognostic (5.98e-2)" "unprognostic (8.26e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (3.25e-3)" "unprognostic (8.77e-2)" "prognostic favorable (9.08e-4)" "unprognostic (8.33e-2)" "unprognostic (6.45e-3)" "unprognostic (5.99e-2)" "unprognostic (4.89e-2)" "unprognostic (9.57e-2)" "unprognostic (4.38e-1)" "prognostic unfavorable (4.53e-4)" "unprognostic (2.52e-1)" 3.9 5.8 19.9 3.7 21.6 12.2 3.7 17.5 20.9 3.9 8.1 7.8 7.8 5.3 3.6 5.6 4.7 3.4 6.9 21.0 16.7 5.0 5.8 4.0 3.6 17.2 19.0 4.5 8.0 5.6 7.9 3.5 16.7 5.8 6.3 6.5 5.9 3.9 13.1 5.0 7.5 3.1 17.0 11.4 5.7 14.3 21.1 3.8 8.0 7.8 3.6 4.1 3.7 21.5 7.8 9.4 6.3 5.7 7.0 5.0 10.3 4.9 7.2 16.7 7.0 29.7 6.1 5.9 10.1 4.9 8.6 14.1 4.7 8.1 8.8 8.3 4.5 3.1 5.6 19.5 6.6 8.5 12.2 5.0 9.6 8.6 5.4 5.5 3.6 8.2 10.8 6.6 4.0 16.5 8.7 21.5 9.5 10.5 11.3 6.5 6.8 6.2 5.4 6.1 6.0 6.4 9.8 29.6 7.8 4.9 7.2 7.3 5.1 11.9 9.8 9.9 7.0 16.2 13.4 6.3 9.3 4.4 5.4 0.1 1.5 1.4 1.4 1.1 1.3 1.3 1.3 1.7 1.3 2.1 1.6 1.9 2.5 1.5 0.5 0.6 1.5 1.0 19.9 21.6 17.5 20.9 21.0 16.7 17.2 19.0 16.7 17.0 21.1 21.5 5.4 9.6 2.2 2.9 7.8 7.4 6.6 4.3 12.5 7.4 11.9 8.6 4.9 10.0 2.8 0.0 8.4 11.0 8.3 34.7 3.9 6.0 45.2 11.4 4.7 6.3 26.4 1.7 6.8 8.0 13.4 5.4 9.7 9.0 4.5 5.4 10.4 7.1 4.8 6.7 5.0 22.2 2.0 4.4 5.4 62.5 5.0 3.6 5.4 1.9 7.0 5.4 4.1 2.0 8.5 8.3 16.1 5.7 6.4 7.4 20.7 4.8 6.7 7.6 6.6 5.8 6.6 41.3 16.9 7.8 7.2 30.1 6.8 10.3 18.4 8.5 SPINK8 ENSG00000229453 "Serine peptidase inhibitor Kazal type 8 (putative)" P0C7L1 3 48306842-48328341 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "bone marrow: 11.5;breast: 44.1" "Group enriched" "Detected in some" 5 "Breast glandular cells: 22.1;Breast myoepithelial cells: 9.9" "Group enriched" "Detected in some" 10 "breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "eosinophil: 1.3;neutrophil: 1.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.7" "Cell line enriched" "Detected in some" 60 "SK-BR-3: 73.2" "Region enriched" "Detected in many" 9 "hippocampal formation: 73.7" "Low region specificity" "Detected in all" HPA053151 Uncertain "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 5: Breast - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "HPA053151: AB_2682059" "prognostic unfavorable (8.47e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" 0.0 0.0 2.2 0.0 2.2 11.5 44.1 2.6 4.5 0.0 0.4 0.0 0.1 0.0 2.5 2.8 0.2 0.0 0.0 3.0 1.8 0.0 0.0 0.1 0.0 2.9 1.5 0.0 0.4 0.0 0.1 0.2 2.6 0.5 0.0 0.3 2.1 0.3 0.0 0.1 0.0 0.0 1.8 0.6 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.1 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 73.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 2.2 2.2 2.6 4.5 3.0 1.8 2.9 1.5 2.6 1.8 2.6 2.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 22.1 9.9 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.1 0.0 1.2 0.0 0.0 2.7 1.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 255.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 7400000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.8 0.7 0.9 16.4 1.5 1.4 34.7 5.0 1.3 42.8 6.4 108.7 159.9 13.2 78.9 255.5 33.6 38.0 1.3 0.9 2.0 79.9 3.5 47.6 6.4 2.8 3.2 2.4 69.2 132.9 31.4 144.9 2.2 52.3 89.2 0.4 162.7 31.4 0.6 148.9 138.2 4.3 1.7 6.9 88.3 1.8 3.2 9.9 34.7 0.4 45.5 57.1 90.1 2.3 124.8 1.0 0.0 0.9 0.1 0.0 323.2 2.3 3.0 4.0 2.4 195.3 202.4 0.3 141.2 0.4 3.6 377.6 30.8 181.9 2.4 1.0 10.6 5.6 3.3 10.8 2.2 21.9 93.9 0.3 264.0 3.9 16.5 3.4 14.7 12.1 2.7 1.1 0.2 96.5 0.9 16.6 37.4 207.6 17.7 12.6 0.0 24.9 179.3 308.2 79.8 3.9 9.3 558.8 15.7 56.9 267.7 16.1 0.0 0.2 2.0 1.2 0.5 1.2 24.5 0.8 0.8 16.3 1.1 0.0 19.7 14.3 0.4 15.9 0.8 8.4 3.0 1.4 32.4 6.0 1.1 0.3 25.9 5.5 18.1 4.0 0.5 7.6 0.9 1.5 5.0 1.3 0.9 2.0 2.8 3.2 2.2 1.7 3.2 2.3 0.8 57.7 14.7 0.0 7.6 76.0 96.7 220.0 55.8 0.1 96.2 63.5 0.5 105.8 207.3 134.3 0.0 1254.0 1.4 477.6 25.4 429.4 0.8 63.3 14.2 6.9 147.3 4.8 0.5 255.1 105.1 10.4 106.5 155.6 10.2 1.9 0.4 0.5 135.4 0.0 0.5 169.4 221.8 10.0 23.8 1.1 3.7 19.8 14.2 0.0 68.6 0.0 0.0 0.0 0.0 309.8 375.2 0.0 2.1 135.7 514.5 44.2 46.6 0.3 0.0 0.1 12.6 0.6 5.9 93.2 87.9 1673.8 6.6 0.1 182.7 222.3 SRARP "C1orf64, ERRF, MGC24047" ENSG00000183888 "Steroid receptor associated and regulated protein" Q8NEQ6 1 16004236-16008807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.3;breast: 5.1;choroid plexus: 6.2" "Group enriched" "Detected in some" 4 "Breast glandular cells: 25.0;Distal tubular cells: 90.1" "Group enriched" "Detected in some" 4 "breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 13 "Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026676 Uncertain Approved Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA026676: AB_1853866" "unprognostic (8.55e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.68e-6)" "unprognostic (3.32e-2)" "unprognostic (1.09e-2)" "unprognostic (1.45e-2)" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-1)" "unprognostic (2.53e-1)" "unprognostic (1.65e-3)" "unprognostic (6.32e-2)" 0.1 0.2 10.3 0.2 9.7 0.7 5.1 8.9 11.3 2.3 6.2 0.1 0.2 1.1 0.1 0.2 0.1 0.2 0.9 8.8 9.3 1.5 0.1 0.1 0.3 9.4 9.4 0.2 0.2 0.0 0.0 0.1 10.0 0.7 0.0 0.8 3.1 0.0 0.2 0.6 0.1 0.0 8.6 0.2 0.3 0.2 11.2 0.0 1.2 0.0 0.0 0.1 0.0 9.2 0.3 0.1 0.3 0.4 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.1 0.4 0.6 7.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.6 0.5 0.0 0.4 0.3 0.3 0.1 0.1 0.2 0.2 0.3 0.2 0.0 0.1 0.4 0.6 0.3 13.6 0.2 0.4 4.3 0.4 0.2 0.4 0.3 0.3 0.1 0.2 0.5 0.2 0.2 0.2 0.6 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.2 1.8 0.3 0.1 0.1 0.0 0.0 10.3 9.7 8.9 11.3 8.8 9.3 9.4 9.4 10.0 8.6 11.2 9.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 25.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.1 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346213-55373100 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 245.5;Club cells: 245.2;Pancreatic endocrine cells: 155.5;Respiratory ciliated cells: 195.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 79.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 12.5 12.0 10.4 2.5 11.5 3.7 12.2 11.0 12.4 12.9 9.2 7.3 3.8 6.8 4.2 26.1 5.6 10.3 9.3 10.7 10.1 9.6 14.5 10.5 2.5 11.0 11.2 3.1 20.2 7.0 5.9 4.0 10.8 7.4 4.1 1.5 16.4 2.9 6.3 15.4 7.0 2.6 10.9 6.8 9.7 3.3 10.9 6.0 7.6 5.4 6.0 10.0 14.7 12.7 9.7 4.3 10.3 10.1 29.4 20.4 5.6 10.4 9.3 2.4 5.4 6.5 19.5 21.2 11.7 11.0 11.1 7.0 5.3 7.9 3.9 6.6 17.1 12.3 5.2 15.8 9.2 23.7 6.1 17.6 14.5 5.4 5.3 7.8 14.4 38.5 21.2 47.7 21.1 10.8 36.0 10.3 13.0 53.2 9.3 11.4 3.3 14.0 12.8 7.9 16.0 9.1 10.7 79.6 8.3 9.0 9.4 17.9 8.3 25.0 4.7 2.0 8.1 28.6 15.8 7.9 34.1 29.5 25.9 25.6 35.8 11.7 16.1 56.5 18.6 12.5 12.0 15.2 30.2 12.7 10.2 14.4 1.8 8.6 59.5 61.7 12.5 23.1 10.4 11.5 11.0 12.4 10.7 10.1 11.0 11.2 10.8 10.9 10.9 12.7 25.4 9.6 15.9 4.6 7.8 13.6 13.3 245.5 5.2 4.9 43.8 29.3 5.3 34.3 245.2 5.5 4.2 27.0 21.2 12.2 3.9 93.4 3.2 51.2 31.0 19.6 12.0 14.9 11.1 105.4 106.0 16.2 13.3 105.9 14.0 6.7 17.5 18.6 63.4 10.1 17.1 22.6 57.0 32.4 34.1 0.5 1.8 27.6 24.9 4.7 31.3 21.9 18.6 8.5 23.4 155.5 10.0 5.7 16.8 17.5 9.4 18.4 195.0 3.9 13.1 13.3 28.2 3.5 20.1 32.7 29.7 7.5 7.2 15.4 23.3 108.6 ST7 "ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7" ENSG00000004866 "Suppression of tumorigenicity 7" Q9NRC1 7 116953238-117230176 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 184.1;Early spermatids: 131.4;Excitatory neurons: 191.5;Inhibitory neurons: 176.0;Oligodendrocyte precursor cells: 111.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 115.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038325, HPA038326" Approved Supported Nucleoplasm,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm Cytosol "HPA038325: AB_10671740, HPA038326: AB_10672644" "unprognostic (3.40e-2)" "unprognostic (1.04e-1)" "unprognostic (1.33e-1)" "unprognostic (4.70e-2)" "unprognostic (1.09e-1)" "unprognostic (8.18e-2)" "unprognostic (3.32e-2)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (4.45e-3)" "unprognostic (1.46e-1)" "unprognostic (2.48e-2)" "prognostic favorable (3.39e-5)" "unprognostic (1.80e-1)" "unprognostic (1.96e-1)" "unprognostic (8.41e-2)" "unprognostic (3.40e-2)" 13.5 21.7 22.6 6.7 22.0 17.8 15.2 50.6 24.7 19.9 11.1 13.6 12.1 14.5 35.8 9.7 18.6 12.3 22.4 21.8 22.6 29.4 41.3 26.1 7.6 15.0 17.4 17.4 32.9 19.0 24.5 20.9 15.9 13.8 12.4 12.6 21.7 21.2 12.5 11.5 11.0 12.6 14.6 10.4 17.3 8.7 22.5 8.6 28.4 11.2 8.6 12.6 11.1 19.7 29.4 17.2 28.2 24.4 31.0 20.5 12.3 23.0 30.2 24.4 35.2 24.0 32.8 7.7 25.5 21.4 34.7 24.6 24.2 24.5 31.3 11.1 33.9 23.4 26.5 20.2 21.8 27.4 39.4 16.1 24.3 30.7 21.8 21.6 24.9 5.2 36.0 54.6 22.3 18.1 0.2 21.0 26.9 40.1 19.3 6.7 18.8 33.6 25.5 16.2 42.2 33.8 27.8 115.5 32.0 20.6 10.1 23.3 19.1 27.6 11.0 30.5 23.3 34.7 28.2 29.6 22.9 24.0 28.6 1.5 3.1 0.4 7.3 1.2 5.1 2.2 4.4 6.2 5.7 1.0 2.9 3.0 0.0 7.0 1.1 5.6 10.3 3.0 22.6 22.0 50.6 24.7 21.8 22.6 15.0 17.4 15.9 14.6 22.5 19.7 6.3 22.4 38.1 184.1 5.0 7.5 8.6 8.8 10.8 12.2 9.0 7.4 13.5 12.8 12.9 5.5 0.0 21.1 6.4 3.1 5.9 6.0 131.4 7.1 5.9 9.5 3.6 15.8 191.5 13.4 22.8 10.6 12.8 14.2 19.6 3.5 8.6 24.5 8.7 3.3 176.0 6.8 8.2 14.4 6.0 53.5 11.1 7.9 7.2 44.0 7.5 12.8 4.1 111.1 46.9 8.8 3.6 6.0 10.3 6.7 3.6 17.3 6.3 1.3 0.0 9.9 12.1 12.8 5.8 7.4 5.5 21.2 4.6 4.6 5.3 8.8 STARD3 "es64, MLN64" ENSG00000131748 "StAR related lipid transfer domain containing 3" Q14849 17 39637090-39664201 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 260.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017021, HPA024307, HPA073948" Uncertain Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Vesicles" "Endoplasmic reticulum" "CAB017021: , HPA024307: , HPA073948: " "unprognostic (1.11e-1)" "unprognostic (2.14e-2)" "unprognostic (6.35e-2)" "unprognostic (8.92e-3)" "unprognostic (2.09e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (3.60e-5)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (6.25e-3)" "unprognostic (5.88e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (1.33e-1)" "unprognostic (5.22e-2)" "unprognostic (8.51e-3)" "unprognostic (3.00e-2)" 24.8 33.4 18.3 18.8 29.1 25.4 23.4 21.6 18.9 22.3 14.9 21.5 24.1 20.4 2.7 24.1 21.5 17.2 16.3 17.9 15.4 18.9 25.8 28.8 22.3 21.1 21.3 21.3 26.5 15.2 24.0 17.1 19.0 20.1 5.2 3.2 21.2 11.3 23.9 27.0 26.7 9.2 18.7 33.1 26.5 26.2 22.5 14.8 21.4 9.5 8.8 21.0 20.1 18.5 29.3 47.6 18.6 33.5 19.9 22.9 31.2 23.1 24.9 27.1 24.3 24.0 47.6 25.2 47.7 17.8 30.8 55.4 11.3 21.0 6.3 36.2 34.5 15.2 18.8 30.1 25.9 29.6 35.5 24.5 19.0 29.8 12.6 19.0 23.4 36.4 41.0 27.4 23.5 24.7 32.2 25.6 22.2 15.3 20.6 28.5 31.4 40.1 15.0 35.7 24.9 29.1 16.1 260.8 64.0 10.8 34.1 41.7 26.3 43.2 29.5 46.5 43.6 27.5 37.8 18.7 36.2 36.8 45.1 23.7 36.3 54.4 42.7 35.5 30.7 20.8 29.6 32.7 38.3 26.1 29.1 27.8 63.6 39.6 29.3 18.7 38.5 33.8 18.3 29.1 21.6 18.9 17.9 15.4 21.1 21.3 19.0 18.7 22.5 18.5 45.8 3.2 7.5 31.0 23.2 16.6 13.0 23.4 14.2 12.6 19.9 14.6 3.4 18.6 14.8 11.0 37.5 28.5 32.9 21.0 9.8 26.5 2.7 9.7 11.7 35.8 27.5 11.1 17.3 35.4 37.2 16.2 29.6 11.0 19.0 22.2 45.0 11.9 49.8 18.5 14.8 11.6 14.2 49.0 18.5 5.3 17.1 27.7 5.4 9.4 18.5 15.8 29.9 12.1 30.2 35.9 22.9 13.2 24.3 20.2 41.5 10.3 8.3 13.2 13.1 21.8 14.4 9.3 16.2 15.9 16.9 40.0 35.2 18.6 15.1 20.1 STAT3 APRF ENSG00000168610 "Signal transducer and activator of transcription 3" P40763 17 42313324-42388540 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001671, CAB003859, HPA058603, CAB068241, CAB068242" Supported Supported Nucleoplasm,Cytosol NA NA 55000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Cytosol" "CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772" "unprognostic (1.83e-2)" "unprognostic (2.42e-1)" "unprognostic (9.23e-3)" "unprognostic (2.91e-1)" "unprognostic (5.59e-3)" "unprognostic (1.78e-2)" "unprognostic (8.26e-2)" "unprognostic (1.51e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-1)" "unprognostic (2.21e-1)" "unprognostic (1.26e-1)" "unprognostic (6.47e-3)" "unprognostic (7.75e-3)" "unprognostic (2.21e-2)" "unprognostic (7.63e-2)" "unprognostic (1.61e-1)" 105.6 68.1 32.4 78.5 34.5 63.2 84.4 38.7 30.2 62.6 32.4 76.9 45.9 71.6 28.2 81.6 74.0 71.7 101.2 28.6 44.6 77.2 143.1 106.0 55.3 48.4 40.7 65.4 67.3 35.3 53.3 55.6 43.4 62.9 46.5 29.9 63.5 48.2 123.9 66.8 68.1 72.1 43.9 68.0 62.3 24.6 43.0 50.5 61.9 92.1 65.2 88.6 64.3 43.1 61.5 116.0 47.4 48.2 103.7 97.6 35.4 66.5 89.7 59.6 58.3 30.3 55.8 18.5 68.2 71.2 90.3 89.2 45.8 72.6 47.7 160.6 31.4 131.2 60.4 62.4 77.3 31.8 79.0 152.1 69.8 47.4 68.9 62.2 81.1 33.4 80.1 56.4 40.1 43.8 118.7 31.3 28.5 63.4 0.0 26.6 133.8 28.1 91.3 77.2 45.2 29.8 81.4 184.9 29.2 57.2 100.5 49.1 68.7 88.9 44.9 54.8 56.5 82.9 75.3 16.4 56.1 32.8 41.6 121.1 78.4 100.0 79.5 79.9 64.4 40.2 57.5 62.6 54.3 36.6 58.7 56.5 262.6 58.3 80.8 29.3 47.9 124.5 32.4 34.5 38.7 30.2 28.6 44.6 48.4 40.7 43.4 43.9 43.0 43.1 216.0 93.0 173.7 46.0 111.6 129.5 105.3 76.8 138.3 92.6 147.1 113.0 59.7 54.3 103.2 134.3 281.5 25.2 115.1 148.9 17.6 83.2 33.5 129.3 187.0 164.7 124.0 54.3 24.2 96.8 38.2 154.0 109.1 153.9 142.0 86.3 115.3 115.7 69.1 25.2 35.8 97.8 69.2 71.0 121.7 13.7 71.7 111.7 72.9 51.5 94.1 131.3 78.2 30.7 41.7 82.9 94.5 60.9 104.6 147.9 206.4 46.3 88.5 406.7 65.7 189.5 169.7 31.5 15.3 93.4 160.1 31.2 170.2 102.3 117.5 90.6 SUPT6H "KIAA0162, SPT6H" ENSG00000109111 "SPT6 homolog, histone chaperone and transcription elongation factor" Q7KZ85 17 28662198-28702679 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012416, HPA036382" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB012416: , HPA036382: AB_2675094" "unprognostic (8.18e-2)" "unprognostic (2.27e-1)" "unprognostic (2.72e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-1)" "unprognostic (8.23e-2)" "prognostic unfavorable (3.68e-5)" "unprognostic (1.02e-1)" "unprognostic (2.18e-2)" "unprognostic (9.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.17e-1)" "prognostic favorable (4.36e-5)" "unprognostic (4.75e-2)" "unprognostic (1.05e-1)" "unprognostic (4.17e-2)" "unprognostic (1.06e-2)" 31.2 33.5 24.6 25.4 25.8 65.3 28.3 25.0 26.8 27.0 26.8 36.6 20.0 30.6 26.8 26.5 26.6 24.7 28.8 24.0 29.0 25.6 35.8 28.9 28.4 24.0 25.2 31.2 31.4 30.8 34.3 27.8 24.3 28.7 20.9 29.2 29.1 25.6 54.5 39.2 32.2 27.3 21.6 34.4 31.3 21.4 28.7 34.0 28.9 32.6 30.3 32.1 25.6 25.6 49.4 101.3 49.8 57.1 59.1 39.3 38.2 66.2 70.3 76.3 67.8 94.7 21.5 52.1 33.6 66.5 58.7 57.5 73.6 48.1 78.4 97.6 65.4 72.9 83.2 59.4 49.4 77.2 77.9 54.6 28.4 81.2 53.6 50.3 50.8 50.3 72.9 59.7 55.1 59.1 76.9 33.4 38.7 43.2 32.4 38.7 91.2 42.7 37.6 95.9 37.8 49.9 77.6 120.5 41.6 67.9 74.2 54.2 80.6 59.8 49.4 57.5 85.3 75.4 62.2 74.4 67.5 34.4 50.5 14.7 4.5 4.4 3.7 2.9 3.9 4.5 3.1 4.1 3.7 4.5 3.1 2.8 6.8 4.3 5.0 6.2 3.1 3.1 24.6 25.8 25.0 26.8 24.0 29.0 24.0 25.2 24.3 21.6 28.7 25.6 33.9 38.5 51.0 24.2 36.5 22.4 19.2 16.8 43.3 29.5 27.4 26.0 51.6 22.8 28.4 20.2 56.3 24.4 38.4 29.5 5.9 22.1 5.4 31.0 45.3 32.6 31.0 33.0 21.6 21.3 21.3 32.7 46.4 49.1 50.5 36.6 22.9 33.9 23.7 30.3 19.7 23.1 8.2 23.0 22.4 17.8 25.7 41.8 8.8 16.9 29.9 22.0 30.9 17.6 19.4 31.9 18.7 26.7 55.7 20.0 23.4 10.5 25.7 44.4 32.9 32.4 32.0 19.8 19.1 40.1 24.3 49.8 38.3 42.0 22.9 25.7 SUSD2 "BK65A6.2, FLJ22778, W5C5" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181487-24189106 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 99.8" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 29 "SK-BR-3: 898.7" "Low region specificity" "Detected in all" HPA004117 Enhanced Approved "Plasma membrane" NA NA 6800000 "Cluster 19: Lung - Lung function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavorable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 12.1 9.6 4.9 1.9 2.8 0.2 9.5 1.7 5.8 13.6 2.2 4.8 12.8 9.8 0.5 2.8 15.0 1.8 12.5 1.6 5.3 32.6 2.9 99.8 2.2 22.9 6.9 5.4 4.3 1.5 7.1 3.6 26.5 5.6 1.0 0.1 4.7 5.6 2.2 28.2 34.6 3.4 6.8 3.6 6.3 3.2 13.2 0.8 17.8 1.4 1.3 5.4 11.0 10.0 5.1 10.4 0.1 0.0 18.8 24.3 0.8 2.4 0.1 0.1 0.0 7.8 0.6 1.4 21.5 0.5 0.4 1.4 0.1 0.5 0.0 0.6 0.3 0.0 0.4 30.6 8.0 0.0 0.3 21.5 0.4 0.1 6.2 0.0 0.1 0.0 0.5 0.3 0.0 9.1 0.3 0.4 0.7 2.5 0.3 0.3 0.0 2.5 0.1 0.2 1.7 13.5 0.7 898.7 0.2 3.6 3.0 0.0 0.0 0.1 0.9 0.7 0.1 1.1 1.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 2.8 1.7 5.8 1.6 5.3 22.9 6.9 26.5 6.8 13.2 10.0 1.7 250.0 151.5 0.3 0.6 0.3 0.3 2.6 0.0 0.0 3.4 3.4 6.8 0.0 20.9 1.8 0.0 13.8 0.3 0.7 5.9 0.1 0.0 1.3 0.7 1.1 1.8 0.0 0.2 0.0 0.7 6.7 0.5 1.3 3.8 0.1 2.9 0.5 1.1 0.0 0.1 5.5 2.0 0.0 0.3 0.4 0.6 0.8 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.4 154.9 27.8 3.6 0.0 0.0 0.6 22.1 1.7 1.3 0.7 2.7 26.4 1.1 0.0 1.6 0.6 SYBU "FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL" ENSG00000147642 Syntabulin Q9NX95 8 109573978-109691791 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 140.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 200.5;Horizontal cells: 95.9;Inhibitory neurons: 129.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 6.4;naive B-cell: 3.2" "Lineage enriched" "Detected in single" 27 "B-cells: 6.4" "Cell line enhanced" "Detected in many" "HaCaT: 24.4;PC-3: 25.7;SK-BR-3: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053057 Uncertain Supported Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA053057: AB_2682028" "unprognostic (4.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-1)" "prognostic favorable (7.74e-4)" "unprognostic (1.22e-2)" "unprognostic (1.37e-1)" "unprognostic (2.16e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-1)" "unprognostic (6.05e-3)" "unprognostic (6.89e-2)" "unprognostic (4.27e-2)" 32.2 38.7 39.1 3.2 42.0 0.0 22.2 44.5 52.4 10.7 4.4 15.4 10.9 5.6 11.5 5.6 20.1 10.3 6.9 42.4 58.6 4.2 52.1 8.8 4.4 24.2 34.0 9.2 140.5 1.5 30.4 2.5 36.6 8.2 19.7 26.1 21.5 11.0 3.8 9.6 12.0 6.9 22.8 1.0 28.2 1.8 50.8 5.4 12.3 7.7 7.8 5.9 8.8 30.2 8.6 5.2 3.6 0.0 0.5 0.6 2.5 3.1 0.0 0.0 0.0 7.9 5.4 0.7 0.5 2.5 1.2 24.4 0.8 5.7 0.0 0.1 11.6 0.0 15.2 8.2 6.2 0.0 0.0 1.9 7.7 0.0 7.2 0.4 3.3 0.6 0.4 1.6 3.5 0.2 0.2 0.0 0.7 7.7 25.7 0.0 0.0 0.0 9.5 2.2 16.3 1.9 6.9 51.4 1.7 2.5 6.8 0.3 5.0 0.3 2.0 0.1 1.5 1.5 0.1 0.5 10.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 39.1 42.0 44.5 52.4 42.4 58.6 24.2 34.0 36.6 22.8 50.8 30.2 39.3 9.6 7.7 16.0 4.3 5.7 2.5 8.3 17.1 46.1 10.9 9.1 2.4 30.0 18.0 11.0 8.4 4.6 0.1 3.6 3.9 5.4 1.4 29.3 3.4 11.8 34.5 0.0 200.5 9.4 0.9 7.9 5.6 20.9 0.0 0.7 10.0 39.1 0.3 95.9 129.6 22.2 2.0 0.8 4.2 0.4 2.1 0.3 1.8 21.5 0.7 2.1 0.0 22.1 5.7 3.9 9.8 0.4 0.1 11.8 16.2 0.1 15.6 7.4 0.0 16.5 4.2 1.3 1.5 3.5 3.3 0.7 0.6 0.1 13.7 4.2 SYNE4 "C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4" ENSG00000181392 "Spectrin repeat containing nuclear envelope family member 4" Q8N205 19 36003307-36008813 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 32.0;Breast myoepithelial cells: 35.9;Cytotrophoblasts: 32.6;Syncytiotrophoblasts: 33.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 32.5;Hep G2: 29.1;MCF7: 34.2;SK-BR-3: 40.1;T-47d: 31.0" "Region enriched" "Detected in single" 15 "cerebellum: 6.8" "Not detected" "Not detected" HPA060253 Uncertain NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 35: Glandular cells - Unknown function" "HPA060253: AB_2684233" "unprognostic (8.54e-2)" "unprognostic (6.48e-2)" "unprognostic (1.32e-2)" "unprognostic (1.24e-1)" "unprognostic (5.54e-2)" "unprognostic (2.42e-3)" "unprognostic (3.76e-2)" "unprognostic (2.03e-2)" "unprognostic (1.93e-1)" "unprognostic (3.15e-2)" "unprognostic (3.36e-3)" "unprognostic (6.02e-2)" "prognostic favorable (8.64e-9)" "unprognostic (1.25e-1)" "unprognostic (2.54e-2)" "unprognostic (4.50e-1)" "unprognostic (1.97e-2)" 0.2 0.2 1.2 0.2 1.0 0.2 5.2 6.7 1.5 2.6 2.5 1.9 3.2 0.7 7.7 1.2 3.9 1.6 0.2 0.7 2.9 8.4 12.0 3.1 0.2 3.7 3.0 0.3 5.4 12.1 12.7 1.6 3.6 10.9 1.4 0.2 9.2 4.0 0.3 1.1 1.3 0.2 1.3 0.3 3.4 0.2 2.5 1.7 8.6 0.0 0.3 0.8 1.3 1.2 0.3 0.3 0.2 0.4 0.1 0.2 4.3 0.0 0.0 0.0 0.1 32.5 3.8 0.3 0.4 0.0 0.2 0.0 0.3 0.4 0.0 1.1 0.5 0.1 0.8 29.1 0.5 0.0 0.2 0.2 0.2 1.1 0.0 0.0 0.2 1.6 0.4 0.4 0.0 34.2 0.5 0.1 0.2 0.3 0.2 0.9 0.0 0.4 2.2 1.0 5.0 0.0 0.0 40.1 0.2 0.2 31.0 0.3 0.0 0.3 0.6 0.5 0.2 0.5 0.7 0.6 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 6.7 1.5 0.7 2.9 3.7 3.0 3.6 1.3 2.5 1.2 0.3 6.4 17.5 0.3 0.7 0.5 14.9 19.9 5.2 0.9 32.0 35.9 0.4 24.3 20.2 29.5 4.2 32.6 0.8 5.4 25.4 21.2 0.0 9.1 1.0 0.8 29.8 0.0 0.6 8.6 24.7 0.7 8.2 10.7 1.3 0.5 0.7 12.5 2.6 0.0 0.9 10.6 26.4 0.6 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.9 11.7 16.9 0.0 0.0 23.9 4.5 24.2 17.3 0.4 0.0 0.3 1.6 0.1 0.4 2.1 0.4 33.9 1.2 0.1 8.8 9.2 SYNPO2L FLJ12921 ENSG00000166317 "Synaptopodin 2 like" Q9H987 10 73644881-73663803 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2" "Cell type enriched" "Detected in some" 52 "Cardiomyocytes: 665.1" "Group enriched" "Detected in some" 6 "breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA055192, HPA057142" Enhanced Supported "Nuclear speckles,Cell Junctions,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nuclear speckles" "Cell Junctions, Cytosol" "HPA055192: AB_2682732, HPA057142: AB_2683348" "unprognostic (2.75e-1)" "unprognostic (1.58e-1)" "unprognostic (1.20e-3)" "unprognostic (3.65e-3)" "unprognostic (1.27e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "unprognostic (4.54e-2)" "unprognostic (3.30e-1)" "unprognostic (2.49e-2)" "unprognostic (4.50e-2)" "unprognostic (2.32e-1)" "unprognostic (7.44e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-1)" "unprognostic (1.72e-2)" "unprognostic (1.34e-1)" 0.1 0.5 0.7 0.1 0.7 0.3 3.6 0.8 0.9 0.4 0.1 0.0 0.1 0.1 0.1 11.8 0.1 0.1 262.3 0.7 0.5 0.1 0.1 1.2 0.2 0.7 0.6 0.2 0.4 0.0 0.1 0.6 0.5 3.1 0.0 0.4 4.8 0.0 279.2 0.3 0.0 0.0 0.5 0.2 0.1 0.3 0.6 0.1 0.2 87.2 0.2 0.0 1.1 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.5 0.6 0.1 0.0 4.1 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.3 0.1 0.0 3.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.1 0.1 0.1 0.0 3.2 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.7 0.7 0.8 0.9 0.7 0.5 0.7 0.6 0.5 0.5 0.6 0.7 0.5 3.2 0.0 0.3 0.9 1.5 1.4 0.0 2.2 1.9 1.0 0.8 665.1 0.0 0.7 0.0 2.1 0.2 0.5 0.0 0.0 0.0 2.6 0.1 0.4 5.0 0.0 0.0 0.3 0.0 0.2 12.6 0.0 0.3 1.3 0.3 0.0 0.4 0.2 0.0 0.9 0.0 0.0 0.6 2.1 1.1 0.9 0.8 1.8 1.0 0.3 0.4 0.0 1.5 1.1 0.0 0.0 0.4 0.3 0.9 0.0 0.2 0.7 1.2 0.0 12.0 5.2 0.8 1.3 0.4 0.4 0.0 0.7 0.2 0.0 1.0 SYT15 CHR10SYT ENSG00000204176 "Synaptotagmin 15" Q9BQS2 10 46578217-46594173 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 54.5;Alveolar cells type 2: 49.5;Endothelial cells: 20.4;Hepatic stellate cells: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-BR-3: 14.6" "HPA036971, HPA036972, HPA064559" Uncertain Approved "Golgi apparatus" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA036971: AB_2675406, HPA036972: AB_2675407, HPA064559: AB_2685286" "unprognostic (1.64e-2)" "unprognostic (9.28e-3)" "unprognostic (1.54e-1)" "unprognostic (6.91e-4)" "unprognostic (1.04e-1)" "unprognostic (1.98e-2)" "unprognostic (3.99e-2)" "unprognostic (1.31e-2)" "unprognostic (5.22e-2)" "unprognostic (8.65e-2)" "unprognostic (2.02e-2)" "unprognostic (1.49e-2)" "unprognostic (3.19e-4)" "unprognostic (4.03e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "unprognostic (1.15e-3)" 3.7 2.3 3.5 3.4 3.8 0.8 3.2 1.9 9.3 4.5 0.0 1.6 1.8 2.9 3.9 3.3 4.5 2.7 4.1 7.6 1.8 2.1 1.4 9.6 5.4 6.9 1.7 2.6 4.8 2.3 0.9 5.1 6.7 2.5 2.1 3.4 3.6 3.5 2.2 11.6 1.5 3.7 0.2 3.5 1.2 1.5 4.3 1.8 2.6 4.1 4.0 2.9 3.4 3.9 2.8 2.9 1.5 0.7 1.7 1.6 2.1 2.9 5.3 2.2 2.5 6.8 5.2 0.6 2.2 2.5 2.1 9.4 0.0 0.8 2.9 1.4 3.2 1.7 2.8 4.5 4.4 3.0 2.1 3.2 0.9 1.4 4.2 2.7 1.2 2.2 0.7 1.7 1.0 4.6 1.5 4.7 1.2 0.5 1.2 1.9 0.0 1.9 3.3 1.3 0.9 1.4 2.4 14.6 1.3 1.4 4.3 1.3 3.8 0.8 3.3 2.0 2.1 2.6 2.9 2.3 1.8 1.9 0.6 0.0 0.6 0.3 0.7 1.4 0.6 0.4 0.6 0.3 0.6 0.2 0.4 0.5 0.0 0.5 1.1 0.4 0.1 0.3 3.5 3.8 1.9 9.3 7.6 1.8 6.9 1.7 6.7 0.2 4.3 3.9 8.0 54.5 49.5 0.7 0.3 6.1 2.2 2.0 0.6 2.2 2.8 1.5 3.6 0.0 3.0 1.8 2.1 1.1 0.6 0.9 1.9 2.0 0.4 0.8 1.2 20.4 1.2 2.7 0.7 5.8 1.4 2.7 0.0 1.0 2.5 1.1 26.4 1.5 0.1 0.0 0.8 1.6 0.0 2.2 3.5 0.6 3.7 0.6 3.6 1.9 0.5 0.6 1.0 1.0 1.1 4.5 0.9 3.8 0.4 5.6 1.1 2.5 1.5 1.8 6.6 3.6 2.7 1.3 1.4 0.5 5.5 1.2 0.8 0.4 1.4 2.4 TAF2 "CIF150, TAF2B, TAFII150" ENSG00000064313 "TATA-box binding protein associated factor 2" Q6P1X5 8 119730774-119832841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "unprognostic (1.69e-2)" "unprognostic (9.33e-3)" "unprognostic (3.79e-2)" "prognostic unfavorable (2.45e-4)" "unprognostic (8.12e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.44e-2)" "unprognostic (1.52e-1)" "unprognostic (1.33e-3)" "unprognostic (1.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.16e-2)" "unprognostic (1.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.16e-2)" "unprognostic (2.47e-2)" 9.2 10.9 4.2 11.2 5.6 14.6 10.6 12.2 6.4 10.3 6.4 9.1 8.8 12.6 11.0 9.5 8.6 9.8 7.1 4.4 6.2 10.6 12.1 7.9 14.2 4.9 4.8 11.2 8.2 11.7 6.5 13.1 5.4 9.4 10.4 10.0 7.7 9.7 7.0 10.8 8.6 11.3 5.0 11.3 9.9 13.7 4.9 15.8 10.6 8.5 14.8 12.5 8.4 7.2 41.3 24.0 27.1 25.1 22.3 24.1 16.9 31.9 26.3 34.7 43.6 15.3 22.9 46.4 27.5 29.1 19.5 26.2 42.1 19.3 49.3 53.2 25.4 58.0 21.7 17.1 35.3 27.9 33.8 22.6 16.9 34.3 39.9 19.0 34.6 24.0 44.4 25.3 32.8 23.2 52.9 12.0 20.4 29.6 27.2 30.6 22.4 25.2 20.7 29.7 35.9 21.1 28.5 88.3 22.6 23.5 26.3 20.7 27.0 23.6 39.1 22.7 46.3 43.2 55.3 57.5 29.0 36.5 22.8 12.5 4.2 7.4 6.0 5.5 5.4 4.7 6.2 6.2 5.5 4.1 5.6 5.8 2.6 6.5 8.1 3.3 7.8 4.4 4.2 5.6 12.2 6.4 4.4 6.2 4.9 4.8 5.4 5.0 4.9 7.2 19.6 12.8 18.8 41.4 23.5 18.7 18.7 14.2 23.3 15.8 15.8 11.7 12.3 11.5 16.7 22.0 20.9 18.1 18.0 10.2 3.9 10.1 2.6 16.7 27.9 19.0 9.6 15.8 56.0 10.7 12.8 18.5 21.4 26.4 21.5 18.2 13.2 17.9 12.5 8.4 52.7 12.8 10.2 14.7 12.9 3.9 15.5 15.8 8.8 37.5 11.7 7.7 21.6 53.3 59.0 11.5 9.8 18.0 23.6 18.2 9.0 15.7 22.3 14.9 13.1 21.3 17.4 34.8 35.5 27.8 20.6 21.1 21.0 17.8 12.0 19.7 TBATA "C10orf27, FLJ32820, spatial" ENSG00000166220 "Thymus, brain and testes associated" Q96M53 10 70771239-70785401 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "lymphoid tissue: 376.5" "Group enriched" "Detected in some" 20 "Early spermatids: 119.6;Late spermatids: 291.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 29 "SK-BR-3: 4.0" "Region enhanced" "Detected in many" "cerebellum: 21.0" "Low region specificity" "Detected in all" NA NA "Cluster 63: T-cells - Adaptive immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.54e-1)" "unprognostic (2.97e-1)" "unprognostic (1.93e-2)" "unprognostic (2.14e-1)" "unprognostic (6.24e-2)" "unprognostic (1.45e-1)" "unprognostic (4.88e-1)" "unprognostic (1.09e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 20.9 0.1 376.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 119.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 291.3 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D31 "Gm85, MGC21654, WDR67" ENSG00000156787 "TBC1 domain family member 31" Q96DN5 8 123041968-123152153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 20.6" "Cell type enhanced" "Detected in many" "Astrocytes: 19.9;Excitatory neurons: 23.4;Inhibitory neurons: 32.0;NK-cells: 24.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 83.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023710 Approved Approved Centrosome NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Centrosome "HPA023710: AB_1858819" "unprognostic (1.39e-1)" "unprognostic (5.44e-3)" "unprognostic (7.21e-2)" "unprognostic (3.18e-5)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (2.91e-4)" "unprognostic (1.53e-2)" "unprognostic (6.59e-2)" "unprognostic (8.88e-2)" "unprognostic (1.13e-1)" "unprognostic (1.18e-4)" "unprognostic (1.78e-3)" "unprognostic (1.57e-1)" "unprognostic (1.76e-2)" "unprognostic (2.33e-1)" 3.9 2.5 5.8 6.0 7.8 7.4 2.0 20.6 6.6 1.7 5.2 4.2 5.4 2.4 1.4 2.5 4.2 2.2 2.7 7.3 4.1 2.8 3.1 2.5 7.2 4.3 5.5 1.7 3.8 2.9 3.5 1.9 5.1 2.3 3.5 4.9 2.4 1.7 4.4 2.9 4.8 2.7 4.4 5.8 3.4 5.1 6.0 14.4 3.1 2.5 6.1 2.2 1.7 7.3 30.6 19.5 15.4 12.9 5.1 5.5 10.9 17.5 6.4 14.0 12.7 17.9 11.4 11.2 21.5 4.7 9.5 21.1 14.3 7.2 19.7 31.3 31.6 28.8 13.5 8.3 7.7 11.9 20.3 4.4 4.2 11.6 11.9 4.1 10.2 31.0 24.0 23.1 10.2 50.5 37.2 8.1 12.8 26.5 29.8 21.2 14.5 16.8 9.4 11.1 16.8 14.7 31.5 83.2 9.7 9.8 15.8 9.2 8.8 12.8 31.9 11.9 22.1 34.5 58.1 15.1 13.2 20.1 19.0 9.1 10.0 10.6 17.4 12.6 26.6 9.2 10.6 14.3 8.8 8.4 10.8 12.3 5.8 20.5 11.2 7.9 11.6 15.6 5.8 7.8 20.6 6.6 7.3 4.1 4.3 5.5 5.1 4.4 6.0 7.3 2.7 0.0 3.4 19.9 3.7 0.5 1.0 2.4 1.2 2.7 1.0 1.3 14.0 0.0 1.4 1.8 6.2 1.6 10.4 2.4 0.0 1.8 4.9 3.4 3.2 2.4 3.0 12.8 23.4 1.1 2.6 2.6 2.6 1.2 7.6 4.2 1.1 1.8 3.9 0.0 32.0 2.0 0.0 6.6 1.9 2.9 1.5 3.8 1.8 14.0 4.6 1.3 24.7 11.1 13.4 1.0 0.6 1.5 5.8 0.7 1.2 2.2 3.7 5.9 0.0 2.4 2.3 10.9 2.7 4.1 1.3 0.1 12.5 2.5 3.5 0.6 TBL2 "DKFZP43N024, WBSCR13, WS-betaTRP" ENSG00000106638 "Transducin beta like 2" Q9Y4P3 7 73567537-73578791 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.2" "Group enriched" "Detected in all" 7 "Early spermatids: 398.2;Late spermatids: 515.4;Spermatocytes: 345.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007477, HPA051533" Supported Cytosol "Secreted in male reproductive system" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA007477: AB_1080214, HPA051533: AB_2681523" "unprognostic (9.04e-2)" "unprognostic (6.61e-3)" "unprognostic (4.24e-2)" "unprognostic (1.10e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.24e-3)" "unprognostic (7.50e-2)" "unprognostic (2.87e-1)" "unprognostic (1.90e-1)" "unprognostic (1.74e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (1.59e-1)" "unprognostic (3.14e-1)" "unprognostic (1.42e-2)" "unprognostic (1.31e-1)" 4.9 9.1 1.7 5.3 1.8 1.6 4.2 2.8 5.4 4.6 2.7 4.7 5.4 4.5 8.3 5.4 4.3 2.7 4.0 1.9 1.7 4.2 5.9 5.5 1.9 1.7 1.6 4.8 16.4 5.6 3.2 4.4 1.8 4.4 5.5 4.0 11.0 4.3 2.9 4.9 4.3 4.6 1.6 3.1 6.4 44.2 1.7 2.3 4.9 1.5 3.2 3.6 4.5 1.8 22.1 27.5 8.7 12.6 19.9 18.2 10.2 26.9 18.4 9.3 17.1 40.9 22.0 18.4 5.4 21.7 19.5 15.9 18.2 9.5 19.4 6.8 10.8 6.6 11.8 26.3 28.5 13.3 22.4 11.4 15.0 28.7 22.1 16.7 10.2 2.4 26.0 12.6 14.7 20.2 13.2 10.7 8.7 23.8 18.1 8.6 14.6 38.8 10.5 16.0 8.4 14.3 25.8 65.8 16.9 10.1 17.2 5.7 18.7 17.1 8.8 17.1 25.7 25.8 18.0 20.0 23.3 15.3 21.3 16.8 11.1 4.9 6.3 7.3 5.9 3.0 5.0 5.2 13.6 4.1 5.9 3.7 1.4 8.8 7.4 10.2 6.5 8.1 1.7 1.8 2.8 5.4 1.9 1.7 1.7 1.6 1.8 1.6 1.7 1.8 8.6 25.6 9.3 3.3 8.1 4.6 14.5 17.3 4.0 10.8 10.8 6.3 4.7 11.5 13.5 5.5 8.4 45.2 6.5 12.7 1.9 26.1 398.2 11.3 14.9 12.6 9.5 6.3 4.1 30.1 54.6 17.3 7.7 11.6 14.0 13.9 10.0 14.7 27.4 3.3 4.5 16.8 6.1 9.4 3.8 515.4 23.6 17.5 7.2 4.7 17.3 8.1 10.3 4.5 4.1 22.6 13.7 26.7 19.9 17.1 14.6 5.1 9.8 13.4 6.6 13.8 15.1 345.8 27.9 7.8 3.7 43.4 5.0 17.0 15.8 9.0 TBX10 "TBX13, TBX7" ENSG00000167800 "T-box transcription factor 10" O75333 11 67631303-67639560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "intestine: 9.7" "Cell type enhanced" "Detected in some" "Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7" "Cancer enhanced" "Detected in some" "colorectal cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5" "Low region specificity" "Detected in single" "HPA047881, HPA076197" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA047881: AB_2680199, HPA076197: " "unprognostic (4.66e-2)" "unprognostic (2.96e-2)" "unprognostic (7.71e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-1)" "unprognostic (1.83e-4)" "unprognostic (3.12e-1)" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (1.83e-1)" "unprognostic (4.90e-1)" "unprognostic (1.17e-10)" "unprognostic (6.77e-2)" "unprognostic (1.68e-1)" "unprognostic (2.95e-1)" "unprognostic (2.75e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 8.4 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 8.0 0.0 0.4 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.1 0.0 12.5 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.9 0.0 0.0 0.0 103.8 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 20.4 0.0 0.0 0.2 42.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.1 TCAP "CMD1N, LGMD2G, T-cap, TELE, telethonin" ENSG00000173991 Titin-cap O15273 17 39665349-39666554 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 47 "heart muscle: 5162.1;skeletal muscle: 15829.0;tongue: 5831.4" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 2473.2" "Group enriched" "Detected in many" 8 "head and neck cancer: 20.2;prostate cancer: 11.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 5.3;SK-BR-3: 8.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.8" "Low region specificity" "Detected in some" "CAB004591, HPA026477" Enhanced NA NA 36000 "Cluster 32: T-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB004591: AB_628340, HPA026477: AB_1857888" "unprognostic (5.29e-2)" "unprognostic (9.29e-2)" "unprognostic (2.40e-3)" "unprognostic (4.32e-3)" "unprognostic (8.79e-2)" "unprognostic (3.68e-2)" "unprognostic (1.61e-1)" "unprognostic (3.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.12e-2)" "unprognostic (1.12e-4)" "unprognostic (2.62e-1)" "unprognostic (4.51e-2)" "unprognostic (8.59e-2)" "unprognostic (1.13e-1)" "unprognostic (2.78e-1)" "prognostic favorable (4.55e-4)" 4.1 4.2 13.0 0.8 16.2 2.9 5.7 13.7 16.1 3.0 11.4 3.2 0.7 2.2 0.0 188.9 2.5 1.8 5162.1 12.1 13.0 3.1 3.4 8.4 3.3 13.2 14.3 3.5 2.7 0.9 5.3 0.9 13.2 107.1 0.1 1.1 137.6 1.6 15829.0 5.5 2.5 0.8 12.2 3.2 2.6 3.5 14.1 1.0 5.0 5831.4 0.9 1.7 3.0 13.0 0.1 2.5 1.7 2.2 0.2 0.3 0.6 0.4 0.2 0.4 0.5 0.9 1.5 1.0 1.6 0.3 1.7 0.9 0.3 0.0 0.0 0.9 2.6 0.7 2.0 0.4 0.1 0.6 0.3 0.7 0.3 1.0 0.1 1.0 0.2 1.1 1.6 0.3 0.0 1.1 0.7 5.3 1.0 0.9 0.6 0.7 1.5 0.7 0.8 0.2 1.0 1.7 1.3 8.4 1.1 0.9 0.6 1.1 1.1 0.8 1.0 1.4 0.5 3.7 2.0 0.5 0.6 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 13.0 16.2 13.7 16.1 12.1 13.0 13.2 14.3 13.2 12.2 14.1 13.0 3.3 0.0 0.0 8.1 0.7 1.7 0.5 0.3 0.0 1.5 1.5 0.9 2473.2 5.7 0.3 1.8 0.0 0.1 0.3 0.4 1.9 0.3 0.4 0.9 0.5 29.0 3.0 1.3 2.2 0.0 0.0 68.5 1.5 0.6 0.0 0.8 2.2 0.0 0.4 10.1 2.7 1.1 0.0 0.6 2.0 0.1 0.3 2.9 1.8 1.0 0.1 0.8 0.0 1.0 2.6 0.5 0.6 0.4 0.9 0.7 0.5 0.3 0.6 1.7 6.6 336.9 25.4 1.0 1.2 0.0 2.0 0.4 1.9 0.5 1.2 0.7 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084141-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "SK-BR-3: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 8: SK-BR-3 - Unknown function" "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TDRD1 CT41.1 ENSG00000095627 "Tudor domain containing 1" Q9BXT4 10 114179270-114232304 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 17.5" "Cell type enhanced" "Detected in some" "Early spermatids: 7.1;Late spermatids: 5.3;Spermatocytes: 25.6;Spermatogonia: 25.5" "Cancer enriched" "Detected in some" 5 "prostate cancer: 4.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 51.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA037729 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 83: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA037729: AB_10670527" "unprognostic (6.77e-2)" "unprognostic (2.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.68e-1)" "unprognostic (1.10e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (3.15e-2)" "unprognostic (6.13e-2)" "unprognostic (1.55e-1)" "unprognostic (1.82e-1)" "unprognostic (1.51e-2)" "unprognostic (9.60e-2)" "unprognostic (3.98e-2)" "unprognostic (4.75e-1)" "unprognostic (1.68e-1)" 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.1 0.6 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.1 0.6 0.1 0.2 2.0 0.2 0.0 0.2 0.3 0.3 0.4 0.5 0.0 0.0 0.0 0.2 0.6 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 17.5 0.3 0.2 0.1 0.5 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 51.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 0.3 0.1 0.6 0.1 0.2 0.3 0.3 0.2 0.1 0.3 0.4 0.6 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 1.1 0.9 3.5 2.8 0.0 0.0 0.0 0.3 2.7 0.3 0.0 0.2 7.1 0.4 0.5 0.2 0.0 0.0 0.5 0.6 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.0 0.0 0.3 5.3 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.7 0.0 0.0 0.0 1.2 2.7 0.0 0.0 0.5 0.5 25.6 25.5 0.0 0.0 0.1 0.1 0.7 0.1 0.0 TEN1 "C17orf106, FLJ39785" ENSG00000257949 "TEN1 subunit of CST complex" Q86WV5 17 75979240-76000586 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 55.1;Exocrine glandular cells: 88.9;Pancreatic endocrine cells: 89.1;Proximal tubular cells: 89.0;Suprabasal keratinocytes: 52.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA065069 Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA065069: AB_2685418" "unprognostic (1.61e-1)" "unprognostic (1.16e-1)" "unprognostic (3.34e-2)" "unprognostic (1.07e-1)" "unprognostic (3.02e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-3)" "unprognostic (2.95e-1)" "unprognostic (2.85e-2)" "unprognostic (9.03e-2)" "unprognostic (8.61e-3)" "unprognostic (3.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.94e-1)" "unprognostic (2.85e-4)" 21.0 27.7 10.1 14.8 10.4 32.2 21.9 10.4 12.7 19.4 11.8 18.9 22.7 16.8 11.8 43.4 15.2 15.9 16.7 10.0 10.8 27.4 49.5 20.7 18.7 10.8 11.4 16.1 32.8 12.8 22.3 11.5 11.7 28.1 9.5 3.4 27.8 10.2 12.1 46.3 25.7 7.8 10.5 23.3 26.9 13.3 11.0 6.7 20.1 7.8 12.9 16.2 25.0 11.5 19.2 15.1 12.1 16.6 16.5 21.6 32.7 12.3 18.4 21.5 21.9 18.6 32.3 25.0 20.4 15.0 22.4 18.1 7.7 18.6 6.3 13.8 24.8 28.7 21.3 21.0 19.8 18.6 45.7 19.4 25.8 11.8 12.3 18.0 29.0 14.6 12.4 24.2 12.8 31.8 23.9 40.3 11.8 19.4 25.6 21.7 12.0 22.7 27.5 33.5 23.8 40.1 9.6 83.5 16.3 9.3 43.4 28.8 15.9 41.7 24.0 17.8 28.3 25.3 10.1 14.2 22.4 13.2 13.3 81.8 53.7 33.4 40.0 52.5 33.3 60.8 31.6 34.0 48.5 49.2 23.7 28.4 32.7 45.3 29.2 52.8 37.9 36.3 10.1 10.4 10.4 12.7 10.0 10.8 10.8 11.4 11.7 10.5 11.0 11.5 14.0 0.0 4.2 0.0 13.0 39.0 0.0 55.1 5.2 0.0 39.2 32.8 0.0 0.0 23.4 5.5 0.0 0.0 21.7 0.1 39.2 39.5 0.0 12.4 13.0 10.2 0.0 0.8 0.0 88.9 0.1 8.8 2.6 19.0 2.5 16.9 0.0 0.0 0.1 0.0 0.0 0.2 34.6 0.0 39.9 0.0 0.0 19.7 30.2 0.0 37.2 0.0 0.0 0.0 0.0 89.1 0.0 0.0 7.9 0.0 0.0 89.0 8.7 0.0 0.0 0.1 12.9 0.0 0.0 6.1 52.7 0.0 9.4 24.4 0.0 0.1 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629306-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.1;skin 1: 53.3" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 132.4;Basal squamous epithelial cells: 120.1;Breast glandular cells: 66.1;Breast myoepithelial cells: 79.6;Cytotrophoblasts: 91.7;Extravillous trophoblasts: 59.7;Squamous epithelial cells: 81.0;Suprabasal keratinocytes: 149.3;Syncytiotrophoblasts: 105.6" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 190.6;MCF7: 169.2;SK-BR-3: 308.9;T-47d: 86.8;WM-115: 114.7" "Region enriched" "Detected in single" 13 "olfactory bulb: 2.4" "Region enhanced" "Detected in single" "olfactory bulb: 1.4" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.8 0.3 1.3 0.2 0.6 0.1 26.1 0.5 1.5 18.3 0.5 4.0 0.2 6.2 5.2 29.1 2.6 1.0 0.3 1.7 0.7 2.0 0.0 2.6 0.1 0.9 0.8 0.3 1.0 2.6 0.8 17.0 1.2 7.1 1.2 2.7 20.7 4.4 2.1 53.3 0.3 1.1 0.5 0.1 0.7 1.0 0.6 0.7 2.3 0.1 3.0 3.9 19.2 1.0 12.8 15.8 0.1 0.2 0.0 0.0 190.6 20.1 36.4 25.0 4.5 3.2 0.3 0.0 1.3 13.3 13.3 42.7 27.3 5.5 17.0 0.1 2.8 0.0 1.7 0.0 0.0 0.0 1.7 0.3 21.4 7.4 7.2 0.0 0.0 8.1 0.2 3.2 0.0 169.2 20.8 1.2 9.5 9.9 20.7 0.1 0.0 7.0 0.0 10.1 5.1 0.1 13.6 308.9 21.8 28.3 86.8 4.6 0.2 16.2 0.4 8.6 15.4 0.1 0.0 0.1 4.0 0.1 114.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.5 1.5 1.7 0.7 0.9 0.8 1.2 0.5 0.6 1.0 0.7 0.0 9.5 3.9 0.3 132.4 29.9 2.4 120.1 4.1 66.1 79.6 1.0 0.0 5.6 9.2 0.0 91.7 1.5 1.7 0.0 0.3 0.3 7.8 18.7 2.0 3.0 0.0 0.0 0.0 59.7 7.4 1.5 16.0 0.0 0.0 0.7 0.0 7.8 0.0 0.0 1.7 10.2 0.3 8.2 0.0 0.0 1.6 21.4 3.7 0.0 0.3 0.0 0.0 0.0 1.0 0.6 0.0 3.8 18.6 0.0 0.0 5.2 0.0 0.0 0.5 2.1 0.0 1.8 81.0 149.3 105.6 1.3 0.0 1.0 18.5 TGFB3 "ARVD, ARVD1" ENSG00000119699 "Transforming growth factor beta 3" P10600 14 75958097-75983011 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Fibroblasts: 28.8;Late spermatids: 48.9;Leydig cells: 27.1;Sertoli cells: 32.9;Smooth muscle cells: 24.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "SK-BR-3: 104.6;T-47d: 75.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063582 Approved Vesicles "Secreted to blood" NA NA 44800 "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" Vesicles "HPA063582: AB_2685049" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (4.32e-3)" "unprognostic (1.29e-1)" "unprognostic (3.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (9.79e-2)" "unprognostic (2.83e-2)" "unprognostic (1.51e-2)" "unprognostic (5.63e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (4.01e-7)" "unprognostic (6.38e-3)" "unprognostic (1.10e-1)" "unprognostic (1.22e-2)" "unprognostic (3.27e-3)" 22.2 13.0 43.4 15.8 45.8 1.0 15.6 33.5 58.4 46.6 18.4 12.8 4.1 25.5 9.6 7.7 14.5 36.6 27.9 31.2 38.4 20.5 17.6 25.7 7.2 40.9 42.3 8.0 27.7 9.9 8.3 55.4 40.0 43.6 4.8 1.8 10.8 17.9 38.6 5.0 6.6 34.3 38.9 5.3 14.1 4.5 42.2 6.5 12.3 11.0 8.8 45.8 16.2 70.1 1.1 1.5 1.1 13.4 2.1 4.3 0.4 1.0 1.5 0.7 0.7 0.8 3.4 0.1 1.0 2.8 0.4 0.9 2.9 0.7 0.3 0.8 1.5 0.1 3.5 1.5 2.7 0.6 0.9 10.2 0.4 1.0 0.4 2.3 3.2 2.7 1.5 6.3 0.8 7.0 0.8 0.8 0.4 0.8 5.3 3.3 4.2 0.7 1.2 0.6 21.9 6.3 4.3 104.6 0.8 1.5 75.2 0.5 0.8 2.0 4.5 2.1 5.8 0.8 1.3 0.4 3.6 1.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.4 45.8 33.5 58.4 31.2 38.4 40.9 42.3 40.0 38.9 42.2 70.1 8.6 0.0 2.8 5.5 0.8 4.5 1.2 2.1 1.2 0.7 15.1 6.1 3.6 0.0 3.3 1.8 4.2 0.5 1.2 1.3 0.0 0.5 16.4 2.6 9.9 10.2 0.0 0.0 1.3 1.3 0.4 28.8 0.0 2.4 0.0 0.5 7.9 0.8 0.9 0.0 3.0 2.6 6.1 0.6 4.4 48.9 27.1 0.9 10.6 1.0 0.7 2.1 3.1 5.5 4.7 0.4 0.1 12.8 0.5 20.6 1.4 0.4 4.2 3.9 32.9 13.9 24.4 0.4 1.4 2.4 3.1 1.4 1.3 1.6 0.4 0.8 TLCD1 ENSG00000160606 "TLC domain containing 1" Q96CP7 17 28724348-28727935 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 36.4;Syncytiotrophoblasts: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "plasmacytoid DC: 21.7" "Lineage enriched" "Detected in many" 11 "dendritic cells: 21.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042366 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA042366: AB_10794419" "unprognostic (1.23e-1)" "unprognostic (3.78e-2)" "unprognostic (8.52e-2)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.28e-4)" "unprognostic (2.82e-1)" "unprognostic (1.04e-1)" "unprognostic (4.47e-3)" "unprognostic (9.96e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (9.05e-5)" "unprognostic (1.56e-1)" "unprognostic (7.56e-2)" "unprognostic (1.86e-2)" "unprognostic (3.93e-2)" 2.6 5.4 14.5 3.2 14.9 1.4 5.2 16.6 21.5 4.4 13.1 8.1 8.1 1.8 13.8 13.1 14.5 2.3 2.3 14.7 14.9 25.9 15.0 7.4 3.2 14.7 15.7 1.1 11.9 3.4 3.9 4.5 14.1 6.5 8.2 1.6 12.9 3.7 0.8 20.6 4.0 1.0 14.7 1.3 8.8 13.1 15.1 4.5 5.3 0.1 9.8 13.8 5.7 13.9 12.4 55.8 14.9 12.7 10.2 18.5 34.6 10.1 17.8 4.7 6.7 31.1 21.3 3.9 15.3 12.1 21.4 19.4 16.6 31.6 7.2 3.1 15.8 6.6 33.4 38.2 10.9 14.0 1.0 12.5 25.4 17.1 30.0 7.3 4.1 1.2 24.3 0.6 8.1 43.5 1.6 5.9 17.0 42.4 10.0 4.6 6.3 23.7 38.9 22.2 28.1 5.6 20.6 116.2 11.3 22.1 57.1 4.9 4.2 4.8 16.2 8.9 16.4 4.0 4.9 9.0 9.1 8.0 16.2 1.9 0.9 0.2 0.2 1.1 0.5 1.4 0.5 0.3 0.9 0.6 0.2 0.3 0.6 0.4 0.7 21.7 0.4 0.4 14.5 14.9 16.6 21.5 14.7 14.9 14.7 15.7 14.1 14.7 15.1 13.9 2.1 0.0 8.4 4.2 2.5 2.4 11.8 23.9 2.2 0.2 19.0 17.1 0.9 7.2 16.6 12.9 0.0 18.3 1.0 7.8 0.0 9.0 17.0 24.1 4.6 1.7 4.8 1.3 0.0 8.3 36.4 4.2 7.1 23.6 0.0 0.9 1.1 18.6 3.5 1.7 0.0 8.8 14.2 0.8 3.7 15.6 1.2 1.5 3.6 0.0 2.1 5.3 0.0 1.0 0.0 10.5 4.5 0.4 1.8 23.7 8.5 6.9 31.0 0.7 0.0 2.0 8.8 20.2 7.2 8.4 2.0 32.3 2.2 3.0 8.0 23.1 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA077642: AB_2686849" "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 79.7 88.6 28.0 75.3 34.3 61.5 81.4 34.0 29.7 67.3 47.6 90.5 59.5 61.0 68.6 62.6 65.8 70.1 70.8 27.1 35.6 94.0 109.6 76.7 74.5 38.5 32.1 56.7 103.5 104.7 40.1 74.2 39.1 72.8 70.2 39.7 89.3 73.7 46.7 52.2 69.8 58.5 34.7 74.4 93.3 85.1 31.0 63.1 97.9 61.5 56.0 80.0 42.9 41.5 49.1 62.4 39.7 72.8 131.4 122.7 41.9 74.4 129.1 56.7 45.8 32.8 78.7 45.6 86.3 105.2 42.6 78.9 20.1 65.7 36.6 74.5 27.3 87.7 30.0 38.6 66.6 106.9 109.2 86.9 92.8 27.7 31.1 79.0 87.2 51.8 65.9 160.3 94.3 79.5 41.1 37.5 47.4 76.1 63.3 21.5 26.5 50.8 126.8 80.3 20.1 47.6 84.5 154.5 102.3 34.2 146.3 146.7 106.0 69.1 25.9 50.5 44.8 82.7 48.5 32.2 94.8 103.7 84.1 420.7 372.7 371.6 136.0 381.4 137.9 205.9 139.7 139.4 256.2 196.6 157.9 139.1 662.3 135.3 434.3 171.7 159.8 483.9 28.0 34.3 34.0 29.7 27.1 35.6 38.5 32.1 39.1 34.7 31.0 41.5 232.8 150.6 147.2 34.0 131.3 0.0 64.1 0.0 84.2 47.8 202.2 152.1 37.0 0.0 66.2 244.6 45.9 137.0 128.2 191.4 103.7 213.8 330.6 116.2 96.4 114.5 74.7 32.0 15.8 338.1 116.9 140.7 85.1 105.8 179.0 72.7 0.0 0.0 210.7 45.4 25.2 172.4 0.0 0.0 0.0 143.8 104.4 193.2 0.0 62.8 205.5 114.1 123.6 42.7 77.0 202.9 176.9 91.0 126.8 87.9 128.9 214.5 99.1 65.9 59.2 67.8 75.7 391.0 40.8 112.5 0.0 130.8 99.3 142.7 182.2 62.8 TMC6 "EVER1, EVIN1, LAK-4P, TNRC6C-AS1" ENSG00000141524 "Transmembrane channel like 6" Q7Z403 17 78107397-78132407 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 110.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 108.7;SK-BR-3: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051430 Uncertain NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA051430: AB_2681483" "unprognostic (6.34e-2)" "unprognostic (5.14e-2)" "unprognostic (5.55e-2)" "unprognostic (2.81e-3)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" "unprognostic (5.36e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-1)" "unprognostic (9.94e-2)" "unprognostic (1.74e-1)" "unprognostic (6.61e-2)" "unprognostic (1.16e-2)" "prognostic favorable (1.82e-4)" "unprognostic (2.70e-2)" "unprognostic (1.10e-2)" "prognostic favorable (3.20e-4)" 29.5 6.8 19.2 45.4 50.5 72.7 25.2 43.4 33.5 11.3 5.2 23.5 21.7 7.6 1.0 25.4 14.1 9.7 35.9 19.3 26.4 20.6 9.1 40.3 69.7 59.3 49.7 3.8 14.6 3.1 5.6 8.8 55.9 20.2 6.6 0.6 29.3 7.9 3.5 17.9 50.6 3.5 35.8 110.5 14.6 2.6 48.4 26.3 12.9 1.8 32.4 14.6 18.4 81.9 17.9 14.0 7.5 6.0 0.0 0.0 15.2 0.0 0.0 0.2 0.2 25.2 19.2 19.7 23.7 0.0 6.3 31.0 1.0 5.9 0.0 2.0 11.3 41.3 4.2 31.0 1.9 38.3 67.0 1.1 16.2 0.0 1.3 0.2 14.7 9.2 108.7 73.3 0.0 36.1 18.9 65.4 5.9 32.9 4.9 8.4 0.6 58.9 11.4 65.1 1.9 4.9 5.7 121.0 33.2 9.7 68.7 57.6 5.2 0.0 8.7 0.1 0.3 57.6 27.3 13.2 0.0 60.4 1.0 17.7 11.6 23.2 56.2 38.3 49.0 28.5 41.7 46.2 18.6 21.7 36.5 39.6 15.3 35.8 63.5 5.7 38.0 33.5 19.2 50.5 43.4 33.5 19.3 26.4 59.3 49.7 55.9 35.8 48.4 81.9 43.8 41.7 29.6 8.1 69.5 11.1 21.0 22.3 7.4 3.2 17.4 6.5 14.7 10.0 41.5 16.5 0.0 1.2 79.8 25.0 0.0 41.2 0.3 5.1 1.6 19.7 9.1 28.4 0.2 23.1 26.4 4.6 10.2 8.0 40.5 0.7 23.6 2.2 67.0 1.7 0.2 14.0 40.7 66.2 29.9 1.2 9.6 44.7 14.2 20.6 62.0 7.5 85.5 1.5 50.8 40.5 53.7 1.2 62.6 31.5 20.3 2.0 20.3 1.8 13.1 4.6 13.5 0.5 2.2 8.4 10.2 3.7 83.7 2.5 30.3 37.4 TMEM125 MGC17299 ENSG00000179178 "Transmembrane protein 125" Q96AQ2 1 43269983-43274002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 75.7;pancreas: 89.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015796 Approved Midbody,Cytosol Yes NA "Cluster 40: NK-cells - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Midbody, Cytosol" "HPA015796: AB_1858081" "unprognostic (2.53e-3)" "unprognostic (8.70e-2)" "unprognostic (1.27e-1)" "unprognostic (1.52e-1)" "unprognostic (3.14e-2)" "unprognostic (8.50e-2)" "unprognostic (8.37e-3)" "prognostic favorable (5.11e-5)" "unprognostic (3.39e-1)" "unprognostic (1.11e-1)" "unprognostic (7.76e-2)" "unprognostic (1.26e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.86e-2)" "unprognostic (2.19e-1)" "unprognostic (4.04e-1)" "unprognostic (5.16e-2)" 0.3 0.7 17.4 3.2 32.2 0.2 11.5 27.6 29.9 16.4 12.8 21.2 35.4 1.6 18.3 10.9 15.5 11.3 0.9 17.0 20.7 16.4 1.1 75.7 0.3 31.5 28.5 1.4 89.6 22.2 31.0 4.4 29.0 22.0 21.0 0.1 31.8 7.1 0.0 12.9 27.5 0.8 22.6 0.3 27.4 1.5 26.8 0.4 44.9 0.0 2.5 2.9 3.4 42.8 26.8 0.0 0.0 0.0 0.0 0.0 21.8 0.0 0.0 0.0 0.0 20.6 48.3 0.1 1.2 0.0 0.0 11.7 0.0 7.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 12.1 0.1 0.1 1.1 31.3 0.0 0.0 0.0 0.7 0.4 8.5 12.4 0.1 0.0 41.2 0.0 3.6 33.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 17.4 32.2 27.6 29.9 17.0 20.7 31.5 28.5 29.0 22.6 26.8 42.8 0.2 121.8 136.9 0.0 0.9 0.0 2.3 18.0 0.6 0.0 30.4 15.2 0.5 42.9 56.0 16.5 0.0 33.5 0.1 72.7 17.6 39.1 3.7 20.1 1.4 0.6 21.7 0.0 0.2 38.5 2.2 0.6 45.3 13.1 1.3 4.9 0.0 0.0 2.4 0.0 0.2 63.0 34.6 0.0 0.2 7.9 0.3 0.6 0.0 0.0 0.6 1.7 1.0 0.0 55.3 22.7 40.1 1.2 0.6 12.2 164.2 33.9 43.8 0.0 0.0 0.0 2.3 1.4 0.3 2.1 0.4 7.3 1.0 0.1 38.6 9.1 TMEM127 "FLJ20507, FLJ22257" ENSG00000135956 "Transmembrane protein 127" O75204 2 96248514-96265997 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (5.15e-3)" "unprognostic (2.67e-1)" "unprognostic (1.72e-2)" "unprognostic (6.51e-2)" "unprognostic (5.82e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.59e-4)" "unprognostic (6.73e-2)" "unprognostic (4.25e-1)" "unprognostic (1.06e-2)" "unprognostic (7.50e-2)" "unprognostic (2.17e-1)" "prognostic favorable (6.69e-5)" "unprognostic (3.59e-1)" "unprognostic (1.52e-1)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" 29.3 34.6 25.9 28.5 24.6 53.0 25.6 20.1 30.6 30.7 15.7 34.4 32.6 30.0 21.4 40.0 25.2 32.3 67.8 26.7 23.6 29.5 35.4 31.6 21.4 24.5 26.3 31.9 28.5 73.1 29.4 26.8 24.5 26.1 30.5 27.6 39.7 42.4 25.9 33.0 34.7 35.1 21.1 34.7 27.8 10.2 29.7 19.1 26.2 30.6 25.4 38.6 27.8 21.9 28.8 38.0 19.9 30.7 86.0 43.3 36.7 36.9 65.9 38.6 35.2 37.9 40.0 17.9 52.8 73.3 67.8 45.1 23.1 34.2 26.8 36.1 17.8 31.2 17.6 37.5 55.4 26.7 54.0 52.7 48.0 48.0 35.3 51.4 44.5 12.1 19.5 37.6 39.8 32.8 17.6 16.8 27.3 33.9 40.4 16.4 25.0 26.9 42.9 48.7 22.3 23.4 27.1 63.8 31.3 40.2 23.6 28.2 52.5 63.9 36.2 55.9 25.8 28.2 29.6 14.1 42.6 30.9 34.7 3.9 6.3 8.2 2.8 6.6 3.0 1.8 2.1 3.0 4.3 1.9 1.6 2.2 14.3 1.5 5.3 2.5 1.6 3.2 25.9 24.6 20.1 30.6 26.7 23.6 24.5 26.3 24.5 21.1 29.7 21.9 24.8 19.2 15.3 7.2 13.4 17.2 16.6 14.5 12.0 22.1 20.0 12.8 39.6 22.8 20.2 27.6 27.1 11.4 19.3 88.2 15.6 29.7 5.2 16.4 15.1 23.1 16.3 9.0 12.9 34.8 13.1 16.7 14.8 28.8 13.9 13.6 29.6 35.7 37.7 21.9 15.7 26.7 12.2 59.8 33.2 5.8 13.7 34.0 16.0 5.6 41.9 7.8 15.5 8.0 6.6 41.0 35.1 17.0 13.0 23.1 43.9 13.3 15.7 16.9 6.6 18.5 19.4 9.1 2.9 12.6 23.3 24.2 14.3 15.9 18.6 34.1 TMEM165 "GDT1, TMPT27, TPARL" ENSG00000134851 "Transmembrane protein 165" Q9HC07 4 55395957-55453397 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 1021.6;Urothelial cells: 601.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038299, HPA062424" Supported Enhanced "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" "HPA038299: AB_10675793, HPA062424: AB_2732682" "unprognostic (2.53e-2)" "unprognostic (1.08e-3)" "unprognostic (3.46e-3)" "unprognostic (7.07e-3)" "unprognostic (5.97e-2)" "unprognostic (9.84e-2)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.41e-1)" "unprognostic (1.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.55e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.18e-8)" "unprognostic (9.05e-2)" "unprognostic (8.96e-2)" "unprognostic (2.72e-1)" "unprognostic (2.18e-2)" 53.4 61.3 39.2 42.6 75.1 11.3 35.2 62.0 70.8 45.9 36.0 32.4 32.0 34.0 31.1 55.8 31.6 46.0 37.3 40.8 51.1 41.6 19.3 52.7 32.6 84.8 72.0 22.3 40.1 32.3 24.0 60.5 78.9 37.8 33.3 15.0 40.4 30.6 17.1 26.2 27.9 40.0 54.5 37.0 39.2 13.7 65.8 24.0 37.8 17.2 42.5 78.8 42.7 117.4 74.6 30.4 47.1 50.2 143.5 105.4 50.0 138.6 212.7 98.0 106.7 34.2 108.3 76.9 98.3 85.9 56.2 53.8 50.0 56.8 98.9 43.8 46.4 66.0 50.1 66.6 89.1 92.1 75.1 109.1 72.7 55.9 37.3 82.4 113.2 25.6 112.8 47.8 116.5 54.5 73.0 76.5 51.7 97.8 70.6 52.0 35.5 42.1 148.6 70.2 48.3 64.7 69.8 261.0 85.8 46.3 41.2 65.3 98.3 83.1 49.6 37.0 102.5 44.4 38.5 48.3 98.9 77.2 67.9 23.7 40.4 26.0 15.2 35.7 17.0 19.0 14.3 17.8 36.5 11.5 12.1 14.4 28.6 18.1 35.9 28.4 18.3 30.2 39.2 75.1 62.0 70.8 40.8 51.1 84.8 72.0 78.9 54.5 65.8 117.4 119.6 54.5 52.4 42.7 87.9 245.1 277.8 295.0 147.4 50.6 85.8 42.7 32.2 71.4 214.9 79.1 81.3 112.5 97.7 42.4 17.6 171.1 32.1 123.6 99.1 108.0 50.4 79.1 58.2 163.5 157.2 110.4 76.0 173.8 21.0 57.6 113.8 18.4 105.7 28.6 71.5 69.4 77.3 97.9 145.7 24.7 58.7 109.5 88.9 59.0 117.5 53.2 123.6 71.4 1021.6 248.0 48.6 63.6 117.1 239.3 51.3 50.0 125.2 91.9 98.6 92.2 129.0 37.8 24.6 169.4 268.8 80.6 81.6 90.6 61.6 601.6 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 94.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 65.9;Intestinal goblet cells: 40.4;Paneth cells: 41.7;Proximal enterocytes: 60.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "cerebral cortex: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 34.2;RT4: 37.9;SCLC-21H: 40.8;SK-BR-3: 58.4;T-47d: 53.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.3 0.1 1.4 0.1 0.7 3.0 0.1 1.0 20.6 0.2 12.1 24.4 1.1 0.3 94.6 7.0 3.6 0.4 0.0 0.2 6.2 24.4 2.2 0.2 0.2 0.0 0.2 22.9 5.2 11.4 1.7 0.1 11.3 6.6 0.1 22.5 4.5 4.9 37.0 23.6 0.3 0.0 0.1 12.6 3.7 0.2 0.6 0.6 0.6 4.3 12.8 41.0 0.1 23.7 15.0 0.1 0.0 0.0 0.1 5.0 0.8 0.3 0.9 0.1 20.9 25.4 0.5 7.6 0.3 7.5 17.0 0.0 9.7 0.3 0.2 0.9 0.1 15.3 9.7 0.2 0.0 0.0 0.0 8.9 0.3 8.0 0.4 0.1 6.3 0.2 0.1 0.0 34.2 0.2 0.1 0.7 13.5 19.3 0.5 0.0 10.9 7.3 37.9 40.8 0.1 6.4 58.4 0.1 0.5 53.7 0.1 0.0 0.0 8.2 9.7 1.1 0.1 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.1 2.9 3.2 4.4 0.0 1.6 4.0 5.8 7.2 2.2 1.1 12.1 5.5 7.5 11.5 18.2 9.2 0.0 7.1 1.4 65.9 1.9 13.2 0.0 19.3 3.4 1.4 7.2 0.0 0.3 11.0 8.7 1.7 23.4 31.7 1.3 0.5 0.0 14.2 0.8 0.0 0.1 40.4 14.2 0.6 2.6 0.0 0.0 1.4 0.0 0.0 0.6 0.5 0.0 0.0 0.0 13.1 41.7 0.0 4.6 10.4 60.5 5.1 28.0 0.6 0.0 1.8 3.0 0.0 0.1 15.4 9.2 16.8 1.2 0.1 19.4 16.0 TMEM199 "C17orf32, MGC45714, VMA12, VPH2" ENSG00000244045 "Transmembrane protein 199" Q8N511 17 28357642-28363683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027051 Uncertain NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" "HPA027051: AB_10600915" "unprognostic (3.01e-1)" "unprognostic (3.45e-2)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.55e-4)" "unprognostic (9.98e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.67e-2)" "unprognostic (5.26e-2)" "unprognostic (1.78e-1)" "unprognostic (6.38e-3)" "unprognostic (1.09e-1)" "unprognostic (9.25e-2)" "unprognostic (2.75e-1)" "unprognostic (1.99e-1)" "unprognostic (3.51e-3)" "unprognostic (5.95e-2)" 8.3 11.9 9.2 10.3 10.4 13.3 8.6 10.1 13.0 9.1 9.6 9.0 7.4 9.5 9.6 10.6 8.0 6.2 9.3 9.5 10.5 12.9 14.4 8.5 12.7 10.2 10.1 8.0 8.9 15.5 11.7 9.5 10.1 9.8 7.9 13.9 9.5 6.8 7.2 11.6 9.0 6.2 9.5 13.2 8.9 7.8 10.4 12.8 10.8 7.5 11.2 8.8 8.8 12.0 12.2 20.4 19.6 16.7 7.9 6.8 16.5 14.8 9.5 20.6 18.5 48.9 9.6 17.6 14.8 11.0 26.4 20.6 21.8 13.9 18.0 32.8 19.6 13.0 17.7 23.6 15.9 18.7 22.0 9.7 12.6 19.6 13.0 12.2 10.2 16.1 21.6 21.8 15.4 24.1 21.3 25.6 16.2 21.0 13.9 17.2 24.4 16.3 15.5 20.2 24.8 26.0 17.8 45.6 27.1 20.1 28.7 16.9 14.0 17.4 13.5 15.0 25.3 29.3 38.9 16.2 21.6 11.4 22.2 28.5 24.2 20.0 15.1 25.2 16.6 17.1 13.1 13.4 20.0 16.0 16.4 14.5 18.9 15.6 23.0 14.0 14.9 19.1 9.2 10.4 10.1 13.0 9.5 10.5 10.2 10.1 10.1 9.5 10.4 12.0 12.4 32.1 8.6 8.8 21.0 5.7 10.5 34.3 15.4 13.8 14.3 14.4 5.6 12.8 23.5 9.2 8.4 40.2 15.5 21.1 43.0 40.2 3.7 12.0 11.4 14.6 15.6 12.2 11.0 31.4 38.1 10.6 7.7 10.9 7.6 11.9 17.5 26.8 51.3 11.8 10.5 15.7 32.6 22.9 9.5 4.5 11.5 22.4 21.4 6.5 45.0 19.1 25.7 7.5 13.7 35.4 19.4 6.4 15.1 13.1 20.3 54.0 15.1 14.0 13.1 8.6 14.2 26.5 35.4 14.0 8.8 48.4 15.2 14.7 13.0 11.4 TMEM25 FLJ14399 ENSG00000149582 "Transmembrane protein 25" Q86YD3 11 118531041-118547280 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 149.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA012163, HPA051562" Approved Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 6900000 "Cluster 48: NK-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus, Vesicles" "HPA012163: AB_1858112, HPA051562: AB_2681535" "unprognostic (1.53e-2)" "unprognostic (7.18e-2)" "unprognostic (2.43e-1)" "unprognostic (6.69e-2)" "unprognostic (3.61e-1)" "unprognostic (6.50e-2)" "unprognostic (1.71e-1)" "unprognostic (4.45e-3)" "unprognostic (1.58e-1)" "unprognostic (3.42e-1)" "unprognostic (1.66e-2)" "unprognostic (8.19e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.15e-1)" "unprognostic (2.51e-1)" "unprognostic (1.26e-1)" "unprognostic (7.01e-2)" 6.9 25.3 35.0 3.8 36.0 2.2 14.6 33.9 44.3 14.9 32.2 16.0 46.0 15.3 25.7 11.1 13.7 8.9 8.9 37.5 36.7 18.6 23.1 9.9 4.8 32.1 30.3 23.4 17.6 23.3 29.5 6.0 32.0 15.7 3.7 22.3 21.0 18.3 18.5 8.7 35.2 10.8 31.5 5.3 13.3 6.5 35.1 5.1 15.9 9.9 5.3 14.4 11.6 35.1 3.4 0.7 5.8 9.5 6.0 0.9 5.6 5.2 9.9 4.9 9.8 27.1 18.8 0.3 20.1 5.3 10.9 14.8 0.0 18.3 4.4 11.9 11.1 0.5 5.4 6.0 16.0 0.3 0.5 7.3 10.9 5.3 0.9 35.9 7.2 13.7 2.6 11.7 4.9 4.1 6.0 0.5 4.9 0.1 12.8 8.1 4.2 12.3 25.3 0.3 17.0 11.5 5.1 33.7 0.1 8.7 43.8 0.6 2.5 2.1 10.6 0.4 1.6 11.7 8.3 3.1 0.4 0.2 0.2 0.7 0.2 0.2 5.1 0.2 7.1 4.0 7.3 2.9 0.5 2.6 10.0 5.4 0.4 7.4 0.2 3.4 6.0 3.5 35.0 36.0 33.9 44.3 37.5 36.7 32.1 30.3 32.0 31.5 35.1 35.1 5.1 6.4 3.9 11.1 6.2 5.7 10.7 14.7 13.1 27.7 27.7 30.6 6.1 14.3 9.3 16.5 29.2 37.1 4.8 0.9 11.7 16.6 2.8 4.1 5.0 6.4 11.4 5.2 20.1 6.4 16.9 8.7 2.6 5.5 8.9 18.0 3.6 9.6 2.9 11.8 22.0 7.8 10.2 0.0 1.9 5.5 23.3 1.1 7.2 2.8 3.4 28.8 5.2 8.5 6.5 5.0 5.5 23.3 5.5 5.5 149.1 25.6 7.4 41.1 0.0 12.1 7.5 3.9 5.2 4.0 3.7 16.3 4.7 15.3 15.0 5.7 TMEM63A KIAA0792 ENSG00000196187 "Transmembrane protein 63A" O94886 1 225845536-225882380 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 365.5;salivary gland: 121.1" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 323.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 112.2;SK-BR-3: 119.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066504, HPA066936, HPA068918" Enhanced "Vesicles,Centriolar satellite" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Centriolar satellite" "HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057" "unprognostic (5.31e-2)" "unprognostic (3.46e-2)" "unprognostic (2.14e-2)" "prognostic favorable (8.79e-4)" "unprognostic (2.05e-1)" "unprognostic (7.16e-3)" "unprognostic (2.52e-2)" "unprognostic (1.76e-2)" "unprognostic (2.57e-1)" "unprognostic (1.27e-1)" "unprognostic (6.55e-2)" "unprognostic (1.59e-1)" "unprognostic (1.19e-1)" "unprognostic (3.14e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.92e-2)" 24.5 17.9 58.1 27.0 167.3 42.7 29.1 132.2 120.4 35.9 24.6 33.8 26.3 25.7 22.7 15.2 28.2 27.3 20.9 71.6 94.9 33.3 40.2 31.2 35.6 199.1 127.1 28.4 56.7 17.8 11.8 24.2 191.7 57.6 37.0 3.6 121.1 37.3 16.5 21.5 34.5 18.1 95.7 31.6 47.7 5.3 135.3 27.8 19.0 13.7 27.0 26.4 23.2 365.5 27.6 8.3 7.0 20.2 54.1 18.7 47.7 20.6 22.2 22.5 22.6 29.7 20.0 7.7 37.1 25.2 13.3 41.4 7.5 12.5 10.3 25.8 13.4 33.4 21.0 18.0 12.6 12.5 84.1 19.5 7.8 13.5 8.1 31.1 14.8 17.0 28.2 6.3 18.0 17.4 11.2 12.7 37.8 87.5 13.2 11.1 21.3 112.2 34.1 71.8 0.6 3.7 15.2 119.3 14.5 16.0 27.7 11.9 17.8 12.9 8.9 12.1 18.9 2.5 10.4 2.0 11.9 7.0 24.3 6.3 3.9 3.6 10.3 3.1 11.4 5.8 13.1 9.8 2.9 5.5 11.4 6.9 5.5 10.2 5.3 11.5 19.8 6.9 58.1 167.3 132.2 120.4 71.6 94.9 199.1 127.1 191.7 95.7 135.3 365.5 11.0 6.4 9.2 45.7 23.3 3.3 24.9 5.7 2.2 0.8 30.0 16.8 6.5 34.3 14.0 20.2 2.1 38.7 37.0 34.7 1.9 36.3 9.1 43.1 10.6 8.6 19.2 6.3 1.0 25.5 6.6 8.9 48.9 49.8 17.2 44.8 10.8 22.2 16.7 0.0 1.7 35.0 24.4 11.7 5.3 13.5 18.3 14.2 3.6 26.2 10.4 12.9 40.2 5.5 323.2 18.4 29.0 13.2 9.1 41.6 13.0 14.8 23.1 1.8 26.3 8.8 10.8 0.6 5.3 4.2 4.1 22.4 23.3 7.2 57.6 35.1 TMEM65 ENSG00000164983 "Transmembrane protein 65" Q6PI78 8 124306189-124372701 "Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 72.6;Horizontal cells: 99.3;Inhibitory neurons: 139.8;Microglial cells: 70.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025020 Uncertain NA NA "Cluster 37: B-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA025020: AB_2205178" "prognostic unfavorable (2.17e-4)" "unprognostic (3.52e-2)" "unprognostic (2.97e-2)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.24e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (2.26e-2)" "unprognostic (1.84e-1)" "unprognostic (4.71e-2)" "unprognostic (7.95e-2)" "unprognostic (8.26e-2)" "unprognostic (5.67e-2)" "unprognostic (8.25e-2)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (3.78e-1)" 3.7 3.1 5.1 4.9 5.1 3.5 5.1 5.2 5.4 5.5 3.4 4.0 15.4 4.8 2.2 5.6 3.0 4.7 11.9 4.9 5.0 4.7 2.7 3.6 4.5 3.8 5.8 4.2 4.8 6.6 2.1 3.3 4.8 2.8 4.5 2.7 8.6 2.0 13.9 10.1 5.5 3.7 3.7 4.7 2.8 1.7 6.2 3.7 5.3 12.4 4.5 3.2 5.3 4.6 7.9 5.4 11.2 4.0 3.4 6.1 0.9 4.5 4.4 6.9 7.9 0.9 3.1 7.4 4.4 8.0 5.3 3.6 5.8 4.3 8.2 23.2 5.9 5.0 4.6 1.6 9.5 3.4 4.8 4.4 8.1 10.0 7.9 9.4 15.8 3.6 2.3 6.2 8.5 6.1 2.4 1.3 3.0 3.5 7.5 1.4 10.6 4.5 7.3 3.4 9.1 5.4 16.6 41.9 7.8 5.7 3.7 4.3 10.3 5.8 13.9 19.4 7.7 4.2 3.3 3.0 8.2 24.6 8.4 0.4 0.1 0.2 0.2 0.1 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.3 0.4 0.1 0.2 0.3 0.0 5.1 5.1 5.2 5.4 4.9 5.0 3.8 5.8 4.8 3.7 6.2 4.6 14.0 12.8 3.9 34.3 15.1 13.4 9.4 3.0 11.4 6.0 14.0 11.8 37.2 15.7 4.8 7.3 0.0 0.6 10.0 17.0 23.5 10.9 3.9 12.1 12.9 14.0 1.2 6.3 72.6 7.8 1.6 13.0 5.6 9.7 1.3 31.2 23.9 4.7 8.9 99.3 139.8 3.7 4.1 19.1 10.5 1.0 9.9 19.8 8.8 70.3 9.3 4.4 14.4 52.3 45.0 9.8 4.7 11.7 10.2 7.8 5.3 19.2 5.8 2.3 6.6 25.9 8.9 3.3 4.5 31.9 12.5 0.7 14.8 7.5 5.2 11.6 TMEM70 FLJ20533 ENSG00000175606 "Transmembrane protein 70" Q9BUB7 8 73972437-73982783 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "skeletal muscle: 100.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 78.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023187, CAB034226" Approved Supported Nucleoplasm,Mitochondria NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Mitochondria Nucleoplasm "CAB034226: AB_2205189, HPA023187: AB_2671101" "unprognostic (2.26e-3)" "unprognostic (4.87e-1)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (8.22e-3)" "unprognostic (9.17e-2)" "unprognostic (1.01e-1)" "unprognostic (7.37e-2)" "unprognostic (7.04e-2)" "unprognostic (2.88e-2)" "unprognostic (9.14e-2)" "unprognostic (3.65e-3)" "unprognostic (6.86e-2)" "unprognostic (5.08e-2)" "unprognostic (2.13e-1)" "unprognostic (2.70e-2)" 18.1 18.2 9.2 9.8 9.7 10.4 11.3 10.5 12.3 8.0 9.5 12.6 5.8 8.9 10.6 9.3 11.3 8.9 19.3 10.3 10.2 12.0 24.4 9.0 10.1 9.6 9.1 10.5 25.0 8.3 7.6 10.3 10.1 7.4 9.7 6.1 9.9 5.9 100.7 7.7 9.5 9.1 9.5 9.6 17.8 9.8 9.5 11.0 6.0 20.5 10.3 11.3 7.4 10.1 21.2 16.4 13.1 13.8 14.9 12.7 13.6 17.6 15.8 19.4 15.3 15.8 11.9 28.4 15.0 12.0 16.4 19.1 24.9 16.8 21.4 18.9 17.5 28.3 10.0 21.2 14.7 15.5 14.5 11.8 15.3 12.2 6.4 7.3 16.4 14.2 22.0 13.5 20.5 15.9 35.8 29.6 12.3 26.6 20.6 25.4 12.8 24.2 20.5 20.0 29.7 13.1 11.0 78.0 23.3 10.2 16.0 14.1 10.6 11.1 13.7 20.7 16.9 19.9 18.7 28.1 16.4 12.1 12.5 6.3 9.1 6.7 8.0 10.2 9.1 17.7 9.0 9.3 9.6 10.9 10.3 9.6 6.7 5.8 7.9 11.0 7.9 12.0 9.2 9.7 10.5 12.3 10.3 10.2 9.6 9.1 10.1 9.5 9.5 10.1 136.2 16.0 30.1 5.5 37.1 67.3 43.7 54.8 24.5 23.9 26.2 22.2 46.3 14.3 35.7 22.0 8.4 71.2 48.1 69.0 66.5 36.6 20.3 40.8 26.2 96.4 13.8 26.5 12.8 63.5 59.6 50.2 17.3 17.1 39.9 17.0 28.5 50.3 132.4 10.1 11.4 31.7 42.7 70.0 74.5 12.1 29.8 73.2 40.9 5.6 38.9 23.1 22.6 3.5 8.1 43.6 37.9 29.0 68.6 42.1 28.8 75.4 58.7 17.5 39.5 61.9 40.8 70.6 29.5 21.5 59.7 70.3 39.8 52.6 34.1 26.2 TMEM79 "FLJ16057, FLJ32254, MATT, MGC13102" ENSG00000163472 "Transmembrane protein 79" Q9BSE2 1 156282935-156293185 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 132.4;skin 1: 89.9;vagina: 59.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 24.1;Squamous epithelial cells: 59.9;Suprabasal keratinocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 30.2;SK-BR-3: 26.7;T-47d: 28.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA055214 Enhanced Approved "Nucleoli fibrillar center" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoli fibrillar center" "HPA055214: AB_2682741" "unprognostic (3.12e-1)" "unprognostic (2.96e-1)" "unprognostic (1.26e-1)" "unprognostic (8.17e-2)" "unprognostic (5.51e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (6.37e-2)" "unprognostic (2.44e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-3)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.72e-1)" "unprognostic (1.96e-1)" "unprognostic (3.98e-2)" "unprognostic (2.37e-1)" 2.1 2.8 5.5 1.5 6.3 2.9 4.5 6.2 7.5 34.5 5.1 2.4 2.6 2.4 2.6 132.4 2.5 1.8 1.8 5.2 5.7 2.4 3.6 1.9 2.9 6.2 6.2 2.4 2.1 6.0 3.7 1.6 6.0 28.4 1.3 1.7 23.5 2.6 2.9 89.9 2.7 1.2 5.8 3.8 2.9 2.0 6.1 3.6 2.2 0.7 10.9 6.9 59.4 7.8 12.5 7.2 2.4 4.7 1.8 1.8 5.9 3.5 1.4 6.2 2.4 8.5 3.4 2.2 7.6 0.9 2.2 10.8 2.8 5.1 2.7 8.3 3.9 2.3 3.3 2.5 3.3 2.6 3.3 1.7 30.2 4.6 4.7 4.4 1.4 8.2 10.5 14.8 2.9 14.1 7.3 4.0 3.6 9.0 5.7 8.5 2.3 5.0 1.3 3.0 4.3 4.7 4.3 26.7 7.0 2.9 28.3 7.4 3.4 11.5 3.8 4.2 9.5 11.3 13.0 5.2 8.0 6.0 8.8 0.0 2.0 3.0 1.7 0.7 1.8 1.7 1.5 1.8 1.6 2.2 2.0 2.4 3.7 1.7 1.3 2.0 2.1 1.7 5.5 6.3 6.2 7.5 5.2 5.7 6.2 6.2 6.0 5.8 6.1 7.8 1.8 3.2 1.5 8.8 3.9 13.3 1.4 24.1 9.1 3.0 10.0 6.5 1.2 2.8 14.3 1.8 2.1 7.7 3.6 2.4 1.9 2.5 0.1 3.7 2.4 2.0 3.0 0.8 1.8 3.3 1.8 2.1 1.5 6.7 0.0 3.1 2.2 2.4 3.4 8.4 2.2 2.9 10.2 2.5 1.8 0.3 1.5 1.4 5.4 3.7 4.4 1.5 1.0 2.5 5.8 4.5 2.1 0.7 1.6 10.7 4.3 1.6 4.2 2.2 0.0 1.0 1.9 1.3 2.1 59.9 33.1 7.4 3.2 2.9 3.1 6.4 TP53INP2 "C20orf110, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH" ENSG00000078804 "Tumor protein p53 inducible nuclear protein 2" Q8IXH6 20 34704339-34713439 "Predicted intracellular proteins" "Autophagy, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 517.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 143.5;Early spermatids: 208.6;Late spermatids: 353.7;Paneth cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 13 "granulocytes: 2.7" "Cell line enriched" "Detected in all" 4 "SK-BR-3: 219.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (3.33e-2)" "unprognostic (2.57e-3)" "unprognostic (1.26e-1)" "unprognostic (3.08e-2)" "unprognostic (2.07e-1)" "unprognostic (1.86e-2)" "unprognostic (1.89e-1)" "unprognostic (3.03e-1)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (1.52e-2)" "unprognostic (2.57e-2)" "prognostic favorable (1.26e-8)" "unprognostic (8.03e-2)" "unprognostic (1.68e-1)" "unprognostic (1.93e-2)" "unprognostic (6.17e-2)" 19.7 28.0 315.7 11.1 439.0 89.7 13.8 343.9 403.1 19.6 159.7 42.2 19.9 26.4 15.7 64.8 19.3 23.8 85.5 233.8 348.8 31.8 45.6 19.6 5.6 517.3 444.7 15.5 16.6 35.1 22.0 10.5 464.6 36.9 38.4 45.9 27.6 31.2 53.1 12.3 23.5 34.7 418.6 6.6 24.4 39.9 376.8 2.9 31.6 94.0 17.2 33.0 23.8 485.7 2.5 3.0 9.8 12.6 22.1 18.1 4.2 9.8 30.9 12.8 10.6 17.3 1.2 7.7 6.6 19.6 25.1 1.9 20.8 4.7 14.0 2.3 2.6 14.0 8.2 16.9 28.6 2.2 10.9 52.3 7.0 10.1 1.4 16.0 20.2 6.9 5.8 24.8 14.5 3.4 1.6 4.8 1.3 2.1 7.4 7.4 6.4 12.4 16.1 8.8 21.4 24.1 8.7 219.0 15.2 11.6 15.8 10.3 15.3 35.0 12.0 4.6 4.1 9.8 12.5 6.2 22.2 31.2 12.5 0.5 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 315.7 439.0 343.9 403.1 233.8 348.8 517.3 444.7 464.6 418.6 376.8 485.7 9.5 3.2 10.6 5.5 8.1 3.7 17.0 11.7 5.7 20.4 17.4 12.3 75.4 15.7 16.7 3.7 52.1 1.7 12.8 143.5 5.9 16.5 208.6 19.6 10.1 10.4 52.4 0.4 4.3 23.9 1.1 9.6 46.9 24.2 7.0 7.5 11.0 28.7 5.3 32.0 6.1 59.5 32.6 10.2 3.6 353.7 7.5 15.5 5.4 2.8 2.6 10.9 0.0 1.0 17.7 24.3 116.1 13.2 7.4 15.3 34.0 8.9 25.1 55.8 19.7 35.9 27.4 4.0 2.7 4.5 3.0 28.5 8.4 9.1 23.9 24.4 TPD52 "D52, hD52, N8L" ENSG00000076554 "Tumor protein D52" P55327 8 80034745-80231232 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 187.6" "Cell type enhanced" "Detected in many" "Ionocytes: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 50.5" "Group enriched" "Detected in many" 5 "B-cells: 50.5;NK-cells: 15.1;T-cells: 22.0" "Cell line enhanced" "Detected in many" "Karpas-707: 252.6;SK-BR-3: 572.5" "HPA028427, HPA062167" Enhanced Approved "Golgi apparatus,Cytosol" NA NA 310000 "Cluster 43: B-cells - Humoral immune response" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol "Golgi apparatus" "HPA028427: AB_10610561, HPA062167: AB_2684704" "prognostic unfavorable (1.11e-5)" "unprognostic (1.35e-1)" "unprognostic (1.37e-2)" "unprognostic (3.77e-3)" "unprognostic (8.24e-2)" "unprognostic (3.75e-1)" "unprognostic (7.99e-3)" "unprognostic (6.47e-2)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.77e-6)" "unprognostic (2.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "unprognostic (1.70e-2)" 5.4 9.2 34.9 28.4 40.2 8.9 75.9 34.2 69.4 19.6 36.6 117.7 98.9 9.9 56.2 34.9 15.3 31.1 11.7 42.9 35.4 46.5 30.7 19.8 44.0 33.2 37.1 2.4 41.8 27.4 34.3 22.9 36.3 104.8 129.7 187.6 80.7 18.3 8.6 46.9 100.3 10.4 32.8 16.0 84.1 5.2 53.3 15.5 64.5 9.8 56.2 20.9 20.2 48.1 131.8 34.9 1.6 23.0 0.0 0.0 51.7 8.6 12.9 34.7 17.1 18.0 37.4 189.9 45.2 0.8 25.5 52.5 52.7 36.3 24.6 23.8 44.2 26.8 46.9 29.4 0.2 8.6 0.7 0.0 25.2 0.1 12.2 21.6 2.0 128.9 0.4 252.6 0.1 43.6 42.6 39.4 11.7 148.8 86.0 0.3 0.7 122.0 60.7 31.6 64.9 44.1 40.1 572.5 110.7 51.0 55.9 34.2 2.1 0.0 35.2 0.6 30.8 94.1 87.1 155.2 22.5 0.2 2.6 0.6 0.1 5.5 12.7 0.1 22.0 50.5 12.4 11.1 2.5 44.7 8.1 9.3 0.5 15.1 0.1 5.2 9.1 8.3 34.9 40.2 34.2 69.4 42.9 35.4 33.2 37.1 36.3 32.8 53.3 48.1 17.3 44.8 67.8 10.4 133.6 80.7 89.6 83.4 51.2 171.1 105.6 54.2 22.2 82.9 78.1 66.2 118.9 98.9 28.6 230.9 170.2 112.8 20.6 25.2 8.4 26.2 169.9 11.6 85.4 79.6 116.9 6.7 97.3 72.8 1.3 15.3 25.7 40.6 13.1 32.0 53.9 331.9 476.0 14.6 24.2 13.0 1.2 10.8 104.9 37.5 91.2 50.3 60.8 69.9 181.0 79.7 317.5 1.5 270.5 214.4 132.3 135.3 21.4 232.2 0.0 49.6 8.3 1.6 18.2 91.4 124.6 231.2 51.3 0.3 247.1 135.4 TRGJP "JP, TCRGJP" ENSG00000211691 "T cell receptor gamma joining P" 7 38273587-38273647 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "bone marrow: 43.1;prostate: 95.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 46 "gdT-cell: 2370.0" "Lineage enriched" "Detected in many" 46 "T-cells: 2370.0" "Group enriched" "Detected in some" 10 "MCF7: 26.9;SK-BR-3: 60.9" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" 0.0 0.0 1.4 5.2 1.0 43.1 0.7 0.3 1.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 1.1 1.2 0.8 0.7 1.2 0.0 0.0 0.4 1.1 0.8 0.0 0.0 0.0 0.0 0.4 1.1 95.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.7 2.8 2.5 1.5 0.6 0.0 0.0 0.6 1.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.7 0.5 2370.0 3.2 49.6 0.8 2.0 26.9 0.8 0.3 0.4 18.5 10.2 51.9 0.9 2.0 0.6 210.4 1.4 1.0 0.3 1.4 0.8 0.7 1.1 0.8 1.1 0.6 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRIM3 "BERP, HAC1, RNF22, RNF97" ENSG00000110171 "Tripartite motif containing 3" O75382 11 6448613-6474459 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043396, HPA048233" Enhanced Approved Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Mitochondria "HPA043396: AB_2678460, HPA048233: AB_2680321" "unprognostic (1.24e-1)" "unprognostic (1.98e-1)" "unprognostic (2.31e-1)" "prognostic favorable (2.20e-4)" "unprognostic (4.01e-2)" "unprognostic (3.88e-2)" "unprognostic (1.61e-3)" "unprognostic (2.84e-1)" "unprognostic (2.24e-1)" "unprognostic (3.91e-1)" "prognostic favorable (5.49e-5)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.07e-5)" "unprognostic (2.51e-1)" "unprognostic (1.66e-1)" "unprognostic (1.54e-1)" "unprognostic (1.93e-1)" 9.5 4.6 6.4 4.6 6.2 1.3 10.3 11.6 7.5 11.2 0.0 13.0 17.8 13.5 1.8 4.8 10.1 4.1 8.0 5.8 3.4 6.3 6.3 9.7 2.4 8.5 3.1 8.7 6.4 2.7 5.9 3.9 9.4 9.5 4.8 4.8 9.0 5.4 11.5 8.4 15.7 5.6 2.2 5.7 10.1 3.8 5.9 1.5 6.8 4.8 1.6 11.2 9.3 6.1 7.2 12.4 4.9 8.3 8.1 7.8 6.7 10.3 6.1 7.8 8.6 7.6 5.0 3.9 3.6 7.9 9.1 5.0 5.1 7.7 3.0 4.8 7.6 1.2 13.5 5.3 5.2 0.4 4.1 6.7 3.7 6.1 3.2 3.3 8.0 2.9 1.7 4.7 7.8 15.2 0.3 1.0 3.5 15.2 10.7 2.4 4.2 4.9 1.9 3.8 5.1 7.8 5.7 54.9 6.6 2.5 20.8 1.3 13.4 20.3 9.5 15.0 6.9 5.5 3.6 0.8 11.0 1.7 7.6 0.0 1.0 0.6 0.5 1.0 0.4 0.1 0.4 0.4 1.2 0.1 0.1 0.6 0.0 0.6 0.2 0.2 0.5 0.5 6.4 6.2 11.6 7.5 5.8 3.4 8.5 3.1 9.4 2.2 5.9 6.1 8.5 6.4 0.0 9.8 2.4 4.8 2.8 2.8 3.4 8.8 8.5 6.0 2.2 2.8 2.7 0.0 10.4 1.8 3.5 16.0 0.0 3.1 3.9 2.8 4.4 6.5 4.8 0.4 13.2 3.5 2.2 6.9 5.6 7.3 1.3 3.6 4.6 2.5 4.7 8.4 12.2 11.4 4.1 0.8 6.5 5.6 5.9 3.5 7.2 11.2 3.4 2.2 3.1 5.0 10.2 3.1 5.4 5.3 2.5 3.2 28.7 3.1 8.4 9.6 13.1 5.0 11.3 3.1 6.0 3.7 5.4 0.8 3.4 3.3 6.6 2.3 TRIM56 RNF109 ENSG00000169871 "Tripartite motif containing 56" Q9BRZ2 7 101085481-101097967 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024358 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA024358: AB_1858308" "unprognostic (6.47e-2)" "unprognostic (1.34e-1)" "unprognostic (1.99e-2)" "unprognostic (1.62e-1)" "unprognostic (9.44e-3)" "unprognostic (8.30e-2)" "prognostic unfavorable (3.87e-4)" "unprognostic (2.63e-1)" "unprognostic (4.11e-1)" "unprognostic (3.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.47e-3)" "unprognostic (8.13e-2)" "unprognostic (1.49e-1)" "prognostic favorable (2.13e-4)" 13.6 11.3 12.9 14.4 13.9 6.7 12.9 11.7 12.2 14.8 12.6 11.8 11.7 13.5 13.4 12.4 14.8 7.5 9.9 10.4 11.5 12.9 10.8 17.7 15.4 17.0 13.8 19.0 10.1 9.6 8.6 8.9 14.0 14.8 9.7 2.0 14.0 13.0 11.9 15.7 14.7 8.5 12.7 21.4 12.4 3.8 14.2 12.9 12.7 6.7 12.4 12.6 13.4 16.8 16.4 20.1 8.5 10.9 19.1 19.7 10.2 13.4 11.7 21.2 19.6 9.6 23.0 19.2 14.0 11.1 29.3 18.4 3.5 12.3 14.2 19.2 5.5 12.2 28.9 7.1 17.1 21.6 26.4 12.6 17.3 13.8 22.4 20.7 11.2 12.2 21.6 23.7 14.8 22.4 18.3 24.0 8.5 8.8 16.7 16.8 13.9 12.7 11.1 16.9 0.4 0.3 14.8 40.8 11.6 10.8 9.3 14.0 21.6 29.4 26.1 22.4 14.4 11.7 12.4 14.7 14.6 17.2 23.6 1.7 1.2 1.2 1.8 0.8 1.4 1.1 1.4 1.2 0.4 1.6 1.3 1.7 3.9 4.1 1.2 1.1 0.7 0.6 12.9 13.9 11.7 12.2 10.4 11.5 17.0 13.8 14.0 12.7 14.2 16.8 62.5 73.7 82.7 3.3 45.7 5.2 82.2 6.7 28.5 3.1 30.4 27.2 21.7 108.7 32.8 51.5 2.1 41.6 45.4 51.9 3.9 61.4 2.1 60.8 53.7 80.6 29.1 43.5 0.1 48.1 25.7 40.0 33.1 42.5 15.2 129.9 114.5 48.1 19.3 10.1 0.1 40.9 4.1 48.7 4.5 5.2 132.3 33.3 1.8 8.4 60.0 20.4 141.1 2.5 3.6 56.9 45.4 94.4 24.9 79.9 76.5 11.4 51.0 4.0 65.7 76.7 38.9 5.4 7.2 15.9 3.3 29.8 44.3 64.5 41.1 60.5 TRMT10A "MGC27034, RG9MTD2, TRM10" ENSG00000145331 "TRNA methyltransferase 10A" Q8TBZ6 4 99546709-99564039 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Methyltransferase, Transferase" "Diabetes mellitus, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 99.5;Spermatogonia: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047601, HPA058241" Uncertain Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli, Actin filaments" Cytosol "HPA047601: AB_2680099, HPA058241: AB_2683651" "unprognostic (5.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.34e-1)" "unprognostic (1.96e-3)" "unprognostic (2.10e-1)" "unprognostic (5.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.59e-2)" "unprognostic (3.65e-2)" "unprognostic (1.57e-1)" "unprognostic (3.51e-1)" "unprognostic (7.49e-3)" "unprognostic (3.32e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.68e-2)" 4.3 3.7 2.0 3.1 2.6 2.2 4.4 2.6 2.9 1.9 1.5 3.6 4.3 2.7 3.9 3.6 5.8 3.4 2.3 1.8 2.5 4.9 9.8 2.4 4.4 2.6 2.5 3.3 5.9 3.7 2.3 3.7 2.9 4.1 3.6 2.8 3.9 2.2 3.9 3.7 4.5 2.7 2.7 3.5 4.4 9.9 2.4 4.3 6.1 2.7 4.4 2.9 2.0 4.3 8.2 5.4 10.1 5.7 6.0 8.4 7.8 9.6 3.7 5.8 4.1 4.9 9.4 10.9 3.7 5.6 5.9 4.4 10.9 5.1 8.6 13.7 5.4 8.0 4.4 7.6 5.5 19.6 7.8 5.4 14.4 5.7 14.0 3.0 6.4 10.0 17.5 9.4 4.5 9.4 16.4 3.5 6.5 13.8 5.0 9.5 10.2 7.2 8.5 6.8 6.3 5.8 5.3 28.3 9.9 8.5 9.3 7.8 4.9 6.9 7.2 5.5 11.1 7.0 12.4 10.0 4.9 10.9 4.7 2.7 3.9 2.1 1.8 3.8 1.7 3.5 3.3 3.3 5.2 5.8 3.5 3.2 4.9 3.3 3.4 3.0 3.9 1.9 2.0 2.6 2.6 2.9 1.8 2.5 2.6 2.5 2.9 2.7 2.4 4.3 7.2 3.2 10.3 8.8 8.7 8.2 5.6 8.4 10.2 4.3 12.1 8.6 6.4 11.5 6.6 11.0 4.2 16.8 6.1 10.6 43.0 13.8 46.8 33.5 12.1 7.2 7.2 2.1 5.3 19.3 16.4 6.9 8.6 21.6 8.2 11.0 8.2 32.6 8.5 5.0 4.6 11.1 12.2 8.1 4.1 17.0 6.5 5.0 5.4 1.9 8.4 8.7 5.2 3.5 19.7 14.1 11.0 7.5 10.4 4.8 19.0 31.9 20.6 5.9 13.1 5.7 8.1 99.5 55.0 10.2 9.5 17.5 5.5 8.1 10.6 6.6 TSTD1 KAT ENSG00000215845 "Thiosulfate sulfurtransferase like domain containing 1" Q8NFU3 1 161037631-161038977 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 684.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 205.3;OE19: 215.1;SK-BR-3: 284.0;T-47d: 274.9;U-266/70: 315.4;U-266/84: 243.2" "Region enriched" "Detected in some" 4 "olfactory bulb: 6.6" "Low region specificity" "Detected in all" "HPA006518, HPA006655" Approved Approved "Cytosol,Cytoplasmic bodies" NA NA 57000 "Cluster 37: B-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cytosol, Cytoplasmic bodies" "HPA006518: AB_2667608, HPA006655: AB_10600919" "unprognostic (6.10e-2)" "unprognostic (4.70e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" "unprognostic (5.77e-2)" "unprognostic (1.63e-1)" "unprognostic (6.56e-2)" "unprognostic (2.51e-3)" "unprognostic (2.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "unprognostic (1.13e-1)" "unprognostic (4.64e-2)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (8.57e-3)" "unprognostic (8.88e-3)" 33.8 72.1 28.3 25.8 31.4 48.3 73.6 19.8 40.3 31.4 34.6 60.3 40.4 10.4 101.5 91.3 69.2 18.9 55.4 28.2 28.0 125.3 74.7 47.4 52.8 21.2 23.4 55.1 93.5 167.2 119.2 13.2 23.2 98.6 40.8 11.4 175.7 43.5 38.7 79.6 50.5 8.5 20.8 39.7 61.3 35.6 27.3 59.5 140.0 18.6 51.2 29.9 46.4 24.9 119.8 1.6 0.3 0.6 0.0 0.0 2.1 0.2 0.0 0.2 0.0 11.1 112.5 25.0 67.9 0.0 0.0 107.2 0.1 46.4 0.0 98.4 84.9 13.3 43.2 0.0 12.2 43.7 0.9 0.6 28.2 0.0 4.8 0.1 15.6 100.8 0.4 130.8 12.8 205.3 118.6 0.6 0.7 215.1 0.3 38.7 0.0 184.8 98.0 32.8 67.5 37.2 0.0 284.0 0.9 54.0 274.9 0.6 0.5 0.0 41.5 0.6 4.8 315.4 243.2 26.3 0.3 0.2 0.4 438.2 24.2 357.7 226.5 72.0 218.8 530.9 296.2 252.0 72.6 506.1 333.3 282.1 337.5 306.5 104.8 203.9 410.8 220.6 28.3 31.4 19.8 40.3 28.2 28.0 21.2 23.4 23.2 20.8 27.3 24.9 6.5 253.2 228.8 1.0 170.3 86.3 307.5 331.1 160.5 16.2 443.9 457.1 68.4 223.1 259.0 367.8 27.1 271.5 101.2 478.1 684.8 169.7 16.3 336.9 29.2 14.0 218.5 29.0 5.8 151.5 112.7 35.8 59.1 201.2 124.7 88.7 10.8 149.3 72.3 3.3 1.9 418.1 402.8 18.7 116.2 25.1 8.4 40.7 151.2 1.9 178.3 73.0 206.0 1.0 0.7 131.5 383.6 9.8 110.5 386.2 426.6 665.8 615.1 31.8 19.7 99.5 37.7 73.3 44.4 199.6 135.8 151.0 149.3 31.7 267.0 384.9 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 21.2" "Cell type enhanced" "Detected in many" "Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.1 0.1 0.6 0.4 0.6 0.1 0.2 0.4 1.1 0.2 1.8 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.1 0.5 0.6 0.1 0.1 0.2 0.3 0.7 0.9 0.3 1.1 0.2 0.1 0.1 0.6 0.2 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.0 0.5 0.2 0.1 21.2 0.5 0.2 0.2 0.1 0.3 0.1 0.1 0.6 0.1 0.3 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.3 0.0 0.3 0.3 0.2 0.2 0.2 0.0 0.4 0.2 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.8 0.3 0.0 0.8 0.0 0.2 0.0 0.1 0.7 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.4 1.1 0.5 0.6 0.7 0.9 0.6 0.5 0.5 0.6 3.7 0.0 3.0 20.2 10.4 0.6 4.4 4.0 0.6 5.3 2.6 2.4 6.4 4.3 5.4 1.8 8.4 1.7 1.8 2.5 0.0 2.1 82.3 24.0 3.6 3.0 4.2 0.4 15.0 1.8 1.7 2.1 4.1 5.2 1.3 3.2 5.0 1.3 1.6 5.0 13.3 2.5 0.0 2.2 0.9 84.7 7.2 1.6 3.6 4.7 2.6 3.4 0.0 5.0 3.2 1.7 2.0 6.0 3.7 2.1 2.3 1.2 56.0 15.3 6.6 7.8 2.7 59.8 3.4 0.1 0.6 3.7 1.3 2.1 2.4 2.3 TTC36 HBP21 ENSG00000172425 "Tetratricopeptide repeat domain 36" A6NLP5 11 118527472-118531197 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 171.5" "Group enriched" "Detected in many" 13 "Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9" "Group enriched" "Detected in some" 7 "breast cancer: 5.0;liver cancer: 12.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-BR-3: 9.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA038731 Enhanced Uncertain Nucleoplasm NA NA 100000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "HPA038731: AB_10672651" "unprognostic (1.57e-3)" "unprognostic (2.58e-3)" "unprognostic (1.16e-1)" "unprognostic (6.50e-2)" "unprognostic (1.02e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.81e-5)" "unprognostic (6.32e-2)" "unprognostic (8.80e-2)" "unprognostic (6.14e-2)" "unprognostic (4.77e-3)" "unprognostic (3.38e-2)" "unprognostic (5.77e-7)" "unprognostic (5.60e-2)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (8.95e-3)" 8.0 1.3 0.8 0.1 0.8 0.0 11.1 0.8 0.7 0.3 0.7 0.5 5.9 0.4 18.5 0.5 0.5 0.1 1.0 0.3 0.6 8.9 171.5 0.3 0.1 1.1 0.7 0.6 1.2 0.0 1.6 0.1 0.6 1.0 0.0 0.3 0.9 0.0 1.4 0.5 4.1 0.0 0.6 0.2 0.7 0.8 0.6 0.0 0.7 0.4 0.0 0.5 0.3 1.0 0.0 0.0 0.1 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.5 0.2 0.7 0.0 0.0 0.2 0.0 0.0 9.7 0.0 0.0 0.8 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.8 0.8 0.7 0.3 0.6 1.1 0.7 0.6 0.6 0.6 1.0 0.3 0.0 0.0 0.3 2.4 0.3 0.6 0.2 0.6 0.1 21.2 11.3 0.3 11.5 0.1 12.9 0.0 1.5 0.1 0.8 17.6 0.2 0.1 1.2 0.6 1.1 2.4 16.4 0.2 0.5 0.2 0.3 2.0 1.7 0.0 0.4 9.7 492.9 0.1 0.0 0.3 9.3 0.0 14.2 0.3 0.2 0.3 0.9 0.0 0.0 0.6 1.1 0.0 0.0 0.1 0.2 7.6 0.0 0.3 1.9 185.5 172.9 0.2 0.8 0.0 0.2 0.2 0.3 0.3 0.3 0.1 2.1 1.1 0.4 11.7 1.3 TTC39A "C1orf34, DEME-6, KIAA0452" ENSG00000085831 "Tetratricopeptide repeat domain 39A" Q5SRH9 1 51287258-51345116 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 59.5" "Group enriched" "Detected in many" 9 "Early spermatids: 425.0;Late spermatids: 616.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 42 "plasmacytoid DC: 31.7" "Lineage enriched" "Detected in single" 42 "dendritic cells: 31.7" "Cell line enhanced" "Detected in many" "HDLM-2: 70.6;MCF7: 52.4;SK-BR-3: 153.7;T-47d: 111.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA028098, HPA043440" Uncertain Enhanced Centrosome NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" Centrosome "HPA028098: AB_10601705, HPA043440: AB_2678483" "unprognostic (5.05e-2)" "unprognostic (1.95e-1)" "unprognostic (3.35e-2)" "unprognostic (7.60e-2)" "unprognostic (8.53e-3)" "unprognostic (2.86e-2)" "prognostic unfavorable (5.05e-5)" "unprognostic (1.46e-1)" "unprognostic (2.58e-1)" "unprognostic (8.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.38e-1)" "unprognostic (7.89e-2)" "unprognostic (1.73e-3)" "unprognostic (5.40e-2)" "unprognostic (5.96e-2)" "unprognostic (1.06e-1)" 2.2 8.2 3.5 3.3 3.5 1.7 35.9 3.0 9.6 14.1 0.0 29.5 6.1 1.0 15.9 18.4 7.5 14.9 15.3 1.0 11.4 26.6 2.8 9.1 1.4 7.4 5.3 0.3 13.5 13.5 11.0 0.3 14.0 20.5 35.2 4.6 11.5 4.2 4.1 10.5 8.1 1.6 2.2 0.3 29.4 59.5 7.7 0.5 10.1 1.7 2.0 8.0 9.4 3.7 6.4 3.4 0.7 0.3 0.4 0.7 28.2 0.3 0.2 0.2 0.2 18.2 2.8 0.1 9.6 0.4 0.4 0.2 3.8 0.2 0.1 70.6 9.7 0.5 1.8 3.2 1.1 0.0 0.7 0.1 1.6 0.1 0.0 0.8 1.4 0.2 0.4 0.1 0.2 52.4 0.6 0.2 4.8 33.8 0.6 0.1 0.2 4.3 28.6 9.1 22.1 1.6 0.5 153.7 1.8 2.0 111.7 0.8 0.8 0.4 2.5 0.5 0.5 5.4 7.1 0.2 2.1 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 31.7 0.0 0.3 3.5 3.5 3.0 9.6 1.0 11.4 7.4 5.3 14.0 2.2 7.7 3.7 0.4 3.2 25.2 1.3 1.1 1.5 5.3 1.7 0.0 2.5 30.8 15.1 13.0 5.7 6.4 9.2 0.0 0.5 15.3 29.3 11.7 38.9 425.0 5.4 3.0 1.9 41.4 9.7 9.7 52.7 4.8 0.9 21.9 9.5 3.8 0.5 0.4 0.6 2.0 0.0 10.2 56.0 6.1 0.3 1.3 616.8 2.5 0.9 0.0 1.0 2.6 1.7 0.0 0.0 0.9 30.5 13.7 2.6 0.4 12.0 2.7 24.4 9.3 7.3 6.6 1.8 1.3 22.8 6.5 4.8 6.5 3.4 1.7 0.5 20.7 14.6 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641916-70675366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.1" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 36.0;Respiratory ciliated cells: 38.1;Urothelial cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.2;Daudi: 15.9;RH-30: 21.3;SK-BR-3: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079473 Approved "Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "HPA079473: " "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 1.4 1.2 6.4 4.0 6.8 0.9 3.7 3.3 9.8 5.4 1.5 0.8 0.8 1.2 1.4 60.1 10.2 3.4 2.1 6.4 5.9 2.9 1.1 4.4 9.3 5.7 3.9 0.1 1.5 2.9 3.7 4.0 5.5 2.5 0.8 6.0 12.6 1.6 9.5 5.9 2.5 0.8 3.7 5.7 4.1 0.5 4.3 5.1 4.0 5.2 15.4 4.4 13.7 6.5 18.2 2.1 6.7 0.3 0.0 0.0 7.1 0.3 0.1 0.5 2.2 0.4 8.9 15.9 2.4 0.1 1.5 6.6 5.0 0.6 0.3 0.5 1.9 2.2 0.7 5.2 0.0 0.0 4.4 0.6 1.2 0.0 0.1 0.3 0.0 3.5 0.0 1.4 7.3 9.0 0.4 0.2 3.7 13.0 2.3 3.7 21.3 0.1 11.0 4.1 4.1 2.0 2.0 36.4 0.0 4.0 12.7 0.6 0.0 0.0 3.2 0.0 0.3 0.0 0.2 4.9 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.3 0.9 0.6 0.7 0.5 0.0 1.2 1.1 0.7 0.8 0.0 1.5 0.0 0.4 0.2 6.4 6.8 3.3 9.8 6.4 5.9 5.7 3.9 5.5 3.7 4.3 6.5 3.8 3.2 7.2 1.3 11.3 1.0 4.7 16.3 1.2 3.8 13.7 10.5 1.8 14.3 24.8 9.2 6.2 24.1 1.5 0.2 1.9 21.0 0.4 8.3 2.3 5.9 1.2 0.0 10.5 5.8 2.5 1.2 4.1 19.1 1.3 15.2 0.4 2.2 2.8 0.0 13.6 0.5 16.2 4.1 0.8 0.7 0.0 2.1 7.2 3.7 3.0 15.8 4.1 9.0 0.7 36.0 0.5 0.0 4.4 13.0 0.0 0.3 38.1 5.4 0.0 0.7 2.1 0.1 2.6 9.0 1.7 7.4 7.6 0.2 0.5 56.9 TTPA AVED ENSG00000137561 "Alpha tocopherol transfer protein" P49638 8 63048553-63086053 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 38 "liver: 165.0" "Group enriched" "Detected in some" 4 "Astrocytes: 37.9;Hepatocytes: 72.0" "Cancer enriched" "Detected in some" 9 "liver cancer: 21.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 2.0;SK-BR-3: 6.0;T-47d: 2.1;U-2 OS: 2.9;U-2197: 3.7" "Low region specificity" "Detected in all" NA NA 10000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (7.82e-3)" "unprognostic (1.30e-7)" "unprognostic (1.78e-1)" "unprognostic (8.44e-2)" "unprognostic (1.25e-2)" "unprognostic (7.84e-2)" "unprognostic (4.04e-2)" "unprognostic (3.50e-1)" "unprognostic (5.40e-2)" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (1.49e-2)" "unprognostic (3.57e-2)" "unprognostic (5.46e-3)" "unprognostic (6.16e-3)" 1.6 0.2 2.7 0.4 2.7 0.2 0.5 3.0 2.3 0.1 0.7 3.1 0.3 0.0 0.0 0.1 0.1 0.3 0.0 2.5 2.5 2.4 165.0 0.7 0.2 2.5 3.2 0.0 1.2 3.6 0.1 1.7 2.4 0.1 4.3 0.9 0.1 0.1 0.2 0.2 0.3 0.2 2.1 0.0 0.3 0.3 3.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.8 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.4 0.0 0.0 0.0 2.0 0.0 1.5 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.1 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.5 6.0 0.6 0.0 2.1 0.2 0.1 0.0 2.9 3.7 0.6 0.2 0.0 0.0 1.3 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 2.7 3.0 2.3 2.5 2.5 2.5 3.2 2.4 2.1 3.0 2.3 0.0 3.2 1.1 37.9 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.4 0.1 7.2 1.3 0.0 0.0 11.2 0.0 2.1 1.9 1.1 0.0 0.0 0.1 0.2 2.4 0.0 1.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 1.8 72.0 0.6 0.0 2.7 2.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 12.9 0.0 10.6 0.1 0.1 1.2 0.0 0.0 0.1 0.0 5.5 0.0 0.2 0.0 0.7 0.1 0.0 1.0 0.0 0.1 9.9 0.1 0.0 4.9 0.1 UBE2H "GID3, UBC8, UBCH" ENSG00000186591 "Ubiquitin conjugating enzyme E2 H" P62256 7 129830732-129952960 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 365.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003302 Approved Approved Mitochondria NA NA 21000 "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA003302: AB_1858526" "unprognostic (1.15e-1)" "unprognostic (5.85e-2)" "unprognostic (5.67e-3)" "unprognostic (2.76e-1)" "unprognostic (2.25e-1)" "unprognostic (3.08e-2)" "unprognostic (1.13e-1)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (6.19e-2)" "prognostic unfavorable (2.33e-5)" "unprognostic (1.13e-1)" "unprognostic (3.73e-2)" "unprognostic (2.37e-1)" "unprognostic (1.12e-1)" "unprognostic (3.58e-1)" "unprognostic (1.23e-1)" 46.8 64.7 43.0 29.1 44.2 42.3 34.4 46.4 49.1 44.7 58.7 42.3 23.4 44.3 37.6 49.9 44.6 44.6 98.2 42.1 45.4 42.1 44.2 38.8 31.8 48.7 43.4 41.7 84.3 49.2 29.4 52.5 45.0 36.1 26.0 42.0 39.3 41.5 69.3 31.2 24.4 49.2 41.8 28.6 34.6 36.4 45.8 37.4 45.0 60.6 39.8 40.1 33.7 47.8 82.6 43.8 58.5 56.1 126.1 107.5 86.5 72.0 97.8 45.8 51.1 22.9 92.5 34.0 87.4 76.6 123.8 62.5 46.2 81.6 59.5 40.9 22.6 11.5 63.5 28.6 98.3 23.6 36.8 146.7 106.9 61.3 99.7 106.3 89.7 36.3 27.5 104.1 71.5 29.9 31.1 26.1 80.0 60.5 49.8 24.4 27.8 77.2 95.9 106.5 20.3 59.6 68.3 164.7 43.8 166.0 17.1 27.2 89.1 51.7 24.2 72.2 76.5 83.5 65.6 58.5 102.1 28.9 49.7 2.2 1.4 3.4 2.8 1.2 3.8 2.3 2.8 2.6 1.3 4.5 3.6 3.8 4.8 0.9 1.5 2.3 4.4 1.3 43.0 44.2 46.4 49.1 42.1 45.4 48.7 43.4 45.0 41.8 45.8 47.8 69.9 41.7 51.8 87.1 43.1 145.8 187.5 65.7 59.7 65.1 83.7 49.4 102.9 44.3 69.3 71.7 60.5 116.3 56.7 38.6 41.1 66.0 93.5 225.7 91.2 81.4 59.1 100.0 97.1 70.9 67.1 65.2 43.8 365.8 14.7 53.9 45.3 73.1 41.8 43.7 116.9 35.3 54.9 40.3 69.8 44.0 44.1 52.0 48.0 89.0 26.2 87.4 51.5 113.1 108.5 118.3 33.6 78.6 60.5 227.6 27.6 49.7 95.3 35.6 13.1 65.9 69.0 46.5 22.5 78.6 153.7 200.4 49.2 79.7 26.6 274.3 UBE2W "FLJ11011, UBC-16" ENSG00000104343 "Ubiquitin conjugating enzyme E2 W" Q96B02 8 73780097-73878910 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045161, HPA073181" Uncertain Approved Nucleoli NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "HPA045161: AB_10960706, HPA073181: AB_2686578" "unprognostic (5.36e-2)" "unprognostic (1.87e-1)" "unprognostic (7.52e-2)" "unprognostic (1.32e-3)" "unprognostic (3.17e-1)" "unprognostic (9.74e-2)" "unprognostic (3.09e-2)" "unprognostic (6.93e-3)" "unprognostic (1.83e-1)" "unprognostic (3.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" "unprognostic (5.01e-2)" "unprognostic (4.38e-2)" "unprognostic (9.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" 7.5 6.2 5.3 7.5 5.3 11.4 7.0 6.3 7.2 5.9 1.1 5.2 4.5 5.1 5.5 8.7 4.7 8.1 8.3 6.1 3.0 11.2 12.6 7.3 7.1 2.8 2.1 5.4 6.7 8.6 4.6 7.3 3.4 6.0 5.9 10.4 5.7 5.2 8.5 5.5 4.7 6.3 1.6 6.7 5.5 9.5 3.3 7.0 9.1 10.0 7.1 9.7 6.2 4.2 10.3 7.0 8.2 8.0 13.0 14.4 6.8 10.8 12.6 10.6 10.8 5.9 11.1 4.8 8.6 11.7 15.7 10.0 11.2 11.7 16.7 7.7 7.2 10.3 6.5 9.0 8.9 5.6 12.9 10.6 12.2 12.4 21.9 8.5 13.4 5.6 5.1 9.7 16.1 8.7 11.8 6.4 6.2 14.3 13.0 3.8 7.5 4.1 19.7 11.6 5.6 6.5 8.5 26.4 13.2 8.4 13.4 10.0 11.8 12.2 9.4 9.7 8.2 8.7 9.5 3.6 11.2 8.2 11.2 23.8 13.1 17.4 4.7 12.8 5.8 6.8 4.8 3.6 9.1 6.8 4.3 5.0 33.1 7.0 14.4 11.9 6.1 6.9 5.3 5.3 6.3 7.2 6.1 3.0 2.8 2.1 3.4 1.6 3.3 4.2 28.7 16.0 14.0 40.1 30.3 55.3 26.4 32.1 19.4 35.5 26.7 14.7 24.3 37.1 22.9 53.3 16.7 18.4 35.0 14.2 50.9 23.2 154.5 18.3 21.0 35.3 23.3 26.5 117.0 17.4 20.0 24.9 13.3 26.9 21.0 16.8 26.0 28.7 39.9 42.1 91.8 12.1 22.4 50.3 107.9 56.8 20.5 45.7 42.7 104.9 67.0 28.8 21.6 66.9 67.7 20.9 12.4 18.8 21.3 34.1 14.7 76.1 19.2 32.2 19.7 27.3 39.9 39.4 30.4 20.9 64.5 55.1 31.0 30.6 12.9 40.9 UBOX5 "KIAA0860, RNF37, Ubce7ip5, UIP5" ENSG00000185019 "U-box domain containing 5" O94941 20 3107573-3160196 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028871 Approved Approved Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA028871: AB_10603140" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (1.77e-1)" "unprognostic (1.04e-1)" "unprognostic (2.18e-1)" "prognostic favorable (4.52e-5)" "unprognostic (2.58e-2)" "unprognostic (1.02e-1)" "unprognostic (3.11e-2)" "unprognostic (1.61e-1)" "prognostic favorable (1.80e-5)" "unprognostic (4.02e-2)" "unprognostic (9.71e-3)" "unprognostic (3.33e-1)" "unprognostic (5.58e-2)" "unprognostic (1.07e-2)" "unprognostic (1.61e-2)" 4.5 4.4 4.3 2.7 5.1 6.9 4.5 5.5 5.1 4.8 2.4 6.2 2.8 5.9 2.7 4.4 4.8 2.6 3.8 4.5 3.8 4.4 3.5 3.7 3.7 3.8 3.7 5.0 6.1 5.4 4.4 3.4 3.5 5.2 2.9 3.8 4.8 4.4 11.2 7.6 4.2 4.1 3.2 4.3 4.7 4.8 3.9 3.8 3.8 6.8 3.0 5.6 4.2 6.1 6.1 6.1 4.8 3.1 6.3 3.5 2.6 4.9 4.7 6.1 6.0 5.8 5.2 4.8 2.0 4.2 7.0 8.5 3.2 7.8 3.6 1.4 2.7 7.9 2.1 5.4 5.0 3.9 2.9 4.5 5.6 4.9 6.2 5.0 3.9 3.7 6.7 4.4 3.5 4.5 7.0 5.0 3.7 6.3 3.7 4.7 5.8 3.3 3.8 6.7 5.9 5.7 3.4 18.8 4.0 3.7 8.1 2.5 4.3 4.0 2.7 4.6 4.4 5.9 9.4 4.2 2.1 3.5 3.0 7.9 5.1 9.4 4.4 5.1 5.0 6.3 5.2 3.6 5.5 4.8 5.3 5.1 8.1 5.2 5.3 3.7 5.6 4.6 4.3 5.1 5.5 5.1 4.5 3.8 3.8 3.7 3.5 3.2 3.9 6.1 2.4 12.8 6.0 6.8 3.6 1.9 4.1 3.4 0.6 6.6 2.8 2.0 1.1 1.5 3.1 0.0 6.2 6.9 1.9 5.6 0.0 4.0 1.4 2.5 2.5 3.6 10.2 0.4 9.6 4.2 4.4 3.5 5.1 2.7 2.5 4.5 4.6 4.3 4.9 6.7 8.5 4.9 6.1 5.0 3.2 1.9 6.8 3.5 3.6 3.7 6.6 4.5 4.1 4.5 10.4 3.9 3.4 3.8 2.3 5.8 4.7 5.2 2.7 5.2 6.6 5.2 2.8 10.2 5.2 1.6 2.4 10.1 3.1 3.8 5.3 5.9 UCP2 "BMIQ4, SLC25A8" ENSG00000175567 "Uncoupling protein 2" P55851 11 73974672-73982843 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 278.1" "Cell type enhanced" "Detected in many" "dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025583, HPA075202" Approved Supported Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 3: T-cells - Adaptive immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "CAB025583: , HPA075202: AB_2732284" "unprognostic (1.13e-1)" "prognostic favorable (4.65e-5)" "unprognostic (8.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.08e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" "unprognostic (1.82e-3)" "unprognostic (2.07e-1)" "unprognostic (4.59e-2)" "unprognostic (1.13e-3)" "unprognostic (1.37e-1)" "prognostic unfavorable (7.80e-6)" "unprognostic (3.77e-2)" "unprognostic (1.58e-1)" "unprognostic (3.77e-3)" "unprognostic (3.88e-3)" 70.9 20.5 12.2 142.9 14.6 132.8 37.6 12.9 24.1 41.3 22.1 33.2 53.4 17.4 7.6 17.7 175.7 42.3 14.1 12.1 15.9 34.9 26.2 69.3 278.1 19.7 19.8 4.9 12.6 8.1 13.8 27.3 19.8 19.7 44.8 6.9 42.7 23.0 99.1 9.2 56.6 30.4 17.6 183.1 55.2 14.5 22.4 217.3 45.1 141.7 240.2 73.6 4.9 26.1 0.9 78.7 20.2 43.5 9.5 0.0 11.6 14.1 9.3 54.9 14.8 153.1 59.0 360.2 165.1 19.5 5.5 3.5 13.3 0.0 28.6 97.1 5.6 241.5 26.4 28.3 32.2 123.9 77.5 8.9 0.0 43.9 0.0 11.0 5.7 144.6 101.5 119.0 9.5 147.5 108.5 55.8 12.8 9.0 21.7 99.7 120.7 202.0 150.4 211.0 23.6 32.3 68.2 395.6 26.6 55.9 123.3 79.3 10.0 0.2 59.7 14.4 21.5 48.4 24.4 293.8 7.2 45.0 0.4 809.1 1116.7 1465.3 1462.8 1945.8 925.0 1914.8 1176.3 1233.5 1228.7 1851.8 1092.9 1143.1 154.2 1816.8 1692.3 3009.5 2589.5 2966.6 12.2 14.6 12.9 24.1 12.1 15.9 19.7 19.8 19.8 17.6 22.4 26.1 4.7 3.2 27.6 0.3 287.4 3.4 2.7 20.2 0.6 0.9 30.9 19.8 5.2 5.7 43.9 92.0 8.4 8.3 404.4 6.2 7.9 1.9 18.7 122.1 10.5 8.9 297.3 695.6 0.0 7.5 12.1 9.9 46.4 102.4 86.2 12.4 9.7 5.0 442.2 0.0 0.1 31.5 89.5 326.6 146.2 46.0 0.9 232.3 26.6 1.9 533.6 4.3 509.8 1.0 1.0 1.8 45.9 0.4 117.9 12.8 4.5 2.7 137.6 8.1 6.6 6.1 11.2 15.2 14.5 1.9 4.5 11.2 189.9 13.5 21.7 43.4 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844552 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 58.9;lymphoid tissue: 66.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7" "Region enriched" "Detected in single" 6 "cerebellum: 5.0" "Low region specificity" "Detected in many" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol NA NA 1500000 "Cluster 38: Basophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol Vesicles "HPA067117: AB_2685784, HPA073525: AB_2686615" "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 7.7 7.3 5.6 23.5 6.8 58.9 7.8 5.8 7.3 18.6 5.0 10.7 8.0 8.6 2.0 23.6 13.8 6.5 14.3 5.0 5.6 6.6 12.6 38.1 25.9 7.9 6.5 19.3 8.8 0.5 11.6 9.0 7.5 8.1 4.5 5.5 7.7 5.1 8.5 6.0 18.5 4.9 6.2 66.2 13.8 6.1 8.2 20.7 5.9 1.5 17.6 10.7 19.6 8.7 44.0 18.7 0.4 0.3 0.5 1.0 47.6 0.1 0.0 0.0 0.1 41.4 97.0 3.4 46.4 0.0 7.5 15.4 0.0 2.2 0.0 0.4 0.5 245.7 136.3 24.2 3.9 94.1 245.9 0.6 2.0 0.5 2.1 2.3 17.9 42.5 87.1 1.1 0.0 71.2 100.9 50.8 0.9 69.9 1.7 32.8 1.0 1.5 1.6 17.7 0.3 66.7 19.2 189.7 0.9 0.5 47.1 56.5 48.1 0.8 65.9 0.5 0.5 1.3 5.9 4.0 0.6 31.3 0.2 59.1 16.0 31.2 19.3 16.9 17.4 6.7 11.4 13.6 12.3 3.6 8.8 11.9 40.1 14.7 25.6 7.2 10.8 18.1 5.6 6.8 5.8 7.3 5.0 5.6 7.9 6.5 7.5 6.2 8.2 8.7 3.8 44.8 8.3 6.8 16.6 1.1 1.7 1.0 0.6 12.0 4.9 2.4 68.3 7.2 4.4 3.7 20.9 4.7 27.0 40.9 0.0 7.2 5.3 1.3 3.3 6.6 6.0 14.9 1.2 6.0 11.6 2.2 2.0 2.3 45.0 9.9 7.9 1.2 58.5 5.0 1.5 3.6 2.0 21.6 8.2 0.5 2.8 22.2 1.8 5.6 22.5 4.5 61.8 3.0 7.9 47.3 30.7 1.5 27.4 1.6 5.5 0.7 1.6 16.2 0.0 4.5 2.6 1.2 1.4 1.5 1.4 25.9 30.9 2.0 6.3 2.3 UQCC1 "BFZB, C20orf44, CBP3, FLJ10850, UQCC" ENSG00000101019 "Ubiquinol-cytochrome c reductase complex assembly factor 1" Q9NVA1 20 35302566-35412031 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 106.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 64.6;Inhibitory neurons: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034875 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Nucleoplasm, Actin filaments" "HPA034875: AB_10603226" "unprognostic (9.66e-2)" "unprognostic (3.93e-1)" "unprognostic (3.45e-1)" "unprognostic (8.72e-3)" "unprognostic (4.01e-1)" "unprognostic (1.31e-1)" "unprognostic (5.73e-2)" "unprognostic (2.75e-1)" "unprognostic (2.82e-2)" "unprognostic (7.66e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "unprognostic (6.72e-3)" "unprognostic (3.23e-1)" "unprognostic (3.60e-1)" "unprognostic (5.27e-2)" "unprognostic (1.34e-2)" 19.4 30.0 22.0 13.8 24.3 4.6 16.5 21.9 27.7 20.1 20.9 26.0 18.9 18.6 22.9 18.8 20.6 12.6 55.3 22.4 23.0 28.6 27.1 15.8 17.9 24.1 23.5 19.8 15.9 37.2 23.9 14.9 26.6 19.7 25.8 29.5 18.7 18.4 106.8 16.3 19.3 18.5 19.9 19.7 23.0 17.6 22.9 21.2 22.3 105.7 21.9 20.1 18.0 22.8 20.2 28.6 33.5 32.2 34.1 38.4 4.8 38.5 43.3 70.7 48.1 97.7 39.4 66.6 68.5 26.1 60.7 53.5 60.0 70.0 52.6 19.0 24.2 89.2 41.3 80.3 22.7 54.2 25.6 37.6 72.3 37.9 48.8 51.2 24.6 53.5 39.9 23.9 50.0 26.8 58.6 29.2 25.4 42.0 61.5 31.4 50.0 37.9 67.6 26.2 46.4 28.7 32.9 148.9 34.0 28.1 23.9 34.6 23.5 46.2 28.8 25.9 34.6 30.1 37.2 26.5 79.7 31.1 36.8 28.6 10.2 14.2 14.8 14.3 18.3 12.3 13.7 14.7 16.0 15.7 16.7 14.7 0.3 22.3 10.2 14.4 14.2 12.6 22.0 24.3 21.9 27.7 22.4 23.0 24.1 23.5 26.6 19.9 22.9 22.8 7.0 0.0 7.8 51.6 7.0 6.4 9.3 18.1 6.8 20.7 7.8 5.8 44.0 10.0 11.8 16.5 8.4 22.9 5.3 13.9 60.7 18.2 15.1 10.5 8.5 10.5 12.0 5.2 64.6 13.1 15.7 9.2 7.7 6.9 8.2 17.5 6.1 14.2 11.6 18.5 68.9 9.1 18.3 6.6 3.9 8.6 10.5 5.8 14.2 33.7 13.2 16.7 10.3 44.2 50.3 19.1 6.6 12.0 5.0 8.4 10.9 19.4 14.8 22.8 6.6 9.6 11.9 24.6 18.2 6.2 5.3 17.4 6.2 19.7 13.2 9.6 URGCP "DKFZp666G166, DKFZp686O0457, FLJ20654, KIAA1507, URG4" ENSG00000106608 "Upregulator of cell proliferation" Q8TCY9 7 43875894-43926411 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019879, HPA020134, HPA029468" Approved Supported Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA019879: AB_1858651, HPA020134: AB_1858652, HPA029468: AB_10601831" "unprognostic (5.66e-2)" "unprognostic (1.10e-3)" "unprognostic (1.18e-1)" "unprognostic (2.75e-1)" "unprognostic (2.21e-3)" "unprognostic (2.42e-2)" "unprognostic (3.74e-2)" "unprognostic (1.26e-1)" "unprognostic (3.79e-1)" "unprognostic (2.21e-1)" "unprognostic (3.23e-3)" "unprognostic (3.71e-1)" "prognostic favorable (1.90e-4)" "unprognostic (1.56e-2)" "unprognostic (8.69e-2)" "unprognostic (4.51e-2)" "unprognostic (1.69e-3)" 15.9 35.6 25.1 9.9 24.6 10.3 15.0 24.5 25.9 19.7 24.1 22.6 24.3 17.7 14.7 17.8 19.5 11.1 25.2 24.5 22.5 24.3 29.6 14.2 10.8 20.7 20.0 20.7 19.1 22.1 27.4 11.9 21.3 21.6 19.0 20.1 15.6 16.1 34.9 18.6 22.8 18.7 19.2 18.5 17.4 9.7 23.4 10.4 18.7 31.6 10.6 20.4 16.6 23.8 28.2 25.1 10.1 32.1 26.3 24.0 9.6 33.2 58.4 35.2 35.6 21.1 21.8 16.5 16.9 31.7 53.5 44.3 28.0 23.8 34.3 31.6 17.3 11.5 25.2 19.0 28.0 17.7 20.3 18.5 28.5 27.8 27.0 23.1 17.7 18.9 28.6 13.1 23.7 21.0 18.6 14.6 19.1 33.1 25.8 24.9 14.6 22.2 33.7 27.7 25.8 44.4 34.4 49.6 15.4 16.5 25.0 21.0 19.5 20.3 9.4 22.8 26.1 34.1 53.6 20.7 23.2 26.7 38.6 4.5 4.7 6.2 8.8 7.4 9.4 5.8 9.2 11.7 10.2 4.9 9.9 8.8 0.5 2.8 8.3 1.6 10.6 6.6 25.1 24.6 24.5 25.9 24.5 22.5 20.7 20.0 21.3 19.2 23.4 23.8 10.1 3.2 9.2 14.7 12.2 11.1 13.4 7.9 9.1 25.9 17.7 17.8 23.8 12.8 7.3 12.9 8.4 6.3 8.9 41.0 17.6 13.0 1.2 16.3 14.3 10.2 8.4 6.3 28.6 13.2 11.8 13.5 23.9 23.2 7.0 21.1 12.5 27.3 6.5 16.8 25.1 12.5 10.2 5.0 10.2 3.4 18.3 7.5 12.4 6.5 4.8 12.2 7.2 7.5 17.6 15.7 23.4 18.8 4.2 14.1 37.9 26.4 8.7 20.4 6.6 13.8 12.6 8.8 8.3 9.1 14.8 3.4 10.8 15.2 16.2 15.0 USP36 "FLJ12851, KIAA1453" ENSG00000055483 "Ubiquitin specific peptidase 36" Q9P275 17 78787381-78841441 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012082, HPA012395, HPA052860" Uncertain Supported Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Nucleoli rim" "Nuclear speckles" "HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974" "unprognostic (1.94e-2)" "unprognostic (2.80e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (5.18e-5)" "unprognostic (9.35e-2)" "unprognostic (1.98e-1)" "unprognostic (2.50e-3)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" "unprognostic (1.33e-1)" "unprognostic (1.68e-2)" "unprognostic (2.78e-2)" "unprognostic (1.31e-2)" "unprognostic (1.45e-1)" "unprognostic (1.81e-1)" "unprognostic (4.03e-3)" "unprognostic (1.78e-1)" 43.9 37.9 20.0 21.5 21.9 46.6 32.9 29.3 23.9 32.6 27.5 31.2 13.4 26.8 22.9 25.0 34.2 18.7 30.2 21.4 20.6 34.4 30.3 36.1 20.6 22.6 21.3 67.4 44.5 18.1 50.3 26.0 21.5 36.2 15.8 26.3 24.9 13.1 30.3 40.4 26.6 16.3 19.4 30.7 31.2 22.2 21.2 15.1 31.6 11.7 20.5 29.3 29.8 30.1 42.7 50.3 14.6 26.9 30.5 33.7 27.8 34.1 34.5 32.1 21.5 49.2 21.0 54.0 16.9 30.6 34.8 30.6 34.5 25.4 57.0 13.0 52.1 49.4 81.0 51.9 31.3 54.7 26.0 29.5 41.0 45.8 101.6 24.7 28.3 24.1 40.0 55.3 26.8 32.6 50.1 55.1 22.6 31.6 39.9 38.1 31.8 36.3 20.2 44.1 42.8 25.8 24.5 112.5 63.7 31.3 29.2 34.4 24.3 75.2 35.3 44.3 61.1 40.7 17.4 66.1 29.6 41.9 24.0 10.1 3.0 2.4 5.5 4.2 6.5 5.1 5.2 4.8 1.8 4.7 5.7 5.6 4.3 4.5 2.7 9.7 3.8 1.9 20.0 21.9 29.3 23.9 21.4 20.6 22.6 21.3 21.5 19.4 21.2 30.1 27.4 12.8 37.4 23.5 55.9 51.7 28.4 8.2 40.9 33.2 18.1 16.9 14.1 18.6 18.8 14.7 33.3 8.3 66.3 14.4 5.9 10.2 20.7 22.3 24.0 28.4 18.5 14.7 19.0 9.6 11.3 26.6 25.0 42.7 20.3 12.8 12.1 16.5 43.3 26.9 22.5 18.6 10.2 24.5 72.8 8.5 11.8 49.4 30.2 10.3 14.9 13.2 16.5 13.6 19.8 13.2 8.4 12.4 57.1 32.4 7.3 5.0 11.1 32.1 6.6 22.1 23.1 18.4 16.5 24.4 43.3 12.9 73.6 13.1 18.6 22.2 UTP23 "C8orf53, MGC14595" ENSG00000147679 "UTP23 small subunit processome component" Q9BRU9 8 116766505-116849463 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044418 Uncertain Approved Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA044418: AB_10961139" "prognostic unfavorable (5.18e-5)" "unprognostic (2.30e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (9.45e-3)" "unprognostic (7.73e-2)" "unprognostic (7.78e-2)" "unprognostic (1.77e-1)" "unprognostic (1.34e-2)" "unprognostic (8.62e-2)" "unprognostic (1.75e-2)" "unprognostic (5.78e-2)" "unprognostic (2.03e-1)" "unprognostic (7.15e-3)" "unprognostic (9.27e-2)" 11.8 7.9 5.6 10.1 6.6 33.2 9.6 8.1 6.7 7.8 4.3 7.1 6.2 9.6 6.5 7.2 8.1 7.9 7.1 5.7 6.0 6.8 7.4 7.8 15.4 5.6 5.5 13.7 9.7 8.1 4.8 9.6 5.7 8.1 5.6 9.6 9.0 6.4 8.6 8.0 7.8 7.4 6.1 10.3 7.7 6.8 5.4 8.2 12.3 6.2 8.9 7.9 5.9 9.0 22.0 22.7 12.9 11.3 17.9 21.3 9.8 21.9 13.3 14.1 15.6 23.8 14.2 34.4 20.5 10.5 14.1 16.1 18.2 12.8 17.4 33.5 35.3 42.5 18.3 16.2 19.1 21.2 19.7 18.6 13.8 15.7 19.1 9.2 15.4 25.9 27.7 22.6 14.1 38.3 50.2 12.4 11.8 35.9 44.1 28.1 14.2 29.7 8.9 19.8 22.7 18.3 14.2 53.8 21.5 6.5 25.8 14.6 16.4 14.7 20.3 35.7 30.9 30.8 48.9 39.7 18.8 27.4 17.4 49.7 24.6 32.6 39.5 26.6 34.2 43.1 35.2 31.2 22.1 41.6 47.7 33.2 24.6 28.1 37.0 36.1 43.6 26.4 5.6 6.6 8.1 6.7 5.7 6.0 5.6 5.5 5.7 6.1 5.4 9.0 33.6 41.7 33.1 36.2 31.0 21.9 27.0 17.4 31.9 23.2 16.7 29.2 23.4 27.1 23.4 7.3 6.2 28.3 24.8 9.9 27.4 17.3 13.9 18.0 37.0 28.7 12.0 12.4 62.6 20.7 17.9 32.9 21.9 20.6 41.8 24.3 25.0 13.8 16.6 16.8 62.2 16.6 14.2 12.6 10.5 4.8 28.9 18.5 10.6 15.9 24.0 27.4 20.6 42.3 43.0 12.4 9.4 28.6 32.0 28.7 9.0 16.2 19.2 22.4 13.1 39.5 26.4 44.0 20.3 26.6 16.2 19.8 29.5 28.8 16.6 19.1 VAPB "ALS8, VAP-B, VAP-C" ENSG00000124164 "VAMP associated protein B and C" O95292 20 58389229-58451101 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013144, CAB013722" Supported Enhanced "Endoplasmic reticulum" NA NA 240000 "Cluster 32: T-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" "CAB013722: , HPA013144: AB_1858717" "unprognostic (3.28e-3)" "unprognostic (3.88e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" "unprognostic (9.36e-2)" "unprognostic (3.15e-2)" "unprognostic (4.76e-3)" "unprognostic (2.80e-1)" "unprognostic (4.47e-2)" "unprognostic (8.06e-3)" "unprognostic (3.11e-2)" "unprognostic (2.99e-1)" "prognostic favorable (1.08e-8)" "unprognostic (1.05e-1)" "unprognostic (5.31e-1)" "unprognostic (6.34e-3)" "unprognostic (2.99e-2)" 15.7 36.4 32.1 11.2 30.4 4.2 14.2 29.6 30.1 13.7 20.3 24.2 19.6 16.4 10.3 19.3 14.9 9.7 29.4 28.8 33.5 24.8 35.0 14.1 9.6 34.6 34.0 17.9 18.9 27.9 21.0 9.2 36.2 17.8 9.9 14.3 16.2 12.3 46.4 13.0 18.2 11.6 36.4 15.0 19.0 8.8 37.0 12.2 23.3 39.6 6.7 18.1 12.9 31.5 31.0 30.4 33.6 18.0 30.3 12.5 29.5 27.0 11.2 41.0 20.1 123.0 29.0 27.2 37.7 18.3 32.3 57.6 27.1 38.9 24.6 12.8 20.2 16.5 32.2 38.9 30.2 15.5 19.8 28.9 44.4 22.8 18.7 19.8 20.5 26.7 39.5 14.9 20.0 96.7 24.5 30.6 17.7 60.2 40.0 24.2 31.3 18.0 31.6 40.7 47.1 32.6 44.7 117.0 48.0 18.4 48.0 23.2 28.6 65.8 31.9 33.3 36.9 19.9 23.1 31.4 55.7 16.8 33.8 2.1 2.3 3.1 3.9 2.4 4.5 2.8 4.6 3.2 2.3 2.3 3.3 4.8 3.7 3.7 3.0 2.3 2.7 2.6 32.1 30.4 29.6 30.1 28.8 33.5 34.6 34.0 36.2 36.4 37.0 31.5 22.5 44.8 26.8 31.6 18.7 11.7 13.5 17.2 23.9 29.7 23.6 21.1 46.5 24.3 16.6 31.3 29.2 34.8 20.7 28.6 35.2 35.1 5.0 18.2 20.9 23.2 21.7 18.7 34.3 30.5 50.3 24.0 20.4 16.0 9.5 23.3 15.7 40.3 16.1 35.3 34.7 23.4 22.4 18.5 10.0 6.1 18.6 17.3 14.2 40.3 22.8 34.3 20.6 35.2 43.7 37.5 22.4 25.2 14.0 17.7 38.9 42.9 19.1 29.7 13.1 22.2 26.0 22.0 29.4 18.2 10.5 44.5 20.5 37.4 27.6 16.6 VPS16 ENSG00000215305 "VPS16 core subunit of CORVET and HOPS complexes" Q9H269 20 2840703-2866732 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043229, HPA048661" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA043229: AB_2678373, HPA048661: AB_2680484" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (7.13e-3)" "unprognostic (2.22e-1)" "unprognostic (3.72e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (1.43e-4)" "unprognostic (9.30e-2)" "unprognostic (5.48e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.89e-5)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.02e-5)" "unprognostic (1.33e-1)" "unprognostic (1.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.22e-3)" 18.2 16.0 9.9 18.2 10.1 23.1 17.6 9.7 11.2 21.3 10.6 17.6 16.9 22.1 10.7 16.4 18.3 13.8 12.8 10.4 10.3 14.8 15.9 17.9 17.9 12.0 9.7 19.1 21.9 19.5 16.0 14.0 11.0 17.9 10.9 8.9 19.1 12.7 18.5 21.5 20.8 20.4 9.1 23.5 18.1 11.3 10.6 21.1 22.5 14.7 17.3 17.0 17.8 10.1 27.1 36.7 28.8 27.8 27.5 30.1 16.0 24.0 31.3 27.5 24.8 22.1 25.5 18.3 16.6 27.6 43.9 34.6 25.0 45.5 14.8 30.0 20.7 21.4 15.4 24.4 27.8 21.6 21.3 38.7 21.0 32.6 21.1 18.1 27.5 35.2 30.6 30.2 23.9 28.2 20.4 40.1 27.3 42.7 30.4 26.4 20.8 28.2 26.0 24.8 23.9 39.6 25.7 57.1 26.7 18.7 29.3 26.2 24.0 27.0 24.7 17.6 16.3 40.9 44.4 17.0 12.7 38.6 26.1 24.0 25.8 28.4 35.2 24.6 19.5 12.3 15.4 22.6 32.1 9.1 15.8 20.4 14.5 34.3 29.5 10.6 25.7 25.5 9.9 10.1 9.7 11.2 10.4 10.3 12.0 9.7 11.0 9.1 10.6 10.1 12.7 12.8 15.9 1.3 10.4 6.0 14.5 13.7 8.6 14.4 9.7 7.6 7.5 18.6 11.0 12.9 8.4 14.2 18.7 24.8 9.8 16.1 2.6 8.2 11.9 11.5 5.4 8.6 4.2 13.2 17.8 12.9 16.3 6.9 7.0 11.8 10.0 15.5 23.3 23.5 4.1 13.0 12.2 18.4 8.8 3.3 13.1 15.2 14.2 1.9 22.3 20.8 33.0 3.0 3.5 13.0 11.6 9.4 12.8 5.6 33.2 19.4 11.2 15.0 13.1 8.4 17.9 20.9 16.1 8.0 3.8 14.1 17.4 17.6 13.9 9.2 VPS37C FLJ20847 ENSG00000167987 "VPS37C subunit of ESCRT-I" A5D8V6 11 61130257-61161615 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 1.4;eosinophil: 1.7;intermediate monocyte: 2.6;myeloid DC: 1.0;neutrophil: 3.8;non-classical monocyte: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.0;granulocytes: 3.8;monocytes: 2.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043348 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles Nucleoplasm "HPA043348: AB_10794658" "unprognostic (1.97e-1)" "unprognostic (1.35e-1)" "unprognostic (2.50e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-1)" "unprognostic (9.01e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (7.42e-2)" "unprognostic (1.14e-1)" "unprognostic (3.00e-1)" "unprognostic (3.41e-2)" "unprognostic (3.17e-2)" "prognostic favorable (2.37e-7)" "unprognostic (1.99e-1)" "unprognostic (1.08e-1)" "unprognostic (3.85e-1)" "unprognostic (7.05e-2)" 14.1 13.8 11.5 13.2 10.9 10.3 14.0 10.0 12.2 14.3 11.9 17.7 17.1 15.9 5.2 22.0 12.5 11.2 15.8 12.6 9.9 16.8 10.7 14.5 8.1 11.9 11.6 14.1 24.1 11.9 20.1 14.1 10.5 20.9 10.5 22.7 23.3 14.6 23.6 22.2 15.5 14.5 9.6 13.3 27.7 15.3 12.0 6.2 12.1 11.8 10.0 18.3 15.9 11.4 33.8 13.1 16.7 16.1 8.0 16.6 37.2 16.4 44.0 23.9 16.2 15.7 15.6 8.8 22.5 22.5 19.7 18.5 15.2 17.3 12.3 19.2 11.4 11.2 9.0 17.8 25.7 9.0 13.7 15.0 26.3 20.6 25.7 14.3 15.8 6.0 29.6 14.6 16.4 41.1 2.0 13.7 20.6 14.7 18.8 3.1 7.2 21.4 18.9 17.2 10.3 25.1 16.4 52.2 28.8 14.0 49.5 22.2 12.1 23.9 17.2 24.4 20.8 6.9 10.0 7.2 21.6 11.1 16.5 0.4 1.4 1.7 0.3 2.6 0.4 0.5 0.2 0.4 1.0 0.5 0.3 0.1 3.8 0.2 2.4 0.1 0.2 0.7 11.5 10.9 10.0 12.2 12.6 9.9 11.9 11.6 10.5 9.6 12.0 11.4 6.3 16.0 6.0 5.9 4.1 12.5 14.3 9.4 10.2 5.8 14.9 9.3 7.5 12.8 10.0 12.9 10.4 30.6 1.2 15.6 11.7 17.4 8.9 5.0 4.0 11.2 16.3 4.2 8.9 19.8 20.9 10.6 13.7 6.8 0.0 5.1 7.1 6.7 17.3 25.2 7.1 18.3 8.2 13.7 11.4 6.5 7.8 13.9 7.2 13.1 12.3 11.5 2.1 4.5 8.3 21.7 11.3 13.5 2.2 17.7 19.0 7.2 12.2 41.7 0.0 6.7 9.2 12.9 16.7 8.4 19.9 35.2 2.9 7.4 10.6 14.5 VPS52 "ARE1, SACM2L" ENSG00000223501 "VPS52 subunit of GARP complex" Q8N1B4 6 33250272-33272047 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 45.3;THP-1: 39.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042667, HPA048128" Approved NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "HPA042667: AB_2678105, HPA048128: AB_2680278" "unprognostic (2.65e-2)" "unprognostic (2.13e-1)" "unprognostic (9.44e-2)" "unprognostic (1.03e-3)" "unprognostic (6.07e-3)" "unprognostic (3.13e-1)" "unprognostic (2.28e-2)" "unprognostic (4.38e-2)" "unprognostic (1.49e-3)" "unprognostic (2.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.21e-1)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.17e-1)" "unprognostic (3.33e-2)" "unprognostic (7.63e-2)" 20.1 28.1 2.4 8.2 3.6 3.8 21.6 2.2 4.8 24.6 5.6 23.6 9.9 23.2 8.3 29.9 20.7 7.3 20.0 2.4 4.0 21.6 24.3 18.2 12.4 4.6 3.0 24.9 25.3 0.0 26.2 3.2 3.9 22.7 6.2 2.9 24.0 2.7 37.8 27.6 25.1 7.0 2.3 27.6 23.7 17.9 3.4 10.4 27.9 23.3 10.0 22.4 24.0 4.0 0.1 6.6 0.4 26.4 9.3 9.2 24.7 0.0 0.0 0.0 0.0 11.1 0.0 0.0 18.1 0.0 10.9 20.2 25.3 0.0 0.0 0.0 2.9 0.0 6.6 13.4 11.2 0.0 24.2 0.0 0.0 0.0 17.8 16.4 11.8 10.5 27.1 2.0 0.0 0.1 0.4 0.0 20.8 11.0 16.7 9.9 4.0 27.5 15.0 17.4 0.0 16.3 13.1 45.3 14.4 0.0 0.8 39.1 0.0 13.7 7.0 16.0 22.2 0.0 0.0 18.7 0.0 11.5 0.0 5.7 4.5 4.1 2.8 3.6 2.1 2.4 3.0 4.1 3.7 2.2 3.3 4.0 2.0 4.9 2.9 1.7 4.5 4.2 2.4 3.6 2.2 4.8 2.4 4.0 4.6 3.0 3.9 2.3 3.4 4.0 8.4 12.8 13.0 18.9 8.8 6.6 6.3 9.0 10.8 13.0 12.2 10.4 1.3 10.0 9.3 3.7 2.1 16.7 6.9 17.7 7.9 11.0 7.8 10.0 8.8 8.7 7.2 7.8 10.7 11.8 16.0 7.3 18.3 14.2 1.3 10.7 11.4 19.1 11.4 6.7 11.1 14.5 12.2 14.1 4.6 7.2 6.8 8.5 7.2 15.9 11.4 13.3 2.1 7.5 16.4 9.7 7.7 9.1 14.2 4.3 13.7 8.9 10.6 12.6 13.1 7.0 6.9 25.7 14.2 15.4 8.7 17.6 6.6 8.4 12.5 6.4 VTCN1 "B7-H4, B7H4, B7S1, B7x, FLJ22418" ENSG00000134258 "V-set domain containing T cell activation inhibitor 1" Q7Z7D3 1 117143587-117210960 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 100.9;fallopian tube: 32.7;pancreas: 30.1" "Cell type enhanced" "Detected in some" "Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1" "Group enriched" "Detected in many" 6 "breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SK-BR-3: 244.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054200 Approved Approved "Plasma membrane,Cell Junctions,Focal adhesion sites" No NA "Cluster 5: Breast - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "Cell Junctions, Focal adhesion sites" "HPA054200: AB_2682415" "unprognostic (4.13e-1)" "unprognostic (1.71e-3)" "unprognostic (2.95e-1)" "unprognostic (3.44e-2)" "unprognostic (1.71e-3)" "unprognostic (2.56e-1)" "unprognostic (7.94e-2)" "unprognostic (4.86e-2)" "unprognostic (3.53e-1)" "unprognostic (1.17e-2)" "unprognostic (4.54e-2)" "unprognostic (5.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.06e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-1)" "unprognostic (1.45e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 100.9 0.0 0.0 15.3 0.0 0.0 0.4 4.5 5.0 0.4 32.7 5.0 0.2 0.0 0.0 17.3 1.1 0.7 0.0 0.0 0.0 0.1 30.1 0.0 0.1 0.8 0.0 3.0 0.0 0.0 22.1 7.8 0.2 2.8 0.0 0.1 0.0 0.0 3.6 1.1 0.1 0.1 0.0 0.0 0.0 3.2 0.1 0.0 1.0 0.1 1.7 0.0 0.0 0.0 44.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 7.5 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.9 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 4.2 0.1 1.2 0.0 0.0 244.8 0.1 29.9 14.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 2.5 6.9 0.0 0.0 62.3 18.4 1.1 0.0 22.6 55.2 0.0 3.4 1.1 0.0 0.0 83.6 2.5 42.7 4.4 0.6 0.0 0.0 0.8 34.2 1.4 0.4 0.0 79.1 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 6.1 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.3 11.3 0.0 0.0 0.0 1.6 0.0 0.3 8.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 3.0 0.5 0.0 0.0 4.8 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 18.1 18.6 10.5 18.5 16.9 21.3 19.6 14.9 13.2 17.2 16.5 18.5 18.1 16.2 15.7 16.6 13.3 17.8 16.1 11.1 12.5 22.9 18.5 17.1 19.6 14.7 13.7 15.6 13.0 24.8 9.5 21.2 14.6 17.4 20.1 11.4 14.3 16.1 15.9 13.6 14.7 20.2 14.0 19.3 16.1 9.5 13.8 21.8 23.3 18.5 21.0 21.1 10.3 24.7 40.0 45.4 24.9 30.6 55.3 58.8 16.3 42.0 63.6 43.0 45.8 17.0 42.1 36.1 29.1 54.1 25.3 30.6 40.2 37.7 56.8 47.5 23.1 48.1 26.5 22.8 53.8 14.8 46.6 58.7 25.1 35.5 31.2 33.2 49.9 30.9 28.3 35.6 53.0 87.6 44.3 11.8 23.7 66.7 46.7 29.8 22.4 36.7 33.2 48.5 13.1 26.3 48.8 109.2 39.5 25.8 47.3 25.5 44.7 23.6 51.9 39.4 37.7 31.7 31.2 31.7 62.4 27.5 33.4 10.4 17.0 12.5 13.5 20.9 14.3 9.5 12.8 13.9 19.7 10.6 10.1 14.3 5.8 17.2 29.3 7.2 16.9 13.0 10.5 16.9 14.9 13.2 11.1 12.5 14.7 13.7 14.6 14.0 13.8 24.7 10.9 3.2 19.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 14.4 9.3 0.0 0.0 5.0 11.0 0.0 13.4 6.9 0.0 5.9 12.2 0.0 9.9 13.5 4.9 0.0 0.0 0.0 17.2 11.0 5.4 0.0 14.8 8.8 11.1 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.9 0.0 0.0 17.2 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 3.8 9.6 0.0 0.0 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 9.9 9.2 5.2 9.5 5.4 12.9 9.2 6.2 5.6 7.6 6.8 10.6 9.3 7.8 4.3 13.4 7.4 6.1 7.7 5.4 5.8 9.4 12.3 8.8 10.1 6.4 5.6 7.5 11.1 6.1 9.0 7.6 6.0 8.8 10.3 4.0 10.5 5.4 9.1 11.0 11.0 6.4 5.4 12.6 10.5 4.9 5.7 7.8 7.4 6.0 10.6 8.9 7.9 5.9 13.2 18.0 8.5 34.4 12.8 10.1 23.7 12.9 15.5 13.3 15.2 31.1 17.7 12.3 16.8 16.6 24.3 16.1 11.5 22.4 10.2 11.6 9.6 14.1 15.9 12.7 12.2 14.8 25.5 12.2 12.7 18.3 9.6 9.2 14.4 13.7 9.9 9.3 14.9 19.2 14.0 13.3 8.9 18.9 15.2 11.6 12.2 11.6 15.9 19.7 8.3 11.1 17.7 51.3 20.2 10.4 36.3 15.8 13.0 17.5 9.0 20.3 17.6 15.6 12.9 9.6 22.7 19.5 10.6 6.4 10.2 7.8 11.3 16.6 11.7 8.5 10.5 9.8 9.9 7.3 8.3 8.5 9.0 10.3 14.2 7.2 12.6 10.0 5.2 5.4 6.2 5.6 5.4 5.8 6.4 5.6 6.0 5.4 5.7 5.9 17.1 9.6 16.7 5.9 16.9 14.5 10.9 9.1 9.6 13.5 15.5 10.3 5.3 5.7 16.2 18.4 12.5 21.6 28.9 31.9 21.5 20.2 29.3 20.6 13.1 12.9 14.9 13.9 7.2 28.2 42.8 12.6 25.0 13.9 19.7 16.4 12.5 14.9 20.8 23.5 7.0 22.6 8.2 16.1 13.9 9.7 9.6 18.3 8.8 1.0 20.5 5.7 23.7 4.5 6.5 27.2 39.3 7.5 23.0 15.6 24.9 20.8 17.2 8.3 13.1 13.0 14.1 7.9 9.8 15.1 13.4 23.3 21.0 14.2 26.0 16.4 WIPF2 "WICH, WIRE" ENSG00000171475 "WAS/WASL interacting protein family member 2" Q8TF74 17 40219304-40284136 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 99.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024000, HPA024001, HPA024467" Enhanced NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA024000: AB_1858840, HPA024001: AB_1858841, HPA024467: AB_1858842" "unprognostic (1.90e-1)" "unprognostic (1.02e-1)" "unprognostic (2.59e-1)" "unprognostic (6.07e-2)" "unprognostic (2.63e-2)" "unprognostic (1.83e-1)" "unprognostic (5.18e-3)" "unprognostic (1.92e-1)" "unprognostic (2.05e-1)" "unprognostic (8.51e-3)" "unprognostic (2.05e-2)" "unprognostic (4.34e-2)" "unprognostic (1.32e-3)" "unprognostic (4.12e-1)" "unprognostic (7.51e-2)" "unprognostic (5.28e-2)" "unprognostic (9.23e-2)" 10.9 7.1 10.4 10.0 9.9 17.4 8.4 11.1 18.8 9.6 2.2 14.3 12.0 10.3 9.3 14.9 9.3 10.0 6.4 11.4 12.0 12.2 7.5 12.7 8.5 8.0 8.3 7.8 10.3 12.4 7.4 12.0 6.2 8.5 13.5 9.4 9.0 10.3 6.9 15.4 13.3 11.8 3.7 11.9 12.8 6.6 10.9 7.8 9.0 6.8 11.3 9.3 10.2 9.1 23.4 36.0 15.3 14.5 15.6 16.4 15.1 20.5 14.1 18.5 19.8 17.7 20.1 13.7 22.8 24.8 23.0 39.4 13.1 15.7 24.3 24.7 15.9 14.8 17.6 21.3 15.9 19.7 16.1 13.2 19.3 19.3 21.8 19.9 18.2 14.6 14.3 12.5 18.0 15.3 19.5 9.9 9.2 17.5 11.1 12.5 18.6 13.6 19.8 38.2 18.8 13.1 37.3 99.2 13.6 26.0 33.5 12.1 26.5 12.5 18.7 24.0 23.8 13.9 23.3 13.9 27.5 10.3 18.9 5.2 2.0 2.4 3.3 1.8 2.7 3.0 1.9 2.0 1.5 2.2 2.2 1.9 7.1 2.6 2.1 2.5 2.4 1.0 10.4 9.9 11.1 18.8 11.4 12.0 8.0 8.3 6.2 3.7 10.9 9.1 28.4 67.3 39.5 71.2 32.5 43.1 33.8 28.7 29.6 38.0 35.7 23.6 11.8 41.5 25.2 46.0 45.9 50.7 29.4 102.5 13.7 29.0 3.9 31.8 27.8 35.5 47.3 17.2 71.8 36.6 31.5 24.5 35.2 54.9 38.1 23.6 43.2 25.3 30.3 42.1 52.7 33.9 26.4 48.3 31.7 3.4 20.2 27.9 16.0 37.5 32.2 20.8 33.0 36.2 36.5 52.0 57.5 25.9 15.9 44.6 60.3 26.4 22.3 17.2 39.5 26.9 23.3 20.6 34.2 54.9 69.0 67.5 31.1 15.9 36.4 70.7 WWP1 "AIP5, DKFZP434D2111" ENSG00000123124 "WW domain containing E3 ubiquitin protein ligase 1" Q9H0M0 8 86342547-86478420 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 171.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023180 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Golgi apparatus, Plasma membrane" "HPA023180: AB_10602587" "unprognostic (3.89e-1)" "unprognostic (6.63e-2)" "unprognostic (3.81e-2)" "unprognostic (7.91e-2)" "unprognostic (3.70e-1)" "unprognostic (1.02e-1)" "unprognostic (1.93e-1)" "unprognostic (4.24e-2)" "unprognostic (1.83e-1)" "unprognostic (9.43e-3)" "unprognostic (3.09e-3)" "unprognostic (1.48e-1)" "prognostic favorable (5.45e-5)" "unprognostic (2.35e-1)" "unprognostic (4.63e-1)" "unprognostic (3.19e-3)" "unprognostic (1.01e-1)" 33.6 22.1 16.3 25.8 21.5 18.2 40.6 19.6 16.3 23.6 24.3 26.9 26.3 23.0 24.6 33.1 18.5 45.3 50.8 14.3 20.7 40.9 111.7 27.2 39.0 18.3 19.0 24.7 28.0 116.3 9.8 36.9 19.7 33.4 33.1 43.2 25.9 25.6 171.4 40.8 28.1 24.6 18.1 45.7 34.3 29.5 19.5 22.7 32.6 122.2 30.6 33.7 15.8 23.1 59.8 27.1 18.3 13.1 23.0 22.4 16.3 21.0 22.5 16.5 19.5 18.9 35.3 24.9 14.0 36.5 22.9 49.3 26.4 34.1 28.5 31.6 21.0 28.7 24.4 44.7 16.8 11.7 14.0 20.5 42.5 18.2 33.3 25.3 74.1 29.0 14.3 28.7 28.4 29.6 27.7 8.1 11.2 82.6 30.0 18.0 21.4 22.5 37.3 44.5 5.5 12.9 21.2 104.7 23.0 39.8 31.3 10.8 84.4 23.9 28.7 26.3 10.7 33.9 22.0 25.7 29.9 1.6 19.0 6.2 2.1 3.9 5.2 1.9 4.6 2.7 6.4 5.3 1.5 2.4 7.5 4.7 1.3 2.4 2.2 1.9 6.5 2.0 16.3 21.5 19.6 16.3 14.3 20.7 18.3 19.0 19.7 18.1 19.5 23.1 51.2 25.6 22.6 29.0 13.0 35.8 26.9 15.4 26.7 28.8 41.7 23.5 82.7 44.3 19.2 29.5 58.4 28.3 19.5 23.7 43.0 20.5 42.1 22.6 20.1 32.3 23.6 3.0 55.3 37.6 3.3 27.6 35.2 35.5 3.8 18.0 62.4 88.8 55.9 40.4 134.6 25.3 14.2 95.2 28.1 12.7 32.3 43.0 30.2 61.8 18.6 23.3 18.6 60.3 103.8 45.1 16.0 36.5 18.5 45.1 15.8 45.7 17.2 52.6 6.6 18.8 16.6 12.4 21.2 28.8 39.5 23.0 32.0 25.1 19.7 38.3 ZBTB10 "FLJ12752, RINZF" ENSG00000205189 "Zinc finger and BTB domain containing 10" Q96DT7 8 80485619-80526265 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 48.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021554, HPA050569" Enhanced Enhanced Nucleoplasm NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA021554: AB_1858937, HPA050569: AB_2681179" "unprognostic (7.97e-2)" "unprognostic (3.53e-1)" "unprognostic (2.26e-1)" "unprognostic (6.67e-2)" "unprognostic (9.28e-2)" "unprognostic (8.97e-3)" "unprognostic (1.29e-2)" "unprognostic (1.87e-1)" "unprognostic (1.13e-1)" "unprognostic (4.86e-1)" "unprognostic (3.66e-2)" "unprognostic (2.15e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.65e-3)" "unprognostic (2.40e-1)" "unprognostic (7.15e-2)" "unprognostic (2.63e-2)" 7.9 7.9 4.1 4.8 5.2 23.7 8.2 12.1 4.4 8.7 3.9 6.9 2.0 11.2 6.1 3.7 11.8 7.4 7.5 3.3 5.1 10.2 18.5 6.2 5.3 4.9 4.4 12.7 14.0 7.1 3.5 17.8 5.0 14.1 7.8 7.3 7.6 6.3 5.4 1.9 2.2 8.9 4.3 7.0 4.6 11.2 4.7 8.6 10.1 8.0 3.4 5.5 3.3 5.7 0.0 4.2 21.1 10.7 9.1 6.9 28.5 3.9 0.0 3.0 3.0 9.2 3.4 12.7 11.0 5.8 9.2 0.9 16.7 5.3 3.5 0.0 26.8 6.5 2.8 7.3 5.3 2.2 2.9 6.5 4.6 3.7 10.6 2.5 7.7 10.5 5.9 24.2 2.5 6.7 12.6 5.5 5.3 1.3 6.6 14.7 11.1 4.5 8.4 12.5 12.6 14.6 5.2 48.5 14.8 23.6 9.4 9.1 9.9 7.3 13.5 0.1 3.6 7.0 3.7 14.0 2.8 0.0 9.1 0.1 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.2 0.1 0.4 0.3 0.3 0.0 0.5 0.2 0.9 0.0 0.0 4.1 5.2 12.1 4.4 3.3 5.1 4.9 4.4 5.0 4.3 4.7 5.7 37.1 25.6 17.0 18.9 55.3 28.4 21.1 8.1 44.3 13.4 48.8 39.8 36.1 25.8 11.8 12.9 16.7 38.3 34.1 38.9 3.9 13.1 83.7 82.4 60.6 34.5 60.4 3.0 12.8 6.9 41.0 29.3 40.8 142.6 9.5 37.0 16.8 31.7 13.3 32.0 11.1 43.0 20.3 21.3 79.6 29.7 19.3 32.0 49.8 13.1 11.2 20.8 8.2 19.6 13.4 8.3 14.8 21.1 24.5 82.1 0.4 14.5 19.4 10.6 26.3 46.6 49.5 14.6 10.6 13.6 12.6 105.2 28.4 19.6 34.7 19.6 ZBTB41 "DKFZp686C06120, FLJ36199, FRBZ1, ZNF924" ENSG00000177888 "Zinc finger and BTB domain containing 41" Q5SVQ8 1 197153682-197201293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034841, HPA034842" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nuclear membrane, Cytosol" Nucleoplasm "HPA034841: AB_2674355, HPA034842: AB_10669995" "unprognostic (2.36e-1)" "unprognostic (5.58e-3)" "unprognostic (8.01e-3)" "unprognostic (6.07e-2)" "unprognostic (4.14e-2)" "unprognostic (3.83e-2)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.43e-1)" "unprognostic (1.81e-2)" "unprognostic (2.81e-1)" "unprognostic (7.51e-3)" "unprognostic (2.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.98e-2)" "unprognostic (1.58e-1)" 3.5 4.7 5.0 3.0 4.7 1.3 7.0 6.6 5.8 5.2 2.2 3.2 3.2 4.2 4.7 3.4 3.7 4.3 3.2 4.6 5.8 5.3 4.4 3.4 3.9 5.5 6.1 6.8 4.0 4.8 3.9 3.3 5.6 4.2 3.5 7.0 3.9 3.4 3.6 3.5 2.9 3.2 6.0 4.4 4.3 3.8 5.8 5.2 7.5 4.7 3.3 3.9 2.4 6.9 8.1 4.6 5.8 4.7 9.0 13.6 4.6 4.8 7.8 4.9 4.6 2.9 6.7 3.0 6.8 10.9 3.0 6.5 4.1 4.1 7.7 2.7 2.4 2.4 6.0 2.6 8.0 4.8 2.3 5.6 10.6 5.0 8.6 10.0 3.4 3.4 5.7 3.5 12.8 3.9 3.6 2.7 2.3 5.6 1.6 2.5 8.1 5.4 6.0 4.5 8.3 7.4 8.6 14.9 9.3 4.2 11.4 3.6 5.6 9.7 5.6 7.8 6.3 4.0 2.2 3.2 4.6 1.7 13.8 0.3 0.1 0.1 0.2 0.1 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.4 0.0 0.4 0.1 0.1 0.2 0.1 5.0 4.7 6.6 5.8 4.6 5.8 5.5 6.1 5.6 6.0 5.8 6.9 11.6 19.2 8.9 21.2 9.4 7.5 6.9 5.8 11.4 13.6 17.5 10.7 14.7 10.0 10.0 16.5 2.1 4.3 10.6 4.2 1.9 6.3 3.2 14.5 18.0 8.2 13.1 1.7 32.1 5.7 4.0 13.3 7.7 11.3 1.3 18.5 6.8 9.2 4.4 25.2 27.9 7.3 2.0 7.3 5.2 4.6 15.5 8.1 12.4 13.1 9.3 28.5 11.3 19.6 41.0 6.8 2.9 12.0 6.3 9.4 4.3 10.4 12.8 9.1 6.6 13.3 12.7 7.0 4.9 10.8 10.1 3.4 7.7 16.0 7.0 6.0 ZC2HC1A "C8orf70, CGI-62, FAM164A" ENSG00000104427 "Zinc finger C2HC-type containing 1A" Q96GY0 8 78666089-78719765 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 44.6" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 105.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 45.1;T-reg: 33.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 42.1;SK-BR-3: 79.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024726 Approved Approved "Actin filaments,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 31: Skin - Epidermis development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Actin filaments" "HPA024726: AB_1846597" "unprognostic (1.12e-1)" "unprognostic (3.02e-1)" "unprognostic (5.36e-3)" "unprognostic (4.00e-2)" "unprognostic (1.13e-1)" "unprognostic (7.79e-2)" "unprognostic (1.19e-7)" "unprognostic (2.96e-1)" "unprognostic (7.25e-2)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.26e-1)" "unprognostic (1.63e-2)" "unprognostic (5.41e-2)" "prognostic unfavorable (5.85e-4)" "unprognostic (2.34e-1)" "unprognostic (5.40e-2)" "unprognostic (4.05e-3)" 6.5 5.5 8.4 5.7 9.5 1.6 13.8 11.0 9.9 10.7 1.7 6.2 2.7 19.5 8.4 11.1 19.0 9.7 8.2 9.4 8.4 7.7 2.3 12.6 5.3 9.3 6.9 22.7 3.7 24.0 8.5 6.6 10.1 12.2 7.3 10.9 7.3 9.9 2.4 44.6 4.2 12.1 6.3 5.8 5.5 8.8 7.6 5.1 19.7 6.3 8.4 9.0 8.8 10.9 5.2 6.3 11.6 9.5 24.1 25.2 5.0 14.1 9.4 6.9 8.8 1.7 9.0 8.6 5.8 14.2 14.5 4.2 7.0 7.8 10.1 28.6 4.5 1.0 5.5 5.2 14.3 1.5 2.8 18.2 13.0 5.6 16.8 21.1 9.6 2.9 1.6 42.1 14.6 5.1 1.7 2.5 2.9 0.4 9.9 0.0 14.8 1.8 10.4 11.0 4.5 18.0 11.0 79.2 15.8 10.7 2.0 0.3 7.9 21.4 8.9 9.9 7.1 10.5 11.4 5.8 10.1 0.1 8.3 45.1 6.7 0.2 0.1 7.5 0.0 8.8 6.7 0.4 6.0 6.3 2.0 0.7 0.3 1.2 15.9 0.5 33.3 2.7 8.4 9.5 11.0 9.9 9.4 8.4 9.3 6.9 10.1 6.3 7.6 10.9 21.7 67.3 23.7 71.8 17.0 29.2 38.7 39.9 52.3 26.3 12.3 47.5 15.9 5.7 27.4 18.4 4.2 29.0 1.0 1.8 27.4 18.1 16.3 55.5 38.0 17.5 9.0 1.7 96.4 8.2 29.9 34.5 13.3 25.8 6.3 18.8 21.8 0.8 15.9 47.1 68.3 4.2 16.2 6.0 11.3 5.9 19.3 11.1 16.0 14.0 18.5 39.2 0.0 65.9 52.4 9.4 2.4 36.9 12.5 13.1 0.1 11.8 105.5 25.5 6.6 32.0 33.9 48.6 32.2 26.0 42.3 17.4 6.5 9.4 4.4 14.6 ZFYVE19 "ANCHR, FLJ14840" ENSG00000166140 "Zinc finger FYVE-type containing 19" Q96K21 15 40807086-40815084 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040283, HPA041946" Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA040283: AB_10673369, HPA041946: AB_2677762" "unprognostic (3.59e-2)" "unprognostic (6.62e-2)" "unprognostic (1.15e-2)" "prognostic favorable (7.36e-4)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (1.84e-2)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (8.61e-2)" "unprognostic (7.69e-3)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (8.40e-3)" "unprognostic (1.72e-1)" 8.8 8.9 14.2 7.9 16.5 8.6 10.2 19.6 17.2 11.1 12.5 12.0 12.3 8.9 10.7 15.4 9.1 6.6 11.5 13.5 16.9 10.4 19.3 9.1 10.0 19.8 17.4 10.5 8.3 14.1 9.5 9.0 19.1 12.4 8.1 6.6 13.7 8.1 13.5 11.6 12.5 8.8 16.9 13.7 9.6 8.1 18.0 10.9 8.9 13.5 10.5 10.8 11.4 17.5 10.0 12.3 8.8 13.3 13.9 13.9 13.4 15.0 19.4 19.9 20.7 8.9 23.5 9.2 16.5 14.7 17.5 18.0 12.7 17.4 12.1 28.6 12.4 16.6 21.5 11.2 12.5 12.0 24.1 13.5 18.3 13.0 12.6 18.0 19.6 15.2 12.9 11.9 12.7 10.7 15.2 14.8 5.5 22.4 17.6 18.8 5.1 11.4 12.1 19.7 16.0 9.7 13.7 34.6 4.8 6.7 16.4 19.8 9.6 12.4 13.8 9.2 9.9 10.3 14.3 9.8 11.8 22.9 12.4 9.0 5.8 5.2 5.3 9.4 6.2 5.2 5.5 5.2 6.5 3.7 6.0 5.5 3.1 8.9 6.2 5.5 6.1 4.7 14.2 16.5 19.6 17.2 13.5 16.9 19.8 17.4 19.1 16.9 18.0 17.5 11.4 6.4 5.6 6.2 6.6 6.4 13.3 19.7 8.0 11.1 14.8 12.2 9.3 15.7 18.0 12.9 12.5 74.7 5.7 22.6 19.6 24.4 5.3 12.4 8.0 9.7 3.5 5.2 7.6 17.6 16.8 9.6 12.2 12.5 12.7 12.7 10.4 21.8 22.4 3.3 9.4 15.5 22.4 9.9 6.8 10.9 12.8 9.7 7.2 7.5 14.3 9.8 8.2 7.1 15.7 19.3 20.7 9.4 4.2 9.1 50.3 27.4 17.9 10.7 13.1 7.3 9.6 18.6 19.4 7.9 7.7 55.1 9.3 8.9 15.5 15.1 ZG16 "hZG16, JCLN, JCLN1, ZG16A" ENSG00000174992 "Zymogen granule protein 16" O60844 16 29778256-29782973 "Predicted secreted proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "intestine: 479.5" "Cell type enriched" "Detected in some" 10 "Intestinal goblet cells: 20216.0" "Cancer enriched" "Detected in some" 6 "colorectal cancer: 21.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-BR-3: 2.3" "Not detected" "Not detected" "HPA052066, HPA052512" Enhanced "Secreted to digestive system" NA NA 1300000 "Cluster 37: Intestine - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA052066: AB_2681716, HPA052512: AB_2681857" "unprognostic (1.64e-2)" "unprognostic (2.05e-1)" "unprognostic (2.60e-3)" "unprognostic (8.20e-2)" "unprognostic (3.50e-2)" "unprognostic (1.93e-2)" "unprognostic (5.14e-2)" "unprognostic (1.65e-1)" "unprognostic (7.77e-2)" "unprognostic (3.27e-1)" "unprognostic (2.56e-2)" "unprognostic (9.99e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" 0.5 0.0 0.0 7.8 0.2 0.1 0.7 0.1 0.1 0.0 0.0 362.9 57.8 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.4 22.2 0.0 0.2 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 479.5 0.1 0.0 0.5 0.0 0.1 136.9 12.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.6 0.0 1107.2 0.0 0.0 0.0 0.1 0.0 0.1 145.5 0.0 0.1 11.9 0.0 0.1 0.0 0.2 40.1 0.0 0.4 44.6 0.0 0.0 0.1 20216.0 0.0 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 484.8 0.0 0.0 0.2 1950.6 1.6 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.5 7.1 0.0 306.7 0.3 ZHX1 ENSG00000165156 "Zinc fingers and homeoboxes 1" Q9UKY1 8 123248451-123275541 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 146.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055357 Supported Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA055357: AB_2682793" "unprognostic (4.36e-3)" "unprognostic (6.73e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (8.73e-3)" "unprognostic (5.61e-2)" "unprognostic (9.22e-2)" "unprognostic (1.51e-1)" "unprognostic (2.01e-1)" "unprognostic (6.00e-2)" "unprognostic (7.97e-2)" "unprognostic (1.44e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (1.76e-2)" 28.2 14.8 24.5 12.1 24.3 13.5 18.7 27.0 28.1 20.8 21.3 15.6 18.4 17.4 15.2 37.0 18.5 15.1 15.2 23.3 31.9 22.9 39.5 14.4 12.6 25.4 27.7 20.8 17.2 22.8 12.7 14.3 26.5 17.9 14.8 35.0 17.4 18.6 15.5 27.8 19.3 19.2 23.1 15.8 14.8 10.1 24.1 19.8 37.7 19.4 15.0 19.8 17.9 29.4 29.7 13.2 18.0 21.3 34.3 28.3 11.6 35.3 19.6 25.6 29.6 23.5 12.4 44.7 46.1 42.8 11.4 19.6 51.3 32.5 32.4 89.5 26.5 72.6 29.1 14.2 23.3 26.9 33.3 21.4 36.9 35.1 30.0 21.9 20.5 21.2 86.0 34.1 38.3 89.7 62.0 12.1 4.8 62.1 27.7 31.3 16.2 32.0 22.9 66.0 86.3 32.1 40.3 113.6 14.1 10.5 45.4 30.6 19.3 40.1 53.4 32.6 23.8 32.1 95.1 49.6 27.2 49.7 11.2 1.5 3.6 3.6 3.8 6.4 4.8 3.3 4.8 3.5 4.9 3.9 4.5 4.8 1.3 6.5 14.0 2.7 5.7 2.9 24.5 24.3 27.0 28.1 23.3 31.9 25.4 27.7 26.5 23.1 24.1 29.4 35.0 25.6 25.7 0.0 15.7 37.1 28.0 19.7 47.3 46.3 28.8 27.1 30.7 25.8 26.8 20.2 47.9 10.4 22.8 33.5 31.3 16.6 10.9 13.0 52.5 30.8 43.3 19.8 0.0 22.3 6.6 33.0 19.4 13.8 28.5 19.1 28.9 71.5 15.0 146.4 0.0 23.1 14.2 24.2 19.0 21.7 46.6 19.4 26.6 0.0 20.5 46.3 27.8 0.0 0.0 16.7 25.8 64.3 15.3 21.2 35.8 33.2 21.4 34.3 39.5 34.4 38.0 38.5 27.6 84.4 62.5 9.6 20.0 27.0 22.8 29.2 ZHX1-C8orf76 ENSG00000259305 "ZHX1-C8orf76 readthrough" Q96EF9 8 123226189-123274284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 26.0" HPA023708 Uncertain Uncertain Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "HPA023708: AB_1845785" "unprognostic (1.06e-1)" "unprognostic (2.11e-1)" "unprognostic (1.37e-2)" "unprognostic (1.83e-3)" "unprognostic (1.13e-1)" "unprognostic (1.16e-1)" "unprognostic (2.49e-3)" "unprognostic (7.10e-2)" "unprognostic (1.91e-2)" "unprognostic (9.34e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-2)" "unprognostic (5.64e-11)" "unprognostic (1.79e-1)" "unprognostic (2.09e-1)" "unprognostic (1.98e-1)" "unprognostic (1.06e-2)" 2.7 2.4 1.4 1.1 1.8 8.5 2.5 2.1 1.8 2.3 1.3 1.8 2.0 1.8 1.8 2.8 2.1 1.1 2.5 1.3 1.4 2.3 2.6 2.9 2.4 1.8 1.7 2.3 1.6 1.1 3.6 1.7 1.6 2.5 2.4 2.9 2.5 1.3 4.1 2.5 1.9 1.6 1.2 3.0 1.8 1.4 1.9 2.2 2.1 1.9 2.7 1.9 2.3 2.3 3.4 4.3 3.1 2.2 1.9 2.1 2.0 1.5 1.5 3.6 2.7 3.5 2.6 2.0 1.3 2.5 2.1 2.2 3.5 1.9 5.4 3.5 7.3 5.9 3.1 4.2 1.9 1.2 3.1 2.8 2.8 2.9 1.8 1.5 4.2 5.9 4.9 2.8 3.2 10.6 5.0 3.9 0.8 6.8 4.7 3.9 2.0 2.8 2.5 3.4 4.8 3.4 3.0 26.0 1.6 1.7 3.9 1.1 0.3 1.5 3.0 2.5 3.4 3.9 5.2 4.3 2.1 3.2 1.1 1.7 2.9 4.8 2.0 4.1 1.9 2.7 2.6 1.8 2.5 2.9 2.1 1.8 1.0 2.7 2.9 2.3 4.9 2.0 1.4 1.8 2.1 1.8 1.3 1.4 1.8 1.7 1.6 1.2 1.9 2.3 2.5 0.0 1.1 4.6 2.0 3.1 5.3 2.5 0.0 0.4 2.2 2.0 1.1 1.5 2.7 3.7 0.0 1.9 5.2 0.9 1.9 1.8 1.4 1.0 1.0 1.7 3.0 0.0 2.0 1.8 2.6 1.8 0.0 0.8 0.0 1.7 2.2 0.8 2.7 10.1 2.8 2.2 4.1 1.3 2.1 1.4 0.9 2.0 1.8 0.0 2.4 0.9 3.1 4.5 4.9 2.2 0.5 1.2 0.7 2.9 1.6 1.3 4.3 1.4 0.0 1.6 1.4 2.7 2.5 0.4 1.4 1.0 1.3 0.8 1.4 7.0 ZMIZ1 "FLJ13541, hZIMP10, KIAA1224, MIZ, RAI17, RP11-519K18.1, Zimp10" ENSG00000108175 "Zinc finger MIZ-type containing 1" Q9ULJ6 10 79068966-79316519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 259.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 176.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045144, HPA071156" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA045144: AB_10962360, HPA071156: " "unprognostic (4.09e-3)" "unprognostic (1.72e-1)" "unprognostic (2.63e-1)" "unprognostic (5.59e-2)" "unprognostic (2.02e-1)" "unprognostic (2.86e-2)" "unprognostic (3.64e-3)" "unprognostic (1.06e-1)" "unprognostic (9.96e-2)" "unprognostic (1.16e-1)" "unprognostic (3.13e-2)" "unprognostic (7.90e-2)" "prognostic favorable (3.64e-7)" "unprognostic (2.42e-1)" "unprognostic (1.18e-1)" "unprognostic (8.22e-2)" "unprognostic (1.34e-2)" 34.0 24.4 24.5 19.2 27.1 26.6 27.7 25.1 30.1 44.7 5.2 28.1 19.2 51.5 18.8 37.5 26.5 25.9 31.8 25.8 27.5 17.2 8.7 26.5 17.5 34.5 36.0 48.5 23.3 19.2 12.5 21.7 29.9 19.5 14.5 14.6 28.4 28.8 34.6 33.7 22.2 26.9 27.2 44.8 27.6 4.5 33.9 16.4 37.3 17.0 18.2 28.4 31.0 23.1 24.0 29.3 54.8 23.6 55.8 16.0 19.1 22.4 40.2 15.6 8.8 8.7 10.8 12.2 17.8 52.8 40.9 33.0 9.2 16.6 8.4 26.5 5.1 43.5 11.1 25.9 39.2 24.3 88.1 21.0 18.2 22.3 15.9 98.4 25.3 10.2 16.9 62.9 13.3 45.4 24.4 37.6 16.2 13.8 44.0 107.5 10.3 12.3 11.6 20.0 56.8 82.8 14.8 176.2 46.8 19.4 56.5 23.4 35.5 58.7 23.5 29.9 29.2 11.5 21.9 0.2 77.0 42.7 11.5 1.3 2.1 1.6 1.2 3.6 0.8 0.5 0.8 0.7 2.6 0.2 0.3 0.6 3.0 3.4 3.0 2.5 1.0 1.2 24.5 27.1 25.1 30.1 25.8 27.5 34.5 36.0 29.9 27.2 33.9 23.1 49.3 38.5 26.0 64.9 14.5 22.8 8.4 14.9 15.4 49.8 27.1 18.0 54.4 20.0 15.8 16.5 0.0 7.1 14.7 39.1 7.9 22.1 47.2 17.9 75.3 49.9 13.8 25.7 23.1 24.1 5.6 36.2 38.7 33.2 50.6 16.8 56.4 9.6 37.9 63.9 16.4 14.5 14.2 34.9 86.0 259.7 28.3 52.4 24.9 46.9 27.2 12.9 4.1 92.5 45.5 19.3 22.5 23.7 14.2 13.0 19.7 8.1 14.7 3.4 19.7 24.7 32.6 1.8 3.2 40.8 23.7 3.6 12.1 14.3 14.8 12.7 ZNF217 ZABC1 ENSG00000171940 "Zinc finger protein 217" O75362 20 53567071-53609907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 129.1;Glandular and luminal cells: 154.8;Squamous epithelial cells: 118.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 148.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051857 Approved Enhanced "Nuclear speckles" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nuclear speckles" "HPA051857: AB_2681641" "unprognostic (4.17e-2)" "unprognostic (4.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (2.49e-3)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.13e-3)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.67e-1)" "unprognostic (2.52e-2)" 15.0 4.2 4.0 20.5 3.8 31.1 22.0 4.0 3.8 17.9 9.6 18.1 12.8 11.8 8.3 13.1 11.1 15.1 5.4 3.2 3.9 11.0 14.5 12.2 29.6 6.0 6.0 9.7 10.1 17.3 4.8 19.0 5.4 16.5 17.5 0.8 18.9 8.2 3.4 16.9 13.5 8.9 4.7 29.2 17.9 22.1 5.9 26.0 10.9 6.4 23.7 21.8 11.6 5.0 28.7 33.4 27.5 40.3 25.1 28.5 60.1 31.3 31.8 34.8 17.1 21.5 31.2 27.5 32.9 38.4 44.9 27.5 22.3 33.0 40.1 19.9 6.3 8.9 14.3 37.8 19.5 14.5 36.7 15.6 31.1 18.6 51.4 27.4 20.1 28.2 19.8 126.9 26.4 113.8 50.1 31.9 29.2 16.2 32.8 38.9 23.0 32.3 20.3 62.8 2.8 7.6 29.2 148.2 30.5 34.6 44.3 60.3 14.2 69.7 25.6 36.0 38.9 52.4 62.4 23.0 25.4 16.0 22.8 9.1 6.1 10.9 3.2 7.4 4.1 5.6 3.4 4.1 4.9 4.3 3.8 3.8 23.3 6.8 15.8 5.0 3.6 3.1 4.0 3.8 4.0 3.8 3.2 3.9 6.0 6.0 5.4 4.7 5.9 5.0 18.7 0.0 8.0 7.5 30.6 129.1 40.3 25.3 71.7 0.6 41.7 22.5 8.2 20.0 26.1 18.4 0.0 16.4 43.7 58.5 9.8 27.5 39.1 76.2 34.4 21.6 6.0 24.4 0.5 16.7 17.7 21.7 42.8 154.8 12.0 24.8 14.6 26.8 16.1 0.0 0.5 32.0 22.4 43.6 52.3 25.9 6.8 39.6 21.4 22.5 43.0 1.8 20.6 3.0 3.4 22.2 39.8 5.3 31.7 65.8 13.8 11.0 30.4 0.5 0.0 13.3 22.7 8.0 23.3 118.8 106.8 45.1 40.5 12.3 24.7 87.1 ZNF225 ENSG00000256294 "Zinc finger protein 225" Q9UK10 19 44112181-44134822 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 9.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 18.1" HPA073778 Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA073778: AB_2686634" "unprognostic (1.52e-1)" "unprognostic (8.99e-2)" "unprognostic (1.36e-1)" "unprognostic (1.65e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-2)" "unprognostic (9.03e-2)" "unprognostic (7.54e-2)" "unprognostic (1.26e-2)" "unprognostic (6.82e-2)" "unprognostic (7.18e-3)" "unprognostic (5.67e-2)" "unprognostic (7.54e-2)" "unprognostic (1.84e-1)" "unprognostic (6.60e-2)" "unprognostic (5.90e-2)" "unprognostic (3.17e-4)" 2.2 3.2 4.3 2.7 5.6 2.3 8.0 5.5 5.3 4.1 4.4 2.5 2.4 3.4 2.5 2.1 3.2 2.8 3.2 4.1 4.9 3.0 2.7 2.7 3.7 4.8 5.0 5.2 1.9 4.5 2.5 3.3 4.7 3.3 2.4 7.0 3.0 3.5 2.5 3.1 2.2 2.5 4.4 4.0 3.0 12.8 4.9 5.3 4.1 2.4 3.9 2.6 2.0 7.0 2.6 4.2 5.4 6.3 7.9 7.0 1.2 4.2 6.4 4.9 6.3 2.6 1.6 1.1 3.2 4.6 2.8 2.2 5.0 3.1 4.3 2.6 4.8 7.7 5.4 2.4 4.6 4.7 6.8 6.6 3.7 4.4 7.1 8.3 4.8 3.4 2.3 1.3 4.2 0.8 3.4 3.3 4.8 1.9 4.3 2.8 7.4 2.5 4.8 5.2 3.2 5.6 7.6 18.1 2.3 5.5 2.0 8.0 4.9 4.5 4.7 2.2 2.8 5.9 3.8 0.8 2.1 2.8 4.1 11.6 3.2 5.2 3.4 4.6 3.3 3.3 2.5 2.6 4.4 5.3 4.7 3.5 0.7 4.4 1.9 2.0 3.8 2.4 4.3 5.6 5.5 5.3 4.1 4.9 4.8 5.0 4.7 4.4 4.9 7.0 1.5 0.0 1.7 3.9 2.7 0.3 0.7 0.5 1.2 4.3 1.3 1.0 1.6 1.5 1.5 1.8 0.0 2.3 6.0 1.0 3.9 1.3 9.7 0.7 1.9 2.0 1.2 4.4 3.4 1.3 1.1 2.1 2.6 0.7 0.0 3.8 2.9 1.8 1.5 6.7 3.4 1.0 0.0 3.5 1.1 2.0 2.8 1.3 0.0 0.0 1.3 3.0 3.1 2.5 5.8 1.3 1.9 1.9 1.4 0.4 1.5 1.2 1.7 4.3 0.0 2.3 1.6 4.1 2.2 0.5 0.4 0.3 2.1 3.4 0.9 0.5 ZNF704 "FLJ16218, Gig1" ENSG00000164684 "Zinc finger protein 704" Q6ZNC4 8 80628451-80874781 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 170.8;Oligodendrocyte precursor cells: 299.6;Oligodendrocytes: 342.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 72.8;RH-30: 46.0;SH-SY5Y: 58.4;SK-BR-3: 72.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024285, HPA024302" Uncertain Approved Nucleoplasm NA NA "Cluster 21: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA024285: AB_2219847, HPA024302: AB_1859427" "unprognostic (5.23e-2)" "unprognostic (1.39e-1)" "unprognostic (2.27e-1)" "unprognostic (3.39e-3)" "unprognostic (6.86e-2)" "unprognostic (1.05e-1)" "unprognostic (1.81e-1)" "unprognostic (1.34e-1)" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (1.26e-1)" "prognostic favorable (4.02e-4)" "unprognostic (1.68e-2)" "unprognostic (1.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.90e-2)" 9.9 5.3 14.6 1.8 18.3 0.7 8.5 27.5 12.0 18.7 0.0 7.3 2.8 16.9 7.2 3.0 13.3 6.3 12.2 12.0 9.7 9.2 3.7 7.5 1.4 14.4 14.4 19.8 20.0 13.8 2.2 5.1 12.8 10.2 6.1 2.5 14.9 8.3 6.5 5.0 4.7 7.2 10.7 3.2 5.2 4.4 14.3 6.9 6.0 7.9 1.1 6.4 7.6 29.9 0.0 2.6 11.5 0.1 0.0 0.0 15.7 0.1 0.0 0.1 0.0 1.3 1.9 0.1 4.5 0.0 0.9 72.8 1.1 2.0 0.0 0.0 12.1 4.3 5.7 9.8 0.0 0.8 0.3 0.4 0.1 0.0 0.3 0.1 4.7 0.6 0.0 0.4 0.1 7.6 11.2 0.2 1.0 6.3 1.1 7.7 46.0 0.2 0.0 25.4 14.5 58.4 2.3 72.2 21.3 3.8 11.6 1.6 0.2 0.0 11.8 0.2 2.5 0.1 0.1 0.3 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.6 18.3 27.5 12.0 12.0 9.7 14.4 14.4 12.8 10.7 14.3 29.9 31.6 51.3 25.9 63.0 0.4 18.5 25.5 4.8 16.5 21.3 28.6 23.4 35.0 21.5 16.5 25.8 0.0 8.8 1.1 20.7 5.9 21.6 20.0 25.5 52.6 21.9 13.8 3.8 112.8 24.5 6.5 40.1 10.7 35.9 27.8 28.7 30.0 10.6 3.2 20.2 170.8 24.7 8.2 5.7 15.7 46.8 32.9 3.6 32.0 56.2 0.0 17.0 0.0 299.6 342.4 9.4 26.5 25.6 0.2 34.7 17.9 18.1 12.8 3.1 13.1 45.1 29.5 1.8 4.2 5.4 5.1 2.9 3.4 60.3 26.2 36.2 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001324-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 44.2" "Cell type enhanced" "Detected in many" "Astrocytes: 38.8;Microglial cells: 149.9;Oligodendrocytes: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 5.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.4;granulocytes: 1.9;monocytes: 5.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Mitochondria Nucleoplasm "HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 3.6 4.3 12.0 14.7 13.0 8.7 5.4 6.4 11.2 6.3 3.1 8.3 9.1 5.3 5.0 17.1 5.2 7.0 10.0 6.9 8.8 5.7 5.3 9.8 10.0 12.2 13.6 4.8 44.2 3.3 4.5 5.7 12.9 7.5 6.9 1.2 9.6 4.3 33.4 12.6 8.0 3.4 10.4 14.2 10.2 1.7 12.4 5.6 6.2 1.5 6.5 7.7 9.2 11.5 9.2 10.7 20.1 7.6 2.7 4.0 10.5 9.4 8.8 6.8 8.6 7.7 8.3 9.3 4.3 9.1 6.4 6.2 5.1 13.5 3.8 6.0 9.4 17.1 4.6 13.1 5.5 5.0 25.6 6.6 7.2 14.6 7.9 3.2 11.8 10.0 5.8 6.2 2.6 23.7 11.1 13.9 15.8 11.3 6.9 13.5 4.5 10.2 2.7 11.4 18.3 12.3 12.5 44.8 6.4 5.2 9.6 17.2 17.1 13.9 6.8 4.2 7.4 5.0 2.7 9.0 10.6 14.6 7.4 0.0 1.6 1.2 0.2 3.5 0.2 0.1 0.1 0.2 1.2 0.1 0.4 0.4 1.9 0.2 5.7 1.4 0.5 0.7 12.0 13.0 6.4 11.2 6.9 8.8 12.2 13.6 12.9 10.4 12.4 11.5 1.7 3.2 8.2 38.8 2.7 5.4 4.7 2.8 1.8 1.4 7.1 3.6 12.1 4.3 6.3 11.0 2.1 2.3 6.8 7.7 0.0 3.6 0.8 4.0 4.1 4.3 4.8 2.5 10.2 6.1 3.0 3.1 7.1 6.2 1.3 2.1 5.7 1.6 11.6 3.3 12.0 8.1 0.0 15.8 33.5 5.5 2.5 15.7 1.8 149.9 13.3 1.4 2.1 22.1 36.4 10.1 11.5 3.0 3.8 8.5 2.3 0.8 3.6 0.9 6.6 1.6 3.0 0.3 2.5 4.3 7.5 2.3 2.5 2.0 6.5 13.7 ZNF800 ENSG00000048405 "Zinc finger protein 800" Q2TB10 7 127346790-127431924 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 74.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023090, HPA052194" Approved Supported "Nucleoli,Nucleoli rim,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 59: Non-specific - Transcription" "Nucleoli, Nucleoli rim" Cytosol "HPA023090: AB_1859457, HPA052194: AB_2681757" "unprognostic (2.93e-2)" "unprognostic (1.10e-1)" "unprognostic (2.27e-1)" "unprognostic (3.34e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-2)" "unprognostic (6.19e-2)" "unprognostic (2.45e-2)" "unprognostic (1.23e-3)" "unprognostic (1.37e-1)" "unprognostic (9.43e-2)" "unprognostic (8.99e-2)" "unprognostic (7.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.08e-1)" "unprognostic (2.53e-2)" "unprognostic (8.96e-3)" 10.7 7.2 5.7 11.6 7.3 74.6 12.0 20.2 5.0 8.4 1.4 10.8 10.4 9.6 7.9 12.5 7.8 11.3 6.0 2.9 4.4 8.2 14.7 10.2 16.6 5.4 6.3 10.3 12.5 11.3 3.5 9.2 5.9 9.3 10.1 9.9 8.2 7.7 5.7 10.6 10.7 9.5 5.9 13.2 11.4 20.6 6.3 13.2 11.0 7.2 14.3 10.5 5.5 7.9 16.0 8.4 9.5 16.5 13.5 17.3 9.2 14.9 17.5 15.1 14.6 7.8 15.0 27.1 9.0 14.6 16.3 11.1 15.7 15.6 20.9 23.9 9.5 17.7 8.5 7.1 16.9 24.2 32.3 15.4 14.9 16.2 22.0 12.5 16.5 16.3 22.3 27.0 16.9 12.4 26.5 17.2 7.9 14.5 10.8 16.7 13.3 18.0 11.0 19.8 13.6 13.9 14.8 58.7 19.8 12.9 7.0 16.3 18.0 25.0 8.0 17.2 18.1 31.7 15.2 39.0 18.8 21.5 21.8 22.1 8.7 13.6 16.1 8.0 16.3 15.4 11.8 16.5 9.0 17.3 19.2 21.0 7.5 25.0 9.0 15.3 18.6 8.0 5.7 7.3 20.2 5.0 2.9 4.4 5.4 6.3 5.9 5.9 6.3 7.9 49.0 38.5 23.5 27.7 65.1 44.7 51.7 14.7 52.3 29.0 28.3 20.6 16.8 11.5 20.1 12.9 22.9 12.0 70.5 30.2 11.7 24.1 44.8 22.2 30.8 37.2 16.2 52.0 46.4 19.2 14.0 32.0 40.2 26.3 29.2 26.3 26.7 17.5 14.4 77.4 35.5 29.3 8.2 25.3 34.1 11.3 27.1 41.7 28.4 45.9 37.9 17.5 79.3 41.7 71.8 24.5 22.0 31.6 57.8 48.3 26.8 13.3 18.3 27.9 26.3 54.9 30.1 111.9 39.9 44.4 47.9 22.0 65.5 30.1 25.5 68.5 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane, Cytosol" "HPA041147: AB_2677329, HPA046751: AB_2679785" "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 3.0 4.1 2.7 3.7 2.6 6.0 3.5 4.6 2.9 3.1 2.7 4.1 4.6 3.4 3.5 3.5 4.2 3.2 4.9 2.7 2.5 3.6 1.9 3.3 5.0 2.6 2.7 5.8 4.2 4.9 1.1 4.0 2.5 4.1 3.5 8.2 4.9 3.4 15.9 6.5 4.4 3.5 1.9 4.6 4.3 3.8 2.9 3.9 4.5 5.1 4.9 3.4 1.4 3.1 7.2 8.6 6.4 7.8 11.2 6.3 6.5 4.8 5.9 10.2 9.3 19.5 8.4 8.4 13.9 6.7 11.2 17.0 10.1 12.9 7.7 3.4 6.1 10.7 11.5 14.0 6.8 9.2 10.9 9.2 10.6 8.6 8.2 7.8 7.9 7.3 9.8 6.7 6.0 20.8 10.0 7.9 3.6 8.1 9.7 7.8 9.1 6.0 6.7 10.1 8.6 5.5 16.2 24.0 5.8 5.7 14.6 7.2 7.0 11.5 7.3 6.4 7.0 6.6 5.0 8.2 9.2 6.8 6.0 2.4 1.4 3.6 0.5 1.8 0.3 2.4 1.7 0.7 0.7 2.2 2.3 2.1 1.6 0.6 1.8 2.2 1.4 0.8 2.7 2.6 4.6 2.9 2.7 2.5 2.6 2.7 2.5 1.9 2.9 3.1 0.8 3.2 2.7 0.7 1.4 1.1 2.4 2.4 2.2 3.0 0.8 0.5 5.7 4.3 1.2 0.0 0.0 2.9 0.3 4.2 3.9 2.4 0.6 1.1 1.7 1.7 2.4 4.4 0.8 3.8 2.8 1.9 4.1 1.5 3.8 2.5 2.5 2.1 1.7 6.7 0.9 2.8 2.0 1.4 1.9 0.7 3.4 0.7 0.0 0.0 1.8 1.6 1.0 0.0 0.8 3.3 3.7 1.5 0.5 1.6 2.4 1.2 0.4 3.8 0.0 2.0 1.8 1.0 2.0 1.4 1.6 2.3 1.8 3.6 3.0 2.0